Single nucleotide polymorphisms in genes

Abstract

The invention provides nucleic acid segments of the human genome, particularly nucleic acid segments from a gene, including polymorphic sites. Allele-specific primers and probes hybridizing to regions flanking or containing these sites are also provided. The nucleic acids, primers and probes are used in applications such as phenotype correlations, forensics, paternity testing, medicine and genetic analysis. A role for the thrombospondin gene(s) in vascular disease is also disclosed. Use of single nucleotide polymorphisms in the thrombospondin gene(s) for diagnosis, prediction of clinical course and treatment response, development of therapeutics and development of cell-culture-based and animal models for research and treatment are disclosed.

Description

BACKGROUND OF THE INVENTION

The genomes of all organisms undergo spontaneous mutation in the course of their continuing evolution, generating variant forms of progenitor nucleic acid sequences (Gusella, Ann. Rev. Biochem . 55, 831-854 (1986)). The variant form may confer an evolutionary advantage or disadvantage relative to a progenitor form, or may be neutral. In some instances, a variant form confers a lethal disadvantage and is not transmitted to subsequent generations of the organism. In other instances, a variant form confers an evolutionary advantage to the species and is eventually incorporated into the DNA of many or most members of the species and effectively becomes the progenitor form. In many instances, both progenitor and variant form(s) survive and co-exist in a species population. The coexistence of multiple forms of a sequence gives rise to polymorphisms.

Several different types of polymorphism have been reported. A restriction fragment length polymorphism (RFLP) is a variation in DNA sequence that alters the length of a restriction fragment (Botstein et al., Am. J. Hum. Genet . 32, 314-331 (1980)). The restriction fragment length polymorphism may create or delete a restriction site, thus changing the length of the restriction fragment. RFLPs have been widely used in human and animal genetic analyses (see WO 90/13668; WO90/11369; Donis-Keller, Cell 51, 319-337 (1987); Lander et al., Genetics 121, 85-99 (1989)). When a heritable trait can be linked to a particular RFLP, the presence of the RFLP in an individual can be used to predict the likelihood that the animal will also exhibit the trait.

Other polymorphisms take the form of short tandem repeats (STRs) that include tandem di-, tri- and tetra-nucleotide repeated motifs. These tandem repeats are also referred to as variable number tandem repeat (VNTR) polymorphisms. VNTRs have been used in identity and paternity analysis (U.S. Pat. No. 5,075,217; Armour et al., FEBS Lett . 307, 113-115 (1992); Horn et al., WO 91/14003; Jeffreys, EP 370,719), and in a large number of genetic mapping studies.

Other polymorphisms take the form of single nucleotide variations between individuals of the same species. Such polymorphisms are far more frequent than RFLPs, STRs and VNTRs. Some single nucleotide polymorphisms (SNP) occur in protein-coding nucleic acid sequences (coding sequence SNP (cSNP)), in which case, one of the polymorphic forms may give rise to the expression of a defective or otherwise variant protein and, potentially, a genetic disease. Examples of genes in which polymorphisms within coding sequences give rise to genetic disease include β-globin (sickle cell anemia), apoE4 (Alzheimer's Disease), Factor V Leiden (thrombosis), and CFTR (cystic fibrosis). cSNPs can alter the codon sequence of the gene and therefore specify an alternative amino acid. Such changes are called “missense” when another amino acid is substituted, and “nonsense” when the alternative codon specifies a stop signal in protein translation. When the cSNP does not alter the amino acid specified the cSNP is called “silent”.

Other single nucleotide polymorphisms occur in noncoding regions. Some of these polymorphisms may also result in defective protein expression (e.g., as a result of defective splicing). Other single nucleotide polymorphisms have no phenotypic effects.

Single nucleotide polymorphisms can be used in the same manner as RFLPs and VNTRs, but offer several advantages. Single nucleotide polymorphisms occur with greater frequency and are spaced more uniformly throughout the genome than other forms of polymorphism. The greater frequency and uniformity of single nucleotide polymorphisms means that there is a greater probability that such a polymorphism will be found in close proximity to a genetic locus of interest than would be the case for other polymorphisms. The different forms of characterized single nucleotide polymorphisms are often easier to distinguish than other types of polymorphism (e.g., by use of assays employing allele-specific hybridization probes or primers).

Only a small percentage of the total repository of polymorphisms in humans and other organisms has been identified. The limited number of polymorphisms identified to date is due to the large amount of work required for their detection by conventional methods. For example, a conventional approach to identifying polymorphisms might be to sequence the same stretch of DNA in a population of individuals by dideoxy sequencing. In this type of approach, the amount of work increases in proportion to both the length of sequence and the number of individuals in a population and becomes impractical for large stretches of DNA or large numbers of persons.

SUMMARY OF THE INVENTION

Work described herein pertains to the identification of polymorphisms which can predispose individuals to disease, by resequencing large numbers of genes in a large number of individuals. Various genes from a number of individuals have been resequenced as described herein, and SNPs in these genes have been discovered (see the Table and FIG. 3 ). Some of these SNPs are cSNPs which specify a different amino acid sequence, some of the SNPs are silent cSNPs and some of these cSNPs specify a stop signal in protein translation. Some of the identified SNPs were located in non-coding regions.

The invention relates to a gene which comprises a single nucleotide polymorphism at a specific location. In a particular embodiment the invention relates to the variant allele of a gene having a single nucleotide polymorphism, which variant allele differs from a reference allele by one nucleotide at the site(s) identified in the Table and FIG. 3 . Complements of these nucleic acid sequences are also included. The nucleic acid molecules can be DNA or RNA, and can be double- or single-stranded. Nucleic acid molecules can be, for example, 5-10, 5-15, 10-20, 5-25, 10-30, 10-50 or 10-100 bases long.

The invention further provides allele-specific oligonucleotides that hybridize to the reference or variant allele of a gene comprising a single nucleotide polymorphism or to the complement thereof. These oligonucleotides can be probes or primers.

The invention further provides a method of analyzing a nucleic acid from an individual. The method determines which base is present at any one of the polymorphic sites shown in the Table and/or FIG. 3 . Optionally, a set of bases occupying a set of the polymorphic sites shown in the Table and/or FIG. 3 is determined. This type of analysis can be performed on a number of individuals, who are tested for the presence of a disease phenotype. The presence or absence of disease phenotype is then correlated with a base or set of bases present at the polymorphic site or sites in the individuals tested.

Thus, the invention further relates to a method of predicting the presence, absence, likelihood of the presence or absence, or severity of a particular phenotype or disorder associated with a particular genotype. The method comprises obtaining a nucleic acid sample from an individual and determining the identity of one or more bases (nucleotides) at polymorphic sites of genes described herein, wherein the presence of a particular base is correlated with a specified phenotype or disorder, thereby predicting the presence, absence, likelihood of the presence or absence, or severity of the phenotype or disorder in the individual.

The thrombospondins are a family of extracellular matrix (ECM) glycoproteins that modulate many cell behaviors including adhesion, migration, and proliferation. Thrombospondins (also known as thrombin sensitive proteins or TSPs) are large molecular weight glycoproteins composed of three identical disulfide-linked polypeptide chains. The results described herein also reveal an important association between alterations, particularly SNPs, in TSP genes, particularly TSP-1 and TSP-4, and vascular disease. In particular, SNPs in these genes which are associated with premature coronary artery disease (CAD)(or coronary heart disease) and myocardial infarction (MI) have been identified and represent a potentially vital marker of upstream biology influencing the complex process of atherosclerotic plaque generation and vulnerability.

Thus, the invention relates to the TSP gene SNPs identified as described herein, both singly and in combination, as well as to the use of these SNPs, and others in TSP genes, particularly those nearby in linkage disequilibrium with these SNPs, for diagnosis, prediction of clinical course and treatment response for vascular disease, development of new treatments for vascular disease based upon comparison of the variant and normal versions of the gene or gene product, and development of cell-culture based and animal models for research and treatment of vascular disease. The invention further relates to novel compounds and pharmaceutical compositions for use in the diagnosis and treatment of such disorders. In preferred embodiments, the vascular disease is CAD or MI.

The invention relates to isolated nucleic acid molecules comprising all or a portion of the variant allele of TSP-1 (e.g., as exemplified by SEQ ID NO: 1), and to isolated nucleic acid molecules comprising all or a portion of the variant allele of TSP-4 (e.g., as exemplified by SEQ ID NO: 3). Preferred portions are at least 10 contiguous nucleotides and comprise the polymorphic site, e.g., a portion of SEQ ID NO: 1 which is at least 10 contiguous nucleotides and comprises the “G” at position 2210, or a portion of SEQ ID NO: 3 which is at least 10 contiguous nucleotides and comprises the “C” at position 1186. The invention further relates to isolated gene products, e.g., polypeptides or proteins, which are encoded by a nucleic acid molecule comprising all or a portion of the variant allele of TSP-1 or TSP-4 (e.g., SEQ ID NO: 1 or SEQ ID NO: 3, respectively). The invention also relates to nucleic acid molecules which hybridize to and/or share identity with the variant alleles identified herein (or their complements) and which also comprise the variant nucleotide at the SNP site.

The invention further relates to isolated proteins or polypeptides comprising all or a portion of the variant amino acid-sequence of TSP-1 (e.g., as exemplified by SEQ ID NO: 2), and to isolated proteins or polypeptides comprising all or a portion of the variant amino acid sequence of TSP-4 (e.g., as exemplified by SEQ ID NO: 4). Preferred polypeptides are at least 10 contiguous amino acids and comprise the polymorphic amino acid, e.g., a portion of SEQ ID NO: 2 which is at least 10 contiguous amino acids and comprises the serine at residue 700, or a portion of SEQ ID NO: 4 which is at least 10 contiguous amino acids and comprises the proline at residue 387. The invention further relates to isolated nucleic acid molecules encoding such proteins and polypeptides, as well as to antibodies which bind, e.g., specifically, to such proteins and polypeptides.

The invention further relates to a method of diagnosing or aiding in the diagnosis of a disorder associated with the presence of one or more of (a) a G at nucleotide position 2210 of SEQ ID NO: 1; or (b) a C at nucleotide position 1186 of SEQ ID NO: 3 in an individual. The method comprises obtaining a nucleic acid sample from the individual and determining the nucleotide present at one or more of the indicated nucleotide positions, wherein presence of one or more of (a) a G at nucleotide position 2210 of SEQ ID NO: 1; or (b) a C at nucleotide position 1186 of SEQ ID NO: 3 is indicative of increased likelihood of said disorder in the individual as compared with an appropriate control, e.g., an individual having the reference nucleotide at one or more of said positions. In a particular embodiment the disorder is a vascular disease selected from the group consisting of atherosclerosis, coronary heart or artery disease, MI, stroke, peripheral vascular diseases, venous thromboembolism and pulmonary embolism. In a preferred embodiment, the vascular disease is selected from the group consisting of CAD and M.

The invention further relates to a method of diagnosing or aiding in the diagnosis of a disorder associated with one or more of (a) a G at nucleotide position 2210 of SEQ ID NO: 1; or (b) a C at nucleotide position 1186 of SEQ ID NO: 3 in an individual. The method comprises obtaining a nucleic acid sample from the individual and determining the nucleotide present at one or more of the indicated nucleotide positions, wherein presence of one or more of (a) an A at nucleotide position 2210 of SEQ ID NO: 1; or (b) a G at nucleotide position 1186 of SEQ ID NO: 3 is indicative of decreased likelihood of said disorder in the individual as compared with an appropriate control, e.g., an individual having the variant nucleotide at said position. In a particular embodiment the disorder is a vascular disease selected from the group consisting of atherosclerosis, coronary heart or artery disease, MI, stroke, peripheral vascular diseases, venous thromboembolism and pulmonary embolism. In a preferred embodiment, the vascular disease is selected from the group consisting of CAD and MI.

In one embodiment, the invention relates to a method for predicting the likelihood that an individual will have a vascular disease (or aiding in the diagnosis of a vascular disease), comprising the steps of obtaining a DNA sample from an individual to be assessed and determining the nucleotide present at one or more of nucleotide positions 2210 of SEQ ID NO: 1 or 1186 of SEQ ID NO: 3. The presence of the reference nucleotide at one or more of these positions indicates that the individual has a lower likelihood of having a vascular disease than an individual having the variant nucleotide at one or more of these positions, or a lower likelihood of having severe symptomology. In a particular embodiment, the individual is an individual at risk for development of a vascular disease.

The invention further relates to a method of diagnosing or aiding in the diagnosis of a disorder associated with the presence of one or more of (a) a serine at amino acid position 700 of SEQ ID NO: 2; or (b) a proline at amino acid position 387 of SEQ ID NO: 4 in an individual. The method comprises obtaining a biological sample containing the TSP-1 and/or TSP-4 protein or relevant portion thereof from the individual and determining the amino acid present at one or more of the indicated amino acid positions, wherein presence of one or more of (a) a serine at amino acid position 700 of SEQ ID NO: 2; or (b) a proline at amino acid position 387 of SEQ ID NO: 4 is indicative of increased likelihood of said disorder in the individual as compared with an appropriate control, e.g., an individual having the reference amino acid at one or more of said positions.

The invention further relates to a method of diagnosing or aiding in the diagnosis of a disorder associated with one or more of (a) a serine at amino acid position 700 of SEQ ID NO: 2; or (b) a proline at amino acid position 387 of SEQ ID NO: 4 in an individual. The method comprises obtaining a biological sample containing the TSP-1 and/or TSP-4 protein or relevant portion thereof from the individual and determining the amino acid present at one or more of the indicated amino acid positions, wherein presence of one or more of (a) an asparagine at amino acid position 700 of SEQ ID NO: 2; or (b) an alanine at amino acid position 387 of SEQ ID NO: 4 is indicative of decreased likelihood of said disorder in the individual as compared with an appropriate control, e.g., an individual having the variant amino acid at one or more of said positions.

In one embodiment, the invention relates to a method for predicting the likelihood that an individual will have a vascular disease (or aiding in the diagnosis of a vascular disease), comprising the steps of obtaining a biological sample comprising the TSP-1 and/or TSP-4 protein or relevant portion thereof from an individual to be assessed and determining the amino acid present at one or more of amino acid positions 700 of SEQ ID NO: 2 or 387 of SEQ ID NO: 4. The presence of the reference amino acid at one or more of these positions indicates that the individual has a lower likelihood of having a vascular disease than an individual having the variant amino acid at one or more of these positions, or a lower likelihood of having severe symptomology. In a particular embodiment, the individual is an individual at risk for development of a vascular disease.

In another embodiment, the invention relates to pharmaceutical compositions comprising a reference TSP-1 and/or TSP-4 gene or gene product, or active portion thereof, for use in the treatment of vascular diseases. The invention further relates to the use of agonists and antagonists of TSP-1 and TSP-4 activity for use in the treatment of vascular diseases. In a particular embodiment the vascular disease is selected from the group consisting of atherosclerosis, coronary heart or artery disease, MI, stroke, peripheral vascular diseases, venous thromboembolism and pulmonary embolism. In a preferred embodiment, the vascular disease is selected from the group consisting of CAD and MI.

BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1A-1D show the reference nucleotide (SEQ ID NO: 1) and amino acid (SEQ ID NO: 2) sequences for TSP-1.

FIGS. 2A-2C show the reference nucleotide (SEQ ID NO: 3) and amino acid (SEQ ID NO: 4) sequences for TSP4.

FIG. 3 shows a table providing detailed information about the SNPs identified herein. Column one shows the internal polymorphism identifier. Column two shows the accession number for the reference sequence in the TIGR database which can be found on the world wide web at tigr.org/tdb/hgi/searching/hgi_reports.html. Column three shows the nucleotide position for the SNP site. Column four shows the gene in which the polymorphism was identified. Column five shows the polymorphic site and additional flanking sequence on each side of the polymorphism. Column six shows the type of mutation produced by the polymorphism. Columns seven and eight show the reference and alternate (variant) nucleotides, respectively, for the SNP. Columns nine and ten show the reference and alternate (variant) amino acids, respectively, encoded by the alleles of the gene.

DETAILED DESCRIPTION OF THE INVENTION

The present invention relates to a gene which comprises a single nucleotide polymorphism (SNP) at a specific location. The gene which includes the SNP has at least two alleles, referred to herein as the reference allele and the variant allele. The reference allele (prototypical or wild type allele) has been designated arbitrarily and typically corresponds to the nucleotide sequence of the gene which has been deposited with GenBank or TIGR under a given Accession number. The variant allele differs from the reference allele by one nucleotide at the site(s) identified in the Table. The present invention also relates to variant alleles of the described genes and to complements of the variant alleles. The invention also relates to nucleic acid molecules which hybridize to and/or share identity with the variant alleles identified herein (or their complements) and which also comprise the variant nucleotide at the SNP site.

The invention further relates to portions of the variant alleles and portions of complements of the variant alleles which comprise (encompass) the site of the SNP and are at least 5 nucleotides in length. Portions can be, for example, 5-10, 5-15, 10-20, 5-25, 10-30, 10-50 or 10-100 bases long. For example, a portion of a variant allele which is 21 nucleotides in length includes the single nucleotide polymorphism (the nucleotide which differs from the reference allele at that site) and twenty additional nucleotides which flank the site in the variant allele. These nucleotides can be on one or both sides of the polymorphism. Polymorphisms which are the subject of this invention are defined in the Table with respect to the reference sequence deposited in GenBank or TIGR under the Accession number indicated. For example, the invention relates to a portion of a gene (e.g., AT3) having a nucleotide sequence as deposited in GenBank (e.g., U11270) comprising a single nucleotide polymorphism at a specific position (e.g., nucleotide 11918). The reference nucleotide for AT3 is shown in column 8, and the variant nucleotide is shown in column 9 of the Table. The nucleotide sequences of the invention can be double- or single-stranded.

The invention further provides allele-specific oligonucleotides that hybridize to the reference or variant allele of a gene comprising a single nucleotide polymorphism or to the complement thereof. These oligonucleotides can be probes or primers.

The invention further provides a method of analyzing a nucleic acid from an individual. The method determines which base is present at any one of the polymorphic sites shown in the Table and/or FIG. 3 . Optionally, a set of bases occupying a set of the polymorphic sites shown in the Table and/or FIG. 3 is determined. This type of analysis can be performed on a number of individuals, who are tested for the presence of a disease phenotype. The presence or absence of disease phenotype is then correlated with a base or set of bases present at the polymorphic site or sites in the individuals tested.

Thus, the invention further relates to a method of predicting the presence, absence, likelihood of the presence or absence, or severity of a particular phenotype or disorder associated with a particular genotype. The method comprises obtaining a nucleic acid sample from an individual and determining the identity of one or more bases (nucleotides) at polymorphic sites of genes described herein, wherein the presence of a particular base is correlated with a specified phenotype or disorder, thereby predicting the presence, absence, likelihood of the presence or absence, or severity of the phenotype or disorder in the individual.

DEFINITIONS

A nucleic acid molecule or oligonucleotide can be DNA or RNA, and single- or double-stranded. Nucleic acid molecules and oligonucleotides can be naturally occurring or synthetic, but are typically prepared by synthetic means. Preferred nucleic acid molecules and oligonucleotides of the invention include segments of DNA, or their complements, which include any one of the polymorphic sites shown in the Table. The segments can be between 5 and 250 bases, and, in specific embodiments, are between 5-10, 5-20, 10-20, 10-50, 20-50 or 10-100bases. For example, the segment can be 21 bases. The polymorphic site can occur within any position of the segment. The segments can be from any of the allelic forms of DNA shown in the Table.

As used herein, the terms “nucleotide”, “base” and “nucleic acid” are intended to be equivalent. The terms “nucleotide sequence”, “nucleic acid sequence”, “nucleic acid molecule” and “segment” are intended to be equivalent.

Hybridization probes are oligonucleotides which bind in a base-specific manner to a complementary strand of nucleic acid. Such probes include peptide nucleic acids, as described in Nielsen et al., Science 254, 1497-1500 (1991). Probes can be any length suitable for specific hybridization to the target nucleic acid sequence. The most appropriate length of the probe may vary depending upon the hybridization method in which it is being used; for example, particular lengths may be more appropriate for use in microfabricated arrays, while other lengths may be more suitable for use in classical hybridization methods. Such optimizations are known to the skilled artisan. Suitable probes and primers can range from about 5 nucleotides to about 30 nucleotides in length. For example, probes and primers can be 5, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 25, 26, 28 or 30 nucleotides in length. The probe or primer preferably overlaps at least one polymorphic site occupied by any of the possible variant nucleotides. The nucleotide sequence can correspond to the coding sequence of the allele or to the complement of the coding sequence of the allele.

As used herein, the term “primer” refers to a single-stranded oligonucleotide which acts as a point of initiation of template-directed DNA synthesis under appropriate conditions (e.g., in the presence of four different nucleoside triphosphates and an agent for polymerization, such as DNA or RNA polymerase or reverse transcriptase) in an appropriate buffer and at a suitable temperature. The appropriate length of a primer depends on the intended use of the primer, but typically ranges from 15 to 30 nucleotides. Short primer molecules generally require cooler temperatures to form sufficiently stable hybrid complexes with the template. A primer need not reflect the exact sequence of the template, but must be sufficiently complementary to hybridize with a template. The term primer site refers to the area of the target DNA to which a primer hybridizes. The term primer pair refers to a set of primers including a 5′ (upstream) primer that hybridizes with the 5′ end of the DNA sequence to be amplified and a 3′ (downstream) primer that hybridizes with the complement of the 3′ end of the sequence to be amplified.

As used herein, linkage describes the tendency of genes, alleles, loci or genetic markers to be inherited together as a result of their location on the same chromosome. It can be measured by percent recombination between the two genes, alleles, loci or genetic markers.

As used herein, polymorphism refers to the occurrence of two or more genetically determined alternative sequences or alleles in a population. A polymorphic marker or site is the locus at which divergence occurs. Preferred markers have at least two alleles, each occurring at frequency of greater than 1%, and more preferably greater than 10% or 20% of a selected population. A polymorphic locus may be as small as one base pair. Polymorphic markers include restriction fragment length polymorphisms, variable number of tandem repeats (VNTR's), hypervariable regions, minisatellites, dinucleotide repeats, trinucleotide repeats, tetranucleotide repeats, simple sequence repeats, and insertion elements such as Alu. The first identified allelic form is arbitrarily designated as the reference form and other allelic forms are designated as alternative or variant alleles. The allelic form occurring most frequently in a selected population is sometimes referred to as the wildtype form. Diploid organisms may be homozygous or heterozygous for allelic forms. A dialleic or biallelic polymorphism has two forms. A triallelic polymorphism has three forms.

Work described herein pertains to the resequencing of large numbers of genes in a large number of individuals to identify polymorphisms which can predispose individuals to disease. For example, polymorphisms in genes which are expressed in liver may predispose individuals to disorders of the liver. By altering amino acid sequence, SNPs may alter the function of the encoded proteins. The discovery of the SNP facilitates biochemical analysis of the variants and the development of assays to characterize the variants and to screen for pharmaceutical that would interact directly with on or another form of the protein. SNPs (including silent SNPs) also enable the development of specific DNA, RNA, or protein-based diagnostics that detect the presence or absence of the polymorphism in particular conditions.

A single nucleotide polymorphism occurs at a polymorphic site occupied by a single nucleotide, which is the site of variation between allelic sequences. The site is usually preceded by and followed by highly conserved sequences of the allele (e.g., sequences that vary in less than 1/100 or 1/1000 members of the populations).

A single nucleotide polymorphism usually arises due to substitution of one nucleotide for another at the polymorphic site. A transition is the replacement of one purine by another purine or one pyrimidine by another pyrimidine. A transversion is the replacement of a purine by a pyrimidine or vice versa. Single nucleotide polymorphisms can also arise from a deletion of a nucleotide or an insertion of a nucleotide relative to a reference allele. Typically the polymorphic site is occupied by a base other than the reference base. For example, where the reference allele contains the base “T” at the polymorphic site, the altered allele can contain a “C”, “G” or “A” at the polymorphic site.

The invention also relates to nucleic acid molecules which hybridize to the variant alleles identified herein (or their complements) and which also comprise the variant nucleotide at the SNP site. Hybridizations are usually performed under stringent conditions, for example, at a salt concentration of no more than 1 M and a temperature of at least 25° C. For example, conditions of 5×SSPE (750 mM NaCl, 50 mM NaPhosphate, 5 mM EDTA, pH 7.4) and a temperature of 25-30° C., or equivalent conditions, are suitable for allele-specific probe hybridizations. Equivalent conditions can be determined by varying one or more of the parameters given as an example, as known in the art, while maintaining a similar degree of identity or similarity between the target nucleotide sequence and the primer or probe used.

The invention also relates to nucleic acid molecules which share substantial sequence identity to the variant alleles identified herein (or their complements) and which also comprise the variant nucleotide at the SNP site. Particularly preferred are nucleic acid molecules and fragments which have at least about 60%, preferably at least about 70, 80 or 85%, more preferably at least about 90%, even more preferably at least about 95%, and most preferably at least about 98% identity with nucleic acid molecules described herein. The percent identity of two nucleotide or amino acid sequences can be determined by aligning the sequences for optimal comparison purposes (e.g., can be introduced in the sequence of a first sequence). The nucleotides or amino acids at corresponding positions are then compared, and the percent identity between the two sequences is a function of the number of identical positions shared by the sequences (i.e., % identity=# of identical positions/total # of positions×100). In certain embodiments, the length of a sequence aligned for comparison purposes is at least 30%, preferably at least 40%, more preferably at least 60%, and even more preferably at least 70%, 80% or 90% of the length of the reference sequence. The actual comparison of the two sequences can be accomplished by well-known methods, for example, using a mathematical algorithm. A preferred, non-limiting example of such a mathematical algorithm is described in Karlin et al., Proc. Natl. Acad. Sci. USA, 90:5873-5877 (1993). Such an algorithm is incorporated into the NBLAST and XBLAST programs (version 2.0) as described in Altschul et al., Nucleic Acids Res., 25:389-3402 (1997). When utilizing BLAST and Gapped BLAST programs, the default parameters of the respective programs (e.g., NBLAST) can be used. See the world wide web at ncbi.nlm.nih.gov. In one embodiment, parameters for sequence comparison can be set at score=100, wordlength=12, or can be varied (e.g., W=5 or W=20).

The term “isolated” is used herein to indicate that the material in question exists in a physical milieu distinct from that in which it occurs in nature. For example, an isolated nucleic acid of the invention may be substantially isolated with respect to the complex cellular milieu in which it naturally occurs. In some instances, the isolated material will form part of a composition (for example, a crude extract containing other substances), buffer system or reagent mix. In other circumstance, the material may be purified to essential homogeneity, for example as determined by PAGE or column chromatography such as HPLC. Preferably, an isolated nucleic acid comprises at least about 50, 80 or 90 percent (on a molar basis) of all macromolecular species present.

I. Novel Polymorphisms of the Invention

Some of the novel polymorphisms of the invention are shown in the Table. Columns one and two show designations for the indicated polymorphism. Column three shows the Genbank or TIGR Accession number for the wild type (or reference) allele. Column four shows the location of the polymorphic site in the nucleic acid sequence with reference to the Genbank or TIGR sequence shown in column three. Column five shows common names for the gene in which the polymorphism is located. Column six shows the polymorphism and a portion of the 3′ and 5′ flanking sequence of the gene. Column seven shows the type of mutation; N, non-sense, S, silent, M, missense. Columns eight and nine show the reference and alternate nucleotides, respectively, at the polymorphic site. Columns ten and eleven show the reference and alternate amino acids, respectively, encoded by the reference and variant, respectively, alleles. Other novel polymorphisms of the invention are shown in FIG. 3 .

II. Analysis of Polymorphisms

A. Preparation of Samples

Polymorphisms are detected in a target nucleic acid from an individual being analyzed. For assay of genomic DNA, virtually any biological sample (other than pure red blood cells) is suitable. For example, convenient tissue samples include whole blood, semen, saliva, tears, urine, fecal material, sweat, buccal, skin and hair. For assay of cDNA or mRNA, the tissue sample must be obtained from an organ in which the target nucleic acid is expressed. For example, if the target nucleic acid is a cytochrome P450, the liver is a suitable source.

Many of the methods described below require amplification of DNA from target samples. This can be accomplished by e.g., PCR. See generally PCR Technology: Principles and Applications for DNA Amplification (ed. H. A. Erlich, Freeman Press, NY, N.Y., 1992); PCR Protocols: A Guide to Methods and Applications (eds. Innis, et al., Academic Press, San Diego, Calif., 1990); Mattila et al., Nucleic Acids Res . 19, 4967 (1991); Eckert et a., PCR Methods and Applications 1, 17 (1991); PCR (eds. McPherson et al., IRL Press, Oxford); and U.S. Pat. No. 4,683,202.

Other suitable amplification methods include the ligase chain reaction (LCR) (see Wu and Wallace, Genomics 4, 560 (1989), Landegren et al., Science 241, 1077 (1988), transcription amplification (Kwoh et al., Proc. Natl. Acad. Sci. USA 86, 1173 (1989)), and self-sustained sequence replication (Guatelli et al., Proc. Nat. Acad. Sci. USA , 87, 1874 (1990)) and nucleic acid based sequence amplification (NASBA). The latter two amplification methods involve isothermal reactions based on isothermal transcription, which produce both single stranded RNA (ssRNA) and double stranded DNA (dsDNA) as the amplification products in a ratio of about 30 or 100 to 1, respectively.

B. Detection of Polymorphisms in Target DNA

There are two distinct types of analysis of target DNA for detecting polymorphisms. The first type of analysis, sometimes referred to as de novo characterization, is carried out to identify polymorphic sites not previously characterized (i.e., to identify new polymorphisms). This analysis compares target sequences in different individuals to identify points of variation, i.e., polymorphic sites. By analyzing groups of individuals representing the greatest ethnic diversity among humans and greatest breed and species variety in plants and animals, patterns characteristic of the most common alleles/haplotypes of the locus can be identified, and the frequencies of such alleles/haplotypes in the population can be determined. Additional allelic frequencies can be determined for subpopulations characterized by criteria such as geography, race, or gender. The de novo identification of polymorphisms of the invention is described in the Examples section. The second type of analysis determines which form(s) of a characterized (known) polymorphism are present in individuals under test. There are a variety of suitable procedures, which are discussed in turn.

1. Allele-Specific Probes

The design and use of allele-specific probes for analyzing polymorphisms is described by e.g., Saiki et al., Nature 324, 163-166 (1986); Dattagupta, EP 235,726, Saiki, WO 89/11548. Allele-specific probes can be designed that hybridize to a segment of target DNA from one individual but do not hybridize to the corresponding segment from another individual due to the presence of different polymorphic forms in the respective segments from the two individuals. Hybridization conditions should be sufficiently stringent that there is a significant difference in hybridization intensity between alleles, and preferably an essentially binary response, whereby a probe hybridizes to only one of the alleles. Some probes are designed to hybridize to a segment of target DNA such that the polymorphic site aligns with a central position (e.g., in a 15-mer at the 7 position; in a 16-mer, at either the 8 or 9 position) of the probe. This design of probe achieves good discrimination in hybridization between different allelic forms.

Allele-specific probes are often used in pairs, one member of a pair showing a perfect match to a reference form of a target sequence and the other member showing a perfect match to a variant form. Several pairs of probes can then be immobilized on the same support for simultaneous analysis of multiple polymorphisms within the same target sequence.

2. Tiling Arrays

The polymorphisms can also be identified by hybridization to nucleic acid arrays, some examples of which are described in WO 95/11995. One form of such arrays is described in the Examples section in connection with de novo identification of polymorphisms. The same array or a different array can be used for analysis of characterized polymorphisms. WO 95/11995 also describes subarrays that are optimized for detection of a variant form of a precharacterized polymorphism. Such a subarray contains probes designed to be complementary to a second reference sequence, which is an allelic variant of the first reference sequence. The second group of probes is designed by the same principles as described in the Examples, except that the probes exhibit complementarity to the second reference sequence. The inclusion of a second group (or further groups) can be particularly useful for analyzing short subsequences of the primary reference sequence in which multiple mutations are expected to occur within a short distance commensurate with the length of the probes (e.g., two or more mutations within 9 to 21 bases).

3. Allele-Specific Primers

An allele-specific primer hybridizes to a site on target DNA overlapping a polymorphism and only primes amplification of an allelic form to which the primer exhibits perfect complementarity. See Gibbs, Nucleic Acid Res . 17, 2427-2448 (1989). This primer is used in conjunction with a second primer which hybridizes at a distal site. Amplification proceeds from the two primers, resulting in a detectable product which indicates the particular allelic form is present. A control is usually performed with a second pair of primers, one of which shows a single base mismatch at the polymorphic site and the other of which exhibits perfect complementarity to a distal site. The single-base mismatch prevents amplification and no detectable product is formed. The method works best when the mismatch is included in the 3′-most position of the oligonucleotide aligned with the polymorphism because this position is most destabilizing to elongation from the primer (see, e.g., WO 93/22456).

4. Direct-Sequencing

The direct analysis of the sequence of polymorphisms of the present invention can be accomplished using either the dideoxy chain termination method or the Maxam—Gilbert method (see Sambrook et al., Molecular Cloning, A Laboratory Manual (2nd Ed., CSHP, New York 1989); Zyskind et al., Recombinant DNA Laboratory Manual , (Acad. Press, 1988)).

5. Denaturing Gradient Gel Electrophoresis

Amplification products generated using the polymerase chain reaction can be analyzed by the use of denaturing gradient gel electrophoresis. Different alleles can be identified based on the different sequence-dependent melting properties and electrophoretic migration of DNA in solution. Erlich, ed., PCR Technology, Principles and Applications for DNA Amplification , (W. H. Freeman and Co, New York, 1992), Chapter 7.

6. Single-Strand Conformation Polymorphism Analysis Alleles of target sequences can be differentiated using single-strand conformation polymorphism analysis, which identifies base differences by alteration in electrophoretic migration of single stranded PCR products, as described in Orita et at., Proc. Nat. Acad. Sci . 86, 2766-2770 (1989). Amplified PCR products can be generated as described above, and heated or otherwise denatured, to form single stranded amplification products. Single-stranded nucleic acids may refold or form secondary structures which are partially dependent on the base sequence. The different electrophoretic mobilities of single-stranded amplification products can be related to base-sequence differences between alleles of target sequences.

7. Single-Base Extension

An alternative method for identifying and analyzing polymorphisms is based on single-base extension (SBE) of a fluorescently-labeled primer coupled with fluorescence resonance energy transfer (FRET) between the label of the added base and the label of the primer. Typically, the method, such as that described by Chen et al., ( PNAS 94:10756-61 (1997), incorporated herein by reference) uses a locus-specific oligonucleotide primer labeled on the 5′ terminus with 5-carboxyfluorescein (FAM). This labeled primer is designed so that the 3′ end is immediately adjacent to the polymorphic site of interest. The labeled primer is hybridized to the locus, and single base extension of the labeled primer is performed with fluorescently labeled dideoxyribonucleotides (ddNTPs) in dye-terminator sequencing fashion, except that no deoxyribonucleotides are present. An increase in fluorescence of the added ddNTP in response to excitation at the wavelength of the labeled primer is used to infer the identity of the added nucleotide.

III. Methods of Use

After determining polymorphic form(s) present in an individual at one or more polymorphic sites, this information can be used in a number of methods.

A. Forensics

Determination of which polymorphic forms occupy a set of polymorphic sites in an individual identifies a set of polymorphic forms that distinguishes the individual. See generally National Research Council, The Evaluation of Forensic DNA Evidence (Eds. Pollard et al., National Academy Press, DC, t996). The more sites that are analyzed, the lower the probability that the set of polymorphic forms in one individual is the same as that in an unrelated individual. Preferably, if multiple sites are analyzed, the sites are unlinked. Thus, polymorphisms of the invention are often used in conjunction with polymorphisms in distal genes. Preferred polymorphisms for use in forensics are biallelic because the population frequencies of two polymorphic forms can usually be determined with greater accuracy than those of multiple polymorphic forms at multi-allelic loci.

The capacity to identify a distinguishing or unique set of forensic markers in an individual is useful for forensic analysis. For example, one can determine whether a blood sample from a suspect matches a blood or other tissue sample from a crime scene by determining whether the set of polymorphic forms occupying selected polymorphic sites is the same in the suspect and the sample. If the set of polymorphic markers does not match between a suspect and a sample, it can be concluded (barring experimental error) that the suspect was not the source of the sample. If the set of markers does match, one can conclude that the DNA from the suspect is consistent with that found at the crime scene. If frequencies of the polymorphic forms at the loci tested have been determined (e.g., by analysis of a suitable population of individuals), one can perform a statistical analysis to determine the probability that a match of suspect and crime scene sample would occur by chance.

p(ID) is the probability that two random individuals have the same polymorphic or allelic form at a given polymorphic site. In biallelic loci, four genotypes are possible: AA, AB, BA, and BB. If alleles A and B occur in a haploid genome of the organism with frequencies x and y, the probability of each genotype in a diploid organism is (see WO 95/12607):

Homozygote: p(AA)=x 2

Homozygote: p(BB)=y 2 =(1−x) 2

Single Heterozygote: p(AB)=p(BA)=xy=x(1−x)

Both Heterozygotes: p(AB+BA)=2xy=2x(1−x)

The probability of identity at one locus (i.e, the probability that two individuals, picked at random from a population will have identical polymorphic forms at a given locus) is given by the equation:

p ( ID )=( x 2 ) 2 +(2 xy ) 2 +( y 2 ) 2 .

These calculations can be extended for any number of polymorphic forms at a given locus. For example, the probability of identity p(ID) for a 3-allele system where the alleles have the frequencies in the population of x, y and z, respectively, is equal to the sum of the squares of the genotype frequencies:

p ( ID )=x 4 +(2 xy ) 2 +(2 yz ) 2 +(2 yz ) 2 +z 4 +y 4

In a locus of n alleles, the appropriate binomial expansion is used to calculate p(ID) and p(exc).

The cumulative probability of identity (cum p(ID)) for each of multiple unlinked loci is determined by multiplying the probabilities provided by each locus.

cum p(ID)=p(ID1)p(ID2)p(ID3) . . . p(IDn)

The cumulative probability of non-identity for n loci (i.e. the probability that two random individuals will be different at 1 or more loci) is given by the equation:

cum p(nonID)=1−cum p(ID).

If several polymorphic loci are tested, the cumulative probability of non-identity for random individuals becomes very high (e.g., one billion to one). Such probabilities can be taken into account together with other evidence in determining the guilt or innocence of the suspect.

B. Paternity Testing

The object of paternity testing is usually to determine whether a male is the father of a child. In most cases, the mother of the child is known and thus, the mother's contribution to the child's genotype can be traced. Paternity testing investigates whether the part of the child's genotype not attributable to the mother is consistent with that of the putative father. Paternity testing can be performed by analyzing sets of polymorphisms in the putative father and the child.

If the set of polymorphisms in the child attributable to the father does not match the set of polymorphisms of the putative father, it can be concluded, barring experimental error, that the putative father is not the real father. If the set of polymorphisms in the child attributable to the father does match the set of polymorphisms of the putative father, a statistical calculation can be performed to determine the probability of coincidental match.

The probability of parentage exclusion (representing the probability that a random male will have a polymorphic form at a given polymorphic site that makes him incompatible as the father) is given by the equation (see WO 95/12607):

p ( exc )= xy (1 −xy )

where x and y are the population frequencies of alleles A and B of a biallelic polymorphic site.

(At a triallelic site p(exc)=xy(1−xy)+yz(1−yz)+xz(1−xz)+3xyz(1−xyz))), where x, y and z and the respective population frequencies of alleles A, B and C).

The probability of non-exclusion is

p(non-exc)=1−p(exc)

The cumulative probability of non-exclusion (representing the value obtained when n loci are used) is thus:

cum p(non-exc)=p(non-exc1)p(non-exc2)p(non-exc3) . . . p(non-excn)

The cumulative probability of exclusion for n loci (representing the probability that a random male will be excluded) cum p(exc)=1−cum p(non-exc).

If several polymorphic loci are included in the analysis, the cumulative probability of exclusion of a random male is very high. This probability can be taken into account in assessing the liability of a putative father whose polymorphic marker set matches the child's polymorphic marker set attributable to his/her father.

C. Correlation of Polymorphisms with Phenotypic Traits

The polymorphisms of the invention may contribute to the phenotype of an organism in different ways. Some polymorphisms occur within a protein coding sequence and contribute to phenotype by affecting protein structure. The effect may be neutral, beneficial or detrimental, or both beneficial and detrimental, depending on the circumstances. For example, a heterozygous sickle cell mutation confers resistance to malaria, but a homozygous sickle cell mutation is usually lethal. Other polymorphisms occur in noncoding regions but may exert phenotypic effects indirectly via influence on replication, transcription, and translation. A single polymorphism may affect more than one phenotypic trait. Likewise, a single phenotypic trait may be affected by polymorphisms in different genes. Further, some polymorphisms predispose an individual to a distinct mutation that is causally related to a certain phenotype.

Phenotypic traits include diseases that have known but hitherto unmapped genetic components (e.g., agammaglobulimenia, diabetes insipidus, Lesch-Nyhan syndrome, muscular dystrophy, Wiskott-Aldrich syndrome, Fabry's disease, familial hypercholesterolemia, polycystic kidney disease, hereditary spherocytosis, von Willebrand's disease, tuberous sclerosis, hereditary hemorrhagic telangiectasia, familial colonic polyposis, Ehlers-Danlos syndrome, osteogenesis imperfecta, and acute intermittent porphyria). Phenotypic traits also include symptoms of, or susceptibility to, multifactorial diseases of which a component is or may be genetic, such as autoimmune diseases, inflammation, cancer, diseases of the nervous system, and infection by pathogenic microorganisms. Some examples of autoimmune diseases include rheumatoid arthritis, multiple sclerosis, diabetes (insulin-dependent and non-independent), systemic lupus erythematosus and Graves disease. Some examples of cancers include cancers of the bladder, brain, breast, colon, esophagus, kidney, leukemia, liver, lung, oral cavity, ovary, pancreas, prostate, skin, stomach and uterus. Phenotypic traits also include characteristics such as longevity, appearance (e.g., baldness, obesity), strength, speed, endurance, fertility, and susceptibility or receptivity to particular drugs or therapeutic treatments.

The correlation of one or more polymorphisms with phenotypic traits can be facilitated by knowledge of the gene product of the wild type (reference) gene. The genes in which cSNPs of the present invention have been identified are genes which have been previously sequenced and characterized in one of their allelic forms.

Correlation is performed for a population of individuals who have been tested for the presence or absence of a phenotypic trait of interest and for polymorphic markers sets. To perform such analysis, the presence or absence of a set of polymorphisms (i.e. a polymorphic set) is determined for a set of the individuals, some of whom exhibit a particular trait, and some of which exhibit lack of the trait. The alleles of each polymorphism of the set are then reviewed to determine whether the presence or absence of a particular allele is associated with the trait of interest. Correlation can be performed by standard statistical methods such as a U-squared test and statistically significant correlations between polymorphic form(s) and phenotypic characteristics are noted. For example, it might be found that the presence of allele A1 at polymorphism A correlates with heart disease. As a further example, it might be found that the combined presence of allele A1 at polymorphism A and allele B1 at polymorphism B correlates with increased milk production of a farm animal.

Such correlations can be exploited in several ways. In the case of a strong correlation between a set of one or more polymorphic forms and a disease for which treatment is available, detection of the polymorphic form set in a human or animal patient may justify immediate administration of treatment, or at least the institution of regular monitoring of the patient. Detection of a polymorphic form correlated with serious disease in a couple contemplating a family may also be valuable to the couple in their reproductive decisions. For example, the female partner might elect to undergo in vitro fertilization to avoid the possibility of transmitting such a polymorphism from her husband to her offspring. In the case of a weaker, but still statistically significant correlation between a polymorphic set and human disease, immediate therapeutic intervention or monitoring may not be justified. Nevertheless, the patient can be motivated to begin simple life-style changes (e.g., diet, exercise) that can be accomplished at little cost to the patient but confer potential benefits in reducing the risk of conditions to which the patient may have increased susceptibility by virtue of variant alleles. Identification of a polymorphic set in a patient correlated with enhanced receptiveness to one of several treatment regimes for a disease indicates that this treatment regime should be followed.

For animals and plants, correlations between characteristics and phenotype are useful for breeding for desired characteristics. For example, Beitz et al., U.S. Pat. No. 5,292,639 discuss use of bovine mitochondrial polymorphisms in a breeding program to improve milk production in cows. To evaluate the effect of mtDNA D-loop sequence polymorphism on milk production, each cow was assigned a value of 1 if variant or 0 if wildtype with respect to a prototypical mitochondrial DNA sequence at each of 17 locations considered. Each production trait was analyzed individually with the following animal model:

Y ijkpn =μ+YS i +P j +X k β l + . . . β 17 +PE n +a n +e p

where Y ijknp is the milk, fat, fat percentage, SNF, SNF percentage, energy concentration, or lactation energy record; μ is an overall mean; YS i is the effect common to all cows calving in year-season; X k is the effect common to cows in either the high or average selection line; β 1 to β 17 are the binomial regressions of production record on mtDNA D-loop sequence polymorphisms; PE n is permanent environmental effect common to all records of cow n; a n is effect of animal n and is composed of the additive genetic contribution of sire and darn breeding values and a Mendelian sampling effect; and e p is a random residual. It was found that eleven of seventeen polymorphisms tested influenced at least one production trait. Bovines having the best polymorphic forms for milk production at these eleven loci are used as parents for breeding the next generation of the herd.

D. Genetic Mapping of Phenotypic Traits

The previous section concerns identifying correlations between phenotypic traits and polymorphisms that directly or indirectly contribute to those traits. The present section describes identification of a physical linkage between a genetic locus associated with a trait of interest and polymorphic markers that are not associated with the trait, but are in physical proximity with the genetic locus responsible for the trait and co-segregate with it. Such analysis is useful for mapping a genetic locus associated with a phenotypic trait to a chromosomal position, and thereby cloning gene(s) responsible for the trait. See Lander et al., Proc. Natl. Acad. Sci . ( USA ) 83, 7353-7357 (1986); Lander et al., Proc. Natl. Acad. Sci . ( USA ) 84, 2363-2367 (1987); Donis-Keller et al., Cell 51, 319-337 (1987); Lander et al., Genetics 121, 185-199 (1989)). Genes localized by linkage can be cloned by a process known as directional cloning. See Wainwright, Med. J. Australia 159, 170-174 (1993); Collins, Nature Genetics 1,3-6 (1992).

Linkage studies are typically performed on members of a family. Available members of the family are characterized for the presence or absence of a phenotypic trait and for a set of polymorphic markers. The distribution of polymorphic markers in an informative meiosis is then analyzed to determine which polymorphic markers co-segregate with a phenotypic trait. See, e.g., Kerem et al., Science 245, 1073-1080 (1989); Monaco et al., Nature 316, 842 (1985); Yamoka et al., Neurology 40, 222-226 (1990); Rossiter et al., FASEB Journal 5, 21-27 (1991).

Linkage is analyzed by calculation of LOD (log of the odds) values. A lod value is the relative likelihood of obtaining observed segregation data for a marker and a genetic locus when the two are located at a recombination fraction θ, versus the situation in which the two are not linked, and thus segregating independently (Thompson & Thompson, Genetics in Medicine (5th ed, W. B. Saunders Company, Philadelphia, 1991); Strachan, “Mapping the human genome” in The Human Genome (BIOS Scientific Publishers Ltd, Oxford), Chapter 4). A series of likelihood ratios are calculated at various recombination fractions (θ), ranging from θ=0.0 (coincident loci) to θ=0.50 (unlinked). Thus, the likelihood at a given value of θ is: probability of data if loci linked at θ to probability of data if loci unlinked. The computed likelihoods are usually expressed as the log 10 of this ratio (i.e., a lod score). For example, a lod score of 3 indicates 1000:1 odds against an apparent observed linkage being a coincidence. The use of logarithms allows data collected from different families to be combined by simple addition. Computer programs are available for the calculation of lod scores for differing values of θ (e.g., LIPED, MLINK (Lathrop, Proc. Nat. Acad. Sci . ( USA ) 81, 3443-3446 (1984)). For any particular lod score, a recombination fraction may be determined from mathematical tables. See Smith et al., Mathematical tables for research workers in human genetics (Churchill, London, 1961); Smith, Ann. Hum. Genet . 32, 127-150(1968). The value of θ at which the lod score is the highest is considered to be the best estimate of the recombination fraction.

Positive lod score values suggest that the two loci are linked, whereas negative values suggest that linkage is less likely (at that value of θ) than the possibility that the two loci are unlinked. By convention, a combined lod score of +3 or greater (equivalent to greater than 1000:1 odds in favor of linkage) is considered definitive evidence that two loci are linked. Similarly, by convention, a negative lod score of −2 or less is taken as definitive evidence against linkage of the two loci being compared. Negative linkage data are useful in excluding a chromosome or a segment thereof from consideration. The search focuses on the remaining non-excluded chromosomal locations.

IV. Modified Polypeptides and Gene Sequences

The invention further provides variant forms of nucleic acids and corresponding proteins. The nucleic acids comprise one of the sequences described in the Table, column 5, in which the polymorphic position is occupied by one of the alternative bases for that position. Some nucleic acids encode full-length variant forms of proteins. Similarly, variant proteins have the prototypical amino acid sequences encoded by nucleic acid sequences shown in the Table, column 5, (read so as to be in-frame with the full-length coding sequence of which it is a component) except at an amino acid encoded by a codon including one of the polymorphic positions shown in the Table. That position is occupied by the amino acid coded by the corresponding codon in any of the alternative forms shown in the Table.

Variant genes can be expressed in an expression vector in which a variant gene is operably linked to a native or other promoter. Usually, the promoter is a eucaryotic promoter for expression in a mammalian cell. The transcription regulation sequences typically include a heterologous promoter and optionally an enhancer which is recognized by the host. The selection of an appropriate promoter, for example trp, lac, phage promoters, glycolytic enzyme promoters and tRNA promoters, depends on the host selected. Commercially available expression vectors can be used. Vectors can include host-recognized replication systems, amplifiable genes, selectable markers, host sequences useful for insertion into the host genome, and the like.

The means of introducing the expression construct into a host cell varies depending upon the particular construction and the target host. Suitable means include fusion, conjugation, transfection, transduction, electroporation or injection, as described in Sambrook, supra. A wide variety of host cells can be employed for expression of the variant gene, both prokaryotic and eukaryotic. Suitable host cells include bacteria such as E. coli , yeast, filamentous fungi, insect cells, mammalian cells, typically immortalized, e.g., mouse, CHO, human and monkey cell lines and derivatives thereof Preferred host cells are able to process the variant gene product to produce an appropriate mature polypeptide. Processing includes glycosylation, ubiquitination, disulfide bond formation, general post-translational modification, and the like. As used herein, “gene product” includes mRNA, peptide and protein products.

The protein may be isolated by conventional means of protein biochemistry and purification to obtain a substantially pure product, i.e., 80, 95 or 99% free of cell component contaminants, as described in Jacoby, Methods in Enzymology Volume 104, Academic Press, New York (1984); Scopes, Protein Purification, Principles and Practice , 2nd Edition, Springer-Verlag, New York (1987); and Deutscher (ed), Guide to Protein Purification, Methods in Enzymology , Vol. 182 (1990). If the protein is secreted, it can be isolated from the supernatant in which the host cell is grown. If not secreted, the protein can be isolated from a lysate of the host cells.

The invention further provides transgenic nonhuman animals capable of expressing an exogenous variant gene and/or having one or both alleles of an endogenous variant gene inactivated. Expression of an exogenous variant gene is usually achieved by operably linking the gene to a promoter and optionally an enhancer, and microinjecting the construct into a zygote. See Hogan et al., “Manipulating the Mouse Embryo, A Laboratory Manual,” Cold Spring Harbor Laboratory. Inactivation of endogenous variant genes can be achieved by forming a transgene in which a cloned variant gene is inactivated by insertion of a positive selection marker. See Capecchi, Science 244, 1288-1292 (1989). The transgene is then introduced into an embryonic stem cell, where it undergoes homologous recombination with an endogenous variant gene. Mice and other rodents are preferred animals. Such animals provide useful drug screening systems.

In addition to substantially full-length polypeptides expressed by variant genes, the present invention includes biologically active fragments of the polypeptides, or analogs thereof, including organic molecules which simulate the interactions of the peptides. Biologically active fragments include any portion of the full-length polypeptide which confers a biological function on the variant gene product, including ligand binding, and antibody binding. Ligand binding includes binding by nucleic acids, proteins or polypeptides, small biologically active molecules, or large cellular structures.

Polyclonal and/or monoclonal antibodies that specifically bind to variant gene products but not to corresponding prototypical gene products are also provided. Antibodies can be made by injecting mice or other animals with the variant gene product or synthetic peptide fragments thereof Monoclonal antibodies are screened as are described, for example, in Harlow & Lane, Antibodies, A Laboratory Manual , Cold Spring Harbor Press, New York (1988); Goding, Monoclonal antibodies, Principles and Practice (2d ed.) Academic Press, New York (1986). Monoclonal antibodies are tested for specific immunoreactivity with a variant gene product and lack of immunoreactivity to the corresponding prototypical gene product. These antibodies are useful in diagnostic assays for detection of the variant form, or as an active ingredient in a pharmaceutical composition.

V. Kits

The invention further provides kits comprising at least one allele-specific oligonucleotide as described herein. Often, the kits contain one or more pairs of allele-specific oligonucleotides hybridizing to different forms of a polymorphism. In some kits, the allele-specific oligonucleotides are provided immobilized to a substrate. For example, the same substrate can comprise allele-specific oligonucleotide probes for detecting at least 10, 100 or all of the polymorphisms shown in the Table. Optional additional components of the kit include, for example, restriction enzymes, reverse-transcriptase or polymerase, the substrate nucleoside triphosphates, means used to label (for example, an avidin-enzyme conjugate and enzyme substrate and chromogen if the label is biotin), and the appropriate buffers for reverse transcription, PCR, or hybridization reactions. Usually, the kit also contains instructions for carrying out the methods.

The thrombospondins are a family of extracellular matrix (ECM) glycoproteins that modulate many cell behaviors including adhesion, migration, and proliferation. Thrombospondins (also known as thrombin sensitive proteins or TSPs) are large molecular weight glycoproteins composed of three identical disulfide-linked polypeptide chains. TSPs are stored in the alpha-granules of platelets and secreted by a variety of mesenchymal and epithelial cells (Majack et al., Cell Membrane 3:57-77 (1987)). Platelets secrete TSPs when activated in the blood by such physiological agonists such as thrombin. TSPs have lectin properties and a broad function in the regulation of fibrinolysis and as a component of the ECM, and are one of a group of ECM proteins which have adhesive properties. TSPs bind to fibronectin and fibrinogen (Lahav et al., Eur J Biochem 145:151-6 (1984)), and these proteins are known to be involved in platelet adhesion to substratum and platelet aggregation (Leung, J Clin Invest 74:1764-1772 (1986)).

Recent work has implicated TSPs in response of cells to growth factors. Submitogenic doses of PDGF induce a rapid but transitory, increase in TSP synthesis and secretion by rat aortic smooth muscle cells (Majack et al., J Biol Chem 101:1059-70 (1985)). PDGF responsiveness to TSP synthesis in glial cells has also been shown (Asch et al, Proc Natl Acad Sci 83:2904-8 (1986)). TSP mRNA levels rise rapidly in response to PDGF (Majack et al., J Biol Chem 262:8821-5 (1987)). TSPs act synergistically with epidermal growth factor to increase DNA synthesis in smooth muscle cells (Majack et al., Proc Natl Acad Sci 83:9050-4 (1986)), and monoclonal antibodies to TSPs inhibit smooth muscle cell proliferation (Majack et al., J Biol Chem 106:415-22 (1988)). TSPs modulate local adhesions in endothelial cells, and TSPs, particularly TSP-1 primarily derived from platelet granules, are known to be an important activator of transforming growth factor beta-1 (TGFB-1) (Crawford et al., Cell 93:1159 (1998)) and appear to be a potential link between platelet-thrombosis and development of atherosclerosis.

To determine pivotal genes associated with premature coronary artery disease, we analyzed DNA from 347 patients with MI or coronary revascularization before age 40 (men) or 45 (women) and 422 general population controls. Cases were drawn (one per family) from a retrospective collection of sibling pairs with premature CAD. Controls were ascertained through random-digit dialing. Both cases and controls were Caucasian. A complete database of phenotypic and laboratory variables for the affected patients afforded logistic regression to control for age, diabetes, body mass index, gender.

Thrombospondin (TSP) 4 and 1 emerged as important SNPs associated with premature CAD and MI. For CAD, 148 of 347 patients carried at least one copy of the TSP-4 variant compared with 142 of 422 control subjects; adjusted odds ratio 1.47, p=0.01. For premature MI, the association was even stronger: 91 of 187 cases vs. 142 of 422 controls had the variant; adjusted odds ratio 2.08, p=0.0003. The TSP-1 SNP was rare. Nonetheless, homozygosity for the variant allele gave an adjusted odds ratio of 9.5, p=0.04.

Specific reference nucleotide (SEQ ID NO: 1) and amino acid (SEQ ID NO: 2) sequences for TSP-1 are shown in FIGS. 1A-1D . Specific reference nucleotide (SEQ ID NO: 3) and amino acid (SEQ ID NO: 4) sequences for TSP-4 are shown in FIGS. 2A-2C . It is understood that the invention is not limited by these exemplified reference sequences, as variants of these sequences which differ at locations other than the SNP sites identified herein can also be utilized. The skilled artisan can readily determine the SNP sites in these other reference sequences which correspond to the SNP sites identified herein by aligning the sequence of interest with the reference sequences specifically disclosed herein, and programs for performing such alignments are commercially available. For example, the ALIGN program in the GCG software package can be used, utilizing a PAM120 weight residue table, a gap length penalty of 12 and a gap penalty of 4, for example.

Two SNPs have been specifically studied as described herein. The first (G334u4) is a change from A (reference nucleotide) to G (alternate or variant nucleotide) at nucleotide position 2210 of the nucleic acid sequence of TSP-1 (FIGS. 1 A- 1 D), resulting in a missense amino acid mutation from asparagine (reference) to serine (alternate) at amino acid 700. The second SNP (G355u2) is a change from G (reference) to C (alternate) at nucleotide position 1186 of the nucleic acid sequence of TSP-4 (FIGS. 2 A- 2 C), resulting in a missense amino acid alteration from alanine (reference) to proline (alternate) at amino acid 387. With respect to the G355u2 SNP, individuals with CAD carried at least one copy of the variant “C” allele more frequently than control individuals (43% as compared with 34%). With respect to the G355u2 SNP, individuals with MI carried at least one copy of the variant “C” allele more frequently than control individuals (49% as compared with 34%). With respect to the G334u4 SNP, individuals with CAD carried two copies of the variant “G” allele more frequently than control individuals (1.7% as compared with 0.2%). With respect to the G334u4 SNP, individuals with MI carried two copies of the variant “G” allele more frequently than control individuals (2% as compared with 0.2%).

As used herein, the term “polymorphism” refers to the occurrence of two or more genetically determined alternative sequences or alleles in a population. A polymorphic marker or site is the locus at which divergence occurs. Preferred markers have at least two alleles, each occurring at frequency of greater than 1%, and more preferably greater than 10% or 20% of a selected population. A polymorphic locus may be as small as one base pair, in which case it is referred to as a single nucleotide polymorphism (SNP).

Thus, the invention relates to a method for predicting the likelihood that an individual will have a vascular disease, or for aiding in the diagnosis of a vascular disease, or predicting the likelihood of having altered symptomology associated with a vascular disease, comprising the steps of obtaining a DNA sample from an individual to be assessed and determining the nucleotide present at one or more of nucleotide positions 2210 of the TSP-1 gene or 1186 of the TSP-4 gene. In a preferred embodiment, the nucleotides present at both of these nucleotide positions are determined. In one embodiment the TSP-1 gene has the nucleotide sequence of SEQ ID NO: 1 and the TSP-4 gene has the nucleotide sequence of SEQ ID NO: 3. The presence of one or more of a G (the variant nucleotide) at position 2210 of SEQ ID NO: 1 or a C (the variant nucleotide) at position 1186 of SEQ ID NO: 1186 indicates that the individual has a greater likelihood of having a vascular disease, or a greater likelihood of having severe symptomology associated with a vascular disease, than if that individual had the reference nucleotide at one or more of these positions. Conversely, the presence of one or more of an A (the reference nucleotide) at position 2210 of SEQ ID NO: 1 or a G (the reference nucleotide) at position 1186 of SEQ ID NO: 3 indicates that the individual has a reduced likelihood of having a vascular disease or a likelihood of having reduced symptomology associated with a vascular disease than if that individual had the variant nucleotide at one or more of these positions.

In a particular embodiment, the individual is an individual at risk for development of a vascular disease. In another embodiment the individual exhibits clinical symptomology associated with a vascular disease. In one embodiment, the individual has been clinically diagnosed as having a vascular disease. Vascular diseases include, but are not limited to, atherosclerosis, coronary heart disease, myocardial infarction (MI), stroke, peripheral vascular diseases, venous thromboembolism and pulmonary embolism. In preferred embodiments, the vascular disease is CAD or MI.

The genetic material to be assessed can be obtained from any nucleated cell from the individual. For assay of genomic DNA, virtually any biological sample (other than pure red blood cells) is suitable. For example, convenient tissue samples include whole blood, semen, saliva, tears, urine, fecal material, sweat, skin and hair. For assay of cDNA or mRNA, the tissue sample must be obtained from a tissue or organ in which the target nucleic acid is expressed.

Many of the methods described herein require amplification of DNA from target samples. This can be accomplished by e.g., PCR. See generally PCR Technology: Principles and Applications for DNA Amplification (ed. H. A. Erlich, Freeman Press, NY, N.Y., 1992); PCR Protocols: A Guide to Methods and Applications (eds. Innis, et al., Academic Press, San Diego, Calif., 1990); Mattila et al., Nucleic Acids Res . 19, 4967 (1991); Eckert et al., PCR Methods and Applications 1, 17 (1991); PCR (eds. McPherson et al., IRL Press, Oxford); and U.S. Pat. No. 4,683,202.

Other suitable amplification methods include the ligase chain reaction (LCR) (see Wu and Wallace, Genomics 4, 560 (1989), Landegren et al., Science 241, 1077 (1988), transcription amplification (Kwoh et al., Proc. Natl. Acad. Sci. USA 86, 1173 (1989)), and self-sustained sequence replication (Guatelli et al., Proc. Nat. Acad. Sci. USA, 87, 1874 (1990)) and nucleic acid based sequence amplification (NASBA). The latter two amplification methods involve isothermal reactions based on isothermal transcription, which produce both single stranded RNA (ssRNA) and double stranded DNA (dsDNA) as the amplification products in a ratio of about 30 or 100 to 1, respectively.

The nucleotide which occupies the polymorphic site of interest (e.g., nucleotide position 2210 in TSP-1 and/or nucleotide position 1186 in TSP-4) can be identified by a variety of methods, such as Southern analysis of genomic DNA; direct mutation analysis by restriction enzyme digestion; Northern analysis of RNA; denaturing high pressure liquid chromatography (DHPLC); gene isolation and sequencing; hybridization of an allele-specific oligonucleotide with amplified gene products; single base extension (SBE). In a preferred embodiment, determination of the allelic form of TSP is carried out using SBE-FRET methods as described herein, or using chip-based oligonucleotide arrays as described herein.

The invention also relates to a method for predicting the likelihood that an individual will have a vascular disease, or for aiding in the diagnosis of a vascular disease, or predicting the likelihood of having altered symptomology associated with a vascular disease, comprising the steps of obtaining a biological sample comprising TSP-1 and/or TSP-4 protein or relevant portion thereof from an individual to be assessed and determining the amino acid present at one or more of amino acid positions 700 of the TSP-1 gene product (e.g., as exemplified by SEQ ID NO: 2) or 387 of the TSP-4 gene product (e.g., as exemplified by SEQ ID NO: 4). In a preferred embodiment, the amino acids present at both of these amino acid positions are determined. As used herein, the term “relevant portion” of the TSP-1 and TSP-4 proteins is intended to encompass any portion of the protein which comprises the polymorphic amino acid positions. The presence of one or more of a serine (the variant amino acid) at position 700 of SEQ ID NO: 2, or a proline (the variant amino acid) at position 387 of SEQ ID NO: 4 indicates that the individual has a greater likelihood of having a vascular disease, or a greater likelihood of having severe symptomology associated with a vascular disease, than if that individual had the reference amino acid at one or more of these positions. Conversely, the presence of one or more of an asparagine (the reference amino acid) at position 700 of SEQ ID NO: 2, or an alanine (the reference amino acid) at position 387 of SEQ ID NO: 4 indicates that the individual has a reduced likelihood of having a vascular disease or a likelihood of having reduced symptomology associated with a vascular disease, than if that individual had the varaint amino acid at one or more of these positions.

In a particular embodiment, the individual is an individual at risk for development of a vascular disease. In another embodiment the individual exhibits clinical symptomology associated with a vascular disease. In one embodiment, the individual has been clinically diagnosed as having a vascular disease.

In this embodiment of the invention, the biological sample contains protein molecules from the test subject. In vitro techniques for detection of protein include enzyme linked immunosorbent assays (ELISAs), Western blots, immunoprecipitations and immunofluorescence. Furthermore, in vivo techniques for detection of protein include introducing into a subject a labeled anti-protein antibody. For example, the antibody can be labeled with a radioactive marker whose presence and location in a subject can be detected by standard imaging techniques. Polyclonal and/or monoclonal antibodies that specifically bind to variant gene products but not to corresponding reference gene products, and vice versa, are also provided. Antibodies can be made by injecting mice or other animals with the variant gene product or synthetic peptide fragments thereof comprising the variant portion. Monoclonal antibodies are screened as are described, for example, in Harlow & Lane, Antibodies, A Laboratory Manual , Cold Spring Harbor Press, New York (1988); Goding, Monoclonal antibodies, Principles and Practice (2d ed.) Academic Press, New York (1986). Monoclonal antibodies are tested for specific immunoreactivity with a variant gene product and lack of immunoreactivity to the corresponding prototypical gene product. These antibodies are useful in diagnostic assays for detection of the variant form, or as an active ingredient in a pharmaceutical composition.

The polymorphisms of the invention may be associated with vascular disease in different ways. The polymorphisms may exert phenotypic effects indirectly via influence on replication, transcription, and translation. Additionally, the described polymorphisms may predispose an individual to a distinct mutation that is causally related to a certain phenotype, such as susceptibility or resistance to vascular disease and related disorders. The discovery of the polymorphisms and their correlation with CAD and MI facilitates biochemical analysis of the variant and reference forms and the development of assays to characterize the variant and reference forms and to screen for pharmaceutical agents that interact directly with one or another form of the protein.

Alternatively, these particular polymorphisms may belong to a group of two or more polymorphisms in the TSP gene(s) which contributes to the presence, absence or severity of vascular disease. An assessment of other polymorphisms within the TSP gene(s) can be undertaken, and the separate and combined effects of these polymorphisms, as well as alternations in other, distinct genes, on the vascular disease phenotype can be assessed.

Correlation between a particular phenotype, e.g., the CAD or MI phenotype, and the presence or absence of a particular allele is performed for a population of individuals who have been tested for the presence or absence of the phenotype. Correlation can be performed by standard statistical methods such as a Chi-squared test and statistically significant correlations between polymorphic form(s) and phenotypic characteristics are noted. This correlation can be exploited in several ways. In the case of a strong correlation between a particular polymorphic form, e.g., the variant allele for TSP-1 and/or TSP-4, and a disease for which treatment is available, detection of the polymorphic form in an individual may justify immediate administration of treatment, or at least the institution of regular monitoring of the individual. Detection of a polymorphic form correlated with a disorder in a couple contemplating a family may also be valuable to the couple in their reproductive decisions. For example, the female partner might elect to undergo in vitro fertilization to avoid the possibility of transmitting such a polymorphism from her husband to her offspring. In the case of a weaker, but still statistically significant correlation between a polymorphic form and a particular disorder, immediate therapeutic intervention or monitoring may not be justified. Nevertheless, the individual can be motivated to begin simple life-style changes (e.g., diet modification, therapy or counseling) that can be accomplished at little cost to the individual but confer potential benefits in reducing the risk of conditions to which the individual may have increased susceptibility by virtue of the particular allele. Furthermore, identification of a polymorphic form correlated with enhanced receptiveness to one of several treatment regimes for a disorder indicates that this treatment regimen should be followed for the individual in question.

Furthermore, it may be possible to identify a physical linkage between a genetic locus associated with a trait of interest (e.g., CAD or MI) and polymorphic markers that are or are not associated with the trait, but are in physical proximity with the genetic locus responsible for the trait and co-segregate with it. Such analysis is useful for mapping a genetic locus associated with a phenotypic trait to a chromosomal position, and thereby cloning gene(s) responsible for the trait. See Lander et al., Proc. Natl. Acad. Sci . ( USA ) 83, 7353-7357 (1986); Lander et al., Proc. Natl. Acad. Sci . ( USA ) 84, 2363-2367 (1987); Donis-Keller et al., Cell 51, 319-337 (1987); Lander et al., Genetics 121, 185-199 (1989)). Genes localized by linkage can be cloned by a process known as directional cloning. See Wainwright, Med. J Australia 159, 170-174 (1993); Collins, Nature Genetics 1,3-6 (1992). Linkage studies are discussed in more detail above.

In another embodiment, the invention relates to pharmaceutical compositions comprising a reference TSP-1 and/or TSP-4 gene or gene product for use in the treatment of vascular disease, e.g., CAD and MI. As used herein, a reference TSP gene product is intended to mean gene products which are encoded by the reference allele of the TSP gene. In addition to substantially full-length polypeptides expressed by the genes, the present invention includes biologically active fragments of the polypeptides, or analogs thereof, including organic molecules which simulate the interactions of the peptides. Biologically active fragments include any portion of the full-length polypeptide which confers a biological function on the variant gene product, including ligand binding, and antibody binding. Ligand binding includes binding by nucleic acids, proteins or polypeptides, small biologically active molecules, or large cellular structures.

For instance, the polypeptide or protein, or fragment thereof, of the present invention can be formulated with a physiologically acceptable medium to prepare a pharmaceutical composition. The particular physiological medium may include, but is not limited to, water, buffered saline, polyols (e.g., glycerol, propylene glycol, liquid polyethylene glycol) and dextrose solutions. The optimum concentration of the active ingredient(s) in the chosen medium can be determined empirically, according to procedures well known to medicinal chemists, and will depend on the ultimate pharmaceutical formulation desired. Methods of introduction of exogenous peptides at the site of treatment include, but are not limited to, intradermal, intramuscular, intraperitoneal, intravenous, subcutaneous, oral and intranasal. Other suitable methods of introduction can also include rechargeable or biodegradable devices and slow release polymeric devices. The pharmaceutical compositions of this invention can also be administered as part of a combinatorial therapy with other agents and treatment regimens.

The invention further pertains to compositions, e.g., vectors, comprising a nucleotide sequence encoding reference or variant TSP-1 and/or TSP-4 gene products. For example, reference genes can be expressed in an expression vector in which a reference gene is operably linked to a native or other promoter. Usually, the promoter is a eukaryotic promoter for expression in a mammalian cell. The transcription regulation sequences typically include a heterologous promoter and optionally an enhancer which is recognized by the host. The selection of an appropriate promoter, for example trp, lac, phage promoters, glycolytic enzyme promoters and tRNA promoters, depends on the host selected. Commercially available expression vectors can be used. Vectors can include host-recognized replication systems, amplifiable genes, selectable markers, host sequences useful for insertion into the host genome, and the like.

The means of introducing the expression construct into a host cell varies depending upon the particular construction and the target host. Suitable means include fusion, conjugation, transfection, transduction, electroporation or injection, as described in Sambrook, supra. A wide variety of host cells can be employed for expression of the variant gene, both prokaryotic and eukaryotic. Suitable host cells include bacteria such as E. coli , yeast, filamentous fungi, insect cells, mammalian cells, typically immortalized, e.g., mouse, CHO, human and monkey cell lines and derivatives thereof Preferred host cells are able to process the variant gene product to produce an appropriate mature polypeptide. Processing includes glycosylation, ubiquitination, disulfide bond formation, general post-translational modification, and the like.

It is also contemplated that cells can be engineered to express the reference allele of the invention by gene therapy methods. For example, DNA encoding the reference TSP gene product, or an active fragment or derivative thereof, can be introduced into an expression vector, such as a viral vector, and the vector can be introduced into appropriate cells in an animal. In such a method, the cell population can be engineered to inducibly or constitutively express active reference TSP gene product. In a preferred embodiment, the vector is delivered to the bone marrow, for example as described in Corey et al. ( Science 244:1275-1281(1989)).

The invention further relates to the use of compositions (i.e., agonists) which enhance or increase the activity of the reference (or variant) TSP (e.g., TSP-1 or TSP-4) gene product, or a functional portion thereof, for use in the treatment of vascular disease. The invention also relates to the use of compositions (i.e., antagonists) which reduce or decrease the activity of the variant (or reference) TSP (e.g., TSP-1 or TSP-4) gene product, or a functional portion thereof, for use in the treatment of vascular disease.

The invention also relates to constructs which comprise a vector into which a sequence of the invention has been inserted in a sense or antisense orientation. For example, a vector comprising a nucleotide sequence which is antisense to the variant TSP-1 or TSP-4 allele may be used as an antagonist of the activity of the TSP-1 or TSP-4 variant allele. Alternatively, a vector comprising a nucleotide sequence of the TSP-1 or TSP-4 reference allele may be used therapeutically to treat vascular diseases. As used herein, the term “vector” refers to a nucleic acid molecule capable of transporting another nucleic acid to which it has been linked. One type of vector is a “plasmid”, which refers to a circular double stranded DNA loop into which additional DNA segments can be ligated. Another type of vector is a viral vector, wherein additional DNA segments can be ligated into the viral genome. Certain vectors are capable of autonomous replication in a host cell into which they are introduced (e.g., bacterial vectors having a bacterial origin of replication and episomal mammalian vectors). Other vectors (e.g., non-episomal mammalian vectors) are integrated into the genome of a host cell upon introduction into the host cell, and thereby are replicated along with the host genome. Moreover, certain vectors, expression vectors, are capable of directing the expression of genes to which they are operably linked. In general, expression vectors of utility in recombinant DNA techniques are often in the form of plasmids (vectors). However, the invention is intended to include such other forms of expression vectors, such as viral vectors (e.g., replication defective retroviruses, adenoviruses and adeno-associated viruses) that serve equivalent functions.

Preferred recombinant expression vectors of the invention comprise a nucleic acid of the invention in a form suitable for expression of the nucleic acid in a host cell. This means that the recombinant expression vectors include one or more regulatory sequences, selected on the basis of the host cells to be used for expression, which is operably linked to the nucleic acid sequence to be expressed. Within a recombinant expression vector, “operably linked” is intended to mean that the nucleotide sequence of interest is linked to the regulatory sequence(s) in a manner which allows for expression of the nucleotide sequence (e.g., in an in vitro transcription/translation system or in a host cell when the vector is introduced into the host cell). The term “regulatory sequence” is intended to include promoters, enhancers and other expression control elements (e.g., polyadenylation signals). Such regulatory sequences are described, for example, in Goeddel, Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, Calif. (1990). Regulatory sequences include those which direct constitutive expression of a nucleotide sequence in many types of host cell and those which direct expression of the nucleotide sequence only in certain host cells (e.g., tissue-specific regulatory sequences). It will be appreciated by those skilled in the art that the design of the expression vector can depend on such factors as the choice of the host cell to be transformed, the level of expression of protein desired, etc.

The expression vectors of the invention can be introduced into host cells to thereby produce proteins or peptides, including fusion proteins or peptides, encoded by nucleic acids as described herein. The recombinant expression vectors of the invention can be designed for expression of a polypeptide of the invention in prokaryotic or eukaryotic cells, e.g., bacterial cells such as E. coli , insect cells (using baculovirus expression vectors), yeast cells or mammalian cells. Suitable host cells are discussed further in Goeddel, supra. Alternatively, the recombinant expression vector can be transcribed and translated in vitro, for example using T7 promoter regulatory sequences and T7 polymerase.

Another aspect of the invention pertains to host cells into which a recombinant expression vector of the invention has been introduced. The terms “host cell” and “recombinant host cell” are used interchangeably herein. It is understood that such terms refer not only to the particular subject cell but also to the progeny or potential progeny of such a cell. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the parent cell, but are still included within the scope of the term as used herein. A host cell can be any prokaryotic or eukaryotic cell. For example, a nucleic acid of the invention can be expressed in bacterial cells (e.g., E. coli ), insect cells, yeast or mammalian cells (such as Chinese hamster ovary cells (CHO) or COS cells). Other suitable host cells are known to those skilled in the art.

Vector DNA can be introduced into prokaryotic or eukaryotic cells via conventional transformation or transfection techniques. As used herein, the terms “transformation” and “transfection” are intended to refer to a variety of art-recognized techniques for introducing foreign nucleic acid (e.g., DNA) into a host cell, including calcium phosphate or calcium chloride co-precipitation, DEAB-dextran-mediated transfection, lipofection, or electroporation. Suitable methods for transforming or transfecting host cells can be found in Sambrook, et al (supra), and other laboratory manuals.

A host cell of the invention, such as a prokaryotic or eukaryotic host cell in culture, can be used to produce (i.e., express) a polypeptide of the invention. Accordingly, the invention further provides methods for producing a polypeptide using the host cells of the invention. In one embodiment, the method comprises culturing the host cell of the invention (into which a recombinant expression vector encoding a polypeptide of the invention has been introduced) in a suitable medium such that the polypeptide is produced. In another embodiment, the method further comprises isolating the polypeptide from the medium or the host cell.

The host cells of the invention can also be used to produce nonhuman transgenic animals. For example, in one embodiment, a host cell of the invention is a fertilized oocyte or an embryonic stem cell into which a nucleic acid of the invention has been introduced. Such host cells can then be used to create non-human transgenic animals in which exogenous nucleotide sequences have been introduced into their genome or homologous recombinant animals in which endogenous nucleotide sequences have been altered. Such animals are useful for studying the function and/or activity of the nucleotide sequence and polypeptide encoded by the sequence and for identifying and/or evaluating modulators of their activity. As used herein, a “transgenic animal” is a non-human animal, preferably a mammal, more preferably a rodent such as a rat or mouse, in which one or more of the cells of the animal includes a transgene. Other examples of transgenic animals include non-human primates, sheep, dogs, cows, goats, chickens, amphibians, etc. A transgene is exogenous DNA which is integrated into the genome of a cell from which a transgenic animal develops and which remains in the genome of the mature animal, thereby directing the expression of an encoded gene product in one or more cell types or tissues of the transgenic animal. As used herein, an “homologous recombinant animal” is a non-human animal, preferably a mammal, more preferably a mouse, in which an endogenous gene has been altered by homologous recombination between the endogenous gene and an exogenous DNA molecule introduced into a cell of the animal, e.g., an embryonic cell of the animal, prior to development of the animal.

A transgenic animal of the invention can be created by introducing a nucleic acid of the invention into the male pronuclei of a fertilized oocyte, e.g., by microinjection, retroviral infection, and allowing the oocyte to develop in a pseudopregnant female foster animal. The sequence can be introduced as a transgene into the genome of a non-human animal. Intronic sequences and polyadenylation signals can also be included in the transgene to increase the efficiency of expression of the transgene. A tissue-specific regulatory sequence(s) can be operably linked to the transgene to direct expression of a polypeptide in particular cells. Methods for generating transgenic animals via embryo manipulation and microinjection, particularly animals such as mice, have become conventional in the art and are described, for example, in U.S. Pat. Nos. 4,736,866 and 4,870,009, U.S. Pat. No. 4,873,191 and in Hogan, Manipulating the Mouse Embryo (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1986). Similar methods are used for production of other transgenic animals. A transgenic founder animal can be identified based upon the presence of the transgene in its genome and/or expression of mRNA in tissues or cells of the animals. A transgenic founder animal can then be used to breed additional animals carrying the transgene. Moreover, transgenic animals carrying a transgene encoding the transgene can further be bred to other transgenic animals carrying other transgenes.

The invention also relates to the use of the variant and reference gene products to guide efforts to identify the causative mutation for vascular diseases or to identify or synthesize agents useful in the treatment of vascular diseases, e.g., CAD and MI. Amino acids that are essential for function can be identified by methods known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham et al., Science, 244:1081-1085 (1989)). The latter procedure introduces single alanine mutations at every residue in the molecule. The resulting mutant molecules are then tested for biological activity in vitro, or in vitro activity. Sites that are critical for polypeptide activity can also be determined by structural analysis such as crystallization, nuclear magnetic resonance or photoaffinity labeling (Smith et al, J Mol. Biol ., 224:899-904 (1992); de Vos et al. Science, 255:306-312 (1992)).

Another aspect of the invention pertains to monitoring the influence of agents (e.g., drugs, compounds) on the expression or activity of proteins of the invention in clinical trials. An exemplary method for detecting the presence or absence of proteins or nucleic acids of the invention in a biological sample involves obtaining a biological sample from a test subject and contacting the biological sample with a compound or an agent capable of detecting the protein, or nucleic acid (e.g., mRNA, genomic DNA) that encodes the protein, such that the presence of the protein or nucleic acid is detected in the biological sample. A preferred agent for detecting mRNA or genomic DNA is a labeled nucleic acid probe capable of hybridizing to mRNA or genomic DNA sequences described herein, preferably in an allele-specific manner. The nucleic acid probe can be, for example, a full-length nucleic acid, or a portion thereof, such as an oligonucleotide of at least 15, 30, 50, 100, 250 or 500 nucleotides in length and sufficient to specifically hybridize under stringent conditions to appropriate mRNA or genomic DNA. Other suitable probes for use in the diagnostic assays of the invention are described herein.

The invention also encompasses kits for detecting the presence of proteins or nucleic acid molecules of the invention in a biological sample. For example, the kit can comprise a labeled compound or agent (e.g., nucleic acid probe) capable of detecting protein or mRNA in a biological sample; means for determining the amount of protein or mRNA in the sample; and means for comparing the amount of protein or mRNA in the sample with a standard. The compound or agent can be packaged in a suitable container. The kit can further comprise instructions for using the kit to detect protein or nucleic acid.

The following Examples are offered for the purpose of illustrating the present invention and are not to be construed to limit the scope of this invention. The teachings of all references cited herein are hereby incorporated herein by reference.

EXAMPLES

Identification of Single Nucleotide Polymorphisms

The polymorphisms shown in the Table were identified by resequencing of target sequences from individuals of diverse ethnic and geographic backgrounds by hybridization to probes immobilized to microfabricated arrays. The strategy and principles for design and use of such arrays are generally described in WO 95/11995.

A typical probe array used in this analysis has two groups of four sets of probes that respectively tile both strands of a reference sequence. A first probe set comprises a plurality of probes exhibiting perfect complementarily with one of the reference sequences. Each probe in the first probe set has an interrogation position that corresponds to a nucleotide in the reference sequence. That is, the interrogation position is aligned with the corresponding nucleotide in the reference sequence, when the probe and reference sequence are aligned to maximize complementarily between the two. For each probe in the first set, there are three corresponding probes from three additional probe sets. Thus, there are four probes corresponding to each nucleotide in the reference sequence. The probes from the three additional probe sets are identical to the corresponding probe from the first probe set except at the interrogation position, which occurs in the same position in each of the four corresponding probes from the four probe sets, and is occupied by a different nucleotide in the four probe sets. In the present analysis, probes were 25 nucleotides long. Arrays tiled for multiple different references sequences were included on the same substrate.

Publicly available sequences for a given gene were assembled into Gap4, which can be found on the world wide web at biozentrum.unibas.ch/˜biocomp/staden/Overview.html. PCR primers covering each exon were designed using Primer 3, which can be found on the world wide web at genome.wi.mit.edu/cgi-bin/primer/primer3.cgi. Primers were not designed in regions where there were sequence discrepancies between reads. Genomic DNA was amplified in at least 50 individuals using 2.5 pmol each primer, 1.5 mM MgCl 2 , 100 μM dNTPs, 0.75 μM AmpliTaq GOLD polymerase, and 19 ng DNA in a 15 μl reaction. Reactions were assembled using a PACKARD MultiPROBE robotic pipetting station and then put in MJ 96-well tetrad thermocyclers (96° C. for 10 minutes, followed by 35 cycles of 96° C. for 30 seconds, 59° C. for 2 minutes, and 72° C. for 2 minutes). A subset of the PCR assays for each individual were run on 3% NuSieve gels in 0.5× TBE to confirm that the reaction worked.

For a given DNA, 5 μl (about 50 ng) of each PCR or RT-PCR product were pooled (Final volume=150-200 1 μl). The products were purified using QiaQuick PCR purification from Qiagen. The samples were eluted once in 35 μl sterile water and 4 μl 10× One-Phor-All buffer (Pharmacia). The pooled samples were digested with 0.2 μ DNaseI (Promega)for 10 minutes at 37° C. and then labeled with 0.5 nmols biotin-N6-ddATP and 15μ Terminal Transferase (GibcoBRL Life Technology) for 60 minutes at 37° C. Both fragmentation and labeling reactions were terminated by incubating the pooled sample for 15 minutes at 100° C.

Low-density DNA chips (Affymetrix,CA) were hybridized following the manufacturer's instructions. Briefly, the hybridization cocktail consisted of 3M TMACl, 10 mM Tris pH 7.8,0.01% Triton X-100, 100 mg/ml herring sperm DNA (Gibco BRL), 200 pM control biotin-labeled oligo. The processed PCR products were denatured for 7 minutes at 100° C. and then added to prewarmed (37° C.) hybridization solution. The chips were hybridized overnight at 44° C. Chips were washed in 1×SSPET and 6×SSPET followed by staining with 2 μg/ml SARPE and 0.5 mg/ml acetylated BSA in 200 μl of 6×SSPET for 8 minutes at room temperature. Chips were scanned using a Molecular Dynamics scanner.

Chip image files were analyzed using Ulysses (Affymetrix, Calif.) which uses four algorithms to identify potential polymorphisms. Candidate polymorphisms were visually inspected and assigned a confidence value: high confidence candidates displayed all three genotypes, while likely candidates showed only two genotypes (homozygous for reference sequence and heterozygdus for reference and variant). Some of the candidate polymorphisms were confirmed by ABI sequencing. Identified polymorphisms were compared to several databases to determine if they were novel. Results arc shown in the Table.

Association of Thrombospondin Gene Polymorphisms with Vascular Disease To determine pivotal genes associated with premature coronary artery disease, we analyzed DNA from 347 patients with MI or coronary revascularization before age 40 (men) or 45 (women) and 422 general population controls. Cases were drawn (one per family) from a retrospective collection of sibling pairs with premature CAD. Controls were ascertained through random-digit dialing. Both cases and controls were Caucasian. A complete database of phenotypic and laboratory variables for the affected patients afforded logistic regression to control for age, diabetes, body mass index, gender.

Thrombospondin (TSP) 4 and 1 emerged as important SNPs associated with premature CAD and MI. For CAD, 148 of 347 patients carried at least one copy of the TSP4 variant compared with 142 of 422 control subjects; adjusted odds ratio 1.47, p=0.01. For premature MI, the association was even stronger: 91 of 187 cases vs. 142 of 422 controls had the variant; adjusted odds ratio 2.08, p=0.0003. The TSP-1 SNP was rare. Nonetheless, homozygosity for the variant allele gave an adjusted odds ratio of 9.5, p=0.04.

		Genbank or TIGR	Position in			Mutation
Poly ID	WIAF ID	Accession Number	Sequence	Gene Description	Flanking Seq	Type	Ref NT	Alt NT	Ref AA	Alt AA
AT3a7	WIAF-13246	U11270	11918	AT3, antithrombin III	CTGCAGGAGT[G/A]GCTGGATGAA	N	G	A	W	*
DRD5u22	WIAF-12913	M67439	310	DRD1, dopamine receptor D1	CATCTGGACC[C/T]TGCTGGGCAA	S	C	T	L	L
DRD5u23	WIAF-12914	M67439	332	DRD1, dopamine receptor D1	GTGCTGGTGT[G/C]CGCAGCCATC	M	G	C	C	S
DRD5u24	WIAF-12915	M67439	369	DRD1, dopamine receptor D1	TGCGCGCCAA[C/G]ATGACCAACG	M	C	G	N	K
DRD5u25	WIAF-12916	M67439	522	DRD1, dopamine receptor D1	TGTGCTCCAC[T/C]GCCTCCATCC	S	T	C	T	T
DRD5u26	WIAF-12917	M67439	953	DRD1, dopamine receptor D1	GCAGAGCACG[C/T]GCAGAGCTGC	M	C	T	A	V
DRD5u27	WIAF-12918	M67439	635	DRD1, dopamine receptor D1	ATGGTCGGCC[T/C]GGCATGGACC	M	T	C	L	P
DRD5u28	WIAF-12919	M67439	606	DRD1, dopamine receptor D1	GCAAGATGAC[T/C]CAGCGCATGG	S	T	C	T	T
DRD5u29	WIAF-12920	M67439	845	DRD1, dopamine receptor D1	TCGCTCATCA[G/A]CTTCTACATC	M	G	A	S	N
DRD5u30	WIAF-12921	M67439	720	DRD1, dopamine receptor D1	GGGGCGGGCT[G/T]GACCTGCCAA	S	G	T	L	L
DRD5u31	WIAF-12922	M67439	1044	DRD1, dopamine receptor D1	AGACCCTGTC[G/A]GTGATCATGG	S	G	A	S	S
DRD5u32	WIAF-12923	M67439	766	DRD1, dopamine receptor D1	GGAGGAGGAC[T/G]TTTGGGAGCC	M	T	G	F	V
DRD5u33	WIAF-12924	M67439	777	DRD1, dopamine receptor D1	TTTGGGAGCC[C/T]GACGTGAATG	S	C	T	P	P
DRD5u34	WIAF-12925	M67439	786	DRD1, dopamine receptor D1	CCGACGTGAA[T/G]GCAGAGAACT	M	T	G	N	K
DRD5u35	WIAF-12926	M67439	887	DRD1, dopamine receptor D1	ACCTACACGC[G/A]CATCTACCGC	M	G	A	R	H
DRD5u36	WIAF-12927	M67439	1279	DRD1, dopamine receptor D1	GTGCAGCCAC[T/G]TCTGCTCCCG	M	T	G	F	V
DRD5u37	WIAF-12928	M67439	1370	DRD1, dopamine receptor D1	GAAATCGCAG[C/T]TGCCTACATC	M	C	T	A	V
DRD5u38	WIAF-12929	M67439	1500	DRD1, dopamine receptor D1	ACCCTGTTGC[T/A]GAGTCTGTCT	S	T	A	A	A
DRD5u39	WIAF-12930	M67439	1338	DRD1, dopamine receptor D1	TCTCCTACAA[C/T]CAAGACATCG	S	C	T	N	N
DRD5u40	WIAF-12931	M67439	1215	DRD1, dopamine receptor D1	CACTCAACCC[C/A]GTCATCTATG	S	C	A	P	P
DRD5u41	WIAF-12932	M67439	1242	DRD1, dopamine receptor D1	ACGCCGACTT[T/C]CAGAAGGTGT	S	T	C	F	F
DRD5u42	WIAF-12933	M67439	1441	DRD1, dopamine receptor D1	CGAGGAGGAG[G/A]GTCCTTTCGA	M	G	A	G	S
DRD5u43	WIAF-12934	M67439	1460	DRD1, dopamine receptor D1	GATCGCATGT[T/C]CCAGATCTAT	M	T	C	F	S
DRD5u44	WIAF-12960	M67439	399	DRD1, dopamine receptor D1	TGTCTCTGGC[C/T]GTGTCTGACC	S	C	T	A	A
DRD5u45	WIAF-12961	M67439	162	DRD1, dopamine receptor D1	TGCCGCCAGG[C/G]AGCAACGGCA	S	C	G	G	G
DRD5u46	WIAF-12962	M67439	195	DRD1, dopamine receptor D1	GGCAGTTCGC[T/G]CTATACCAGC	S	T	G	A	A
DRD5u47	WIAF-12963	M67439	264	DRD1, dopamine receptor D1	TGGGGCCCTC[A/G]CAGGTGGTCA	S	A	G	S	S
DRD5u48	WIAF-12964	M67439	465	DRD1, dopamine receptor D1	TGGCCGGTTA[C/T]TGGCCCTTTG	S	C	T	Y	Y
DRD5u49	WIAF-12965	M67439	511	DRD1, dopamine receptor D1	CTTCGACATC[A/T]TGTGCTCCAC	M	A	T	M	L
DRD5u50	WIAF-12966	M67439	557	DRD1, dopamine receptor D1	ATCAGCGTGG[A/G]CCGCTACTGG	M	A	G	D	G
DRD5u51	WIAF-12967	M67439	476	DRD1, dopamine receptor D1	TGGCCCTTTG[G/A]AGCGTTCTGC	M	G	A	G	E
DRD5u52	WIAF-12968	M67439	1004	DRD1, dopamine receptor D1	AGCCTGCGCG[C/T]TTCCATCAAG	M	C	T	A	V
DRD5u53	WIAF-12969	M67439	1036	DRD1, dopamine receptor D1	GGTTCTCAAG[A/C]CCCTGTCGGT	M	A	C	T	P
DRD5u54	WIAF-12970	M67439	859	DRD1, dopamine receptor D1	CTACATCCCC[G/A]TTGCCATCAT	M	G	A	V	I
DRD5u55	WIAF-12971	M67439	931	DRD1, dopamine receptor D1	GATTTCCTCC[C/T]TGGAGAGGGC	S	C	T	L	L
G10u1	WIAF-10234	J04111	1308	JUN, v-jun avian sarcoma virus 17	CCCTCAACGC[C/T]TCGTTCCTCC	S	C	T	A	A
				oncogene homolog
G10u2	WIAF-10235	J04111	1471	JUN, v-jun avian sarcoma virus 17	GCTGCTCAAG[C/T]TGGCGTCGCC	S	C	T	L	L
				oncogene homolog
G10u3	WIAF-10253	J04111	2010	JUN, v-jun avian sarcoma virus 17	TGGAGTCCCA[G/A]GAGCGGATCA	S	G	A	Q	Q
				oncogene homolog
G1001u1	WIAF-13746	D26135	993	DGKG, diacylglycerol kinase,	CCCCAGTGGT[G/A]TACCTGAAGG	S	G	A	V	V
				gamma (90 kD)
G1001u2	WIAF-13764	D26135	2313	DGKG, diacylglycerol kinase,	ATGTGATGAG[A/T]GAGAAACATC	M	A	T	R	S
				gamma (90 kD)
G1002u1	WIAF-13918	X57206	334	ITPKB, inositol 1,4,5-	CCCCAAGATC[A/C]GGACAAGCCT	M	A	C	Q	P
				trisphosphate 3-kinase B
G1002u2	WIAF-13925	X57206	575	ITPKB, inositol 1,4,5-	CCAACTCAGC[T/C]TTCCTGCATA	S	T	C	A	A
				trisphosphate 3-kinase B
G1004u1	WIAF-13567	L36151	1854	PIK4CA, phosphatidylinositol 4-	GCCGCTCAGA[C/T]TCCGAGGATG	S	C	T	D	D
				kinase, catalytic, alpha
				polypeptide
G1006u1	WIAF-12375	HT2690	858	PRKCA, protein kinase C, alpha	GGTACAAGTT[G/A]CTTAACCAAG	S	G	A	L	L
G1008u1	WIAF-12397	HT2136	300	PRKCZ, protein kinase C, zeta	CTGGCCTGCC[A/G]TGTCCGGGAG	S	A	G	P	P
G1008u2	WIAF-12398	HT2136	246	PRKCZ, protein kinase C, zeta	AGTGCAGGGA[T/C]GAAGGCCTCA	S	T	C	D	D
G1008u3	WIAF-12399	HT2136	504	PRKCZ, protein kinase C, zeta	GCTGCCACGG[C/T]CTCGTCCCGC	S	C	T	G	G
G1008u4	WIAF-12403	HT2136	807	PRKCZ, protein kinase C, zeta	AGAAGAATGA[C/T]CAAATTTACG	S	C	T	D	D
G1008u5	WIAF-12404	HT2136	1514	PRKCZ, protein kinase C, zeta	GGATTTTCTG[A/T]CATCAAGTCC	M	A	T	D	V
G1008u6	WIAF-12412	HT2136	166	PRKCZ, protein kinase C, zeta	CAAGTGGGTG[G/A]ACAGCGAAGG	M	G	A	D	N
G1008u7	WIAF-12418	HT2136	560	PRKCZ, protein kinase C, zeta	TCCCAAGAGC[C/T]TCCAGTAGAC	M	C	T	P	L
G1009u1	WIAF-12396	L05186	2495	PTK2, PTK2 protein tyrosine	TCATCAACAA[G/A]ATGAAACTGG	S	G	A	K	K
				kinase 2
G1011u1	WIAF-11988	X07876	1250	WNT2, wingless-type MMTV	TCCCATGTCA[C/A]CCGGATGACC	M	C	A	T	N
				integration site family member 2
G1011u2	WIAF-11997	X07876	788	WNT2, wingless-type MMTV	GACTATGGGA[T/C]CAAATTTGCC	M	T	C	I	T
				integration site family member 2
G1011u3	WIAF-12014	X07876	1338	WNT2, wingless-type MMTV	TGCACACATG[C/A]AAGGCCCCCA	N	C	A	C	*
				integration site family member 2
G1011u4	WIAF-13475	X07876	856	WNT2, wingless-type MMTV	CCTGATGAAT[C/T]TTCACAACAA	M	C	T	L	F
				integration site family member 2
G1011u5	WIAF-13476	X07876	958	WNT2, wingless-type MMTV	GACATGCTGG[C/T]TGGCCATGGC	S	C	T	L	L
				integration site family member 2
G1011u6	WIAF-13477	X07876	789	WNT2, wingless-type MMTV	ACTATGGGAT[C/T]AAATTTGCCC	S	C	T	I	I
				integration site family member 2
G1011u7	WIAF-13478	X07876	823	WNT2, wingless-type MMTV	TGCAAAGGAA[A/G]GGAAAGGAAA	M	A	G	R	G
				integration site family member 2
G1012u1	WIAF-12408	HT48910	1574	WNT2B, wingless-type MMTV	ATACTTGCAA[A/G]GCCCCCAAGA	S	A	G	K	K
				integration site family, member 2B
G1016a1	WIAF-12125	Z22534	793	ACVR1, activin A receptor, type I	GGCAAGGGGA[A/G]AATGTTGCCG	S	A	G	E	E
G1016u2	WIAF-12392	Z22534	373	ACVR1, activin A receptor, type I	CTGGCCAAGC[T/C]GTGGAGTGCT	S	T	C	A	A
G1018u1	WIAF-12413	X74210	1150	ADCY2, adenylate cyclase 2	CAAATTGCGA[G/T]TGGGTATTAA	M	G	T	V	L
				(brain)
G1019u1	WIAF-12394	U83867	5475	SPTAN1, spectrin, alpha, non-	GGGACCTAAC[T/C]GGCGTGCAGA	S	T	C	T	T
				erythrocytic 1 (alpha-fodrin)
G1019u2	WIAF-12406	U83867	1223	SPTAN1, spectrin, alpha, non-	GCCCTCATCA[A/G]TGCAGATGAG	M	A	G	N	S
				erythrocytic 1 (alpha-fodrin)
G1019u3	WIAF-12409	U83867	3555	SPTAN1, spectrin, alpha, non-	CTGAAGGTCT[T/C]ATGGCAGAGG	S	T	C	L	L
				erythrocytic 1 (alpha-fodrin)
G1019u4	WIAF-12415	U83867	3369	SPTAN1, spectrin, alpha, non-	TCCGTGAAGC[G/A]AATGAACTAC	S	G	A	A	A
				erythrocytic 1 (alpha-fodrin)
G1019u5	WIAF-12417	U83867	5839	SPTAN1, spectrin, alpha, non-	TGAGACAGAC[T/A]TCACCGTCCA	M	T	A	F	I
				erythrocytic 1 (alpha-fodrin)
G1022u1	WIAF-12393	U45945	631	ATP1B2, ATPase, Na+/Ka+	CATGAATGTT[A/G]CCTGTGCTGG	M	A	G	T	A
				transporting, beta 2 polypeptide
G1022u2	WIAF-12400	U45945	432	ATP182, ATPase, Na+/K+	GCCGCCCTGG[G/A]CGCTATTACG	S	G	A	G	G
				transporting, beta 2 polypeptide
G1023u1	WIAF-12401	D89722	395	ARNTL, aryl hydrocarbon receptor	AACATTAAGA[G/C]GTGCCACCAA	M	G	C	G	R
				nuclear translocator-like
G1023u2	WIAF-12407	D89722	681	ARNTL, aryl hydrocarbon receptor	CTCATACATG[C/T]AAAAACTGGA	M	C	T	A	V
				nuclear translocator-like
G1024u1	WIAF-12410	U85946	731	Homo sapiens brain secretory	GATAGATTTT[C/T]AGAAGTTAAA	M	C	T	S	L
				protein hSec10p (HSEC10) mRNA,
				complete cds.
G1027u1	WIAF-12402	L47647	1135	CKB, creatine kinase, brain	TCGAGATGGA[A/G]CAGCGGCTGG	S	A	G	E	E
G1027u2	WIAF-12405	L47647	499	CKB, creatine kinase, brain	GGGAGCGCCG[A/C]GCCATCGAGA	S	A	C	R	R
G103u1	WIAF-10427	HT2269	335	ERCC5, excision repair cross-	GGGATCGCCA[T/C]GGGAACTCAA	S	T	C	H	H
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u2	WIAF-10429	HT2269	1221	ERCC5, excision repair cross-	CCCTCCTTCT[C/T]CAAGAACTTT	M	C	T	P	S
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u3	WIAF-10431	HT2269	1783	ERCC5, excision repair cross-	TCTCCAACTT[G/C]TACAAATTCT	M	G	C	C	S
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u4	WIAF-10432	HT2269	2077	ERCC5, excision repair cross-	ACTGAATCTG[C/A]AGGCCAGGAT	M	C	A	A	E
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u5	WIAF-10446	HT2269	3338	ERCC5, excision repair cross-	AATTTGAGCT[A/T]CTTGATAAGG	S	A	T	L	L
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u6	WIAF-10447	HT2269	3487	ERCC5, excision repair cross-	TCAGAATCAT[C/T]TGATGGATCT	M	C	T	S	F
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u7	WIAF-10448	HT2269	3507	ERCC5, excision repair cross-	TTCAAGTGAA[C/G]ATGCTGAAAG	M	C	G	H	D
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u8	WIAF-10457	HT2269	1388	ERCC5, excision repair cross-	CTCTTGACGA[T/G]GACGAAGATG	M	T	G	D	E
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u9	WIAF-10458	HT2269	1362	ERCC5, excision repair cross-	CCGGACTCTT[T/C]CAGCCATTAA	M	T	C	S	P
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u10	WIAF-10459	HT2269	2357	ERCC5, excision repair cross-	CTGAGAAAGA[T/C]GCGGAAGATT	S	T	C	D	D
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u11	WIAF-10462	HT2269	3109	ERCC5, excision repair cross-	TGGAACAGAA[C/T]GAAGACAGAT	M	C	T	T	M
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u12	WIAF-10463	HT2269	3138	ERCC5, excision repair cross-	GTTTCCTGTA[T/C]TAAAGCAACT	S	T	C	L	L
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u14	WIAF-10484	HT2269	3553	ERCC5, excision repair cross-	AGAACAGCTG[C/T]GAAAGAGCCA	M	C	T	A	V
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103u15	WIAF-10485	HT2269	1429	ERCC5, excision repair cross-	GATGTGCAGA[C/T]GGGAGGGCCA	M	C	T	T	M
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G103a16	WIAF-12097	HT2269	3335	ERCC5, excision repair cross-	AAGAATTTGA[G/T]CTACTTGATA	M	G	T	E	D
				complementing rodent repair
				deficiency, complementation group
				5 (xeroderma pigmentosum,
				complementation group G (Cockayne
				syndrome))
G1030u1	WIAF-12411	U07358	203	ZPK, zipper (leucine) protein	ACACTTCTGA[C/T]TGCACTCCCG	S	C	T	D	D
				kinase
G1030u2	WIAF-12416	U07358	1806	ZPK, zipper (leucine) protein	GCCACCCCAT[G/T]AACCTGGAGG	N	G	T	E	*
				kinase
G1031a1	WIAF-12124	U87460	2825	GPR37, G protein-coupled receptor	GAGTCACCAC[C/T]TTCACCTTAT	S	C	T	T	T
				37 (endothelin receptor type B-
				like)
G1032u1	WIAF-12381	U57911	926	C11ORF8, chromosome 11 open	ACGTACATCA[A/C]TGCCTCGACG	M	A	C	N	T
				reading frame 8
G1033u1	WIAF-12437	M65188	431	GJA1, gap junction protein, alpha	TCTGTACCCA[C/T]ACTCTTGTAC	M	C	T	T	I
				1, 43 kD (connexin 43)
G1033u2	WIAF-12438	M65188	169	GJA1, gap junction protein, alpha	AGGCAACATG[G/C]GTGACTGGAG	M	G	C	G	R
				1, 43 kD (connexin 43)
G1033u3	WIAF-12439	M65188	467	GJA1, gap junctiono protein, alpha	TATGTGATGC[G/A]AAAGGAAGAG	M	G	A	R	Q
				1, 43 kD (connexin 43)
G1033u4	WIAF-12440	M65188	263	GJA1, gap junction protein, alpha	TTCATTTTCC[G/A]AATCCTGCTG	M	G	A	R	Q
				1, 43 kD (connexin 43)
G1033u5	WIAF-12441	M65188	218	GJA1, gap junction protein, alpha	CAAGCCTACT[C/T]AACTGCTGGA	M	C	T	S	L
				1, 43 kD (connexin 43)
G1033u6	WIAF-12442	M65188	498	GJA1, gap junction protein, alpha	AGAAAGAGGA[A/G]GAACTCAAGG	S	A	G	E	E
				1, 43 kD (connexin 43)
G1033u7	WIAF-12465	M65188	550	GJA1, gap junction protein, alpha	GCACTTGAAG[C/A]AGATTGAGAT	M	C	A	Q	K
				1, 43 kD (connexin 43)
G1033u8	WIAF-12466	M65188	548	GJA1, gap junction protein, alpha	ATGCACTTGA[A/G]GCAGATTGAG	M	A	G	K	R
				1, 43 kD (connexin 43)
G1033u9	WIAF-12486	M65188	933	GJA1, gap junction protein, alpha	CGCTGAGCCC[T/C]GCCAAAGACT	S	T	C	P	P
				1, 43 kD (connexin 43)
G1033u10	WIAF-12487	M65188	990	GJA1, gap junction protein, alpha	CCTCACCAAC[C/T]GCTCCCCTCT	S	C	T	T	T
				1, 43 kD (connexin 43)
G1033u11	WIAF-12488	M65188	1034	GJA1, gap junction protein, alpha	AAGCTGGTTA[C/A]TGGCGACAGA	M	C	A	T	N
				1, 43 kD (connexin 43)
G1033u12	WIAF-12489	M65188	1158	GJA1, gap junction protein, alpha	CTAACTCCCA[T/C]GCACAGCCTT	S	T	C	H	H
				1, 43 kD (connexin 43)
G1033u13	WIAF-12490	M65188	1222	GJA1, gap junction protein, alpha	TGGACATGAA[T/C]TACAGCCACT	S	T	C	L	L
				1, 43 kD (connexin 43)
G1033u14	WIAF-12491	M65188	1069	GJA1, gap junction protein, alpha	CCGCAATTAC[A/G]ACAAGCAAGC	M	A	G	N	D
				1, 43 kD (connexin 43)
G1033u15	WIAF-12492	M65188	1250	GJA1, gap junction protein, alpha	TATTTGTGTC[T/C]GTACCCACAC	M	T	C	S	S
				1, 43 kD (connexin 43)
G1033u16	WIAF-12496	M65188	423	GJA1, gap junction protein, alpha	TATTTGTGTC[T/C]GTACCCACAC	S	T	C	S	S
				1, 43 kD (connexin 43)
G1033u17	WIAF-12503	M65188	880	GJA1, gap junction protein, alpha	CGTTAAGGAT[C/T]GGGTTAAGGG	M	C	T	R	W
				1, 43 kD (connexin 43)
G1033u18	WIAF-12504	M65188	855	GJA1, gap junction protein, alpha	AACTCTTCTA[T/C]GTTTTCTTCA	S	T	C	Y	Y
				1, 43 kD (connexin 43)
G1033u19	WIAF-12505	M65188	576	GJA1, gap junction protein, alpha	AGTTCAAGTA[C/T]GGTATTGAAG	S	C	T	Y	Y
				1, 43 kD (connexin 43)
G1033u20	WIAF-12512	M65188	1255	GJA1, gap junction protein, alpha	CCAGCGACCT[T/G]CAAGCAGAGC	M	T	G	S	A
				1, 43 kD (connexin 43)
G1033u21	WIAF-12513	M65188	1078	GJA1, gap junction protein, alpha	CAACAAGCAA[G/A]CAAGTGAGCA	M	G	A	A	T
				1, 43 kD (connexin 43)
G1033u22	WIAF-12514	M65188	1097	GJA1, gap junction protein, alpha	CAAAACTGGG[C/G]TAATTACAGT	M	C	G	A	G
				1, 43 kD (connexin 43)
G1034u1	WIAF-12443	J03544	1201	PYGB, phosphorylase, glycogen;	AGACCTGTGC[A/G]TACACCAACC	S	A	G	A	A
				brain
G1034u2	WIAF-12469	J03544	771	PYGB, phosphorylase, glycogen;	GACACCCCAG[T/C]GCCCGGCTAC	M	T	C	V	A
				brain
G1034u3	WIAF-12470	J03544	1465	PYGB, phosphorylase, glycogen;	TCCACTCGGA[G/C]ATCGTGAAAC	M	G	C	E	D
				brain
G1034u4	WIAF-12471	J03544	1583	PYGB, phosphorylase, glycogen;	GGGGCTGGCC[G/A]ATACCATCGT	M	G	A	D	N
				brain
G1034u5	WIAF-12472	J03544	1774	PYGB, phosphorylase, glycogen;	CCATGTTCGA[T/C]GTGCATGTGA	S	T	C	D	D
				brain
G1034u6	WIAF-12474	J03544	2449	PYGB, phosphorylase, glycogen;	AGGTGGACCA[G/A]CTGTACCGGA	S	G	A	Q	Q
				brain
G1034u7	WIAF-12508	J03544	718	PYGB, phosphorylase, glycogen;	CCCCCGACGG[C/T]GTGAAGTGGC	S	C	T	G	G
				brain
G1035u1	WIAF-12484	U97105	1962	DPYSL2, dihydropyrimidinase-like	GCAGAGGAGC[A/G]GCAGAGGATC	M	A	G	Q	R
				2
G1035u2	WIAF-12485	U97105	2842	DPYSL2, dihydropyrimidinase-like	ATGACGGACC[T/C]GTGTGTGAAG	S	T	C	P	P
				2
G1035u3	WIAF-12511	U97105	2062	DPYSL2, dihydropyrimidinase-like	CCATCACCAT[C/T]GCCAACCAGA	S	C	T	I	I
				2
G1036u1	WIAF-12444	D88460	311	WASL, Wiskott-Aldrich syndrome-	ACGTGGGGTC[C/T]CTGTTGCTCA	S	C	T	S	S
				like
G1038u1	WIAF-12445	HT2746	994	PCTK2, PCTAIRE protein kinase 2	TAGAAGAAAG[G/A]TATTGCATCG	M	G	A	V	I
G1039u1	WIAF-12429	HT2747	955	serine/threonine kinase, PCTAIRE-3	ATCCAAGAGT[C/T]GCATGTCAGC	M	C	T	R	C
G1039u2	WIAF-12458	HT2747	808	serine/threonine kinase, PCTAIRE-3	CACAGAAGAG[A/T]CGTGGCCCGG	M	A	T	T	S
G1041u1	WIAF-12459	X72886	544	H. sapiens TYRO3 mRNA.	CAAGTGGCTG[G/C]CCCTGGAGAG	M	G	C	A	P
G1041u2	WIAF-12460	X72886	693	H. sapiens TYRO3 mRNA.	TTGGCGGGAA[C/T]CGCCTGAAAC	S	C	T	N	N
G1041u3	WIAF-12502	X72886	561	H. sapiens TYRO3 mRNA.	AGAGCCTGGC[C/T]GACAACCTGT	S	C	T	A	A
G1043u1	WIAF-12448	M94055	5481	Human voltage-gated sodium channel	CTCTGAGTGA[G/A]GATGACTTTG	S	G	A	E	E
				mRNA, complete cds.
G1043u2	WIAF-12449	M94055	5205	Human voltage-gated sodium channel	TTGAGACCTT[T/C]GGCAACAGCA	S	T	C	F	F
				mRNA, complete cds.
G1043u3	WIAF-12450	M94055	5224	Human voltage-gated sodium channel	CATGATCTGC[C/T]TGTTCCAAAT	S	C	T	L	L
				mRNA, complete cds.
G1043u4	WIAF-12451	M94055	5514	Human voltage-gated sodium channel	AGGTTTGGGA[G/A]AAGTTTGATC	S	G	A	E	E
				mRNA, complete cds.
G1043u5	WIAF-12452	M94055	5217	Human voltage-gated sodium channel	GCAACAGCAT[G/C]ATCTGCCTGT	M	G	C	M	I
				mRNA, complete cds.
G1043u6	WIAF-12453	M94055	5334	Human voltage-gated sodium channel	GCTCAGTTAA[A/G]GGAGACTGTG	S	A	G	K	K
				mRNA, complete cds.
G1043u7	WIAF-12454	M94055	5424	Human voltage-gated sodium channel	TGTACATCGC[G/C]GTCATCCTGG	S	G	C	A	A
				mRNA, complete cds.
G1043u8	WIAF-12455	M94055	5322	Human voltage-gated sodium channel	ATCACCCTGG[A/C]AGCTCAGTTA	S	A	C	G	G
				mRNA, complete cds.
G1043u9	WIAF-12456	M94055	1200	Human voltage-gated sodium channel	ATGGCTACAG[G/A]AGCTTTGACA	S	G	A	T	T
				mRNA, complete cds.
G1043u10	WIAF-12499	M94055	1170	Human voltage-gated sodium channel	TCTGTGTGAA[G/T]GCTGGTAGAA	M	G	T	K	N
				mRNA, complete cds.
G1046a1	WIAF-13187	U50352	267	ACCN1, amiloride-sensitive cation	TCCCAGCTGT[G/A]ACCCTCTGTA	S	G	A	V	V
				channel 1, neuronal (degenerin)
G1046a2	WIAF-13188	U50352	282	ACCN1, amiloride-sensitive cation	TCTGTAACCT[C/g]AATGGCTTCC	S	C	g	L	L
				channel 1, neuronal (degenerin)
G1046a3	WIAF-13189	U50352	315	ACCN1, amiloride-sensitive cation	TCACCACCAA[C/t]GACCTGTACC	S	C	t	N	N
				channel 1, neuronal (degenerin)
G1046a4	WIAF-13190	U50352	386	ACCN1, amiloride-sensitive cation	CCCCATCTGG[C/a]TGACCCCTCC	M	C	a	A	D
				channel 1, neuronal (degenerin)
G1046a5	WIAF-13191	U50352	417	ACCN1, amiloride-sensitive cation	CCCTGCGGCA[G/A]AAGGCCAACT	S	G	A	Q	Q
				channel 1, neuronal (degenerin)
G1048u1	WIAF-12641	HT5174S	3214	REST, RE1-silencing transcription	CAGTCAAAGC[G/A]GCTAAGGGAG	S	G	A	A	A
				factor
G1048u2	WIAF-12642	HT5174S	3199	REST, RE1-silencing transcription	CAAAGGAAGC[C/G]TTGGCAGTCA	S	C	G	A	A
				factor
G1048u3	WIAF-12657	HT5174S	2125	REST, RE1-silencing transcription	CTCCCATGGA[G/T]ACTGCTCAGA	M	G	T	S	D
				factor
G1048u4	WIAF-12660	HT5174S	2333	REST, RE1-silencing transcription	GGAACCTGTT[A/C]AGATAGAGCT	M	A	C	K	Q
				factor
G1051u1	WIAF-12431	HT28321	658	SCNN1G, sodium channel,	ATGACACCTC[C/T]GACTGTGCCA	S	C	T	S	S
				nonvoltge-gated 1, gamma
G1051u2	WIAF-12434	HT28321	1735	SCNN1G, sodium channel,	AAGCCAAGGA[G/A]TGGTGCGCCT	S	G	A	E	S
				nonvoltage-gated 1, gamma
G1051u3	WIAF-12473	HT28321	409	SCNN1G, sodium channel,	AGTCCCTGTA[T/C]GGCTTTCCAG	S	T	C	Y	Y
				nonvoltage-gated 1, gamma
G1051u4	WIAF-12475	HT28321	953	SCNN1G, sodium channel,	AGTCATTTTG[T/C]ACATAAACGA	M	T	C	Y	H
				nonvoltage-gated 1, gamma
G1051u5	WIAF-12476	HT28321	975	SCNN1G, sodium channel,	GAGGAATACA[A/G]CCCATTCCTC	M	A	G	N	S
				nonvoltage-gated 1, gamma
G1051u6	WIAF-12477	HT28321	1192	SCNN1G, sodium channel,	CTGCCTACTC[G/A]CTCCAGATCT	S	G	A	S	S
				nonvoltage-gated 1, gamma
G1053a1	WIAF-13192	HT2201	4085	SCN5A, sodium channel, voltage-	CGTCCTCTGA[G/A]AGCTCTGTCA	N	G	A	R	K
				gated, type V, alpha polypeptide
				(long (electrocardiographic) QT
				syndrome 3)
G1053a2	WIAF-13193	HT2201	5607	SCN5A, sodium channel, voltage-	ACTTTGCCGA[C/T]GCCCTGTCTG	S	C	T	D	D
				gated, type v, alpha polypeptide
				(long (electrocardiographic) QT
				syndrome 3)
G1053a3	WIAF-13194	HT2201	5828	SCN5A, sodium channel, voltage-	GAGCCCATCA[C/T]CACCACACTC	M	C	T	T	I
				gated, type v, alpha polypeptide
				(long (electrocardiographic) QT
				syndrome 3)
G1053a4	WIAF-13202	HT2201	713	SCN5A, sodium channel, voltage-	GCGTTCACTT[T/A]CCTTCGGGAC	M	T	A	F	Y
				gated, type v, alpha polypeptide
				(long (electrocardiographic) QT
				syndrome 3)
G1053a5	WIAF-13203	HT2201	6148	SCN5A, sodium channel, voltage-	CCACAGTGAA[G/T]ATCTCGCCGA	M	G	T	D	Y
				gated, type v, alpha polypeptide
				(long (electrocardiographic) QT
				syndrome 3)
G1053a6	WIAF-13204	HT2201	6217	SCN5A, sodium channel, voltage-	GGCCTGGCTG[G/T]CCAGGACACA	—	G	T	—	—
				gated, type v, alpha polypeptide
				(long (electrocardiographic) QT
				syndrome 3)
G1053a7	WIAF-13205	HT2201	6324	SCN5A, sodium channel, voltage-	AATGGGCCTC[G/A]GCCCCGCGGA	—	G	A	—	—
				gated, type v, alpha polypeptide
				(long (electrocardiographic) QT
				syndrome 3)
G1054u1	WIAF-12419	HT2202	2252	SCN5A, sodium channel, voltage-	TTGGGAAGAG[C/T]TACAAGGAGT	S	C	T	S	S
				gated, type IV, alpha polypeptide
G1054u2	WIAF-12423	HT2202	4559	SCN4A, sodium channel, voltage-	TGGTCATGTT[C/T]ATCTACTCCA	S	C	T	F	F
				gated, type IV, alpha polypeptide
G1054u3	WIAF-12424	HT2202	4856	SCN4A, sodium channel, voltage-	TGAACATGTA[C/G]ATCGCCATCA	N	C	G	Y	*
				gated, type IV, alpha polypeptide
G1054u4	WIAF-12425	HT2202	4777	SCN4A, sodium channel, voltage-	GTGAAGGGTG[A/G]CTGCGGGAAC	M	A	G	D	G
				gated, type IV, alpha polypeptide
G1054u5	WIAF-12426	HT2202	4863	SCN4A, sodium channel, voltage-	GTACATCGCC[A/G]TCATCCTGGA	M	A	G	I	V
				gated, type IV, alpha polypeptide
G1054u6	WIAF-12427	HT2202	4566	SCN4A, sodium channel, voltage-	GTTCATCTAC[T/G]CCATCTTCGG	M	T	G	S	A
				gated, type IV, alpha polypeptide
G1054u7	WIAF-12428	HT2202	4923	SCN4A, sodium channel, voltage-	TGGTGAAGAT[G/T]ACTTTGAGAT	M	G	T	D	Y
				gated, type IV, alpha polypeptide
G1054u8	WIAF-12446	HT2202	3595	SCN4A, sodium channel, voltage-	TTCTGGCTGA[T/C]CTTCAGCATC	M	T	C	I	T
				gated, type IV, alpha polypeptide
G1054u9	WIAF-12447	HT2202	4203	SCN4A, sodium channel, voltage-	GGAGACAGAC[G/A]ACCAGAGCCA	M	G	A	D	N
				gated, type IV, alpha polypeptide
G1054u10	WIAF-12495	HT2202	4811	SCN4A, sodium channel, voltage-	TCTGCTTCTT[C/A]TGCAGCTATA	N	C	A	F	L
				gated, type IV, alpha polypeptide
G1054u11	WIAF-12497	HT2202	5555	SCN4A, sodium channel, voltage-	CAGGGCAGAC[T/G]GTGCGCCCAG	S	T	G	T	T
				gated, type IV, alpha polypeptide
G1054u12	WIAF-12498	HT2202	5480	SCN4A, sodium channel, voltage-	CAGGGGACGC[C/T]GGACCCACTA	S	C	T	A	A
				gated, type IV, alpha polypeptide
G1059u1	WIAF-12432	HT33704	112	APLP1, amyloid beta (A4)	CGCTGCTGCT[G/A]CCACTATTGC	S	G	A	L	L
				precursor-like protein 1
G1059u2	WIAF-12433	HT33704	140	APLP1, amyloid beta (A4)	TCTGCGCGCG[C/T]AGCCCGCCAT	N	C	T	Q	*
				precursor-like protein 1
G1059u3	WIAF-12435	HT33704	1344	APLP1, amyloid beta (A4)	CAGCATGTGG[C/T]CGCCGTGGAT	M	C	T	A	V
				precursor-like protein 1
G1059u4	WIAF-12457	HT33704	1687	APLP1, amyloid beta (A4)	ATGAGCGAAA[G/A]GTGAATGCGT	S	G	A	K	K
				precursor-like protein 1
G1059u5	WIAF-12500	HT33704	976	APLP1, amyloid beta (A4)	GGTTCCTGAG[A/G]GCCAAGATGG	S	A	G	R	R
				precursor-like protein 1
G1059u6	WIAF-12501	HT33704	1786	APLP1, amyloid beta (A4)	GTGAGGCTGT[A/G]TCGGGTCTGC	S	A	G	V	V
				precursor-like protein 1
G1060u1	WIAF-12436	HT1418	1744	APLP2, amyloid beta (A4)	CGAAGAAATT[C/G]AAGAGGAAAT	M	C	G	Q	E
				precursor-like protein 2
G1060u2	WIAF-12467	HT1418	2213	APLP2, anyloid beta (A4)	ATCAGCCTGG[T/G]GATGCTGAGG	M	T	G	V	G
				precursor-like protein 2
G1060u3	WIAF-12468	HT1418	2256	APLP2, anyloid beta (A4)	GCCACGGGAT[C/T]GTGGAGGTTG	S	C	T	I	I
				precursor-like protein 2
G1066a1	WIAF-13195	HT3538	566	CCKBR, cholecystokinin B receptor	CTTTGGCACC[G/A]TCATCTGCAA	M	G	A	V	I
G1066a2	WIAF-13196	HT3538	607	CCKBR, cholecystokinin B receptor	GGGTGTCTGT[G/A]AGTGTGTCCA	S	G	A	V	V
G1066a3	WIAF-13206	HT3538	864	CCKBR, cholecystokinin B receptor	CTGCTGCTTC[T/A]GCTCTTGTTC	M	T	A	L	Q
G1067u1	WIAF-12478	HT0830	684	KCNA1, potassium voltage-gated	AAACGCTGTG[C/T]ATCATCTGGT	S	C	T	C	C
				channel, shaker-related subfamily,
				member 1 (episodic ataxia with
				myokymia)
G1067u2	WIAF-12479	HT0830	722	KCNA1, potassium voltage-gated	GTGCGCTTCT[T/C]CGCCTGCCCC	M	T	C	F	S
				channel, shaker-related subfamily,
				member 1 (episodic ataxia with
				myokymia)
G1067u3	WIAF-12480	HT0830	804	KCNA1, potassium voltage-gated	ATTTCATCAC[C/G]CTGGGCACCG	S	C	G	T	T
				channel, shaker-related subfamily,
				member 1 (episodic ataxia with
				myokymia)
G1067u4	WIAF-12509	HT0830	690	KCNA1, potassium voltage-gated	TGTGCATCAT[C/T]TGGTTCTCCT	S	C	T	I	I
				channel, shaker-related subfamily,
				member 1 (episodic ataxia with
				myokymia)
G1068u1	WIAF-12493	HT0831	774	KCNA2, potassium voltage-gated	TGAACATCAT[T/A]GACATTGTGG	S	T	A	I	I
				channel, shaker-related subfamily,
				member 2
G1070a1	WIAF-13197	HT27728	522	KCNJ6, potassium inwardly-	CACAGTGACC[T/C]GGCTCTTTTT	M	T	C	W	R
				rectifying channel, subfamily J.
				member 6
G1070a2	WIAF-13201	HT27728	1244	KCNJ6, potassium inwardly-	CCCTGGAGGA[T/C]GGGTTCTACG	S	T	C	D	D
				rectifying channel, subfamily J.
				member 6
G1070a3	WIAF-13207	HT27728	707	KCNJ6, potassium inwardly-	ATAAATGCCC[G/A]GAGGGAATTA	S	G	A	P	P
				rectifying channel, subfamily J.
				member 6
G1071u1	WIAF-12422	HT38672	1534	KCNJ3, potassium inwardly-	TTCCGGGCAA[C/T]TCAGAAGAAA	S	C	T	N	N
				rectifying channel, subfamily J.
				member 3
G1073u1	WIAF-12461	HT4556	1127	KCNJ1, potassium inwardly-	CACTGTGCCA[T/C]GTGCCTTTAT	M	T	C	M	T
				rectifying channel, subfamily J.
				member 1
G1074u1	WIAF-12462	HT27804	289	KCNAB2, potassium voltage-gated	ACCTCTTCGA[T/C]ACAGCAGAAG	S	T	C	D	D
				channel, shaker-related subfamily,
				beta member 2
G1079u1	WIAF-12463	HT27383	1130	potassium channel, inwardly	ACCTGGCCGA[T/A]GAGATCCTGT	M	T	A	D	E
				rectifing (GB:D50582)
G1079u2	WIAF-12464	HT27383	1192	potassium channel, inwardly	CGTTACTCTG[T/G]GGACTACTCC	M	T	G	V	G
				rectifing (GB:D50582)
G1079u3	WIAF-12481	HT27383	708	potassium channel, inwardly	GCTTGGCTAC[A/G]TCTTCATGAA	M	A	G	I	V
				rectifing (GB:D50582)
G1079u4	WIAF-12482	HT27383	779	potassium channel, inwardly	CGGTGATCGC[T/C]CTGCGCCACG	S	T	C	A	A
				rectifing (GB:D50582)
G1079u5	WIAF-12483	HT27383	276	potassium channel, inwardly	GGACCCTGCC[G/A]AGCCCAGGTA	M	G	A	E	K
				rectifing (GB:D50582)
G1079u6	WIAF-12510	HT27383	489	potassium channel, inwardly	GTGGCTCATC[G/A]CCTTCGCCCA	M	G	A	A	T
				rectifing (GB:D50582)
G1080u1	WIAF-12536	HT4412	1099	KCNJ4, potassium inwardly-	TGGACTACTC[A/G]CGTTTTCACA	S	A	G	S	S
				rectifying channel, subfamily J.
				member 4
G1080u2	WIAF-12537	HT4412	1050	KCNJ4, potassium inwardly-	GGCCACCGCT[T/A]TGAGCCTGTG	M	T	A	F	Y
				rectifying channel, subfamily J.
				member 4
G1081u1	WIAF-12538	HT27724	1090	KCNJ2, potassium inwardly-	GGCCACCGCT[A/T]TGAGCCTGTG	M	A	T	Y	F
				rectifying channel, subfamily J.
				member 2
G1082u1	WIAF-12662	HT28319	768	potassium channel, inwardly	CGCGGGTCAC[C/T]GAGGAGGGCT	S	C	T	T	T
				rectifying, high conductance,
				alpha subunit
G1082u2	WIAF-12663	HT28319	854	potassium channel, inwardly	CTGGTGTCGC[C/T]CATCACCATC	M	C	T	P	L
				rectifying, high conductance,
				alpha subunit
G1082u3	WIAF-12679	HT28319	471	potassium channel, inwardly	TCTCCATCGA[G/C]ACGCAGACCA	M	G	C	E	D
				rectifying, high conductance,
				alpha subunit
G1084a1	WIAF-13198	HT0383	2028	KCNB1, potassium voltage-gated	CACTCCCCAG[C/A]AAGACTGGGG	M	C	A	S	R
				channel, Shab-related subfamily,
				member 1
G1084a2	WIAF-13199	HT0383	2033	KCNB1, potassiuim voltage-gated	CCCAGCAAGA[C/G]TGGGGGCAGC	M	C	G	T	S
				channel, Shab-related subfamily,
				member 1
G1084a3	WIAF-13200	HT0383	2321	KCNB1, potassium voltage-gated	GAGTGTGCCA[C/A]GCTTTTGGAC	M	C	A	T	K
				channel, Shab-related subfamily,
				member 1
G1084a4	WIAF-13208	HT0383	870	KCNB1, potassium voltage-gated	ACAACCCCCA[G/A]CTGGCCCACG	S	G	A	Q	Q
				channel, Shab-related subfamily,
				member 1
G1088u1	WIAF-12516	HT0522	1503	KCNA5, potassium voltage-gated	TCCTGGGCAA[G/A]ACCTTGCAGG	S	G	A	K	K
				channel, shaker-related subfamily,
				member 5
G1088u2	WIAF-12519	HT0522	1249	KCNA5, potassium voltage-gated	CGAGCTGCTC[G/A]TGCGGTTCTT	M	G	A	V	M
				channel, shaker-related subfamily,
				member 5
G1088u3	WIAF-12520	HT0522	973	KCNA5, potassium voltage-gated	CTCTGGGTCC[G/A]CGCGGGCCAT	M	G	A	A	T
				channel, shaker-related subfamily,
				member 5
G1088u4	WIAF-12521	HT0522	1013	KCNA5, potassium voltage-gated	GTTATCCTCA[T/C]CTCCATCATC	M	T	C	I	T
				channel, shaker-related subfamily,
				member 5
G1090u1	WIAF-12651	HT1497	1836	KCNA6, potassium voltage-gated	CAACCAGCCA[G/A]TGGAGGAGGC	M	G	A	S	N
				channel, shaker-related subfamily,
				member 6
G1091u1	WIAF-12714	HT0222	843	KCNA3, potassium voltage-gated	CATCATCTGG[T/C]TCTCCTTCGA	M	T	C	F	L
				channel, shaker-related subfamily,
				member 3
G1094a1	WIAF-13218	HT27381	1280	KCNJ8, potassium inwardly-	GTGTATTCTG[G/a]GGATTACTCC	M	T	a	V	E
				rectifying channel, subfamily J.
				member 8
G1095u1	WIAF-12532	HT2629	765	KCNMA1, potassium large	TTCTCTACTT[C/T]GGCTTGCGGT	S	C	T	F	F
				conductance calcium-activated
				channel, subfamily M, alpha member
				1
G1095u2	WIAF-12533	HT2629	2441	KCNMA1, potassium large	GTGGTCTGCA[T/C]CTTTGGCGAC	M	T	C	I	T
				conductance calcium-activated
				channel, subfamily M, alpha member
				1
G1095u3	WIAF-12534	HT2629	2714	KCNMA1, potassium large	GATGATACTT[C/G]GCTGCAGGAC	M	C	G	S	W
				conductance calcium-activated
				channel, subfamily M, alpha member
				1
G1095u4	WIAF-12535	HT2629	2439	KCNMA1, potassium large	TCGTGGTCTG[C/T]ATCTTGGGCG	S	C	T	C	C
				conductance calcium-activated
				channel, subfamily M, alpha member
				1
G1095u5	WIAF-12539	HT2629	3048	KCNMA1, potassium large	CACTCATGAG[C/T]GCGACCTACT	S	C	T	S	S
				conductance calcium-activated
				channel, subfamily M, alpha member
				1
G1095u6	WIAF-12544	HT2629	2352	KCNMA1, potassium large	GGATGTTTCA[C/T]TGGTGTGCAC	S	C	T	H	H
				conductance calcium-activated
				channel, subfamily M, alpha member
				1
G1095u7	WIAF-12545	HT2629	2392	KCNMA1, potassium large	CATCCTGACT[C/T]GAAGTGAAGC	N	C	T	R	*
				conductance calcium-activated
				channel, subfamily M, alpha member
				1
G1095u8	WIAF-12546	HT2629	2295	KCNMA1, potassium large	CTGGCAATGA[T/C]CAGATTGACA	S	T	C	D	D
				conductance calcium-activated
				channel, subfamily M, alpha member
				1
G1095u9	WIAF-12548	HT2629	2949	KCNMA1, potassium large	AGTTTTTGGA[C/T]CAAGACGATG	S	C	T	D	D
				conductance calcium-activated
				channel, subfamily M, alpha member
				1
G1095u10	WIAF-12549	HT2629	2865	KCNMA1, potassium large	TGCACGGGAT[G/A]TTACGTCAAC	M	G	A	M	I
				conductance calcium-activated
				channel, subfamily M, alpha member
				1
G1096u1	WIAF-12547	L26318	930	PRKM8, protein kinase mitogen-	TGCTGGTAAT[A/T]GATGCATCTA	S	A	T	I	I
				activated 8 (MAP kinase)
G1098u1	WIAF-12515	L19711	2650	DAG1, dystroglycan 1 (dystrophin-	TCTACCTGCA[C/T]ACAGTCATTC	S	C	T	H	H
				associated glycoprotein 1)
G110u1	WIAF-10385	HT27392	230	meiosis-specific recA homolog,	CAAAGGTATA[C/T]AGATGACAAC	N	T	C	Q	*
				HsLim15
G110u2	WIAF-10397	HT27392	1050	meiosis-specific recA homolog,	CCTGAAAATG[A/G]AGCCACCTTC	M	A	G	E	G
				HsLim15
G110u3	WIAF-10399	HT27392	674	meiosis-specific recA homolog,	TGAACATCAG[A/G]TGGAGCTACT	M	A	G	M	V
				HsLim15
G1106u1	WIAF-12647	HT5073	5781	MAP1B, microtubule-associated	ACTATGAGAA[G/A]ATAGAGAGAA	S	G	A	K	K
				protein 1B
G1106u2	WIAF-12648	HT5073	5916	MAP1B, microtubule-associated	CTGAAGAGGG[C/T]GGGTACTCAT	S	C	T	G	G
				protein 1B
G1106u3	WIAF-12650	HT5073	1837	MAP1B, microtubule-associated	AGACAAGCCA[G/A]TAAAAACAGA	M	G	A	V	I
				protein 1B
G1106u4	WIAF-12653	HT5073	2476	MAP1B, microtubule-associated	CACCACAGCA[G/A]CTGTCATGGC	M	G	A	A	T
				protein 1B
G1106u5	WIAF-12656	HT5073	3913	MAP1B, microtubule-associated	GCCCAATGAG[A/G]TTAAAGTCTC	M	A	G	I	V
				protein 1B
G1106u6	WIAF-12667	HT5073	559	MAP1B, microtubule-associated	GATTTTCACC[G/A]ATCAAGAGAT	M	G	A	D	N
				protein 1B
G1106u7	WIAF-12668	HT5073	570	MAP1B, microtubule-associated	ATCAAGAGAT[C/T]GGGGAGTTAC	S	C	T	I	I
				protein 1B
G1106u8	WIAF-12669	HT5073	6175	MAP1B, microtubule-associated	TACTTCCACA[T/C]ACTGTTACGA	M	T	C	Y	H
				protein 1B
G1106u9	WIAF-12670	HT5073	1215	MAP1B, microtubule-associated	TCACTCTCCA[G/C]TACCTAAACA	M	G	C	Q	H
				protein 1B
G1106u10	WIAF-12672	HT5073	1821	MAP1B, microtubule-associated	AGGTAATGGT[G/A]AAAAAAGACA	S	G	A	V	V
				protein 1B
G1106u11	WIAF-12673	HT5073	2727	MAP1B, microtubule-associated	GTCGTGCCGA[G/T]TCCCCTGATG	M	G	T	E	D
				protein 1B
G1106u12	WIAF-12674	HT5073	2739	MAP1B, microtubule-associated	CCCCTGATGA[G/A]GGAATCACTA	S	G	A	E	E
				protein 1B
G1106u13	WIAF-12676	HT5073	3643	MAP1B, microtubule-associated	AGATGCCACT[G/A]ATGGCAAGGA	M	G	A	D	N
				protein 1B
G1106u14	WIAF-12677	HT5073	3609	MAP1B, microtubule-associated	CACCGCTCAA[C/T]GGATTTTCTG	S	C	T	N	N
				protein 1B
G1106u15	WIAF-12682	HT5073	4752	MAP1B, microtubule-associated	TTCCAGAGCC[A/T]ACAACAGATG	S	A	T	P	P
				protein 1B
G1110u1	WIAF-12517	HT1096	1527	myelin aesociated glycoprotein	GCGGCCTCGT[G/C]CTCACCAGCA	S	G	C	V	V
G1110u2	WIAF-12518	HT1096	1678	myelin aseociated glycoprotein	TGTGGGCGCC[G/T]TGGTCGCCTT	M	G	T	V	L
G1110u3	WIAF-12522	HT1096	1271	myelin associated glycoprotein	GCCGTGTCAC[C/T]CGAGGATGAT	M	C	T	P	L
G1113u1	WIAF-12523	HT2242	353	myelin transcription factor 1	AATTCCGATC[G/T]GATCCTCAGG	M	G	T	R	L
G1116a1	WIAF-13217	HT28451	417	myelin oligodendrocyte	CAAGCTTATC[G/A]AGACCCTCTC	S	G	A	S	S
				glycoprotein (MOG)
G1116a2	WIAF-13219	HT28451	913	myelin oligodendrocyte	GCAGATCACT[C/G]TTGGCCTCGT	M	C	G	L	V
				glycoprotein (MOG)
G1116a3	WIAF-13220	HT28451	922	myelin oligodendrocyte	TCTTGGCCTC[G/A]TCTTCCTCTG	M	G	A	V	I
				glycoprotein (MOG)
G1120u1	WIAF-12525	HT3695	1200	neurofilament, subunit H	TAGAGATAGC[T/C]GCTTACAGAA	S	T	C	A	A
G1123u1	WIAF-12542	HT2569	2269	OMG, oligodendrocyte myelin	CAGCTGCAAC[T/C]CTAACTATTC	S	T	C	T	T
				glycoprotein
G1126u1	WIAF-12526	HT28354	626	PSEN2, presenilin 2 (Alzheimer	GAGCGAAGCA[T/C]GTGATCATGC	S	T	C	H	H
				disease 4)
G1126u2	WIAF-12527	HT28354	494	PSEN2, presenilin 2 (Alzheimer	ATGGAGAGAA[T/C]ACTGCCCAGT	S	T	C	N	N
				disease 4)
G1126u3	WIAF-12528	HT28354	434	PSEN2, presenilin 2 (Alzheimer	TAATGTCGGC[C/T]GAGAGcCCCA	S	C	T	A	A
				disease 4)
G1126u4	WIAF-12543	HT28354	550	PSEN2, presenilin 2 (Alzheimer	GACCCTGACC[G/A]CTATGTCTGT	M	G	A	R	H
				disease 4)
G117u1	WIAF-10391	HT27765	156	GTBP, G/T mismatch-binding	ACTTCTCACC[A/G]GGAGATTTGG	S	A	G	P	P
				protein
G117u2	WIAF-10392	HT27765	420	GTBP, G/T mismatch-binding	AACGTGCAGA[T/C]GAAGCCTTAA	S	T	C	D	D
				protein
G117u3	WIAF-10407	HT27765	939	GTBP, G/T mismatch-binding	CCCACGTTAG[T/C]GGAGGTGGTG	S	T	C	S	S
				protein
G117u4	WIAF-10411	HT27765	1622	GTBP, G/T mismatch-binding	CATTGTTCGA[G/A]ATTTAGGACT	M	G	A	R	K
				protein
G117u5	WIAF-10412	HT27765	2405	GTBP, G/T mismatch-binding	GACAGCAGGG[C/T]TATAATGTAT	M	C	T	A	V
				protein
G117u6	WIAF-10413	HT27765	2387	GTBP, G/T mismatch-binding	AAGAGTCAGA[A/T]CCACCCAGAC	M	A	T	N	I
				protein
G125u1	WIAF-10371	HT28632	1999	ATM, ataxia telangiectasia	CAGTAATTTT[C/T]CTCATCTTGT	M	C	T	P	S
				mutated (includes complementation
				groups A, C and D)
G125u2	WIAF-10372	HT28632	2631	ATM, ataxia telangiectasia	TAATGAATGA[C/A]ATTGCAGATA	M	C	A	D	E
				mutated (includes complementation
				groups A, C and D)
G125u3	WIAF-10373	HT28632	3084	ATM, ataxia telangiectasia	CAATGGAAGA[T/C]GTTCTTGAAC	M	T	G	D	E
				mutated (includes complementation
				groups A, C and D)
G125u5	WIAF-10375	HT28632	4767	ATM, ataxia telangiectasia	CACTTATACC[C/T]CTTGTGTATG	S	C	T	P	P
				mutated (includes complementation
				groups A, C and D)
G125u6	WIAF-10383	HT28632	8713	ATM, ataxia telangiectasia	ATTCTTGGAT[C/T]CAGCTATTTG	M	C	T	P	S
				mutated (includes complementation
				groups A, C and D)
G125u7	WIAF-10396	HT28632	1825	ATM, ataxia telangiectasia	GACTTTGGCA[C/G]TGACCACCAG	M	C	G	L	V
				mutated (includes complementation
				groups A, C and D)
G125u8	WIAF-10398	HT28632	2924	ATM, ataxia telangiectasia	ACTACTGCTC[A/G]CACCAATACT	M	A	G	Q	R
				mutated (includes complementation
				groups A, C and D)
G125u9	WIAF-10405	HT28632	8967	ATM, ataxia telangiectasia	TTGAAGGTGT[C/T]TTCAGAAGAT	S	C	T	V	V
				mutated (includes complementation
				groups A, C and D)
G125u10	WIAF-10408	HT28632	6954	ATM, ataxia telangiectasia	CCAAACACCT[T/C]GTAGAACTCT	S	T	C	L	L
				mutated (includes complementation
				groups A, C and D)
G125u11	WIAF-10409	HT28632	6855	ATM, ataxia telangiectasia	TTCAGGAGCC[T/C]ATCATGGCTC	S	T	C	P	P
				mutated (includes complementation
				groups A, C and D)
G125u12	WIAF-10410	HT28632	6801	ATM, ataxia telangiectasia	TATATATTAA[G/T]TGGCAGAAAC	M	G	T	K	N
				mutated (includes complementation
				groups A, C and D)
G125u13	WIAF-10421	HT28632	335	ATM, ataxia telangiectasia	CATTCAGATT[C/G]CAAACAAGGA	M	C	G	S	C
				mutated (includes complementation
				groups A, C and D)
G125u14	WIAF-11607	HT28632	3966	ATM, ataxia telangiectasia	TTCCACATCT[G/A]GTGATTAGAA	S	G	A	L	L
				mutated (includes complementation
				groups A, C and D)
G125a15	WIAF-13130	HT28632	8642	ATM, ataxia telangiectasia	GAGAAATATG[A/C]AGTCTTCATG	M	A	C	E	A
				mutated (includes complementation
				groups A, C and D)
G136u1	WIAF-10388	HT3337	535	MLH1, mutL ( E. coli ) homolog 1	AGGAGAAAAG[C/T]TTTAAAAAAT	M	C	T	A	V
				(colon cancer, nonpolyposis type
				2)
G136u2	WIAF-10389	HT3337	769	MLH1, mutL ( E. coli ) homolog 1	TTCAAAATGA[A/G]TGGTTACATA	M	A	G	N	S
				(colon cancer, nonpolyposis type
				2)
G144u1	WIAF-11638	HT3625	1129	FOS, v-fos FBJ murine	CCTGTGCACT[C/T]CGGTGGTCAC	M	C	T	P	S
				osteosarcoma viral oncogene
				homolog
G1461u1	WIAF-12562	HT0329	684	pRB-binding protein	TTGCCAAGAA[G/A]TCCAAGAACC	S	G	A	K	K
G1466u1	WIAF-12571	HT27849	2128	API2, apoptosis inhibitor 2	ATGATCCATG[G/C]GTAGAACATG	M	G	C	W	C
G1468u1	WIAF-12563	HT4986	1928	apoptosis inhibitor, neuronal	CCACCAGACC[A/T]GACGAGGGGC	S	A	T	P	P
G1468u2	WIAF-12564	HT4986	3057	apoptosis inhibitor, neuronal	TTTGCAATTC[C/G]TTCAAGGGAG	M	C	G	L	V
G1472u1	WIAF-12565	HT28478	242	BAK1, BCL2-antagonist/killer 1	GGCAGGAGTG[C/T]GGAGAGCCTG	S	C	T	C	C
G1472u2	WIAF-12572	HT28478	509	BAK1, BCL2-antagonist/killer 1	TGCAGCCCAC[G/A]GCAGAGAATG	S	G	A	T	T
G1473u1	WIAF-12568	HT28606	394	CASP6, caspase 6, apoptosis-	GGTGTCAAGT[G/C]TTAGCCACGG	M	G	C	V	L
				related cysteine protease
G1473u2	WIAF-12576	HT28606	411	CASP6, caspase 6, apoptosis-	ACGCAGATGC[C/T]GATTGCTTTG	S	C	T	A	A
				related cysteine protease
G1479u1	WIAF-12550	Y09077	711	ATR, ataxia telangiectastia and	AGTTTATTAA[T/C]GGTTCTTACT	M	T	C	M	T
				Rad3 related
G1479u2	WIAF-12551	Y09077	4303	ATR, ataxia telangiectastia and	TTGCGTATGC[T/C]GATAATAGCC	S	T	C	A	A
				Rad3 related
G1479u3	WIAF-12552	Y09077	1894	ATR, ataxia telangiectastia and	ATTCTGATGA[T/C]GGCTGTTTAA	S	T	C	D	D
				Rad3 related
G1479u4	WIAF-12553	Y09077	1855	ATR, ataxia telangiectastia and	ATTTATGTGG[T/A]ATGCTCTCAC	S	T	A	G	G
				Rad3 related
G1479u5	WIAF-12558	Y09077	5287	ATR, ataxia telangiectastia and	TCATTGATTA[T/C]CATGGTGTAG	S	T	C	Y	Y
				Rad3 related
G1479u6	WIAF-12559	Y09077	5539	ATR, ataxia telangiectastia and	CAGCTTTTTA[T/C]GACTCACTGA	S	T	C	Y	Y
				Rad3 related
G1479u7	WIAF-12569	Y09077	1540	ATR, ataxia telangiectastia and	ATCCTGTTAT[T/C]GAGATGTTAG	S	T	C	I	I
				Rad3 related
G1479u8	WIAF-12570	Y09077	2521	ATR, ataxia telangiectastia and	ATTTAATGGA[A/G]GATCCAGACA	S	A	G	E	E
				Rad3 related
G1482u1	WIAF-12560	HT27870	3176	BLM, Bloom syndrome	AAAATATAAC[G/A]GAATGCAGGA	S	G	A	T	T
G1482u2	WIAF-12561	HT27870	3605	BLM, Bloom syndrome	GAAATAAAGC[C/A]CAAACTGTAC	S	C	A	A	A
G1482u3	WIAF-12573	HT27870	2677	BLM, Bloom syndrome	TATGTATTAC[C/T]GAAAAAGCCT	M	C	T	P	L
G1483u1	WIAF-12597	HT1470	1910	MYBL2, v-myb avian myeloblastosis	GGATGAGGAT[G/A]TGAAGCTGAT	M	G	A	V	M
				viral oncogene homolog-like 2
G1483u2	WIAF-12610	HT1470	244	MYBL2, v-myb avian myeloblastosis	ATGAGGAGGA[C/T]GAGCAGCTGA	S	C	T	D	D
				viral oncogene homolog-like 2
G1483u3	WIAF-12611	HT1470	1406	MYBL2, v-myb avian myeloblastosis	CACTGAGAAT[A/G]GCACCAGTCT	M	A	G	S	G
				viral oncogene homolog-like 2
G1485u1	WIAF-12581	HT1432	1941	BCR, breakpoint cluster region	TGGAGATGAG[A/G]AAATGGGTCC	S	A	G	R	R
G1485u2	WIAF-12582	HT1432	3144	BCR, breakpoint cluster region	TGACCATCAA[T/C]AAGGAAGATG	S	T	C	N	N
G1485u3	WIAF-12583	HT1432	3777	BCR, breakpoint cluster region	ATAACAAGGA[T/C]GTGTCGGTGA	S	T	C	D	D
G1485u4	WIAF-12603	HT1432	2831	BCR, breakpoint cluster region	CAGATCAAGA[G/A]TGACATCCAG	M	G	A	S	N
G1485u5	WIAF-12608	HT1432	4217	BCR, breakpoint cluster region	ATCCCTGCCC[C/T]GGACAGCAAG	M	C	T	P	L
G1486u1	WIAF-12578	HT33770	1909	BRCA2, breast cancer 2, early	ATTGATAATG[G/A]AAGCTGGCCA	M	G	A	G	E
				onset
G1486u2	WIAF-12579	HT33770	3623	BRCA2, breast cancer 2, early	AGTTTAGAAA[A/G]CCAAGCTACA	S	A	G	K	K
				onset
G1486u3	WIAF-12586	HT33770	1341	BRCA2, breast cancer 2, early	AAATGTAGCA[A/C]ATCAGAAGCC	M	A	C	N	H
				onset
G1486u4	WIAF-12594	HT33770	446	BRCA2, breast cancer 2, early	CTTATAATCA[G/A]CTGGCTTCAA	S	G	A	Q	Q
				onset
G1486u5	WIAF-12598	HT33770	3013	BRCA2, breast cancer 2, early	ACCATGGTTT[T/C]ATATGGAGAC	M	T	C	L	S
				onset
G1486u6	WIAF-12599	HT33770	3187	BRCA2, breast cancer 2, early	CAAAAAAATA[A/T]TGATTACATG	M	A	T	N	I
				onset
G1486u7	WIAF-12604	HT33770	4971	BRCA2, breast cancer 2, early	AGCATGTGAG[A/C]CCATTGAGAT	M	A	C	T	P
				onset
G1486u8	WIAF-12607	HT33770	4034	BRCA2, breast cancer 2, early	ATGATTCTGT[C/T]GTTTCAATGT	S	C	T	V	V
				onset
G1487u1	WIAF-12584	HT27632	2536	BRCA1, breast cancer 1, early	AGTCAGTGTG[C/G]AGCATTTGAA	M	C	G	A	G
				onset
G1487u2	WIAF-12587	HT27632	4697	BRCA1, breast cancer 1, early	CATCTCAAGA[G/C]GAGCTCATTA	M	G	C	E	D
				onset
G1487u3	WIAF-12595	HT27632	469	BRCA1, breast cancer 1, early	TCTCCTGAAC[A/G]TCTAAAAGAT	M	A	G	H	R
				onset
G1487u4	WIAF-12600	HT27632	3667	BRCA1, breast cancer 1, early	AGCGTCCACA[A/G]AGGAGAGCTT	M	A	G	K	R
				onset
G1487u5	WIAF-12601	HT27632	3537	BRCA1, breast cancer 1, early	TATGGGAAGT[A/G]GTCATGCATC	M	A	G	S	G
				onset
G1487u6	WIAF-12602	HT27632	4956	BRCA1, breast cancer 1, early	ATCTGCCCAG[A/G]GTCCAGCTGC	M	A	G	S	G
				onset
G1487u7	WIAF-12605	HT27632	2090	BRCA1, breast cancer 1, early	AGTACAACCA[A/G]ATGCCAGTCA	S	A	G	Q	Q
				onset
G1487u8	WIAF-12614	HT27632	233	BRCA1, breast cancer 1, early	TCTCCACAAA[G/A]TGTGACCACA	S	G	A	K	K
				onset
G1492u1	WIAF-12585	HT3506	3912	cell death-associated kinase	TCCAGGTCCG[T/C]GGCCTGGAGA	S	T	C	R	R
G1492u2	WIAF-12593	HT3506	4352	cell death-associated kinase	TACAACACCA[A/G]TAACGGGGCT	M	A	G	N	S
G1492u3	WIAF-12606	HT3506	2127	cell death-associated kinase	GCAATTTGGA[C/T]ATCTCCAACA	S	C	T	D	D
G1492u4	WIAF-12612	HT3506	1605	cell death-associated kinase	TGAAATTTCT[C/T]AGTGAGAACA	S	C	T	L	L
G1494u1	WIAF-12589	HT28507	366	cell death-inducing protein Bik	TTCACCACAC[T/C]TAAGGAGAAC	M	T	C	L	P
G1495u1	WIAF-12580	HT27803	759	CSE1L, chromosome segregation 1	TTTCTTCCCT[G/C]ATCCTGATCT	S	G	C	L	L
				(yeast homolog)-like
G1501u1	WIAF-13502	HT1949	1181	MCC, mutated in colorectal	CAGCAATGAC[A/C]TTCCCATCGC	M	A	C	I	L
				cancers
G1501u2	WIAF-13503	HT1949	1753	MCC, mutated in colorectal	CAGCTGAGAA[C/T]GCTGCCAAGG	S	C	T	N	N
				cancers
G1501u3	WIAF-13504	HT1949	2344	MCC, mutated in colorectal	TGTCCCTAGC[T/C]GAACTCAGGA	S	T	C	A	A
				cancers
G1501u4	WIAF-13521	HT1949	445	MCC, mutated in colorectal	AGCGAACGAC[G/A]CTTCGCTATG	S	G	A	T	T
				cancers
G1501u5	WIAF-13522	HT1949	1504	MCC, mutated in colorectal	AAAGCAATGC[T/C]GAGAGGATGA	S	T	C	A	A
				cancers
G1501u6	WIAF-13527	MT1949	2511	MCC, mutated in colorectal	TTCGTGAATG[A/G]TCTAAAGCGG	M	A	G	D	G
				cancers
G1502u1	WIAF-12633	HT1547	870	CCND1, cyclin D1 (PRAD1:	AGTGTGACCC[A/G]GACTGCCTCC	S	A	G	P	P
				parathyroid adenomatosis 1)
G1503u1	WIAF-13741	U37022	1151	CDK4, cyclin-dependent kinase 4	CATGCCAATT[G/A]CATCGTTCAC	M	G	A	C	Y
G1503u2	WIAF-13742	U37022	1410	CDK4, cyclin-dependent kinase 4	CTGAAGCCGA[C/T]CAGTGGGGCA	S	C	T	D	D
G1503u3	WIAF-13743	U37022	1328	CDK4, cyclin-dependent kinase 4	TATGCAACAC[C/T]TGTGGACATG	M	C	T	P	L
G1503u4	WIAF-13780	U37022	1194	CDK4, cyclin-dependent kinase 4	TTCTGGTGAC[A/G]AGTGGTGGAA	S	A	G	T	T
G1503u5	WIAF-13781	U37022	1443	CDK4, cyclin-dependent kinase 4	TGATTGGGCT[G/A]CCTCCAGAGG	S	G	A	L	L
G1503u6	WIAF-13787	U37022	1633	CDK4, cyclin-dependent kinase 4	CTCTTATCTA[C/T]ATAAGGATGA	M	C	T	H	Y
G1517u1	WIAF-12618	HT1132	3894	ERBB3, v-erb-b2 avian	CAGACCTCAG[T/C]GCCTCTCTGG	S	T	C	S	S
				erythroblastic leukemia viral
				oncogene homolog 3
G152u1	WIAF-11608	HT3854	1673	HSPA1L, heat shock 70 kD protein-	GTGAGTGATG[A/C]AGGTTTGAAG	M	A	C	E	A
				like 1
G152u2	WIAF-11629	HT3854	1683	HSPA1L, heat shock 70 kD protein-	AAGGTTTGAA[G/A]GGCAAGATTA	S	G	A	K	K
				like 1
G152u3	WIAF-11609	HT3854	1478	HSPA1L, heat shock 70 kD protein-	GTCACAGCCA[C/T]GGACAAGAGC	M	C	T	T	M
				like 1
G152u4	WIAF-11610	HT3854	1443	HSPA1L, heat shock 70 kD protein-	TGACGTTTGA[C/T]ATTGATGCCA	S	C	T	D	D
				like 1
G1520u1	WIAF-12162	HT1175	2211	DNA excision repair protein ERCC2,	TGACCGTGGA[C/T]GAGGGTGTCC	S	C	T	D	D
				5′ end
G1520u2	WIAF-12166	HT1175	546	DNA excision repair protein ERCC2,	CCCACTGCCG[A/C]TTCTATGAGG	S	A	C	R	R
				5′ end
G1527u1	WIAF-12168	HT0086	577	GSTM2, glutathione S-transferase	TCATCTCCCG[A/C]TTTGAGGGCT	S	A	C	R	R
				M2 (muscle)
G1527u2	WIAF-12169	HT0086	644	GSTM2, glutathione S-transferase	ACCTGTGTTC[A/T]CAAAGATGGC	M	A	T	T	S
				M2 (muscle)
G1527u3	WIAF-12171	HT0086	100	GSTM2, glutathione S-transferase	ACTCAAGCTA[C/T]GAGGAAAAGA	S	C	T	Y	Y
				M2 (muscle)
G1527u4	WIAF-12172	HT0086	41	GSTM2, glutathione S-transferase	CGGGTACTGG[A/G]ACATCCGCGG	M	A	G	N	D
				M2 (muscle)
G1527u5	WIAF-12173	HT0086	215	GSTM2, glutathione S-transferase	GATTGATGGG[A/G]CTGAGAAGAT	M	A	G	T	A
				M2 (muscle)
G1527u6	WIAF-12194	HT0086	238	GSTM2, glutathione S-transferase	CCGAGAGCAA[T/C]GCCATCGTGC	S	T	C	N	N
				M2 (muscle)
G1528u1	WIAF-11950	HT1811	529	GSTM3, glutathione S-transferase	GTATATTTGA[C/G]CCCAAGTGCC	M	C	G	D	E
				M3 (brain)
G1528u2	WIAF-11951	HT1811	674	GSTM3, glutathione S-transferase	CAACAAGCCT[G/A]TATGCTGAGC	M	G	A	V	I
				M3 (brain)
G1528u3	WIAF-11989	HT1811	572	GSTM3, glutathione S-transferase	GGCTTTGATG[T/G]GCCGTTTTGA	M	T	G	C	G
				M3 (brain)
G1528u4	WIAF-13470	HT1811	240	GSTM3, glutathione S-transferase	GAGAGGAATG[C/A]CATCTTGCGC	M	C	A	A	D
				M3 (brain)
G1529u1	WIAF-14146	HT2006	797	GSTM4, glutathione S-transferase	TGGACGCCTT[C/T]CCAAATGTGA	S	C	T	F	F
				M4
G153u1	WIAF-12163	HT3856	1212	HSPA1B, heat shock 70 kD protein 1	TGGGGCTGGA[G/A]ACGGCCGGAG	S	G	A	E	E
G153u2	WIAF-12182	HT3856	676	HSPA1B, heat shock 70 kD protein 1	GGCCGGGGAC[A/G]CCCACCTGGG	M	A	G	T	A
G153u3	WIAF-12183	HT3856	1695	HSPA1B, heat shock 70 kD protein 1	TCAGCGAGGC[C/G]GACAAGAAGA	S	C	G	A	A
G153u4	WIAF-12189	HT3856	330	HSPA1B, heat shock 70 kD protein 1	AGAAGGGGGA[G/C]ACCAAGGCAT	M	G	C	E	D
G153u5	MIAF-12190	HT3856	1053	HSPA1B, heat shock 70 kD protein 1	AGCTGCTGGA[A/G]GACTTCTTGA	S	A	G	Q	Q
G1530u1	WIAF-11964	HT3010	673	GSTM5, glutathione S-transferase	ATTCCTCCGA[G/A]GTCTTTTGTT	M	G	A	G	S
				M5
G1530u2	WIAF-11995	HT3010	593	GSTM5, glutathione S-transferase	GACGCCTTCC[T/C]AAACTTGAAG	M	T	C	L	P
				M5
G1530u3	WIAF-13473	HT3010	693	GSTM5, glutathione S-transferase	TTGGAAAGTC[A/G]GCTACATGGA	S	A	G	S	S
				M5
G1533u1	WIAF-13458	HT27460	543	GSTT2, glutathione S-transferase	CTCTCGGCTA[C/T]GAACTGTTTG	S	C	T	Y	Y
				theta 2
G1533u2	WIAF-13460	HT27460	417	GSTT2, glutathione S-transferase	GGACTGCGAT[G/A]GACCAGGCCC	M	G	A	M	I
				theta 2
G1533u3	WIAF-13461	HT27460	359	GSTT2, glutathione S-transferase	CAGGTGTTGG[G/A]GCCACTCATT	M	G	A	G	E
				theta 2
G1533u4	WIAF-13462	HT27460	363	GSTT2, glutathione S-transferase	TGTTGGGGCC[A/C]CTGATTGGGG	S	A	C	P	P
				theta 2
G1533u5	WIAF-13463	HT27460	385	GSTT2, glutathione S-transferase	CCAGGTGCCC[G/A]AGGAGAAGGT	M	G	A	E	K
				theta 2
G1535u1	WIAF-11952	HT0436	517	HCK, hemopoietic cell kinase	CCGCGTTGAC[T/C]CTCTGGAGAC	M	T	C	S	P
G1535u2	WIAF-12013	HT0436	783	HCK, hemopoietic cell kinase	TGGACCACTA[C/T]AAGAAGGGGA	S	C	T	Y	Y
G1535u3	WIAF-13464	HT0436	357	HCK, hemopoietic cell kinase	TCATCGTGGT[T/C]GCCCTGTATG	S	T	C	V	V
G1535u4	WIAF-13465	HT0436	387	HCK, hemopoietic cell kinase	CCATTCACCA[C/T]GAAGACCTCA	S	C	T	H	H
G1535u5	WIAF-13466	HT0436	471	HCK, hemopoietic cell kinase	CCCTGGCCAC[C/G]CGGAAGGAGG	S	C	G	T	T
G1535u6	WIAF-13467	HT0436	240	HCK, hemopoietic cell kinase	CCAGCGCCAG[C/T]CCACACTGTC	S	C	T	S	S
G1535u7	WIAF-13468	HT0436	394	HCK, hemopoietic cell kinase	CCACGAAGAC[C/T]TCAGCTTCCA	M	C	T	L	F
G1537u1	WIAF-12020	U04045	1514	MSH2, mutS ( E. coli ) homolog 2	GTGAATTAAG[A/G]GAAATAATGA	S	A	G	R	R
				(colon cancer, nonpolyposis type
				1)
G1537u2	WIAF-12044	U04045	599	MSH2, mutS ( E. coli ) homolog 2	GACTGTGTGA[A/T]TTCCCTGATA	M	A	T	E	D
				(colon cancer, nonpolyposis type
				1)
G1537u3	WIAF-12045	U04045	1452	MSH2, mutS ( E. coli ) homolog 2	AGATATGGAT[C/T]AGGTGGAAAA	N	C	T	Q	*
				(colon cancer, nonpolyposis type
				1)
G1537u4	WIAF-12076	U04045	938	MSH2, mutS ( E. coli ) homolog 2	GACAGTTTGA[A/T]CTGACTACTT	M	A	T	E	D
				(colon cancer, nonpolyposis type
				1)
G1537u5	WIAF-12077	U04045	1878	MSH2, mutS ( E. coli ) homolog 2	TCAGCTAGAT[G/A]CTGTTGTCAG	M	G	A	A	T
				(colon cancer, nonpolyposis type
				1)
G1543u1	WIAF-13856	J00119	553	MOS, v-mos Moloney murine sarcoma	GAGTTTCTGG[G/T]CTGAGCTCAA	M	G	T	A	S
				viral oncogene homolog
G1543u2	WIAF-13857	J00119	621	MOS, v-mos Moloney murine sarcoma	GCACGCGCAC[G/A]CCCGCAGGOT	S	G	A	T	T
				viral oncogene homolog
G1544u1	WIAF-12018	U59464	3821	PTCH, patched (Drosophila)	CATCCCGAAT[C/T]CAGGCATCAC	M	C	T	S	F
				homolog
G1544u2	WIAF-12019	U59464	3618	PTCH, patched (Drosophila)	GCGTGGTCCG[C/T]TTCGCCATGC	S	C	T	R	R
				homolog
G1544u3	WIAF-12027	U59464	1761	PTCH, patched (Drosophila)	ATTTTGCCAT[G/T]GTTCTGCTCA	M	G	T	M	I
				homolog
G1544u4	WIAF-12029	U59464	4074	PTCH, patched (Drosophila)	CTGCCATGGG[C/T]AGCTCCGTGC	S	C	T	G	G
				homolog
G1544u5	WIAF-12043	U59464	3845	PTCH, patched (Drosophila)	CCCTCGAACC[C/T]GAGACAGCAG	M	C	T	P	L
				homolog
G1544u6	WIAF-12056	U59464	1433	PTCH, patched (Drosophila)	CTGCTGGTTG[C/T]ACTGTCAGTG	M	C	T	A	V
				homolog
G1544u7	WIAF-12058	U59464	3298	PTCH, patched (Drosophila)	CACCGTTCAC[G/C]TTGCTTTGGC	M	G	C	V	L
				homolog
G1544u8	WIAF-12062	U59464	3986	PTCH, patched (Drosophila)	TCTACTGAAG[G/A]GCATTCTGGC	M	G	A	G	E
				homolog
G1544u9	WIAF-13489	U59464	1665	PTCH, patched (Drosophila)	CCATCAGCAA[T/C]GTCACAGCCT	S	T	C	N	N
				homolog
G1544u10	WIAF-13490	U59464	2396	PTCH, patched (Drosophila)	AAATACTTTT[C/T]TTTCTACAAC	M	C	T	S	F
				homolog
G1544u11	WIAF-13491	U59464	2199	PTCH, patched (Drosophila)	GGACACTCTC[A/G]TCTTTTGCTG	S	A	G	S	S
				homolog
G1544u12	WIAF-13492	U59464	2222	PTCH, patched (Drosophila)	AAGCACTATG[C/T]TCCTTTCCTC	M	C	T	A	V
				homolog
G1544u13	WIAF-13500	U59464	1686	PTCH, patched (Drosophila)	TCTTCATGGC[C/T]GCGTTAATCC	S	C	T	A	A
				homolog
G1545u1	WIAF-12032	HT0473	1835	RAG1, recombination activating	GGACATGGAA[G/A]AAGACATCTT	M	G	A	E	K
				gene 1
G1545u2	WIAF-12035	HT0473	2519	RAG1, recombination activating	TGACATTGGC[A/G]ATGCAGCTGA	M	A	G	N	D
				gene 1
G1545u3	WIAF-12046	HT0473	3045	RAG1, recombination activating	CGGAAAATGA[A/G]TGCCAGGCAG	M	A	G	N	S
				gene 1
G1545u4	WIAF-12047	HT0473	3146	RAG1, recombination activating	TCATAATGCA[T/C]TAAAAACCTC	S	T	C	L	L
				gene 1
G1545u5	WIAF-12075	HT0473	2513	RAG1, recombination activating	CCACTGTGAC[A/T]TTGGCAATGC	M	A	T	I	F
				gene 1
G1545u6	WIAF-13484	HT0473	1322	RAG1, recombination activating	GTCGCTGACT[C/T]GGAGAGCTCA	M	C	T	R	W
				gene 1
G1545u7	WIAF-13494	HT0473	2571	RAG1, recombination activating	GAAGTGTATA[A/G]GAATCCCAAT	M	A	G	K	R
				gene 1
G1545u8	WIAF-13498	HT0473	1018	RAG1, recombination activating	TTCTGGCTGA[C/A]CCTGTGGAGA	M	C	A	D	E
				gene 1
G1545u9	WIAF-13499	HT0473	2782	RAG1, recombination activating	ATCTTTACCT[G/C]AAGATGAAAC	S	G	C	L	L
				gene 1
G1548u1	WIAF-12015	HT4999	133	IFI27, interferon, alpha-	CTCTGCCGTA[G/A]TTTTGCCCCT	M	G	A	V	I
				inducible protein 27
G1548u2	WIAF-13482	HT4999	380	IFI27, interferon, alpha-	ATCCTGGGCT[C/T]CATTGGGTCT	M	C	T	S	F
				inducible protein 27
G1548u3	WIAF-13483	HT4999	135	IFI27, interferon, alpha-	CTGCCGTAGT[T/C]TTGCCCCTGG	S	T	C	V	V
				inducible protein 27
G155u1	WIAF-11634	HT3962	991	CHC1, chromosome condensation 1	AGCTGGATGT[G/A]CCTGTGGTAA	S	G	A	V	V
G155u2	WIAF-11635	HT3962	1271	CHC1, chromosome condensation 1	CGGGTTCGGC[C/T]TCTCCAACTA	M	C	T	L	F
G155u3	WIAF-11636	HT3962	1192	CHC1, chromosome condensation 1	GCCGGGGCCA[C/T]GTGAGATTCC	S	C	T	H	H
G155u4	WIAF-11637	HT3962	1267	CHC1, chromosome condensation 1	TGTACGGCTT[C/T]GGCCTCTCCA	S	C	T	F	F
G155u5	WIAF-11649	HT3962	1657	CHC1, chromosome condensation 1	TGATGGGCAA[A/G]CAGCTGGAGA	S	A	G	K	K
G1550u1	WIAF-12057	M16038	611	LYN, v-yes-1 Yamaguchi sarcoma	GCAAAGTCCC[T/G]TTTAACAAAA	M	T	G	L	R
				viral related oncogene homolog
G1550u2	WIAF-12061	M16038	1371	LYN, v-yes-1 Yamaguchi sarcoma	TGGCATACAT[C/T]GAGCGGAAGA	S	C	T	I	I
				viral related oncogene homolog
G1550u3	WIAF-12080	M16038	1059	LYN, v-yes-1 Yamaguchi sarcoma	AAAGGCTTGG[C/T]GCTGGGCAGT	S	C	T	G	G
				viral related oncogene homolog
G1550u4	WIAF-12081	M16038	996	LYN, v-yes-1 Yamaguchi sarcoma	AGCCACAGAA[G/A]CCATGGGATA	S	G	A	K	K
				viral related oncogene homolog
G1552u1	WIAF-12030	HT4578	2355	PMS1, postmeiotic segregation	CCTGCTATTT[A/T]AAAGACTTCT	N	A	T	K	*
				increased ( S. cerevisiae ) 1
G1552u2	WIAF-12031	HT4578	2231	PMS1, postmeiotic segregation	ACAAAGTTGA[C/T]TTAGAAGAGA	S	C	T	D	D
				increased ( S. cerevisiae ) 1
G1552u3	WIAF-12040	HT4578	617	PMS1, postmeiotic segregation	TCATGAGCTT[T/C]GGTATCCTTA	S	T	C	F	F
				increased ( S. cerevisiae ) 1
G1552u4	WIAF-12063	HT4578	1723	PMS1, postmeiotic segregation	TCATGTAACA[A/G]AAAATCAAAT	M	A	G	K	R
				increased ( S. cerevisiae ) 1
G1552u5	WIAF-12064	HT4578	1732	PMS1, postmeiotic segregation	AAAAAATCAA[A/G]TGTAATAGAT	M	A	G	N	S
				increased ( S. cerevisiae ) 1
G1552u6	WIAF-12065	HT4578	1660	PMS1, postmeiotic segregation	TTACCATGTA[A/G]AGTAAGTAAT	M	A	G	K	R
				increased ( S. cerevisiae ) 1
G1552u7	WIAF-12066	HT4578	1975	PMS1, postmeiotic segregation	GAACGATACA[A/G]TAGTCAAATG	M	A	G	N	S
				increased ( S. cerevisiae ) 1
G1552u8	WIAF-12067	HT4578	1881	PMS1, postmeiotic segregation	TTTAGAGGAT[G/T]CAACACTACA	M	G	T	A	S
				increased ( S. cerevisiae ) 1
G1552u9	WIAF-12068	HT4578	2454	PMS1, postmeiotic segregation	TTTAGACGTT[T/A]TATATAAAAT	M	T	A	L	I
				increased ( S. cerevisiae ) 1
G1552u10	WIAF-12069	HT4578	2457	PMS1, postmeiotic segregation	AGACGTTTTA[T/C]ATAAAATGAC	M	T	C	Y	H
				increased ( S. cerevisiae ) 1
G1552u11	WIAF-12082	HT4578	2557	PMS1, postmeiotic segregation	ATACCAGGAG[T/C]TTCAATTACT	M	T	C	V	A
				increased ( S. cerevisiae ) 1
G1552u12	WIAF-12083	HT4578	971	PMS1, postmeiotic segregation	TTTTCTTTCT[G/T]AAAATCGATG	S	G	T	L	L
				increased ( S. cerevisiae ) 1
G1554u1	WIAF-12028	HT4161	1500	ELK3, ELK3, ETS-domain protein	CTCAGAAATC[C/T]TGATGACGTC	S	C	T	S	S
				(SRF accessory protein 2) NOTE:
				Symbol and name provisional.
G1554u2	WIAF-12059	HT4161	1380	ELK3, ELK3, ETS-domain protein	CTGCCAGGCT[G/A]CAAGGGCCAA	S	G	A	L	L
				(SRF accessory protein 2) NOTE:
				Symbol and name provisional.
G1554u3	WIAF-12060	HT4161	1436	ELK3, ELK3, ETS-domain protein	CACATGCCAG[T/C]GCCAATCCCC	M	T	C	V	A
				(SRF accessory protein 2) NOTE:
				Symbol and name provisional.
G1562u1	WIAF-12024	HT28220	804	PDCD1, programmed cell death 1	GGGGCTCAGC[T/C]GACGGCCCTC	S	T	C	A	A
G1562u2	WIAF-13488	HT28220	644	PDCD1, programmed cell death 1	GACCCCTCAG[C/T]CGTGCCTGTG	M	C	T	A	V
G1563u1	WIAF-13493	HT1187	1748	EGFR, epidermal growth factor	CCGGAGCCCA[G/A]GGACTGCGTC	M	G	A	R	K
				receptor (avian erythroblastic
				leukemia viral (v-erb-b) oncogene
				homolog)
G1563u2	WIAF-13497	HT1187	2073	EGFR, epidermal growth factor	ACGGATGCAC[T/A]GGGCCAGGTC	S	T	A	T	T
				receptor (avian erythroblastic
				leukemia viral (v-erb-b) oncogene
				homolog)
G1566u1	WIAF-12016	HT27594	235	PDCD2, programmed cell death 2	GCGCCGCCTGC[C/G]TGGCCGCCCG	M	C	G	P	R
G1566u2	WIAF-12033	HT27594	904	PDCD2, programmed cell death 2	TTGGAATTCC[A/G]GGTCATGCCT	M	A	G	Q	R
G1566u3	WIAF-12041	HT27594	331	PDCD2, programmed cell death 2	AATCAACTAC[C/T]CAGGAAAAAC	M	C	T	P	L
G1566u4	WIAF-12071	HT27594	649	PDCD2, programmed cell death 2	CCTGAGGTTG[T/C]GGAAAAGGAA	M	T	C	V	A
G1566u5	WIAF-12072	HT27594	633	PDCD2, programmed cell death 2	AGAAGATGAG[A/T]TTATGCCTGA	M	A	T	I	F
G1567u1	WIAF-12042	M95936	293	AKT2, v-akt murine thymoma viral	GAGAGGCCGC[G/A]ACCCAACACC	M	G	A	R	Q
				oncogene homolog 2
G1572u1	WIAF-12212	HT3998	1894	proto-oncogene c-abl, tyrosine	TGTTCCAGGA[A/G]TCCAGTATCT	S	A	G	E	E
				protein kinase, alt. transcript 2
G1572u2	WIAF-12233	HT3998	3694	proto-oncogene c-abl, tyrosine	AGCTTCAGAT[C/T]TGCCCGGCGA	S	C	T	I	I
				protein kinase, alt. transcript 2
G1572u3	WIAF-12234	HT3998	3721	proto-oncogene c-abl, tyrosine	GCAGTGGTCC[G/A]GCGGCCACTC	S	G	A	P	P
				protein kinase, alt. transcript 2
G1573u1	WIAF-12021	HT0642	343	CBL, Cas-Br-M (murine) ecotropic	TCATGGACAA[G/C]GTGGTGCGGT	M	G	C	K	N
				retroviral transforming sequence
G1573u2	WIAF-12022	HT0642	363	CBL, Cas-Br-M (murine) ecotropic	TTGTGTCAGA[A/T]CCCAAAGCTG	M	A	T	N	I
				retroviral transforming sequence
G1573u3	WIAF-12034	HT0642	2364	CBL, Cas-Br-M (murine) ecotropic	AATATTCAGT[C/T]CCAGGCGCCA	M	C	T	S	F
				retroviral transforming sequence
G1573u4	WIAF-12049	HT0642	387	CBL, Cas-Br-M (murine) ecotropic	CTAAAGAATA[G/A]CCCACCTTAT	M	G	A	S	N
				retroviral transforming sequence
G1573u5	WIAF-12050	HT0642	947	CBL, Cas-Br-M (murine) ecotropic	AACTCATCCT[G/A]GCTACATGGC	M	G	A	G	S
				retroviral transforming sequence
G1573u6	WIAF-12070	HT0642	2740	CBL, Cas-Br-M (murine) ecotropic	TCGAGAACCT[C/T]ATGAGTCAGG	S	C	T	L	L
				retroviral transforming sequence
G1573u7	WIAF-12073	HT0642	661	CBL, Cas-Br-M (murine) ecotropic	TCTTTCCAAG[T/C]GGACTCTTTC	S	T	C	S	S
				retroviral transforming sequence
G1573u8	WIAF-12074	HT0642	2569	CBL, Cas-Br-M (murine) ecotropic	CTCTGGATGG[T/C]GATCCTACAA	S	T	C	G	G
				retroviral transforming sequence
G1573u9	WIAF-13486	HT0642	2006	CBL, Cas-Br-M (murine) ecotropic	CCGGCACTCA[C/T]TTCCATTTTC	M	C	T	L	F
				retroviral transforming sequence
G1574u1	WIAF-12037	HT1508	2493	FES, feline sarcoma (Snyder-	AGCGGCCCAG[C/T]TTCAGCACCA	S	C	T	S	S
				Theilen) viral (v-fes)/Fujinami
				avian sarcoma (PRCII) viral (v-
				fps) oncogene homolog
G1574u2	WIAF-12051	HT1508	189	FES, feline sarcoma (Snyder-	CCCAGCGGCT[C/T]AAGAGTGACA	S	C	T	V	V
				Theilen) viral (v-fes)/Fujinami
				avian sarcoma (PRCII) viral (v-
				fps) oncogene homolog
G1574u3	WIAF-12052	HT1508	1441	FES, feline sarcoma (Snyder-	GAAGCCCCTG[C/T]ATGAGCAGCT	M	C	T	H	Y
				Theilen) viral (v-fes)/Fujinami
				avian sarcoma (PRCII) viral (v-
				fps) oncogene homolog
G1574u4	WIAF-12053	HT1508	2202	FES, feline sarcoma (Snyder-	GAGAGGAAGC[C/T]GATGGGGTCT	S	C	T	A	A
				Theilen) viral (v-fes)/Fujinami
				avian sarcoma (PRCII) viral (v-
				fps) oncogene homolog
G1574u5	WIAF-12054	HT1508	2088	FES, feline sarcoma (Snyder-	CTGCTGGCAT[G/T]GAGTACCTGG	M	G	T	M	I
				Theilen) viral (v-fes)/Fujinami
				avian sarcoma (PRCII) viral (v-
				fps) oncogene homolog
G1574u6	WIAF-12078	HT1508	1577	FES, feline sarcoma (Snyder-	GATGGTCTGC[C/T]CCGGCACTTC	M	C	T	P	L
				Theilen) viral (v-fes)/Fujinami
				avian sarcoma (PRCII) viral (v-
				fps) oncogene homolog
G1574u7	WIAF-13495	HT1508	579	FES, feline sarcoma (Snyder-	GTGACAAGGC[T/C]AAGGACAAGT	S	T	C	A	A
				Theilen) viral (v-fes)/Fujinami
				avian sarcoma (PRCII) viral (v-
				fps) oncogene homolog
G1575u1	WIAF-12079	HT1052	963	FGR, Gardner-Rasheed feline	TGGGCACCGG[C/T]TGCTTCGGGG	S	C	T	G	G
				sarcoma viral (v-fgr) oncogene
				homolog
G1575u2	WIAF-13487	HT1052	232	FGR, Gardner-Rasheed feline	CAGAAGCTAC[G/A]GGGCAGCAGA	M	G	A	G	R
				sarcoma viral (v-fgr) oncogene
				homolog
G1585u1	WIAF-12017	HT1675	996	CRK, v-crk avian sarcoma virus	TGGATCAACA[G/A]AATCCCGATG	S	G	A	Q	Q
				CT10 oncogene homolog
G1585u2	WIAF-12036	HT1675	446	CRK, v-crk avian sarcoma virus	ACTACAACGT[T/C]GATAGAACCA	M	T	C	L	S
				CT10 oncogene homolog
G1587u1	WIAF-12023	HT0590	1473	proto-oncogene dbl	GGCCAATCCA[A/G]TTTGTGGTAC	S	A	G	Q	Q
G1587u2	WIAF-12025	HT0590	2549	proto-oncogene dbl	GTCCAGGCTT[C/T]TAATGTAGAT	M	C	T	S	F
G1587u3	WIAF-12026	HT0590	2828	proto-oncogene dbl	GCATCACAAT[C/T]TGCAGAAATC	M	C	T	S	F
G1587u4	WIAF-12038	HT0590	982	proto-oncogene dbl	AAATTCTCAG[G/C]AGCTATTATC	M	G	C	E	Q
G1587u5	WIAF-12039	HT0590	2343	proto-oncogene dbl	AACCAATGCA[G/T]CGACACCTTT	M	G	T	Q	H
G1587u6	WIAF-12048	HT0590	683	proto-oncogene dbl	GACACTGAAG[G/A]AGCTGTCAGT	M	G	A	G	E
G1587u7	WIAF-12055	HT0590	2686	proto-oncogene dbl	TTCTCTTCAG[C/T]AGAATGATGA	N	C	T	Q	*
G1587u8	WIAF-13485	HT0590	2136	proto-oncogene dbl	ACTGTGAAGG[T/A]TCTGCTCTGT	S	T	A	G	G
G1587u9	WIAF-13496	HT0590	1566	proto-oncogene dbl	AAAATCAGAG[C/T]AACTTAAAAA	S	C	T	S	S
G159u1	WIAF-11616	HT4209	1059	RAD23B, RAD23 ( S. cerevisiae )	AGTACTGGGG[C/T]TCCTCAGTCT	M	C	T	A	V
				homolog B
G1590u1	WIAF-13897	HT2455	1257	ETS2, v-ets avian	GCCAGTCTCT[G/C]TGCCTCAATA	S	C	G	L	L
				erythroblastosis virus E26
				oncogene homolog 2
G1590u2	WIAF-13913	HT2455	1107	ETS2, v-ets avian	ATTCTGGGAC[T/G]CCCAAAGACC	S	T	G	T	T
				erythroblastosis virus E26
				oncogene homolog 2
G1590u3	WIAF-13914	HT2455	1314	ETS2, v-ets avian	GGAGTGACCC[A/G]GTGGAGCAAG	S	A	G	P	P
				erythroblastosis virus E26
				oncogene homolog 2
G1591u1	WIAF-13924	HT2333	417	HRAS, v-Ha-ras Harvey rat sarcoma	TCCAGAACCA[T/C]TTTGTGGACG	S	T	C	H	H
				viral oncogene homolog
G1595u1	WIAF-12262	HT33778	1302	proto-oncogene 1-myc, alt.	GCATACCTCA[G/C]TGGCTACTAA	M	G	C	S	T
				transcript 1
G1597u1	WIAF-12243	HT0410	900	MAS1, MAS1 oncogene	CCATCTTGGT[C/T]GTGAAGATCC	S	C	T	V	V
G160u1	WIAF-11630	HT4247	690	RAD23A, RAD23 ( S. cerevisiae )	AGAGCCAGGT[A/G]TCGGAGCAGC	S	A	G	V	V
				homolog A
G1602u1	WIAF-14180	HT1903	1321	proto-oncogene pim-1	GTCGCCGGGG[C/A]CCAGCAAATA	M	C	A	P	T
G1604u1	WIAF-12319	HT2788	1182	REL, v-rel avian	CCTCCCAAAG[T/C]GCTGGGATTA	S	T	C	S	S
				reticuloendotheliosis viral
				oncogene homolog
G1609u1	WIAF-12358	HT33646	348	RIPK1, receptor (TNFRSF)-	GACGCAGGGT[C/T]TCCCATGACC	S	C	T	V	V
				interacting serine-threonine
				kinase 1
G161u1	WIAF-11654	HT4251	1522	DNA repair and recombination	TATGATCCAT[C/T]TTAACTGAGG	M	C	T	S	F
				homolog RAD52
G1610a1	WIAF-12101	HT27727	501	replication protein Rpa4, 30 kDa	TGCAACTCCT[G/A]CTATTAAGAC	M	G	A	A	T
G1610a2	WIAF-12102	HT27727	554	replication protein Rpa4, 30 kDa	TACCGTGTAA[C/T]GTGAACCAGC	S	C	T	N	N
G1610u3	WIAF-12307	HT27727	450	replication protein Rpa4, 30 kDa	TTCTGCTGCT[G/A]ATGGAGCGAG	M	G	A	D	N
G1610u4	WIAF-12320	HT27727	1037	replication protein Rpa4, 30 kDa	TGATTCATGA[G/C]TGTCCTCATC	M	G	C	E	D
G1610u5	WIAF-12321	HT27727	857	replication protein Rpa4, 30 kDa	TAGAGGACAT[G/A]AACGAGTTCA	M	G	A	M	I
G1610u6	WIAF-12343	HT27727	539	replication protein Rpa4, 30 kDa	GAATTCAGGA[C/T]GTTGTACCGT	S	C	T	D	D
G1630u1	WIAF-12302	HT3563	4312	DCC, deleted in colorectal	ACTCATGAAG[C/T]AGCTTAATGC	N	C	T	Q	*
				carcinoma
G1632u1	WIAF-13572	HT27355	742	tumor suppressor, PDGF receptor	TTTATGACAT[G/C]AAGCGGGGCT	M	G	C	M	I
				beta-like
G1632u2	WIAF-13584	HT27355	1102	tumor suppressor, PDGF receptor	TGGAAGACTT[C/T]GAGACCATTG	S	C	T	F	F
				beta-like
G1632u3	WIAF-13601	HT27355	258	tumor suppressor, PDGF receptor	AAGACGCAGT[C/T]TATCATGATG	M	C	T	S	F
				beta-like
G1633u1	WIAF-13957	HT1778	1263	FER, fer (fpa/fes related)	TTCAGGCAAA[T/C]GAGATCATGT	S	T	C	N	N
				tyrosine kinase (phosphoprotein
				NCP94)
G1633u2	WIAF-13958	HT1778	2407	FER, fer (fpa/fes related)	TATGTTGTAT[C/T]TCGAGAGTAA	M	C	T	L	F
				tyrosine kinase (phosphoprotein
				NCP94)
G1634u1	WIAF-13505	HT3216	1569	ELK1, ELK1, member of ETS	TCTCGACCCC[C/T]GTGGTGCTCT	S	C	T	P	P
				oncogene family
G1634u2	WIAF-13858	HT3216	456	ELK1, ELK1, member of ETS	GGCTGTGGGG[A/G]CTACGCAAGA	S	A	G	G	G
				oncogene family
G1634u3	WIAF-13859	HT3216	745	ELK1, ELK1, member of ETS	AGGCCCAGGC[G/A]GTTTGGCACG	M	G	A	G	S
				oncogene family
G1638u1	WIAF-14172	HT1224	98	uracil-DNA glycosylase	GCTGGGACCT[G/C]TTCCACAAAT	—	G	C	—	—
G1643u1	WIAF-13517	HT3751	629	DXS648E, DNA segment on	TACATCCCCA[G/A]TCGTGGCCCT	M	G	A	S	N
				chromosome X (unique) 648
				expressed sequence
G1645u1	WIAF-14087	D21089	363	XPC, xeroderma pigmentosum,	AAAACCTCAA[G/A]GTTATAAAGG	S	G	A	K	K
				complementation group C
G1645u2	WIAF-14088	D21089	2166	XPC, xeroderma pigmentosum,	TGCATTCCAG[G/A]GACACGTGGC	S	G	A	R	R
				complementation group C
G1645u3	WIAF-14089	D21089	1580	XPC, xeroderma pigmentosum,	GGGAGCCATC[G/A]TAAGGACCCA	M	G	A	R	H
				complementation group C
G1645u4	WIAF-14090	D21089	1601	XPC, xeroderma pigmentosum,	AGCTTGCCAG[T/C]GGCATCCTCA	M	T	C	V	A
				complementation group C
G1645u5	WIAF-14091	D21089	2920	XPC, xeroderma pigmentosum,	CCCATTTGAG[A/C]AGCTGTGAGC	M	A	C	K	Q
				complementation group C
G1645u6	WIAF-14103	D21089	405	XPC, xeroderma pigmentosum,	ATGACCTCAG[G/A]GACTTTCCAA	S	G	A	R	R
				complementation group C
G1645u7	WIAF-14104	D21089	151	XPC, xeroderma pigmentosum,	GGGACGCGAA[C/G]TGCGCAGCCA	M	C	G	L	V
				complementation group C
G1645u8	WIAF-14105	D21089	2133	XPC, xeroderma pigmentosum,	AAGCGGTCTA[C/T]TCCAGGGATT	S	C	T	Y	Y
				complementation group C
G167u1	WIAF-11632	HT4579	83	PMS2L8, postmeiotic segregation	CCTATTGATC[G/A]GAAGTCAGTC	M	G	A	R	Q
				increased 2-like 8
G167u2	WIAF-11633	HT4579	219	PMS2L8, postmeiotic segregation	GAGTGGATCT[T/C]ATTGAAGTTT	S	T	C	L	L
				increased 2-like 8
G167u3	WIAF-11644	HT4579	768	PMS2L8, postmeiotic segregation	TGCCCCCTAG[T/C]GACTCCGTGT	S	T	C	S	S
				increased 2-like 8
G167u4	WIAF-11622	HT4579	1645	PMS2L8, postmeiotic segregation	GAAAGCGCCT[G/A]AAACTGACGA	M	G	A	E	K
				increased 2-like 8
G167u5	WIAF-11645	HT4579	1512	PMS2L8, postmeiotic segregation	ACTCGGGGCA[C/T]GGCAGCACTT	S	C	T	H	H
				increased 2-like 8
G167u6	WIAF-11646	HT4579	1619	PMS2L8, postmeiotic segregation	TCGCAGGAAC[A/G]TGTGGACTCT	M	A	G	H	R
				increased 2-like 8
G167u7	WIAF-11647	HT4579	1432	PMS2L8, postmeiotic segregation	CGTCCTGAGA[C/T]CTCAGAAAGA	M	C	T	P	S
				increased 2-like 8
G167u8	WIAF-11625	HT4579	2490	PMS2L8, postmeiotic segregation	GGACTGCTCT[T/C]AACACAAGCG	S	T	C	L	L
				increased 2-like 8
G167u9	WIAF-11619	HT4579	804	PMS2L8, postmeiotic segregation	TGAGCTGTTC[G/C]GATGCTCTGC	S	G	C	S	S
				increased 2-like 8
G167u10	WIAF-11623	HT4579	1555	PMS2L8, postmeiotic segregation	CATCCCAGAC[A/G]CGGGCAGTCA	M	A	G	T	A
				increased 2-like 8
G167u11	WIAF-11624	HT4579	2364	PMS2L8, postmeiotic segregation	CCTTCGGACC[C/T]CAGGACGTCG	S	C	T	P	P
				increased 2-like 8
G167u12	WIAF-11626	HT4579	2348	PMS2L8, postmeiotic segregation	ACTAGTAAAA[A/G]CTGGACCTTC	M	A	G	N	S
				increased 2-like 8
G181u1	WIAF-11697	HT48793	311	ERCC4, excision repair cross-	ATATTTGCGA[C/T]AAGTAGGATA	M	C	T	T	I
				complementing rodent repair
				deficiency, complementation group
				4
G181u2	WIAF-11698	HT48793	295	ERCC4, excision repair cross-	CACACAAGGT[G/C]GTGTTATATT	M	G	C	G	R
				complementing rodent repair
				deficiency, complementation group
				4
G181u3	WIAF-11699	HT48793	234	ERCC4, excision repair cross-	TTGAACACCT[C/T]CCTCGCCGTG	S	C	T	L	L
				complementing rodent repair
				deficiency, complementation group
				4
G181u4	WIAF-11704	HT48793	808	ERCC4, excision repair cross-	TTTGTGGCAC[C/T]AGCTTGGACC	N	C	T	Q	*
				complementing rodent repair
				deficiency, complementation group
				4
G181u5	WIAF-11705	HT48793	640	ERCC4, excision repair cross-	TTCTATGACA[C/T]CTACCATGCT	M	C	T	P	S
				complementing rodent repair
				deficiency, complementation group
				4
G181u6	WIAF-11670	HT48793	1117	ERCC4, excision repair cross-	AGAAAGCAAC[C/T]CAAAGTGGGA	M	C	T	P	S
				complementing rodent repair
				deficiency, complementation group
				4
G185u1	WIAF-11668	HT5122	319	ACVR2B, activin A receptor, type	TCTGCAACGA[G/A]CGCTTCACTC	S	G	A	E	E
				IIB
G185u2	WIAF-11707	HT5122	70	ACVR2B, activin A receptor, type	AGACACGGGA[G/C]TGCATCTACT	M	G	C	E	D
				IIB
G185u3	WIAF-11672	HT5122	812	ACVR2B, activin A receptor, type	CCTCACGGAT[T/C]ACCTCAAGGG	M	T	C	Y	H
				IIB
G185u4	WIAF-13542	X77533	1109	ACVR2B, activin A receptor, type	GGCTCCTGAG[G/A]TGCTCGAGGG	M	G	A	V	M
				IIB
G185u5	WIAF-13558	X77533	997	ACVR2B, activin A receptor, type	TGCTGAAGAG[C/T]GACCTCACAG	S	C	T	S	S
				IIB
G187u1	WIAF-11669	HT97400	183	androgen	CCAGAGACAG[C/T]GCGACCCGGA	M	C	T	R	C
G191u1	WIAF-10176	AF025375	414	CXCR4, chemokine (C-X-C motif),	ACCTGGCCAT[C/T]GTCCACGCCA	S	C	T	I	I
				receptor 4 (fusin)
G193u1	WIAF-10178	D29984	231	CCR2, chemokine (C-C motif)	AGTGCTTGAC[T/A]GACATTTACC	S	T	A	T	T
				receptor 2
G193u2	WIAF-10179	D29984	190	CCR2, chemokine (C-C motif)	CATGCTGGTC[G/A]TCCTCATCTT	M	G	A	V	I
				receptor 2
G194u1	WIAF-10211	D43767	121	SCYA17, small inducible cytokine	ACATCCACGC[A/C]GCTCGAGGGA	S	A	C	A	A
				subfamily A (Cys-Cys), member 17
G197u1	WIAF-10167	D50403	1515	NRAMP1, natural resistance-	GGTGCTAGTC[T/C]GCGCCATCAA	M	T	C	C	R
				associated macrophage protein 1
				(might include Leishmaniasis)
G197u2	WIAF-10173	D50403	1629	NRAMP1, natural resistance-	CACCTACCTG[G/C]TCTGGACCTG	M	G	C	V	L
				associated macrophage protein 1
				(might include Leishmaniasis)
G20u1	WIAF-10249	U14722	896	ACVR1B, activin A receptor, type	CGGTACACAG[T/C]GACAATTGAG	M	T	C	V	A
				IB
G20u2	WIAF-10250	U14722	866	ACVR1B, activin A receptor, type	GAGCACGGGT[C/T]CCTGTTTGAT	M	C	T	S	F
				IB
G20u3	WIAF-10251	U14722	1391	ACVR1B, activin A receptor, type	CAGAGTTATG[A/T]GGCACTGCGG	M	A	T	E	V
				IB
G20u4	WIAF-10252	U14722	1236	ACVR1B, activin A receptor, type	TATATTGGGA[G/C]ATTGCTCGAA	M	G	C	E	D
				IB
G20u5	WIAF-10261	U14722	518	ACVR1B, activin A receptor, type	GAGATGTGTC[T/C]CTCCAAAGAC	M	T	C	L	P
				IB
G207a1	WIAF-10516	L25259	866	Human CTLA4 counter-receptor (B7-	AGCTGTACTT[C/T]CAACAGTTAT	M	C	T	P	S
				2) mRNA, complete cds.
G208u1	WIAF-10204	L31581	85	CCR7, chemokine (C-C motif)	GGGGAAACCA[A/G]TGAAAAGCGT	M	A	G	M	V
				receptor 7
G211u1	WIAF-10213	M24545	174	SCYA2, small inducible cytokine	TCACCTGCTG[T/C]TATAACTTCA	S	T	C	C	C
				A2 (monocyte chemotactic protein
				1, homologous to mouse Sig-je)
G214u1	WIAF-10191	M27533	452	CD80, CD80 antigen (CD28 antigen	TGAAAGAAGT[G/A]GCAACGCTGT	S	G	A	V	V
				ligand 1, B7-1 antigen)
G215u1	WIAF-11659	M28393	822	PRF1, perforin 1 (preforming	GCATCTCTGC[C/T]GAAGCCAAGG	S	C	T	A	A
				protein)
G215u2	WIAF-11723	M28393	159	PRF1, perforin 1 (preforming	TGACCAGCCT[C/T]CGCCGCTCCG	S	C	T	L	L
				protein)
G215u3	WIAF-11724	M28393	96	PRF1, perforin 1 (preforming	CAGAGTGCAA[G/A]CGCAGCCACA	S	G	A	K	K
				protein)
G215u4	WIAF-11725	M28393	1377	PRF1, perforin 1 (preforming	ATAACAACCC[C/T]ATCTGGTCAG	S	C	T	P	P
				protein)
G215u5	WIAF-11726	M28393	1326	PRF1, perforin 1 (preforming	TGAAGCTCTT[C/T]TTTGGTGGCC	S	C	T	F	F
				protein)
G215u6	WIAF-11727	M28393	1076	PRF1, perforin 1 (preforming	CGGCGGGAGG[C/T]ACTGAGGAGG	M	C	T	A	V
				protein)
G217u1	WIAF-11691	M31932	649	FCGR2B, Fc fragment of IgG, low	GCAGCTCTTC[A/G]CCAATGGGGA	S	A	G	S	S
				affinity IIb, receptor for (CD32)
G217u2	WIAF-11692	M31932	625	FCGR2B, Fc fragment of IgG, low	TCACTGTCCA[A/G]GTGCCCAGCA	S	A	G	Q	Q
				affinity IIb, receptor for (CD32)
G217u3	WIAF-11712	M31932	332	FCGR2B, Fc fragment of IgG, low	GACTGGCCAG[A/C]CCAGCCTCAG	M	A	C	T	P
				affinity IIb, receptor for (CD32)
G217u4	WIAF-11713	M31932	101	FCGR2B, Fc fragment of IgG, low	GGCTTCTGCA[G/T]ACAGTCAAGC	M	G	T	D	Y
				affinity IIb, receptor for (CD32)
G218u1	WIAF-10184	M36712	677	CD8B1, CD8 antigen, beta	TTTTACAAAT[A/G]AGCAGAGAAT	N	A	G	*	*
				polypeptide 1 (p37)
G218u2	WIAF-10188	M36712	326	CD8B1, CD8 antigen, beta	GCTGTGTTTC[G/C]GGATGCAAGC	M	G	C	R	P
				polypeptide 1 (p37)
G218u3	WIAF-10189	M36712	196	CD8B1, CD8 antigen, beta	CAGTAACATG[C/T]GCATCTACTG	M	C	T	R	C
				polypeptide 1 (p37)
G218u4	WIAF-10190	M36712	225	CD8B1, CD8 antigen, beta	AGCGCCAGGC[A/C]CCGAGCAGTG	S	A	C	A	A
				polypeptide 1 (p37)
G218u5	WIAF-10194	M36712	583	CD8B1, CD8 antigen, beta	GGTGGCTGGC[G/A]TCCTGGTTCT	M	G	A	V	I
				polypeptide 1 (p37)
G218u6	WIAF-10208	M36712	372	CD8B1, CD8 antigen, beta	TGAAGCCGGA[A/G]GACAGTGGCA	S	A	G	E	E
				polypeptide 1 (p37)
G218u7	WIAF-10209	M36712	400	CD8B1, CD8 antigen, beta	CTGCATGATC[G/T]TCGGGAGCCC	M	G	T	V	F
				polypeptide 1 (p37)
G218u8	WIAF-10210	M36712	270	CD8B1, CD8 antigen, beta	TCTGGGATTC[C/T]GCAAAAGGGA	S	C	T	S	S
				polypeptide 1 (p37)
G218a9	WIAF-10518	M36712	618	CD8B1, CD8 antigen, beta	GAGTGGCCAT[C/G]CACCTGTGCT	M	C	G	I	M
				polypeptide 1 (p37)
G218a10	WIAF-13223	M36712	556	CD8B1, CD8 antigen, beta	TTGTAGCCCC[A/G]TCACCCTTGG	M	A	G	I	V
				polypeptide 1 (p37)
G218a11	WIAF-13224	M36712	836	CD8B1, CD8 antigen, beta	CTGTGTGTGA[T/C]GTGCATGGGA	—	T	C	—	—
				polypeptide 1 (p37)
G22u1	WIAF-10301	U86136	6719	Human telomerase-associated	GGTGGTAACC[G/A]TCGGGCTAGA	M	G	A	V	I
				protein TP-1 mRNA, complete cds.
G22u2	WIAF-10302	U86136	7537	Human telomerase-associated	CTGATGGGAT[C/G]CTATGGAACC	M	C	G	I	M
				protein TP-1 mRNA, complete cds.
G22u3	WIAF-10311	U86136	1798	Human telomerase-associated	ATGATGCCAT[T/C]GATGCCCTCG	S	T	C	I	I
				protein TP-1 mRNA, complete cds.
G22u4	WIAF-10312	U86136	2397	Human telomerase-associated	CTGTCTCTGG[C/T]TGGCCAAAGG	M	C	T	A	V
				protein TP-1 mRNA, complete cds.
G22u5	WIAF-10313	U86136	3289	Human telomerase-associated	AGAAAGGGAT[A/C]ACCTGCCGCA	S	A	C	I	I
				protein TP-1 mRNA, complete cds.
G22u6	WIAF-10314	U86136	3242	Human telomerase-associated	AGAGGCCGCA[T/C]GTCGGATCTC	M	T	C	C	R
				protein TP-1 mRNA, complete cds.
G22u7	WIAF-10315	U86136	4482	Human telomerase-associated	CCGTTTGCCT[G/A]CCTCGTCCAG	M	G	A	C	Y
				protein TP-1 mRNA, complete cds.
G22u8	WIAF-10316	U86136	4363	Human telomerase-associated	GTTTGACTGT[G/A]GACCAGCTGC	S	G	A	V	V
				protein TP-1 mRNA, complete cds.
G22u9	WIAF-10317	U86136	4230	Human telomerase-associated	GTGTCTGAGA[G/A]ACTCCGGACC	M	G	A	R	K
				protein TP-1 mRNA, complete cds.
G22u10	WIAF-10318	U86136	4419	Human telomerase-associated	GGGACTAAGA[G/C]CTGGGAAGAA	M	G	C	S	T
				protein TP-1 mRNA, complete cds.
G22u11	WIAF-10319	U86136	5269	Human telomerase-associated	TCTCCGATGA[T/C]ACACTCTTTC	S	T	C	D	D
				protein TP-1 mRNA, complete cds.
G22u12	WIAF-10320	U86136	5015	Human telomerase-associated	GCTGCTCTCC[C/T]GGAGATGGCA	M	C	T	R	W
				protein TP-1 mRNA, complete cds.
G22u13	WIAF-10321	U86136	5133	Human telomerase-associated	GTGGCCTTCT[C/T]CACCAATGGG	M	C	T	S	F
				protein TP-1 mRNA, complete cds.
G22u14	WIAF-10322	U86136	7764	Human telomerase-associated	ACAGCCCTCC[A/G]TGTGCTACCT	M	A	G	H	R
				protein TP-1 mRNA, complete cds.
G22u15	WIAF-10323	U86136	7884	Human telomerase-associated	TGCCTGGAAC[C/T]TTGGCTGGGC	M	C	T	P	L
				protein TP-1 mRNA, complete cds.
G22u16	WIAF-10324	U86136	7744	Human telomerase-associated	AGATTCACTC[G/A]GGCTCTGTCA	S	G	A	S	S
				protein TP-1 mRNA, complete cds.
G22u17	WIAF-10337	U86136	1018	Human telomerase-associated	CCATTGCTGC[T/C]TTCTTGCCGG	S	T	C	A	A
				protein TP-1 mRNA, complete cds.
G22u18	WIAF-10338	U86136	1000	Human telomerase-associated	TGGCCAATAA[C/A]ATCTTGGCCA	M	C	A	N	K
				protein TP-1 mRNA, complete cds
G22u19	WIAF-10339	U86136	1182	Human telomerase-associated	ATGACGGACA[A/G]ATTTGCCCAG	M	A	G	K	R
				protein TP-1 mRNA, complete cds.
G22u20	WIAF-10340	U86136	1939	Human telomerase-associated	AGCAGCTTCG[T/G]ATGGCAATGA	S	T	G	R	R
				protein TP-1 mRNA, complete cds.
G22u21	WIAF-10341	U86136	2227	Human telomerase-associated	TCACGAGGGC[G/A]GAGCAGGTGG	S	G	A	A	A
				protein TP-1 mRNA, complete cds.
G22u22	WIAF-10342	U86136	2776	Human telomerase-associated	GGCGCAGCAT[C/T]CGGCTTTTCA	S	C	T	I	I
				protein TP-1 mRNA, complete cds.
G22u23	WIAF-10343	U86136	2877	Human telomerase-associated	GCCCCTCACC[G/A]TATCAGCCTT	M	G	A	R	H
				protein TP-1 mRNA, complete cds.
G22u24	WIAF-10344	U86136	3087	Human telomerase-associated	TCAGGGCGCT[C/T]TGTGACAGAG	M	C	T	S	F
				protein TP-1 mRNA, complete cds.
G22u25	WIAF-10345	U86136	3662	Human telomerase-associated	CAAGGTGGCA[C/T]CATTAGTCTT	M	C	T	P	S
				protein TP-1 mRNA, complete cds.
G22u26	WIAF-10346	U86136	4762	Human telomerase-associated	TTTCGAAGTT[C/T]CTTACCAACC	S	C	T	F	F
				protein TP-1 mRNA, complete cds.
G22u27	WIAF-10351	U86136	1737	Human telomerase-associated	CTCCAGCATG[G/C]GAAGTCGGTG	M	G	C	G	A
				protein TP-1 mRNA, complete cds.
G22u28	WIAF-10352	U86136	3543	Human telomerase-associated	ACAGTGCAAC[A/G]GCTGATGCTG	M	A	G	Q	R
				protein TP-1 mRNA, complete cds.
G22u29	WIAF-10353	U86136	4232	Human telomerase-associated	GTCTGAGAGA[C/T]TCCGGACCCT	M	C	T	L	F
				protein TP-1 mRNA, complete cds.
G22u30	WIAF-10354	U86136	4523	Human telomerase-associated	GGAGGGCCCT[C/T]TGGAGCGCCC	S	C	T	L	L
				protein TP-1 mRNA, complete cds.
G22u31	WIAF-10355	U86136	5333	Human telomerase-associated	TGGTTGTCGG[G/T]TGCTGCAGAC	M	G	T	V	L
				protein TP-1 mRNA, complete cds.
G22u32	WIAF-10356	U86136	6208	Human telomerase-associated	AGCTGCTGAC[G/A]CGGCCACACA	S	G	A	T	T
				protein TP-1 mRNA, complete cds.
G22u33	WIAF-10357	U86136	7703	Human telomerase-associated	TAGTGAGCCA[A/G]CACCACATCT	M	A	G	T	A
				protein TP-1 mRNA, complete cds.
G22u34	WIAF-10360	U86136	3881	Human telomerase-associated	CATCGATGGG[G/A]CTGATAGGTT	M	G	A	A	T
				protein TP-1 mRNA, complete cds.
G222u1	WIAF-11700	M57230	697	IL6ST, interleukin 6 signal	TGAGTGGGAT[G/C]GTGGAAGGGA	M	G	C	G	R
				transducer (gp130, oncostatin M
				receptor)
G222u2	WIAF-11701	M57230	708	IL6ST, interleukin 6 signal	GTGGAAGGGA[A/G]ACACACTTGG	S	A	G	E	E
				transducer (gp130, oncostatin M
				receptor)
G222u3	WIAF-11702	M57230	677	IL6ST, interleukin 6 signal	GAGGGGAAGA[A/G]AATGAGGTGT	M	A	G	K	R
				transducer (gp130, oncostatin M
				receptor)
G222u4	WIAF-11706	M57230	1616	IL6ST, interleukin 6 signal	AAGAAATATA[T/C]ACTTGAGTGG	M	T	C	I	T
				transducer (gp130, oncostatin M
				receptor)
G222u5	WIAF-11667	M57230	1444	IL6ST, interleukin 6 signal	TGATCGCTAT[C/G]TAGCAACCCT	M	C	G	L	V
				transducer (gp130, oncostatin M
				receptor)
G222u6	WIAF-11708	M57230	981	IL6ST, interleukin 6 signal	TCTTAAAATT[G/C]ACATGGACCA	M	G	C	L	F
				transducer (gp130, oncostatin M
				receptor)
G226u1	WIAF-11714	M85079	869	TGFBR2, transforming growth	CACTGGGAGT[T/C]GCCATATCTG	S	T	C	V	V
				factor, beta receptor II (70-80 kD)
G226u2	WIAF-11715	M85079	1749	TGFBR2, transforming growth	AGATTATGAG[C/T]CTCCATTTGG	M	C	T	P	S
				factor, beta receptor II (70-80 kD)
G226u3	WIAF-11716	M85079	1601	TGFBR2, transforming growth	TGGGAACTGC[A/G]AGATACATGG	S	A	G	A	A
				factor, beta receptor II (70-80 kD)
G226u4	WIAF-11721	M85079	1256	TGFBR2, transforming growth	TACTCCAGTT[C/G]CTGACGGCTG	M	C	G	F	L
				factor, beta receptor II (70-80 kD)
G226u5	WIAF-11722	M85079	1502	TGFBR2, transforming growth	TCGTGAAGAA[C/T]GACCTAACCT	S	C	T	N	N
				factor, beta receptor II (70-80 kD)
G226u6	WIAF-11671	M85079	888	TGFBR2, transforming growth	TGTCATCATC[A/C]TCTTCTACTG	M	A	C	I	L
				factor, beta receptor II (70-80 kD)
G226u7	WIAF-11674	M85079	1425	TGFBR2, transforming growth	CCTCCACAGT[G/A]ATCACACTCC	M	G	A	D	N
				factor, beta receptor II (70-80 kD)
G227u1	WIAF-10197	M86511	685	CD14, CD14 antigen	CCTGTCTGAC[A/G]ATCCTGGACT	M	A	G	N	D
G227u2	WIAF-10212	M86511	497	CD14, CD14 antigen	GAAGCCACAG[G/A]ACTTGCACTT	M	G	A	G	E
G2278u1	WIAF-14117	AF034611	959	CUBN, cubilin (intrinsic factor-	AGATAAATAA[T/C]GGCGGCTGTT	S	T	C	N	N
				cobalamin receptor)
G2278u2	WIAF-14118	AF034611	781	CUBN, cubilin (intrinsic factor-	GGGTGGATGT[C/T]TTCACCCAAC	M	C	T	S	F
				cobalamin receptor)
G2278u3	WIAF-14119	AF034611	641	CUBN, cubilin (intrinsic factor-	CTGAGACGTA[C/T]GGACCCCAGT	S	C	T	Y	Y
				cobalamin receptor)
G2278u4	WIAF-14121	AF034611	1185	CUBN, cubilin (intrinsic factor-	TGGTTATGGG[C/A]CAAATGGATG	M	C	A	P	T
				cobalamin receptor)
G2278u5	WIAF-14133	AF034611	1532	CUBN, cubilin (intrinsic factor-	TCTGGGTTAT[C/G]AAAACTGAAA	M	C	G	I	M
				cobalamin receptor)
G2278u6	WIAF-14134	AF034611	2208	CUBN, cubilin (intrinsic factor-	GCCTTTCACT[C/T]ACACCAGGCA	M	C	T	H	Y
				cobalamin receptor)
G228u1	WIAF-10199	U00672	586	IL10RA, interleukin 10 receptor,	GCAAGGTGCC[G/A]GGAAACTTCA	S	G	A	P	P
				alpha
G228u2	WIAF-10200	U00672	731	IL10RA, interleukin 10 receptor,	AGAGGAGTGC[A/G]TCTCCCTCAC	M	A	G	I	V
				alpha
G2280u1	WIAF-13970	AJ001515	1747	RYR3, ryanodine receptor 3	CAGGTATCTT[G/A]GAAGTTTTGC	S	G	A	L	L
G2280u2	WIAF-13974	AJ001515	8593	RYR3, ryanodine receptor 3	TAGAAGCCAT[T/C]GTCAGCAGTG	S	T	C	I	I
G2282u1	WIAF-12694	D00726	263	FECH, ferrochelatase	ACATGGGAGG[C/T]CCTGAAACTC	S	C	T	G	G
				(protoporphyria)
G2282u2	WIAF-12695	D00726	514	FECH, ferrochelatase	TACTATATTG[G/A]ATTTCGGTAC	M	G	A	G	E
				(protoporphyria)
G2285u1	WIAF-12688	D16611	673	CPO, coproporphyrinogen oxidase	AGAAGACGCT[G/A]TCCATTTTCA	M	G	A	V	I
				(coproporphyria, harderoporphyria)
G2285u2	WIAF-12689	D16611	783	CPO, coproporphyrinogen oxidase	ATCGTGGAGA[G/A]CGGCGGGGCA	S	G	A	E	E
				(coproporphyria, harderoporphyria)
G2287u1	WIAF-12687	D28472	502	PTGER4, prostaglandin E receptor	GGGCCTCACG[C/T]TCTTTGCAGT	M	C	T	L	F
				4 (subtype EP4)
G2287u2	WIAF-12691	D28472	1309	PTGER4, prostaglandin E receptor	TGAAAATGGC[C/T]TTGGAGGCAG	M	C	T	L	F
				4 (subtype EP4)
G2287u3	WIAF-12707	D28472	243	PTGER4, prostaglandin E receptor	AGGAGACGAC[C/T]TTCTACACGC	S	C	T	T	T
				4 (subtype EP4)
G2287u4	WIAF-12710	D28472	1343	PTGER4, prostaglandin E receptor	GGTGTGCCTG[G/A]CATGGGCCTG	M	G	A	G	D
				4 (subtype EP4)
G229u1	WIAF-10185	U16752	202	SDF1, stromal cell-derived factor	CATGTTGCCA[G/A]AGCCAACGTC	M	G	A	R	K
				1
G2295u1	WIAF-12727	D89079	613	LTB4R, leukotriene b4 receptor	CTATGTCTGC[G/C]GAGTCAGCAT	M	G	C	G	R
				(chemokine receptor-like 1)
G2295u2	WIAF-12728	D89079	1248	LTB4R, leukotriene b4 receptor	AGGGCACGGG[T/C]TCCGAGGCGT	S	T	C	G	G
				(chemokine receptor-like 1)
G2295u3	WIAF-12753	D89079	1348	LTB4R, leukotriene b4 receptor	CCTCACTGCC[T/G]CCAGCCCTCT	M	T	G	S	A
				(chemokine receptor-like 1)
G230u1	WIAF-10201	U31628	627	IL15RA, interleukin 15 receptor,	ACAGCCAAGA[A/C]CTGGGAACTC	M	A	C	N	T
				alpha
G2300u1	WIAF-12735	J02959	102	LTA4H, leukotriene A4 hydrolase	ACCTGCACCT[G/T]CGCTGCAGCG	S	G	T	L	L
G2300u2	WIAF-12738	J02959	1380	LTA4H, leukotriene A4 hydrolase	CCTGGCTCTA[C/T]TCTCCTGGAC	S	C	T	Y	Y
G2302u1	WIAF-12741	J03037	627	CA2, carbonic anhydrase II	TCCTGAATCC[C/T]TGGATTACTG	S	C	T	L	L
G2302u2	WIAF-12742	J03037	819	CA2, carbonic anhydrase II	GCCACTGAAG[A/G]ACAGGCAAAT	M	A	G	N	D
G2303u1	WIAF-12751	J03571	304	ALOX5, arachidonate 5-	CGCTGAAGAC[G/A]CCCCACGGGG	S	G	A	T	T
				lipoxygenase
G2303u2	WIAF-12752	J03571	794	ALOX5, arachidonate 5-	AGAGCTGCCC[G/A]AGAAGCTCCC	M	G	A	E	K
				lipoxygenase
G2304u1	WIAF-12772	J03575	840	PDHA1, pyruvate dehydrogenase	TCCGAGAGGC[A/G]ACAAGGTTTG	S	A	G	A	A
				(lipoamide) alpha 1
G2304u2	WIAF-12779	J03575	1044	PDHA1, pyruvate dehydrogenase	CCAGTGTGGA[A/C]GAACTAAAGG	M	A	C	E	D
				(lipoamide) alpha 1
G2305u1	WIAF-12763	J03576	456	PDHB, pyruvate dehydrogenase	TCTTCAGGGG[A/G]CCCAATGGTG	S	A	G	G	G
				(lipoamide) beta
G2305u2	WIAF-12764	J03576	650	PDHB, pyruvate dehydrogenase	GTTCCTTTTG[A/C]ATTTCTCCCG	M	A	C	E	A
				(lipoamide) beta
G231u1	WIAF-10202	U32324	734	IL11RA, interleukin 11 receptor,	CCAGGGCCTG[C/T]GGGTAGAGTC	M	C	T	R	W
				alpha
G2312u1	WIAF-12762	J05096	3726	ATP1A2, ATPase, Na+/K+	TCAAGAACCA[C/T]ACAGAGATCG	S	C	T	H	H
				transporting, alpha 2 (+)
				polypeptide
G2313u1	WIAF-12760	J05200	6141	RYR1, ryanodine receptor 1	TGCAATTCAA[A/G]GATGGTACAG	S	A	G	K	K
				(skeletal)
G2313u2	WIAF-12767	J05200	3048	RYR1, ryanodine receptor 1	CGGCGCAGAC[A/G]ACACTGGTGG	S	A	G	T	T
				(skeletal)
G2313u3	WIAF-12768	J05200	3084	RYR1, ryanodine receptor 1	ATGGGCACAA[C/T]CTGTGGGCCC	S	C	T	N	N
				(skeletal)
G2313u4	WIAF-12777	J05200	5667	RYR1, ryanodine receptor 1	GCATCTTTGG[C/T]GATGAGGATG	S	C	T	G	G
				(skeletal)
G2313u5	WIAF-12780	J05200	6600	RYR1, ryanodine receptor 1	GCTCGCTGCT[C/T]ATCGTGCAGA	S	C	T	L	L
				(skeletal)
G2313u6	WIAF-12781	J05200	7191	RYR1, ryanodine receptor 1	AGCCTGAGTG[C/T]TTCGGACCCG	S	C	T	C	C
				(skeletal)
G2313u7	WIAF-12782	J05200	7602	RYR1, ryanodine receptor 1	ACCACAAGGC[G/A]TCCATGGTGC	S	G	A	A	A
				(skeletal)
G2313u8	WIAF-12784	J05200	9288	RYR1, ryanodine receptor 1	CAGACGCCCC[A/G]GCTGTGGTCA	S	A	G	P	P
				(skeletal)
G2313u9	WIAF-12786	J05200	13690	RYR1, ryanodine receptor 1	TCCAAAGAAG[G/A]AGGAAGCTGG	M	G	A	E	K
				(skeletal)
G2313u10	WIAF-12789	J05200	3147	RYR1, ryanodine receptor 1	ACATCCCAGC[G/A]CGCCGAAACC	S	C	A	A	A
				(skeletal)
G2314u1	WIAF-12771	J05272	1920	IMPDH1, IMP (inosine	TGAAGATCGC[A/G]CAGGGTGTCT	S	A	G	A	A
				monophosphate) dehydrogenase 1
G2319u1	WIAF-12814	K03191	651	CYP1A1, cytochrome P450,	CCCCTACAGG[T/C]ATGTGGTGGT	M	T	C	Y	H
				subfamily I (aromatic compound-
				inducible), polypeptide 1
G232u1	WIAF-11657	U58917	1490	Homo sapiens IL-17 receptor mRNA,	TGAACATGAT[C/T]CTCCCGGACT	S	C	T	I	I
				complete cds.
G232u2	WIAF-11677	U58917	1293	Homo sapiens IL-17 receptor mRNA,	GCAGGCCATC[T/C]CGGAGGCAGG	M	T	C	S	P
				complete cds.
G232u3	WIAF-11658	U58917	1132	Homo sapiens IL-17 receptor mRNA,	GGCCTGCCTG[C/T]GGCTGACCTG	M	C	T	A	V
				complete cds.
G232u4	WIAF-11679	U58917	905	Homo sapiens IL-17 receptor mRNA,	GCAGCTGCCT[C/T]AATGACTGCC	S	C	T	L	L
				complete cds.
G232u5	WIAF-11682	U58917	1794	Homo sapiens IL-17 receptor mRNA,	GTTCGAATGT[G/T]AGAACCTCTA	N	G	T	E	*
				complete cds.
G232u7	WIAF-11660	U58917	743	Homo sapiens IL-17 receptor mRNA,	TGACCAGTTT[T/C]CCGCACATGG	S	T	C	F	F
				complete cds.
G2322u1	WIAF-12853	L01406	1316	GHRHR, growth hormone releasing	CTGACATCTA[T/C]GTGCTAGGCT	M	T	C	M	T
				hormone receptor
G2328u1	WIAF-12845	L20316	1285	GCGR, glucagon receptor	TGCGGGCACG[G/C]CAGATGCACC	S	G	C	R	R
G2329u1	WIAF-12850	L22214	713	ADORA1, adenosine A1 receptor	TGCTGGCAAT[T/C]GCTGTGGACC	S	T	C	I	I
G2329u2	WIAF-12851	L22214	716	ADORA1, adenosine A1 receptor	TGGCAATTGC[T/G]GTGGACCGCT	S	T	G	A	A
G2335a1	WIAF-12136	L32961	265	ABAT, 4-aminobutyrate	CCTAGATCTC[A/G]GGAGTTAATG	M	A	G	Q	R
				aminotransferase
G2335a2	WIAF-12137	L32961	407	ABAT, 4-aminobutyrate	TCTCCTCTGT[T/C]CCCATAGGTT	S	T	C	V	V
				aminotransferase
G2335u3	WIAF-12838	L32961	365	ABAT, 4-aminobutyrate	TTGATGTGGA[C/T]GGCAACCGAA	S	C	T	D	D
				aminotransferase
G2335u4	WIAF-12839	L32961	583	ABAT, 4-aminobutyrate	ATCACCATGG[C/T]CTGCGGCTCC	M	C	T	A	V
				aminotransferase
G2335u5	WIAF-12841	L32961	1082	ABAT, 4-aminobutyrate	TGGACGAGGT[C/A]CAGACCGGAG	S	C	A	V	V
				aminotransferase
G2335u6	WIAF-12852	L32961	227	ABAT, 4-aminobutyrate	ATTATGATGG[G/A]CCTCTGATGA	S	G	A	G	G
				aminotransferase
G2337u1	WIAF-13577	L34820	149	ALDH5A1, aldehyde dehydrogenase 5	TGTTCTCGAA[A/G]GAATGCCAAG	M	A	G	K	R
				family, member A1 (succinate-
				semialdehyde dehydrogenase)
G2342a1	WIAF-12138	M12530	1602	TF, transferrin	GCCTAAACCT[G/C]TGTGAACCCA	S	G	C	L	L
G2342a2	WIAF-12139	M12530	1795	TF, transferrin	TACCAGGAAA[C/T]CTGTGGAGGA	M	C	T	P	S
G2346u1	WIAF-12829	M13928	234	ALAD, aminolevulinate, delta-,	TGGCCAGGTA[T/C]GGTGTGAAGC	S	T	C	Y	Y
				dehydratase
G2346u2	WIAF-12830	M13928	529	ALAD, aminolevulinate, delta-,	TGAGGTGGCA[T/C]TGGCGTATGC	S	T	C	L	L
				dehydratase
G2346u3	WIAF-12843	M13928	480	ALAD, aminolevulinate, delta-,	TGAGTGAAAA[C/T]GGAGCATTCC	S	C	T	N	N
				dehydratase
G2348u1	WIAF-12835	M14016	621	UROD, uroporphyrinogen	CTCTGGTCCC[A/G]TATCTGGTAG	S	A	G	P	P
				decarboxylase
G235u1	WIAF-11678	U83171	100	SCYA22, small inducible cytokine	CAGGCCCCTA[C/T]GGCGCCAACA	S	C	T	Y	Y
				subfamily A (Cys—Cys), member 22
G2363a1	WIAF-10519	M37435	596	CSF1, colony stimulating factor 1	GACAAGGACT[G/T]GAATATTTTC	M	G	T	W	L
				(macrophage)
G2363a2	WIAF-13225	M37435	498	CSF1, colony stimulating factor 1	AAGAGCATGA[C/T]AAGGCCTGCG	S	C	T	D	D
				(macrophage)
G2363a3	WIAF-13226	M37435	712	CSF1, colony stimulating factor 1	CAGTGACCCG[G/T]CCTCTGTCTC	M	G	T	A	S
				(macrophage)
G2369u1	WIAF-12854	M30773	857	PPP3R1, protein phosphatase 3	TTGATTTGGA[C/T]AATTCTGGTT	S	C	T	D	D
				(formerly 2B), regulatory subunit
				B (19 kD), alpha isoform
				(calcineurin B, type I)
G2369u2	WIAF-12855	M30773	1274	PPP3R1, protein phosphatase 3	ATGTGTGACT[C/T]TTATCAGAGA	—	C	T	—	—
				(formerly 2B), regulatory subunit
				B (19 kD), alpha isoform
				(calcineurin B, type I)
G237u1	WIAF-11662	U86358	311	SCYA25, small inducible cytokine	CACCACAACA[T/C]GCAGACCTTC	M	T	C	M	T
				subfamily A (Cys—Cys), member 25
G237u2	WIAF-11680	U86358	134	SCYA25, small inducible cytokine	GTGCTCCGGC[G/A]CGCCTGGACT	M	G	A	R	H
				subfamily A (Cys—Cys), member 25
G237u3	WIAF-11681	U86358	133	SCYA25, small inducible cytokine	TGTGCTCCGG[C/T]GCGCCTGGAC	M	C	T	R	C
				subfamily A (Cys—Cys), member 25
G237u5	WIAF-11661	U86358	302	SCYA25, small inducible cytokine	GCAAAGCTCC[A/G]CCACAACATG	M	A	G	H	R
				subfamily A (Cys—Cys), member 25
G237u6	WIAF-11663	U86358	378	SCYA25, small inducible cytokine	AGTTATCATC[A/G]TCCAAGTTTA	S	A	G	S	S
				subfamily A (Cys—Cys), member 25
G2373u1	WIAF-12870	M36035	500	BZRP, benzodiazapine receptor	GCTGGCCTTC[G/A]CGACCACACT	M	G	A	A	T
				(peripheral)
G2376u1	WIAF-13025	M57414	979	TACR2, tachykinin receptor 2	CTGCTGCCCA[T/C]GGGTCACACC	M	T	C	W	R
G238u1	WIAF-10177	X01394	239	TNF, tumor necrosis factor (TNF	GCTCCAGGCG[G/T]TGCTTGTTCC	S	G	T	R	R
				superfamily, member 2)
G2381u1	WIAF-12894	M59941	730	CSF2RB, colony stimulating factor	CAGAGGTTTG[C/T]TGGGACTCCC	S	C	T	C	C
				2 receptor, beta, low-affinity
				(granulocyte-macrophage)
G2381u2	WIAF-12896	M59941	1306	CSF2RB, colony stimulating factor	GGATCTGGAG[C/T]GAGTGGAGTG	S	C	T	S	S
				2 receptor, beta, low-affinity
				(granulocyte-macrophage)
G2381u3	WIAF-12900	M59941	1972	CSF2RB, colony stimulating factor	CGATGGGACC[G/A]GGACAGGCCG	S	G	A	P	P
				2 receptor, beta, low-affinity
				(granulocyte-macrophage)
G2381u4	WIAF-12901	M59941	1982	CSF2RB, colony stimulating factor	GGGACAGGCC[G/A]TGGAAGTGGA	M	G	A	V	M
				2 receptor, beta, low-affinity
				(granulocyte-macrophage)
G2381u5	WIAF-12942	M59941	773	CSF2RB, colony stimulating factor	CCAGAACCTG[G/C]AGTGCTTCTT	M	G	C	E	Q
				2 receptor, beta, low-affinity
				(granulocyte-macrophage)
G2381u6	WIAF-12946	M59941	2458	CSF2RB, colony stimulating factor	CCCCACAGCC[C/A]GAGGGCCTCC	S	C	A	P	P
				2 receptor, beta, low-affinity
				(granulocyte-macrophage)
G2384u1	WIAF-12908	M61831	1000	AHCY, S-adenosylhomocysteine	GCCGTGGAGA[A/C]GGTGAACATC	M	A	C	K	T
				hydrolase
G2387u1	WIAF-12910	M63967	2585	ALDH5, aldehyde dehydrogenase 5	CTGCTGAACC[T/G]CCTGGCAGAC	M	T	G	L	R
G2387u2	WIAF-12911	M63967	2996	ALDH5, aldehyde dehydrogenase 5	TATGGCCCAA[C/G]AGCAGGTGCG	M	C	G	T	R
G2387u3	WIAF-12954	M63967	2522	ALDH5, aldehyde dehydrogenase 5	GCCCGGGAAG[C/T]CTTCCGCCTG	M	C	T	A	V
G2387u4	WIAF-12955	M63967	2448	ALDH5, aldehyde dehydrogenase 5	ACCCTACCAC[C/T]GGGGAGGTCA	S	C	T	T	T
G2387u5	WIAF-12956	M63967	2460	ALDH5, aldehyde dehydrogenase 5	GGGAGGTCAT[C/T]GGGCACGTGG	S	C	T	I	I
G2387u6	WIAF-12957	M63967	2991	ALDH5, aldehyde dehydrogenase 5	CGGGGTATGG[C/T]CCAACAGCAG	S	C	T	G	G
G2387u7	WIAF-12958	M63967	3022	ALDH5, aldehyde dehydrogenase 5	CGCCCAGCAC[A/G]TGGATGTTGA	M	A	G	M	V
G2387u8	WIAF-12959	M63967	2943	ALDH5, aldehyde dehydrogenase 5	CCCTCATCAA[G/C]GAGGCAGGCT	M	G	C	K	N
G2388u1	WIAF-12888	M64590	588	GLDC, glycine dehydrogenase	TGCCACAGAC[G/A]ATTTTGCGGA	S	G	A	T	T
				(decarboxylating; glycine
				decarboxylase, glycine cleavage
				system protein P)
G2388u2	WIAF-12889	M64590	651	GLDC, glycine dehydrogenase	ACCAGCCTGA[G/A]GTGTCTCAGG	S	G	A	E	E
				(decarboxylating; glycine
				decarboxylase, glycine cleavage
				system protein P)
G2388u3	WIAF-12890	M64590	698	GLDC, glycine dehydrogenase	CAGACCATGG[T/C]GTGTGACATC	M	T	C	V	A
				(decarboxylating; glycine
				decarboxylase, glycine cleavage
				system protein P)
G2388u4	WIAF-12891	M64590	557	GLDC, glycine dehydrogenase	TATATTGGCA[T/C]GGGCTATTAT	M	T	C	M	T
				(decarboxylating; glycine
				decarboxylase, glycine cleavage
				system protein P)
G2388u5	WIAF-12938	M64590	587	GLDC, glycine dehydrogenase	GTGCCACAGA[C/G]GATTTTGCGG	M	C	G	T	R
				(decarboxylating; glycine
				decarboxylase, glycine cleavage
				system protein P)
G2388u6	WIAF-12939	M64590	518	GLDC, glycine dehydrogenase	CTGCATGCCA[T/C]TTCAAGCAAA	M	T	C	I	T
				(decarboxylating; glycine
				decarboxylase, glycine cleavage
				system protein P)
G2388u7	WIAF-12940	M64590	810	GLDC, glycine dehydrogenase	GGAAATTTCT[C/T]GTTGATCCCC	S	C	T	L	L
				(decarboxylating; glycine
				decarboxylase, glycine cleavage
				system protein P)
G2388u8	WIAF-12941	M64590	1481	GLDC, glycine dehydrogenase	CATTGTGGCT[G/A]CTCAGTGAAG	M	G	A	C	Y
				(decarboxylating; glycine
				decarboxylase, glycine cleavage
				system protein P)
G2388u9	WIAF-12947	M64590	1841	GLDC, glycine dehydrogenase	AAACTGAACA[G/A]TTCGTCTGAA	M	G	A	S	N
				(decarboxylating; glycine
				decarboxylase, glycine cleavage
				system protein P)
G2388u10	WIAF-12948	M64590	2325	GLDC, glycine dehydrogenase	GACAGGTCTA[C/T]CTAGACGGGG	S	C	T	Y	Y
				(decarboxylating; glycine
				decarboxylase, glycine cleavage
				system protein P)
G2388u11	WIAF-12949	M64590	2362	GLDC, glycine dehydrogenase	GGTGGGAATC[T/A]GTCGCCCTGG	M	T	A	C	S
				(decarboxylating; glycine
				decarboxylase, glycine cleavage
				system protein P)
G2388u12	WIAF-12950	M64590	3220	GLDC, glycine dehydrogenase	TTAGTCCTCT[C/G]TCCCTAAGTT	—	C	G	—	—
				(decarboxylating; glycine
				decarboxylase, glycine cleavage
				system protein P)
G2391u1	WIAF-12998	M69238	623	ARNT, aryl hydrocarbon receptor	TGGTGTATGT[G/C]TCTGACTCCG	S	G	C	V	V
				nuclear translocator
G2391u2	WIAF-13002	M69238	1072	ARNT, aryl hydrocarbon receptor	TGCCTAGTGG[C/T]CATTGGCAGA	M	C	T	A	V
				nuclear translocator
G2391u3	WIAF-13021	M69238	966	ARNT, aryl hydrocarbon receptor	ACCTCACTTC[G/A]TGGTGGTCCA	M	G	A	V	M
				nuclear translocator
G2394u1	WIAF-13003	M73747	2061	TSHR, thyroid stimulating hormone	TTGCTGGTAC[T/A]CTTCTATCCA	M	T	A	L	H
				receptor
G2394u2	WIAF-13004	M73747	2248	TSHR, thyroid stimulating hormone	TTACCCACGA[C/G]ATGAGGCAGG	M	C	G	D	E
				receptor
G2396u1	WIAF-12995	M74542	1027	ALDH3, aldehyde dehydrogenase 3	CCCCCAGTCC[C/G]CGGTGATGCA	M	C	G	P	A
G2396u2	WIAF-13019	M74542	1295	ALDH3, aldehyde dehydrogenase 3	GGCAAGAAGA[G/A]CTTCGAGACT	M	G	A	S	N
G2403u1	WIAF-13583	M83670	280	CA4, carbonic anhydrase IV	TACGATAAGA[A/T]GCAAACGTGG	M	A	T	K	M
G2409u1	WIAF-10010	HT2156	1268	AGTR1, angiotensin receptor 1	CCACTCAAAC[C/T]TTTCAACAAA	M	C	T	L	F
G2411u1	WIAF-13541	M97759	210	ADORA2B, adenosine A2b receptor	TGGCGGGCAA[C/T]GTGCTGGTGT	S	C	T	N	N
G2422u1	WIAF-14077	S90469	375	POR, P450 (cytochrome)	GCAGCCTGCC[A/G]GAGATCGACA	S	A	G	P	P
				oxidoreductase
G2422u2	WIAF-14078	S90469	852	POR, P450 (cytochrome)	TCCTGGCTGC[A/G]GTCACCACCA	S	A	G	A	A
				oxidoreductase
G2422u3	WIAF-14082	S90469	1496	POR, P450 (cytochrome)	AAGGAGCCTG[T/C]CGGGGAGAAC	M	T	C	V	A
				oxidoreductase
G2422u4	WIAF-14099	S90469	1443	POR, P450 (cytochrome)	AGACCAAGGC[C/T]GGCCGCATCA	S	C	T	A	A
				oxidoreductase
G2422u5	WIAF-14100	S90469	1704	POR, P450 (cytochrome)	GCCGCCGCTC[G/A]GATGAGGACT	S	G	A	S	S
				oxidoreductase
G2427u1	WIAF-14079	U07919	1369	ALDH6, aldehyde dehydrogenase 6	ACTATGGACT[C/T]ACAGCAGCCG	S	C	T	L	L
G2427u2	WIAF-14096	U07919	1347	ALDH6, aldehyde dehydrogenase 6	ATAAAAAGAG[C/T]GAATAGCACC	M	C	T	A	V
G243u1	WIAF-11684	X57522	926	TAP1, transporter 1, ABC (ATP	ATAGCCAGTG[C/G]AGTGCTGGAG	M	C	G	A	G
				binding cassette)
G243u2	WIAF-11685	X57522	627	TAP1, transporter 1, ABC (ATP	ACCCTACCGC[C/T]TTCGTTGTCA	S	C	T	A	A
				binding cassette)
G243u3	WIAF-11686	X57522	538	TAP1, transporter 1, ABC (ATP	CCTGCCGGGA[C/G]TTGCCTTGTT	M	C	G	L	V
				binding cassette)
G243u4	WIAF-11687	X57522	798	TAP1, transporter 1, ABC (ATP	TGGTGGTCCT[C/G]TCCTCTCTTG	S	C	G	L	L
				binding cassette)
G243u5	WIAF-11689	X57522	1465	TAP1, transporter 1, ABC (ATP	TAGTATTTCA[G/T]GTATGCTGCT	M	G	T	G	C
				binding cassette)
G243u6	WIAF-11690	X57522	177	TAP1, transporter 1, ABC (ATP	AGAGTCCCAG[A/G]CCCGGCCGGG	S	A	G	R	R
				binding cassette)
G243u7	WIAF-11693	X57522	1067	TAP1, transporter 1, ABC (ATP	AACATCATGT[C/T]TCGGGTAACA	M	C	T	S	F
				binding cassette)
G243u8	WIAF-11665	X57522	1207	TAP1, transporter 1, ABC (ATP	GGTCACCCTG[A/G]TCACCCTGCC	M	A	G	I	V
				binding cassette)
G243u9	WIAF-11664	X57522	1757	TAP1, transporter 1, ABC (ATP	CCAAACCGCC[C/T]AGATGTCTTA	M	C	T	P	L
				binding cassette)
G244u1	WIAF-10174	X60592	239	TNFRSF5, tumor necrosis factor	CTTGCGGTGA[A/G]AGCGAATTCC	S	A	G	E	E
				receptor superfamily, member 5
G2441u1	WIAF-13682	U30246	1355	SLC12A2, solute carrier family 12	TGCTTAAGGA[A/G]CATTCCATAC	S	A	G	E	E
				(sodium/potassium/chloride
				transporters), member 2
G2441u2	WIAF-13714	U30246	2691	SLC12A2, solute carrier family 12	AGCCAAATAT[C/G]AGCGATGGCT	M	C	G	Q	E
				(sodium/potassium/chloride
				transporters), member 2
G2443u1	WIAF-14004	U37143	1456	CYP2J2, cytochrome P450,	CTGAAGTTTA[G/A]AATGGGTATC	M	G	A	R	K
				subfamily IIJ (arachidonic acid
				epoxygenase) polypeptide 2
G2443u2	WIAF-14032	U37143	376	CYP2J2, cytochrome P450,	TTTAAGAAAA[A/G]TGGATTGATT	M	A	G	N	S
				subfamily IIJ (arachidonic acid
				epoxygenase) polypeptide 2
G2443u3	WIAF-14033	U37143	1502	CYP2J2, cytochrome P450,	TCTGCGCTGT[T/A]CCTCAGGTGT	S	T	A	V	V
				subfamily IIJ (arachidonic acid
				epoxygenase) polypeptide 2
G2444u1	WIAF-14065	U37519	771	ALDH3, aldehyde dehydrogenase 3	CCCGCAGGGA[A/G]TTGCGTGGTG	M	A	G	N	S
G2444u2	WIAF-14066	U37519	1698	ALDH3, aldehyde dehydrogenase 3	AAGGAGATCC[G/A]CTACCCACCC	M	G	A	R	H
G2445u1	WIAF-14114	U38178	236	CNP, 2′,3′-cyclic nucleotide 3′	TGCCGGGCGC[G/A]CCTCTCGCTG	M	G	A	R	H
				phosphodiesterase
G2445u2	WIAF-14115	U38178	849	CNP, 2′,3′-cyclic nucleotide 3′	GTGCCGCCGA[A/G]GAAAAAGTGC	S	A	G	E	E
				phosphodiesterase
G2445u3	WIAF-14122	U38178	1655	CNP, 2′,3′-cyclic nucleotide 3′	GTTATCTTGC[A/T]GAGATCTCTG	M	A	T	Q	L
				phosphodiesterase
G2445u4	WIAF-14241	X95520	941	CNP, 2′,3′-cyclic nucleotide 3′	TGCAAAATAT[T/C]CAGGAGACCG	?	T	C	?	?
				phosphodiesterase
G2445u5	WIAF-14242	X95520	1057	CNP, 2′,3′-cyclic nucleotide 3′	TGGAGTTGAT[C/T]TTTCAGTGCT	?	C	T	?	?
				phosphodiesterase
G2445u6	WIAF-14243	X95520	1583	CNP, 2′,3′-cyclic nucleotide 3′	TCTACTGGCT[C/G]TCTAACTAAT	?	C	G	?	?
				phosphodiesterase
G2448u1	WIAF-13973	U46689	1895	ALDH10, aldehyde dehydrogenase 10	TTGTCAAGGC[A/T]GAATATTACT	S	A	T	A	A
				(fatty aldehyde dehydrogenase)
G2457u1	WIAF-13898	U90277	1304	GRIN2A, glutamate receptor,	GGTCCCGATG[C/T]ACACCTTGCA	M	C	T	H	Y
				ionotropic, N-methyl D-aspartate
				2A
G2457u2	WIAF-13899	U90277	1934	GRIN2A, glutamate receptor,	AAGAAGTAAT[G/T]GCACCGTCTC	M	G	T	G	C
				ionotropic, N-methyl D-aspartate
				2A
G2457u3	WIAF-13900	U90277	2230	GRIN2A, glutamate receptor,	TCGCTGTCAT[A/G]TTCCTGGCTA	M	A	G	I	M
				ionotropic, N-methyl D-aspartate
				2A
G2457u4	WIAF-13902	U90277	2916	GRIN2A, glutamate receptor,	GGCATCTACA[G/A]CTGCATTCAT	M	G	A	S	N
				ionotropic, N-methyl D-aspartate
				2A
G2457u5	WIAF-13903	U90277	3251	GRIN2A, glutamate receptor,	CTATGTATTC[C/T]AGGGACAACA	N	C	T	Q	*
				ionotropic, N-methyl D-aspartate
				2A
G2457u6	WIAF-13917	U90277	2756	GRIN2A, glutamate receptor,	GGACATTGAC[A/G]ACATGGCGGG	M	A	G	N	D
				ionotropic, N-methyl D-aspartate
				2A
G2468u1	WIAF-13642	X04011	1017	CYBB, cytochrome b-245, beta	AGGTGTCCAA[G/A]CTGGAGTGGC	S	G	A	K	K
				polypeptide (chronic granulomatous
				disease)
G2473u1	WIAF-13670	X06990	1417	ICAM1, intercellular adhesion	GGTCACCCGC[G/A]AGGTGACCGT	M	G	A	E	K
				molecule 1 (CD54), human
				rhinovirus receptor
G2473u2	WIAF-13695	X06990	179	ICAM1, intercellular adhesion	GACCAGCCCA[A/T]GTTGTTGGGC	M	A	T	K	M
				molecule 1 (CD54), human
				rhinovirus receptor
G2480u1	WIAF-14148	X55330	800	AGA, aspartylglucosaminidase	TTGGCATGGT[T/G]GTAATCCATA	S	T	G	V	V
G2480u2	WIAF-14149	X55330	852	AGA, aspartylglucosaminidase	AAATGGTATA[A/T]AATTCAAAAT	N	A	T	K	*
G2480u3	WIAF-14158	X55330	616	AGA, aspartylglucosaminidase	TTATCTACCA[G/C]TGCTTCTCAA	M	G	C	S	T
G2485u1	WIAF-13612	X59543	2301	RRM1, ribonucleotide reductase M1	ATTGATCAAA[G/A]CCAATCTTTG	M	G	A	S	N
				polypeptide
G2485u2	WIAF-13613	X59543	2410	RRM1, ribonucleotide reductase M1	ATTTAAGGAC[G/A]AGACCAGCAG	S	G	A	T	T
				polypeptide
G2485u3	WIAF-13651	X59543	548	RRM1, ribonucleotide reductase M1	CAAGTCAACA[T/C]TGGATATTGT	S	T	C	L	L
				polypeptide
G2485u4	WIAF-13652	X59543	199	RRM1, ribonucleotide reductase M1	TGCATGTGAT[C/T]AAGCGAGATG	S	C	T	I	I
				polypeptide
G2485u5	WIAF-13653	X59543	1037	RRM1, ribonucleotide reductase M1	CAACACAGCT[C/A]GATATGTGGA	S	C	A	R	R
				polypeptide
G2485u6	WIAF-13660	X59543	1955	RRM1, ribonucleotide reductase M1	GAAGATTGCA[A/C]AGTATGGTAT	M	A	C	K	Q
				polypeptide
G2485u7	WIAF-13877	X59543	860	RRM1, ribonucleotide reductase M1	GAGTATGAAA[G/C]ATGACAGCAT	M	G	C	D	H
				polypeptide
G2486u1	WIAF-14075	X59618	543	RRM2, ribonucleotide reductase M2	TCAGCACTGG[G/C]AATCCCTGAA	M	G	C	E	Q
				polypeptide
G2486u2	WIAF-14076	X59618	189	RRM2, ribonucleotide reductase M2	TCGCTGCGCC[T/G]CCACTATGCT	—	T	G	—	—
				polypeptide
G2486u3	WIAF-14092	X59618	524	RRM2, ribonucleotide reductase M2	TTGACCTCTC[C/G]AAGGACATTC	S	C	G	S	S
				polypeptide
G2488u1	WIAF-13585	X63563	1633	POLR2B, polymerase (RNA) II (DNA	CCTTGATGGC[G/A]TATATTTCAG	S	G	A	A	A
				directed) polypeptide B (140 kD)
G2488u2	WIAF-13586	X63563	2452	POLR2B, polymerase (RNA) II (DNA	CTGTAGACCG[C/T]GGCTTCTTCA	S	C	T	R	R
				directed) polypeptide B (140 kD)
G2488u3	WIAF-13587	X63563	2740	POLR2B, polymerase (RNA) II (DNA	TCAGAACTAG[T/C]GAGACGGGCA	S	T	C	S	S
				directed) polypeptide B (140 kD)
G2488u4	WIAF-13602	X63563	1411	POLR2B, polymerase (RNA) II (DNA	GGGGTGATCA[A/G]AAGAAAGCTC	S	A	G	Q	Q
				directed) polypeptide B (140 kD)
G2488u5	WIAF-13603	X63563	2386	POLR2B, polymerase (RNA) II (DNA	CAATTGTGGC[C/T]ATTGCATCAT	S	C	T	A	A
				directed) polypeptide B (140 kD)
G2489u1	WIAF-14181	X63564	1346	POLR2A, polymerase (RNA) II (DNA	TGGTGGACAA[T/C]GAGCTGCCTG	S	T	C	N	N
				directed) polypeptide A (220 kD)
G2489u2	WIAF-14236	X63564	1847	POLR2A, polymerase (RNA) II (DNA	TGAATCTTAG[C/T]GTGACAACTC	?	C	T	?	?
				directed) polypeptide A (220 kD)
G2489u3	WIAF-14237	X63564	2678	POLR2A, polymerase (RNA) II (DNA	CTGAATACAA[C/T]AACTTCAAGT	?	C	T	?	?
				directed) polypeptide A (220 kD)
G2489u4	WIAF-14238	X63564	3059	POLR2A, polymerase (RNA) II (DNA	AGCTGCGCTA[C/T]GGCGAAGACG	?	C	T	?	?
				directed) polypeptide A (220 kD)
G2489u5	WIAF-14239	X63564	3827	POLR2A, polymerase (RNA) II (DNA	TGGGCCAGTC[C/T]GCTCGAGATG	?	C	T	?	?
				directed) polypeptide A (220 kD)
G2489u6	WIAF-14240	X63564	3992	POLR2A, polymerase (RNA) II (DNA	TGCCTGACTT[T/C]GATGTGGCCC	?	T	C	?	?
				directed) polypeptide A (220 kD)
G2489u7	WIAF-14245	X63564	3938	POLR2A, polymerase (RNA) II (DNA	CCCAGAGCAC[G/A]GTGGTGGCAG	?	G	A	?	?
				directed) polypeptide A (220 kD)
G250u1	WIAF-11696	HT0155	1113	IL3RA, interleukin 3 receptor,	CTGTGTCTTC[G/C]TGATCTGCAG	M	G	C	V	L
				alpha (low affinity)
G251u1	WIAF-11666	HT0240	179	interleukin 1 beta convertase	TGGATAAGAC[C/T]CGAGCTTTGA	S	C	T	T	T
G251u2	WIAF-11694	HT0240	973	interleukin 1 beta convertase	GATGCTATTA[A/G]GAAAGCCCAC	M	A	G	K	R
G251u3	WIAF-11695	HT0240	783	interleukin 1 beta convertase	CCCAGATATA[C/T]TACAACTCAA	S	C	T	L	L
G2513u1	WIAF-13736	HT27365	1721	PLCB3, phospholipase C, beta 3	AACTATCTAT[G/A]AAAAGCCAAA	M	G	A	M	I
				(phosphatidylinositol-specific)
G2513u2	WIAF-13737	HT27365	1741	PLCB3, phospholipase C, beta 3	AACTATTGGG[A/T]AATGTGTTCA	M	A	T	E	V
				(phosphatidylinositol-specific)
G2513u3	WIAF-13738	HT27365	1697	PLCB3, phospholipase C, beta 3	AATCTGTTCA[A/G]TACAGGGATT	S	A	G	Q	Q
				(phosphatidylinositol-specific)
G2513u4	WIAF-13739	HT27365	1908	PLCB3, phospholipase C, beta 3	CTGTCAGATT[G/A]TAGCAATGAA	M	G	A	V	I
				(phosphatidylinositol-specific)
G2513u5	WIAF-13740	HT27365	2172	PLCB3, phospholipase C, beta 3	TATAGAGATA[C/T]ACGGAATTCC	M	C	T	H	Y
				(phosphatidylinositol-specific)
G2513u6	WIAF-13744	HT27365	3019	PLCB3, phospholipase C, beta 3	TTGAAGGGCC[A/G]AGGAGATCTG	M	A	G	Q	R
				(phosphatidylinositol-specific)
G2513u7	WIAF-13745	HT27365	3024	PLCB3, phospholipase C, beta 3	GGGCCAAGGA[G/A]ATCTGTTGAA	M	G	A	D	N
				(phosphatidylinositol-specific)
G2513u8	WIAF-13771	HT27365	1079	PLCB3, phospholipase C, beta 3	ACATTTTTGA[T/C]CCTGAGCAAA	S	T	C	D	D
				(phosphatidylinositol-specific)
G2513u9	WIAF-13772	HT27365	1546	PLCB3, phospholipase C, beta 3	AAGTTGCCTT[C/T]TGATCCAGAT	M	C	T	S	F
				(phosphatidylinositol-specific)
G2513u10	WIAF-13773	HT27365	1514	PLCB3, phospholipase C, beta 3	AATTAAAAAG[A/T]ATGATCATTG	M	A	T	R	S
				(phosphatidylinositol-specific)
G2513u11	WIAF-13774	HT27365	1445	PLCB3, phospholipase C, beta 3	AGGTCTTTGG[C/T]AATAAACTCT	S	C	T	G	G
				(phosphatidylinositol-specific)
G2513u12	WIAF-13778	HT27365	2087	PLCB3, phospholipase C, beta 3	TTCATATCAA[G/A]ATCATCAGTG	S	G	A	K	K
				(phosphatidylinositol-specific)
G2513u13	WIAF-13779	HT27365	2367	PLCB3, phospholipase C, beta 3	TGAATGTTTG[C/T]AGCCTGGATA	N	C	T	Q	*
				(phosphatidylinositol-specific)
G2513u14	WIAF-13782	HT27365	2719	PLCB3, phospholipase C, beta 3	CTCATCACCA[G/A]TGACAATACT	M	G	A	S	N
				(phosphatidylinositol-specific)
G2513u15	WIAF-13783	HT27365	2567	PLCB3, phospholipase C, beta 3	TTGATGACAT[C/T]TTTAAAATAG	S	C	T	I	I
				(phosphatidylinositol-specific)
G2513u16	WIAF-13784	HT27365	2864	PLCB3, phospholipase C, beta 3	TAGAAATGGC[G/A]GACACAGTCC	S	G	A	A	A
				(phosphatidylinositol-specific)
G2513u17	WIAF-13785	HT27365	2571	PLCB3, phospholipase C, beta 3	TGACATCTTT[A/T]AAATAGCGGT	N	A	T	K	*
				(phosphatidylinositol-specific)
G2513u18	WIAF-13786	HT27365	2706	PLCB3, phospholipase C, beta 3	TCTGTCATCT[C/T]GGCTCATCAC	M	C	T	R	W
				(phosphatidylinositol-specific)
G252u1	WIAF-10195	HT0425	397	FCER2, Fc fragment of IgE, low	GAGGGCTGCC[C/T]GGAACGTCTC	M	C	T	R	W
				affinity II, receptor for (CD23A)
G252u2	WIAF-10206	HT0425	930	FCER2, Fc fragment of IgE, low	ATGGGAGCCA[T/C]GTGGACTACA	S	T	C	H	H
				affinity II, receptor for (CD23A)
G253u1	WIAF-10175	HT0573	228	IFNB1, interferon, beta 1,	GGCTTGAATA[C/T]TGCCTCAAGG	S	C	T	Y	Y
				fibroblast
G254u1	WIAF-10196	HT0611	466	IL4R, interleukin 4 receptor	TCAGTGCGGA[T/C]AACTATACAC	S	T	C	D	D
G254u2	WIAF-10198	HT0611	1474	IL4R, interleukin 4 receptor	CATGCCTTCT[T/C]CCACCTTCGG	S	T	C	L	L
G254u3	WIAF-10207	HT0611	1902	IL4R, interleukin 4 receptor	AGTGGCTATC[A/G]GGAGTTTGTA	M	A	G	Q	R
G260u1	WIAF-10186	HT1090	453	IL1R1, interleukin 1 receptor,	TGTTATAATG[C/G]ACAAGCCATA	M	C	G	A	G
				type I
G261u1	WIAF-10187	HT1101	434	IL7R, interleukin 7 receptor	CCTGAGTGTC[A/G]TCTATCGGGA	M	A	G	I	V
G261u2	WIAF-10203	HT1101	517	IL7R, interleukin 7 receptor	TTTTAATGCA[T/C]GATGTAGCTT	S	T	C	H	H
G267u1	WIAF-11735	HT1877	881	IL2RB, interleukin 2 receptor,	TCCTCGTGGG[C/T]CTCAGCGGGG	S	C	T	G	G
				beta
G267u2	WIAF-11759	HT1877	379	IL2RB, interleukin 2 receptor,	AGTCAAGCAT[C/T]CTGGGCCTGC	M	C	T	S	F
				beta
G268u1	WIAF-11758	HT1985	568	CD19 antigen	GCCTCCGTGT[G/C]TCCCACCGAG	M	G	C	V	L
G268u2	WIAF-11734	HT1985	783	CD19 antigen	ACGATCGCCC[G/T]GCCAGAGATA	S	G	T	P	P
G270u1	WIAF-11736	HT2415	530	IL6R, interleukin 6 receptor	AGGAGGTGGC[A/G]AGAGGCGTGC	S	A	G	A	A
G270u2	WIAF-11760	HT2415	1590	IL6R, interleukin 6 receptor	CATTGCCATT[G/A]TTCTGAGGTT	M	G	A	V	I
G270u3	WIAF-11737	HT2415	1510	IL6R, interleukin 6 receptor	CCAGTGCAAG[A/C]TTCTTCTTCA	M	A	C	D	A
G270u4	WIAF-11761	HT2415	1451	IL6R, interleukin 6 receptor	CTACTAATAA[A/T]GACGATGATA	M	A	T	K	N
G270u5	WIAF-11766	HT2415	1843	IL6R, interleukin 6 receptor	TTCCCCAGAT[A/G]GCTGGCTGGG	N	A	G	*	W
G270u6	WIAF-11767	HT2415	1829	IL6R, interleukin 6 receptor	ATACAGACTA[C/T]TTCTTCCCCA	S	C	T	Y	Y
G271u1	WIAF-11762	HT2531	577	CD2, CD2 antigen (p50), sheep red	TCAGAGGGTC[A/G]TCACACACAA	M	A	G	I	V
				blood cell receptor
G271u2	WIAF-11739	HT2531	861	CD2, CD2 antigen (p50), sheep red	GGAAGCCCCA[A/C]CAAATTCCAG	M	A	C	X	H
				blood cell receptor
G271u3	WIAF-11768	HT2531	818	CD2, CD2 antigen (p50), sheep red	CTGGAGACAA[G/A]AGCCCACAGA	M	G	A	R	K
				blood cell receptor
G271u4	WIAF-11738	HT2531	736	CD2, CD2 antigen (p50), sheep red	CCTCTTGATG[G/A]TCTTTGTGGC	M	G	A	V	I
				blood cell receptor
G273u1	WIAF-11763	HT3139	667	IL2RA, interleukin 2 receptor,	ATCATGGTGC[C/T]TGGCTGCCAG	M	C	T	P	L
				alpha
G273u2	WIAF-11764	HT3139	956	IL2RA, interleukin 2 receptor,	AAAGTCCAAT[G/C]CAGCCAGTGG	M	G	C	M	I
				alpha
G273u3	WIAF-11765	HT3139	701	IL2RA, interleukin 2 receptor,	ACGATGACCC[G/A]CCAGAGATCC	S	G	A	P	P
				alpha
G273u4	WIAF-11740	HT3139	1133	IL2RA, interleukin 2 receptor,	AAATGACCCA[C/T]GGGAAGACAA	S	C	T	H	H
				alpha
G273u5	WIAF-11769	HT3139	1163	IL2RA, interleukin 2 receptor,	AGCCCCAGCT[C/A]ATATGCACAG	S	C	A	L	L
				alpha
G276u1	WIAF-10192	HT3670	644	CD4 antigen	CTGGTAGTAG[C/G]CCCTCAGTGC	M	C	G	S	R
G276u2	WIAF-10193	HT3670	1535	CD4 antigen	CCTGCCAGTG[T/C]CCTCACCGGT	S	T	C	C	C
G276u3	WIAF-10205	HT3670	1217	CD4 antigen	TGATGCTGAG[T/C]TTGAAACTGG	S	T	C	S	S
G277u1	WIAF-10007	D10232	851	RENBP, renin-binding protein	CACGTGATTG[A/G]CAAGTTCCTA	M	A	G	D	G
G277u2	WIAF-10032	D10232	842	RENBP, renin-binding protein	CTTCGAGCCC[A/G]CGTGATTGAC	M	A	G	H	R
G277u3	WIAF-10042	D10232	634	RENBP, renin-binding protein	GCTGGCGGGC[A/G]AATACGCAGA	M	A	G	K	E
G279u1	WIAF-10047	K01740	1658	F8C, coagulation factor VIIIc,	ACTGATGTCC[G/A]TCCTTTGTAT	M	G	A	R	H
				procoagulant component (hemophilia
				A)
G279u2	WIAF-10049	K01740	2328	F8C, coagulation factor VIIIc,	CCTTACTGAA[G/A]GTTTCTAGTT	S	G	A	K	K
				procoagulant component (hemophilia
				A)
G279u3	WIAF-10050	K01740	4650	F8C, coagulation factor VIIIc,	CTGTTCTCCC[G/A]AAACCAGACT	S	G	A	P	P
				procoagulant component (hemophilia
				A)
G279u4	WIAF-10061	K01740	6919	F8C, coagulation factor VIIIc,	CCAGAAGACA[A/G]TGAAAGTCAC	M	A	G	M	V
				procoagulant component (hemophilia
				A)
G279u5	WIAF-10080	K01740	480	F8C, coagulation factor VIIIc,	TTAAGAACAT[G/A]GCTTCCCATC	M	G	A	M	I
				procoagulant component (hemophilia
				A)
G279u6	WIAF-10082	K01740	2129	F8C, coagulation factor VIIIc,	TACATTCTAA[G/A]CATTGGAGCA	M	G	A	S	N
				procoagulant component (hemophilia
				A)
G279u7	WIAF-10084	K01740	2533	F8C, coagulation factor VIIIc,	GTTTGCACAC[A/G]GAACACCTAT	M	A	G	R	G
				procoagulant component (hemophilia
				A)
G279u8	WIAF-10086	K01740	6639	F8C, coagulation factor VIIIc,	ACCCTCCAAT[T/C]ATTGCTCGAT	S	T	C	I	I
				procoagulant component (hemophilia
				A)
G279u9	WIAF-10087	K01740	5957	F8C, coagulation factor VIIIc,	GAGAATTATC[G/A]CTTCCATGCA	M	G	A	R	H
				procoagulant component (hemophilia
				A)
G279a10	WIAF-10495	K01740	5829	F8C, coagulation factor VIIIc,	TGACAGTACA[G/A]GAATTTGCTC	S	G	A	Q	Q
				procoagulant component (hemophilia
				A)
G279a11	WIAF-10496	K01740	5852	F8C, coagulation factor VIIIc,	TTTTTCACCA[T/G]CTTTGATGAG	M	T	G	I	S
				procoagulant component (hemophilia
				A)
G279a12	WIAF-10502	K01740	2492	F8C, coagulation factor VIIIc,	ACCACAATTC[C/T]AGAAAATGAC	M	C	T	P	L
				procoagulant component (hemophilia
				A)
G279a13	WIAF-10503	K01740	6906	F8C, coagulation factor VIIIc,	TGCAAGTGGA[C/T]TTCCAGAAGA	S	C	T	D	D
				procoagulant component (hemophilia
				A)
G279a14	WIAF-13120	K01740	1980	F8C, coagulation factor VIIIc,	CAGAGAATAT[A/c]CAACGCTTTC	S	A	c	I	I
				procoagulant component (hemophilia
				A)
G279a15	WIAF-13121	K01740	1982	F8C, coagulation factor VIIIc,	GAGAATATAC[A/c]ACGCTTTCTC	M	A	c	Q	P
				procoagulant component (hemophilia
				A)
G282u1	WIAF-10067	L25615	976	AVPR1A, arginine vasopressin	CGCCTTTCTT[C/A]ATCATCCAGA	M	C	A	F	L
				receptor 1A
G282u2	WIAF-10070	L25615	460	AVPR1A, arginine vasopressin	TCGGCATGTT[T/C]GCGTCGGCCT	S	T	C	F	F
				receptor 1A
G282u3	WIAF-10071	L25615	343	AVPR1A, arginine vasopressin	GCCTGGCCGA[C/T]CTGGCCGTGG	S	C	T	D	D
				receptor 1A
G282u4	WIAF-10072	L25615	68	AVPR1A, arginine vasopressin	TCTCTCCGCC[G/A]GTCCCGACGC	M	G	A	G	S
				receptor 1A
G282u5	WIAF-10073	L25615	535	AVPR1A, arginine vasopressin	AGACTCTGCA[A/G]CAGCCCGCGC	S	A	G	Q	Q
				receptor 1A
G282u6	WIAF-10092	L25615	1075	AVPR1A, arginine vasopressin	CCTTGAATAG[C/A]TGCTGTAATC	M	C	A	S	R
				receptor 1A
G282a7	WIAF-10499	L25615	1089	AVPR1A, arginine vasopressin	TGTAATCCCT[G/A]GATATACATG	N	G	A	W	*
				receptor 1A
G284u1	WIAF-10182	M16827	1179	ACADM, acyl-Coenzyme A	AATATCCTGT[A/G]GAAAAACTAA	S	A	G	V	V
				dehydrogenase, C-4 to C-12
				straight chain
G284a2	WIAF-10515	M16827	696	ACADM, acyl-Coenzyme A	TTGTGGAAGC[A/G]GATACCCCAG	S	A	G	A	A
				dehydrogenase, C-4 to C-12
				straight chain
G285u1	WIAF-10108	M28372	258	ZNF9, zinc finger protein 9 (a	CTCTTCCAGA[T/C]ATTTGTTATC	S	T	C	D	D
				cellular retroviral nucleic acid
				binding protein)
G289u1	WIAF-10041	M63012	172	PON1, paraoxonase 1	CTCTGAAGAC[A/T]TGGAGATACT	M	A	T	M	L
G290u1	WIAF-10085	M63959	354	LRPAP1, low density lipoprotein-	CTCATACGCA[A/G]CCTCAATGTC	M	A	G	N	S
				related protein-associated protein
				1 (alpha-2-macroglobulin receptor-
				associated protein 1)
G290a2	WIAF-13122	M63959	223	LRPAP1, low density lipoprotein-	AGCGACTGCA[T/A]CTTCCTCCCG	M	T	A	H	Q
				related protein-associated protein
				1 (alpha-2-macroglobulin receptor-
				associated protein 1)
G292u1	WIAF-10180	M74096	1002	ACADL, acyl-Coenzyme A	AGTGCAACAT[A/C]AATTAGCAGA	M	A	C	K	Q
				dehydrogenase, long chain
G293u1	WIAF-10068	M74775	723	LIPA, lipase A, lysosomal acid,	AAGGACTTAT[T/C]TGGAGACAAA	M	T	C	F	S
				cholesterol esterase (Wolman
				disease)
G293a2	WIAF-10497	M74775	107	LIPA, lipase A, lysosomal acid,	TGAGGGGTCT[G/A]GAGGGAAACT	M	G	A	G	R
				cholesterol esterase (Wolman
				disease)
G293a3	WIAF-10498	M74775	86	LIPA, lipase A, lysosomal acid,	GGTTCTCTGG[C/A]CCCTGCATTC	M	C	A	P	T
				cholesterol esterase (Wolman
				disease)
G295u1	WIAF-10057	U04270	1282	KCNH2, potassium voltage-gated	AAAGGAGCGA[A/T]CCCACAATGT	M	A	T	T	S
				channel, subfamily H, member 2
G295u2	WIAF-10062	U04270	1875	KCNH2, potassium voltage-gated	CGCACTGGCT[A/G]GCCTGCATCT	S	A	G	L	L
				channel, subfamily H, member 2
G295u3	WIAF-10064	U04270	2040	KCNH2, potassium voltage-gated	ACTTCACCTT[C/T]AGCAGCCTCA	S	C	T	F	F
				channel, subfamily H, member 2
G295u4	WIAF-10088	U04270	1650	KCNH2, potassium voltage-gated	CCGGCCGCAT[C/T]GCCGTCCACT	S	C	T	I	I
				channel, subfamily H, member 2
G295u5	WIAF-10090	U04270	2139	KCNH2, potassium voltage-gated	CCCTCATGTA[T/C]GCTAGCATCT	S	T	C	Y	Y
				channel, subfamily H, member 2
G2951u1	WIAF-14147	HT0030	1334	ZNF42, zinc finger protein 42	CCCTGCTCTG[A/G]TCACCACCCG	M	A	G	I	V
				(myeloid-specific retinoic acid-
				responsive)
G2951u2	WIAF-14157	HT0030	1558	ZNF42, zinc finger protein 42	ACCAGCTTAC[G/A]CACACCGAGG	S	G	A	T	T
				(myeloid-specific retinoic acid-
				responsive)
G2959u1	WIAF-13501	HT0134	1014	GRLF1, glucocorticoid receptor	GTGGAGAGAC[T/C]CTGCATAGCT	S	T	C	T	T
				DNA binding factor 1
G2959u2	WIAF-13518	HT0134	1853	GRLF1, glucocorticoid receptor	GAGCCATCTT[A/C]CAGCCTGTTT	M	A	C	Y	S
				DNA binding factor 1
G296a1	WIAF-10514	U12778	961	ACADSB, acyl-Coenzyme A	TATTCCATAT[A/G]TTAAAGAAAG	M	A	G	I	V
				dehydrogenase, short/branched
				chain
G2968u1	WIAF-12699	HT0244	1754	SMARCA1, SWI/SNF related, matrix	CAGAAGAAAC[C/T]AGTACGTGTA	M	C	T	P	L
				associated, actin dependent
				regulator of chromatin, subfamily
				a, member 1
G2968u2	WIAF-12716	HT0244	2624	SMARCA1, SWI/SNF related, matrix	TGGGAACGTT[G/T]CAATGAATTA	M	G	T	C	F
				associated, actin dependent
				regulator of chromatin, subfamily
				a, member 1
G297u1	WIAF-10109	U16660	402	ECH1, enoyl Coenzyme A hydratase	ACATGGCTTC[G/A]GACATCCTGC	S	G	A	S	S
				1, peroxisomal
G297u2	WIAF-10110	U16660	149	ECH1, enoyl Coenzyme A hydratase	GCACAAGAGG[A/C]GGCTTCCGGA	M	A	C	E	A
				1, peroxisomal
G2970u1	WIAF-12746	HT0281	682	BR140: bromodomain-containing	ATGACATGGA[C/T]GAGGAGGACT	S	C	T	D	D
				protein, 140 kD (peregrin)
G2975u1	WIAF-12729	HT0334	1104	B-cell-specific transcription	AGTTTTCCGG[G/A]AGTCCCTACA	S	G	A	G	G
				factor
G2975u2	WIAF-12730	HT0334	1185	B-cell-specific transcription	GCTCCCCCTA[C/T]TATTATAGCG	S	C	T	Y	Y
				factor
G2976a1	WIAF-12129	HT0340	1600	SATB1, special AT-rich sequence	GTCCTGCCCC[C/A]CTCATCAGCA	S	C	A	P	P
				binding protein 1 (binds to
				nuclear matrix/scaffold-
				associating DNA's)
G2976u2	WIAF-12743	HT0340	2116	SATB1, special AT-rich sequence	TGGCCTCTCC[A/G]GCAGAGTCAG	S	A	G	P	P
				binding protein 1 (binds to
				nuclear matrix/scaffold-
				associating DNA's)
G2978u1	WIAF-12721	HT0346	1140	MSX1, msh (Drosophila) homeo box	CATAGAGGGT[C/T]CCAGGTCCCC	—	C	T	—	—
				homolog 1 (formerly homeo box 7)
G298u1	WIAF-10048	U33837	8995	Human glycoprotein receptor gp330	CCGGACAGGA[G/A]GTGCATTCCC	M	G	A	R	K
				precursor, mRNA, complete cds.
G298u2	WIAF-10051	U33837	13217	Human glycoprotein receptor gp330	ATGCAGCCAT[C/T]GAACTGCCTA	S	C	T	I	I
				precursor, mRNA, complete cds.
G298u3	WIAF-10077	U33837	6298	Human glycoprotein receptor gp330	AACTCTTTCA[T/C]TGTTGTTTCA	M	T	C	I	T
				precursor, mRNA, complete cds.
G298u4	WIAF-10078	U33837	6371	Human glycoprotein receptor gp330	CCATGGTGCC[G/A]GTGGCAGGCC	S	G	A	P	P
				precursor, mRNA, complete cds.
G298u5	WIAF-10079	U33837	6914	Human glycoprotein receptor gp330	ACTCTGAAGT[G/A]ATTCGTTATG	S	G	A	V	V
				precursor, mRNA, complete cds.
G298u6	WIAF-10081	U33837	8718	Human glycoprotein receptor gp330	GTTCCAATGC[G/A]CATCTGGGCG	M	G	A	A	T
				precursor, mRNA, complete cds.
G298u7	WIAF-10083	U33837	9088	Human glycoprotein receptor gp330	ACTTGCTCTG[A/G]AAATGAATTC	M	A	G	E	G
				precursor, mRNA, complete cds.
G298u8	WIAF-10096	U33837	6949	Human glycoprotein receptor gp330	ACTCCTTATG[G/C]CATCACTGTT	M	G	C	G	A
				precursor, mRNA, complete cds.
G298u9	WIAF-10097	U33837	7149	Human glycoprotein receptor gp330	TTGCTTGGAA[A/G]ACAATGGTGG	M	A	G	N	D
				precursor, mRNA, complete cds.
G298u10	WIAF-10100	U33837	8590	Human glycoprotein receptor gp330	TACACAAAAT[G/A]TCATAATTCA	M	G	A	C	Y
				precursor, mRNA, complete cds.
G298u11	WIAF-10101	U33837	12948	Human glycoprotein receptor gp330	CATCTTTGAA[G/C]ACCAGTTATA	M	G	C	D	H
				precursor, mRNA, complete cds.
G2980u1	WIAF-12723	HT0356	437	TLE1, transducin-like enhancer of	TCATGGCCAC[G/A]GACCCCCAGT	M	G	A	G	R
				split 1, homolog of Drosophila
				E(sp1)
G2980u2	WIAF-12726	HT0356	2044	TLE1, transducin-like enhancer of	AGTGGCTGGC[A/G]GTGGGCATGG	S	A	G	A	A
				split 1, homolog of Drosophila
				E(sp1)
G2980u3	WIAF-12747	HT0356	379	TLE1, transducin-like enhancer of	CCATGGCAGA[G/A]TTGAATGCCA	S	G	A	E	E
				split 1, homolog of Drosophila
				E(sp1)
G2980u4	WIAF-12748	HT0356	276	TLE1, transducin-like enhancer of	ATCGCCAAGA[G/A]ATTGAATACG	M	G	A	R	K
				split 1, homolog of Drosophila
				E(sp1)
G2980u5	WIAF-12749	HT0356	1876	TLE1, transducin-like enhancer of	GCCACACAGA[C/T]GGAGCCAGCT	S	C	T	D	D
				split 1, homolog of Drosophila
				E(sp1)
G2980u6	WIAF-12750	HT0356	1759	TLE1, transducin-like enhancer of	CCGCCTGCTA[C/T]GCCCTGGCCA	S	C	T	Y	Y
				split 1, homolog of Drosophila
				E(sp1)
G2981u1	WIAF-12720	HT0357	2206	TLE2, transducin-like enhancer of	ACAAATACAT[T/C]GTGACAGGCT	S	T	C	I	I
				split 2, homolog of Drosophila
				E(sp1)
G2981u2	WIAF-12737	HT0357	1036	TLE2, transducin-like enhancer of	CGGACAGCGT[C/T]GCCCTGAGGA	S	C	T	V	V
				split 2, homolog of Drosophila
				E(sp1)
G2981u3	WIAF-12740	HT0357	2181	TLE2, transducin-like enhancer of	CTGAGTTGTG[A/T]CATCTCCAGA	M	A	T	D	V
				split 2, homolog of Drosophila
				E(sp1)
G2983u1	WIAF-12833	HT0360	636	TLE3, transducin-like enhancer of	TGTCACCCTC[G/C]GAAAGCCTCC	S	G	C	S	S
				split 3, homolog of Drosophila
				E(sp1)
G2983u2	WIAF-12834	HT0360	1944	TLE3, transducin-like enhancer of	TGGACAACAC[G/A]GTGCGCTCCT	S	G	A	T	T
				split 3, homolog of Drosophila
				E(sp1)
G2983u3	WIAF-12848	HT0360	1710	TLE3, transducin-like enhancer of	ACCTGGCCTC[G/A]CCCACGCCCC	S	G	A	S	S
				split 3, homolog of Drosophila
				E(sp1)
G2985u1	WIAF-12724	HT0421	995	homeotic protein D3	GGCTTCGCCA[G/A]CGCCAACCTG	M	G	A	S	N
G2985u2	WIAF-12725	HT0421	1003	homeotic protein D3	CAGCGCCAAC[C/T]TGCAGGGCAG	S	C	T	L	L
G2986u1	WIAF-14124	HT0468	1197	CSDA, cold shock domain protein A	GCCGTGGATA[C/T]CGGCGTCCCT	S	C	T	Y	Y
G2987u1	WIAF-12758	HT0474	2068	ZNF7, zinc finger protein 7 (KOX	AGTGGTTTTA[C/T]GAATATGGGA	S	C	T	Y	Y
				4, clone HF.16)
G2987u2	WIAF-12773	HT0474	985	ZNF7, zinc finger protein 7 (KOX	GAGAGAAGCC[G/C]TACGAATGTG	S	G	C	P	P
				4, clone HF.16)
G2987u3	WIAF-12775	HT0474	1278	ZNF7, zinc finger protein 7 (KOX	AGCCAGCAGT[C/T]GCAGCTGGTT	M	C	T	S	L
				4, clone HF.16)
G3005a1	WIAF-12133	HT0735	1441	homeotic protein 5.1	GAGGCAGCGG[C/T]CCCGGGCCTG	S	C	T	G	G
G3008a1	WIAF-12134	HT0753	1850	ATF4, activating transcription	TAAAAGAGAG[G/A]GCGGATTCCC	S	G	A	R	R
				factor 4 (tax-responsive enhancer
				element B67)
G3008u2	WIAF-12798	HT0753	946	ATF4, activating transcription	CCCTTCGACC[C/A]GTCGGGTTTG	M	C	A	P	Q
				factor 4 (tax-responsive enhancer
				element B67)
G3008u3	WIAF-12812	HT0753	1482	ATF4, activating transcription	CACTGCTTAC[G/A]TTGCCATGAT	M	G	A	V	I
				factor 4 (tax-responsive enhancer
				element B67)
G3008u4	WIAF-12813	HT0753	1847	ATF4, activating transcription	CTCTAAAAGA[G/C]AGGGCGGATT	M	G	C	E	D
				factor 4 (tax-responsive enhancer
				element B67)
G301u1	WIAF-10127	U71285	3639	MTR, 5-methyltetrahydrofolate-	TGTGGAGACT[C/T]GCAGACATCG	S	C	T	L	L
				homocysteine methyltransferase
G3012u1	WIAF-12794	HT0873	402	MAD, MAX dimerization protein	TGGTGCCACT[G/T]GGACCCGAAT	S	G	T	L	L
G3014u1	WIAF-14183	HT0899	274	homeotic protein 2, distal-less	AAAAGACTCA[G/A]TACTTGGCCT	S	G	A	Q	Q
G3020u1	WIAF-12797	HT0956	852	MLLT3, myeloid/lymphoid or mixed-	GTGCCTTCAA[A/G]GAACCTTCCA	S	A	G	K	K
				lineage leukemia (trithorax
				(Drosophila) homolog);
				translocated to, 3
G3023u1	WIAF-13724	HT0966	381	zinc finger, X-linked, duplicated	GCTGCAGCAA[G/A]CAATATGACA	S	G	A	K	K
				A
G3023u2	WIAF-13725	HT0966	220	zinc finger, X-linked, duplicated	GGCCAAACTC[G/A]GCGCCCACCA	M	G	A	G	S
				A
G3023u3	WIAF-13726	HT0966	69	zinc finger, X-linked, duplicated	AGTCGCACGA[T/C]AAACTGCGGC	S	T	C	D	D
				A
G3023u4	WIAF-13727	HT0966	249	zinc finger, X-linked, duplicated	ACTTCGAACC[C/T]GAGAGGCCTT	S	C	T	P	P
				A
G3023u5	WIAF-13765	HT0966	661	zinc finger, X-linked, duplicated	CAGGTTCTCT[G/A]CTCGCAGTAG	M	G	A	A	T
				A
G3023u6	WIAF-13766	HT0966	1302	zinc finger, X-linked, duplicated	TGACTCCTTC[G/T]AGCACCCTTT	S	G	T	S	S
				A
G3027u1	WIAF-12800	HT1035	124	HOXB7, homeo box B7	TTATGCGAAT[G/A]CTTTATTTTC	M	G	A	A	T
G3027u2	WIAF-12816	HT1035	450	HOXB7, homeo box B7	GGGACTCGGA[C/T]TTGGCGGCCG	S	C	T	D	D
G3028u1	WIAF-12806	HT1037	701	homeotic protein C8	AGACCCTGGA[A/G]CTGGAGAAGG	S	A	G	E	E
G3029u1	WIAF-14153	HT1100	441	zinc finger protein 8	TCAGACTCAG[G/A]GAAAACTGCG	S	G	A	R	R
G3029u2	WIAF-14155	HT1100	1416	zinc finger protein 8	GGCGTGAACA[A/G]TCCTCGAGCA	S	A	G	Q	Q
G303u1	WIAF-10000	X13916	4110	LRP1, low density lipoprotein-	ATGGAGCTGG[G/A]GCCCGACAAC	M	G	A	G	E
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u2	WIAF-10001	X13916	4012	LRP1, low density lipoprotein-	GCGAGCTCTG[C/T]GACCAGTGCT	S	C	T	C	C
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u3	WIAF-10002	X13916	4702	LRP1, low density lipoprotein-	GCCTGCCCCG[C/T]ATTGAGGCAG	S	C	T	R	R
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u4	WIAF-10003	X13916	6395	LRP1, low density lipoprotein-	CTGGATCGCA[G/A]GCAACATCTA	M	G	A	G	S
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u5	WIAF-10004	X13916	6937	LRP1, low density lipoprotein-	AAGGCACCAA[C/T]GTGTGCCGCGG	S	C	T	N	N
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u6	WIAF-10005	X13916	9391	LRP1, low density lipoprotein-	GGCTGAAGGA[T/C]GACGGCCGGA	S	T	C	D	D
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u7	WIAF-10011	X13916	766	LRP1, low density lipoprotein-	ACTGCATGGA[C/T]GGCTCAGATG	S	C	T	D	D
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u8	WIAF-10015	X13916	9040	LRP1, low density lipoprotein-	ACCCGACCTG[C/T]GGCCCCAGTG	S	C	T	C	C
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u9	WIAF-10019	X13916	11749	LRP1, low density lipoprotein-	CCCTGCGCTG[C/T]AACATGTTCG	S	C	T	C	C
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u10	WIAF-10020	X13916	1917	LRP1, low density lipoprotein-	GACCAGTATG[G/A]GAAGCCGGGT	M	G	A	G	E
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u11	WIAF-10021	X13916	4810	LRP1, low density lipoprotein-	AGAAGCGCAT[C/T]CTTTGGATTG	S	C	T	I	I
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u12	WIAF-10022	X13916	6367	LRP1, low density lipoprotein-	TTGGCCGTGT[G/C]GAGGGCATTG	S	G	C	V	V
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u13	WIAF-10023	X13916	6247	LRP1, low density lipoprotein-	CTGTCGGCAT[C/T]GACTTCCACG	S	C	T	I	I
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u14	WIAF-10024	X13916	8371	LRP1, low density lipoprotein-	ACGCCTCAGA[T/C]GAGATGAACT	S	T	C	D	D
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u15	WIAF-10030	X13916	11395	LRP1, low density lipoprotein-	ACGGCAGCGA[C/T]GAGGAGGCCT	S	C	T	D	D
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u16	WIAF-10031	X13916	12763	LRP1, low density lipoprotein-	ACGTCTTTGA[G/A]GATTACATCT	S	G	A	E	E
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u17	WIAF-10035	X13916	640	LRP1, low density lipoprotein-	ACGGATCTGA[C/T]GAGGCCCCTG	S	C	T	D	D
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u18	WIAF-10037	X13916	1609	LRP1, low density lipoprotein-	GCCGCCTTGT[C/T]TACTGGGCAG	S	C	T	V	V
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u19	WIAF-10038	X13916	1629	LRP1, low density lipoprotein-	GATGCCTATC[T/G]GGACTATATT	M	T	G	L	R
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u20	WIAF-10039	X13916	2210	LRP1, low density lipoprotein-	CACCAGCTAC[C/T]TCATTGGCCG	M	C	T	L	F
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u21	WIAF-10043	X13916	7287	LRP1, low density lipoprotein-	GATGGCTCCA[G/A]GAGGATCACC	M	G	A	R	K
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u22	WIAF-10044	X13916	8258	LRP1, low density lipoprotein-	CTCTGACGAG[A/G]TCCCTTGCAA	M	A	G	I	V
				related protein 1 (alpha-2-
				macroglobulin receptor)
G303u23	WIAF-10045	X13916	11871	LRP1, low density lipoprotein-	GTGCGCACCG[A/G]GAAAGCGGCC	M	A	G	E	G
				related protein 1 (alpha-2-
				macroglobulin receptor)
G3031u1	WIAF-14097	HT1128	611	PSMC3, proteasome (prosome,	TGGGGATCCA[A/G]CCTCCAAAAG	S	A	G	Q	Q
				macropain) 26S subunit, ATPase, 3
G3034u1	WIAF-12836	HT1182	137	TCF12, transcription factor 12	ATAAGGGAGC[G/A]TGAGGAGTCT	M	G	A	R	H
				(HTF4, helix-loop-helix
				transcription factors 4)
G3034u2	WIAF-12837	HT1182	421	TCF12, transcription factor 12	ATCTTCAATT[A/G]TGGGTTCCTT	M	A	G	M	V
				(HTF4, helix-loop-helix
				transcription factors 4)
G3038u1	WIAF-12864	HT1373	1700	NFKB1, nuclear factor of kappa	AGAGAAGGCT[A/G]TGCAGCTTGC	M	A	G	M	V
				light polypeptide gene enhancer in
				B-cells 1 (p105)
G3038u2	WIAF-12881	HT1373	1936	NFKB1, nuclear factor of kappa	TGTACCAGAC[G/A]CCCTTGCACT	S	G	A	T	T
				light polypeptide gene enhancer in
				B-cells 1 (p105)
G3038u3	WIAF-12882	HT1373	2641	NFKB1, nuclear factor of kappa	AGCTGCAGCT[G/C]TATAAGTTAC	S	G	C	L	L
				light polypeptide gene enhancer in
				B-cells 1 (p105)
G3039u1	WIAF-13027	HT1375	3761	GLI3, GLI-Kruppel family member	AACAGCCCCG[G/T]AAGTGGCACC	M	G	T	G	V
				GLI3 (Greig cephalopolysyndactyly
				syndrome)
G3039u2	WIAF-13028	HT1375	3963	GLI3, GLI-Kruppel family member	CGCCAAATGA[G/T]TCAGCTGGCA	M	G	T	E	D
				GLI3 (Greig cephalopolysyndactyly
				syndrome)
G304u1	WIAF-12242	HT637	158	FABP3, fatty acid binding protein	CTCACCCTAA[A/G]AACACACAGC	M	A	G	K	R
				3, muscle and heart (mammary-
				derived growth inhibitor)
G3043u1	WIAF-12867	HT1486	842	IRF2, interferon regulatory	GTGCCGAGGG[G/A]CGGCCACACT	S	G	A	G	G
				factor 2
G3047u1	WIAF-12875	HT1518	1233	transcription factor 1, nucleolar	TCCGTTTCCT[C/T]GAGAGCCTGC	S	C	T	L	L
G3047u2	WIAF-12876	HT1518	1746	transcription factor 1, nucleolar	GGATTAAGAA[G/A]GCAGCCGAAG	S	G	A	K	K
G3047u3	WIAF-12877	HT1518	1829	transcription factor 1, nucleolar	TCCAAGAAGA[T/C]GAAATTCCAG	M	T	C	M	T
G3048u1	WIAF-12884	HT1530	628	transcription factor USF	AGTGGAGCGT[C/T]GCCGCCGAGA	M	C	T	R	C
G305u1	WIAF-10150	HT0034	777	prolyl 4-hydroxylase, beta	CCCTTGTCAT[C/T]GAGTTCACCG	S	C	T	I	I
				subunit/protein disulfide
				isomerase/thyroid hormone-binding
				protein, alt. transcript 1
G305u2	WIAF-10154	HT0034	186	prolyl 4-hydroxylase, beta	TGGCGGCCCA[C/A]AAGTACCTGC	M	C	A	H	Q
				subunit/protein disulfide
				isomerase/thyroid hormone-binding
				protein, alt. transcript 1
G305u3	WIAF-10155	HT0034	1428	prolyl 4-hydroxylase, beta	GGACGGTCAT[T/C]GATTACAACG	S	T	C	I	I
				subunit/protein disulfide
				isomerase/thyroid hormone-binding
				protein, alt. transcript 1
G3050u1	WIAF-12860	HT1558	2098	FSRG1: female sterile homeotic-	AACATTGCAA[T/C]GGCATTTTGA	S	T	C	N	N
				related gene 1 (mouse homolog)
G3050u2	WIAF-12861	HT1558	2845	FSRG1: female sterile homeotic-	TAGGCCCTTC[T/C]GGCTTTGGAC	S	T	C	S	S
				related gene 1 (mouse homolog)
G3050u3	WIAF-12862	HT1558	3409	FSRG1: female sterile homeotic-	CCTCGTCGTC[G/A]TCTTCAGACA	S	G	A	S	S
				related gene 1 (mouse homolog)
G3050u4	WIAF-12874	HT1558	1699	FSRG1: female sterile homeotic-	TCTCTTCTGT[G/C]TCACACACAG	S	G	C	V	V
				related gene 1 (mouse homolog)
G3050u5	WIAF-12878	HT1558	2093	FSRG1: female sterile homeotic-	GTTAAAACAT[T/G]GCAATGGCAT	M	T	G	C	G
				related gene 1 (mouse homolog)
G3050u6	WIAF-12879	HT1558	2746	FSRG1: female sterile homeotic-	CTGGGGCCGA[C/T]GAAGATGACA	S	C	T	D	D
				related gene 1 (mouse homolog)
G3051u1	WIAF-12866	HT1569	1423	MEF2B, MADS box transcription	CTTGGCCGAC[G/A]GCTGGCCCCG	S	G	A	T	T
				enhancer factor 2, polypeptide B
				(myocyte enhancer factor 2B)
G3051u2	WIAF-13022	HT1569	661	MEF2B, MADS box transcription	CAGAGTACAG[C/T]GAGCCCCACG	S	C	T	S	S
				enhancer factor 2, polypeptide B
				(myocyte enhancer factor 2B)
G3057a1	WIAF-12142	HT1669	5565	alpha-fetoprotein enhancer-binding	AGACTGCTCT[T/C]GAGGCTCATA	S	T	C	L	L
				protein
G3057a2	WIAF-12143	HT1669	5634	alpha-fetoprotein enhancer-binding	CTCTGTCTGC[G/A]ATGCTCTTAG	S	G	A	A	A
				protein
G3057a3	WIAF-12144	HT1669	5664	alpha-fetoprotein enhancer-binding	GGGGACTCCA[G/T]ATGAAAGGAG	M	G	T	Q	H
				protein
G3057a4	WIAF-12145	HT1669	5703	alpha-fetoprotein enhancer-binding	GCTTTTCCCA[C/T]CTACCCCCAA	S	C	T	H	H
				protein
G3057u5	WIAF-12885	HT1669	2227	alpha-fetoprotein enhancer-binding	TCTGGAGATC[C/T]ATATGAGGTC	M	C	T	H	Y
				protein
G3057u6	WIAF-12892	HT1669	3720	alpha-fetoprotein enhancer-binding	AGACCTTGCC[G/A]GCTCAGCTAC	S	G	A	P	P
				protein
G3057u7	WIAF-12893	HT1669	4137	alpha-fetoprotein enhancer-binding	CAAGGTTTAC[G/A]GACTACCAGC	S	G	A	T	T
				protein
G3057u8	WIAF-12897	HT1669	4783	alpha-fetoprotein enhancer-binding	GAAGACCAAC[A/C]CTCCCCAGCA	M	A	C	T	P
				protein
G3057u9	WIAF-12898	HT1669	5215	alpha-fetoprotein enhancer-binding	TCCAACCTCC[A/C]CAATGAACAC	M	A	C	T	P
				protein
G3057u10	WIAF-12904	HT1669	7266	alpha-fetoprotein enhancer-binding	CCCTGCAGGC[C/T]GCGTTGACTT	S	C	T	A	A
				protein
G3057u11	WIAF-12907	HT1669	8345	alpha-fetoprotein enhancer-binding	CCAACAGACG[A/C]CTATTCGGAG	M	A	C	D	A
				protein
G3057u12	WIAF-12943	HT1669	4257	alpha-fetoprotein enhancer-binding	TGGTGTGGTT[T/C]CAGAATGCCC	S	T	C	F	F
				protein
G3057u13	WIAF-12951	HT1669	7333	alpha-fetoprotein enhancer-binding	ACCAGGCTTT[T/A]CTCCTTATTA	M	T	A	S	T
				protein
G3057u14	WIAF-13030	HT1669	303	alpha-fetoprotein enhancer-binding	GCAGCCTGTC[G/A]GAGGACGAGT	S	G	A	S	S
				protein
G3057u15	WIAF-13031	HT1669	777	alpha-fetoprotein enhancer-binding	GCCTTCCAGA[G/A]GAGGACGAGG	S	G	A	E	E
				protein
G306u1	WIAF-10118	HT0040	1618	CPT2, carnitine	CTCTACTGCC[G/A]TCCACTTTGA	M	G	A	V	I
				palmitoyltransferase II
G307u1	WIAF-10076	HT0114	110	EDN2, endothelin 2	CGTTGCGCTA[G/A]CCCTGCTCGT	M	G	A	A	T
G3070u1	WIAF-12972	HT2085	625	pre-B-cell leukemia transcription	AGAAATATGA[A/G]CAGGCATGTA	S	A	G	E	E
				factor 3
G3070u2	WIAF-12973	HT2085	841	pre-B-cell leukemia transcription	GTAACTTCAG[T/C]AAACAGGCCA	S	T	C	S	S
				factor 3
G3071u1	WIAF-12886	HT2086	995	AGER, advanced glycosylation end	CCTGCGAGGC[T/C]GTGATGATCC	S	T	C	A	A
				product-specific receptor
G3071u2	WIAF-12887	HT2086	1475	AGER, advanced glycosylation end	GAGGCCAGAT[C/G]TACAGCCCAC	M	C	G	I	M
				product-specific receptor
G3071u3	WIAF-12935	HT2086	933	AGER, advanced glycosylation end	ACGCATGGTG[A/G]GCATCATCCA	M	A	G	S	G
				product-specific receptor
G3071u4	WIAF-12936	HT2086	1052	AGER, advanced glycosylation end	GTAACTTCAG[C/T]AAACAGGCCA	S	C	T	S	S
				product-specific receptor
G3071u5	WIAF-12937	HT2086	836	AGER, advanced glycosylation end	AGAAGTATGA[G/A]CAGGCATGTA	S	G	A	E	E
				product-specific receptor
G308u1	WIAF-10094	HT0192	484	ANX4, annexin IV (placental	ATGGACGGAG[C/G]CTTGAAGATG	M	C	G	S	R
				anticoagulant protein II)
G308u2	WIAF-10095	HT0192	333	ANX4, annexin IV (placental	GGGATGATGA[C/T]GCCCACGGTG	M	C	T	T	M
				anticoagulant protein II)
G3081u1	WIAF-12997	HT2188	689	PSMC2, proteasome (prosome,	GGCATTGAGC[C/T]TCCCAAGGGC	M	C	T	P	L
				macropain) 26S subunit, ATPase, 2
G3083u1	WIAF-12976	HT2228	106	IGHMBP2, immunoglobulin mu	TGCTGGAGCT[T/C]GAGAGAGACG	S	T	C	L	L
				binding protein 2
G3083u2	WIAF-12985	HT2228	2260	IGHMBP2, immunoglobulin mu	TGGAGTTCAT[G/C]GCCAGCAAGA	M	G	C	M	I
				binding protein 2
G3083u3	WIAF-12986	HT2228	2060	IGHMBP2, immunoglobulin mu	GGGACCTGCT[A/G]CGTCCACCAG	M	A	G	T	A
				binding protein 2
G3083u4	WIAF-12987	HT2228	2365	IGHMBP2, immunoglobulin mu	ACGACAGTTC[C/T]GGGGAAGGGA	S	C	T	S	S
				binding protein 2
G3083u5	WIAF-13005	HT2228	411	IGHMBP2, immunoglobulin mu	TTTGATGAGT[C/T]CCACGATTTC	M	C	T	S	F
				binding protein 2
G3083u6	WIAF-13006	HT2228	272	IGHMBP2, immunoglobulin mu	ATACGGGTCC[G/A]CGGCAGCTCT	M	G	A	A	T
				binding protein 2
G3083u7	WIAF-13010	HT2228	2581	IGHMBP2, immunoglobulin mu	TCAGGAGCGC[G/A]CAGGGGCAGC	S	G	A	A	A
				binding protein 2
G3083u8	WIAF-13011	HT2228	2594	IGHMBP2, immunoglobulin mu	GGGGCAGCCC[G/A]CCAGCAAGGA	M	G	A	A	T
				binding protein 2
G3088u1	WIAF-12984	HT2318	884	HIVEP1, human immunodeficiency	TGTGGCACTA[C/T]GTCCCCCTCC	M	C	T	T	M
				virus type I enhancer-binding
				protein 1
G3088u2	WIAF-12988	HT2318	2469	HIVEP1, human immunodeficiency	TCTTGTCACC[A/G]CGTCAACACC	S	A	G	P	P
				virus type I enhancer-binding
				protein 1
G3088u3	WIAF-12989	HT2318	3066	HIVEP1, human immunodeficiency	TTCTTGGTAC[T/C]GGACAGTCCC	S	T	C	T	T
				virus type I enhancer-binding
				protein 1
G3088u4	WIAF-12991	HT2318	4008	HIVEP1, human immunodeficiency	TTATCCGGCA[G/T]CACAACATCC	M	G	T	Q	H
				virus type I enhancer-binding
				protein 1
G3088u5	WIAF-12992	HT2318	4880	HIVEP1, human immunodeficiency	CAAATCCATG[C/G]ACCGCCTAGC	M	C	G	A	G
				virus type I enhancer-binding
				protein 1
G3088u6	WIAF-12993	HT2318	5148	HIVEP1, human immunodeficiency	TTGACAGCAT[G/A]TCTAATTCGC	M	G	A	M	I
				virus type I enhancer-binding
				protein 1
G3088u7	WIAF-12999	HT2318	5834	HIVEP1, human immunodeficiency	CCAGCTGATA[A/G]TTCATCAACA	M	A	G	N	S
				virus type I enhancer-binding
				protein 1
G3088u8	WIAF-13000	HT2318	6065	HIVEP1, human immunodeficiency	CAAAGTCAAC[G/A]GCCAGTCACT	M	G	A	R	Q
				virus type I enhancer-binding
				protein 1
G3088u9	WIAF-13001	HT2318	7652	HIVEP1, human immunodeficiency	CATAGGAATA[C/T]GGTCACAGAA	M	C	T	T	M
				virus type I enhancer-binding
				protein 1
G3088u10	WIAF-13008	HT2318	741	HIVEP1, human immunodeficiency	TTCTGCAGCA[A/G]CCATCTGAAC	S	A	G	Q	Q
				virus type I enhancer-binding
				protein 1
G3088u11	WIAF-13009	HT2318	948	HIVEP1, human immunodeficiency	CAGAACTGAG[C/T]ACCTTGTCAC	S	C	T	S	S
				virus type I enhancer-binding
				protein 1
G3088u12	WIAF-13012	HT2318	1909	HIVEP1, human immunodeficiency	TGAAACTTTA[C/T]TAAAATCAAG	S	C	T	L	L
				virus type I enhancer-binding
				protein 1
G3088u13	WIAF-13013	HT2318	2803	HIVEP1, human immunodeficiency	TCTTCTGTCT[G/A]TACCTTCACT	M	G	A	V	I
				virus type I enhancer-binding
				protein 1
G3088u14	WIAF-13015	HT2318	3342	HIVEP1, human immunodeficiency	GCGGTCTGCA[A/G]CCTCAGATTC	S	A	G	Q	Q
				virus type I enhancer-binding
				protein 1
G3088u15	WIAF-13016	HT2318	3542	HIVEP1, human immunodeficiency	CCTAAACATA[G/A]TGTTACCATA	M	G	A	S	N
				virus type I enhancer-binding
				protein 1
G3088u16	WIAF-13017	HT2318	4972	HIVEP1, human immunodeficiency	TGGGTCTTCT[A/G]AAAGTGAGGA	M	A	G	K	E
				virus type I enhancer-binding
				protein 1
G3095u1	WIAF-12994	HT2435	701	TCF2, transcription factor 2,	CCGCTCTGTA[C/T]ACCTGGTACG	S	C	T	Y	Y
				hepatic; LF-B3; variant hepatic
				nuclear factor
G3095u2	WIAF-13018	HT2435	362	TCF2, transcription factor 2,	GGGCCGAGCC[C/T]GACACCAAGC	S	C	T	P	P
				hepatic; LF-B3; variant hepatic
				nuclear factor
G3095u3	WIAF-13020	HT2435	1620	TCF2, transcription factor 2,	CCAGTTCTCC[C/T]AGCAGCTGCA	N	C	T	Q	*
				hepatic; LF-B3; variant hepatic
				nuclear factor
G3100a1	WIAF-12147	HT2483	526	ZNF141, zinc finger protein 141	GAATGAGTGT[A/G]AGTTGCAGAA	M	A	G	K	E
				(clone pHZ-44)
G3102u1	WIAF-12975	HT2508	259	NRF1, nuclear respiratory factor	CGCCTTCTTC[G/T]CCCGAGGACA	S	G	T	S	S
				1
G3103u1	WIAF-13617	HT2511	1106	E2F2, E2F transcription factor 2	CCTTGGACCA[G/T]CTCATCCAGA	M	G	T	Q	H
G3103u2	WIAF-13659	HT2511	1154	E2F2, E2F transcription factor 2	CTGAGGACAA[G/A]GCCAACAAGA	S	G	A	K	K
G311u1	WIAF-10291	HT0402	1339	A2M, alpha-2-macroglobulin	GTCCCTGTTA[C/T]GGCTACCAGT	S	C	T	Y	Y
G311u2	WIAF-10292	HT0402	1201	A2M, alpha-2-macroglobulin	TCATATTCAT[C/T]AGAGGAAATG	S	C	T	I	I
G311u3	WIAF-10293	HT0402	3041	A2M, alpha-2-macroglobulin	TACTCCAGAG[G/A]TCAAGTCCAA	M	G	A	V	I
G311u4	WIAF-10294	HT0402	3676	A2M, alpha-2-macroglobulin	TGACATCCTA[T/C]GTGCTCCTCG	S	T	C	Y	Y
G311u5	WIAF-10296	HT0402	3364	A2M, alpha-2-macroglobulin	ATATCACCAT[C/T]GCCCTTCTGG	S	C	T	I	I
G311u6	WIAF-10297	HT0402	3203	A2M, alpha-2-macroglobulin	CCAAGCTCGA[G/T]CCTACATCTT	M	G	T	A	S
G311a7	WIAF-10494	HT0402	1122	A2M, alpha-2-macroglobulin	TCACACTTTC[G/A]ACAGGGAATT	M	G	A	R	Q
G3119u1	WIAF-13947	HT2654	2876	GLI, glioma-associated oncogene	TTTCTGGGGG[G/A]TTCCCAGGTT	M	G	A	G	D
				homolog (zinc finger protein)
G3119u2	WIAF-13959	HT2654	654	GLI, glioma-associated oncogene	AGTGCCGGGA[G/A]GAACCCTTGG	S	G	A	E	E
				homolog (zinc finger protein)
G3119u3	WIAF-13965	HT2654	3376	GLI, glioma-associated oncogene	TGGGGAAACA[G/C]AATTCCTCAA	M	G	C	E	Q
				homolog (zinc finger protein)
G312u1	WIAF-10006	HT0428	898	PLAU, plasminogen activator,	CTCACCACAA[C/T]GACATTGCCT	S	C	T	N	N
				urokinase
G312u2	WIAF-10029	HT0428	498	PLAU, plasminogen activator,	GGCCTAAAGC[C/T]GCTTGTCCAA	M	C	T	P	L
				urokinase
G312a3	WIAF-10521	HT0428	767	PLAU, plasminogen activator,	TGATTACCCA[A/C]AGAAGGAGGA	M	A	C	K	Q
				urokinase
G3125u1	WIAF-13675	HT2674	740	GTF2F2, general transcription	ACATCACAAA[A/G]CAACCTGTGG	S	A	G	K	K
				factor IIF, polypeptide 2 (30 kD
				subunit)
G313u1	WIAF-10129	HT0462	3086	platelet-derived growth factor,	CATGCGTGTG[G/A]ACTCAGACAA	M	G	A	D	N
				alpha polypeptide (GB:M21574)
G313u2	WIAF-10130	HT0462	1078	platelet-derived growth factor,	ATGAGAAAGG[T/G]TTCATTGAAA	S	T	G	G	G
				alpha polypeptide (GB:M21574)
G313u3	WIAF-10133	HT0462	1571	platelet-derived growth factor,	GGAGATCCAC[T/C]CCCGAGACAG	M	T	C	S	P
				alpha polypeptide (GB:M21574)
G313u4	WIAF-10135	HT0462	2611	platelet-derived growth factor,	CTCGCAACGT[C/T]CTCCTGGCAC	S	C	T	V	V
				alpha polypeptide (GB:M21574)
G314u1	WIAF-10069	HT0467	1890	ALOX15, arachidonate 15-	TCAGGGAGGA[G/A]CTGGCTGCCC	S	G	A	E	E
				lipoxygenase
G3141u1	WIAF-13934	HT27498	878	NFATC3, nuclear factor of	CCAGAGGATA[G/A]CTGGCTACTC	M	G	A	S	N
				activated T-cells, cytoplasmic 3
G3141u2	WIAF-13936	HT27498	1189	NFATC3, nuclear factor of	GCCTGCCTCA[T/C]GCAATGGGAA	M	T	C	C	R
				activated T-cells, cytoplasmic 3
G3141u3	WIAF-13938	HT27498	2241	NFATC3, nuclear factor of	CTCTGCGGGG[T/C]TTCCCTTCAG	S	T	C	G	G
				activated T-cells, cytoplasmic 3
G3141u4	WIAF-13944	HT27498	702	NFATC3, nuclear factor of	ATGCCTCTGA[C/T]GAGGCAGCCC	S	C	T	D	D
				activated T-cells, cytoplasmic 3
G3159u1	WIAF-13891	HT2757	523	SP4, Sp4 transcription factor	CTTCAAAAGA[G/A]AATAACGTTT	S	G	A	E	E
G3159u2	WIAF-13892	HT2757	1514	SP4, Sp4 transcription factor	ACAGAATGTT[C/T]AACTTCAAGC	N	C	T	Q	*
G3159u3	WIAF-13893	HT2757	2236	SP4, Sp4 transcription factor	TGTTTTGTGG[C/T]AAAAGATTCA	S	C	T	G	G
G3165u1	WIAF-13860	HT27636	437	transcription factor B-ATF	AGCAGCTCAC[A/G]GAGGAACTGA	S	A	G	T	T
G3165u2	WIAF-13861	HT27636	512	transcription factor B-ATF	CCAGCACGCC[C/G]TCGCCCCCCG	S	C	G	P	P
G3173u1	WIAF-13556	HT2772	1686	ZNF74, zinc finger protein 74	TGCACAGCGA[G/A]GGGAAGCCCT	S	G	A	E	E
				(Cos52)
G3175u1	WIAF-13948	HT2776	2037	transcriptional regulator, via	TGTTCGGACC[A/G]GAAGCACCCA	S	A	G	P	P
				glucocorticoid receptor
G3182u1	WIAF-14036	HT2783	1614	MHC2TA, MHC class II	ATCCTAGACG[C/G]CTTCGAGGAG	M	C	G	A	G
				transactivator
G3182u2	WIAF-14037	HT2783	2791	MHC2TA, MHC class II	TGAGCGACAC[G/A]GTGGCGCTGT	S	G	A	T	T
				transactivator
G3182u3	WIAF-14059	HT2783	1657	MHC2TA, MHC class II	TGCACAGCAC[G/A]TGCGGACCGG	S	G	A	T	T
				transactivator
G3182u4	WIAF-14060	HT2783	1606	MHC2TA, MHC class II	TTCTGCTCAT[C/T]CTAGACGCCT	S	C	T	I	I
				transactivator
G3183u1	WIAF-13950	HT27861	392	zinc finger protein C2H2-150	TACTCTAGAG[G/A]AGCCTGTTGG	M	G	A	E	K
G3184u1	WIAF-13864	HT27862	271	zinc finger protein C2H2-171	GAAACTCCAG[T/G]TCAAAGACTT	M	T	G	F	V
G3184u2	WIAF-13865	HT27862	248	zinc finger protein C2H2-171	CTGCTTGAAT[T/C]CATGTATGAR	M	T	C	F	S
G320u1	WIAF-10136	HT0791	552	ANX7, annexin VII (synexin)	CCAACTTCGA[T/C]GCTATAAGAG	S	T	C	D	D
G320u2	WIAF-10137	HT0791	1350	ANX7, annexin VII (synexin)	TTGACCTTGT[A/G]CAAATAAAAC	S	A	G	V	V
G3208u1	WIAF-14186	HT27930	485	zinc finger protein ZNF37A	GTCAGAAGTC[A/G]GCCCTAATTG	S	A	G	S	S
G3218u1	WIAF-13526	HT28104	187	zinc finger protein ZNF169,	CCCGACAGCT[C/T]ATTAAGAAAG	M	C	T	H	Y
				Krueppel-type
G323u1	WIAF-10066	HT0915	1361	Homo sapiens inducible nitric	ACTTCTGTGA[C/T]GTCCAGCGCT	S	C	T	D	D
				oxide synthase (NOS) mRNA,
				complete cds.
G325u1	WIAF-10106	HT0962	3817	FBN1, fibrillin 1 (Marfan	TGTGAATGCC[C/T]GCCTGGCCAT	M	C	T	P	L
				syndrome)
G325u2	WIAF-10113	HT0962	722	FBN1, fibrillin 1 (Marfan	AGATAGCTCC[T/G]TCCTGTGGCT	S	T	G	P	P
				syndrome)
G325u3	WIAF-10114	HT0962	2022	FBN1, fibrillin 1 (Marfan	GATCTGCAAT[A/C]ATGGACGCTG	M	A	C	N	H
				syndrome)
G325u4	WIAF-10116	HT0962	3603	FBN1, fibrillin 1 (Marfan	GAACTGCACA[G/C]ACATTGACGA	M	G	C	D	H
				syndrome)
G325u5	WIAF-10117	HT0962	2270	FBN1, fibrillin 1 (Marfan	TCTGCATGAA[C/T]GGGCGTTGCG	S	C	T	N	N
				syndrome)
G326u1	WIAF-10036	HT1009	1854	KLKB1, kallikrein B plasma,	GCAAACACAA[C/T]GGAATGTGGC	S	C	T	N	N
				(Fletcher factor) 1
G327u1	WIAF-10052	HT1011	1599	HRG, histidine-rich glycoprotein	AAGCCAGACA[A/T]TCAGCCCTTT	M	A	T	N	I
G327u2	WIAF-10054	HT1011	1083	HRG, histidine-rich glycoprotein	CCACTATTGC[C/T]CATGTCCTGC	M	C	T	P	L
G327u3	WIAF-10055	HT1011	1140	HRG, histidine-rich glycoprotein	GCCCAAAGAC[A/G]TTCTCATAAT	M	A	G	H	R
G328u1	WIAF-10145	HT1087	255	SAA1, serum amyloid A1	GTGCCTGGGC[T/C]GCAGAAGTGA	S	T	C	A	A
G328a2	WIAF-10511	HT1087	248	SAA1, serum amyloid A1	CCTGGGGGTG[C/T]CTGGGCTGCA	M	C	T	A	V
G328a3	WIAF-10512	HT1087	305	SAA1, serum amyloid A1	TTCTTTGGCC[A/G]TGGTGCGGAG	M	A	G	H	R
G328a4	WIAF-13126	HT1087	295	SAA1, serum amyloid A1	TATCCAGAGA[T/C]TCTTTGGCCA	M	T	C	F	L
G328a5	WIAF-13127	HT1087	82	SAA1, serum amyloid A1	CTTGGTCCTG[G/A]GTGTCAGCAG	M	G	A	G	S
G329u1	WIAF-10140	HT1141	2514	PLCG1, phospholipase C, gamma 1	CTGACCTTCA[T/C]CAAGAGCGCC	M	T	C	I	T
				(formerly subtype 148)
G329u2	WIAF-10162	HT1141	1036	PLCG1, phospholipase C, gamma 1	TATGCCCGGA[C/A]ACCATGAACA	M	C	A	D	E
				(formerly subtype 148)
G329u3	WIAF-10163	HT1141	911	PLCG1, phospholipase C, gamma 1	GTTCATGCTC[A/G]GCTTCCTCCG	M	A	G	S	G
				(formerly subtype 148)
G3295u1	WIAF-14017	HT3460	1229	FUBP, far upstream element	CCATAAAAAG[C/T]ATAAGCCAGC	S	C	T	S	S
				binding protein
G3296u1	WIAF-14168	HT3466	6289	transcription factor TFIIIC, RNA	CAGCCTGGAC[G/A]AGAGCCCCAT	M	G	A	E	K
				polymerase III, alpha subunit
G3296u2	WIAF-14179	HT3466	235	transcription factor TFIIIC, RNA	GGGCATCAGC[T/A]TCTATGAGGA	M	T	A	F	I
				polymerase III, alpha subunit
G3298u1	WIAF-13523	HT3504	1803	DNA-binding protein HRFX2	ACTTTGCCAA[C/T]GTGCAGGAGC	S	C	T	N	N
G3298u2	WIAF-13524	HT3504	1743	DNA-binding protein HRFX2	GGGCGGTGCT[G/A]CAGAACACGT	S	G	A	L	L
G3298u3	WIAF-13528	HT3504	2002	DNA-binding protein HRFX2	GTTCTTGCTG[A/G]AATGGTCCTT	M	A	G	K	E
G33u1	WIAF-10254	X82540	1044	INHBC, inhibin, beta C	AAGGCCAACA[C/T]AGCTGCAGGC	M	C	T	T	I
G33u2	WIAF-10255	X82540	1136	INHBC, inhibin, beta C	CAGCAACATT[G/A]TCAAGACTGA	M	G	A	V	I
G33u3	WIAF-10256	X82540	1185	INHBC, inhibin, beta C	GGGTGCAGTT[A/G]GTCTATGTGT	N	A	G	*	W
G33u4	WIAF-10259	X82540	892	INHBC, inhibin, beta C	TTTTTGTGGA[C/T]TTCCGTGAGA	S	C	T	D	D
G3303u1	WIAF-13566	HT3523	981	POU6F1, POU domain, class 6,	CAGGCCAGGA[G/A]ATCACTGAAA	S	G	A	E	E
				transcription factor 1
G3304u1	WIAF-13932	HT3544	970	SP2, Sp2 transcription factor	TCAACAACCT[C/T]GTGAACGCCA	S	C	T	L	L
G3304u2	WIAF-13935	HT3544	1891	SP2, Sp2 transcription factor	AGAAGCACGT[T/G]TGCCACATCC	S	T	G	V	V
G3304u3	WIAF-13943	HT3544	920	SP2, Sp2 transcription factor	TGTGGTGAAG[T/C]TGACAGGTGG	S	T	C	L	L
G3311u1	WIAF-13839	HT3585	757	GATA3, GATA-binding protein 3	CCCACTCCCG[T/C]GGCAGCATGA	S	T	C	R	R
G3311u2	WIAF-13840	HT3585	901	GATA3, GATA-binding protein 3	TCGGATGCAA[G/A]TCCAGGCCCA	S	G	A	K	K
G3316u1	WIAF-13818	HT3607	282	zinc finger protein HKE-T1,	AAAGAGTTTC[A/G]GTCAGAGTTC	M	A	G	S	G
				Kruppel-like
G3319u1	WIAF-14214	HT3613	1086	SMARCA3, SWI/SNF related, matrix	AAACTCTTAC[A/G]GCCATTGCAG	S	A	G	T	T
				associated, actin dependent
				regulator of chromatin, subfamily
				a, member 3
G3319u2	WIAF-14221	HT3613	1261	SMARCA3, SWI/SNF related, matrix	TAGATGTAGT[G/C]AACAACCCAG	M	G	C	E	Q
				associated, actin dependent
				regulator of chromatin, subfamily
				a, member 3
G3320u1	WIAF-13692	HT3622	624	BCL6, B-cell CLL/lymphoma 6 (zinc	ATTTGCGGGA[G/C]GGCAACATCA	M	G	C	E	D
				finger protein 51)
G3320u2	WIAF-13717	HT3622	1062	BCL6, B-cell CLL/lymphoma 6 (zinc	ACAGCCGGCC[G/A]ACTTTGGAGG	S	G	A	P	P
				finger protein 51)
G3321u1	WIAF-13761	HT3641	235	STAT2, signal transducer and	TCTTGGATCA[G/C]CTGAACTATG	M	G	C	Q	H
				activator of transcription 2,
				113 kD
G3321u2	WIAF-13762	HT3641	774	STAT2, signal transducer and	CAAAAAGCCT[G/C]CATCAGAGCT	M	G	C	C	S
				activator of transcription 2,
				113 kD
G3328u1	WIAF-13543	HT3681	1550	transcription factor znf6	CCACAATGGT[A/G]TCAGAGGAGG	S	A	G	V	V
G3328u2	WIAF-13544	HT3681	1389	transcription factor znf6	AGAGGATTTA[G/C]AGGAAGATGA	M	G	C	E	Q
G3336u1	WIAF-13848	HT3732	216	XBP1, X-box binding protein 1	ACCTGAGCCC[C/T]GAGGAGAAGG	S	C	T	P	P
G334u1	WIAF-10008	HT1220	893	THBS1, thrombospondin 1	TACATTGGCC[A/C]CAAGACAAAG	M	A	C	H	P
G334u2	WIAF-10009	HT1220	2000	THBS1, thrombospondin 1	TCACAGCCCT[T/C]CGGCCAGGGT	M	T	C	F	S
G334u3	WIAF-10016	HT1220	1521	THBS1, thrombospondin 1	CCCAGATGAA[T/C]GGGAAACCCT	S	T	C	N	N
G334u4	WIAF-10017	HT1220	2210	THBS1, thrombospondin 1	GGCTGGCCCA[A/G]TGAGAACCTG	M	A	G	N	S
G334u5	WIAF-10018	HT1220	2979	THBS1, thrombospondin 1	GTGAGACCGA[T/C]TTCCGCCGAT	S	T	C	D	D
G334u6	WIAF-10033	HT1220	1136	THBS1, thrombospondin 1	TGTCACTGTC[A/G]GAACTCAGTT	M	A	G	Q	R
G334u7	WIAF-10034	HT1220	1859	THBS1, thrombospondin 1	AGTGGAAATG[G/A]CATCCAGTGC	M	G	A	G	D
G3343u1	WIAF-13545	HT3770	1104	ZNF76, zinc finger protein 76	GCAGTGCCCA[C/T]GGCGAGCTGG	S	C	T	H	H
				(expressed in testis)
G3343u2	WIAF-13561	HT3770	425	ZNF76, zinc finger protein 76	GAGCAGTATG[C/A]CAGCAAGGTT	M	C	A	A	D
				(expressed in testis)
G3343u3	WIAF-13562	HT3770	143	ZNF76, zinc finger protein 76	CACCAGGTGA[C/T]GGTACAGAAA	M	C	T	T	M
				(expressed in testis)
G3343u4	WIAF-13563	HT3770	646	ZNF76, zinc finger protein 76	GAAGAGCCAC[G/T]TTCGTACCCA	M	G	T	V	F
				(expressed in testis)
G3343u5	WIAF-13564	HT3770	611	ZNF76, zinc finger protein 76	AGCTGTGGAA[A/G]GGCCTTTGCC	M	A	G	K	R
				(expressed in testis)
G3344u1	WIAF-13664	HT3772	925	zinc finger protein MAZ	AGCTGTCGCA[C/T]TCGCACGAGA	S	C	T	H	H
G3345u1	WIAF-13508	HT3823	315	TCF6L1, transcription factor 6-	TTCGATTTTC[T/C]AAAGAACAAC	S	T	C	S	S
				like 1 (mitochondrial
				transcription factor 1-like)
G3345u2	WIAF-13509	HT3823	167	TCF6L1, transcription factor 6-	GGCGTGCTGA[G/C]TGCCCTGGGA	M	G	C	S	T
				like 1 (mitochondrial
				transcription factor 1-like)
G3345u3	WIAF-13531	HT3823	625	TCF6L1, transcription factor 6-	TTATAACGTT[T/G]ATGTAGCTGA	M	T	G	Y	D
				like 1 (mitochondrial
				transcription factor 1-like)
G3352u1	WIAF-13589	HT4005	1190	MITF, microphthalmia-associated	CTCGGAACTG[G/A]GACTGAGGCC	M	G	A	G	E
				transcription factor
G3352u2	WIAF-13604	HT4005	1156	MITF, microphthalmia-associated	TCTCACGGAT[G/A]GCACCATCAC	M	G	A	G	S
				transcription factor
G3353u1	WIAF-13937	HT4010	360	GTF2H3, general transcription	ATCTAATGAC[C/A]AAAAGTGACA	S	C	A	T	T
				factor IIH, polypeptide 3 (34 kD
				subunit)
G3358u1	WIAF-13671	HT4187	398	ETV5, ets variant gene 5 (ets-	GATGATGAAC[A/G]GTTTGTCCCA	M	A	G	Q	R
				related molecule)
G3358u2	WIAF-13672	HT4187	223	ETV5, ets variant gene 5 (ets-	TCAGCAAGTC[C/T]CTTTTATGGT	M	C	T	P	S
				related molecule)
G3358u3	WIAF-13673	HT4187	1236	ETV5, ets variant gene 5 (ets-	GACTGGAAGG[C/G]AAAGTCAAAC	S	C	G	G	G
				related molecule)
G3358u4	WIAF-13674	HT4187	1678	ETV5, ets variant gene 5 (ets-	TTACCTCCTG[G/A]ACATGGACCG	M	G	A	D	N
				related molecule)
G3358u5	WIAF-13706	HT4187	414	ETV5, ets variant gene 5 (ets-	TCCCAGATTT[T/C]CAGTCTGATA	S	T	C	F	F
				related molecule)
G3358u6	WIAF-13707	HT4187	1238	ETV5, ets variant gene 5 (ets-	CTGGAAGGCA[A/G]AGTCAAACAG	M	A	G	K	R
				related molecule)
G336u1	WIAF-10152	HT1258	566	ACAT1, acetyl-Coenzyme A	AGAGCATGTC[C/A]AATGTTCCAT	S	C	A	S	S
				acetyltransferase 1 (acetoacetyl
				Coenzyme A thiolase)
G3369u1	WIAF-14047	HT4302	614	zinc finger protein DB1	ATCTCAATCG[A/G]CACAAGCTCT	S	A	G	R	R
G337u1	WIAF-10268	HT1259	464	EDNRB, endothelin receptor type B	AAAGGAGACA[G/T]GACGGCAGGA	M	G	T	R	M
G337u2	WIAF-10298	HT1259	1281	EDNRB, endothelin receptor type B	TGAAGCTCAC[T/A]CTTTATAATC	S	T	A	T	T
G3373u1	WIAF-14203	HT4342	1253	MTF1, metal-regulatory	CTCAACAGAC[A/G]GCTTCCTTGA	S	A	G	T	T
				transcription factor 1
G3390u1	WIAF-14182	HT4483	680	ZNF133, zinc finger protein 133	AGAGCCAGAG[C/T]TCTACCTCGA	M	C	T	L	F
				(clone pHZ-13)
G3390u2	WIAF-14184	HT4483	1026	ZNF133, zinc finger protein 133	GCTCAGACAG[G/A]GAACCCTGAG	M	G	A	G	E
				(clone pHZ-13)
G3390u3	WIAF-14185	HT4483	1423	ZNF133, zinc finger protein 133	AAAAGCCTTA[T/C]GTGTGCCGGG	S	T	C	Y	Y
				(clone pHZ-13)
G3390u4	WIAF-14197	HT4483	811	ZNF133, zinc finger protein 133	CTGGGGATCC[A/G]GGCCCAGGGG	S	A	G	P	P
				(clone pHZ-13)
G3390u5	WIAF-14198	HT4483	1420	ZNF133, zinc finger protein 133	GGGAAAAGCC[T/G]TATGTGTGCC	S	T	G	P	P
				(clone pHZ-13)
G3390u6	WIAF-14199	HT4483	2143	ZNF133, zinc finger protein 133	CAGCTCTAAT[C/T]ACACACAAGC	S	C	T	I	I
				(clone pHZ-13)
G3391u1	WIAF-13631	HT4484	391	ZNF136, zinc finger protein 136	AGCATTGTAT[A/G]TGGAGAAGTC	M	A	G	Y	C
				(clone pHZ-20)
G3396u1	WIAF-13978	HT4491	1283	ZNF135, zinc finger protein 135	CACAGCTCCT[C/T]GCTCAGCCAG	M	C	T	S	L
				(clone pHZ-17)
G3396u2	WIAF-13979	HT4491	1296	ZNF135, zinc finger protein 135	TCAGCCAGCA[C/T]GAAAGGACGC	S	C	T	H	H
				(clone pHZ-17)
G3396u3	WIAF-13980	HT4491	1028	ZNF135, zinc finger protein 135	AGTCACAGCT[C/T]GTCCCTCACC	M	C	T	S	L
				(clone pHZ-17)
G3396u4	WIAF-13981	HT4491	1057	ZNF135, zinc finger protein 135	GCGAATCCAC[A/G]CTGGGGAGAA	M	A	G	T	A
				(clone pHZ-17)
G3396u5	WIAF-13982	HT4491	1152	ZNF135, zinc finger protein 135	CAGGAGAGAA[A/G]CCCTATGAAT	S	A	G	K	K
				(clone pHZ-17)
G3396u6	WIAF-13983	HT4491	1243	ZNF135, zinc finger protein 135	AAAGCCGTAT[G/C]GGTGCAATGA	M	G	C	G	R
				(clone pHZ-17)
G3396u7	WIAF-13984	HT4491	1045	2HF135, zinc finger protein 135	CACCAAACAT[C/T]AGCGAATCCA	N	C	T	Q	*
				(clone pHZ-17)
G340u1	WIAF-10139	HT1386	459	CYP27A1, cytochrome P450,	CCTATGGGCC[G/A]TTCACCACGG	S	G	A	P	P
				subfamily XXVIIA (steroid 27-
				hydroxylase, cerebrotendinous
				xanthomatosis), polypeptide 1
G340u2	WIAF-10160	HT1386	801	CYP27A1, cytochrome P450,	TCCCCAAGTG[G/A]ACTCGCCCCG	N	G	A	W	*
				subfamily XXVIIA (steroid 27-
				hydroxylase, cerebrotendinous
				xanthomatosis), polypeptide 1
G341u1	WIAF-10121	HT1388	912	MUT, methylmalonyl Coenzyme A	GAGCTGGCCT[A/G]TACTTTAGCA	M	A	G	Y	C
				mutase
G341u2	WIAF-10128	HT1388	2087	MUT, methylmalonyl Coenzyme A	TGCTGTGGGC[G/A]TAAGCACCCT	M	G	A	V	I
				mutase
G3410u1	WIAF-13749	HT4550	1720	zinc finger homeodomain protein	TGAGTCCTCT[G/T]TTTCATCAGC	M	G	T	V	F
G3410u2	WIAF-13750	HT4550	2843	zinc finger homeodomain protein	AAACATCATT[T/C]GATTGAACAC	M	T	C	L	S
G3410u3	WIAF-13751	HT4550	2745	zinc finger homeodomain protein	AGATATTCCA[A/T]AAGAGTAGTT	M	A	T	Q	H
G3410u4	WIAF-13775	HT4550	236	zinc finoer homeodomain protein	AGAGAAGGGA[A/C]TGCTAAGAAC	M	A	C	N	T
G3410u5	WIAF-13776	HT4550	195	zinc finger homeodomain protein	TGCCAACAGA[C/T]CAGACAGTGT	S	C	T	D	D
G3410u6	WIAF-13777	HT4550	606	zinc finger homeodomain protein	ATAACTTTAG[T/C]TGCTCCCTGT	S	T	C	S	S
G3410u7	WIAF-13793	HT4550	2073	zinc finger homeodomain protein	CAGTTTTACC[A/G]GTGGGATCAA	S	A	G	P	P
G343u1	WIAF-10120	HT1552	561	HK1, hexokinase 1	CTTGCCAACA[A/G]TCCAAAATAG	S	A	G	Q	Q
G343u2	WIAF-10124	HT1552	159	HK1, hexokinase 1	ACAAGTATCT[G/C]TATGCCATGC	S	G	C	L	L
G348u1	WIAF-10269	HT1906	2212	PECAM1, platelet/endothelial cell	TGACGATGTC[A/G]GAAACCATGC	S	A	G	G	G
				adhesion molecule (CD31 antigen)
G348u2	WIAF-10277	HT1906	1656	PECAM1, platelet/endothelial cell	GCCATTCCCA[C/T]GCCAAAATGT	S	C	T	H	H
				adhesion molecule (CD31 antigen)
G348u3	WIAF-10283	HT1906	577	PECAM1, platelet/endothelial cell	AGAGTACCAG[C/G]TGTTGGTGGA	S	C	G	V	V
				adhesion molecule (CD31 antigen)
G348a5	WIAF-13119	HT1906	?	PECAM1, platelet/endothelial cell	ATTGTTCCC[C/G]	?	C	G
				adhesion molecule (CD31 antigen)
G351u1	WIAF-10123	HT1990	1047	OSBP, oxysterol binding protein	TGCTGGCAGA[G/A]TCAGATGAAT	S	G	A	E	E
G351u2	WIAF-10132	HT1990	1023	OSBP, oxysterol binding protein	TGGCCAAGGC[C/A]AAAGCTGTGA	S	C	A	A	A
G355u1	WIAF-10146	HT2143	1670	THBS4, thrombospondin 4	AACTGCCTGA[G/A]TGTCTTAAAT	M	G	A	S	N
G355u2	WIAF-10165	HT2143	1186	THBS4, thrombospondin 4	TCGAAATGGA[G/C]CGTGCGTTCC	M	G	C	A	P
G355a3	WIAF-10510	HT2143	1962	THBS4, thrombospondin 4	ACTGCCCCAC[C/G]GTCATTAACA	S	C	G	T	T
G355a4	WIAF-13125	HT2143	1963	THBS4, thrombospondin 4	CTGCCCCACC[G/a]TCATTAACAG	M	G	a	V	I
G3552u1	WIAF-12701	HT28101	1006	CLCN2, chloride channel 2	AAGAGACTAT[T/C]ACAGCCCTCT	S	T	C	I	I
G3552u2	WIAF-12731	HT28101	1823	CLCN2, chloride channel 2	CCGCCACCAG[C/T]AGTACCGGGT	N	C	T	Q	*
G3552u3	WIAF-12736	HT28101	2254	CLCN2, chloride channel 2	GGAGCGCAGA[G/C]TCGGCAGGCA	M	G	C	E	D
G3565u1	WIAF-12744	HT2896	334	calcyclin	GCCCTCAAGG[G/A]CTGAAAATAA	M	G	A	G	D
G357u1	WIAF-10267	HT2244	4300	C4B, complement component 4B	ATGAGTACGA[T/C]GAGCTTCCAG	S	T	C	D	D
G357u2	WIAF-10280	HT2244	5095	C4B, complement component 4B	TCATGGGTCT[G/A]GATGGGGCCA	S	G	A	L	L
G357u3	WIAF-10295	HT2244	2996	C4B, complement component 4B	CTCAGATCCA[T/C]TGGACACTTT	S	T	C	L	L
G359u1	WIAF-10026	HT2411	936	PLAT, plasminogen activator,	CGCAGGCTGA[A/G]GTGGGAGTAC	M	A	G	T	M
				tissue
G359a2	WIAF-10520	HT2411	1444	PLAT, plasminogen activator,	AGGCCTTGTC[T/C]CCTTTCTATT	S	T	C	S	S
				tissue
G3592u1	WIAF-12759	HT4214	743	CLCN4, chloride channel 4	CTTCTAACGA[G/A]ACCACTTTTG	S	G	A	E	E
G3592u2	WIAF-12761	HT4214	835	CLCN4, chloride channel 4	GCTTACATTC[T/G]GAATTACTTA	M	T	G	L	R
G361u1	WIAF-10053	HT2479	857	cystathionine beta synthase, alt.	TGGCTCACTA[C/T]GACACCACCG	S	C	T	Y	Y
				transcript 1
G361u2	WIAF-10056	HT2479	1097	cystathionine beta synthase, alt.	TCATCCCCAC[G/A]GTGCTGGACA	S	G	A	T	T
				transcript 1
G362u1	WIAF-10058	HT2638	223	ADRB2, adrenergic, beta-2-,	GGCACCCAAT[G/A]GAAGCCATGC	M	G	A	G	R
				receptor, surface
G362u2	WIAF-10059	HT2638	429	ADRB2, adrenergic, beta-2-,	TCATGGGCCT[G/A]GCAGTGGTGC	S	G	A	L	L
				receptor, surface
G362u3	WIAF-10060	HT2638	256	ADRB2, adrenergic, beta-2-,	CGTCACGCAG[G/C]AAAGGGACGA	M	G	C	E	Q
				receptor, surface
G362u4	WIAF-10093	HT2638	1230	ADRB2, adrenergic, beta-2-,	AGGCCTATGG[G/C]AATGGCTACT	S	G	C	G	G
				receptor, surface
G3620u1	WIAF-12808	HT97200	458	ACATN, acetyl-Coenzyme A	CACTCTCTGG[A/G]TATGAAGAGC	M	A	G	D	G
				transporter
G3627u1	WIAF-12820	HT97387	347	NAPG, N-ethylmaleimide-sensitive	GCAGAAACTA[C/T]CAGAGGCCGT	M	C	T	P	S
				factor attachment protein, gamma
G366u1	WIAF-10046	HT2764	987	BDKRB2, bradykinin receptor B2	GCCTCCTTCA[T/C]GGCCTACAGC	M	T	C	M	T
G366a2	WIAF-10500	HT2764	820	BDKRB2, bradykinin receptor B2	AGATCCAGAC[G/A]GAGAGGAGGG	S	G	A	T	T
G366a3	WIAF-10501	HT2764	961	BDKRB2, bradykinin receptor B2	GCATCATCGA[T/C]GTAATCACAC	S	T	C	D	D
G367u1	WIAF-10156	HT27685	6965	ACACA, acetyl-Coenzyme A	ATCATCCATA[T/C]GACGCAGCAC	N	T	C	*	C
				carboxylase alpha
G370u1	WIAF-10281	HT27888	3250	LEPR, leptin receptor	AAAATTCTCC[G/A]TTGAAGGATT	S	G	A	P	P
G370u2	WIAF-10282	HT27888	3229	LEPR, leptin receptor	TCACCAAGTG[C/T]TTCTCTAGCA	S	C	T	C	C
G370u3	WIAF-10284	HT27888	1005	LEPR, leptin receptor	CAATATCAAG[T/C]GAAATATTCA	M	T	C	V	A
G370u4	WIAF-10285	HT27888	1894	LEPR, leptin receptor	CAGAGAATAA[C/T]CTTCAATTCC	S	C	T	N	N
G370u5	WIAF-10299	HT27888	1222	LEPR, leptin receptor	TTCTGACAAG[T/C]GTTGGGTCTA	S	T	C	S	S
G370u6	WIAF-10300	HT27888	2161	LEPR, leptin receptor	CTATGAAAAA[G/C]GAGAAAATG	M	G	C	K	N
G371u1	WIAF-10107	HT27943	349	CRAT, carnitine acetyltransferase	TCATCTACTC[G/C]AGCCCAGGCG	S	G	C	S	S
G371a2	WIAF-12093	HT27943	287	CRAT, carnitine acetyltransferase	GGAGAACTGG[C/T]TGTCTGAGTG	S	C	T	L	L
G372a1	WIAF-10506	HT28247	1099	HADHA, hydroxyacyl-Coenzyme A	TGGAGCTCCA[C/A]AGAAGGATGT	M	C	A	Q	K
				dehydrogenase/3-ketoacyl-Coenzyme
				A thiolase/enoyl-Coenzyme A
				hydratase (trifunctional protein),
				alpha subunit
G374u1	WIAF-10103	HT28496	4435	FASN, fatty acid synthase	CACCTCCCAC[G/A]TCCCGGAGGT	M	G	A	V	I
G374u2	WIAF-10104	HT28496	5996	FASN, fatty acid synthase	CTGGACAGGG[T/C]GACCCGAGAG	M	T	C	V	A
G374u3	WIAF-10105	HT28496	5644	FASN, fatty acid synthase	CAAGAGCTAC[A/G]TCATCGCTGG	M	A	G	I	V
G374u4	WIAF-10115	HT28496	6387	FASN, fatty acid synthase	TGGCACACAT[C/T]CTGGGCATCC	S	C	T	I	I
G374u5	WIAF-10119	HT28496	567	FASN, fatty acid synthase	GGGGCATCAA[C/T]GTCCTGCTGA	S	C	T	N	N
G374a6	WIAF-12094	HT28496	5520	FASN, fatty acid synthase	ACATGGCCCA[A/G]GGGAAGCACA	S	A	G	Q	Q
G377u1	WIAF-10142	HT2996	929	PCCB, propionyl Coenzyme A	GGACCCGGCT[T/C]CCGTCCGTGA	M	T	C	S	P
				carboxylase, beta polypeptide
G377u2	WIAF-10143	HT2996	1416	PCCB, propionyl Coenzyme A	CACCTTTGTG[G/A]TGATACCAAC	M	G	A	G	D
				carboxylase, beta polypeptide
G380u1	WIAF-10122	HT3159	831	INSR, insulin receptor	TCTACCTGGA[C/T]GGCAGGTGTG	S	C	T	D	D
G380u2	WIAF-10126	HT3159	1698	INSR, insulin receptor	GGCAGGATGC[A/G]TGTGGTTCCA	S	A	G	A	A
G380u4	WIAF-11605	HT3159	2382	INSR, insulin receptor	GCGTGCCCAC[G/A]AGTCCGGAGG	S	G	A	T	T
G383u1	WIAF-10125	HT33546	3633	phospholipase C, beta 3, alt.	AGCAGCGGGC[G/A]AGGCTCCCCC	M	G	A	R	Q
				transcript 2
G385u1	WIAF-10141	HT3383	1505	PRCP, prolylcarboxypeptidase	ATGACAGTGC[A/G]GGAAAGCAGC	S	A	G	A	A
				(angiotensinase C)
G385u2	WIAF-10157	HT3383	1360	PRCP, prolylcarboxypeptidase	ATCACAGACA[C/G]TCTGGTTGCA	M	C	G	T	S
				(angiotensinase C)
G387u1	WIAF-11729	HT3439	2697	SREBF2, sterol regulatory element	CACTCTCCAG[G/C]AGCTCCGTGC	M	G	C	R	S
				binding transcription factor 2
G387u2	WIAF-11770	HT3439	1901	SREBF2, sterol regulatory element	GCTGCTGCCG[C/G]CAACCTACAA	M	C	G	A	G
				binding transcription factor 2
G388u1	WIAF-10270	HT3440	245	SELPLG, selectin P ligand	CTCCAGAAAT[G/A]CTGAGGAACA	M	G	A	M	I
G390u1	WIAF-10276	HT3568	2049	NOS3, nitric oxide synthase 3	TTGCTCGTGC[C/G]GTGGACACAC	S	C	G	A	A
				(endothelial cell)
G391u1	WIAF-10013	HT3630	6205	VWF, von Willebrand factor	AGGACCTGGA[G/C]GTGATTCTCC	M	G	C	E	D
G391u2	WIAF-10265	HT3630	4554	VWF, von Willebrand factor	GCCCCTGAGA[A/G]CAAGGCCTTC	M	A	G	N	S
G391u3	WIAF-10266	HT3630	7489	VWF, von Willebrand factor	TGGCCTCAAC[C/T]GCCACCAATG	S	C	T	T	T
G391u4	WIAF-10272	HT3630	2470	VWF, von Willebrand factor	ACTGTACCAT[G/A]AGTGGAGTCC	M	G	A	M	I
G391u5	WIAF-10273	HT3630	2615	VWF, von Willebrand factor	GCTCGAGTGT[A/G]CGAAAACGTG	M	A	G	T	A
G391u6	WIAF-10274	HT3630	2635	VWF, von Willebrand factor	GCCAGAACTA[T/C]GACCTGGAGT	S	T	C	Y	Y
G391u7	WIAF-10275	HT3630	4045	VWF, von Willebrand factor	TCTCGGAACC[C/A]CCGTTGCACG	S	G	A	P	P
G391u8	WIAF-10278	HT3630	4446	VWF, von Willebrand factor	AACTTTGTCC[G/A]CTACGTCCAG	M	G	A	R	H
G391u9	WIAF-10279	HT3630	5152	VWF, von Willebrand factor	GCCCTAATGC[C/T]AACGTGCAGG	S	C	T	A	A
G391u10	WIAF-10286	HT3630	3448	VWF, von Willebrand factor	TTACCAGTGA[C/T]GTCTTCCAGG	S	C	T	D	D
G391u11	WIAF-10287	HT3630	4891	VWF, von Willebrand factor	ACATGGTGAC[C/T]GTGGAGTACC	S	C	T	T	T
G391u12	WIAF-10288	HT3630	4805	VWF, von Willebrand factor	CAGGAGCAAG[G/A]AGTTCATGGA	M	G	A	E	K
G391u13	WIAF-10289	HT3630	4943	VWF, von Willebrand factor	CCTGCAGCGG[G/T[TGCGAGAGAT	M	G	T	V	L
G391u14	WIAF-10290	HT3630	4915	VWF, von Willebrand factor	TCAGCGAGGC[A/C]CAGTCCAAAG	S	A	C	A	A
G391a15	WIAF-10517	HT3630	6194	VWF, von Willebrand factor	AAACAAGGAG[C/T]AGGACCGGGA	N	C	T	Q	*
G391a16	WIAF-13222	HT3630	6419	VWF, von Willebrand factor	TCACCTTGGT[C/T]ACATCTTCAC	M	C	T	H	Y
G3941u1	WIAF-14123	HT3464	1265	mannosidase, alpha, lysosomal	CAGGTGTGCA[A/G]CCAGCTGGAG	M	A	G	N	S
G3941u2	WIAF-14135	HT3464	965	mannosidase, alpha, lysosomal	ACCAACCACA[C/T]TGTGATGACC	M	C	T	T	I
G395u1	WIAF-10271	HT4158	1627	ECE1, endothelin converting	TCACTGCCGA[T/C]CAGCTCAGGA	S	T	C	D	D
				enzyme 1
G395a2	WIAF-13110	HT4158	1493	ECE1, endothelin converting	CATCTACAAC[A/T]TGATAGGATA	M	A	T	M	L
				enzyme 1
G3959u1	WIAF-13634	HT4490	250	ADTB1, adaptin, beta 1 (beta	TGAAGAAGCT[G/A]GTATACCTCT	S	G	A	L	L
				prime)
G3959u2	WIAF-13640	HT4490	2029	ADTB1, adaptin, beta 1 (beta	TTCTTGGCGG[T/C]GGCCTTGACA	S	T	C	G	G
				prime)
G3959u3	WIAF-13641	HT4490	2395	ADTB1, adaptin, beta 1 (beta	AGGTCCACGC[G/A]CCACTCAGCC	S	G	A	A	A
				prime)
G3967u1	WIAF-13997	HT2958	918	ACTC, actin, alpha, cardiac	GAGGCACCAC[T/C]ATGTACCCTG	S	T	C	T	T
				muscle
G3968u1	WIAF-14159	HT1986	1747	ACTN3, actinin, alpha 3	CGAGGCTGAC[C/T]GAGAGCGAGG	N	C	T	R	*
G3968u2	WIAF-14164	HT1986	1900	ACTN3, actinin, alpha 3	GGTGCCCAGC[C/T]GTGACCAGAC	M	C	T	R	C
G3968u3	WIAF-14165	HT1986	2184	ACTN3, actinin, alpha 3	ACACCGTCTA[C/T]AGCATGGAGC	S	C	T	Y	Y
G3968u4	WIAF-14167	HT1986	2557	ACTN3, actinin, alpha 3	GATCTTGGCA[G/A]GAGACAAGAA	M	G	A	G	R
G3968u5	WIAF-14175	HT1986	1212	ACTN3, actinin, alpha 3	GGCTGCTCTC[G/A]GAGATCCGGC	S	G	A	S	S
G3979u1	WIAF-13884	HT0623	776	GPC1, glypican 1	TGCTGCTGCC[T/G]GATGACTACC	S	T	G	P	P
G3979u2	WIAF-13885	HT0623	680	GPC1, glypican 1	TGTACTACCG[C/T]GGTGCCAACC	S	C	T	R	R
G3979u3	WIAF-13886	HT0623	1361	GPC1, glypican 1	AGCTGGTCTC[T/C]GAAGCCAAGG	S	T	C	S	S
G3979u4	WIAF-13887	HT0623	1163	GPC1, glypican 1	AGAGTGTCAT[C/T]GGCAGCGTGC	S	C	T	I	I
G3979u5	WIAF-13888	HT0623	1670	GPC1, glypican 1	ACGCCAGTGA[C/T]GACGGCAGCG	S	C	T	D	D
G3979u6	WIAF-13905	HT0623	1069	GPC1, glypican 1	CTTGCCAACC[A/T]GGCCGACCTG	M	A	T	Q	L
G3979u7	WIAF-13906	HT0623	1514	GPC1, glypican 1	TCATGGGTGA[C/T]GGCCTGGCCA	S	C	T	D	D
G3979u8	WIAF-13907	HT0623	1720	GFC1, glypican 1	GACCTCTGCG[G/C]CCGGAAGGTC	M	G	C	G	A
G3979u9	WIAF-13908	HT0623	1676	GPC1, glypican 1	GTGACGACGG[C/T]AGCGGCTCGG	S	C	T	G	G
G3979u10	WIAF-13909	HT0623	1719	GPC1, glypican 1	TGACCTCTGC[G/A]GCCGGAAGGT	M	G	A	G	S
G399u1	WIAF-10102	HT48511	450	AQP3, aquaporin 3	TCTGGCACTT[T/C]GCCGACAACC	S	T	C	F	F
G399u2	WIAF-10111	HT48511	192	AQP3, aquaporin 3	GCTCCGTGGC[C/T]CAGGTTGTGC	S	C	T	A	A
G399u3	WIAF-10112	HT48511	165	AQP3, aquaporin 3	CCCTCATCCT[C/G]GTGATGTTTG	S	C	G	L	L
G3997u1	WIAF-13649	HT27682	473	MFAP2, microfibrillar-associated	TGTGTGCCCA[C/T]GAGGAGCTCC	S	C	T	H	H
				protein 2
G3997u2	WIAF-13650	HT27682	377	MFAP2, microfibrillar-associated	CCATACACAG[G/T]CCTTGGAAAC	M	G	T	R	S
				protein 2
G3997u3	WIAF-13876	HT27682	453	MFAP2, microfibrillar-associated	GGAGATCTGT[G/T]TTCGTACAGT	M	G	T	V	F
				protein 2
G4022u1	WIAF-14020	HT2426	240	TGM1, transglutaminase 1 (K	TGGCTGCTGT[T/C]CATGCCGAAA	M	T	C	S	P
				polypeptide epidermal type I,
				protein-glutamine-gamma-
				glutamyltransferase)
G4022u2	WIAF-14021	HT2426	371	TGM1, transglutaminase 1 (K	CCCGGGGCAG[C/T]GGTGTCAATG	S	C	T	S	S
				polypeptide epidermal type I,
				protein-glutamine-gamma-
				glutamyltransferase)
G4022u3	WIAF-14022	HT2426	506	TGM1, transglutaminase 1 (K	ACGAGCTGAT[A/G]GTGCGCCGCG	M	A	G	I	M
				polypeptide epidermal type I,
				protein-glutamine-gamma-
				glutamyltransferase)
G4022u4	WIAF-14031	HT2426	2491	TGM1, transglutaminase 1 (K	GCTGGAGGTG[A/T]CAGTCACTTA	M	A	T	D	V
				polypeptide epidermal type I,
				protein-glutamine-gamma-
				glutamyltransferase)
G4038u1	WIAF-13998	HT4211	411	LAMB3, laminin, beta 3 (nicein	GGTGGCAGTC[C/A]CAGAATGATG	S	C	A	S	S
				(125 kD), kalinin (140 kD), BM600
				(125 kD))
G4038u2	WIAF-13999	HT4211	258	LAMB3, laminin, beta 3 (nicein	CTTCATCTAC[C/T]TGTGGACTGA	S	C	T	T	T
				(125 kD), kalinin (140 kD), BM600
				(125 kD))
G4038u3	WIAF-14002	HT4211	1830	LAMB3, laminin, beta 3 (nicein	GAGGCTACTG[C/T]AATCGCTACC	S	C	T	C	C
				(125 kD), kalinin (140 kD), BM600
				(125 kD))
G4038u4	WIAF-14003	HT4211	2668	LAMB3, laminin, beta 3 (nicein	GACCAGGCAG[A/T]TGATTAGGGC	M	A	T	M	L
				(125 kD), kalinin (140 kD), BM600
				(125 kD))
G4038u5	WIAF-14018	HT4211	248	LAMB3, laminin, beta 3 (nicein	TTTCTCCGAG[C/T]TTCATCTACC	M	C	T	A	V
				(125 kD), kalinin (140 kD), BM600
				(125 kD))
G4038u6	WIAF-14019	HT4211	887	LAMB3, laminin, beta 3 (nicein	CACGGCCATG[C/T]TGATCGCTGC	M	C	T	A	V
				(125 kD), kalinin (140 kD), BM600
				(125 kD))
G4038u7	WIAF-14023	HT4211	1266	LAMB3, laminin, beta 3 (nicein	AGTGTGATCC[G/A]GATGGGGCAG	S	G	A	P	P
				(125 kD), kalinin (140 kD), BM600
				(125 kD))
G4038u8	WIAF-14025	HT4211	1693	LAMB3, laminin, beta 3 (nicein	CTATGGAGAC[G/A]TGGCCACAGG	M	G	A	V	M
				(125 kD), kalinin (140 kD), BM600
				(125 kD))
G4038u9	WIAF-14026	HT4211	1553	LAMB3, laminin, beta 3 (nicein	GGCTGTGAAC[C/T]GTGTGCCTGC	M	C	T	P	L
				(125 kD), kalinin (140 kD), BM600
				(125 kD))
G4038u10	WIAF-14029	HT4211	3562	LAMB3, laminin, beta 3 (nicein	CCTGACAGGA[C/T]TGGAGAAGCG	S	C	T	L	L
				(125 kD), kalinin (140 kD), BM600
				(125 kD))
G4038u11	WIAF-14030	HT4211	3546	LAMB3, laminin, beta 3 (nicein	TGCTGCGCTC[A/G]GCGGACCTGA	S	A	G	S	S
				(125 kD), kalinin (140 kD), BM600
				(125 kD))
G4045u1	WIAF-13571	HT0652	1266	adducin, beta subunit	TGGAGCAGGA[G/T]AAGCACCGGC	M	G	T	E	D
G4050u1	WIAF-14106	HT1466	1366	villin	CGTTTGGCAG[G/A]GCAGCCAGGC	M	G	A	G	S
G4050u2	WIAF-14107	HT1466	1468	villin	GGTCCCAATG[G/A]GCAAGGAGCC	M	G	A	G	S
G4050u3	WIAF-14108	HT1466	1932	villin	CCACAGAGAT[C/T]CCTGACTTCA	S	C	T	I	I
G4050u4	WIAF-14110	HT1466	2438	villin	TTTGGGATGA[C/T]TCCAGCTGCC	M	C	T	T	I
G4057u1	WIAF-13648	HT33633	371	CNN3, calponin 3, acidic	TTCAGGCTTA[T/C]GGTATGAAGC	S	T	C	Y	Y
G4066u1	WIAF-13676	HT4301	654	troponin T, beta, skeletal	AGATTGACAA[G/A]TTCGAGTTTG	S	G	A	K	K
G4066u2	WIAF-13677	HT4301	774	troponin T, beta, skeletal	GCAAAGTCGG[C/T]GGGCGCTGGA	S	C	T	G	G
G4066u3	WIAF-13708	HT4301	625	troponin T, beta, skeletal	GGAGCTCTGG[G/C]AGACCCTGCA	M	G	C	E	Q
G4080u1	WIAF-14142	HT1396	13130	HSPG2, heparan sulfate	GATTCTCCTC[G/A]GGCATCACAG	S	G	A	S	S
				proteoglycan 2 (perlecan)
G4080u2	WIAF-14150	HT1396	10340	HSPG2, heparan sulfate	TTGAGTTCCA[C/T]TGTGCTGTGC	S	C	T	H	H
				proteoglycan 2 (perlecan)
G4080u3	WIAF-14151	HT1396	12392	HSPG2, heparan sulfate	AATGCTATGA[T/C]AGCTCCCCAT	S	T	C	D	D
				proteoglycan 2 (perlecan)
G4080u4	WIAF-14152	HT1396	3416	HSPG2, heparan sulfate	TGGCTGTGCC[C/T]GAGGAAACCG	S	C	T	P	P
				proteoglycan 2 (perlecan)
G4080u5	WIAF-14154	HT1396	4588	HSPG2, heparan sulfate	GTGCCGCTGG[T/C]GGCCAGCATC	M	T	C	V	A
				proteoglycan 2 (perlecan)
G4080u6	WIAF-14156	HT1396	9582	HSPG2, heparan sulfate	GGACAGCCAC[G/A]CGGTGCTGCA	M	G	A	A	T
				proteoglycan 2 (perlecan)
G4096u1	WIAF-13890	HT4237	394	motor protein	CAAAGAAATC[G/A]ATTCAGTCGG	S	G	A	S	S
G4096u2	WIAF-13910	HT4237	455	motor protein	ATCTAAACAG[C/T]CTGCCTCACA	M	C	T	P	S
G4096u3	WIAF-13911	HT4237	1150	motor protein	CTAAGGTTGT[A/G]TCTCAGTATC	S	A	G	V	V
G4109u1	WIAF-14034	HT28223	1238	phosphoglucomutase-related protein	TACAGCGTGG[C/T]GAAGACGGAT	M	C	T	A	V
G4109u2	WIAF-14035	HT28223	1043	phosphoglucomutase-related protein	ATTATTGCTG[C/A]CCGGAAGCAG	M	C	A	A	D
G4112u1	WIAF-13615	HT4401	374	KIF5A, kinesin family member 5A	AGATGTCCTT[G/A]CTGGCTACAA	M	G	A	A	T
G4112u2	WIAF-13623	HT4401	2767	KIF5A, kinesin family member 5A	AGAGAGTTAA[G/T]GCCCTGGAGG	M	G	T	K	N
G4114u1	WIAF-14113	HT4160	830	fibrinogen-like protein pT49	AACTTCACCA[G/A]AACATGGCAA	M	G	A	R	K
G4118u1	WIAF-14010	HT0841	564	MYL5, myosin, light polypeptide	TCGATGTGGC[G/A]GGCAACCTGG	S	G	A	A	A
				5, regulatory
G4118u2	WIAF-14011	HT0841	368	MYL5, myosin, light polypeptide	TTCACCATGT[T/C]TCTGAACCTG	M	T	C	F	S
				5, regulatory
G4118u3	WIAF-14012	HT0841	533	MYL5, myosin, light polypeptide	GAGGTGGACC[A/G]GATGTTCCAG	M	A	G	Q	R
				5, regulatory
G4122u1	WIAF-13955	HT97538	161	myosin-I	TCGAGAACCT[A/G]CGGCGGCGAT	S	A	G	L	L
G4124u1	WIAF-13895	HT0925	1517	TGM3, transglutaminase 3 (E	TCGCTGGCAT[G/A]CTGGCAGTAG	M	G	A	M	I
				polypeptide, protein-glutamine-
				gamma-glutamyltransferase)
G4124u2	WIAF-13896	HT0925	1433	TGM3, transglutaminase 3 (E	AACCCAACAC[G/A]CCATTTGCCG	S	G	A	T	T
				polypeptide, protein-glutamine-
				gamma-glutamyltransferase)
G4126u1	WIAF-13830	HT2465	1039	myosin binding protein H	ACTCGTACTC]C/G]TTCCGGGTCT	S	C	G	S	S
G4126u2	WIAF-13853	HT2465	369	myosin binding protein H	AGAGAGGGAG[G/C]CTCGGACTGG	M	G	C	G	A
G4130u1	WIAF-13614	HT1657	198	CFL1, cofilin 1 (non-muscle)	CTGTCGACGA[T/C]CCCTACGCCA	S	T	C	D	D
G4138u1	WIAF-13598	HT33664	601	MAGP2: Microfibril-associated	GAAAGATGAG[C/T]TTTGCCGTCA	M	C	T	L	F
				glycoprotein-2
G4138u2	WIAF-13599	HT33664	405	MAGP2: Microfibril-associated	ATGACTTGGC[C/T]TCCCTCAGTG	S	C	T	A	A
				glycoprotein-2
G4138u3	WIAF-13600	HT33664	327	MAGP2: Microfibril-associated	AAGATCCTAA[T/C]CTGGTGAATG	S	T	C	N	N
				glycoprotein-2
G4159u1	WIAF-14048	HT3443	1119	SNL, singed (Drosophila)-like	GCTGCTACTT[T/C]GACATCGAGT	S	T	C	F	F
				(sea urchin fascin homolog like)
G4170u1	WIAF-13580	HT5069	1131	Golgi protein, peripheral,	GAAATATACC[A/G]TAAGTATGGA	M	A	G	I	V
				brefeldin A-sensitive
G4170u2	WIAF-13581	HT5069	930	Golgi protein, peripheral,	GTATAATAAA[C/T]TCCTGGAGTT	M	C	T	L	F
				brefeldin A-sensitive
G4170u3	WIAF-13582	HT5069	2312	Golgi protein, peripheral,	AGCACCCTTA[A/G]GCATCTTGGA	N	A	G	*	*
				brefeldin A-sensitive
G4170u4	WIAF-13596	HT5069	359	Golgi protein, peripheral,	TCAACCAGCT[T/G]TCTGTGCCTT	S	T	G	L	L
				brefeldin A-sensitive
G4170u5	WIAF-13597	HT5069	1007	Golgi protein, peripheral,	AAAAAGGCAA[T/A]ACTGTTCCTG	M	T	A	N	K
				brefeldin A-sensitive
G4171u1	WIAF-13688	HT1587	667	KIF5B, kinesin family member 5B	TTTTTAATTA[T/C]ATTTACTCCA	S	T	C	Y	Y
G4171u2	WIAF-13689	HT1587	1036	KIF5B, kinesin family member 5B	TTAGTAAAAC[T/C]GGAGCTGAAG	S	T	C	T	T
G4176u1	WIAF-14204	HT33754	130	TNR, tenascin R (restrictin,	GCTCATTGGC[G/A]TCAACCTGAT	M	G	A	V	I
				janusin)
G4176u2	WIAF-14205	HT33754	463	TNR, tenascin R (restrictin,	CTGTCCATGT[G/T]CCAGTTCAGC	M	G	T	A	S
				janusin)
G4176u3	WIAF-14206	HT33754	249	TNR, tenascin R (restrictin,	ACTACAACAC[G/A]TCCAGCAAAG	S	G	A	T	T
				janusin)
G4176u4	WIAF-14208	HT33754	2009	TNR, tenascin R (restrictin,	CTGGTCCCCA[G/A]GGGCATTGGT	M	G	A	R	K
				janusin)
G4176u5	WIAF-14209	HT33754	2175	TNR, tenascin R (restrictin,	CAGCCTCCTC[G/A]GAGACCTCCA	S	G	A	S	S
				janusin)
G4176u6	WIAF-14210	HT33754	3318	TNR, tenascin R (restrictin,	AATCCACCGA[C/T]GGAAGCCGCA	S	C	T	D	D
				janusin)
G4176u7	WIAF-14211	HT33754	3221	TNR, tenascin R (restrictin,	CCGGCAAACC[T/C]GACAGCCAGT	M	T	C	L	P
				janusin)
G4176u8	WIAF-14217	HT33754	1635	TNR, tenascin R (restrictin,	TCTCGGACAC[C/T]GTGGCTTTTG	S	C	T	T	T
				janusin)
G4178u1	WIAF-14138	HT0224	2827	ACTN2, actinin, alpha 2	GCTGCGTTCT[C/T]TTCCGCACTC	M	C	T	S	F
G4178u2	WIAF-14139	HT0224	2818	ACTN2, actinin, alpha 2	CTGGATTACG[C/T]TGCGTTCTCT	M	C	T	A	V
G418u1	WIAF-11750	L07594	2370	TGFBR3, transforming growth	GAGTGCACTT[C/T]CCTATCCCGC	S	C	T	F	F
				factor, beta receptor III
				(betaglycan, 300 kD)
G418u2	WIAF-11751	L07594	2586	TGFBR3, transforming growth	AGAAGACGTT[C/T]ACCAAGCCCC	S	C	T	F	F
				factor, beta receptor III
				(betaglycan, 300 kD)
G418u3	WIAF-11752	L07594	2671	TGFBR3, transforming growth	AATTTCTCCA[C/T]CAATTTTCCA	M	C	T	P	S
				factor, beta receptor III
				(betaglycan, 300 kD)
G418u4	WIAF-11771	L07594	438	TGFBR3, transforming growth	TGTGTGAACT[G/T]TCACCTGTCA	S	G	T	L	L
				factor, beta receptor III
				(betaglycan, 300 kD)
G418u5	WIAF-11744	L07594	392	TGFBR3, transforming growth	CTGATGAGCT[T/C]CTGTTTAGCC	M	T	C	F	S
				factor, beta receptor III
				(betaglycan, 300 kD)
G418u6	WIAF-11772	L07594	1470	TGFBR3, transforming growth	AGCTACGGAT[C/T]CTGCTGGACC	S	C	T	I	I
				factor, beta receptor III
				(betaglycan, 300 kD)
G418u7	WIAF-11773	L07594	1170	TGFBR3, transforming growth	TCTTGAAGTG[C/A]AAAAAGTCTG	N	C	A	C	*
				factor, beta receptor III
				(betaglycan, 300 kD)
G418u8	WIAF-11745	L07594	1463	TGFBR3, transforming growth	CCTCCTGAGC[T/C]ACGGATCCTG	M	T	C	L	P
				factor, beta receptor III
				(betaglycan, 300 kD)
G418u9	WIAF-11746	L07594	2211	TGFBR3, transforming growth	ATGTTGAGGT[A/G]TCTGTTACTA	S	A	G	V	V
				factor, beta receptor III
				(betaglycan, 300 kD)
G4181u1	WIAF-14207	HT2008	425	SPTBN1, spectrin, beta, non-	CTCTGCGCGG[C/T]TTTTTGAGCG	M	C	T	L	F
				erythrocytic 1
G4181u2	WIAF-14213	HT2008	3565	SPTBN1, spectrin, beta, non-	AGACAGCGAT[C/T]GCCTCGGAGG	S	C	T	I	I
				erythrocytic 1
G4181u3	WIAF-14218	HT2008	1258	SPTBN1, spectrin, beta, non-	ACCTTCTGGA[A/G]TGGATTGAAC	S	A	G	E	E
				erythrocytic 1
G4181u4	WIAF-14219	HT2008	1780	SPTBN1, spectrin, beta, non-	AGCTCGAGGC[C/T]GAGAATTACC	S	C	T	A	A
				erythrocytic 1
G4181u5	WIAF-14220	HT2008	3637	SPTBN1, spectrin, beta, non-	ACATCAAGAA[T/C]GAGATCGACA	S	T	C	N	N
				erythrocytic 1
64183u1	WIAF-13976	HT2640	404	TPM4, tropomyosin 4	CCAAGCACAT[T/C]GCGGAAGAGG	S	T	C	I	I
G4185u1	WIAF-13554	HT3451	257	MFAP1, microfibrillar-associated	AAGGCCAGAC[T/G]ATGCCCCTAT	M	T	G	Y	D
				protein 1
G4185u2	WIAF-13555	HT3451	1108	MFAP1, microfibrillar-associated	CCAACAAAGC[T/G]GTTAAGGGCA	S	T	G	A	A
				protein 1
G4185u3	WIAF-13570	HT3451	274	MFAP1, microfibrillar-associated	CTATGGAGTC[C/T]TCAGATGAGG	S	C	T	S	S
				protein 1
G4196u1	WIAF-13665	HT97558	941	NUP88, nucleoporin 88 kD	GGGTCCATTG[C/A]CCATGCATCT	M	C	A	A	D
G4196u2	WIAF-13666	HT97558	1092	NUP88, nucleoporin 88 kD	ATGACCACAC[G/A]TCAGAAAAGT	S	G	A	T	T
G4196u3	WIAF-13667	HT97558	1551	NUP88, nucleoporin 88 kD	TCCATCCAGC[G/A]TCTCCTCCCC	S	G	A	A	A
G4196u4	WIAF-13668	HT97558	2220	NUP88, nucleoporin 88 kD	AGGGTGAACA[T/C]ATAAGGGAAA	S	T	C	H	H
G4196u5	WIAF-13669	HT97558	2205	NUP88, nucleoporin 88 kD	CCATCCTGAA[A/G]GAGGAGGGTG	S	A	G	K	K
G4208u1	WIAF-13921	HT1122	1329	VCL, vinculin	TGATCCTAAA[G/C]AAAGAGATGA	M	G	C	E	Q
G4208u2	WIAF-13922	HT1122	2438	VCL, vinculin	CCATCTCCCC[A/G]ATGGTGATGG	S	A	G	P	P
G4208u3	WIAF-13941	HT1122	818	VCL, vinculin	GGGATGAAGA[T/C]GCCTGGGCCA	S	T	C	D	D
G4208u4	WIAF-13942	HT1122	1556	VCL, vinculin	AAGCACAGCG[G/A]TGGATTGATA	S	G	A	R	R
G4213u1	WIAF-13605	HT2813	163	NUP153, nucleoporin 153 kD	GCCAGGGTGG[T/C]TACAAAGATA	S	T	C	L	L
G4213u2	WIAF-13606	HT2813	742	NUP153, nucleoporin 153 kD	GAATTCTTCA[A/G]TCCTTAAAAC	M	A	G	I	V
G4213u3	WIAF-13609	HT2813	1800	NUP153, nucleoporin 153 kD	TTAGACCTGC[A/C]GAAATCCTGA	S	A	C	A	A
G4213u4	WIAF-13627	HT2813	1829	NUP153, nucleoporin 153 kD	AGTGTTCTAG[A/C]TATTCTGAAA	M	A	C	D	A
G4213u5	WIAF-13632	HT2813	3258	NUP153, nucleoporin 153 kD	CTTTTGGCAA[C/T]GTGGAGCCTG	S	C	T	N	N
G4213u6	WIAF-13635	HT2813	4162	NUP153, nucleoporin 153 kD	CTCTGGAACA[A/G]CTCCTAATTC	M	A	G	T	A
G4218u1	WIAF-13854	HT1681	1122	phosphatidyl-inositol glycan,	AACCTTATTA[T/C]TTTATGTGAG	M	T	C	I	T
				class A
G4223u1	WIAF-14160	HT1684	1434	CD36L2, CD36 antigen (collagen	ATTAGATGAC[T/C]TTGTTGAAAC	M	T	C	F	L
				type I receptor, thrombospondin
				receptor)-like 2 (lysosomal
				integral membrane protein II)
G4223u2	WIAF-14173	HT1684	696	CD36L2, CD36 antigen (collagen	GTGGTCCCAG[G/A]TGCACTTCCT	M	G	A	V	M
				type I receptor, thrombospondin
				receptor)-like 2 (lysosomal
				integral membrane protein II)
G4223u3	WIAF-14174	HT1684	986	CD36L2, CD36 antigen (collagen	CAGACAAGTG[C/T]AATATGATTA	S	C	T	C	C
				type I receptor, thrombospondin
				receptor)-like 2 (lysosomal
				integral membrane protein II)
G4223u4	WIAF-14176	HT1684	1437	CD36L2, CD36 antigen (collagen	AGATGACTTT[G/A]TTGAAACGGG	M	G	A	V	I
				type I receptor, thrombospondin
				receptor)-like 2 (lysosomal
				integral membrane protein II)
G4227u1	WIAF-14056	HT1929	912	proteoglycan 2	ATGCCTCCAA[G/A]AAAGATGGGG	S	G	A	K	K
G4227u2	WIAF-14057	HT1929	1254	proteoglycan 2	GGAACTTTGC[G/A]TACTGGGCTG	S	G	A	A	A
G4227u3	WIAF-14058	HT1929	1321	proteoglycan 2	CCGAGGAGGC[T/C]ACTGGCGTCG	M	T	C	Y	H
G4229u1	WIAF-13961	HT1689	74	SDC4, syndecan 4 (amphiglycan,	GCTGCTGCTG[T/C]TCTTCGTAGG	M	T	C	F	L
				ryudocan)
G4230u1	WIAF-13525	HT4995	602	TRAM protein	CCATAACCTG[A/C]TGACATTTCA	M	A	C	M	L
G4243u1	WIAF-14169	HT2901	406	KRT17, keratin 17	AGCTGGAGGT[G/A]AAGATCCGTG	S	G	A	V	V
G4243u2	WIAF-14170	HT2901	478	KRT17, keratin 17	ACAGGACAAT[T/C]GAGGAGCTGC	S	T	C	I	I
G4243u3	WIAF-14171	HT2901	389	KRT17, keratin 17	GGAGGAGGCC[A/G]ACACTGAGCT	M	A	G	N	D
G4243u4	WIAF-14178	HT2901	564	KRT17, keratin 17	CTGGCTGCTG[A/C]TGACTTCCGC	M	A	C	D	A
G4244u1	WIAF-14086	HT1056	386	clathrin, light polypeptide a	ATCGATTGCA[G/C]TCAGAGCCTG	M	G	C	Q	H
G4246u1	WIAF-14044	HT97492	259	SLN, sarcolipin	GTCCTATCAG[T/C]ACTGAGAGGC	M	T	C	Y	H
G4246u2	WIAF-14045	HT97492	189	SLN, sarcolipin	ACACCCGGGA[G/A]CTGTTTCTCA	S	G	A	E	E
G4254u1	WIAF-13546	HT3393	86	TNNI2, troponin I, skeletal, fast	ACCTGAAGAG[C/T]GTGATGCTGC	S	C	T	S	S
G4254u2	WIAF-13553	HT3393	530	TNNI2, troponin I, skeletal, fast	TCGAGGAGAA[G/C]TCTGGCATGG	M	G	C	K	N
G4255u1	WIAF-13644	HT2907	562	CRYAB, crystallin, alpha B	AGTTCCACAG[G/A]AAATACCGGA	S	G	A	R	R
G4255u2	WIAF-13645	HT2907	367	CRYAB, crystallin, alpha B	CCTCCTTCCT[G/A]CGGGCACCCA	S	G	A	L	L
G4255u3	WIAF-13872	HT2907	271	CRYAB, crystallin, alpha B	CCAGCCGCCT[C/T]TTTGACCAGT	S	C	T	L	L
G4255u4	WIAF-13873	HT2907	580	CRYAB, crystallin, alpha B	GGATCCCAGC[T/C]GATGTAGACC	S	T	C	A	A
G4257u1	WIAF-14052	HT1694	394	PIGF, phosphatidylinositol	TAGAGTTGGC[A/G]TTGGAAACAT	S	A	G	A	A
				glycan, class F
G4257u2	WIAF-14053	HT1694	252	PIGF, phosphatidylinositol	TATTTAGTAG[T/C]GAAACCAAAT	M	T	C	V	A
				glycan, class F
G4257u3	WIAF-14069	HT1694	291	PIGF, phosphatidylinositol	TCATTATCAC[A/G]CAAGGTAACT	M	A	G	H	R
				glycan, class F
G4264u1	WIAF-13519	HT0968	1720	TJP1, tight junction protein 1	CGGTCAGTGG[C/T]TTCCAGCCAG	M	C	T	A	V
				(zona occludens 1)
G4264u2	WIAF-13520	HT0968	2272	TJP1, tight junction protein 1	CATGCTGATG[A/G]TCACACACCT	M	A	G	D	G
				(zona occludens 1)
G4264u3	WIAF-13529	HT0968	5408	TJP1, tight junction protein 1	AGCCTCCTGA[A/T]GCTGATGGTG	M	A	T	E	D
				(zona occludens 1)
G434u1	WIAF-11748	M21121	286	SCYA5, small inducible cytokine	TACATCAACT[C/T]TTTGGAGATG	M	C	T	S	F
				A5 (RANTES)
G434u2	WIAF-11749	M21121	137	SCYA5, small inducible cytokine	GCTTTGCCTA[C/T]ATTGCCCGCC	S	C	T	Y	Y
				A5 (RANTES)
G435u1	WIAF-11741	M31933	754	FCGR2B, Fc fragment of IgG, low	GTCACTGGGA[T/C]TGCTGTAGCG	M	T	C	I	T
				affinity IIb, receptor for (CD32)
G435u2	WIAF-11743	M31933	395	FCGR2B, Fc fragment of IgG, low	GGGAGTACAC[G/A]TGCCAGACTG	S	G	A	T	T
				affinity IIb, receptor for (CD32)
G435u3	WIAF-11742	M31933	673	FCGR2B, Fc fragment of IgG, low	TACACGCTGT[T/A]CTCATCCAAG	M	T	A	F	Y
				affinity IIb, receptor for (CD32)
G4369u1	WIAF-13728	HT0900	1176	GBE1, glucan (1,4-alpha-),	TTACGTCCAT[G/A]CTTTATCATC	M	G	A	M	I
				branching enzyme 1 (glycogen
				branching enzyme, Andersen
				disease, glycogen storage disease
				type IV)
G4369u2	WIAF-13729	HT0900	1609	GBE1, glucan (1,4-alpha-),	GAGTGTCCTG[A/G]CTCCTTTTAC	M	A	G	T	A
				branching enzyme 1 (glycogen
				branching enzyme, Andersen
				disease, glycogen storage disease
				type IV)
G4373u1	WIAF-13559	HT0940	1117	HSD17B2, hydroxysteroid (17-beta)	GCCAGCAAGG[A/T]CTTCTCTCCG	M	A	T	D	V
				dehydrogenase 2
G4373u2	WIAF-13560	HT0940	1195	HSD17B2, hydroxysteroid (17-beta)	CCAGGGAAAG[G/A]CGCTTACTTG	M	G	A	G	D
				dehydrogenase 2
G438u1	WIAF-11830	M63121	583	TNFRSF1A, tumor necrosis factor	ACCGTGTGTG[G/A]CTGCAGGAAG	M	G	A	G	D
				receptor superfamily, member 1A
G438u2	WIAF-11790	M63121	618	TNFRSF1A, tumor necrosis factor	TTATTGGAGT[G/A]AAAACCTTTT	M	G	A	E	K
				receptor superfamily, member 1A
G440u1	WIAF-11806	M74447	261	TAP2, transporter 2, ABC (ATP	TGCTAAAGCT[A/G]AGAGGGCTGC	S	A	G	L	L
				binding cassette)
G440u2	WIAF-11807	M74447	2089	TAP2, transporter 2, ABC (ATP	CAGGCTGCAG[G/A]CAGTTCAGCG	M	G	A	A	T
				binding cassette)
G440u3	WIAF-11808	M74447	2155	TAP2, transporter 2, ABC (ATP	TGCCCAGCTC[C/T]AGGAGGGACA	N	C	T	Q	*
				binding cassette)
G440u4	WIAF-11818	M74447	1789	TAP2, transporter 2, ABC (ATP	GAACAACATT[G/A[CTTATGGGCT	M	G	A	A	T
				binding cassette)
G440u5	WIAF-11819	M74447	1565	TAP2, transporter 2, ABC (ATP	AAGGGGCTGA[C/T]GTTTACCCTA	M	C	T	T	M
				binding cassette)
G440u6	WIAF-11820	M74447	1254	TAP2, transporter 2, ABC (ATP	TGCACTTGGG[G/T]GTGCAGATGC	S	G	T	G	G
				binding cassette)
G440u7	WIAF-11788	M74447	1231	TAP2, transporter 2, ABC (ATP	GTACCTGCTC[A/G]TAAGGAGGGT	M	A	G	I	V
				binding cassette)
G440u8	WIAF-11821	M74447	1404	TAP2, transporter 2, ABC (ATP	TGCTCAGCAA[C/T]GTGGGAGCTG	S	C	T	N	N
				binding cassette)
G440u9	WIAF-11783	M74447	2187	TAP2, transporter 2, ABC (ATP	CCCGCCTGGT[T/G]CAGCAGCGGC	S	T	G	V	V
				binding cassette)
G440u10	WIAF-11786	M74447	1825	TAP2, transporter 2, ABC (ATP	TGATAAGGTG[A/G]TGGCGGCTGC	M	A	G	M	V
				binding cassette)
G4400u1	WIAF-14007	HT97396	839	A33	GCCAATCAAA[G/T]GAGGGCTCAC	M	G	T	K	N
G4404u1	WIAF-14013	HT1215	109	ACP2, acid phosphatase 2,	CCGCCCACCC[G/A]GGCCCGGAGT	M	G	A	R	Q
				lysosomal
G4404u2	WIAF-14016	HT1215	1271	ACP2, acid phosphatase 2,	ACCGCCACGT[C/T]GCAGATGGGG	S	C	T	V	V
				lysosomal
G4406u1	WIAF-13661	HT3564	872	ACPP, acid phosphatase, prostate	ACAAAAAACT[T/C]ATCATGTATT	S	T	C	L	L
G4406u2	WIAF-13662	HT3564	839	ACPP, acid phosphatase, prostate	ATCACATGAA[G/A]AGAGCAACTC	S	G	A	K	K
G4406u3	WIAF-13881	HT3564	741	ACPP, acid phosphatase, prostate	AGAATTGTCA[G/T]AATTGTCCCT	N	G	T	E	*
G441u1	WIAF-10166	M77349	698	TGFBI, transforming growth	GTGCCCGGCT[C/G]CTGAAAGCCG	S	C	G	L	L
				factor, beta-induced, 68 kD
G441u2	WIAF-10168	M77349	1028	TGFBI, transforming growth	GGCTGTCTGT[A/G]GAGACCCTGG	S	A	G	V	V
				factor, beta-induced, 68 kD
G441u3	WIAF-10169	M77349	1667	TGFBI, transforming growth	ACACAGTCTT[T/C]GCTCCCACAA	S	T	C	F	F
				factor, beta-induced, 68 kD
G441u4	WIAF-10171	M77349	1463	TGFBI, transforming growth	GTAATAGCCT[C/T]TGCATTGAGA	S	C	T	L	L
				factor, beta-induced, 68 kD
G4411u1	WIAF-14005	HT97468	492	acyl-CoA	GCTGACCAAT[A/G]AGGCCACCCT	M	A	G	K	E
G4411u2	WIAF-14008	HT97468	1076	acyl-CoA	TGCCCGAGAC[C/T]GAGGACGAGA	S	C	T	T	T
G4412u1	WIAF-13576	HT1882	657	ACADS, acyl-Coenzyme A	GCAAAACAAG[G/A]GCATCAGTGC	M	G	A	G	S
				dehydrogenase, C-2 to C-3 short
				chain
G4412u2	WIAF-13579	HT1882	1022	ACADS, acyl-Coenzyme A	TGACCTGGCG[C/T]GCTGCCATGC	S	C	T	R	R
				dehydrogenase, C-2 to C-3 short
				chain
G4415u1	WIAF-14080	HT2503	2170	acyl-Coenzyme A:cholesterol	TCATTATATT[C/T]GAGCAGATTC	S	C	T	F	F
				acyltransferase
G4415u2	WIAF-14081	HT2503	1993	acyl-Coenzyme A:cholesterol	TTTCAGTTCC[C/T]TATTTTCTGT	S	C	T	P	P
				acyltransferase
G4415u3	WIAF-14098	HT2503	2006	acyl-Coenzyme A:cholesterol	TTTTCTGTTT[C/G]AACATTGGCG	M	C	G	Q	E
				acyltransferase
G4415u4	WIAF-14101	HT2503	2365	acyl-Coenzyme A:cholesterol	GGGGTTATGT[C/T]GCTATGAAGT	S	C	T	V	V
				acyltransferase
G4417u1	WIAF-13819	HT0542	356	AOAH, acyloxyacyl hydrolase	TCCAGCCAAC[G/A]ATGACCAGTC	M	G	A	D	N
				(neutrophil)
G4417u2	WIAF-13820	HT0542	340	AOAH, acyloxyacyl hydrolase	TTCAGTCCTC[G/A]GCCTCTCCAG	S	G	A	S	S
				(neutrophil)
G4417u3	WIAF-13824	HT0542	1595	AOAH, acyloxyacyl hydrolase	GCTAAATAAA[G/A]ACATGACCTA	M	G	A	D	N
				(neutrophil)
G4417u4	WIAF-13841	HT0542	382	AOAH, acyloxyacyl hydrolase	CCAGCCTCTC[G/A]AATGGGCACA	S	G	A	S	S
				(neutrophil)
G4417u5	WIAF-13842	HT0542	458	AOAH, acyloxyacyl hydrolase	CAACTCGACG[G/A]TCCAGGCCTC	M	G	A	V	I
				(neutrophil)
G4417u6	WIAF-13843	HT0542	1201	AOAH, acyloxyacyl hydrolase	GATTTCTGGA[C/T]TCCACTGTTG	S	C	T	D	D
				(neutrophil)
G4417u7	WIAF-13844	HT0542	1321	AOAH, acyloxyacyl hydrolase	ACCTGAAGAA[A/G]TTTATAGAAA	S	A	G	K	K
				(neutrophil)
G4417u8	WIAF-13845	HT0542	1404	AOAH, acyloxyacyl hydrolase	GATGTCTGCA[G/A]TGGGAAGAGT	M	G	A	S	N
				(neutrophil)
G4417u9	WIAF-13846	HT0542	1759	AOAH, acyloxyacyl hydrolase	AATTTACAAA[C/T]TTCAATCTTT	S	C	T	N	N
				(neutrophil)
G4417u10	WIAF-13847	HT0542	1644	AOAH, acyloxyacyl hydrolase	CTCCAGGTCA[G/A]CCCCTGCCAC	M	G	A	S	N
				(neutrophil)
G442u1	WIAF-11828	M94582	933	IL8RA, interleukin 8 receptor,	CACATCGACC[G/A]GGCTCTGGAT	M	G	A	R	Q
				alpha
G442u2	WIAF-11829	M94582	721	IL8RA, interleukin 8 receptor,	TCATCGTGCC[A/G]CTGCTGATCA	S	A	G	P	P
				alpha
G442u3	WIAF-11780	M94582	1027	IL8RA, interleukin 8 receptor,	GCCATGGACT[C/T]CTCAAGATTC	S	C	T	L	L
				alpha
G442u4	WIAF-11792	M94582	78	IL8RA, interleukin 8 receptor,	ATGGAGAGTG[A/G]CAGCTTTGAA	M	A	G	D	G
				alpha
G4423u1	WIAF-13752	HT2216	71	ADSL, adenylosuccinate lyase	GCTATGCCAG[C/T]CCGGAGATGT	S	C	T	S	S
G4423u2	WIAF-13794	HT2216	126	ADSL, adenylosuccinate lyase	ATGGCGGCAG[C/T]TGTGGCTGTG	S	C	T	L	L
G4423u3	WIAF-13795	HT2216	674	ADSL, adenylosuccinate lyase	AGCTTGACAA[G/A]ATGGTGACAG	S	G	A	K	K
G4428u1	WIAF-13954	HT97524	57	ADFP, adipose differentiation-	TGGTCAACCT[G/A]CCCTTGGTGA	S	G	A	L	L
				related protein; adipophilin
G4434u1	WIAF-13506	HT0863	551	ARF3, ADP-ribosylation factor 3	TCTGGAGACA[C/T]TACTTCCAGA	S	C	T	H	H
G444u1	WIAF-10172	U28694	398	CCR3, chemokine (C-C motif)	CGAGATCTTT[T/G]TCATAATCCT	M	T	G	F	V
				receptor 3
G444u2	WIAF-10181	U28694	214	CCR3, chemokine (C-C motif)	TCCTCATAAA[A/G]TACAGGAGGC	S	A	G	K	K
				receptor 3
G4440u1	WIAF-14054	HT1392	136	ADRBK1, adrenergic, beta,	GCAAGAAGAT[A/C]CTGCTGCCCG	S	A	C	I	I
				receptor kinase 1
G445u1	WIAF-10183	U40373	319	Human cell surface glycoprotein	TAGAAGGGCA[C/T]GTGGTGATTC	S	C	T	H	H
				CD44, mRNA, complete cds.
G4456u1	WIAF-13629	HT0626	796	ALDOC, aldolase C, fructose-	CCCTGCTCAA[G/A]CCCAACATGG	S	G	A	K	K
				bisphosphate
G446u1	WIAF-11832	U64198	754	IL12RB2, interleukin 12 receptor,	TGAAGCCTTC[C/G]CATGTAATTT	S	C	G	S	S
				beta 2
G446u2	WIAF-11795	U64198	2569	IL12RB2, interleukin 12 receptor,	TTTTCTCAAC[G/A]CATTACTTCC	S	G	A	T	T
				beta 2
G446u3	WIAF-11833	U64198	2500	IL12RB2, interleukin 12 receptor,	TGCAAGGTAA[A/G]GCCAATTGGA	S	A	G	K	K
				beta 2
G446u4	WIAF-11835	U64198	1918	IL12RB2, interleukin 12 receptor,	CTCCTCGCCA[G/C]GTCTCTGCAA	M	G	C	Q	H
				beta 2
G446u5	WIAF-11793	U64198	991	IL12RB2, interleukin 12 receptor,	GTGGAGCAGA[G/A]ATCTTCGTTG	S	G	A	E	E
				beta 2
G446u6	WIAF-11794	U64198	2469	IL12RB2, interleukin 12 receptor,	AGTTCCCACG[G/C]AAATGAGAGG	M	G	C	G	A
				beta 2
G446a7	WIAF-13128	U64198	1964	IL12RB2, interleukin 12 receptor,	GGTGACTTGG[C/g]AGCCTCCCAG	M	C	g	Q	E
				beta 2
G446a8	WIAF-13129	U64198	2060	IL12RB2, interleukin 12 receptor,	TCTAAACTGG[C/G]TACGGAGTCG	M	C	G	L	V
				beta 2
G447u1	WIAF-11796	X03663	384	CSF1R, colony stimulating factor	CCAGTGTCCC[C/T]GAGCTGGTCG	S	C	T	P	P
				1 receptor, formerly McDonough
				feline sarcoma viral (v-fms)
				oncogene homolog
G447u2	WIAF-11836	X03663	1026	CSF1R, colony stimulating factor	ACAACAACAC[T/C]AAGCTCGCAA	S	T	C	T	T
				1 receptor, formerly McDonough
				feline sarcoma viral (v-fms)
				oncogene homolog
G447u3	WIAF-11837	X03663	886	CSF1R, colony stimulating factor	GCTGAAAGTG[C/A]AGAAAGTCAT	M	C	A	Q	K
				1 receptor, formerly McDonough
				feline sarcoma viral (v-fms)
				oncogene homolog
G447u4	WIAF-11797	X03663	2425	CSF1R, colony stimulating factor	GAAGAAATAT[G/A]TCCGCAGGGA	M	G	A	V	I
				1 receptor, formerly McDonough
				feline sarcoma viral (v-fms)
				oncogene homolog
G4473u1	WIAF-13904	HT1352	860	FUCA1, fucosidase, alpha-L-1,	TTCAAGCCAC[A/G]GAGCTTGCCA	M	A	G	Q	R
				tissue
G4473u2	WIAF-13916	HT1352	440	FUCA1, fucosidase, alpha-L-1,	ACAAACTGGC[C/T]GAGTCCTGTG	M	C	T	P	L
				tissue
G4479u1	WIAF-13637	HT1995	2465	AMPD2, adenosine monophosphate	GCCTCAATGA[G/T]CCTGGTCCAT	—	G	T	—	—
				deaminase 2 (isoform L)
G4479u2	WIAF-13866	HT1995	1258	AMPD2, adenosine monophosphate	TGGATGTGCA[T/C]GCGGACAGGA	S	T	C	H	H
				deaminase 2 (isoform L)
G4479u3	WIAF-13867	HT1995	1280	AMPD2, adenosine monophosphate	CACTTTCCAT[C/T]GCTTTGACAA	M	C	T	R	C
				deaminase 2 (isoform L)
G4479u4	WIAF-13868	HT1995	1201	AMPD2, adenosine monophosphate	TGCGGGAGGT[C/T]TTTGAGAGCA	S	C	T	V	V
				deaminase 2 (isoform L)
G4479u5	WIAF-13869	HT1995	1579	AMPD2, adenosine monophosphate	GTACCAAGGG[C/T]CAGCTGGCCA	S	C	T	G	G
				deaminase 2 (isoform L)
G4492u1	WIAF-14084	HT3390	866	ANX11, annexin XI (56 kD	CCTGGGGAGT[C/T[GCTCCAACAA	M	C	T	R	C
				autoantigen)
G4492u2	WIAF-14085	HT3390	850	ANX11, annexin XI (56 kD	AGGCCATCAT[T/C]GACTGCCTGG	S	T	C	I	I
				autoantigen)
G450u1	WIAF-10170	X85740	1196	CCR4, chemokine (C-C motif)	TCCAAATTTA[C/T]TCTGCTGACA	S	C	T	Y	Y
				receptor 4
G4502u1	WIAF-13510	HT4840	165	ASS, argininosuccinate synthetase	AAGGCTATGA[C/T]GTCATTGCCT	S	C	T	D	D
G4502u2	WIAF-13511	HT4840	369	ASS, argininosuccinate synthetase	GGCCCTGCAT[C/T]GCCCGCAAAC	S	C	T	I	I
G4502u3	WIAF-13512	HT4840	73	ASS, argininosuccinate synthetase	AATCCCAGAC[G/A]CTATGTCCAG	—	G	A	—	—
G4502u4	WIAF-13513	HT4840	129	ASS, argininosuccinate synthetase	TGGACACCTC[G/C]TGCATCCTCG	S	G	C	S	S
G4502u5	WIAF-13514	HT4840	285	ASS, argininosuccinate synthetase	AGTTTGTGGA[G/A]GAGTTCATCT	S	G	A	E	E
G4502u6	WIAF-13515	HT4840	234	ASS, argininosuccinate synthetase	AGGCACTGAA[G/A[CTTGGGGCCA	S	G	A	K	K
G4502u7	WIAF-13516	HT4840	316	ASS, argininosuccinate synthetase	CCAGTCCAGC[G/A]CACTGTATGA	M	G	A	A	T
G4502u8	WIAF-13537	HT4840	426	ASS, argininosuccinate synthetase	TGTCCCACGG[C/T]GCCACAGGAA	S	C	T	G	G
G4502u9	WIAF-13538	HT4840	530	ASS, argininosuccinate synthetase	GAATTCTACA[A/G]CCGGTTCAAG	M	A	G	N	S
G4502u10	WIAF-13539	HT4840	750	ASS, argininosuccinate synthetase	TTCTCGAGAT[C/T]GAGTTCAAAA	S	C	T	I	I
G4502u11	WIAF-13540	HT4840	960	ASS, argininosuccinate synthetase	ATGCTCATTT[A/G]GACATCGAGG	S	A	G	L	L
G4508u1	WIAF-13663	HT28557	1767	ARSD, arylsulfatase D	CAGTTTTCCA[T/C]GAGCAACATC	M	T	C	M	T
G4508u2	WIAF-13693	HT28557	433	ARSD, arylsulfatase D	TTCAGTGGAA[C/T]GCAGGCTCAG	S	C	T	N	N
G4508u3	WIAF-13694	HT28557	747	ARSD, arylsulfatase D	GGTTTCTTCT[C/G]TGTCTCCGCG	M	C	G	S	C
G4508u4	WIAF-13696	HT28557	1012	ARSD, arylsulfatase D	CCACGAGTGC[A/G]TTCCTGGGGA	S	A	G	A	A
G4508u5	WIAF-13697	HT28557	1302	ARSD, arylsulfatase D	CGAGTGATTG[G/A]AGAGCCCACG	M	G	A	G	E
G4508u6	WIAF-13698	HT28557	1285	ARSD, arylsulfatase D	GGGTGCTCCC[G/A]GCCGGCCGAG	S	G	A	P	P
G4508u7	WIAF-13699	HT28557	1807	ARSD, arylsulfatase D	AGCCGTGCTG[C/T]GGACATTTCC	S	C	T	C	C
G4508u8	WIAF-13718	HT28557	483	ARSD, arylsulfatase D	GCAAGAATCT[T/C]GCAGCAGCAT	M	T	C	L	S
G4518u1	WIAF-13809	HT3430	515	ASPA, aspartoacylase	ACAACACCAC[C/T]TCTAACATGG	S	C	T	T	T
				(aminoacylase 2, Canavan disease)
G4518u2	WIAF-13810	HT3430	851	ASPA, aspartoacylase	AAGTTGATTA[C/T]CCCCGGGATG	S	C	T	Y	Y
				(aminoacylase 2, Canavan disease)
G4518u3	WIAF-13811	HT3430	787	ASPA, aspartoacylase	CATCATTTCA[A/G]TGAAGGAAAA	M	A	G	N	S
				(aminoacylase 2, Canavan disease)
G4518u4	WIAF-13837	HT3430	618	ASPA, aspartoacylase	ACCCTGCTAC[G/A]TTTATCTGAT	M	G	A	V	I
				(aminoacylase 2, Canavan disease)
G452a1	WIAF-10509	HT0695	553	APOA4, apolipoprotein A-IV	ACCCAGGTCA[A/G]CACGCAGGCC	M	A	G	N	S
G452a2	WIAF-13124	HT0695	563	APOA4, apolipoprotein A-IV	ACACGCAGGC[C/T]GAGCAGCTGC	S	C	T	A	A
G4524u1	WIAF-14120	HT1541	726	ATP5A1, ATP synthase, H+	CTCAATTGCT[A/G]TTGACACAAT	M	A	G	I	V
				transporting, mitochondrial F1
				complex, alpha subunit, isoform 1,
				cardiac muscle
G4524u2	WIAF-14131	HT1541	153	ATP5A1, ATP synthase, H+	ATCTTTCATT[G/T]CTGCAAGGAA	M	G	T	A	S
				transporting, mitochondrial F1
				complex, alpha subunit, isoform 1,
				cardiac muscle
G4526u1	WIAF-14130	HT4994	400	ATPSD, ATP synthase, H+	TCCATCGCAG[T/C]GAACGCCGAC	M	T	C	V	A
				transporting, mitochondrial F1
				complex, delta subunit
G453u1	WIAF-10138	HT0768	1747	PDGFRB, platelet-derived growth	CTGCCGCCCA[C/T]GCTGCTGGGG	M	C	T	T	M
				factor receptor, beta polypeptide
G453u2	WIAF-10147	HT0768	2957	PDGFRB, platelet-derived growth	TTTTGCCTTT[A/G]AAGTGGATGG	S	A	G	L	L
				factor receptor, beta polypeptide
G453u3	WIAF-10148	HT0768	3608	PDGFRB, platelet-derived growth	AGCCGGAGCC[A/G]GAGCTGGAAC	S	A	G	P	P
				factor receptor, beta polypeptide
G453u4	WIAF-10149	HT0768	457	PDGFRB, platelet-derived growth	CAGGGCCTGG[T/G]CGTCACACCC	M	T	G	V	G
				factor receptor, beta polypeptide
G453u5	WIAF-10151	HT0768	1505	PDGFRB, platelet-derived growth	AGCTGACACT[G/C]GTTCGCGTGA	S	G	C	L	L
				factor receptor, beta polypeptide
G453u6	WIAF-10153	HT0768	3446	PDGFRB, platelet-derived growth	ACCCCAAACC[C/T]GAGGTTGCTG	S	C	T	P	P
				factor receptor, beta polypeptide
G453u7	WIAF-10161	HT0768	2030	PDGFRB, platelet-derived growth	TTTGGCAGAA[G/A]AAGCCACGTT	S	G	A	K	K
				factor receptor, beta polypeptide
G4533u1	WIAF-13616	HT1618	343	ATP synthase, H+ transporting,	GTTACATGAT[C/T]GACAACGTGA	S	C	T	I	I
				subunit D, vacuolar
G4534u1	WIAF-13569	HT3556	654	ATP6E, ATPase, H+ transporting,	TAAAGGTTTC[C/T]AACACCCTGG	S	C	T	S	S
				lysosomal (vaculoar proton pump)
				31 kD
G4535u1	WIAF-13747	HT27972	357	APT50, ATP synthase, H+	TCACTACCAA[C/T]CTGATCAATT	S	C	T	N	N
				transporting, mitochondrial F1
				complex, O subunit (oligomycin
				sensitivity conferring protein)
G4535u2	WIAF-13748	HT27972	144	APT50, ATP synthase, H+	AGGTATACGG[T/C]ATTGAAGGTC	S	T	C	G	G
				transporting, mitochondrial F1
				complex, O subunit (oligomycin
				sensitivity conferring protein)
G4535u3	WIAF-13792	HT27972	329	APT50, ATP synthase, H+	ATCACAGCAA[A/G]AGAGAGGTTC	M	A	G	K	R
				transporting, mitochondrial F1
				complex, O subunit (oligomycin
				sensitivity conferring protein)
G4539u1	WIAF-13711	HT48520	288	ATPase, 14 kDa subunit, vacuolar	TGCCCTGGAC[G/A]CCCACCAGCA	M	G	A	A	T
G4548u1	WIAF-14127	HT1574	3138	ATPase, Ca2+ transporting, plasma	CGCAATGTCT[T/C]TGACGGCATC	M	T	C	F	S
				membrane, isoform 2
G4548u2	WIAF-14137	HT1574	2089	ATPase, Ca2+ transporting, plasma	GCACTATCTG[C/T]GTGGCCTACC	S	C	T	C	C
				membrane, isoform 2
G4548u3	WIAF-14140	HT1574	2924	ATPase, Ca2+ transporting, plasma	CAGGACCATG[A/T]TGAAGAACAT	M	A	T	M	L
				membrane, isoform 2
G4549u1	WIAF-14161	HT1346	524	ATP2B4, ATPase, Ca++	TGCACTGACC[C/T]AGATTAATGT	N	C	T	Q	*
				transporting, plasma membrane 4
G4549u2	WIAF-14162	HT1346	715	ATP2B4, ATPase, Ca++	ATGTCACGCT[C/T]ATCATCCTGG	S	C	T	L	L
				transporting, plasma membrane 4
G4549u3	WIAF-14163	HT1346	508	ATP2B4, ATPase, Ca++	AGCTGCGTTC[G/A]AGGGATGCAC	S	G	A	S	S
				transporting, plasma membrane 4
G4549u4	WIAF-14166	HT1346	1084	ATP2B4, ATPase, Ca++	TGATCCAAGG[G/A]AATGATCTGA	S	G	A	G	G
				transporting, plasma membrane 4
G4552u1	WIAF-13630	HT0867	710	ATP7A, ATPase, Cu++ transporting,	TACTAGCACT[A/G]TTGAAGGAAA	M	A	G	I	V
				alpha polypeptide (Menkes
				syndrome)
G456u1	WIAF-10074	HT2834	408	EDN1, endothelin 1	CCTGGCGGCT[T/G]CGCCGGTCCA	S	T	G	L	L
G456u2	WIAF-10075	HT2834	585	EDN1, endothelin 1	CAGACCGTGA[A/G]AATAGATGCC	S	A	G	E	E
G456a3	WIAF-10507	HT2834	861	EDN1, endothelin 1	TGAAAGGCAA[T/G]CCCTCCAGAG	M	T	G	K	N
G4565u1	WIAF-14041	HT28561	320	ATP1G1, ATPase, Na+/K+	CGAGGCTGCT[G/A]TTACGGCTCA	S	G	A	L	L
				transporting, gamma 1 polypeptide
G4565u2	WIAF-14062	HT28561	216	ATP1G1, ATPase, Na+/K+	CAGTGACGGG[G/A]ACAAAGGTCT	M	G	A	D	N
				transporting, gamma 1 polypeptide
G4565u3	WIAF-14063	HT28561	315	ATP1G1, ATPase, Na+/K+	ACCGCCGAGG[C/A]TGCTGTTACG	M	C	A	L	M
				transporting, gamma 1 polypeptide
G4565u4	WIAF-14064	HT28561	531	ATP1G1, ATPase, Na+/K+	TTTCCCCAGG[T/C]GAATGGGCTG	N	T	C	*	R
				transporting, gamma 1 polypeptide
G4568u1	WIAF-14212	HT0082	717	AMFR, autocrine motility factor	TGCCTCATGC[A/G]TACGTCCCAC	M	A	G	I	V
				receptor
G457a1	WIAF-10489	HT2903	321	SELL, selectin L (lymphocyte	ACAAATCTCT[C/T]ACTGAAGAAG	S	C	T	L	L
				adhesion molecule 1)
G457a2	WIAF-10490	HT2903	577	SELL, selectin L (lymphocyte	CCAGTGTCAG[T/C]TTGTGATTCA	M	T	C	F	L
				adhesion molecule 1)
G457a3	WIAF-10491	HT2903	601	SELL, selectin L (lymphocyte	TGAGCCTTTG[G/C]AGGCCCCAGA	M	G	C	E	Q
				adhesion molecule 1)
G457a4	WIAF-10492	HT2903	637	SELL, selectin L (lymphocyte	CTGTACTCAC[C/T]CTTTGGGAAA	M	C	T	P	S
				adhesion molecule 1)
G4573u1	WIAF-13568	HT28320	943	MGAT2, mannosyl (alpha-1,6-)-	CGGACAACCT[G/T]ACGCTGCGGT	S	G	T	L	L
				glycoprotein beta-1,2-N-
				acetylglucosaminyltransferase
G4574u1	WIAF-13805	HT0198	163	beta-1,4 N-	CGGCCTCCGG[C/G]TACCTCTTGC	M	C	G	L	V
				acetylgalactosaminyltransferase
G4574u2	WIAF-13806	HT0198	415	beta-1,4 N-	TGCCACAAGA[G/A]AGCAGGAGTT	M	G	A	E	K
				acetylgalactosaminyltransferase
G4574u3	WIAF-13807	HT0198	726	beta-1,4 N-	AACTACAACT[G/T]GTCACTTACA	S	G	T	L	L
				acetylgalactosaminyltransferase
G4574u4	WIAF-13836	HT0198	559	beta-1,4 N-	AGGGCTGAGC[C/A]TTCAGGCAGC	M	C	A	L	I
				acetylgalactosaminyltransferase
G4575u1	WIAF-13626	HT0341	1251	GCNT1, glucosaminyl (N-acetyl)	AGTATGATCT[A/G]TCTGACATGC	S	A	G	L	L
				transferase 1, core 2 (beta-1,6-N-
				acetylglucosaminyltransferase)
G4577u1	WIAF-13971	HT1495	1268	SIAT1, sialyltransferase 1 (beta-	ATTTCTTTAA[C/T]AACTACAAGA	S	C	T	N	N
				galactoside alpha-2,6-
				sialytransferase)
G458u1	WIAF-10063	HT2968	1464	ALB, albumin	GTGCAGAAGA[C/A]TATCTATCCG	M	C	A	D	E
G458u2	WIAF-10089	HT2968	1470	ALB, albumin	AAGACTATCT[A/C]TCCGTGGTCC	S	A	C	L	L
G458u3	WIAF-10091	HT2968	1707	ALB, albumin	TTGTTGAGCT[C/T]GTGAAACACA	S	C	T	L	L
G458a4	WIAF-10504	HT2968	889	ALB, albumin	CAGGGCGGAC[C/T]TTGCCAAGTA	M	C	T	L	F
G458a5	WIAF-10508	HT2968	1475	ALB, albumin	TATCTATCCG[T/A]GGTCCTGAAC	M	T	A	V	E
G458a6	WIAF-12091	HT2968	1330	ALB, albumin	CCAGAATGCG[C/T]TATTAGTTCG	S	C	T	L	L
G458a7	WIAF-12092	HT2968	1408	ALB, albumin	CCTAGGAAAA[G/a]TGGGCAGCAA	M	G	a	V	M
G4592u1	WIAF-14126	HT2128	985	branched-chain keto acid	ACCAGCCCTT[T/C]CTCATCGAGG	S	T	C	F	F
				dehydrogenase E1, alpha
				polypeptide
G4593u1	WIAF-13574	HT97373	1743	BARD1, BRCA1 associated RING	GCTAGCCACT[G/C]CTCAGTAATG	M	G	C	C	S
				domain 1
G4593u2	WIAF-13592	HT97373	1167	BARD1, BRCA1 associated RING	TGTTCTTCAC[C/T]ACCTTCATGC	M	C	T	P	L
				domain 1
G4593u3	WIAF-13593	HT97373	1591	BARD1, BRCA1 associated RING	AGAATGGGCA[C/T]GTGGATATAG	S	C	T	H	H
				domain 1
G4593u4	WIAF-13594	HT97373	2030	BARD1, BRCA1 associated RING	AAAGTATGAA[A/G]TTCCTGAAGG	M	A	G	I	V
				domain 1
G4593u5	WIAF-13595	HT97373	2006	BARD1, BRCA1 associated RING	AAGAAAAGTA[T/C]GTGAACAGGA	M	T	C	C	R
				domain 1
G4599u1	WIAF-13920	HT4273	1803	CDH13, cadherin 13, H-cadherin	TCGTACCCGA[C/T]GTCTCCTACG	S	C	T	D	D
				(heart)
G4614u1	WIAF-13733	HT4835	91	S100A3, S100 calcium-binding	AGGATGGCCA[G/A]GCCTCTGGAG	M	G	A	R	K
				protein A3
G4614u2	WIAF-13734	HT4835	203	S100A3, S100 calcium-binding	TGCTGCAGAA[G/A]GAGCTGGCCA	S	G	A	K	K
				protein A3
G4614u3	WIAF-13769	HT4835	344	S100A3, S100 calcium-binding	TCTACTGCCA[C/T]GAGTACTTCA	S	C	T	H	H
				protein A3
G462u1	WIAF-10134	HT4753	600	PDGFA, platelet-derived growth	ACGGGGTCCA[C/T]GCCACTAAGC	S	C	T	H	H
				factor alpha polypeptide
G4627u1	WIAF-14042	HT0771	186	ANX6, annexin VI (p68)	GGAGGCCATA[C/T]TGGACATAAT	S	C	T	L	L
G4627u2	WIAF-14043	HT0771	1664	ANX6, annexin VI (p68)	CAGACACACC[T/C]AGTGGAGACA	S	T	C	P	P
G4627u3	WIAF-14067	HT0771	1498	ANX6, annexin VI (p68)	AAGGAGGACT[A/G]TCACAAGTCC	M	A	G	Y	C
G4644u1	WIAF-13801	HT1736	1990	CPS1, carbamoyl-phosphate	TGGTGGAGAA[G/A]TCAGTGACAG	S	G	A	K	K
				synthetase 1, mitochondrial
G4644u2	WIAF-13802	HT1736	1866	CPS1, carbamoyl-phosphate	ATTGGCTACC[C/T]AGTGATGATC	M	C	T	P	L
				synthetase 1, mitochondrial
G4644u3	WIAF-13803	HT1736	1993	CPS1, carbamoyl-phosphate	TGGAGAAGTC[A/C]GTGACAGGTT	S	A	C	S	S
				synthetase 1, mitochondrial
G4644u4	WIAF-13804	HT1736	1860	CPS1, carbamoyl-phosphate	GACACCATTG[G/A]CTACCCAGTG	M	G	A	G	D
				synthetase 1, mitochondrial
G4644u5	WIAF-13831	HT1736	1087	CPS1, carbamoyl-phosphate	AGCCTGTTTT[G/T]AATATCACAA	M	G	T	L	F
				synthetase 1, mitochondrial
G4644u6	WIAF-13835	HT1736	1958	CPS1, carbamoyl-phosphate	CACAAAGGCC[T/C]TTGCTATGAC	M	T	C	F	L
				synthetase 1, mitochondrial
G4644u7	WIAF-13855	HT1736	1332	CPS1, carbamoyl-phosphate	AAAGCTACCA[C/A]CATTACATCA	M	C	A	T	N
				synthetase 1, mitochondrial
G4659u1	WIAF-14143	HT1183	1830	catenin, alpha	GTGCCAACGT[T/C]CCTCAACCGT	S	T	C	V	V
G466u1	WIAF-10164	U00968	2403	SREBF1, sterol regulatory element	AGCAGTGCCC[G/A]CCAGGCCTGC	M	G	A	R	H
				binding transcription factor 1
G4662u1	WIAF-13710	HT2142	2183	CTNNB1, catenin (cadherin-	TTTTGTTCCG[A/C]ATGTCTGAGG	S	A	C	R	R
				associated protein), beta 1 (88 kD)
G467a1	WIAF-13304	X72861	827	ADRB3, adrenergic, beta-3-,	GGCCATCGCC[T/C]GGACTCCGAG	M	T	C	W	R
				receptor
G467a2	WIAF-13305	X72861	832	ADRB3, adrenergic, beta-3-,	TCGCCTGGAC[T/A]CCGAGACTCC	S	T	A	T	T
				receptor
G467a3	WIAF-13306	X72861	870	ADRB3, adrenergic, beta-3-,	TTCGTGACTT[C/T]GCTGGCCGCA	M	C	T	S	L
				receptor
G467a4	WIAF-13307	X72861	1761	ADRB3, adrenergic, beta-3-,	TGCGCCGCCG[C/T]CCGCCCGGCC	M	C	T	A	V
				receptor
G467a5	WIAF-13308	X72861	1899	ADRB3, adrenergic, beta-3-,	TCTGTTGATC[A/C]GAACCTGTGG	—	A	C	—	—
				receptor
G4671u1	WIAF-13956	HT1925	161	NDUFB7, NADH dehydrogenase	TGGTGGCCAC[A/G]CAGCAGGAGA	S	A	G	T	T
				(ubiquinone) 1 beta subcomplex, 7
				(18 kD, B18)
G4673u1	WIAF-13889	HT0191	1349	CDC25A, cell division cycle 25A	TCTGGGGCCA[G/C]CCCCAAAGAG	M	G	C	S	T
G4674u1	WIAF-13821	HT1393	261	CDC25B, cell division cycle 25B	ACGACCTCGC[C/T]GGGCTCGGCA	S	C	T	A	A
G4674u2	WIAF-13822	HT1393	1297	CDC25B, cell division cycle 25B	GATGGTGGCC[C/T]TATTGACGGG	S	C	T	L	L
G4674u3	WIAF-13823	HT1393	1083	CDC25B, cell division cycle 25B	ATAAGCGGAG[G/A]CGGAGCGTGA	S	G	A	R	R
G4674u4	WIAF-13827	HT1393	1446	CDC25B, cell division cycle 25B	AGAGCCCCAT[C/T]GCGCCCTGTA	S	C	T	I	I
G468a1	WIAF-13309	L37019	192	ASIP, agouti (mouse)-signaling	AAATCCAAAC[C/A]GATCGGCAGA	M	C	A	P	Q
				protein
G4691u1	WIAF-13753	HT97602	179	CMKBR9, chemokine (C-C motif)	TATAGCCTGA[T/A]TTTTGTGTTG	M	T	A	I	N
				receptor 9
G4691u2	WIAF-13754	HT97602	134	CMKBR9, chemokine (C-C motif)	AAGGATGCAG[T/C]GGTGTCCTTT	M	T	C	V	A
				receptor 9
G4691u3	WIAF-13755	HT97602	193	CMKBR9, chemokine (C-C motif)	TGTGTTGGGC[C/T]TCAGCGGGAA	M	C	T	L	F
				receptor 9
G4691u4	WIAF-13756	HT97602	770	CMKBR9, chemokine (C-C motif)	AAAATAGCTG[C/T]AGCCTTGGTG	M	C	T	A	V
				receptor 9
G4691u5	WIAF-13759	HT97602	1130	CMKBR9, chemokine (C-C motif)	TCTGAGAACT[A/C]CCCTAACAAG	M	A	C	Y	S
				receptor 9
G4691u6	WIAF-13796	HT97602	482	CMKBR9, chemokine (C-C motif)	AGGCTGAGGA[C/A]CCGGGCCAAG	M	C	A	T	N
				receptor 9
G4691u7	WIAF-13797	HT97602	259	CMKBR9, chemokine (C-C motif)	GATGGTTGAG[A/G]TCTATCTGCT	M	A	G	I	V
				receptor 9
G4691u8	WIAF-13798	HT97602	434	CMKBR9, chemokine (C-C motif)	ATGAGCCTGG[A/G]CAAGTACCTG	M	A	G	D	G
				receptor 9
G4691u9	WIAF-13799	HT97602	755	CMKBR9, chemokine (C-C motif)	CAGGGCCGGG[C/T]TTTAAAAATA	M	C	T	A	V
				receptor 9
G4699u1	WIAF-14040	HT4277	1426	BAAT, bile acid Coenzyme A: amino	TTCCAGATGT[G/T]ACCAGTCAAC	S	G	T	V	V
				acid N-acyltransferase (glycine N-
				choloyltransferase)
G4726u1	WIAF-14128	HT48614	1606	AOC3, amine oxidase, copper	TCCACCCCAG[T/C]GGGGCCATAG	S	T	C	S	S
				containing 3 (vascular adhesion
				protein 1)
G4726u2	WIAF-14129	HT48614	2242	AOC3, amine oxidase, copper	TTCCTAACAC[A/G]GTGACTGTGG	S	A	G	T	T
				containing 3 (vascular adhesion
				protein 1)
G4726u3	WIAF-14141	HT48614	659	AOC3, amine oxidase, copper	CCTGCCCTAT[C/T]ACCGACGCCC	M	C	T	H	Y
				containing 3 (vascular adhesion
				protein 1)
G4744u1	WIAF-13683	HT2599	564	CTH, cystathionase (cystathionine	ATATTGTCCA[T/C]AAGCATGGAG	S	T	C	H	H
				gamma-lyase)
G4748u1	WIAF-14144	HT1061	242	CYBA, cytochrome b-245, alpha	GGGACAGAAG[C/T]ACATGACCGC	M	C	T	H	Y
				polypeptide
G4748u2	WIAF-14145	HT1061	265	CYBA, cytochrome b-245, alpha	TGGTGAAGCT[G/C]TTCGGGCCCT	S	G	C	L	L
				polypeptide
G4750u1	WIAF-14116	HT48417	156	CYB5, cytochrome b-5	TGAAGTACTA[C/T]ACCCTAGAGG	S	C	T	Y	Y
G4751u1	WIAF-13770	HT1285	495	UQCRC2, ubiquinol-cytochrome c	AGAATTTCGT[C/A]GTTGGGAAGT	M	C	A	R	S
				reductase core protein II
G4788u1	WIAF-13931	HT28249	1864	DSC3, desmocollin 3	CTGTTGATCC[T/C]GATGAACCTG	S	T	C	R	P
G4788u2	WIAF-13933	HT28249	2000	DSC3, desmocollin 3	TGGATTTCAA[G/T]AATATACCAT	N	G	T	E	*
G4788u3	WIAF-13945	HT28249	2524	DSC3, desmocollin 3	ACACTTACTC[G/A]GAGTGGCACA	S	G	A	S	S
G479u1	WIAF-12567	U36310	894	GPD2, glycerol-3-phosphate	GGGAAAGTGC[A/G]TGTGAGCGGC	M	A	G	H	R
				dehydrogenase 2 (mitochondrial)
G479u2	WIAF-12574	U36310	1657	GPD2, glycerol-3-phosphate	CTGGCAAAAG[G/T]TGGCCTATTG	M	G	T	R	S
				dehydrogenase 2 (mitochondrial)
G479u3	WIAF-12575	U36310	1131	GPD2, glycerol-3-phosphate	GTTATTTTCT[T/C]CTTACCCTGG	M	T	C	F	S
				dehydrogenase 2 (mitochondrial)
G480u1	WIAF-12575	HT336	250	GRB2, growth factor receptor-	AATGAAACCA[C/A]ATCCGTGGTT	M	C	A	H	N
				bound protein 2
G4819u1	WIAF-13985	HT97576	1804	EYA1, eyes absent (Drosophila)	CCCTGCACCA[T/C]GCCTTGGAAC	S	T	C	H	H
				homolog 1
G482u1	WIAF-12181	J04501	1186	GYS1, glycogen synthase 1	CTGACGTCTT[T/C]CTGGAGGCAT	S	T	C	F	F
				(muscle)
G482u2	WIAF-12195	J04501	1406	GYS1, glycogen synthase 1	CCTTCCCGAC[A/G]TGAACAAGAT	M	A	G	M	V
				(muscle)
G4827u1	WIAF-14177	HT97477	68	elongation	CGAGCTGGCC[A/G]TGATGGTGAT	M	A	G	H	R
G483a1	WIAF-12113	HT4341	1850	GSY2	TTACCAGCAT[G/T]CCAGACACCT	M	G	T	A	S
G483u2	WIAF-12148	HT4341	1130	GSY2	GTTTTTCATT[A/C]TGCCTGCCAA	M	A	C	M	L
G483u3	WIAF-12149	HT4341	880	GSY2	GCTTGAATGT[T/G]AAGAAATTTT	S	T	G	V	V
G483u4	WIAF-12150	HT4341	1115	GSY2	CATCACAGTG[G/A]TGGTGTTTTT	M	G	A	V	M
G483u5	WIAF-12156	HT4341	1230	GSY2	GAAAAGTTTG[G/A]AAAAAAACTC	M	G	A	G	E
G483u6	WIAF-12159	HT4341	2033	GSY2	TGAGAGATAC[G/A]ATGAGGAAGA	M	G	A	D	N
G483u7	WIAF-12160	HT4341	1836	GSY2	TACTTAGGCA[G/C]ATATTACCAG	M	G	C	R	T
G483u8	WIAF-12161	HT4341	1678	GSY2	CTTACGGTAT[T/C]TACATCGTTG	S	T	C	I	I
G483u9	WIAF-12177	HT4341	790	GSY2	GCGCTCACGT[G/C]TTCACCACGG	S	G	C	V	V
G483u10	WIAF-12188	HT4341	1728	GSY2	TGCAATCAGC[T/C]GACTAAGTTT	M	T	C	L	P
G484u1	WIAF-12151	HT5111	487	GSY3	CATCAAAGTG[A/G]TTGGCAATGG	M	A	G	I	V
G484u2	WIAF-12187	HT5111	1141	GSY3	AACCCGGGAA[C/T]AAATCCGAGA	N	C	T	Q	*
G489u1	WIAF-12152	HT2607	1181	IRS1, insulin receptor substrate	AAGAAGTGGC[G/A]GCACAAGTCG	M	G	A	R	Q
				1
G489u2	WIAF-12184	HT2607	1031	IRS1, insulin receptor substrate	ATGGCGAGCC[C/T]TCCGGAGAGC	M	C	T	P	L
				1
G492a1	WIAF-13345	L08603	307	MC4R, melanocortin 4 receptor	AGAAACCATT[A/G]TCATCACCCT	M	A	G	I	V
G493u1	WIAF-12154	X67594	346	MC1R, melanocortin 1 receptor	CGCGCTGGTG[G/T]TGGCCACCAT	M	G	T	V	L
				(alpha melanocyte stimulating
				hormone receptor)
G493u2	WIAF-12167	X67594	646	MC1R, melanocortin 1 receptor	GACCCTGCCG[C/T]GGGCGCGGCA	M	C	T	R	W
				(alpha melanocyte stimulating
				hormone receptor)
G493u3	WIAF-12170	X67594	1110	MC1R, melanocortin 1 receptor	AGGTGCTGAC[A/G]TGCTCCTGGT	S	A	G	T	T
				(alpha melanocyte stimulating
				hormone receptor)
G493u4	WIAF-12186	X67594	442	MC1R, melanocortin 1 receptor	CGGGAGCAAC[G/T]TGCTGGAGAC	M	G	T	V	L
				(alpha melanocyte stimulating
				hormone receptor)
G498u1	WIAF-11809	J04127	1305	CYP19, cytochrome P450, subfamily	CTTATAGGTA[C/T]TTTCAGCCAT	S	C	T	Y	Y
				XIX (aromatization of androgens)
G498u2	WIAF-11810	J04127	1377	CYP19, cytochrome P450, subfamily	TGAAAGCCAT[C/T]CTCGTTACAC	S	C	T	I	I
				XIX (aromatization of androgens)
G498u3	WIAF-11811	J04127	1406	CYP19, cytochrome P450, subfamily	CGATTCCACG[T/C]GAAGACATTG	M	T	C	V	A
				XIX (aromatization of androgens)
G498u4	WIAF-11838	J04127	1055	CYP19, cytochrome P450, subfamily	ATTGGTGAGA[G/A]AGACATAAAG	M	G	A	R	K
				XIX (aromatization of androgens)
G498u5	WIAF-11800	J04127	1001	CYP19, cytochrome P450, subfamily	ATTGCAAAGC[A/G]CCCTAATGTT	M	A	G	H	R
				XIX (aromatization of androgens)
G499u1	WIAF-11785	HT1439	2142	ESR1, estrogen receptor 1	TCCCTGCCAC[A/G]GTCTGAGAGC	S	A	G	T	T
G499u2	WIAF-11801	HT1439	443	ESR1, estrogen receptor 1	CCCCTGAACC[G/A]TCCGCAGCTC	M	G	A	R	H
G500u1	WIAF-11803	X99101	793	ESR1, estrogen receptor 1	CATGATCAGC[T/C]GGGCCAAGAA	M	T	C	W	R
G500u2	WIAF-11816	X99101	489	ESR1, estrogen receptor 1	GGAAGTGTTA[C/T]GAAGTGGGAA	S	C	T	Y	Y
G500u3	WIAF-11817	X99101	474	ESR1, estrogen receptor 1	AGGCCTGCCG[A/G]CTTCGGAAGT	S	A	G	R	R
G505u1	WIAF-11824	HT1113	1063	PRLR, prolactin receptor	GCTTTGAAGG[G/A]CTATAGCATG	M	G	A	G	D
G505u2	WIAF-11827	HT1113	2083	PRLR, prolactin receptor	GCAACATCAA[G/A]CAAGTGCAGG	M	G	A	S	N
G505u3	WIAF-11787	HT1113	582	PRLR, prolactin receptor	GAGGACATAC[A/G]TCATGATGGT	M	A	G	I	V
G505u4	WIAF-11802	HT1113	792	PRLR, prolactin receptor	CCTGTATGAA[A/C]TTCGATTAAA	M	A	C	I	L
G509u1	WIAF-11789	M32313	378	SRD5A1, steroid-5-alpha-	CACTGTTGGC[A/G]TGTACAATGG	S	A	G	A	A
				reductase, alpha polypeptide 1 (3-
				oxo-5 alpha-steroid delta 4-
				dehydrogenase alpha 1)
G510a1	WIAF-13348	U17280	582	STAR, steroidogenic acute	CCAATGTCAA[G/A]GAGATCAAGG	S	G	A	K	K
				regulatory protein
G52u1	WIAF-10224	HT0488	1139	inhibin, beta B	CCAACATGAT[T/C]GTGGAGGAGT	S	T	C	I	I
G520u1	WIAF-13507	D31770	517	ACVR2, activin A receptor, type	CTTATTTTCC[G/A]GAGATGGAAG	S	G	A	P	P
				II
G520u2	WIAF-13532	D31770	1177	ACVR2, activin A receptor, type	CAGCTTGCAT[T/G]GCTGACTTTG	M	T	G	I	M
				II
G520u3	WIAF-13533	D31770	1189	ACVR2, activin A receptor, type	CTGACTTTGG[G/C]TTGGCCTTAA	S	G	C	G	G
				II
G520u4	WIAF-13534	D31770	1024	ACVR2, activin A receptor, type	TCTCTTGGAA[T/C]GAACTGTGTC	S	T	C	N	N
				II
G523u1	WIAF-12155	HT4996	538	OXTR, oxytocin receptor	TGAGCGGGAA[C/T]GCGTGTGTGC	S	C	T	N	N
G523u2	WIAF-12180	HT4996	1057	OXTR, oxytocin receptor	TCTGGCAGAA[C/T]TTGCGGCTCA	S	C	T	N	N
G524a1	WIAF-13349	L05144	190	PCK1, phosphoenolpyruvate	TGGACAGCCT[G/A]CCCCAGGCAG	S	G	A	L	L
				carboxykinase 1 (soluble)
G528u1	WIAF-11831	V00572	988	PGK1, phosphoglycerate kinase 1	AAGCCACTGT[G/C]GCTTCTGGCA	S	G	C	V	V
G53u1	WIAF-10307	HT0508	723	DNA repair protein XRCC1	CCAGCGACCC[G/A]GCAGGACCTA	S	G	A	P	P
G53u2	WIAF-10308	HT0508	746	DNA repair protein XRCC1	TATGCAGCTG[C/T]TACCCTCCAG	M	C	T	A	V
G53u3	WIAF-10309	HT0508	1884	DNA repair protein XRCC1	GGGATCCCAG[C/T]TTTGAGGAGG	S	C	T	S	S
G53u4	WIAF-10362	HT0508	425	DNA repair protein XRCC1	AACCCCAACC[G/A]CGTTCGCATG	M	G	A	R	H
G534a1	WIAF-13310	U28281	1284	SCTR, secretin receptor	GCTTCCTCAA[T/C]GGGGAGGTGC	S	T	C	N	N
G534a2	WIAF-13311	U28281	1404	SCTR, secretin receptor	AGCAGAGCCA[G/A]GGCACCTGCA	S	G	A	Q	Q
G535u1	WIAF-12157	HT5001	1158	SHC1	ATGCTCTTCG[G/C]GTGCCTCCAC	S	G	C	R	R
G535u2	WIAF-12196	HT5001	774	SHC1	ATGAGGAGGA[G/A]GAAGAGCCAC	S	G	A	E	E
G536u1	WIAF-13923	M20747	535	SLC2A4, solute carrier family 2	GCCTGGCCAA[C/T]GCTGCTGCCT	S	C	T	N	N
				(facilitated glucose transporter),
				member 4
G538u1	WIAF-11812	M55531	438	SLC2A5, solute carrier family 2	GCAGCAGAGT[C/T]GCCACATCAT	S	C	T	V	V
				(facilitated glucose transporter),
				member 5
G538u2	WIAF-11813	M55531	124	SLC2A5, solute carrier family 2	GACGCTTGTG[C/T]TTGCCCTGGC	M	C	T	L	F
				(facilitated glucose transporter),
				member 5
G538u3	WIAF-11791	M55531	816	SLC2A5, solute carrier family 2	ACAGGGAGGT[G/A]GCCGAGATCC	S	G	A	V	V
				(faciliatated glucose transporter),
				member 5
G539u1	WIAF-12158	K03195	224	Human (HepG2) glucose transporter	TCATGCTGGC[T/C]GTGGGAGGAG	S	T	C	A	A
				gene mRNA, complete cds.
G539u2	WIAF-12191	K03195	1244	Human (HepG2) glucose transporter	CCATCGCGCT[A/G]GCACTGCTGG	S	A	G	L	L
				gene mRNA, complete cds.
G540a1	WIAF-12114	HT960	1100	SOS1	AGTGAAGATC[A/C]AGAAGACAAG	M	A	C	Q	P
G540u2	WIAF-12165	HT960	933	SOS1	ATGATCGTTT[C/T]CTTAGTCAGT	S	C	T	F	F
G540u3	WIAF-12178	HT960	399	SOS1	TAGTAGCAGT[C/T]TTAGAATACA	S	C	T	V	V
G540u4	WIAF-12193	HT960	195	SOS1	CTCAGCCCCG[A/C]AGTGCTTCAG	S	A	C	R	R
G540u5	WIAF-12197	HT960	1329	SOS1	GTTGTAATGA[A/G]TTTATAATGG	S	A	G	E	E
G540u6	WIAF-12198	HT960	1339	SOS1	ATTTATAATG[G/A]AAGGAACTCT	M	G	A	E	K
G543a1	WIAF-13312	J00306	1373	SST, somatostatin	AAGCAGGAAC[T/C]GGCCAAGTAC	M	T	C	L	P
G543a2	WIAF-13313	J00306	1603	SST, somatostatin	AGTATTGTCC[A/G]TATCAGACCT	—	A	G	—	—
G544u1	WIAF-12174	HT27489	982	SUR, sulfonylurea receptor	CCATTGACAT[G/C]GCCACGGAAA	M	G	C	M	I
				(hyperinsulinemia)
G546u1	WIAF-13618	HT225	426	TKT, transketolase (Wernicke-	GCTACATTGC[C/T]GAGCAGAACA	S	C	T	A	A
				Korsakoff syndrome)
G551u1	WIAF-11709	HT1118	257	TNFRSF1B, tumor necrosis factor	GCTGCAGCAA[A/G]TGCTCGCCGG	S	A	G	K	K
				receptor superfamily, member 1B
G551u2	WIAF-11710	HT1118	449	TNFRSF1B, tumor necrosis factor	TCTGCACCTG[C/T]AGGCCCGGCT	S	C	T	C	C
				receptor superfamily, member 1B
G551u3	WIAF-11719	HT1118	648	TNFRSF1B, tumor necrosis factor	GATCTGTAAC[G/A]TGGTGGCCAT	M	G	A	V	M
				receptor superfamily, member 1B
G551u4	WIAF-11673	HT1118	676	TNFRSF1B, tumor necrosis factor	AATGCAAGCA[T/G]GGATGCAGTC	M	T	G	M	R
				receptor superfamily, member 1B
G551u5	WIAF-11720	HT1118	808	TNFRSF1B, tumor necrosis factor	CCAAGCACCT[C/T]CTTCCTGCTC	M	C	T	S	F
				receptor superfamily, member 1B
G552u1	WIAF-12229	HT5108	384	TRAP3	GCCGCTGCCC[G/A]CTCATGCTGA	S	G	A	P	P
G555u1	WIAF-12211	U94592	478	UCP2, uncoupling protein 2	CGCGCTACAG[T/C]CAGCGCCCAG	M	T	C	V	A
				(mitochondrial, proton carrier)
G556u1	WIAF-11804	AF001787	480	UCP2, uncoupling protein 2	TCGGCCTCTA[T/C]GACTCCGTCA	S	T	C	Y	Y
				(mitochondrial, proton carrier)
G556u2	WIAF-11805	AF001787	563	UCP2, uncoupling protein 2	TGCACCACAG[G/A]AGCCATGGCG	M	G	A	G	E
				(mitochondrial, proton carrier)
G556u3	WIAF-11823	AF001787	1113	UCP2, uncoupling protein 2	TACGGGAATC[A/G]CCGTTTTGAA	S	A	G	S	S
				(mitochondrial, proton carrier)
G556u4	WIAF-11782	AF001787	386	UCP2, uncoupling protein 2	ATCCTGACCA[T/C]GGTGCGGACT	M	T	C	M	T
				(mitochondrial, proton carrier)
G561a1	WIAF-12111	HT1176	2430	IDE, insulin-degrading enzyme	ACTGTGGCAT[C/A]GAGATATACT	S	C	A	I	I
G561u2	WIAF-12222	HT1176	3099	IDE, insulin-degrading enzyme	ATATTAACTT[C/G]ATGGCTGCAA	M	C	G	F	L
G562u1	WIAF-12223	HT27503	680	tumor necrosis factor receptor	CCTGTAGTGA[A/C]TCGGCCGCTG	M	A	C	N	T
				type 1 associated protein
G562u2	WIAF-12224	HT27503	900	tumor necrosis factor receptor	CGCTGCAGCG[C/A]CTGGTGGAGG	S	C	A	R	R
				type 1 associated protein
G573u1	WIAF-12199	HT28094	469	SSTR1, somatostatin receptor 1	GGACCGCTAC[G/C]TGGCCGTGGT	M	G	C	V	L
G573u2	WIAF-12208	HT28094	480	SSTR1, somatostatin receptor 1	TGGCCGTGGT[G/A]CATCCCATCA	S	G	A	V	V
G573u3	WIAF-12209	HT28094	879	SSTR1, somatostatin receptor 1	TGCAGCTGGT[T/C]AACGTGTTTG	S	T	C	V	V
G574u1	WIAF-11822	HT4058	1054	SSTR5, somatostatin receptor 5	GCCACGGAGC[C/T]GCGTCCAGAC	M	C	T	P	L
G575u1	WIAF-12200	HT28095	99	SSTR3, somatostatin receptor 3	ACGTGTCGGC[G/A]GGCCCAAGCC	S	G	A	A	A
G575u2	WIAF-12217	HT28095	453	SSTR3, somatostatin receptor 3	CCACCGCTC[G/A]GCCCGCTGGC	S	G	A	S	S
G585u1	WIAF-12204	HT1022	1133	PYGL, phosphorylase, glycogen;	AGCTGAATGA[T/C]ACTCACCCTC	S	T	C	D	D
				liver (Hers disease, glycogen
				storage disease type VI)
G585u2	WIAF-12205	HT1022	1988	PYGL, phosphorylase, glycogen;	AGCTGATCAC[T/C]TCAGTGGCAG	S	T	C	T	T
				liver (Hers disease, glycogen
				storage disease type VI)
G585u3	WIAF-12225	HT1022	1883	PYGL, phosphorylase, glycogen;	TGTACAACCG[C/T]ATTAAGAAAG	S	C	T	R	R
				liver (Hers disease, glycogen
				storage disease type VI)
G585u4	WIAF-12226	HT1022	2037	PYGL, phosphorylase, glycogen;	AAGCAAGTTG[A/G]AAGTCATCTT	M	A	G	K	E
				liver (Hers disease, glycogen
				storage disease type VI)
G585u5	WIAF-12231	HT1022	1387	PYGL, phosphorylase, glycogen;	GATGTGGACC[C/G]TCTGAGAAGG	M	C	G	P	R
				liver (Hers disease, glycogen
				storage disease type VI)
G586a1	WIAF-12112	HT1878	2410	PFKM, phosphofructokinase, muscle	CCGGGGAAGC[T/G]GCCGTCTAAA	S	T	G	A	A
G586u2	WIAF-12206	HT1878	375	PFKM, phosphofructokinase, muscle	GGACGACTCC[G/A[AGCTGCCTAC	M	G	A	R	Q
G586u3	WIAF-12207	HT1878	322	PFKM, phosphofructokinase, muscle	TGGGAGGCAC[G/A]GTGATTGGAA	S	G	A	T	T
G586u4	WIAF-12227	HT1878	334	PFKM, phosphofructokinase, muscle	TGATTGGAAG[T/C]GCCCGGTGCA	S	T	C	S	S
G586u5	WIAF-12228	HT1878	408	PFKM, phosphofructokinase, muscle	CGTGGGATCA[C/G]CAATCTCTGT	M	C	G	T	S
G586u6	WIAF-12235	HT1878	717	PFKM, phosphofructokinase, muscle	CACGTGGAT[A/G]CCTGGCCCTT	M	A	G	Y	C
G587u1	WIAF-12615	HT3847	366	phosphofructokinase, liver	ATGGCAGCCT[T/C]ACAGGTGCCA	S	T	C	L	L
G589u1	WIAF-12210	L39211	1327	CPT1A, carnitine	CAGCGTTCTT[C/T]GTGACGTTAG	S	C	T	F	F
				palmitoyltransferase I, liver
G589u2	WIAF-12215	L39211	2080	CPT1A, carnitine	AATATCTCGC[T/C]GTGGAGTCCC	S	T	C	A	A
				palmitoyltransferase I, liver
G589u3	WIAF-12216	L39211	679	CPT1A, carnitine	ACTTCAAACG[G/T]ATGACAGCAC	S	G	T	R	R
				palmitoyltransferase I, liver
G589u4	WIAF-12218	L39211	1844	CPT1A, carnitine	CCTCACATAC[G/C]AGGCCTCCAT	M	G	C	E	Q
				palmitoyltransferase I, liver
G592u1	WIAF-11814	X96586	1089	NSMAF, neutral sphingomyelinase	TCCGGGATCT[C/T]AGTAAGCCAG	S	C	T	L	L
				(N-SMase) activation asociated
				factor
G592u2	WIAF-11815	X96586	2020	NSMAF, neutral sphingomyelinase	AAGTATATCA[T/G]TTTCAAATAT	M	T	G	F	V
				(N-SMase) activation asociated
				factor
G592u3	WIAF-11834	X96586	1673	NSMAF, neutral sphingomyelinase	GTAGCCATGC[T/C]TACGCAAATC	M	T	C	L	P
				(N-SMase) activation asociated
				factor
G592u4	WIAF-11784	X96586	1889	NSMAF, neutral sphingomyelinase	CACGAGCACT[A/G]TAAAATCCAC	M	A	G	Y	C
				(N-SMase) activation asociated
				factor
G592u5	WIAF-11798	X96586	1677	NSMAF, neutral sphingomyelinase	CCATGCTTAC[G/A]CAAATCTTGG	S	G	A	T	T
				(N-SMase) activation associated
				factor
G592u6	WIAF-11799	X96586	2429	NSMAF, neutral sphingomyelinase	TGCCATTCAG[G/C]GATTGTATGT	M	G	C	G	A
				(N-SMase) activation associated
				factor
G592a7	WIAF-13156	X96586	2205	NSMAF, neutral sphingomyelinase	ATTCTGCATC[G/A]TGGGACTCTA	S	G	A	S	S
				(N-SMase) activation associated
				factor
G594u1	WIAF-10065	HT3921	1153	annexin V, alt. transcript 2	TTGTGAAATC[T/A]ATTCGAAGTA	S	T	A	S	S
G594u2	WIAF-10098	HT3921	567	annexin V, alt. transcript 2	CGAAGTAATG[C/T]TCAGCGCCAG	M	C	T	A	V
G594u3	WIAF-10099	HT3921	774	annexin V, alt. transcript 2	ATTGCTTCAA[G/C]GACACCTGAA	M	G	C	R	T
G594a4	WIAF-10505	HT3921	424	annexin V, alt. transcript 2	GAGTAGTCGC[C/T]ATGGCACAGG	—	C	T	—	—
G594a5	WIAF-13123	HT3921	571	annexin V, alt. transcript 2	GTAATGCTCA[G/C]CGCCAGGAAA	M	G	C	Q	H
G595u1	WIAF-12203	HT27983	1008	NRIP1, nuclear receptor	TGCAAGATTA[C/T]AGGCTGTTGC	N	C	T	Q	*
				interacting protein 1
G595u2	WIAF-12220	HT27983	785	NRIP1, nuclear receptor	CCCTCAGTCA[T/C]GATTCTTTAA	S	T	C	H	H
				interacting protein 1
G595u3	WIAF-12232	HT27983	1231	NRIP1, nuclear receptor	GTTGGCAGTT[A/T]CCAGCTCCCA	M	A	T	Y	F
				interacting protein 1
G595u4	WIAF-12261	HT27983	2048	NRIP1, nuclear receptor	GCAGTACTCA[G/A]TCTGAAAAGC	S	G	A	Q	Q
				interacting protein 1
G595u5	WIAF-12274	HT27983	2376	NRIP1, nuclear receptor	TCCTGAACCA[G/T]GGCTTTCTGG	M	G	T	G	W
				interacting protein 1
G595u6	WIAF-12275	HT27983	3498	NRIP1, nuclear receptor	ACTATATTAC[A/G]TGCTTCAAAA	M	A	G	M	V
				interacting protein 1
G595u7	WIAF-12276	HT27983	3671	NRIP1, nuclear receptor	ACAATAGCCA[T/C]ATGGGAAATA	S	T	C	H	H
				interacting protein 1
G595u8	WIAF-12294	HT27983	2020	NRIP1, nuclear receptor	ATCAAATGGA[A/G]TTCCCCACCA	M	A	G	N	S
				interacting protein 1
G595u9	WIAF-12295	HT27983	3140	NRIP1, nuclear receptor	ATTTGTCCCC[G/A]CACAGAAGTA	S	G	A	P	P
				interacting protein 1
G596u1	WIAF-10144	HT3537	3299	PC, pyruvate carboxylase	TGCGGTCCAT[C/T]TTGGTCAAGG	S	C	T	I	I
G596u2	WIAF-10158	HT3537	2662	PC, pyruvate carboxylase	ACCAACCTGC[A/C]CTTCCAGGCC	M	A	C	H	P
G596u3	WIAF-10159	HT3537	2156	PC, pyruvate carboxylase	CCATCTCATA[C/A]ACGGGCGACG	N	C	A	Y	*
G598a1	WIAF-12118	HT48666	5585	HERC1, hect (homologous to the E6	GGGACCTATG[C/T]TGATAAACTG	M	C	T	A	V
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u2	WIAF-12236	HT48666	4456	HERC1, hect (homologous to the E6	CCTGTTAATA[T/C]TAGGAGTAAG	S	T	C	L	L
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u3	WIAF-12237	HT48666	6356	HERC1, hect (homologous to the E6	GGTAATGAAG[G/T]CACGTGTGTT	M	G	T	G	V
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u4	WIAF-12240	HT48666	12219	HERC1, hect (homologous to the E6	GTACCTTTGT[C/T]ATCCAGGCCA	S	C	T	V	V
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u5	WIAF-12241	HT48666	12480	HERC1, hect (homologous to the E6	CCAGGCAGAT[C/G]GAGGCCTTAC	M	C	G	I	M
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u6	WIAF-12244	HT48666	12975	HERC1, hect (homologous to the E6	GAGTAATCAT[T/A]GAAGATGTGG	S	T	A	I	I
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u7	WIAF-12245	HT48666	1424	HERC1, hect (homologous to the E6	TCCAATAATC[A/T]GTCAACTTTA	M	A	T	Q	L
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u8	WIAF-12250	HT48666	5854	HERC1, hect (homologous to the E6	TTCAAAGCA[A/T]TTCAATCAAA	M	A	T	I	F
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u9	WIAF-12251	HT48666	6754	HERC1, hect (homologous to the E6	TATTCAGCTC[G/A]TCCGTATCCT	M	G	A	V	I
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u10	WIAF-12252	HT48666	7635	HERC1, hect (homologous to the E6	ATCTTTACCT[C/T]GGTGCTATGA	S	C	T	L	L
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u11	WIAF-12254	HT48666	9189	HERC1, hect (homologous to the E6	GTGGAAATCC[A/G]TACTACCTGT	S	A	G	P	P
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u12	WIAF-12255	HT48666	10119	HERC1, hect (homologous to the E6	TTGTGGCATT[G/C]CTAGCAGACA	M	G	C	L	F
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u13	WIAF-12257	HT48666	11109	HERC1, hect (homologous to the E6	ATCCATCTAT[T/C]GTAAATGGCA	S	T	C	I	I
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u14	WIAF-12258	HT48666	13513	HERC1, hect (homologous to the E6	CTATGGACCT[C/T]AGATAACTGT	N	C	T	Q	*
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u15	WIAF-12259	HT48666	13697	HERC1, hect (homologous to the E6	ACCATCACAG[A/G]GATGTGCCAG	M	A	G	E	G
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u16	WIAF-12265	HT48666	1098	HERC1, hect (homologous to the E6	CCCTTTACGA[G/A]GCAGCATTAT	S	G	A	E	E
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u17	WIAF-12272	HT48666	6079	HERC1, hect (homologous to the E6	TATGTGGGAG[A/G]CACCCATTGC	M	A	G	T	A
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u18	WIAF-12273	HT48666	9551	HERC1, hect (homologous to the E6	AAGAGCTCCT[C/T]TGGGAGAATA	M	C	T	S	F
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u19	WIAF-12277	HT48666	666	HERC1, hect (homologous to the E6	GTCTTTGCAA[C/T]GATGTCATTC	S	C	T	N	N
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u20	WIAF-12278	HT48666	882	HERC1, hect (homologous to the E6	GCTCATTGCG[A/G]TATCTTCTTG	S	A	G	R	R
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u21	WIAF-12279	HT48666	893	HERC1, hect (homologous to the E6	TATCTTCTTG[A/T]ATGGATAGAA	M	A	T	E	V
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u22	WIAF-12280	HT48666	13276	HERC1, hect (homologous to the E6	AGAAGTCAGC[A/G]TTCACACGGT	M	A	G	I	V
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u23	WIAF-12283	HT48666	6519	HERC1, hect (homologous to the E6	CCTGTGTGTT[A/T]GACATGGAAG	M	A	T	L	F
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u24	WIAF-12284	HT48666	8386	HERC1, hect (homologous to the E6	GGGGTTCTCT[C/T]TTCGGCAGAT	M	C	T	L	F
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u25	WIAF-12286	HT48666	10266	HERC1, hect (homologous to the E6	CAGCTCAGCA[A/T]CTCGTGCGCA	M	A	T	Q	H
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u26	WIAF-12287	HT48666	10099	HERC1, hect (homologous to the E6	CTTTGTTGTA[A/G]CACAGGCCCT	M	A	G	T	A
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u27	WIAF-12289	HT48666	11835	HERC1, hect (homologous to the E6	AGAACTGTCT[G/C]CCTGACCCTG	S	G	C	L	L
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u28	WIAF-12290	HT48666	12689	HERC1, hect (homologous to the E6	TTAAACCACA[C/T]TTTGGCAGTG	M	C	T	T	I
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u29	WIAF-12291	HT48666	14655	HERC1, hect (homologous to the E6	ACGTGGACAA[C/T]GCCGAGGGCT	S	C	T	N	N
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u30	WIAF-12296	HT48666	393	HERC1, hect (homologous to the E6	ATTCCCCATT[T/C]GCCGGGGCAC	S	T	C	F	F
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u31	WIAF-12297	HT48666	479	HERC1, hect (homologous to the E6	GGCAAGGTGA[A/G]GCAGCAGCAG	M	A	G	K	R
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u32	WIAF-12298	HT48666	1197	HERC1, hect (homologous to the E6	ATGCTCCCAT[T/C]GTCTCCGAAA	S	T	C	I	I
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u33	WIAF-12300	HT48666	3595	HERC1, hect (homologous to the E6	TCCAGAGGAA[C/T]AGGACACTGC	N	C	T	Q	*
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G598u34	WIAF-12301	HT48666	3661	HERC1, hect (homologous to the E6	CACTCCTCAA[T/C]TGGATAAATG	S	T	C	L	L
				AP (UBE3A) carboxyl terminus)
				domain and RCC1 (CHC1)-like domain
				(RLD) 1
G601u1	WIAF-12246	HT27734	106	PRKMK5, protein kinase, mitogen-	TGGAGAACCA[G/A]GTGCTGGTAA	S	G	A	Q	Q
				activated, kinase 5 (MAP kinase
				kinase 5)
G601u2	WIAF-12247	HT27734	351	PRKMK5, protein kinase, mitogen-	GTAAATGGAC[A/G]GTTAATAGAG	M	A	G	Q	R
				activated, kinase 5 (MAP kinase
				kinase 5)
G601u3	WIAF-12292	HT27734	617	PRKMK5, protein kinase, mitogen-	AGCATATCAT[G/C]TCCCGAGTGG	M	G	C	V	L
				activated, kinase 5 (MAP kinase
				kinase 5)
G603u1	WIAF-12248	HT4291	1336	mitogen-activated protein (MAP)	AGTCATCAGC[T/C]TTGTGCCACC	M	T	C	F	L
				kinase p38
G603u2	WIAF-12281	HT4291	1230	mitogen-activated protein (MAP)	CTCAGTACCA[C/T]GATCCTGATG	S	C	T	H	H
				kinase p38
G610u1	WIAF-12249	HT48690	1012	protein kinase, mitogen-activated	CCGAGCCATA[T/C]GATGAGAGCG	S	T	C	Y	Y
				p38Beta (MAP kinase p38Beta)
G610u2	WIAF-12263	HT48690	799	protein kinase, mitogen-activated	AAATCTCCTC[G/A]GAACACGCCC	S	G	A	S	S
				p38Beta (MAP kinase p38Beta)
G610u3	WIAF-12264	HT48690	848	protein kinase, mitogen-activated	GCCCCAGAAG[G/A]ACCTGAGCAG	M	G	A	D	N
				p38Beta (MAP kinase p38Beta)
G610u4	WIAF-12282	HT48690	439	protein kinase, mitogen-activated	TCCTGGTTTA[C/T]CAGCTGCTGC	S	C	T	Y	Y
				p38Beta (MAP kinase p38Beta)
G612u1	WIAF-12344	HT1436	1513	RAF1, v-raf-1 murine leukemia	TTTGCATGCA[A/G]AGAACATCAT	M	A	G	K	E
				viral oncogene homolog 1
G614u1	WIAF-12267	HT321	603	BRAF, v-raf murine sarcoma viral	GACAGTCTAA[A/G]GAAAGCACTG	M	A	G	K	R
				oncogene homolog B1
G614u2	WIAF-12268	HT321	2282	BRAF, v-raf murine sarcoma viral	CCAAACAGAG[G/A]ATTTTAGTCT	M	G	A	D	N
				oncogene homolog B1
G614u3	WIAF-12299	HT321	973	BRAF, v-raf murine sarcoma viral	AGGAAGAGGC[G/A]TCCTTAGCAG	S	G	A	A	A
				oncogene homolog B1
G616u1	WIAF-12253	HT48746	498	TRAF-interacting protein (I-TRAF)	AAGAAGACAA[G/T]AGGTTTCTTC	N	G	T	E	*
G616u2	WIAF-12269	HT48746	1338	TRAF-interacting protein (I-TRAF)	GCATATACCT[C/G]GAGTATGTGA	M	C	G	R	G
G616u3	WIAF-12285	HT48746	377	TRAF-interacting protein (I-TRAF)	ATAACAATTA[T/C]GGCTGTGTCC	S	T	C	Y	Y
G616u4	WIAF-12288	HT48746	1032	TRAF-interacting protein (I-TRAF)	TGAAATTCAG[G/A]GAATTGACCC	M	G	A	G	R
G617u1	WIAF-12256	HT1614	52	PPP1CA, protein phosphatase 1,	GAAGCTCAAC[C/T]TGGACTCGAT	S	C	T	L	L
				catalytic subunit, alpha isoform
G617u2	WIAF-12270	HT1614	792	PPP1CA, protein phosphatase 1,	AAGACGGCTA[C/T]GAGTTCTTTG	S	C	T	Y	Y
				catalytic subunit, alpha isoform
G618u1	WIAF-12238	HT27508	1598	protein phosphatase, 2A B56-alpha	CATTGAACCA[A/C]CACAGTTCAA	M	A	C	T	P
				subunit
G618u2	WIAF-12271	HT27508	1135	protein phosphatase, 2A B56-alpha	ATCAGAAATT[C/T]GTACAACAGC	S	C	T	F	F
				subunit
G62u1	WIAF-10369	HT0855	214	ERCC6, excision repair cross-	AGGAGTACCT[G/C]TCCTTTCGTT	S	G	C	L	L
				complementing rodent repair
				deficiency, complementation group
				6
G62u2	WIAF-10370	HT0855	926	ERCC6, excision repair cross-	AAAACTGTCT[T/C]TTGAAAGGAA	M	T	C	F	L
				complementing rodent repair
				deficiency, complementation group
				6
G62u3	WIAF-10428	HT0855	2904	ERCC6, excision repair cross-	AGCACGGACA[C/T]GCAGGCCCGG	M	C	T	T	M
				complementing rodent repair
				deficiency, complementation group
				6
G62u4	WIAF-10430	HT0855	3386	ERCC6, excision repair cross-	TGACCCTCAC[A/G]TGAGTAGTAA	M	A	G	M	V
				complementing rodent repair
				deficiency, complementation group
				6
G62u5	WIAF-10451	HT0855	1376	ERCC6, excision repair cross-	TTCTGGGGAA[G/A]AAGCTGAAGC	M	G	A	E	K
				complementing rodent repair
				deficiency, complementation group
				6
G62u6	WIAF-10452	HT0855	3716	ERCC6, excision repair cross-	TAAGCATTGC[A/G]GAGACGCCAA	M	A	G	R	G
				complementing rodent repair
				deficiency, complementation group
				6
G62u7	WIAF-10453	HT0855	3967	ERCC6, excision repair cross-	CCCTGAAAGC[A/C]CTGAGGCTCT	S	A	C	A	A
				complementing rodent repair
				deficiency, complementation group
				6
G62u8	WIAF-10454	HT0855	4016	ERCC6, excision repair cross-	TGGTGTTCCC[A/G]CCTGGACTGG	M	A	G	T	A
				complementing rodent repair
				deficiency, complementation group
				6
G62u9	WIAF-10455	HT0855	3979	ERCC6, excision repair cross-	TGAGGCTCTC[T/C]CGTCAGCGGT	S	T	C	S	S
				complementing rodent repair
				deficiency, complementation group
				6
G62u10	WIAF-10456	HT0855	3729	ERCC6, excision repair cross-	GACGCCAAGT[T/G]TGAAGGAACT	M	T	G	F	C
				complementing rodent repair
				deficiency, complementation group
				6
G62u11	WIAF-10476	HT0855	1275	ERCC6, excision repair cross-	TCTGGAGATG[G/A]TACTGACTAT	M	G	A	G	D
				complementing rodent repair
				deficiency, complementation group
				6
G62u12	WIAF-10477	HT0855	2017	ERCC6, excision repair cross-	TGATCTTGGA[C/T]GAAGGACACA	S	C	T	D	D
				complementing rodent repair
				deficiency, complementation group
				6
G62u13	WIAF-10479	HT0855	3265	ERCC6, excision repair cross-	CTAACATATC[T/C]GTAAATGATG	S	T	C	S	S
				complementing rodent repair
				deficiency, complementation group
				6
G62u14	WIAF-10481	HT0855	4317	ERCC6, excision repair cross-	GGGCACCTGC[A/G]GGAAGCTTCT	M	A	G	Q	R
				complementing rodent repair
				deficiency, complementation group
				6
G620a1	WIAF-12116	HT1943	1256	PPP2CB, protein phosphatase 2	TATCATGGAA[T/A]TAGATGACAC	M	T	A	L	I
				(formerly 2A), catalytic subunit,
				beta isoform
G620a2	WIAF-12117	HT1943	1326	PPP2CB, protein phosphatase 2	CCTCATGTTA[C/G]ACGGCGCACC	M	C	G	T	R
				(formerly 2A), catalytic subunit,
				beta isoform
G620u3	WIAF-12239	HT1943	819	PPP2CB, protein phosphatase 2	TTTTATGATG[A/G]ATGTCTGCGA	M	A	G	E	G
				(formerly 2A), catalytic subunit,
				beta isoform
G623u1	WIAF-12260	HT3979	459	PPP1CB, protein phosphatase 1,	TTCATGGACA[A/G]TATACAGATT	S	A	G	Q	Q
				catalytic subunit, beta isoform
G625u1	WIAF-12266	HT1961	227	PPP2R2A, protein phosphatase 2	CATTCTGGAG[A/G]ATTACTAGCA	M	A	G	E	G
				(formerly 2A), regulatory subunit
				B (PR 52), alpha isoform
G628a1	WIAF-12104	HT2780	1104	PPP1CC, protein phosphatase 1,	AGGGGTATGA[T/A]CACAAAGCAA	M	T	A	I	N
				catalytic subunit, gamma isoform
G628a2	WIAF-12105	HT2780	973	PPP1CC, protein phosphatase 1,	CCAATTATTG[C/T]GGAGAGTTTG	S	C	T	C	C
				catalytic subunit, gamma isoform
G628u3	WIAF-12311	HT2780	888	PPP1CC, protein phosphatase 1,	GATCTTATAT[G/T]TAGAGCCCAT	M	G	T	C	F
				catalytic subunit, gamma isoform
G630a1	WIAF-12103	HT5086	704	protein phosphatase 2A, 130 kDa	AAAGATGCAG[A/G]TCTGAACTCT	M	A	G	D	G
				regulatory subunit
G630a2	WIAF-12106	HT5086	1015	protein phosphatase 2A, 130 kDa	CGATGGGAAC[G/T]CCCCATCCTT	M	G	T	A	S
				regulatory subunit
G630a3	WIAF-12107	HT5086	1024	protein phosphatase 2A, 130 kDa	CGCCCCATCC[T/c]TTGGTTTACT	M	T	c	F	L
				regulatory subunit
G630a4	WIAF-12108	HT5086	837	protein phosphatase 2A, 130 kDa	ACTTAAAGGA[T/C]ATTGCAGGAG	S	T	C	D	D
				regulatory subunit
G630u5	WIAF-12325	HT5086	1200	protein phosphatase 2A, 130 kDa	TAAAGATGTG[C/T]TTGGACATCT	S	C	T	C	C
				regulatory subunit
G630u6	WIAF-12326	HT5086	2810	protein phosphatase 2A, 130 kDa	ATGTTCAGGG[C/T]TGCAGGGGGA	M	C	T	A	V
				regulatory subunit
G630u7	WIAF-12351	HT5086	512	protein phosphatase 2A, 130 kAa	ATTATGGCAG[C/T]AACTTACAGA	M	C	T	A	V
				regulatory subunit
G630u8	WIAF-12352	HT5086	703	protein phosphatase 2A, 130 kDa	CAAAGATGCA[G/A]ATCTGAACTC	M	G	A	D	N
				regulatory subunit
G630u9	WIAF-12353	HT5086	1069	protein phosphatase 2A, 130 kDa	ACCTTTGTCT[C/T]ATAGAAACTC	M	C	T	H	Y
				regulatory subunit
G634u1	WIAF-11825	X04434	2283	IGF1R, insulin-like growth factor	TGCAAGTGGC[C/T]AACACCACCA	S	C	T	A	A
				1 receptor
G634u2	WIAF-11826	X04434	2279	IGF1R, insulin-like growth factor	GTCATGCAAG[T/C]GGCCAACACC	M	T	C	V	A
				1 receptor
G634u3	WIAF-11781	X04434	1731	IGF1R, insulin-like growth factor	ACAAGGACGT[G/A]GAGCCCGGCA	S	G	A	V	V
				1 receptor
G634a4	WIAF-13106	X04434	948	IGF1R, insulin-like growth factor	TCCACGACGG[C/A]GAGTGCATGC	S	C	A	G	G
				1 receptor
G634a5	WIAF-13107	X04434	1089	IGF1R, insulin-like growth factor	CTTCTGCTCA[G/C]ATGCTCCAAG	M	G	C	Q	H
				1 receptor
G634a6	WIAF-13108	X04434	2539	IGF1R, insulin-like growth factor	AGAAGGAGCA[G/A]ATGACATTCC	M	G	A	D	N
				1 receptor
G634a7	WIAF-13109	X04434	2606	IGF1R, insulin-like growth factor	AAGTGGCCGG[A/C]ACCTGAGAAT	M	A	C	E	A
				1 receptor
G634a8	WIAF-13113	X04434	1543	IGF1R, insulin-like growth factor	CTCCACCACC[A/T]CGTCGAAGAA	M	A	T	T	S
				1 receptor
G634a9	WIAF-13112	X04434	1549	IGF1R, iusulin-like growth factor	CACCACGTCG[A/G]AGAATCGCAT	M	A	G	K	E
				1 receptor
G634a10	WIAF-13113	X04434	1596	IGF1R, insulin-like growth factor	CCCCTGACTA[C/T]AGGGATCTCA	S	C	T	Y	Y
				1 receptor
G645u1	WIAF-12332	HT5191	1127	retinoic acid-binding protein II	TCTGCAGACT[C/T]TTCAGGAGAG	M	C	T	L	F
G645u2	WIAF-12333	HT5191	1048	retinoic acid-binding protein II	AAGCATTAGA[G/A]GCCTTACAGA	S	G	A	R	E
G646u1	WIAF-12303	X81479	1204	EMR1, egf-like module containing,	CAAATATCCA[T/C]GTGGACTAAA	M	T	C	M	T
				mucin-like, hormone receptor-like
				sequence 1
G646u2	WIAF-12304	X81479	1919	EMR1, egf-like module containing,	TTCTGCTGTG[T/G]CGCTCCATCC	M	T	G	C	W
				mucin-like, hormone receptor-like
				sequence 1
G646u3	WIAF-12316	X81479	590	EMR1, egf-like module containing,	CTTGCCCAGA[G/T]CATGCAACTT	M	G	T	E	D
				mucin-like, hormone receptor-like
				sequence 1
G646u4	WIAF-12317	X81479	799	EMR1, egf-like module containing,	GCACCAAGCA[G/A]TGGACAGTTG	M	G	A	S	N
				mucin-like, hormone receptor-like
				sequence 1
G646u5	WIAF-12318	X81479	558	EMR1, egf-like module containing,	TGAAGACGTG[A/G]ATGAATGTGC	M	A	G	N	D
				mucin-like, hormone receptor-like
				sequence 1
G646u6	WIAF-12334	X81479	207	EMR1, egf-like module containing,	TTACTATTGC[A/G]CTTGCAAACA	M	A	G	T	A
				mucin-like, hormone receptor-like
				sequence 1
G646u7	WIAF-12335	X81479	458	EMR1, egf-like module containing,	TCACCAGCAG[G/C]GTCTGCCCTG	M	G	C	R	S
				mucin-like, hormone receptor-like
				sequence 1
G646u8	WIAF-12336	X81479	1308	EMR1, egf-like module containing,	CTCAGCAAAT[G/A]TCACTCCGGC	M	G	A	V	I
				mucin-like, hormone receptor-like
				sequence 1
G646u9	WIAF-12337	X81479	1285	EMR1, egf-like module containing,	ACACTGGCAT[C/T]TTTTTGGAAA	M	C	T	S	F
				mucin-like, hormone receptor-like
				sequence 1
G646u10	WIAF-12338	X81479	2026	EMR1, egf-like module containing,	GACAACAAGA[C/T]GGGCTGCGCC	M	C	T	T	M
				mucin-like, hormone receptor-like
				sequence 1
G647u1	WIAF-12339	HTS190	174	RARA, retinoic acid receptor,	TGCCTCCCTA[C/T]GCCTTCTTCT	S	C	T	Y	Y
				alpha
G648a1	WIAF-13332	HT0070	469	retinoic acid receptor, beta	AACGTGAGCC[A/G]GGAGCAGCGT	—	A	G	—	—
G648a2	WIAF-13333	HT0070	532	retinoic acid receptor, beta	ATTGTTTTTA[A/G]GGTGAGAAAT	—	A	G	—	—
G650u1	WIAF-12323	X52773	862	RXRA, retinoid X receptor, alpha	CTCGCCGAAC[G/A]ACCCTGTCAC	M	G	A	D	N
G650u2	WIAF-12341	X52773	102	RXRA, retinoid X receptor, alpha	TCCTGCCGCT[C/T]GATTTCTCCA	S	C	T	L	L
G650u3	WIAF-12348	X52773	673	RXRA, retinoid X receptor, alpha	GGCCATGGGC[A/G]TGAAGCGGGA	M	A	G	M	V
G650u4	WIAF-12349	X52773	902	RXRA, retinoid X receptor, alpha	GAGAAACAGC[T/C]TTTCACCCTG	N	T	C	L	P
G653a1	WIAF-13326	HT1458	439	RARB, retinoic acid receptor,	AGGAGAAAGC[T/C]CTGAAAGCAT	S	T	C	A	A
				beta
G655a1	WIAF-13327	J0S252	1158	PCSK2, proprotain convertase	CCTTCAGCAA[C/T]GGGAGGAAAA	S	C	T	N	N
				subtilisin/kexin type 2
G655a2	WIAF-13334	J05252	678	PCSK2, proprotein convertase	CCTATCCTTA[C/A]CCTCGGTACA	N	C	A	Y	*
				subtilisin/kexin type 2
G655a3	WIAF-13335	J05252	744	PCSK2, proprotein convertase	TTTCTGCTGC[C/T]GCCAACAACA	S	C	T	A	A
				subtilisin/kexin type 2
G658u1	WIAF-11856	J02943	971	CBG, corticosteroid binding	TCTATGACCT[T/C]GGAGATGTGC	S	T	C	L	L
				globulin
G658u2	WIAF-13407	J02943	771	CRG, corticosteroid binding	CCTTCATGAC[T/G]CAGAGCTCCC	M	T	G	S	A
				globulin
G658u3	WIAF-13408	J02943	773	CBG, corticosteroid binding	TTCATGACTC[A/G]GAGCTCCCCT	S	A	G	S	S
				globulin
G658u4	WIAF-13409	J02943	1046	CSG, corticosteroid binding	TCACCCAGGA[C/T]GCCCAGCTGA	S	C	T	D	D
				globulin
G663u1	WIAF-13400	WT3157	1202	TPO, thyroid peroxidase	CGCCACGCGC[G/A]CCTGCGGCCT	S	G	A	A	A
G663u2	WIAF-13401	HT3157	1282	TPO, thyroid peroxidase	GGCCGCGCCA[G/C]CGAGGTCCCC	M	G	C	S	T
G668a1	WIAF-13350	U53506	350	D102, deiodinase, iodothyronine,	TCGATGCCTA[C/A]AAACAGGTGA	N	C	A	Y	*
				type II
G668a2	WIAF-13351	U53506	354	D102, deiodinase, iodothyronine,	TGCCTACAAA[C/A]AGGTGAAATT	M	C	A	Q	K
				type II
G668a3	WIAF-13352	U53506	408	D102, deiodinase, iodothyronine,	TGTCTCCAGT[A/G]CAGAAGGAGG	M	A	G	T	A
				type II
G673a1	WIAF-13328	M57464	1723	Human ret proto-oncogene mRNA for	CGAGCCTGGG[G/A]AGCCCCGGGG	M	G	A	E	K
				tyrosine kinase.
G673a2	WIAF-13336	M57464	1186	Human ret proto-oncogene mRNA for	GGCTCGCCGA[T/A]TTGCCCAGAT	M	T	A	F	I
				tyrosine kinase.
G673a3	WIAF-13337	MS7464	3227	Human ret proto-oncogene rnRNA for	ACTGCCAGGC[G/A]TTCAGTGGCA	S	G	A	A	A
				tyrosine kinase.
G673a4	WIAF-13338	M57464	2118	Human ret proto-oncogene mRNA for	TTGGAAAAAC[T/A]CTAGGAGAAG	S	T	A	T	T
				tyrosine kinase.
G673a5	WIAF-13339	M57464	2238	Human ret proto-oncogene mRNA for	CGAGTGAGCT[T/G]CGAGACCTGC	S	T	G	L	L
				tyrosine kinase.
G678u1	WIAF-13353	D49492	1439	GDF10, growth differentiation	TCGGCTGGAA[T/A]GAATGGATAA	M	T	A	N	K
				factor 10
G68u1	WIAF-10434	HT1115	1214	ERCC3, excision repair cross-	CTGTGGAGCA[G/A]TGGAAAGCCC	S	G	A	Q	Q
				complementing rodent repair
				deficiency, complementation group
				3 (xeroderma pigmentosum group B
				complementing)
G68u2	WIAF-10435	HT1115	1155	ERCC3, excision repair cross-	TGTGACTGCT[G/C]CATGCACTGT	M	G	C	A	P
				complementing rodent repair
				deficiency, complementation group
				3 (xeroderma pigmentosum group B
				complementing)
G68u3	WIAF-10436	HT1115	1327	ERCC3, excision repair cross-	AGCACCTACT[C/T]CATGCTGGGC	M	C	T	S	F
				complementing rodent repair
				deficiency, complementation group
				3 (xeroderma pigmentosum group B
				complementing)
G68u4	WIAF-10461	HT1115	926	ERCC3, excision repair cross-	AGGAAATGAT[T/C]GAGGAACTCC	S	T	C	I	I
				complementing rodent repair
				deficiency, complementation group
				3 (xeroderma pigmentosum group B
				complementing)
G68u5	WIAF-10464	HT1115	1430	ERCC3, excision repair cross-	AAGTGCACAC[C/T]ATACCAGCCA	S	C	T	T	T
				complementing rodent repair
				deficiency, complementation group
				3 (xeroderma pigmentosum group B
				complementing)
G684a1	WIAF-13359	X51801	712	BMP7, bone morphogenetic protein	GTTTATCAGG[T/G]GCTCCAGGAG	M	T	G	V	G
				7 (osteogenic protein 1)
G684a2	WIAF-13360	X51801	719	BMP7, bone morphogenetic protein	AGGTGCTCCA[G/A]GAGCACTTGG	S	G	A	Q	Q
				7 (osteogenic protein 1)
G68a3	WIAF-13361	X51801	796	BMP7, bone morphogenetic protein	GGCTGGCTGG[T/G]GTTTGACATC	M	T	G	V	G
				7 (osteogenic protein 1)
G684a4	WIAF-13362	X51801	862	BMP7, bone morphogenetic protein	GGCCTGCAGC[T/G]CTCGGTGGAG	M	T	G	L	R
				7 (osteogenic protein 1)
G684a5	WIAF-13363	X51801	658	BMP7, bone morphogenetic protein	ATCTACAAGG[A/G]CTACATCCGG	M	A	G	D	G
				7 (osteogenic protein 1)
G684u6	WIAF-13834	X51801	1421	BMP7, bone morphogenetic protein	GCCACTAGCT[C/T]CTCCGAGAAT	—	C	T	—	—
				7 (osteogenic protein 1)
G685a1	WIAF-13329	DB9675	862	BMPR1B, bone morphogenetic	GTTCCCTTTA[T/G]GATTATCTGA	N	T	G	Y	*
				protein receptor, type IB
G685a2	WIAF-13330	D89675	920	BMPR1B, bone morphogenetic	GCTAAATCAA[T/C]GCTGAAGTTA	M	T	C	M	T
				protein receptor, type IB
G6B5a3	WIAF-13331	D89675	770	BMPR1B, bone morphogenetic	TATCAGACAG[T/G]GTTGATGAGG	M	T	G	V	G
				protein receptor, type IB
G685a4	WIAF-13340	D89675	1303	BMPR1B, bone morphogenetic	TCCTTATCAT[G/A]ACCTAGTGCC	M	G	A	D	N
				protein receptor, type IB
G685a5	WIAF-13341	D89675	1372	BMPR1B, bone morphogenetic	GTTACGCCCC[T/G]CATTCCCAAA	M	T	G	S	A
				protein receptor, type IB
G665a6	WIAF-13342	D89675	1173	BMPR1B, bone morphogenetic	TGTTGGACGA[G/A]AGCTTGAACA	S	G	A	E	E
				protein receptor, type IB
G6B6u1	WIAF-13816	Z48923	2705	BMPR2, bone morphogenetic protein	AAATTTGGCA[G/A]CAAGCACAAA	N	G	A	S	N
				receptor, type II
				(serine/threonine kinase)
G686u2	WIAF-13817	Z48923	2749	BMPR2, bone morphogenetic protein	TGGAGTTGCC[A/T]AGATGAATAC	N	A	T	K	*
				receptor, type II
				(serine/threonine kinase)
G687a1	WIAF-13343	MT1455	626	CALB1, calbindin 1, (28 kD)	ATGATCAGGA[C/T]GGCAATGGAT	S	C	T	D	D
G696u1	WIAF-11839	HT27700	1075	calcium-sensing receptor	GGGCACAATT[G/C]CAGCTGATGA	M	G	C	A	P
G696u2	WIAF-11840	HT27700	1551	calcium-sensing receptor	TACCTGTGGA[C/T]ACCTTTCTGA	S	C	T	D	D
G696u3	WIAF-11841	HT27700	1688	calcium-sensing receptor	TTACGGATAT[C/T]CTACAATGTG	M	C	T	S	F
G696u4	WIAF-11842	HT27700	1698	calcium-sensing receptor	CCTACAATGT[G/T]TACTTAGCAG	S	G	T	V	V
G696u5	WIAF-11858	MT27700	1767	calcium-sensing receptor	GGAGAGGGCT[C/T]TTCACCAATG	S	C	T	L	L
G696u6	WIAF-11859	HT27700	1689	calcium-sensing receptor	TACGGATATC[C/T]TACAATGTGT	S	C	T	G	S
G696u7	WIAF-11860	MT27700	2541	calciun-sensing receptor	TCGTGCTCTG[C/T]ATCTCATGCA	S	T	T	C	C
G696u8	WIAF-11861	HT27700	2581	calcium-sensing receptor	TGTCCTCCTG[G/A]TGTTTGAGGC	M	G	A	V	M
G696u9	WIAF-11863	HT27700	3159	calcium-sensing receptor	TCTCCCGCAA[G/C]CGGTCCAGCA	M	G	C	K	N
G696u10	WIAF-11872	HT27700	562	calcium-sensing receptor	TCCTATTCAT[T/A]TTGGAGTAGC	M	T	A	F	I
G696u11	WIAF-11878	HT27700	2941	calcium-sensing receptor	CATTCCAGCC[T/G]ATGCCAGCAC	M	T	G	Y	D
G696u12	WIAF-13396	HT27700	1145	calcium-sensing receptor	AGGGATATCT[G/A]CATCGACTTC	M	G	A	C	Y
G696u13	WIAF-13395	HT27700	670	calcium-sensing receptor	GATATTTGCC[A/G]TAGAGGAGAT	M	A	G	I	V
G696u14	WIAF-13396	HT27700	2243	calcium-sensing receptor	TTCTGGTCCA[A/G]TGAGAACCAC	M	A	G	H	S
G696u15	WIAF-13397	HT27700	2742	calcium-sensing receptor	AGCTGGAGGA[T/C]GAGATCATCT	S	T	C	D	D
G698u1	WIAF-13547	X61598	393	CBP1, collagen-binding protein 1	TCAGCAACTC[G/C]ACGGCGCGCA	S	G	C	S	S
G698u2	WIAF-13549	X61598	628	CBP1, collagen-binding protein 1	CGGCGCCCTG[C/T]TAGTCAACGC	S	C	T	L	L
G698u3	WIAF-13550	X61598	1230	CBP1, collagen-binding protein 1	GCGGCTCCCT [G/A]CTATTCATTG	S	G	A	L	L
G701u1	WIAF-12382	HT27657	706	CGRP tyos I receptor	AACGATGTTG[C/A]AGCAGGAACT	M	C	A	A	E
G701u2	WIAF-12391	HT27657	841	CGRP type I receptor	TGGACAAATT[A/T]TACCCAGTGT	M	A	T	Y	F
G704u1	WIAF-14046	X60382	1396	COL10A1, collagen, type X, alpha	AGGCATTCCA[G/A]GATTCCCTGG	M	G	A	G	R
				1 (Schmid metaphyseal
				chondrodysplasia)
G704u2	WIAF-14070	X60382	1648	COL10A1, collagen, type X, alpha	TGCCAACCAG[G/C]GGGTAACAGG	M	G	C	G	R
				1 (Schmid metaphyseal
				chondrodysplasia)
G704u2	WIAF-14070	X60382	1648	COL10A1, collagen, type X, alpha	CATACCACGT[G/C]CATGTGAAAG	S	G	C	V	V
				1 (Schmid metaphyseal
				chondrodysplasia)
G704u3	WIAF-14071	X60382	1824	COL10A1, collagen, type X, alpha	CATACCACGT[G/C]CATGTGAAAG	S	G	C	V	V
				1 (Schmid metaphyseal
				chondrodysplasia)
G704u4	WIAF-14072	X60382	1582	COL10A1, collagen, type X, alpha	AGTCATGCCT[G/C]AGGGTTTTAT	M	G	C	E	Q
				1 (Schmid metaphyseal
				chondrodysplasia)
G705a1	WIAF-13228	J04177	686	COL11A1, collagen, type XI, alpha	AGAAGAAAAC[T/A]GTGACAATGA	S	T	A	T	T
				1
G705e2	WIAF-13229	J04177	698	COL11A1, collagen, type XI, alpha	TGACAATGAT[T/A]GTTGATTGTA	S	T	A	I	I
				1
G705a3	WIAF-13230	J04177	888	COL11A1, collagen, type XI, alpha	TAGTCCAGAC[T/A]GTGACTCTTC	M	T	A	C	S
				1
G705a4	WIAF-13231	J04177	894	COL11A1, collagen, type XI, alpha	AGACTGTGAC[T/A]CTTCAGCACC	H	T	A	S	T
				1
G705a5	WIAF-13232	J04177	651	COL11A1, collagen, type XI, alpha	TGACCGGAAG[T/A]GGCATCGGGT	M	T	A	W	R
				1
G705a6	WIAF-13233	J04177	661	COL11A1, collagen, type XI, alpha	TGGCATCGGG[T/A]AGCAATCAGC	M	T	A	V	E
				1
G705a7	WIAF-13234	J04177	1597	COL11A1, collagen, type XI, alpha	CGTCCTGGCT[T/C]ACCAGGGGCT	M	T	C	L	S
				1
G705a8	WIAF-13235	J04177	2745	COL11A1, collagen, type XI, alpha	TGGGTTTCCA[G/A]GTGCCAATGG	M	G	A	G	S
				1
G705a9	WIAF-13236	J04177	4385	COL11A1, collagen, type XI, alpha	GTCCAGAAGG[T/A]CTTCGGGGCA	S	T	A	G	G
				1
G705a10	WIAF-13237	J04177	4576	COL11A1, collagen, type XI, alpha	GAAAAAGGTG[A/T]CCGAGGGCTC	M	A	T	D	V
				1
G705a11	WIAF-13238	J04177	4306	COL11A1, collagen, type XI, alpha	GCTAAGGGGG[A/C]AGGAGGTGCA	M	A	C	E	A
				1
G705a12	WIAF-13239	J04177	4837	COL11A1, collagen, type XI, alpha	AGACATACTG[A/G]AGGCATGCAA	M	A	G	E	G
				1
G705a13	WIAF-13240	J04177	4931	COL11A1, collagen, type XI, alpha	AACAAGACAT[C/T]GAGCATATGA	S	C	T	I	I
				1
G705e14	WIAF-13346	J04177	299	COL11A1, collagen, type XI, alpha	AAGCACTAGA[T/G]TTTCACAATT	M	T	G	D	E
				1
G705a15	WIAF-13347	J04177	2225	COL11A1, collagen, type XI, alpha	GGGAGCCTGG[G/C]CCTCCAGGTC	S	G	C	G	G
				1
G705u16	WIAF-13679	J04177	5493	COL11A1, collagen, type XI, alpha	AATTGATCAA[G/A]TACCTATTGT	M	G	A	V	I
				1
G705u17	WIAF-13700	J04177	3484	COL11A1, collagen, type XI, alpha	GGAGTTCAAG[G/A]TCCTGTTGGT	M	G	A	G	D
				1
G705u18	WIAF-13709	J04177	5392	COL11A1, collagen, type XI, alpha	GAGATGTCCT[A/T]TGACAATAAT	M	A	T	Y	F
				1
G707u1	WIAF-12363	U32169	4996	COL11A2, collagen, type XI, alpha	TCCCCTGAGA[C/T]TCCGTGGGGC	M	C	T	L	F
				2
G707u2	WIAF-12374	U32169	3580	COL11A2, collagen, type XI, alpha	CAATGGCGCT[G/A]ATGGCCCACA	M	G	A	D	N
				2
G707u3	WIAF-12385	U32169	2059	COL11A2, collagen, type XI, alpha	GCCTGGCTCA[G/A]ACGGACCCCC	M	G	A	D	N
				2
G708a1	WIAF-13354	U73778	1885	COL12A1, collagen, type XII,	GCCTCTCCTC[C/T]TGCAGAGACC	M	C	T	P	L
				alpha 1
G708a2	WIAF-13355	U73778	3630	COL12A1, collagen, type XII,	TGTTGGACAA[G/A]AAATGACAAC	M	G	A	E	K
				alpha 1
G708a3	WIAF-13356	U73778	3905	COL12A1, collagen, type XII,	GCTTGTTGCA[A/T]GCTGTGGCAA	M	A	T	Q	H
				alpha 1
G708a4	WIAF-13357	U73778	7051	COL12A1, collagen, type XII,	ATTCCACCAG[C/A]CCGGGATGTA	M	C	A	A	D
				alpha 1
G708a5	WIAF-13358	U73778	8036	COL12A1, collagen, type XII,	IAAGAAGTAAA[G/A]ACATTATTTT	S	G	A	K	K
				alpha 1
G708a6	WIAF-13364	U73778	1461	COL12A1, collagen, type XII,	TGGCTCCTAT[A/T]GCATTGGGAT	M	A	T	S	C
				alpha 1
G708a7	WIAF-13365	U73778	2344	COL12A1, collagen, type XII,	ATTACTTGGA[C/T]TCAAGCTCCA	M	C	T	T	I
				alpha 1
G708a8	WIAF-13366	U73778	5207	COL12A1, collagen, type XII,	CAGATAAGAT[G/A]GAGACCATCT	M	G	A	M	I
				alpha 1
G708a9	WIAF-13367	U73778	6592	COL12A1, collagen, type XII,	GAGCCCATGG[A/T]AGCCTTTGTT	M	A	T	E	V
				alpha 1
G708a10	WIAF-13368	U73778	7434	COL12A1, collagen, type XII,	CCAGGATGAG[G/A]TCAAGAAGGC	M	G	A	V	I
				alpha 1
G708a11	WIAF-13369	U73778	9108	COL12A1, collagen, type XII,	ACCTCGGGGG[C/G]TGCCTGGGCC	M	C	G	L	V
				alpha 1
G708a12	WIAF-13370	U73778	9111	COL12A1, collagen, type XII,	TCGGGGGCTG[C/T]CTGGGCCCCC	M	C	T	P	S
G708a13	WIAF-13371	U73778	9196	COL12A1, collagen, type XII,	CCCCCTGGCC[G/A]TCCTGAAAC	M	G	A	I	H
				alpha 1
G708u14	WIAF-13972	U73778	3044	COL12A1, collagen, type XII,	CAGTATTTGC[C/A]ACTTACAGCA	S	C	A	A	A
				alpha 1
G708U15	WIAF-13977	U73778	5853	COL12A1, collagen, type XII,	TGTGACTGTA[G/C]TTCCCGTTTA	M	G	C	V	L
				alpha 1
G710u1	WIAF-12371	D38163	3082	COL19A1, collagen, type XIX,	AGGAAACAAG[G/T]GCTCCATGGG	M	G	T	G	C
				alpha 1
G710u2	WIAF-12388	D38163	2889	COL19A1, collagen, type XIX,	TCCAGGGACT[C/T]CAGGGAATGA	M	C	T	P	S
				alpha 1
G711u1	WIAF-12360	L25286	1449	COL15A1, collagen, type XV, alpha	TGTGGGTCCA[A/G]GCAGTGAAGA	M	A	G	S	G
				1
G711u2	WIAF-12372	L25286	4001	COL15A1, collagen, type XV, alpha	ATATTCCAAT[A/G]TACTCCTTTG	M	A	G	I	M
				1
G711u3	WIAF-12373	L25286	3867	COL15A1, collagen, type XV, alpha	CCATTTGCAA[G/T]ATCTGTCCAC	M	G	T	D	Y
				1
G711a4	WIAF-13372	L25286	395	COL15A1, collagen, type XV, alpha	CCAGCAGCAC[C/T]CGTGGTGGCG	S	C	T	T	T
				1
G711a5	WIAF-13373	L25286	3101	COL15A1, collagen, type XV, alpha	AAGGCGACCA[G/A]GGAGCCCAGG	S	G	A	Q	Q
				1
G712u1	WIAF-13619	M92642	3608	COL16A1, collagon, type XVI,	GGCGACCAGG[G/A]ATTTCGGC	M	G	A	G	B
				alpha 1
G712u2	WIAF-13620	M92642	4944	COL16A1, collagon, type XVI,	CCATGAAAAC[C/T]ATGAAGGGGC	S	C	T	T	T
				alpha 1
G712u3	WIAF-13621	M92642	4707	COL16A1, collagon, type XVI,	CCAAAGGTGA[A/C]AAAGGGGACA	M	A	C	E	D
				alpha 1
G712u4	WIAF-13654	M92642	421	COL16A1, collagon, type XVI,	GCCCACGCGA[C/A]GAGTATTCCC	S	C	A	R	R
				alpha 1
G712u5	WIAF-13655	M92642	444	COL16A1, collagon, type XVI,	GGGGTCTCCC[G/A]GAGGAGTTTG	S	G	A	P	P
				alpha 1
G712u6	WIAF-13656	N92642	338	COL16A1, collagon, type XVI,	CTCATGAAGA[A/C]GTCTGCCATC	M	A	C	K	T
				alpha 1
G712u7	WIAF-13862	N92542	3227	COL16A1, collagon, type XVI,	CCTGGTCCTC[C/T]GGGATTGCCA	M	C	T	P	L
				alpha 1
G712u8	WIAF-13863	M92642	3199	COL16A1, collagon, type XVI,	TCCTGGCTGT[G/T]TTTGGAGCCC	N	G	T	V	F
				alpha 1
G712u9	WIAF-13678	N92642	318	COL16A1, collagon, type XVI,	ACCTCATCCA[C/T]CGACTCAGCC	S	C	T	H	H
				alpha 1
G712u10	WIAF-13882	M92642	1346	COL16A1, collagon, type XVI,	ACAGGCGAGA[A/G]GGGCCAGAAA	N	A	G	K	R
				alpha 1
G712u11	WIAF-13883	N92642	1309	COL16A1, collagon, type XVI,	GTCAGGAGCT[C/T]GGGGACCCTC	S	C	T	L	L
				alpha 1
G715a1	WIAF-13344	Z74615	3504	COL1A1, collagen, type I, alpha 1	TCCTGGTGAA[C/G]AAGGTCCCTC	M	C	G	Q	E
G717u1	WIAF-12639	Z74616	3988	COL1A2, collagen, type I, alpha 2	ATGAGGAGAC[T/C]GGCAACCTGA	S	T	C	T	T
G720u1	WIAF-12367	X14420	3494	COL3A1, collagen, type III, alpha	GGTGCAATCG[G/A]CAGTCCAGGA	M	G	A	G	D
				1 (Ehlers-Danlos syndrome type IV,
				autosomal dominant)
G720u2	WIAF-12383	X14420	3035	COL3A1, collagen, type III, alpha	GGTGTCAAGG[G/A]TGAAAGTGGG	N	G	A	G	D
				1 (Ehlers-Danlos syndrome type IV,
				autosomal dominant)
G720a3	WIAF-13374	X14420	214	COL3A1, collagen, type III, alpha	TCTTGGTCAG[T/C]CCTATGCGGA	M	T	C	S	P
				1 (Ehlers-Danlos syndrome type IV,
				autosomal dominant)
G720a4	WIAF-13376	X14420	1953	COL3A1, collagen, type III, alpha	CTGGACCTCA[A/G]GGACCCCCAG	S	A	G	Q	Q
				1 (Ehlers-Danlos syndrome type IV,
				autosomal dominant)
G720a5	WIAF-13376	X14420	2194	COL3A1, collagen, type III, alpha	TAGAGGTGGA[G/A]CTGGTCCCCC	M	G	A	A	T
				1 (Ehlers-Danlos syndrome type IV,
				autosomal dominant)
G720a6	WIAF-13377	X14420	3731	COL3A1, collagen, type III, alpha	GGGATTGGAG[G/A]TGAAAAAGCT	M	G	A	G	D
				1 (Ehlers-Danlos syndrome type IV,
				autosomal dominant)
G722u1	WIAF-14132	HT3162	140	COL4A2, collagen, type IV, alpha	GAGATTGGCG[C/T]GACTGGTGAT	M	C	T	A	V
				2
G724a1	WIAF-12120	X81053	3892	COL4A4, collagen, type IV, alpha	CTCGTGGAAA[G/A]AAAGGTCCCC	S	G	A	K	K
				4
G724a2	WIAF-12121	X81053	4187	COL4A4, collagen, type IV, alpha	GAAAGGACCA[A/G]TGGGATTCCC	M	A	G	M	V
				4
G724a3	WIAF-12122	X81053	3802	COL4A4, collagen, type IV, alpha	ATGATGTGGG[G/A]CCACCTGGTC	S	G	A	G	G
				4
G724a4	WIAF-12123	X81053	1838	COL4A4, collagen, type IV, alpha	ACCAGGAAAG[C/A]ATGGTGCCTC	M	C	A	H	N
				4
G724u5	WIAF-12364	X81053	376	COL4A4, collagen, type IV, alpha	CTGTTTGCCA[C/T]TGTGTTCCTG	S	C	T	H	H
				4
G724u6	WIAF-12365	X81053	2018	COL4A4, collagen, type IV, alpha	TCCAGGGGAT[C/G]ATGAAGATGC	M	C	G	H	D
				4
G724u7	WIAF-12366	X81053	4756	COL4A4, collagen, type IV, alpha	GCCTTCCCGT[A/G]TTTAGCACGC	S	A	G	V	V
				4
G724u8	WIAF-12377	X81053	3595	COL4A4, collagen, type IV, alpha	CTGGACCACC[A/G]GGGTGCCCAG	S	A	G	P	P
				4
G724u9	WIAF-12378	X81053	3516	COL4A4, collagen, type IV, alpha	GGAGCATCCG[G/C]AGAGCAGGGC	M	G	C	G	A
				4
G724u10	WIAF-12379	X81053	4288	COL4A4, collagen, type IV, alpha	CTGGTCTTCC[A/G]GGTCCCAGAG	S	A	G	P	P
				4
G724u11	WIAF-12380	X81053	5140	COL4A4, collagen, type IV, alpha	GCCACTTTTT[C/A]GCAAATAAGT	M	C	A	F	L
				4
G724u12	WIAF-12387	X81053	207	COL4A4, collagen, type IV, alpha	GACTTGCCTG[C/T]GATGTGGTCT	—	C	T	—	—
				4
G727u1	WIAF-12362	D90279	5135	COL5A1, collagen, type V, alpha 1	TTCAAGGTTT[A/T]CTGCAACTTC	M	A	T	Y	F
G727u2	WIAF-12369	D90279	4686	COL5A1, collagen, type V, alpha 1	AACAGGGTAT[C/T]ACTGGTCCTT	S	C	T	I	I
G727u3	WIAF-12370	D90279	4608	COL5A1, collagen, type V, alpha 1	TCGGTCCTCC[G/C]GGTGAACAGG	S	G	C	P	P
G727a4	WIAF-13300	D90279	2034	COL5A1, collagen, type V, alpha 1	ACGGCCTGGC[T/A]GGGTTGCCAG	S	T	A	A	A
G727a5	WIAF-13301	D90279	2073	COL5A1, collagen, type V, alpha 1	GTGACCCTGG[T/C]CCTTCCGGCC	S	T	C	G	G
G727a6	WIAF-13302	D98279	3763	COL5A1, collagen, type V, alpha 1	CGGGCAGAAA[G/A]GTGATGAAGG	M	G	A	G	S
G729u1	WIAF-11844	L02870	2345	COL7A1, collagen, type VII, alpha	ATGGACTGGA[G/A]CCAGATACTG	S	G	A	E	E
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u2	WIAF-11845	L02870	3083	COL7A1, collagen, type VII, alpha	TATCCTGGCG[G/A]CCACTCAGAG	S	G	A	R	R
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u3	WIAF-11846	L02870	3031	COL7A1, collagen, type VII, alpha	GACTCGGTGA[C/T]TTTGGCCTGG	N	C	T	T	I
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u4	WIAF-11851	L02870	1289	COL7A1, collagen, type VII, alpha	CGGACTATGA[G/T]GTGACCGTGA	W	G	T	E	D
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u5	WIAF-11852	L02870	1032	COL7A1, collagen, type VII, alpha	CCAAGTGACT[G/T]TGATTGCCCT	N	G	T	V	L
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u6	WIAF-11853	L02570	1897	COL7A1, collagen, type VII, alpha	CGCCGGGAGC[C/T]GGAAACTCCA	M	C	T	P	L
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u7	WIAF-11854	L02870	1827	COL7A1, collagen, type VII, alpha	GCTTAGCTAC[A/T]CTGTGCGGGT	M	A	T	T	G
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u8	WIAF-11855	L02870	1893	COL7A1, collagen, type VII, alpha	TGTCCGCCGG[G/A]AGCCGGAAAC	M	G	A	E	K
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u9	WIAF-11864	L02870	2142	COL7A1, collagen, type VII, alpha	GGGCCCTGCT[G/A]CAGTCATCGT	M	G	A	A	T
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u10	WIAF-11865	L02870	2353	COL7A1, collagen, type VII, alpha	GAGCCAGATA[C/T]TGAGTATACG	M	C	T	T	I
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u11	WIAF-11866	L02870	2221	COL7A1, collagen, type VII, alpha	TCATCTGTCA[C/T]CATTACCTGG	M	C	T	T	I
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u12	WIAF-11869	L02870	6585	COL7A1, collagen, type VII, alpha	ACCAGGAGAG[C/T]GTGGTATGGC	M	C	T	R	C
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u13	WIAF-11870	L02870	8169	COL7A1, collagen, type VII, alpha	GGGTGACCGA[G/T]GCTTTGACGG	M	G	T	G	C
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u14	WIAF-11877	L02870	438	COL7A1, collagen, type VII, alpha	CGCCATCCGT[G/A]AGCTTAGCTA	M	G	A	E	K
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u15	WIAF-11882	L02870	3481	COL7A1, collagen, type VII, alpha	AGGATCCGTG[A/T]CATGCCCTAC	M	A	T	D	V
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u16	WIAF-11883	L02870	5654	COL7A1, collagen, type VII, alpha	ACGGAGAACC[T/C]CGGGACCCTG	S	T	C	P	P
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u17	WIAF-12884	L02670	7124	COL7A1, collagen, type VII, alpha	TGCCAGGGCC[G/C]CGAGGCGAGA	S	G	C	P	P
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u18	WIAF-11885	L02870	7757	COL7A1, collagen, type VII, alpha	GCTTGGATGG[T/C]GACAAAGGAC	S	T	C	G	G
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u19	WIAF-13389	L02870	1615	COL7A1, collagen, type VII, alpha	ACCGTGGTTC[C/T]CACTGTACCA	M	C	T	P	L
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u20	WIAF-13390	L02870	2930	COL7A1, collagen, type VII, alpha	TCCTAGGGCC[G/A]GCTGGAGAAG	S	G	A	P	P
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u21	WIAF-13399	L02870	5145	COL7A1, collagen, type VII, alpha	CCACGGAGAT[C/T]CTGGAGAGGA	M	C	T	P	S
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G729u22	WIAF-13411	L02870	3472	COL7A1, collagen, type VII, alpha	ATCTTGCAAA[G/A]GATCCGTGAC	M	G	A	R	K
				1 (epidermolysis bullosa,
				dystrophic, dominant and
				recessive)
G730a1	WIAF-13303	X57527	305	COL8A1, collagen, type VIII,	ATGGGCAAGG[A/G]AGCCGTTCCC	M	A	G	E	G
				alpha 1
G732u1	WIAF-12616	M95610	936	COL9A2, collagen, type IX, alpha	CAGGCGGGAC[A/G]GCCCGGAAGT	S	A	G	T	T
				2
G732u2	WIAF-12617	M95610	696	COL9A2, collagen, type IX, alpha	AAGGGAGAGA[C/T]GGGCCCTCAT	S	C	T	D	D
				2
G732u3	WIAF-12619	M95610	1288	COL9A2, collagen, type IX, alpha	AAGTGGGTGA[C/T]CCAGGGGTGG	M	C	T	P	S
				2
G732u4	WIAF-12620	M95610	962	COL9A2, collagen, type IX, alpha	CCACCAGGGC[C/G]TAGCGGGTGT	M	C	G	P	R
				2
G737u1	WIAF-13394	M13436	?	INHBA, inhibin, beta A (activin	TGCTCCCTG[G/T]	?	G	T
				A, activin AB alpha polypeptide)
G738a1	WIAF-13383	M58549	183	MGP, matrix Gla protein	ATGGAGAGCT[A/G]AAGTCCAAGA	M	A	G	K	E
G738a2	WIAF-13384	M58549	330	MGP, matrix Gla protein	GCGCCGAGGG[A/G]CCAAATGAGA	M	A	G	T	A
G739u1	WIAF-11867	U94332	862	TNFRSF11B, tumor necrosis factor	TGCTGAAGTT[A/G]TGGAAACATC	S	A	G	L	L
				receptor superfamily, member 11b
				(osteoprotagerin)
G739u2	WIAF-11874	U94332	1244	TNFRSF11B, tumor necrosis factor	GTATCAGAAG[T/C]TATTTTTAGA	S	T	C	L	L
				receptor superfamily, member 11b
				(osteoprotagerin)
G743u1	WIAF-13402	HT847	1669	PTHR1, parathyroid hormone	CCCTGGAGAC[C/A]CTCGAGACCA	S	C	A	T	T
				receptor 1
G747u1	WIAF-12414	J03040	123	SPARC, secreted protein, acidic,	CTCAGCAAGA[A/G]GCCCTGCCTG	S	A	G	E	E
				cysteine-rich (osteonectin)
G748u1	WIAF-12628	HT0157	117	VDR, vitamin D (1,25-	CCTTCAGGGA[T/C]GGAGGCAATG	M	T	C	M	T
				dihydroxyvitamin D3) receptor
G748u2	WIAF-12629	HT0157	1171	VDR, vitamin D (1,25-	CCGCGCGGAT[T/C]GAGGCCATCC	S	T	C	I	I
				dihydroxyvitamin D3) receptor
G748u3	WIAF-12640	HT0157	172	VDR, vitamin D (1,25-	TTGACCGGAA[C/T]GTGCCCCGGA	S	C	T	W	N
				dihydroxyvitamin D3) receptor
G749u1	WIAF-11862	HT3734	679	osteopontin, alt. transcript 1	ATCACCTCAC[A/T]CATGGAAAGC	M	A	T	H	L
G749u2	WIAF-11875	HT3734	386	osteopontin, alt. transcript 1	AAGATGATGA[A/G]GACCATGTGG	S	A	G	D	D
G749u3	WIAF-11876	HT3734	419	osteopontin, alt. transcript 1	CCATTGACTC[G/A]AACGACTCTG	S	G	A	S	S
G749a4	WIAF-12084	HT3734	1711	osteopontin, alt. tranecript 1	TAAACAGGCT[G/A]ATTCTGGAAG	M	G	A	D	N
G749u5	WIAF-13387	HT3734	738	osteopontin, alt. transcript 1	CCAGGACCTG[A/C]ACGCGCCTTC	M	A	C	N	H
G749u6	WIAF-13388	HT3734	716	osteopontin, alt. transcript 1	CATACAAGGC[C/A]ATCCCCGTTG	S	C	A	A	A
G751u1	WIAF-12631	HT5036	410	ADM, adrenomedullin	GACAGCAGTC[C/G]GGATGCCGCC	M	C	G	P	R
G752u1	WIAF-11843	HT1782	1405	CHGA, chromogranin A (parathyroid	CGGCCATTGA[A/G]CGAGAGCTGG	S	A	G	E	E
				secretory protein 1)
G752u2	WIAF-11873	HT1782	1187	CHGA, chromogranin A (parathyroid	GGACAACCGG[G/A]ACAGTTCCAT	M	G	A	D	N
				secretory protein 1)
G754u1	WIAF-13382	K02043	663	NPPA, natriuretic peptide	GTACAATGCC[G/A]TGTCCAACGC	M	G	A	V	M
				precursor A
G756u1	WIAF-12395	HT3508	2086	SCNN1A, sodium channel,	CAGTTCCTCC[A/G]CCTGTCCTCT	M	A	G	T	A
				nonvoltage-gated 1 alpha
G757u1	WIAF-12420	HT28563	797	SCNN1B, sodium channel,	CCTGCAGGCC[A/C]CCAACATCTT	M	A	C	T	P
				nonvoltage-gated 1, beta (Liddle
				syndrome)
G757u2	WIAF-12421	HT28563	1006	SCNN1B, sodium channel,	GAACTGAATT[C/T]GGCCTGAAGT	S	C	T	F	F
				nonvoltage-gated 1, beta (Liddle
				syndrome)
G757u3	WIAF-12430	HT28563	1768	SCNN1B, sodium channel,	TCATCGACTT[T/C]GTGTGGATCA	S	T	C	F	F
				nonvoltage-gated 1, beta (Liddle
				syndrome)
G757u4	WIAF-12494	HT28563	662	SCNN1B, sodium channel,	AAGCAGCTCA[G/C]CATCAGAAAA	M	G	C	A	P
				nonvoltage-gated 1, beta (Liddle
				syndrome)
G757u5	WIAF-12506	HT28563	1091	SCNN1B, sodium channel,	GATGCTTCAC[G/C]AGCAGAGGTC	M	G	C	E	Q
				nonvoltage-gated 1, beta (Liddle
				syndrome)
G757u6	WIAF-12507	HT28563	1452	SCNN1B, sodium channel,	ACCTGCATTG[G/T]CATGTGCAAG	M	G	T	G	V
				nonvoltage-gated 1, beta (Liddle
				syndrome)
G758u1	WIAF-12621	HT27856	415	SCNN1D, sodium channel,	CGGGAACCCA[C/T]GTCGGCCGAG	M	C	T	R	C
				nonvoltage-gated 1, delta
G758u2	WIAF-12632	HT27856	325	SCNN1D, sodium channel,	CCTCTTTGAG[C/T]GTCACTGGCA	M	C	T	R	C
				nonvoltage-gated 1, delta
G758u3	WIAF-12634	HT27856	879	SCNN1D, sodium channel,	ATGGCGTCTG[G/A]ACAGCTCAGC	N	G	A	W	*
				nonvoltage-gated 1, delta
G758u4	WIAF-12635	HT27856	1138	SCNN1D, sodium channel,	CGTGGAGGTG[G/C]AGCTGCTACA	M	G	C	E	Q
				nonvoltage-gated 1, delta
G762u1	WIAF-12622	HT27531	1850	NPR3, natriuretic peptide	TAGGAGCTGG[C/T]TTGCTAATGG	S	C	T	G	G
				receptor C/guanylate cyclase C
				(atrionatriuretic peptide receptor
				C)
G762u2	WIAF-12623	HT27531	1926	NPR3, natriuretic peptide	AGAAGAAAGT[A/G]ACCTTGGAAA	M	A	G	N	D
				receptor C/guanylate cyclase C
				(atrionatriuretic peptide receptor
				C)
G762u3	WIAF-12624	HT27531	1791	NPR3, natriuretic peptide	CAAATCATCA[G/T]GTGGCCTAGA	M	G	T	G	C
				receptor C/guanylate cyclase C
				(atrionatriuretic peptide receptor
				C)
G762u4	WIAF-12636	HT27531	1963	NPR3, natriuretic peptide	GAAGATTCCA[T/C]CAGATCCCAT	M	T	C	I	T
				receptor C/guanylate cyclase C
				(atrionatriuretic peptide receptor
				C)
G763u1	WIAF-12659	HT3183	1633	NPR2, natriuretic peptide	CTGGGCCCTT[C/T]CCTGATGAAC	M	C	T	S	F
				receptor B/guanylate cyclase B
				(atrionatriuretic peptide receptor
				B)
G763u2	WIAF-12678	HT3183	668	NPR2, natriuretic peptide	TGCCATCACT[T/C]CTGCTGTTGG	S	T	C	L	L
				receptor B/guanylate cyclase B
				(atrionatriuretic peptide receptor
				B)
G763u3	WIAF-12684	HT3183	2354	NPR2, natriuretic peptide	TGTTTGAACT[C/T]AAACATATGA	S	C	T	L	L
				receptor B/guanylate cyclase B
				(atrionatriuretic peptide receptor
				B)
G764u1	WIAF-12698	HT1221	3021	NPR1, natriuretic peptide	CCCCGTTACT[G/T]TCTCTTTGGG	M	G	T	C	F
				receptor A/guanylate cyclase A
				(atrionatriuretic peptide receptor
				A)
G764u2	WIAF-12708	HT1221	588	NPR1, natriuretic peptide	GAGCGCCAAG[C/T]GCTCATGCTC	M	C	T	A	V
				receptor A/guanylate cyclase A
				(atrionatriuretic peptide receptor
				A)
G764u3	WIAF-12709	HT1221	1897	NPR1, natriuretic peptide	GTCCCCGTGG[G/A]AGCCTGCAGG	S	G	A	G	G
				receptor A/guanylate cyclase A
				(atrionatriuretic peptide receptor
				A)
G765u1	WIAF-10012	HT2456	604	DCP1, dipeptidyl carboxypeptidase	GCTGGCACAA[A/G]GCTGCGGGCA	S	A	G	N	N
				1 (angiotensin I converting
				enzyme)
G765u2	WIAF-10014	HT2456	2350	DCP1, dipeptidyl carboxypeptidase	TGATGGCCAC[A/G]TCCCGGAAAT	S	A	G	T	T
				1 (angiotensin I converting
				enzyme)
G765u3	WIAF-10025	HT2456	1668	DCP1, dipeptidyl carboxypeptidase	CCCACTGCAC[C/A]AGTGTGACAT	M	C	A	Q	K
				1 (angiotensin I converting
				enzyme)
G765u4	WIAF-10027	HT2456	3220	DCP1, dipeptidyl carboxypeptidase	TCCCCTTCAG[C/T]TACCTCGTCG	S	C	T	S	S
				1 (angiotensin I converting
				enzyme)
G765u5	WIAF-10028	HT2456	3409	DCP1, dipeptidyl carboxypeptidase	TCAGGTACTT[T/C]GTCAGCTTCA	S	T	C	F	F
				1 (angiotensin I converting
				enzyme)
G765u6	WIAF-10040	HT2456	775	DCP1, dipeptidyl carboxypeptidase	AGCCCCTCTA[C/T]CTGAACCTCC	S	C	T	Y	Y
				1 (angiotensin I converting
				enzyme)
G772u1	WIAF-12626	HT2121	1064	AVPR2, arginine vasopressin	TCAGCAGCAG[C/T]GTGTCCTCAG	S	C	T	S	S
				receptor 2 (nephrogenic diabetes
				insipidus)
G772u2	WIAF-12627	HT2121	998	AVPR2, arginine vasopressin	CCTTTGTGCT[A/G]CTCATGTTGC	S	A	G	L	L
				receptor 2 (nephrogenic diabetes
				insipidus)
G773u1	WIAF-12644	HT2141	163	SLC6A6, solute carrier family 6	CTAGCAAGAT[C/T]GACTTTGTGC	S	C	T	X	T
				(neurotransmitter transporter,
				taurine), member 6
G773u2	WIAF-12645	HT2141	445	SLC6A6, solute carrier family 6	TCGTCATCCT[G/C]GCCTGGGCCA	S	G	C	L	L
				(neurotransmitter transporter,
				taurine), member 6
G773u3	WIAF-12665	HT2141	289	SLC6A6, solute carrier family 6	TGTTTGGGAG[C/T]GGCCTGCCTG	S	C	T	S	G
				(neurotransmitter transporter,
				taurine), member 6
G773u4	WIAF-12666	HT2141	382	SLC6A6, solute carrier family 6	CCTTGTTCTC[T/C]GGTATCGGCT	S	T	C	S	S
				(neurotransmitter transporter,
				taurine), member 6
G776u1	WIAF-11857	U66088	1457	SLC5A5, solute carrier family 5	TAGAAGACCT[C/T]ATCAAACCTC	S	C	T	L	L
				(sodium iodide symporter), member
				5
G776u2	WIAF-11871	U66088	2039	SLC5A5, solute carrier family 5	GATTGTTGTG[G/C]TGGGACCTCG	M	G	C	W	C
				(sodium iodide symporter), member
				5
G776u3	WIAF-13398	U66088	1379	SLC5A5, solute carrier family 5	GGCTTTTCCT[G/A]GCCTGTGCTT	S	G	A	L	L
				(sodium iodide symporter), member
				5
G777u1	WIAF-12646	HT27843	4348	SMRT	ATACAATATC[A/G]GCCAGCCTGG	M	A	G	S	G
G777u2	WIAF-12664	HT27843	2031	SMRT	CTGAGCTGGG[T/C]AAGCCGCGGC	S	T	C	G	G
G777u3	WIAF-12655	HT27843	2052	SMRT	AGAGCCCCCT[G/A]ACCTATGAGG	S	G	A	L	L
G777u4	WIAF-12675	HT27843	2205	SMRT	CTCGTGAGAT[C/T]GCCAAGTCCC	S	C	T	I	I
G778u1	WIAF-14093	HT1449	8212	TG, thyroglobulin	ATCTCGTCTC[T/C]GAAGACATCT	M	T	C	L	P
G778u2	WIAF-14111	HT1449	6033	TG, thyroglobulin	ATGTGAACGA[C/T]GGTGCGATGC	M	C	T	R	W
G778u3	WIAF-14112	HT1449	6894	TG, thyroglobulin	GTATCTCAAT[G/T]TGTTCATCCC	M	G	T	V	L
G778u4	WIAF-14125	HT1449	2375	TG, thyroglobulin	ATGGGCCTCC[T/C]GAGCAGGTCT	S	T	C	P	P
G778u5	WIAF-14136	HT1449	1931	TG, thyroglobulin	AGGATGTCGA[A/G]TGCTTTTCCG	S	A	G	Q	Q
G783u1	WIAF-12649	X97674	4008	H. sapiens mRNA for transcriptional	CTAGTGGTAT[G/C]CCAGCAACTA	M	G	C	M	I
				intermediary factor 2.
G783u2	WIAF-12658	X97674	2566	H. sapiens mRNA for transcriptional	GCCTGGCAGT[G/A]AGCTGGACAA	M	G	A	E	K
				intermediary factor 2.
G783u3	WIAF-12671	X97674	3828	H. sapiens mRNA for transcriptional	CTCTGAGGCC[T/C]GGAGTACCAA	S	T	C	P	P
				intermediary factor 2.
G785u1	WIAF-13385	HT1291	386	TTR, transthyretin (prealbumin,	CCAACGACTC[C/T]GGCCCCCGCC	S	C	T S	S
				amyloidosis type I)
G787u1	WIAF-12652	HT27477	468	TRIP15: thyroid receptor	GAAAATTATA[T/C]TTAGAACGAG	S	T	C	Y	Y
				interacting protein 15
G792u1	WIAF-12661	HT27476	265	thyroid receptor interactor 14	CAGCTGGAAC[G/A]TGAAGAGGGC	M	G	A	V	M
G793u1	WIAF-12643	HT5152	458	thyroid receptor interactor 8	GGAAGCTTTT[C/G]AAAGAATGTT	M	C	G	S	*
G794u1	WIAF-12664	HT5136	1110	PSMC5, proteasome (prosome,	GCGTGTGCAC[G/A]GAAGCTGGCA	S	G	A	T	T
				macropain) 26S subunit, ATPase, 5
G797u1	WIAF-11847	HT3919	140	glutamate receptor 3, flip isoform	CTCACGGAGG[A/G]TTCCCCAACA	S	A	G	G	G
G797u2	WIAF-11848	HT3919	759	glutamate receptor 3, flip isoform	GGTTGTGATC[C/T]TAGGGAAACA	S	C	T	L	L
G797u3	WIAF-11849	HT3919	1253	glutamate receptor 3. flip isoform	GCTACTGGAA[C/T]GAGTATGAAA	S	C	T	N	N
G797u4	WIAF-11850	MT3919	1770	glutamate receptor 3, flip isoform	TCTTTTCCTA[G/A]TCAGCAGGTT	M	G	A	V	I
G797u5	WIAF-13404	HT3919	2711	glutamate receptor 3, flip isoform	GCTAGAACGT[G/A]TATGGAACAG	S	G	A	V	V
G797u6	WIAF-13405	HT3919	2376	glutamate receptor 3, flip isoform	CTCAGCATTA[G/A]GAACGCCTGT	M	G	A	G	R
G798u1	WIAF-11868	X77748	2655	GRM3, glutamate receptor,	TGCAGACGAC[A/G]ACCATGTGCA	S	A	G	T	T
				metabotropic 3
G798u2	WIAF-11879	X77748	2771	GRM3, glutamate receptor,	CACAGACTGC[A/G]CCTCAACAGG	M	A	G	H	R
				metabotropic 3
G798a3	WIAF-12085	X77748	2699	GRM3, glutamate receptor,	GTGGTCTTGG[G/C]CTGTTTGTTT	M	G	C	G	A
				metabotropic 3
G798a4	WIAF-12086	X77748	2738	GRM3, glutamate receptor,	ATCCTGTTTC[A/G]ACCCCAGAAG	M	A	G	Q	R
				metabotropic 3
G798a5	WIAF-12087	X77748	2072	GRM3, glutamate receptor,	ACACCCTTGG[T/C]CAAAGCATCG	M	T	C	V	A
				metabotropic 3
G798a6	WIAF-12088	X77748	2235	GRM3, glutamate receptor,	CCCTGCTGAC[C/T]AAGACAAACT	S	C	T	T	T
				metabotropic 3
G798u7	WIAF-13391	X77748	1131	GRM3, glutamate receptor,	GCGCCAATGC[C/T]TCCTTCACCT	S	C	T	A	A
				metabotropic 3
G799u1	WIAF-11880	M81883	2000	GAD1, glutamate decarboxylase 1	CAACAAATGC[C/T]TGGAACTGGC	S	C	T	L	L
				(brain, 67 kD)
G799u2	WIAF-11881	M81883	1822	GAD1, glutamate decarboxylase 1	AGGGTATACT[C/T]CAAGGATGCA	S	C	T	L	L
				(brain, 67 kD)
G799u3	WIAF-13392	MB1883	661	GAD1, glutamate decarboxylase 1	GCGTGGCCCA[T/C]GGATGCACCA	S	T	C	H	H
				(brain, 67 kD)
G799u4	WIAF-13393	MB1883	556	GAD1, glutamate decarboxylase 1	AGCTGATGGC[G/A]TCTTCGACCC	S	G	A	A	A
				(brain, 67 kD)
G799u5	WIAF-13410	MB1883	1229	GAD1, glutamate decarboxylase 1	CCTCATGGAA[C/T]AAATAACACT	N	C	T	Q	*
G801u1	WIAF-23403	D49394	1596	HTR3, 5-hydroxytryptamine	TTTACCTGCT[A/G]GCGGTGCTGG	S	A	G	L	L
				(serotonin) receptor 3
G803a1	WIAF-13118	U66406	1446	EFNB3, ephrin-B3	CTGGGCCTGG[G/A]GGGTGGAGGT	M	G	A	G	E
G804u1	WIAF-11887	Z26653	7237	LAMA2, laminin, alpha 2 (merosin,	TCACTGATGG[G/T]CACATAAAAG	S	G	T	G	G
				congenital muscular dystrophy)
G804u2	WIAF-21901	Z26653	9351	LAMA2, laminin, alpha 2 (merosin,	GCAAGCCACT[G/C]GAGGTTAATT	M	G	C	W	S
				congenital muscular dystrophy)
G804u3	WIAF-11924	Z26653	8740	LAMA2, laminin, alpha 2 (merosin,	ACACTACCCG[A/G]AGAATTGGTC	S	A	G	R	R
				congenital muscular dystrophy)
G804u4	WIAF-11943	Z26653	8577	LAMA2, laminin, alpha 2 (merosin,	ACCAAAATCA[A/G]TGATGGCCAG	M	A	G	N	S
				congenital muscular dystrophy)
G804a5	WIAF-12089	Z26653	3372	LAMA2, laminin, alpha 2 (merosin,	CTCTGTGACT[G/A]CTTCCTCCCT	M	G	A	C	Y
				congenital muscular dystrophy)
G804a6	WIAF-13227	Z26653	7047	LAMA2, laminin, alpha 2 (merosin,	GTCAGTCCTC[A/g]GGTGGAAGAT	M	A	g	Q	R
				congenital muscular dystrophy)
G804u7	WIAF-13437	Z26653	6791	LAMA2, laminin, alpha 2 (merosin,	TGTGAGAGCC[C/T]TGGATGGACC	S	C	T	L	L
				congenital muscular dystrophy)
G805u1	WIAF-13416	U14755	799	LHX1, LIM homeobox protein 1	AAGTAACAGC[A/G]GTGTTGCCAA	M	A	G	S	G
G805u2	WIAF-13417	U14755	743	LHX1, LIM homeobox protein 1	GGCGAGGAAC[T/C]CTACATCATC	M	T	C	L	P
G805u3	WIAF-13428	U14755	639	LHX1, LIM honeobox protein 1	GCCGTCAGGG[C/A]ATCTCCCCTA	S	C	A	G	G
G806u1	WIAF-11866	AF026547	2656	CSPG3, chondroitin sulfate	TTGGAGTTCC[A/G]GCCATGTCTA	S	A	G	P	P
				proteoglycan 3 (neurocan)
G806u2	WIAF-11895	AF026547	529	CSPG3, chondroitin sulfate	TGACCTTCGC[T/C]GAGGCCCAGG	S	T	C	A	A
				proteoglycan 3 (neurocan)
G806u3	WIAF-11896	AF026S47	477	CSPG3, chondroitin sulfate	GAGGTGACAG[G/A]TGTTGTGTTC	M	G	A	G	D
				proteoglycan 3 (neurocan)
G806u4	WIAF-11917	AF026547	89	CSPG3, chondroitin sulfate	ACAGGATATC[A/G]CCGATGCCAG	M	A	G	T	A
				proteoglycan 3 (neurocan)
G806u5	WIAF-11918	AF026547	213	CSPG3, chondroitin sulfate	AGCGCAGCCC[G/C]AGATGCCCCT	M	G	C	R	P
				proteoglycan 3 (neurocan)
G806u6	WIAF-11929	AF026547	769	CSPG3, chondroitin sulfate	GCTTTGCCCG[G/A]GAGCTGGGGG	S	G	A	R	R
				proteoglycan 3 (neurocan)
G806u7	WIAF-11931	AF026547	3148	CSPG3, chondroitin sulfate	ACATTGATGA[C/T]TGCCTCTGCA	S	C	T	D	D
				proteoglycan 3 (neurocan)
G806u8	WIAF-11949	AF026547	209	CSPG3, chondroitin sulfate	GCCAAGCGCA[G/A]CCCGAGATGC	M	G	A	A	T
				proteoglycan 3 (neurocan)
G806a9	WIAF-13114	AF026547	3430	CSPG3, chondroitin sulfate	ATGAAAACAC[G/A]TGGATCGGCC	S	G	A	T	T
				proteoglycan 3 (neurocan)
G806u10	WIAF-13420	AF026547	2113	CSPG3, chondroitin sulfate	CCAGGGCAGA[C/G]TTCAGAGAAA	M	C	G	D	E
				proteoglycan 3 (neurocan)
G806u11	WIAF-13431	AF026547	94	CSPG3, chondroitin sulfate	ATATCACCGA[T/G]GCCAGCGAAA	M	T	G	D	E
				proteoglycan 3 (neurocan)
G806u12	WIAF-13432	AF026547	275	CSPG3, chondroitin sulfate	ACAGGACTTG[C/T]CCATCCTGGT	M	C	T	P	S
				proteoglycan 3 (neurocan)
G808a1	WIAF-13117	Y13276	177	TLX, tailless homolog	GCATGAGCAA[G/a]CCAGCCGGAT	S	G	a	K	K
				(Drosophila)
G810u1	WIAF-11890	X98248	990	SORT1, sortilin 1	ATAAGGATAC[C/A]ACAAGAAGGA	S	C	A	T	T
G810u2	WIAF-11891	X98248	1093	SORT1, sortilin 1	GGCAGCAAAT[G/T]ATGACATGGT	M	G	T	D	Y
G810u3	WIAF-11907	X98248	1683	SORT1, sortilin 1	CAGACGAAGG[T/G]CAATGCTGGC	S	T	G	G	G
G810u4	WIAF-11908	X98248	1433	SORT1, sortilin 1	ATCTCCCAGA[A/C]ACTGAATGTT	M	A	C	K	T
G810u5	WIAF-13909	X95248	1354	SORT1, sortilin 1	GAAGCCTCAA[A/G]ACAGTGAATG	M	A	G	N	D
G810u6	WIAF-11910	X98248	2180	SORT1, sortilin 1	TACCGGAAAA[T/A]TCCAGGGGAC	M	T	A	I	N
G810u7	WIAF-11911	X98248	2264	SORT1, sortilin 1	AACTTTTTGA[G/A]TCCGGAAAAA	M	G	A	S	N
G810u8	WIAF-11925	X98248	1993	SORT1, sortilin 1	TCGAGACTAT[G/A]TTGTGACCAA	H	G	A	V	I
G810u9	WIAF-11939	X98248	1351	SORT1, sortilin 1	GAGGAAGCCT[G/C]AAAACAGTGA	M	G	C	E	Q
G810u10	WIAF-11940	X98248	2232	SORT1, sortilin 1	AAGTAAAAGA[C/T]TTGAAAAAGA	S	C	T	D	D
G810a11	WIAF-13115	X98248	1769	SORT1, sortilin 1	TCCATGAATA[T/A]CAGCATTTPG	W	T	A	I	N
G810a12	WIAF-13116	X98248	1757	SORT1, sortilin 1	CCTGGAGCTA[G/A]GTCCATGAAT	M	G	A	R	K
GB11u1	WIAF-11893	HT3676	900	synapain I, alt. transcript 1	TGACCAAGAC[G/A]ATGCCACTG	S	G	A	T	T
G811u2	WIAF-11894	HT3676	758	synapain I, alt. transcript 1	ACCTTCTACC[C/T]CAATCACAAA	M	C	T	P	L
GB11u3	WIAF-11927	HT3676	996	synapain I, alt. transcript 1	CGTCAGTGTC[A/T]GGGAACTGGA	S	A	T	S	S
G811u4	WIAF-11928	HT3676	1054	synapain I, alt. transcript 1	CATGTCTGAc[A/G]CATACAAGCT	H	A	G	R	G
G811u5	WIAF-13418	HT3676	249	synapain I, alt. transcript 1	TGTCCAACGC[G/A]GTCAAGCAGA	S	G	A	A	A
G811u6	WIAF-13419	HT3676	432	synapain I, alt. transcript 1	TTAAAGTAGA[G/A]CAGGCCGAAT	S	G	A	E	E
G812u1	WIAF-11898	HT4564	163	STX1A, syntaxin 1A (brain)	CCAACCCCGA[T/C]GAGAAGACGA	S	T	C	D	D
G812u2	WIAF-11942	HT4564	604	STX1A, syntaxin 1A (brain)	TACACGACAT[G/T]TTCATGGACA	M	G	T	H	I
G813u1	WIAF-11934	U72508	939	Human B7 mRNA, complete cds.	TATGACAGAG[G/A]ACAGAGGATG	N	G	A	G	E
GB13u2	WIAF-11948	U72508	619	Human B7 mRNA, complete cds.	GCATCCACAT[G/C]GTGACAGGTC	M	G	C	M	I
G816u1	WIAF-11897	HT4230	151	HTR2B, 5-hydroxytryptamine	CTAACTGGTC[T/G]GGATTACAGA	S	T	G	S	S
				(serotonin) receptor 2B
G816u2	WIAF-11930	HT4230	189	HTR2B, 5-hydroxytryptamine	GAAATGAAAC[A/G]GATTGTTGGG	M	A	G	Q	R
				(serotonin) receptor 2B
G818u1	WIAF-11902	HT2694	753	TPH, tryptophan hydroxylase	CTAACTGGTC[C/T]TGCACTCAAT	S	C	T	H	H
				(tryptophan 5-monooxygenase)
G818u2	WIAF-11903	HT2694	775	TPH, tryptophan hydroxylase	TGTGAGACAC[A/G]GTTCAGATCC	M	A	G	S	G
				(tryptophan 5-monooxygenase)
G818u3	WIAF-11904	HT2694	1211	TPH, tryptophan hydroxylase	TATAATCCAT[A/C]TACACGGAGT	M	A	C	Y	S
				(tryptophan 5-monooxygenase)
G818u4	WIAF-11905	HT2694	1081	TPH, tryptophan hydroxylase	GATTACCTGC[A/C]AACAGGAATG	M	A	C	K	Q
				(tryptophan 5-monooxygenase)
G818u5	WIAF-11933	HT2694	795	TPH, tryptophan hydroxylase	CCTTCTATAC[C/T]CCAGAGCCAG	S	C	T	T	T
				(tryptophan 5-monooxygenase)
G818u6	WIAF-11935	HT2694	1239	TPH, tryptophan hydroxylase	TCCTGAAAGA[C/T]ACCAAGAGCA	S	C	T	D	D
				(tryptophan 5-monooxygenase)
G822u1	WIAF-11906	HT0207	936	ASMT, acetylserotonin N-	CAGACGGAAA[G/T]TGCTCACACC	M	G	T	K	N
				methyltransferase
G822u2	WIAF-11919	HT0207	637	ASMT, acetylserotonin N-	TGGTGGGACA[C/T]GGATAAAGCT	M	C	T	R	W
				methyltransferase
G822u3	WIAF-11936	HT0207	318	ASMT, acetylserotonin N-	GAAAAGCTTT[C/T]TATCGAAACA	S	C	T	F	F
				methyltransferase
G822u4	WIAF-11937	HT0207	116	ASMT, acetylserotonin N-	AATGACTACG[C/T]CAACGGCTTC	W	C	T	A	V
				methyltransferase
G822u5	WIAF-11938	HT0207	930	ASMT, acetylserotonin N-	ACTGGGCAGA[C/T]GGAAAGTGCT	S	C	T	D	D
				methyltransferase
G822u6	WIAF-13427	HT0207	120	ASMT, acetylserotonin N-	ACTACGCCAA[C/A]GGCTTCATGG	M	C	A	N	K
				methyltransferase
G825u1	WIAF-11888	HT4974	236	ADAR, adenosine deaminase, RNA-	GCTCAGATAC[C/T]AGGAGCCTGG	N	C	T	Q	*
				specific
G825u2	WIAF-11900	HT4974	3076	ADAR, adenosine deaminase, RNA-	TCTTTGACAA[A/G]TCCTGCAGCG	S	A	G	K	K
				specific
G825u3	WIAF-11912	HT4974	2537	ADAR, adenosine deaminase, RNA-	CTTGATTGGG[G/C]AGAACGAGAA	M	G	C	E	Q
				specific
G825u4	WIAF-11941	HT4974	3558	ADAR, adenosine deaminase, RNA-	GATGGCTATG[A/G]CCTGGAGATC	M	A	G	D	G
				specific
G825a5	WIAF-12090	HT4974	1305	ADAR, adenosine deaminase, RNA-	CCTGAGACCA[A/G]AAGAAACGCA	M	A	G	K	R
				specific
G825u6	WIAF-13426	HT4974	3683	ADAR, adenosine deaminase, RNA-	CCGCAGGGAT[C/T]TACTGAGACT	S	C	T	L	L
				specific
G826u1	WIAF-12554	X99383	2109	ADARB1, adenosine deaminase, RNA-	AGATTACCAA[A/G]CCCAACGTGT	S	A	G	K	K
				specific, B1 (homolog of rat RED1)
G826u2	WIAF-12566	X99383	1698	ADARB1, adenosine deaminase, RNA-	TGTCCTGCAG[T/G]GACAAGATTG	M	T	G	S	R
				specific, B1 (homolog of rat RED1)
G829u1	WIAF-13735	U49262	1404	DVL3, dishevelled 3 (homologous	GGGTTGGAGG[T/C]CCGTGACTGC	W	T	C	V	A
				to Drosophila dsh)
G83u1	WIAF-10449	HT1576	133	DNMT1, DNA (cytosine-5-)	ATGATGACCC[G/A]TCTCTTGAAG	S	G	A	P	P
				methyltransferase 1
G83u2	WIAF-10450	HT1576	1871	DNMT1, DNA (cytosine-5-)	AAGCTGGTCT[A/G]CCAGATCTTC	M	A	G	Y	C
				methyltransferase 1
G83u3	WIAF-10468	HT1576	928	DNMT1, DNA (cytosine-5-)	AAATCCACAG[A/G]TTTCTGATGA	M	A	G	I	V
				methyltransferase 1
G83u4	WIAF-10469	HT1576	1562	DNMT1, DNA (cytosine-5-)	AATTCCGACT[C/T]GACCTATGAG	M	C	T	S	L
				methyltransferase 1
G83u5	WIAF-10471	HT1576	2424	DNMT1, DNA (cytosine-5-)	GGGCCACGTC]G/A]GACCCTCTGG	S	G	A	S	S
				methyltransferase 1
G83u6	WIAF-10473	HT1576	3790	DNMT1, DNA (cytosine-5-)	GTTCTTCCTC[C/T]TGGAGAATGT	S	C	T	L	L
				methyltransferase 1
G83u7	WIAF-10486	HT1576	1581	DNMT1, DNA (cytosine-5-)	AGGACCTGAT[C/A]AACAAGATCG	S	C	A	I	I
				methyltransferase 1
G832u1	WIAF-12577	L13387	1129	PAFAH1B1, platelet-activating	AGACATTCAC[A/T]GGACACAGAG	S	A	T	T	T
				factor acetylhydrolase, isoform
				1b, alpha subunit (45 kD)
G835u1	WIAF-12555	U38276	1311	SEMA3F, sema domain,	CCTCTGGCTC[C/A]GTGTTCCGAG	S	C	A	S	S
				immunoglobulin domain (Ig), short
				basic domain, secreted, 3F
G835u2	WIAF-12556	U38276	1229	SEMA3F, sema domain,	ACTCACTTTG[A/T]TGAGCTCCAG	M	A	T	D	V
				immunoglobulin domain (Ig), short
				basic domain, secreted, 3F
G835u3	WIAF-12557	U38276	1473	SEMA3F, sema domain,	GAACCTTCAC[G/A]CCATCTATGA	S	G	A	T	T
				immunoglobulin domain (Ig), short
				basic domain, secreted, 3F
G835a4	WIAF-13138	U3B276	1726	SEMA3F, sema domain,	TGACCAGGAG[A/T]TGGAGGAGCT	M	A	T	M	L
				immunoglobulin domain (Ig), short
				basic domain, secreted, 3F
G836u1	WIAF-12592	U28369	1056	SEMA3B, sema domain,	AACGACGTGG[G/A]CGGCCAGCGC	M	G	A	G	D
				immunoglobulin domain (Ig), short
				basic domain, secreted, 3B
G836u2	WIAF-12609	U28369	1479	SEMA3B, sema domain,	GTCCTGCCCA[C/T]TGGGGGGCGC	M	C	T	T	I
				immunoglobulin domain (Ig), short
				basic domain, secreted, 3B
G838u1	WIAF-12590	U72671	1107	ICAMS, intercellular adhesion	CGCAGCTGGG[A/G]CCCAAGCTCT	M	A	G	T	A
				molecule 5, telencephalin
G838u2	WIAF-12591	U72671	966	ICAMS, intercellular adhesion	CAGGCAGCTG[A/G]TCTGCAACGT	M	A	G	I	V
				molecule 5, telencephalin
G840a1	WIAF-12109	HT961	2232	SOS1, son of sevenless	CTCAGGCAAA[T/C]GGAGTAAGCC	S	T	C	N	N
				(Drosophila) homolog 1
G840a2	WIAF-12110	HT961	2404	SOS1, son of sevenless	ACCGTCTAAA[C/G]TTGTAGGGAG	M	C	G	L	V
				(Drosophila) homolog 1
G840u3	WIAF-12213	HT961	3813	SOS1, son of sevenless	CAAGGGTACC[G/A]CGTCGATGCT	S	G	A	P	P
				(Drosophila) homolog 1
G841u1	WIAF-12153	HT97420	1372	SMOH, smoothened (Drosophila)	TTTTGGCTTC[C/G]TGGCCTTTGG	M	C	G	L	V
				homolog
G841u2	WIAF-12179	HT97420	858	SMOH, smoothened (Drosophila)	CCCAGTTCAT[G/T]GATGGTGGCC	M	G	T	M	I
				homolog
G841u3	WIAF-12185	HT97420	1164	SMOH, smoothened (Drosophila)	CTGTGAGTGG[C/G]ATTTGTTTTG	S	C	G	G	G
				homolog
G847u1	WIAF-12588	L41939	2019	RPHB2, EphB2	GGTCTGCAGT[G/T]GCCACCTGAA	M	G	T	G	C
G847u2	WIAF-12596	L41939	1806	EPHB2, EphB2	GTGTAACAGA[A/C]GACGGGGGTT	S	A	C	R	R
G847u3	WIAF-12613	L41939	2885	EPHB2, EphB2	AGGCCATCAA[G/C]ATGGGGCAGT	M	G	C	X	H
G848u1	WIAF-12685	L40636	2484	EPHB1, EphB1	GTCAACAGTA[A/G]CCTGGTGTGC	M	A	G	N	S
G848u2	WIAF-12690	L40636	2020	EPHB1, EphB1	CCTTCACTTA[T/C]GAGGATCCCA	S	T	C	Y	Y
G849u1	WIAF-11920	D83492	1544	EPHB6, EphB6	ACCTGTGTGG[C/T]TCATGCAGAG	M	C	T	A	V
G849u2	WIAF-11921	D83492	3301	EPHB6. EphB6	CTTTGGGATA]C/T]TCATGTGGGA	M	C	T	L	F
G849u3	WIAF-13412	D83492	1139	EPHB6, EphB6	GAGACCTTCA[C/T]CCTTTACTAC	M	C	T	T	I
G849u4	WIAF-13413	D83492	1895	EPHB6, EphB6	TTTGAGGTGC[A/C]AGGCTCAGCA	M	A	C	Q	P
G849u5	WIAF-13414	D83492	2338	EPHB6, EphB6	CTATGACCAG[G/A]CAGAAGACGA	M	G	A	A	T
G849u6	WiAF-13415	D83492	2567	EPHB6, EphB6	GGGGCTTTGG[C/G]CTTCCTCCTG	M	C	G	A	G
G849u7	WIAF-13422	D83492	2860	EPHB6, EphB6	GGCCATCCAG[G/A]CCCTGTGGGC	M	G	A	A	T
G849u8	WIAF-13423	D83492	2782	EPHB6, EphB6	GGAGGTCATT[G/C]GGACAGGCTC	M	G	C	G	R
G849u9	WIAF-13424	D83492	3038	EPHB6, EphB6	TTCCTCAGGC[A/G]GCGGGAGGGC	M	A	G	Q	R
G849u10	WIAF-13425	D83492	3637	EPHB6, EphB6	AGCCATTGGA[C/T]TGGAGTGCTA	S	C	T	L	L
G856u1	WIAF-12625	D45906	1323	LIMK2, LIM domain kinase 2	AGCTGAACCT[G/C]CTGACAGAGT	S	G	C	L	L
G858u1	WIAF-12630	U65019	864	MADH2, MAD (mothers against	TTTGGTGTTC[G/A]ATAGCATATT	S	G	A	S	S
				decapentaplegic, Drosophila)
				homolog 2
G86u1	WIAF-10437	HT1701	263	RAD51, RAD51 ( S. cerevisiae )	TGAAGCAAAT[G/C]CAGATACTTC	M	G	C	A	P
				homolog ( E coli RecA homolog)
G86u2	WIAF-10465	HT1701	861	RAD51, RAD51 ( S. cerevisiae )	GCATCAGCCA[T/C]GATGGTAGAA	M	T	C	M	T
				homolog ( E coli RecA homolog)
G86u3	WIAF-10466	HT1701	924	RAD51, RAD51 ( S. cerevisiae )	TACAGAACAG[A/G]CTACTCGGGT	M	A	G	D	G
				homolog ( E coli RecA homolog)
G864a1	WIAF-13139	X82324	183	POU3F4, POU domain, class 3,	CAGCAATGGG[C/]ATCCCCTCGG	M	C	t	H	Y
				transcription factor 4
G866u1	WIAF-12637	HT0101	2576	glutamate receptor (GB:M64752)	AAATCCCGTA[G/A]TGAATCCAAG	M	G	A	S	N
G866u2	WIAF-12638	HT0301	1131	glutamate receptor (GB:M64752)	TAACAGGAAA[C/T]GTGCAGTTTA	S	C	T	N	N
G869u1	WIAF-13406	HT33620	3627	GRIN2C, glutamate receptor,	AGATCAGCAG[G/T]GTAGCCCGTG	M	G	T	R	S
				ionotropic, N-methyl D-aspartate
				2C
G870u1	WIAF-11889	HT4468	714	SLC1A1, solute carrier family 1	CAGAAGAGTC[C/G]TTCACAGCTG	S	C	G	S	S
				(neuronal/epithelial high affinity
				glutamate transporter, system
				Xag), member 1
G870u2	WIAF-11913	HT4468	314	SLC1A1, solute carrier family 1	CTAGAGAAAT[T/A]CTACTTTGCT	M	T	A	F	Y
				(neuronal/epithelial high affinity
				glutamate transporter, system
				Xag), member 1
G870u3	WIAF-11914	HT4468	579	SLC1A1, solute carrier family 1	AAGTCAGTAC[G/A]GTGGATGCCA	S	G	A	T	T
				(neuronal/epithelial high affinity
				glutamate transporter, system
				Xag), member 1
G870u4	WIAF-11922	HT4468	706	SLC1A1, solute carrier family 1	GAACATGACA[G/A]AAGAGTCCTT	M	G	A	E	K
				(neuronal/epithelial high affinity
				glutamate transporter, system
				Xag), member 1
G870u5	WIAF-11923	HT4468	978	SLC1A1, solute carrier family 1	GGGAGATCAT[A/G]GAAGTTGAAG	M	A	G	I	M
				(neuronal/epithelial high affinity
				glutamate transporter, system
				Xag), member 1
G871u1	WIAF-11892	HT3187	1004	SLC1A3, solute carrier family 1	TTCTCTTAAC[G/C]AAGCCATCAT	M	G	C	E	Q
				(glial high affinity glutamate
				transporter), member 3
G871u2	WIAF-11915	HT3187	1154	SLC1A3, solute carrier family 1	TGTTGGCTTA[C/T]TCATTCACGC	M	C	T	L	F
				(glial high affinity glutamate
				transporter), member 3
G871u3	WIAF-11926	HT3187	1412	SLC1A3, solute carrier family 1	GGCTGCCATT[T/G]TCATTGCTCA	M	T	G	F	V
				(glial high affinity glutamate
				transporter), member 3
G871u4	WIAF-11944	HT3187	1217	SLC1A3, solute carrier family 1	AAACCCTTGG[G/A]TTTTTATTGG	M	G	A	V	I
				(glial high affinity glutamate
				transporter), member 3
G872u1	WIAF-13433	HT4077	1271	SLC1A2, solute carrier family 1	CTGTTGGAGC[A/C]ACCATTAACA	S	A	C	A	A
				(glial high affinity glutamate
				transporter), member 2
G879u1	WIAF-11899	HT28317	1273	GRM2, glutamate receptor,	GACTTTGTGC[T/C]CAACGTCAAG	M	T	C	L	P
				metabotropic 2
G879u2	WIAF-11932	HT28317	2349	GRM2, glutamate receptor,	CTTCTATGTC[A/G]CCTCCAGTGA	M	A	G	T	A
				metabotropic 2
G879u3	WIAF-13421	HT28317	2186	GRM2, glutamate receptor,	ATGCAAGTAT[G/T]TTGGGCTCGC	M	G	T	M	I
				metabotropic 2
G879u4	WIAF-13429	HT28317	2567	GRM2, glutamate receptor,	CCCAGTTTGT[C/T]CCCACTGTTT	S	C	T	V	V
				metabotropic 2
G879u5	WIAF-13436	HT28317	2046	GRM2, glutamate receptor,	ACAGGTGGCC[A/G]TCTGCCTGGC	M	A	G	I	V
				metabotropic 2
G879u6	WIAF-13438	HT28317	2425	GRM2, glutamate receptor,	GTGCTTGGCT[G/T]CCTCTTTGCG	M	G	T	C	F
				metabotropic 2
G879u7	WIAF-13439	HT28317	2463	GRM2, glutamate receptor,	CCTGTTCCAG[C/T]CGCAGAAGAA	M	C	T	P	S
				metabotropic 2
G880u1	WIAF-12164	HT33719	2117	GRM4, glutamate receptor,	AGCCCGACCT[T/G]GGCACCTGCT	S	T	G	L	L
				metabotropic 4
G880u2	WIAF-12176	HT33719	2427	GRM4, glutamate receptor,	GGACCTGTCG[C/T]TCATCTGCCT	M	C	T	L	F
				metabotropic 4
G880u3	WIAF-12192	HT33719	2372	GRM4, glutamate receptor,	ACCAGCGGAC[A/G]CTCGACCCCC	S	A	G	T	T
				metabotropic 4
G883a1	WIAF-13140	HT48863	1408	GRM7, glutamate receptor,	ATCGCAAATG[C/a]ACAGGACAGG	M	C	a	C	*
				metabotropic 7
G883a2	WIAF-13141	HT48863	2027	GRM7, glutamate receptor,	TCCTGTCTTC[C/t]TGGCAATGTT	S	C	t	L	L
				metabotropic 7
G883a3	WIAF-13147	HT48863	1813	GRM7, glutamate receptor,	TGTGCACACT[A/g]CCATGTAAGC	S	A	g	L	L
				metabotropic 7
G883a4	WIAF-13148	HT48863	1536	GRM7, glutamate receptor,	TGTGCGGACT[A/t]CCGGGGTGTC	M	A	t	Y	F
				metabotropic 7
G883a5	WIAF-13149	HT48863	2473	GRM7, glutamate receptor,	AAGCCAGAGG[G/a]GTTCTCAAGT	S	G	s	G	G
				metabotropic 7
G883a6	WIAF-13150	HT48863	2434	GRM7, glutamate receptor,	TCATAGACTA[C/t]GATGAACACA	S	C	t	Y	Y
				metabotropic 7
G884u1	WIAF-11916	U95025	1052	GRM8, glutamate receptor,	CGAACTCTTG[C/A]CAATAATCGA	M	C	A	A	D
				metabotropic 8
G884u2	WIAF-11945	U95025	2016	GRM8, glutamate receptor,	AAACAAACCG[T/C]ATCCACCGAA	S	T	C	R	R
				metabotropic 8
G884u3	WIAF-11946	U95025	1852	GRM8, glutamate receptor,	GAGGGCTTCA[G/A]GACGCGAACT	M	G	A	G	R
				metabotropic 8
G884u4	WIAF-11947	U95025	2078	GRM8, glutamate receptor,	ATTAGTCCAG[C/G]ATCTCAGCTG	M	C	G	A	G
				metabotropic 8
G884u5	WIAF-13430	U95025	1897	GRM8, glutamate receptor,	TTTTCTCTGT[T/G]ATTCAATCAC	M	T	G	Y	D
				metabotropic 8
G884u6	WIAF-13435	U95025	2364	GRM8, glutamate receptor,	TTACCATGTA[T/C]ACCACCTGCA	S	T	C	Y	Y
				metabotropic 8
G885u1	WIAF-13434	AF002700	1363	GFRA2, GDNF family receptor alpha	AACTCAGGCC[C/A]CAGCAGAGCC	M	C	A	P	H
				2
G886a1	WIAF-13142	U95847	497	GFRA1, GDNF family receptor alpha	GAAGTCGCTC[T/a]ACAACTGCCG	M	T	a	Y	N
				1
G886a2	WIAF-13143	U95847	1385	GFRA1, GDNF family receptor alpha	GTCTGAGAAT[G/a]AAATTCCCAC	M	G	a	E	K
				1
G886a3	WIAF-13151	U95847	781	GFRA1, GDNF family receptor alpha	GCGTGTCCAA[T/c]GATGTCTGCA	G	T	c	N	N
				1
G892u1	WIAF-11956	U12140	798	NTRK2, neurotrophic tyrosine	TGGGCAATCC[A/G]TTTACATGCT	S	A	G	P	P
				kinase, receptor, type 2
G892u2	WIAF-11957	U12140	834	NTRK2, neurotrophic tyrosine	GGATCAAGAC[T/A]CTCCAAGAGG	S	T	A	T	T
				kinase, receptor, type 2
G892u3	WIAF-11958	U12140	956	NTRK2, neurotrophic tyrosine	GCAAATCTGG[C/T]CGCACCTAAC	M	C	T	A	V
				kinase, receptor, type 2
G892u4	WIAF-11960	U12140	1738	NTRK2, neurotrophic tyrosine	CTCCAAGTTT[G/A]GCATGAAAGG	M	G	A G	S
				kinase, receptor, type 2
G892u5	WIAF-11962	U12140	2486	NTRK2, neurotrophic tyrosine	GTCGGTGGCC[A/G]CACAATGCTG	M	A	G H	R
				kinase, receptor, type 2
G892u6	WIAF-11965	U12140	1106	NTRK2, neurotrophic tyrosine	TCCTTAAGGA[T/C]AACTAACATT	M	T	C X	T
				kinase, receptor, type 2
G892u7	WIAF-11966	U12140	2085	NTRK2, neurotrophic tyrosine	AGGATGCCAG[T/C]GACAATGCAC	S	T	C	S	S
				kinase, receptor, type 2
G892u8	WIAF-11967	U12140	2230	NTRK2, neurotrophic tyrosine	GGACCTCAAC[A/C]AGTTCCTCAG	M	A	C	K	Q
				kinase, receptor, type 2
G892u9	WIAF-11968	U12140	2223	NTRK2, neurotrophic tyrosine	AGCATGGGGA[C/T]CTCAACAAGT	S	C	T	D	D
				kinase, receptor, type 2
G892u10	WIAF-11992	U12140	1602	NTRK2, neurotrophic tyrosine	GTAATGAAAT[c/T]CCTTCCACAG	S	C	T	I	I
				kinase, receptor, type 2
G892u11	WIAF-11998	U12140	1354	NTRK2, neurotrophic tyrosine	TACTAAAATA[C/T]ATGTTACCAA	M	C	T	H	Y
				kinase, receptor, type 2
G892u12	WIAF-11999	U12140	1944	NTRK2, neurotrophic tyrosine	CATTTGTTCA]G/C]CACATCAAGC	M	G	C	Q	H
				kinase, receptor, type 2
G892u13	WIAF-12000	U12140	2103	NTRK2, neurotrophic tyrosine	CACGCAAGGA[C/T]TTCCACCGTG	S	C	T	D	D
				kinase, receptor, type 2
G892u14	WIAF-12001	U12140	1860	NTRK2, neurotrophic tyrosine	CTGTCATTAT[T/C]GGAATGACCA	S	T	C	I	I
				kinase, receptor, type 2
G892a15	WIAF-13144	U12140	1868	NTRK2, neurotrophic tyrosine	ATTGGAATGA[C/G]CAAGATCCCT	M	C	G	T	S
				kinase, receptor, type 2
G892a16	WIAF-13145	U12140	1903	NTRK2, neurotrophic tyrosine	CCAGTACTTT[G/T]GCATCACCAA	M	G	T	G	C
				kinase, receptor, type 2
G892a17	WIAF-13140	U12140	1965	NTRK2, neurotrophic tyrosine	CACATAACAT[T/G]GTTCTGAAAA	M	T	G	I	M
				kinase, receptor, type 2
G892u18	WIAF-13442	U12140	958	NTRK2, neurotrophic tyrosine	AAATCTGGCC[G/T]CACCTAACCT	M	G	T	A	S
				kinase, receptor, type 2
G892u19	WIAF-13446	U12140	2502	NTRK2, neurotrophic tyrosine	TGCTGCCCAT[T/C]CGCTGGATGC	S	T	C	I	I
				kinase, receptor, type 2
G892u20	WIAF-13447	U12140	2317	NTRK2, neurotrophic tyrosine	GATGCTGCAT[A/T]TAGCCCAGCA	M	A	T	I	L
				kinase, receptor, type 2
G892u21	WIAF-13448	U12140	2364	NTRK2, neurotrophic tyrosine	CGTCCCAGCA[C/A]TTCGTGCACC	M	C	A	H	Q
				kinase, receptor, type 2
G892u22	WIAF-13449	Ul2140	2507	NTRK2, neurotrophic tyrosine	CCCATTCGCT[G/A]GATGCCTCCA	N	G	A	W	*
				kinase, receptor, type 2
G892u23	WIAF-13471	U12140	2389	NTRK2, neurotrophic tyrosine	TTTGGCCACC[A/C]GGAACTGCCT	S	A	C	R	R
				kinase, receptor, type 2
G892u24	WIAF-13472	U12140	2416	NTRK2, neurotrophic tyrosine	GGAGAACTTG[C/T]TGGTGAAAAT	S	C	T	L	L
				kinase, receptor, type 2
G892u25	WIAF-13474	U12140	359	NTRK2, neurotrophic tyrosine	GGGATGTCGT[C/T]CTGGATAAGG	M	C	T	S	F
				kinase, receptor, type 2
G892u26	WIAF-13479	U12140	1044	NTRK2, neurotrophic tyrosine	TGTATTGGGA[T/C]GTTGGTAACC	S	T	C	D	D
				kinase, receptor, type 2
G9u1	WIAF-10222	J03826	1130	FDXR, ferredoxin reductase	GGTATAAGAG[C/T]CGCCGTGTCG	S	C	T	S	S
G9u2	WIAF-10258	J03826	388	FDKR, ferredoxin reductase	CCGGAGCTGC[A/G]GGAGGCCTAC	M	A	G	Q	R
G900u1	WIAF-11970	HT3470	497	STK4A, syntaxin 4A (placental)	TGCAATTCAA[T/C]GCAGTCCGAA	M	T	C	M	T
G901u1	WIAF-11969	HT27792	758	STX3A, syntaxin 3A	TGCACACAGT[G/A]GACCACGTGG	S	G	A	V	V
G901u2	WIAF-11971	HT27792	317	STX3A, syntaxin 3A	ACGTCCGGAA[C/A]AAACTGAAGA	M	C	A	N	X
0901u3	WIAF-12002	HT27792	611	STX3A, syntaxin 3A	AGCAAGCCCT[C/T]AGTGAGATTG	S	C	T	L	L
G901u4	WIAF-12003	HT27792	909	STX3A, syntaxin 3A	GCTGAATTAA[G/A]AGTGGCCTAA	—	G	A	—	—
G901u5	WIAF-12004	HT27792	163	STX3A, syntaxin 3A	ATTGAGGAAA[C/T]TCGGCTTAAC	M	C	T	T	I
G901a6	WIAF-13152	HT27792	62	STX3A, syntaxin 3A	CAGCTGACAC[A/G]GGATGATGAT	M	A	G	Q	R
G901u7	WIAF-13453	HT27792	828	STX3A, syntaxin 3A	CCGGAAGAAA[T/C]TGATAATTAT	S	T	C	L	L
G901u8	WIAF-13455	HT27792	226	STX3A, syntaxin 3A	TACAGTATCA[T/C]TCTGTCTGCA	M	T	C	I	T
G902u1	WIAF-13454	HT27744	848	STX5A, syntaxin 5A	ACTTCCAGTC[T/A]GTCACCTCCA	S	T	A	S	S
G902u2	WIAF-13456	HT27744	338	STX5A, ayntaxin 5A	ATTTCGTGAG]A/G]GCCAAGGGCA	S	A	G	R	R
G905u1	WIAF-12202	HT27789	487	CREBL1, cAMP responsive element	TCCAGATCAA[C/T]GTTATCCCCA	S	C	T	N	N
				binding protein-like 1
G905u2	WIAF-12219	HT27789	151	CREBL1, cAMP responsive element	ATTCTGGCCT[A/T]GATGAAGTGG	S	A	T	L	L
				binding protein-like 1
G905u3	WIAF-12230	HT27789	649	CREBL1, cAMP responsive element	AGTCCCTGTC[C/G]CCTTCAGGAT	S	C	G	S	S
				binding protein-like 1
G906u1	WIAF-12214	HT4372	2127	N-ethylmaleimide-sensitive factor	AAGGGAAGAA[G/A]GTCTGGATAG	S	G	A	K	K
G906u2	WIAF-12221	HT4372	514	N-ethylmaleimide-sensitive factor	GGGAGAGCCT[G/A]CGACAGGGAA	M	G	A	A	T
G908u1	WIAF-12201	HT3665	98	RAB5A, RAB5A, member RAS	GCCCAAATAC[T/G]GGAAATAAAA	S	T	G	T	T
				oncogene family
G91u1	WIAF-10438	HT1848	496	ERCC1, excision repair cross-	TCGTGCGCAA[C/T]GTGCCCTGGG	S	C	T	H	H
				complementing rodent repair
				deficiency, complementation group
				1 (includes overlapping antisense
				sequence)
G91u2	WIAF-10439	HT1848	367	ERCC1, excision repair cross-	CTGGGGCCAC[G/A]TGCCCCACAG	S	G	A	T	T
				complementing rodent repair
				deficiency, complementation group
				1 (includes overlapping antisense
				sequence)
G914a1	WIAF-13210	HT3672	252	synaptobrevin 1	GCAGTGCTGC[C/A]AAGCTAAAGA	S	C	A	A	A
G915a1	WIAF-12115	D63506	1390	Homo sapiens mRNA for unc-	TTACCTTGGT[G/A]TTCCCATTGT	M	G	A	V	I
				18homologue, complete cds.
G915u2	WIAF-12293	D63506	685	Homo sapiens mRNA for unc-	ACAGCTTGTT[G/A]AAAAAAAGCT	M	G	A	E	K
				18homologue, complete cds.
G916a1	WIAF-13209	HT28523	308	Huntingtin associated protein 1-	GAGCAGTTTT[C/T]GGAGGCCAGC	M	C	T	S	L
				like protein
G916a2	WIAF-13211	HT28523	762	Huntingtin associated protein 1-	CGGAGGAGTT[G/C]GTGCCCCAGG	M	G	C	L	F
				like protein
G916a3	WIAF-13212	HT28523	560	Huntingtin associated protein 1-	GAGCTCAGAA[C/T]GTCTCTAAGG	M	C	T	T	M
				like protein
G917u1	WIAF-11972	U79734	1075	HIP1, huntingtin interacting	AGAGCCAGCG[G/A]GTTGTGCTGC	S	G	A	R	R
				protein 1
G917u2	WIAF-11973	U79734	1005	HIP1, huntingtin interacting	GACCACTTAA[T/C]TGAGCGACTA	M	T	C	I	T
				protein 1
G917u3	WIAF-11977	U79734	1539	HIP1, huntingtin interacting	CTGCAAGGCA[G/A]CCTGGAAACT	M	G	A	S	N
				protein 1
G917u4	WIAF-12005	U79734	817	HIP1, huntingtin interacting	TGGTGGTGAT[C/T]CCTGCAGAGG	S	C	T	I	I
				protein 1
G917u5	WIAF-12006	U79734	1906	HIP1, huntingtin interacting	GCTGGAGCCA[G/C]TATCTGGCCT	M	G	C	Q	H
				protein 1
G917u6	WIAF-13157	U79734	993	HIP1, huntingtin interacting	AAGGATGAGA[A/G]GGACCACTTA	M	A	G	K	R
				protein 1
G919u1	WIAF-11974	D30742	707	CAMK4, calcium/calmodulin-	ACTGCGCACC[T/C]GAAATTCTTA	S	T	C	P	P
				dependent protein kinase IV
G919u2	WIAF-11991	D30742	1139	CAMK4, calcium/calmodulin-	AGAGCCACAA[G/A]GCTAGCCGAG	S	G	A	K	K
				dependent protein kinase IV
G919u3	WIAF-12007	D30742	834	CAMK4, calcium/calmodulin-	CATGTTCAGG[A/T]GAATTCTGAA	N	A	T	R	*
				dependent protein kinase IV
G919u4	WIAF-13443	D30742	1088	CAMK4, calcium/calmodulin-	TGGCCTCTTC[C/G]CGCCTGGGAA	S	C	G	S	S
				dependent protein kinase IV
G920u1	WIAF-11979	X78520	1952	CLCN3, chloride channel 3	ATGACATTCC[T/C]GATCGTCCAG	S	T	C	P	P
G920u2	WIAF-11980	X78520	1819	CLCN3, chloride channel 3	ATAGCCTTCC[C/T]TAATCCATAC	M	C	T	P	L
G920u3	WIAF-11981	X78520	2094	CLCN3, chloride channel 3	CATTGGAGCG[A/G]TCGCAGGAAG	M	A	G	I	V
G920u4	WIAF-11983	X78520	2822	CLCN3, chloride channel 3	ATATTTTCCG[A/G]AAGCTGGGAC	S	A	G	R	R
G920u5	WIAF-11984	X78520	2745	CLCN3, chloride channel 3	GCCATTGAAG[C/T]TTCGAAGCAT	M	C	T	L	F
G920u6	WIAF-11987	X78520	2499	CLCN3, chloride channel 3	TCCCTTAGCT[G/T]TCCTGACACA	M	G	T	V	F
G920u7	WIAF-12008	X78520	1251	CLCN3, chloride channel 3	CATCATCAGA[G/A]GTTACTTGGG	M	G	A	G	S
G920u8	WIAF-12011	X78520	888	CLCN3, chloride channel 3	AGTAGTAACA[C/T]TAACAGGATT	S	C	T	L	L
G920u9	WIAF-13459	X78520	2804	CLCN3, chloride channel 3	CAATGGAGAT[T/C]GTGGTGGATA	S	T	C	I	I
G921u1	WIAF-11954	J02908	931	CLU, clusterin (complement lysis	GAGAGGTTGA[C/T]CAGGAAATAC	M	C	T	T	I
				inhibitor, SP-40,40, sulfated
				glycoprotein 2, testosterone-
				repressed prostate message 2,
				apolipoprotein J)
G921u2	WIAF-11955	J02908	880	CLU, clusterin (complement lysis	CCCTCCCAGG[C/T]TAAGCTGCGG	M	C	T	A	V
				inhibitor, SP-40,40, sulfated
				glycoprotein 2, testosterone-
				repressed prostate message 2,
				apolipoprotein J)
G921u3	WIAF-11990	J02908	1051	CLU, clusterin (complement lysis	CTCACGCAAG[G/C]CGAAGACCAG	M	G	C	G	A
				inhibitor, SP-40,40, sulfated
				glycoprotein 2, testosterone-
				repressed prostate message 2,
				apolipoprotein J)
G921u4	WIAF-13469	J02908	986	CLU, clusterin (complement lysis	TCAACACCTC[C/T]TCCTTGCTGG	S	C	T	S	S
				inhibitor, SP-40,40, sulfated
				glycoprotein 2, testosterone-
				repressed prostate message 2,
				apolipoprotein J)
G923u1	WIAF-11993	M19650	1059	Human 2′,3′-cyclic nucleotide 3′-	GAGCTAAGCC[G/A]GGGCAAGCTC	M	G	A	R	Q
				phosphodiesterase mRNA, complete
				cs.
G923u2	WIAF-11994	M19650	1062	Human 2′,3′-cyclic nucleotide 3′-	CTAAGCCGGG[G/T]CAAGCTCTAT	M	G	T	G	V
				phosphodiesterase mRNA, complete
				cs.
G923u3	WIAF-13445	M19650	1141	Human 2′,3′-cyclic nucleotide 3′-	TCTTCACGGG[G/A]TACTACGGGA	S	G	A	G	G
				phosphodiesterase mRNA, complete
				cs.
G925u1	WIAF-11953	L11315	666	CAK, cell adhesion kinase	GGGTCATGAG]T/C]GTCTGTCTGC	S	T	C	S	S
G925u2	WIAF-11959	L11315	2562	CAK, cell adhesion kinase	TGCTGCCCAT[C/T]CGCTGGATGG	S	C	T	T	I
G925u3	WIAF-11996	L11315	2049	CAK, cell adhesion kinase	AAGATCTGGT[T/C]AGTCTTGATT	S	T	C	V	V
G925u4	WIAF-13440	L11315	1601	CAK. cell adhesion kinase	TACCAGGAGC[C/T]CCGGCCTCGT	M	C	T	P	L
G925u5	WIAF-13441	L11315	1629	CAK, cell adhesion kinase	CGCCCCACTC[C/T]GCTCCCTGTG	S	C	T	S	S
G925u6	WIAF-13451	L11315	2262	CAK, cell adhesion kinase	TGGAGAACGG[C/T]GACCTCAACC	S	C	T	G	G
G926u1	WIAF-11961	AF018956	577	NRP1, neuropilin 1	TGAAAGCTTT[G/T]ACCTGGAGCC	M	G	T	D	Y
G926u2	WIAF-11963	AF018956	1683	NRP1, neuropilin 1	CCACGCGATT[C/G]ATCAGGATCT	M	C	G	F	L
G926u3	WIAF-11975	AF018956	2176	NRP1, neuropilin 1	GACCTTCTGG]T/C]ATCACATGTC	M	T	C	Y	H
G926u4	WIAF-11976	AF018956	2092	NRP1, neuropilin 1	TTCCCAAGCT[G/T]ACGAAAATCA	M	G	T	D	Y
G926a5	WIAF-13158	AF018956	747	NRP1, neuropilin 1	TTTTTTACAC[C/T]GACAGCGCGA	S	C	T	T	T
G926a6	WIAF-13159	AF018956	996	NRP1, neuropilin 1	ACTTGGGCCT[T/C]CTGCGCTTTG	S	T	C	L	L
G926u7	WIAF-13444	AF018956	644	NRP1, neuropilin 1	GAAATCTGGG[A/C]TGGATTCCCT	M	A	C	D	A
G926u8	WIAF-13450	AF018956	1738	NRP1, neuropilin 1	CAGAATGGAG[C/G]TGCTGGGCTG	M	C	G	L	V
G926u9	WIAF-13452	AF018956	537	NRP1, neuropilin 1	TTGTCTTTGC[G/A]CCAAAGATGT	S	G	A	A	A
G926u10	WIAF-13457	AF018956	2197	NRP1, neuropilin 1	TGGGTCCCAC[G/A]TCGGCACACT	M	G	A	V	I
G927u1	WIAF-11978	AF022860	870	NRP2, neuropilin 2	GGATTGCTAA[T/C]GAACAGATCA	S	T	C	N	N
G927u2	WIAF-11982	AF022860	1674	NRP2, neuropilin 2	ATGACACCCC[T/G]GACATCCGAA	S	T	G	P	P
G927u3	WIAF-11985	AF022860	1250	NRP2, neuropilin 2	TGGCACTCAG[G/A]TATCGCCCTC	M	G	A	G	D
G927u4	WIAF-11986	AF022860	1071	NRP2, neuropilin 2	ATGGCTACTA[C/T]GTCAAATCCT	S	C	T	Y	Y
G927u5	WIAF-12009	AF022860	726	NRP2, neuropilin 2	GTTCATCGAC]G/A]GGGATCCTCT	S	G	A	T	T
G927u6	WIAF-12010	AF022860	2522	NRP2, neuropilin 2	GCAACCTCAG[G/T]GTCTGGCGCC	M	G	T	G	V
G927u7	WIAF-12012	AF022860	123	NRP2, neuropilin 2	GCTATATCAC[C/T]TCTCCCGGTT	S	C	T	T	T
G927a8	WIAF-13160	AF022860	2427	NRP2, neuropilin 2	CTTTTGGAGT[G/T]GACATCCCAG	S	G	T	V	V
G927a9	WIAF-13161	AF022860	2430	NRP2, neuropilin 2	TTGCAGTGGA[C/G]ATCCCAGAAA	M	C	G	D	E
G927a10	WIAF-13162	AF022860	2463	NRP2, neuropilin 2	AAGGATATGA[A/G]GATGAAATTG	S	A	G	E	E
G927a11	WIAF-13163	AF022860	2473	NRP2, neuropilin 2	AGATGAAATT[G/T]ATGATGAATA	M	G	T	D	Y
G927u12	WIAF-13480	AF022860	724	NRP2, neuropilin 2	TCGTTCATCG[A/T]CGGGGATCCT	M	A	T	T	S
G927u13	WIAF-13481	AF022860	767	NRP2, neuropilin 2	ATGGCGGTGG[C/T]CAAGGATGGC	M	C	T	A	V
G930a1	WIAF-13164	HT2608	609	GABRA2, gamma-aminobutyric acid	ACAATGGGAA[G/a]AAATCAGTAG	S	G	a	K	K
				(GABA) A receptor, alpha 2
G931a1	WIAF-13153	HT2609	1111	GABRA3, gamma-aminobutyric acid	ACTGGTTCAT[A/g]GCCGTCTGTT	M	A	g	I	M
				(GABA) A receptor, alpha 3
G931a2	WIAF-13165	HT2609	1448	GABRA3, gamma-aminobutyric acid	TGTCAGCAAG[G/A]TTGACAAAAT	M	G	A	V	I
				(GABA) A receptor, alpha 3
G932a1	WIAF-13154	HT27773	1077	GABRA4, gamma-aminobutyric acid	CAAAAGAAAG[A/G]CATCAAAGCC	M	A	G	T	A
				(GABA) A receptor, alpha 4
G932a2	WIAF-13155	HT27773	1189	GABRA4, gamma-aminobutyric acid	AGAACAAATG[C/A]TTTGGTTCAC	M	C	A	A	D
				(GABA) A receptor, alpha 4
G936u1	WIAF-12308	HT3432	1027	GABRB2, gamma-aminobutyric acid	AATTACGATG[C/T]TTCAGCTGCA	M	C	T	A	V
				(GABA) A receptor, beta 2
G936u2	WIAF-12327	HT3432	362	GABRB2, gamma-aminobutyric acid	AAGGCTATGA[C/T]ATTCGTCTGA	S	C	T	D	D
				(GABA) A receptor, beta 2
G936u3	WIAF-12328	HT3432	571	GABRB2, gamma-aminobutyric acid	CTCTGGGTGC[C/T]TGATACCTAT	M	C	T	P	L
				(GABA) A receptor, beta 2
G939u1	WIAF-12330	HT2236	1219	GABRB2, gamma-aminobutyric acid	CTGGATGGAA[G/C]CTACAGTGAG	M	G	C	S	T
				(GABA) receptor, rho 2
G939u2	WIAF-12355	HT2236	1003	GABRB2, gamma-aminobutyric acid	ACCACCATCA[T/C]CACGGGCGTG	M	T	C	I	T
				(GABA) receptor, rho 2
G939u3	WIAF-12356	HT2236	1041	GABRB2, gamma-aminobutyric acid	CGTCTCCTAC]G/A]TCAAGGCCGT	M	G	A	V	I
				(GABA) receptor, rho 2
G950u1	WIAF-13622	U64871	785	Human putative G protein-coupled	GTCCTGCTCC[A/C]GTTCACCACT	M	A	C	Q	P
				receptor (GBR19) gene, complete
				cds.
G950u2	WIAF-13624	U64871	443	Human putative G protein-coupled	GATAACAGCA[A/C]GCCACATTTG	M	A	C	K	T
				receptor (GBR19) gene, complete
				cds.
G950u3	WIAF-13625	U64871	818	Human putative G protein-coupled	CTGGGTAGTG[C/T]AACGTGCAAG	M	C	T	A	V
				receptor (GBR19) gene, complete
				cds.
G955a1	WIAF-13166	HT3860	5110	calcium channel, voltage-gated,	CTGGCCTCTT[T/c]ACCGTGGAGA	S	T	c	F	F
				alpha 1 subunit, L type, alt.
				transcript 1
G955a2	WIAF-33167	HT3860	3842	calcium channel, voltage-gated,	CTACCCCAAC[C/a]CAGAAACTAC	M	C	a	P	T
				alpha 1 subunit, L type, alt.
				transcript 1
G955a3	WIAF-13168	HT3860	5624	calcium channel, voltage-gated,	GTGTGCCCCA[G/a]AGTCCGAGCC	M	G	a	E	K
				alpha 1 subunit, L type, alt.
				transcript 1
G955a4	WIAF-13169	HT3860	5703	calcium channel, voltage-gated,	ATCAGCTTCT[A/g]CATGCTCTGT	M	A	g	Y	C
				alpha 1 subunit, L type, alt.
				transcript 1
G955a5	WIAF-13170	HT3860	5889	calcium channel, voltage-gated,	ACCACCTGGA[T/c]GAGTTTAAAA	S	T	c	D	D
				alpha 1 subunit, L type, alt.
				transcript 1
G955a6	WIAF-13171	HT3860	6616	calcium channel, voltage-gated,	CCGGCTCCAA[C/t]GCCAACATCA	S	C	t	N	N
				alpha 1 subunit, L type, alt.
				transcript 1
G956u1	WIAF-14187	HT2199	1334	calcium channel, voltage-gated,	CTTCACATAG[C/T]CCTTTTGGTA	M	C	T	A	V
				alpha 1D subunit, DHP-sensitive
G956u2	WIAF-14188	HT2199	1452	calcium channel, voltage-gated,	AAGAGGACCC[A/T]GCTCCATGTG	S	A T	P	P
				alpha 1D subunit, DHP-sensitive
G956u3	WIAF-14189	HT2199	1614	calcium channel, voltage-gated,	GCTGGACAGA[C/T]GTGCTCTACT	S	C	T	D	D
				alpha 1D subunit, DHP-sensitive
G956u4	WIAF-14190	HT2199	2540	calcium channel, voltage-gated,	GGCAAGTTTA[A/T]TTTTGATGAA	M	A	T	N	I
				alpha 1D subunit, DHP-sensitive
G956u5	WIAF-14191	HT2199	3210	calcium channel, voltage-gated,	TGCTGAGCAG[T/C]GCTGCCCTGG	S	T	C	S	S
				alpha 1D subunit, DHP-sensitive
G956u6	WIAF-14192	HT2199	3326	calcium channel, voltage-gated,	TTGAAGATGA[C/T]AACTTTTGGA	M	C	T	T	I
				alpha 1D subunit, DHP-sensitive
G956u7	WIAF-14193	HT2199	3274	calcium channel, voltage-gated,	ACTGGGTTAC[T/C]TTGACTATGC	M	T	C	F	L
				alpha 1D subunit, DHP-sensitive
G956u8	WIAF-14194	HT2199	5127	calcium channel, voltage-gated,	TGCCTGTCAA[C/T]AGTGACGGGA	S	C	T	N	N
				alpha 1D subunit, DHP-sensitive
G956u9	WIAF-14195	HT2199	5173	calcium channel, voltage-gated,	TGCTTTGGTT[C/T]GAACGGCTCT	N	C	T	R	*
				alpha 1D subunit, DHP-sensitive
G956u10	WIAF-14200	HT2199	1437	calcium channel, voltage-gated,	CAGATATCGT[A/G]GCTGAAGAGG	S	A	G	V	V
				alpha 1D subunit, DHP-sensitive
G956u11	WIAF-14201	HT2199	2567	calcium channel, voltage-gated,	ACCAAGCGGA[G/T]CACCTTTGAC	M	G	T	S	I
				alpha 1D subunit, DHP-sensitive
G956u12	WIAF-14202	HT2199	4464	calcium channel, voltage-gated,	TCACCTTTTT[C/T]CGTCTTTTCC	S	C	T	F	F
				alpha 1D subunit, DHP-sensitive
G956u13	WIAF-14215	HT2199	6927	calcium channel, voltage-gated,	GCTACAGCGA[C/T]CAAGAGCCAG	S	C	T	D	D
				alpha 1D subunit, DHP-sensitive
G956u14	WIAF-14216	HT2199	6858	calcium channel, voltage-gated,	CCCGAGCCAA[C/T]GGCGATGTGG	S	C	T	N	N
				alpha 1D subunit, DHP-sensitive
G957u1	WIAF-12306	HT4229	915	calcium channel, voltage-gated,	TACATCGAGC[G/A]TGCTTCATGA	M	G	A	?	R
				alpha 1E subunit, alt. transcript
				2
G9S7u2	WIAF-12309	HT4229	3555	calcium channel, voltage-gated,	GCCACTACAT[C/T]GTGAACCTGC	S	C	T	I	I
				alpha 1E subunit, alt. transcript
				2
G957u3	WIAF-12310	HT4229	4116	calcium channel, voltage-gated,	ATGTAGATCA[C/T]GAGAAAAACA	S	C	T	M	H
				alpha 1E subunit, alt. transcript
				2
G957u4	WIAF-12313	HT4229	5181	calcium channel, voltage-gated,	AGAACGAGAA[T/C]GAACGCTGCG	S	T	C	N	N
				alpha 1E subunit, alt. transcript
				2
G957u5	WIAF-12314	HT4229	5971	calcium channel, voltage-gated,	TATGGACCCC[G/A]CCGATGACGG	S	G	A	T	T
				alpha 1E subunit, alt. transcript
				2
G957u6	WIAF-12315	HT4229	5985	calcium channel, voltage-gated,	ATGACGGACA[G/T]TTCCAAGAAC	M	G	T	Q	M
				alpha 1E subunit, alt. transcript
				2
G957u7	WIAF-12329	HT4229	3100	calcium channel, voltage-gated,	GCTGGCAGGA[G/A]GCCTTGATGA	M	G	A	G	S
				alpha 1E subunit, alt. transcript
				2
G957u8	WIAF-12331	HT4229	6492	calcium channel, voltage-gated,	CCCTCCTTTC[C/T]TACAGCTCCC	M	C	T	?	R
				alpha 1E subunit, alt. transcript
				2
G957u9	WIAF-12354	HT4229	3839	calcium channel, voltage-gated,	AACGCTTTGG[G/C]AACCAACAAA	M	G	C	G	A
				alpha 1E subunit, alt. transcript
				2
G957u10	WIAF-12357	HT4229	4753	calcium channel, voltage-gated,	TGACTTCATC[A/G]CCGTGATTGG	M	A	G	T	A
				alpha 1E subunit, alt. transcript
				2
G960u1	WIAF-12305	HT3336	1246	CACNB3, calcium channel, voltage-	TTGATGCCCT[C/T]TGATGAGGCC	M	C	T	S	F
				dependent, beta 3 subunit
G960u2	WIAF-12340	HT3336	1288	CACNB3, calcium channel, voltage-	TGGACAGGAT[C/T]TTCACAGCGT	M	C	T	S	F
				dependent, beta 3 subunit
G960u3	WIAF-12345	HT3336	641	CACNB3, calcium channel, voltage-	AGGCTCTCTT[C/T]GACTTCCTCA	S	C	T	F	F
				dependent, beta 3 subunit
C960u4	WIAF-12346	HT3336	576	CACNB3, calcium channel, voltage-	CATGCGGCCT[G/A]GCGTGCTGGT	W	G	A	V	M
				dependent, beta 3 subunit
G961u1	WIAF-12322	U95019	2037	CACNB2, calcium channel, voltage-	ACTCTGCCTA[C/T]GTAGAGCGAA	S	C	T	Y	Y
				dependent, beta 2 subunit
G961u2	WIAF-12347	U95019	2007	CACNB2, calcium channel, voltage-	CATTTGACTC[G/A]GAAACCCAGG	S	G	A	S	S
				dependent, beta 2 subunit
G962u1	WIAF-12324	U95020	1423	CACNB4, calcium channel, voltage-	CCAATTGAAA[G/A]ACGAAGTCTA	M	G	A	R	K
G962u2	WIAF-12342	U95020	167	CACNB4, calcium channel, voltage-	GGAGCAGGTT[G/T]AAAAGATCCG	M	G	T	L	F
G962u3	WIAF-12350	U95020	1571	CACNB4, calcium channel, voltage-	ACACTTACAA[A/G]CCCCATAGGA	S	A	G	K	K
G965u1	WIAF-12312	U40583	1276	CHRNA7, cholinergic receptor,	TCCTGCACGG[T/C]GGGCAACCCC	S	T	C	G	G
				nicotinic, alpha polypeptide 7
G968a1	WIAF-12119	HT27592	1008	CHRNA1, cholinergic receptor,	ACACACACCA[C/T]CGCTCACCCA	S	C	T	H	M
				nicotinic, alpha polypepide 1
				(muscle)
G968u2	WIAF-12368	HT27592	1136	CHRNA1, cholinergic receptor,	AAGATTTTTA[C/T]AGAAGACATT	M	C	T	T	I
				nicotinic, alpha polypepide 1
				(muscle)
G973a1	WIAF-13172	HT48774	800	CHRNA2, cholinergic receptor,	ACACTTCAGA[C/t]GTGGTGATTG	S	C	t	D	D
				nicotinic, alpha polypeptide 2
				(neuronal)
G973a2	WIAF-13173	HT48774	927	CHRNA2, cholinergic receptor,	CTGGAACCCC[G/a]CTGATTTTGG	M	G	a	A	T
				nicotinic, alpha polypeptide 2
				(neuronal)
G977u1	WIAF-13949	Y08419	366	CHRNA5, cholinergic receptor,	AAGTTATACG[T/C]GTTCCTTCAG	S	T	C	R	R
				nicotinic, alpha polypeptide 5
G978a1	WIAF-13179	Y08417	1331	CHRNB3, cholinergic receptor,	CCATTAGATA[C/a]ATTTCGAGAC	N	C	a	Y	*
				nicotinic, beta polypeptide 3
G983a1	WIAF-13214	HT0374	236	NPY, neuropeptide Y	GATACTACTC[G/A]GCGCTGCGAC	S	G	A	S	S
G983a2	WIAF-13215	HT0374	290	NPY, neuropeptide Y	GAAAACGATC[C/T]AGCCCAGAGA	S	C	T	S	S
G983a3	WIAF-13216	HT0374	111	NPY, neuropeptide Y	GCGACTGGGG[C/T]TGTCCGGACT	S	C	T	L	L
G987a1	WIAF-13174	HT27830	159	PPYR1, pancreatic polypeptide	TGGTCTTCAT[C/T]GTCACTTCCT	S	C	T	I	I
				receptor 1
G987a2	WIAF-13175	HT27830	222	PPYR1, pancreatic polypeptide	TGATGTGTGT[G/A]ACTGTGAGGC	S	G	A	V	V
				receptor 1
G987a3	WIAF-13176	HT27830	322	PPYR1, pancreatic polypeptide	GCCGCTGACC[G/T]CCGTCTACAC	M	G	T	A	S
				receptor 1
G987a4	WIAF-13177	HT27830	1074	PPYR1, pancreatic polypeptide	TGGAGGAGTC[G/A]GAGCATCTGC	S	G	A	S	S
				receptor 1
G987a5	WIAF-13178	HT27830	975	PPYR1, pancreatic polypeptide	CCTCCACCTG[C/T]GTCAACCCAT	S	C	T	C	C
				receptor 1
G987a6	WIAF-13180	HT27830	615	PPYR1, pancreatic polypeptide	AGTTCCTGGC[A/g]GATAAGGTGG	S	A	g	A	A
				receptor 1
G987a7	WIAF-13181	HT27830	718	PPYR1, pancreatic polypeptide	GGGCTTCATC[C/T]TGGTCTGTTA	S	C	T	L	L
				receptor 1
G987a8	WIAF-13182	HT27830	745	PPYR1, pancreatic polypeptide	CATCTACCGG[C/t]GCCTCCAGAG	M	C	t	P	C
				receptor 1
G987e9	WIAF-13183	HT27830	842	PPYR1, pancreatic polypeptide	GTGATGGTGG[T/A]GGCCTTTGCC	M	T	A	V	E
				receptor 1
G987a10	WIAF-13184	HT27830	852	PPYR1, pancreatic polypeptide	TGGCCTTTGC[c/T]GTGCTCTGGC	S	C	T	A	A
				receptor 1
G987a11	WIAF-13185	HT27830	889	PPYR1, pancreatic polypeptide	CAACAGCCTG[G/a]AAGACTGGCA	H	G	a	E	K
				receptor 1
G987a12	WIAF-13186	HT27830	924	PPYR1, pancreatic polypeptide	CCATCTGCCA[C/T]GGGAACCTCA	S	C	T	H	H
				receptor 1
G989u1	WIAF-13573	D86519	891	NPY6R, neuropeptide Y receptor Y6	TGACTCATGC[C/T]TACTGGGGCA	S	C	T	A	A
G989u2	WIAF-13588	D86519	465	NPY6R, neuropeptide Y receptor Y6	ACCACCCAGC]A/G]TCTAATACAA	S	A	G	A	A
G989u3	WIAF-13591	D86519	980	NPY6R, neuropeptide Y receptor Y6	GAGCCCTTCC[G/A]CAACCTCTCT	M	G	A	R	N
G991u1	WIAF-12390	HT97376	336	Notch2	AAGGTACTTG[C/T]GTTCAGAAAA	S	C	T	C	C
G993u1	WIAF-12359	U95299	1343	NOTCH4, Notch (Drosophila)	TCCACACTCT[G/T]CCTGTGTCAG	M	G	T	C	F
				homolog 4
G993u2	WIAF-12361	U95299	2020	NOTCH4, Notch (Drosophila)	TAAGGACCAG[A/G]AAGACAAGGC	H	A	G	K	E
				homolog 4
G993u3	WIAF-12384	U95299	5775	NOTCH4, Notch (Drosophila)	GGGCCTATTC[G/T]CATTGCCGGA	S	G	T	S	S
				homolog 4
G996a1	WIAF-13213	HT3329	356	OPRM1, opioid receptor, mu 1	CTTAGATGGC[A/G]ACCTGTCCGA	M	A	G	N	D
LPLa4	WIAF-13314	HT1320	443	LPL, lipoprotein lipase	ATGTATGAGA[G/T]TTGGGTGCCA	M	G	T	S	I
LPLa5	WIAF-13315	HT1320	579	LPL, lipoprotein lipase	GACAGGATGT[G/A]GCCCGGTTTA	S	G	A	V	V
LPLa6	WIAF-13316	HT1320	609	LPL, lipoprotein lipase	TGGAGGAGGA[G/A]TTTAACTACC	S	G	A	E	E
LPLa7	WIAF-13317	HT1320	1338	LPL, lipoprotein lipase	CAAATAAGAC[C/A]TACTCCTTCC	S	C	A	T	T
LPLa8	WIAF-13318	HTl32C	1117	LPL, lipoprotein lipase	CAATCTGGGC[T/G]ATGAGATCAA	M	T	G	Y	D
LPLa9	WIAF-13319	HT1320	715	LPL, lipoprotein lipase	CAGAATTACT[G/A]GCCTCGATCC	M	G	A	G	S
LPLa10	WIAF-13320	HT1320	834	LPL. lipoprotein lipase	CTGGTCGAAG[C/A]ATTGGAATCC	M	C	A	S	R
LPLa11	WIAF-13321	HT1320	951	LPL, lipoprotein lipase	GACGTGGAGA[T/A]GTG&ACCAGC	M	T	A	D	R
LPLa12	WIAF-13322	HT1320	1595	LPL, lipoprotein lipase	AATAAGAAGT[C/G]AGGCTGAAAC	N	C	G	S	*
LPLa13	WIAF-13323	HT1320	1597	LPL, lipoprotein lipase	TAAGAAGTCA[G/A]GCTGAAACTG	M	G	A	G	S
LPLa14	WIAF-13324	HT1320	1606	LPL, lipoprotein lipase	AGGCTGAAAC[T/C]GGGCGAATCT	—	T	C	—	—
LPLa15	WIAF-13325	HT1320	1611	LPL, lipoprotein lipase	GAAACTGGGC[G/A]AATCTACAGA	—	G	A	—	—

While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.

2551 1 5722 DNA Homo sapiens 1ggacgcacag gcattccccg cgcccctcca gccctcgccg ccctcgccac cgctcccggc 60cgccgcgctc cggtacacac aggatccctg ctgggcacca acagctccac catggggctg 120gcctggggac taggcgtcct gttcctgatg catgtgtgtg gcaccaaccg cattccagag 180tctggcggag acaacagcgt gtttgacatc tttgaactca ccggggccgc ccgcaagggg 240tctgggcgcc gactggtgaa gggccccgac ccttccagcc cagctttccg catcgaggat 300gccaacctga tcccccctgt gcctgatgac aagttccaag acctggtgga tgctgtgcgg 360gcagaaaagg gtttcctcct tctggcatcc ctgaggcaga tgaagaagac ccggggcacg 420ctgctggccc tggagcggaa agaccactct ggccaggtct tcagcgtggt gtccaatggc 480aaggcgggca ccctggacct cagcctgacc gtccaaggaa agcagcacgt ggtgtctgtg 540gaagaagctc tcctggcaac cggccagtgg aagagcatca ccctgtttgt gcaggaagac 600agggcccagc tgtacatcga ctgtgaaaag atggagaatg ctgagttgga cgtccccatc 660caaagcgtct tcaccagaga cctggccagc atcgccagac tccgcatcgc aaaggggggc 720gtcaatgaca atttccaggg ggtgctgcag aatgtgaggt ttgtctttgg aaccacacca 780gaagacatcc tcaggaacaa aggctgctcc agctctacca gtgtcctcct cacccttgac 840aacaacgtgg tgaatggttc cagccctgcc atccgcacta actacattgg ccacaagaca 900aaggacttgc aagccatctg cggcatctcc tgtgatgagc tgtccagcat ggtcctggaa 960ctcaggggcc tgcgcaccat tgtgaccacg ctgcaggaca gcatccgcaa agtgactgaa 1020gagaacaaag agttggccaa tgagctgagg cggcctcccc tatgctatca caacggagtt 1080cagtacagaa ataacgagga atggactgtt gatagctgca ctgagtgtca ctgtcagaac 1140tcagttacca tctgcaaaaa ggtgtcctgc cccatcatgc cctgctccaa tgccacagtt 1200cctgatggag aatgctgtcc tcgctgttgg cccagcgact ctgcggacga tggctggtct 1260ccatggtccg agtggacctc ctgttctacg agctgtggca atggaattca gcagcgcggc 1320cgctcctgcg atagcctcaa caaccgatgt gagggctcct cggtccagac acggacctgc 1380cacattcagg agtgtgacaa aagatttaaa caggatggtg gctggagcca ctggtccccg 1440tggtcatctt gttctgtgac atgtggtgat ggtgtgatca caaggatccg gctctgcaac 1500tctcccagcc cccagatgaa tgggaaaccc tgtgaaggcg aagcgcggga gaccaaagcc 1560tgcaagaaag acgcctgccc catcaatgga ggctggggtc cttggtcacc atgggacatc 1620tgttctgtca cctgtggagg aggggtacag aaacgtagtc gtctctgcaa caaccccgca 1680ccccagtttg gaggcaagga ctgcgttggt gatgtaacag aaaaccagat ctgcaacaag 1740caggactgtc caattgatgg atgcctgtcc aatccctgct ttgccggcgt gaagtgtact 1800agctaccctg atggcagctg gaaatgtggt gcttgtcccc ctggttacag tggaaatggc 1860atccagtgca cagatgttga tgagtgcaaa gaagtgcctg atgcctgctt caaccacaat 1920ggagagcacc ggtgtgagaa cacggacccc ggctacaact gcctgccctg ccccccacgc 1980ttcaccggct cacagccctt cggccagggt gtcgaacatg ccacggccaa caaacaggtg 2040tgcaagcccc gtaacccctg cacggatggg acccacgact gcaacaagaa cgccaagtgc 2100aactacctgg gccactatag cgaccccatg taccgctgcg agtgcaagcc tggctacgct 2160ggcaatggca tcatctgcgg ggaggacaca gacctggatg gctggcccaa tgagaacctg 2220gtgtgcgtgg ccaatgcgac ttaccactgc aaaaaggata attgccccaa ccttcccaac 2280tcagggcagg aagactatga caaggatgga attggtgatg cctgtgatga tgacgatgac 2340aatgataaaa ttccagatga cagggacaac tgtccattcc attacaaccc agctcagtat 2400gactatgaca gagatgatgt gggagaccgc tgtgacaact gtccctacaa ccacaaccca 2460gatcaggcag acacagacaa caatggggaa ggagacgcct gtgctgcaga cattgatgga 2520gacggtatcc tcaatgaacg ggacaactgc cagtacgtct acaatgtgga ccagagagac 2580actgatatgg atggggttgg agatcagtgt gacaattgcc ccttggaaca caatccggat 2640cagctggact ctgactcaga ccgcattgga gatacctgtg acaacaatca ggatattgat 2700gaagatggcc accagaacaa tctggacaac tgtccctatg tgcccaatgc caaccaggct 2760gaccatgaca aagatggcaa gggagatgcc tgtgaccacg atgatgacaa cgatggcatt 2820cctgatgaca aggacaactg cagactcgtg cccaatcccg accagaagga ctctgacggc 2880gatggtcgag gtgatgcctg caaagatgat tttgaccatg acagtgtgcc agacatcgat 2940gacatctgtc ctgagaatgt tgacatcagt gagaccgatt tccgccgatt ccagatgatt 3000cctctggacc ccaaagggac atcccaaaat gaccctaact gggttgtacg ccatcagggt 3060aaagaactcg tccagactgt caactgtgat cctggactcg ctgtaggtta tgatgagttt 3120aatgctgtgg acttcagtgg caccttcttc atcaacaccg aaagggacga tgactatgct 3180ggatttgtct ttggctacca gtccagcagc cgcttttatg ttgtgatgtg gaagcaagtc 3240acccagtcct actgggacac caaccccacg agggctcagg gatactcggg cctttctgtg 3300aaagttgtaa actccaccac agggcctggc gagcacctgc ggaacgccct gtggcacaca 3360ggaaacaccc ctggccaggt gcgcaccctg tggcatgacc ctcgtcacat aggctggaaa 3420gatttcaccg cctacagatg gcgtctcagc cacaggccaa agacgggttt cattagagtg 3480gtgatgtatg aagggaagaa aatcatggct gactcaggac ccatctatga taaaacctat 3540gctggtggta gactagggtt gtttgtcttc tctcaagaaa tggtgttctt ctctgacctg 3600aaatacgaat gtagagatcc ctaatcatca aattgttgat tgaaagactg atcataaacc 3660aatgctggta ttgcaccttc tggaactatg ggcttgagaa aacccccagg atcacttctc 3720cttggcttcc ttcttttctg tgcttgcatc agtgtggact cctagaacgt gcgacctgcc 3780tcaagaaaat gcagttttca aaaacagact catcagcatt cagcctccaa tgaataagac 3840atcttccaag catataaaca attgctttgg tttccttttg aaaaagcatc tacttgcttc 3900agttgggaag gtgcccattc cactctgcct ttgtcacaga gcagggtgct attgtgaggc 3960catctctgag cagtggactc aaaagcattt tcaggcatgt cagagaaggg aggactcact 4020agaattagca aacaaaacca ccctgacatc ctccttcagg aacacgggga gcagaggcca 4080aagcactaag gggagggcgc atacccgaga cgattgtatg aagaaaatat ggaggaactg 4140ttacatgttc ggtactaagt cattttcagg ggattgaaag actattgctg gatttcatga 4200tgctgactgg cgttagctga ttaacccatg taaataggca cttaaataga agcaggaaag 4260ggagacaaag actggcttct ggacttcctc cctgatcccc acccttactc atcaccttgc 4320agtggccaga attagggaat cagaatcaaa ccagtgtaag gcagtgctgg ctgccattgc 4380ctggtcacat tgaaattggt ggcttcattc tagatgtagc ttgtgcagat gtagcaggaa 4440aataggaaaa cctaccatct cagtgagcac cagctgcctc ccaaaggagg ggcagccgtg 4500cttatatttt tatggttaca atggcacaaa attattatca acctaactaa aacattcctt 4560ttctcttttt tccgtaatta ctaggtagtt ttctaattct ctcttttgga agtatgattt 4620ttttaaagtc tttacgatgt aaaatattta ttttttactt attctggaag atctggctga 4680aggattattc atggaacagg aagaagcgta aagactatcc atgtcatctt tgttgagagt 4740cttcgtgact gtaagattgt aaatacagat tatttattaa ctctgttctg cctggaaatt 4800taggcttcat acggaaagtg tttgagagca agtagttgac atttatcagc aaatctcttg 4860caagaacagc acaaggaaaa tcagtctaat aagctgctct gccccttgtg ctcagagtgg 4920atgttatggg attccttttt tctctgtttt atcttttcaa gtggaattag ttggttatcc 4980atttgcaaat gttttaaatt gcaaagaaag ccatgaggtc ttcaatactg ttttacccca 5040tcccttgtgc atatttccag ggagaaggaa agcatataca cttttttctt tcatttttcc 5100aaaagagaaa aaaatgacaa aaggtgaaac ttacatacaa atattacctc atttgttgtg 5160tgactgagta aagaattttt ggatcaagcg gaaagagttt aagtgtctaa caaacttaaa 5220gctactgtag tacctaaaaa gtcagtgttg tacatagcat aaaaactctg cagagaagta 5280ttcccaataa ggaaatagca ttgaaatgtt aaatacaatt tctgaaagtt atgttttttt 5340tctatcatct ggtataccat tgctttattt ttataaatta ttttctcatt gccattggaa 5400tagaatattc agattgtgta gatatgctat ttaaataatt tatcaggaaa tactgcctgt 5460agagttagta tttctatttt tatataatgt ttgcacactg aattgaagaa ttgttggttt 5520tttctttttt ttgttttttt tttttttttt tttttttttg cttttgacct cccattttta 5580ctatttgcca ataccttttt ctaggaatgt gctttttttt gtacacattt ttatccattt 5640tacattctaa agcagtgtaa gttgtatatt actgtttctt atgtacaagg aacaacaata 5700aatcatatgg aaatttatat tt 5722 2 1170 PRT Homo sapiens 2Met Gly Leu Ala Trp Gly Leu Gly Val Leu Phe Leu Met His Val Cys 1 5 10 15Gly Thr Asn Arg Ile Pro Glu Ser Gly Gly Asp Asn Ser Val Phe Asp 20 25 30Ile Phe Glu Leu Thr Gly Ala Ala Arg Lys Gly Ser Gly Arg Arg Leu 35 40 45Val Lys Gly Pro Asp Pro Ser Ser Pro Ala Phe Arg Ile Glu Asp Ala 50 55 60Asn Leu Ile Pro Pro Val Pro Asp Asp Lys Phe Gln Asp Leu Val Asp65 70 75 80Ala Val Arg Ala Glu Lys Gly Phe Leu Leu Leu Ala Ser Leu Arg Gln 85 90 95Met Lys Lys Thr Arg Gly Thr Leu Leu Ala Leu Glu Arg Lys Asp His 100 105 110Ser Gly Gln Val Phe Ser Val Val Ser Asn Gly Lys Ala Gly Thr Leu 115 120 125Asp Leu Ser Leu Thr Val Gln Gly Lys Gln His Val Val Ser Val Glu 130 135 140Glu Ala Leu Leu Ala Thr Gly Gln Trp Lys Ser Ile Thr Leu Phe Val145 150 155 160Gln Glu Asp Arg Ala Gln Leu Tyr Ile Asp Cys Glu Lys Met Glu Asn 165 170 175Ala Glu Leu Asp Val Pro Ile Gln Ser Val Phe Thr Arg Asp Leu Ala 180 185 190Ser Ile Ala Arg Leu Arg Ile Ala Lys Gly Gly Val Asn Asp Asn Phe 195 200 205Gln Gly Val Leu Gln Asn Val Arg Phe Val Phe Gly Thr Thr Pro Glu 210 215 220Asp Ile Leu Arg Asn Lys Gly Cys Ser Ser Ser Thr Ser Val Leu Leu225 230 235 240Thr Leu Asp Asn Asn Val Val Asn Gly Ser Ser Pro Ala Ile Arg Thr 245 250 255Asn Tyr Ile Gly His Lys Thr Lys Asp Leu Gln Ala Ile Cys Gly Ile 260 265 270Ser Cys Asp Glu Leu Ser Ser Met Val Leu Glu Leu Arg Gly Leu Arg 275 280 285Thr Ile Val Thr Thr Leu Gln Asp Ser Ile Arg Lys Val Thr Glu Glu 290 295 300Asn Lys Glu Leu Ala Asn Glu Leu Arg Arg Pro Pro Leu Cys Tyr His305 310 315 320Asn Gly Val Gln Tyr Arg Asn Asn Glu Glu Trp Thr Val Asp Ser Cys 325 330 335Thr Glu Cys His Cys Gln Asn Ser Val Thr Ile Cys Lys Lys Val Ser 340 345 350Cys Pro Ile Met Pro Cys Ser Asn Ala Thr Val Pro Asp Gly Glu Cys 355 360 365Cys Pro Arg Cys Trp Pro Ser Asp Ser Ala Asp Asp Gly Trp Ser Pro 370 375 380Trp Ser Glu Trp Thr Ser Cys Ser Thr Ser Cys Gly Asn Gly Ile Gln385 390 395 400Gln Arg Gly Arg Ser Cys Asp Ser Leu Asn Asn Arg Cys Glu Gly Ser 405 410 415Ser Val Gln Thr Arg Thr Cys His Ile Gln Glu Cys Asp Lys Arg Phe 420 425 430Lys Gln Asp Gly Gly Trp Ser His Trp Ser Pro Trp Ser Ser Cys Ser 435 440 445Val Thr Cys Gly Asp Gly Val Ile Thr Arg Ile Arg Leu Cys Asn Ser 450 455 460Pro Ser Pro Gln Met Asn Gly Lys Pro Cys Glu Gly Glu Ala Arg Glu465 470 475 480Thr Lys Ala Cys Lys Lys Asp Ala Cys Pro Ile Asn Gly Gly Trp Gly 485 490 495Pro Trp Ser Pro Trp Asp Ile Cys Ser Val Thr Cys Gly Gly Gly Val 500 505 510Gln Lys Arg Ser Arg Leu Cys Asn Asn Pro Ala Pro Gln Phe Gly Gly 515 520 525Lys Asp Cys Val Gly Asp Val Thr Glu Asn Gln Ile Cys Asn Lys Gln 530 535 540Asp Cys Pro Ile Asp Gly Cys Leu Ser Asn Pro Cys Phe Ala Gly Val545 550 555 560Lys Cys Thr Ser Tyr Pro Asp Gly Ser Trp Lys Cys Gly Ala Cys Pro 565 570 575Pro Gly Tyr Ser Gly Asn Gly Ile Gln Cys Thr Asp Val Asp Glu Cys 580 585 590Lys Glu Val Pro Asp Ala Cys Phe Asn His Asn Gly Glu His Arg Cys 595 600 605Glu Asn Thr Asp Pro Gly Tyr Asn Cys Leu Pro Cys Pro Pro Arg Phe 610 615 620Thr Gly Ser Gln Pro Phe Gly Gln Gly Val Glu His Ala Thr Ala Asn625 630 635 640Lys Gln Val Cys Lys Pro Arg Asn Pro Cys Thr Asp Gly Thr His Asp 645 650 655Cys Asn Lys Asn Ala Lys Cys Asn Tyr Leu Gly His Tyr Ser Asp Pro 660 665 670Met Tyr Arg Cys Glu Cys Lys Pro Gly Tyr Ala Gly Asn Gly Ile Ile 675 680 685Cys Gly Glu Asp Thr Asp Leu Asp Gly Trp Pro Asn Glu Asn Leu Val 690 695 700Cys Val Ala Asn Ala Thr Tyr His Cys Lys Lys Asp Asn Cys Pro Asn705 710 715 720Leu Pro Asn Ser Gly Gln Glu Asp Tyr Asp Lys Asp Gly Ile Gly Asp 725 730 735Ala Cys Asp Asp Asp Asp Asp Asn Asp Lys Ile Pro Asp Asp Arg Asp 740 745 750Asn Cys Pro Phe His Tyr Asn Pro Ala Gln Tyr Asp Tyr Asp Arg Asp 755 760 765Asp Val Gly Asp Arg Cys Asp Asn Cys Pro Tyr Asn His Asn Pro Asp 770 775 780Gln Ala Asp Thr Asp Asn Asn Gly Glu Gly Asp Ala Cys Ala Ala Asp785 790 795 800Ile Asp Gly Asp Gly Ile Leu Asn Glu Arg Asp Asn Cys Gln Tyr Val 805 810 815Tyr Asn Val Asp Gln Arg Asp Thr Asp Met Asp Gly Val Gly Asp Gln 820 825 830Cys Asp Asn Cys Pro Leu Glu His Asn Pro Asp Gln Leu Asp Ser Asp 835 840 845Ser Asp Arg Ile Gly Asp Thr Cys Asp Asn Asn Gln Asp Ile Asp Glu 850 855 860Asp Gly His Gln Asn Asn Leu Asp Asn Cys Pro Tyr Val Pro Asn Ala865 870 875 880Asn Gln Ala Asp His Asp Lys Asp Gly Lys Gly Asp Ala Cys Asp His 885 890 895Asp Asp Asp Asn Asp Gly Ile Pro Asp Asp Lys Asp Asn Cys Arg Leu 900 905 910Val Pro Asn Pro Asp Gln Lys Asp Ser Asp Gly Asp Gly Arg Gly Asp 915 920 925Ala Cys Lys Asp Asp Phe Asp His Asp Ser Val Pro Asp Ile Asp Asp 930 935 940Ile Cys Pro Glu Asn Val Asp Ile Ser Glu Thr Asp Phe Arg Arg Phe945 950 955 960Gln Met Ile Pro Leu Asp Pro Lys Gly Thr Ser Gln Asn Asp Pro Asn 965 970 975Trp Val Val Arg His Gln Gly Lys Glu Leu Val Gln Thr Val Asn Cys 980 985 990Asp Pro Gly Leu Ala Val Gly Tyr Asp Glu Phe Asn Ala Val Asp Phe 995 1000 1005Ser Gly Thr Phe Phe Ile Asn Thr Glu Arg Asp Asp Asp Tyr Ala Gly 1010 1015 1020Phe Val Phe Gly Tyr Gln Ser Ser Ser Arg Phe Tyr Val Val Met Trp1025 1030 1035 1040Lys Gln Val Thr Gln Ser Tyr Trp Asp Thr Asn Pro Thr Arg Ala Gln 1045 1050 1055Gly Tyr Ser Gly Leu Ser Val Lys Val Val Asn Ser Thr Thr Gly Pro 1060 1065 1070Gly Glu His Leu Arg Asn Ala Leu Trp His Thr Gly Asn Thr Pro Gly 1075 1080 1085Gln Val Arg Thr Leu Trp His Asp Pro Arg His Ile Gly Trp Lys Asp 1090 1095 1100Phe Thr Ala Tyr Arg Trp Arg Leu Ser His Arg Pro Lys Thr Gly Phe1105 1110 1115 1120Ile Arg Val Val Met Tyr Glu Gly Lys Lys Ile Met Ala Asp Ser Gly 1125 1130 1135Pro Ile Tyr Asp Lys Thr Tyr Ala Gly Gly Arg Leu Gly Leu Phe Val 1140 1145 1150Phe Ser Gln Glu Met Val Phe Phe Ser Asp Leu Lys Tyr Glu Cys Arg 1155 1160 1165Asp Pro 1170 3 3074 DNA Homo sapiens 3gaattccggg gagcaggaag agccaacatg ctggccccgc gcggagccgc cgtcctcctg 60ctgcacctgg tcctgcagcg gtggctagcg gcaggcgccc aggccacccc ccaggtcttt 120gaccttctcc catcttccag tcagaggcta aacccaggcg ctctgctgcc agtcctgaca 180gaccccgccc tgaatgatct ctatgtgatt tccaccttca agctgcagac taaaagttca 240gccaccatct tcggtcttta ctcttcaact gacaacagta aatattttga atttactgtg 300atgggacgct taagcaaagc catcctccgt tacctgaaga acgatgggaa ggtgcatttg 360gtggttttca acaacctgca gctggcagac ggaaggcggc acaggatcct cctgaggctg 420agcaatttgc agcgaggggc cggctcccta gagctctacc tggactgcat ccaggtggat 480tccgttcaca atctccccag ggcctttgct ggcccctccc agaaacctga gaccattgaa 540ttgaggactt tccagaggaa gccacaggac ttcttggaag agctgaagct ggtggtgaga 600ggctcactgt tccaggtggc cagcctgcaa gactgcttcc tgcagcagag tgagccactg 660gctgccacag gcacagggga ctttaaccgg cagttcttgg gtcaaatgac acaattaaac 720caactcctgg gagaggtgaa ggaccttctg agacagcagg ttaaggaaac atcatttttg 780cgaaacacca tagctgaatg ccaggcttgc ggtcctctca agtttcagtc tccgacccca 840agcacggtgg tcgccccggc tccccctgca ccgccaacac gcccacctcg tcggtgtgac 900tccaacccat gtttccgagg tgtccaatgt accgacagta gagatggctt ccagtgtggg 960ccctgccccg agggctacac aggaaacggg atcacctgta ttgatgttga tgagtgcaaa 1020taccatccct gctacccggg cgtgcactgc ataaatttgt ctcctggctt cagatgtgac 1080gcctgcccag tgggcttcac agggcccatg gtgcagggtg ttgggatcag ttttgccaag 1140tcaaacaagc aggtctgcac tgacattgat gagtgtcgaa atggagcgtg cgttcccaac 1200tcgatctgcg ttaatacttt gggatcttac cgctgtgggc cttgtaagcc ggggtatact 1260ggtgatcaga taaggggatg caaagtggaa agaaactgca gaaacccaga gctgaaccct 1320tgcagtgtga atgcccagtg cattgaagag aggcaggggg atgtgacatg tgtgtgtgga 1380gtcggttggg ctggagatgg ctatatctgt ggaaaggatg tggacatcga cagttacccc 1440gacgaagaac tgccatgctc tgccaggaac tgtaaaaagg acaactgcaa atatgtgcca 1500aattctggcc aagaagatgc agacagagat ggcattggcg acgcttgtga cgaggatgct 1560gacggagatg ggatcctgaa tgagcaggat aactgtgtcc tgattcataa tgtggaccaa 1620aggaacagcg ataaagatat ctttggggat gcctgtgata actgcctgag tgtcttaaat 1680aacgaccaga aagacaccga tggggatgga agaggagatg cctgtgatga tgacatggat 1740ggagatggaa taaaaaacat tctggacaac tgcccaaaat ttcccaatcg tgaccaacgg 1800gacaaggatg gtgatggtgt gggggatgcc tgtgacagtt gtcctgatgt cagcaaccct 1860aaccagtctg atgtggataa tgatctggtt ggggactcct gtgacaccaa tcaggacagt 1920gatggagatg ggcaccagga cagcacagac aactgcccca ccgtcattaa cagtgcccag 1980ctggacaccg ataaggatgg aattggtgac gagtgtgatg atgatgatga caatgatggt 2040atcccagacc tggtgccccc tggaccagac aactgccggc tggtccccaa cccagcccag 2100gaggatagca acagcgacgg agtgggagac atctgtgagt ctgactttga ccaggaccag 2160gtcatcgatc ggatcgacgt ctgcccagag aacgcagagg tcaccctgac cgacttcagg 2220gcttaccaga ccgtgggcct ggatcctgaa ggggatgccc agatcgatcc caactgggtg 2280gtcctgaacc agggcatgga gattgtacag accatgaaca gtgatcctgg cctggcagtg 2340gggtacacag cttttaatgg agttgacttc gaagggacct tccatgtgaa tacccagaca 2400gatgatgact atgcaggctt tatctttggc taccaagata gctccagctt ctacgtggtc 2460atgtggaagc agacggagca gacatattgg caagccaccc cattccgagc agttgcagaa 2520cctggcattc agctcaaggc tgtgaagtct aagacaggtc caggggagca tctccggaac 2580tccctgtggc acacggggga caccagtgac caggtcaggc tgctgtggaa ggactccagg 2640aatgtgggct ggaaggacaa ggtgtcctac cgctggttcc tacagcacag gccccaggtg 2700ggctacatca gggtacgatt ttatgaaggc tctgagttgg tggctgactc tggcgtcacc 2760atagacacca caatgcgtgg aggccgactt ggcgttttct gcttctctca agaaaacatc 2820atctggtcca acctcaagta tcgctgcaat gacaccatcc ctgaggactt ccaagagttt 2880caaacccaga atttcgaccg cttcgataat taaaccaagg aagcaatctg taactgcttt 2940tcggaacact aaaaccatat atattttaac ttcaattttc tttagctttt accaacccaa 3000atatatcaaa acgttttatg tgaatgtggc aataaaggag aagagatcat ttttaaaaaa 3060aaaaaaaaaa aaaa 3074 4 961 PRT Homo sapiens 4Met Leu Ala Pro Arg Gly Ala Ala Val Leu Leu Leu His Leu Val Leu 1 5 10 15Gln Arg Trp Leu Ala Ala Gly Ala Gln Ala Thr Pro Gln Val Phe Asp 20 25 30Leu Leu Pro Ser Ser Ser Gln Arg Leu Asn Pro Gly Ala Leu Leu Pro 35 40 45Val Leu Thr Asp Pro Ala Leu Asn Asp Leu Tyr Val Ile Ser Thr Phe 50 55 60Lys Leu Gln Thr Lys Ser Ser Ala Thr Ile Phe Gly Leu Tyr Ser Ser65 70 75 80Thr Asp Asn Ser Lys Tyr Phe Glu Phe Thr Val Met Gly Arg Leu Ser 85 90 95Lys Ala Ile Leu Arg Tyr Leu Lys Asn Asp Gly Lys Val His Leu Val 100 105 110Val Phe Asn Asn Leu Gln Leu Ala Asp Gly Arg Arg His Arg Ile Leu 115 120 125Leu Arg Leu Ser Asn Leu Gln Arg Gly Ala Gly Ser Leu Glu Leu Tyr 130 135 140Leu Asp Cys Ile Gln Val Asp Ser Val His Asn Leu Pro Arg Ala Phe145 150 155 160Ala Gly Pro Ser Gln Lys Pro Glu Thr Ile Glu Leu Arg Thr Phe Gln 165 170 175Arg Lys Pro Gln Asp Phe Leu Glu Glu Leu Lys Leu Val Val Arg Gly 180 185 190Ser Leu Phe Gln Val Ala Ser Leu Gln Asp Cys Phe Leu Gln Gln Ser 195 200 205Glu Pro Leu Ala Ala Thr Gly Thr Gly Asp Phe Asn Arg Gln Phe Leu 210 215 220Gly Gln Met Thr Gln Leu Asn Gln Leu Leu Gly Glu Val Lys Asp Leu225 230 235 240Leu Arg Gln Gln Val Lys Glu Thr Ser Phe Leu Arg Asn Thr Ile Ala 245 250 255Glu Cys Gln Ala Cys Gly Pro Leu Lys Phe Gln Ser Pro Thr Pro Ser 260 265 270Thr Val Val Ala Pro Ala Pro Pro Ala Pro Pro Thr Arg Pro Pro Arg 275 280 285Arg Cys Asp Ser Asn Pro Cys Phe Arg Gly Val Gln Cys Thr Asp Ser 290 295 300Arg Asp Gly Phe Gln Cys Gly Pro Cys Pro Glu Gly Tyr Thr Gly Asn305 310 315 320Gly Ile Thr Cys Ile Asp Val Asp Glu Cys Lys Tyr His Pro Cys Tyr 325 330 335Pro Gly Val His Cys Ile Asn Leu Ser Pro Gly Phe Arg Cys Asp Ala 340 345 350Cys Pro Val Gly Phe Thr Gly Pro Met Val Gln Gly Val Gly Ile Ser 355 360 365Phe Ala Lys Ser Asn Lys Gln Val Cys Thr Asp Ile Asp Glu Cys Arg 370 375 380Asn Gly Ala Cys Val Pro Asn Ser Ile Cys Val Asn Thr Leu Gly Ser385 390 395 400Tyr Arg Cys Gly Pro Cys Lys Pro Gly Tyr Thr Gly Asp Gln Ile Arg 405 410 415Gly Cys Lys Val Glu Arg Asn Cys Arg Asn Pro Glu Leu Asn Pro Cys 420 425 430Ser Val Asn Ala Gln Cys Ile Glu Glu Arg Gln Gly Asp Val Thr Cys 435 440 445Val Cys Gly Val Gly Trp Ala Gly Asp Gly Tyr Ile Cys Gly Lys Asp 450 455 460Val Asp Ile Asp Ser Tyr Pro Asp Glu Glu Leu Pro Cys Ser Ala Arg465 470 475 480Asn Cys Lys Lys Asp Asn Cys Lys Tyr Val Pro Asn Ser Gly Gln Glu 485 490 495Asp Ala Asp Arg Asp Gly Ile Gly Asp Ala Cys Asp Glu Asp Ala Asp 500 505 510Gly Asp Gly Ile Leu Asn Glu Gln Asp Asn Cys Val Leu Ile His Asn 515 520 525Val Asp Gln Arg Asn Ser Asp Lys Asp Ile Phe Gly Asp Ala Cys Asp 530 535 540Asn Cys Leu Ser Val Leu Asn Asn Asp Gln Lys Asp Thr Asp Gly Asp545 550 555 560Gly Arg Gly Asp Ala Cys Asp Asp Asp Met Asp Gly Asp Gly Ile Lys 565 570 575Asn Ile Leu Asp Asn Cys Pro Lys Phe Pro Asn Arg Asp Gln Arg Asp 580 585 590Lys Asp Gly Asp Gly Val Gly Asp Ala Cys Asp Ser Cys Pro Asp Val 595 600 605Ser Asn Pro Asn Gln Ser Asp Val Asp Asn Asp Leu Val Gly Asp Ser 610 615 620Cys Asp Thr Asn Gln Asp Ser Asp Gly Asp Gly His Gln Asp Ser Thr625 630 635 640Asp Asn Cys Pro Thr Val Ile Asn Ser Ala Gln Leu Asp Thr Asp Lys 645 650 655Asp Gly Ile Gly Asp Glu Cys Asp Asp Asp Asp Asp Asn Asp Gly Ile 660 665 670Pro Asp Leu Val Pro Pro Gly Pro Asp Asn Cys Arg Leu Val Pro Asn 675 680 685Pro Ala Gln Glu Asp Ser Asn Ser Asp Gly Val Gly Asp Ile Cys Glu 690 695 700Ser Asp Phe Asp Gln Asp Gln Val Ile Asp Arg Ile Asp Val Cys Pro705 710 715 720Glu Asn Ala Glu Val Thr Leu Thr Asp Phe Arg Ala Tyr Gln Thr Val 725 730 735Gly Leu Asp Pro Glu Gly Asp Ala Gln Ile Asp Pro Asn Trp Val Val 740 745 750Leu Asn Gln Gly Met Glu Ile Val Gln Thr Met Asn Ser Asp Pro Gly 755 760 765Leu Ala Val Gly Tyr Thr Ala Phe Asn Gly Val Asp Phe Glu Gly Thr 770 775 780Phe His Val Asn Thr Gln Thr Asp Asp Asp Tyr Ala Gly Phe Ile Phe785 790 795 800Gly Tyr Gln Asp Ser Ser Ser Phe Tyr Val Val Met Trp Lys Gln Thr 805 810 815Glu Gln Thr Tyr Trp Gln Ala Thr Pro Phe Arg Ala Val Ala Glu Pro 820 825 830Gly Ile Gln Leu Lys Ala Val Lys Ser Lys Thr Gly Pro Gly Glu His 835 840 845Leu Arg Asn Ser Leu Trp His Thr Gly Asp Thr Ser Asp Gln Val Arg 850 855 860Leu Leu Trp Lys Asp Ser Arg Asn Val Gly Trp Lys Asp Lys Val Ser865 870 875 880Tyr Arg Trp Phe Leu Gln His Arg Pro Gln Val Gly Tyr Ile Arg Val 885 890 895Arg Phe Tyr Glu Gly Ser Glu Leu Val Ala Asp Ser Gly Val Thr Ile 900 905 910Asp Thr Thr Met Arg Gly Gly Arg Leu Gly Val Phe Cys Phe Ser Gln 915 920 925Glu Asn Ile Ile Trp Ser Asn Leu Lys Tyr Arg Cys Asn Asp Thr Ile 930 935 940Pro Glu Asp Phe Gln Glu Phe Gln Thr Gln Asn Phe Asp Arg Phe Asp945 950 955 960Asn 5 31 DNA Homo sapiens 5tggatggctg gcccartgag aacctggtgt g 31 6 31 DNA Homo sapiens 6gagtgtcgaa atggascgtg cgttcccaac t 31 7 21 DNA Homo sapiens 7ctgcaggagt rgctggatga a 21 8 21 DNA Homo sapiens 8catctggacc ytgctgggca a 21 9 21 DNA Homo sapiens 9gtgctggtgt scgcagccat c 21 10 21 DNA Homo sapiens 10tgcgcgccaa satgaccaac g 21 11 21 DNA Homo sapiens 11tgtgctccac ygcctccatc c 21 12 21 DNA Homo sapiens 12gcagagcacg ygcagagctg c 21 13 21 DNA Homo sapiens 13atggtcggcc yggcatggac c 21 14 21 DNA Homo sapiens 14gcaagatgac ycagcgcatg g 21 15 21 DNA Homo sapiens 15tcgctcatca rcttctacat c 21 16 21 DNA Homo sapiens 16ggggcgggct kgacctgcca a 21 17 21 DNA Homo sapiens 17agaccctgtc rgtgatcatg g 21 18 21 DNA Homo sapiens 18ggaggaggac ktttgggagc c 21 19 21 DNA Homo sapiens 19tttgggagcc ygacgtgaat g 21 20 21 DNA Homo sapiens 20ccgacgtgaa kgcagagaac t 21 21 21 DNA Homo sapiens 21acctacacgc rcatctaccg c 21 22 21 DNA Homo sapiens 22gtgcagccac ktctgctccc g 21 23 21 DNA Homo sapiens 23gaaatcgcag ytgcctacat c 21 24 21 DNA Homo sapiens 24accctgttgc wgagtctgtc t 21 25 21 DNA Homo sapiens 25tctcctacaa ycaagacatc g 21 26 21 DNA Homo sapiens 26cactcaaccc mgtcatctat g 21 27 21 DNA Homo sapiens 27acgccgactt ycagaaggtg t 21 28 21 DNA Homo sapiens 28cgaggaggag rgtcctttcg a 21 29 21 DNA Homo sapiens 29gatcgcatgt yccagatcta t 21 30 21 DNA Homo sapiens 30tgtctctggc ygtgtctgac c 21 31 21 DNA Homo sapiens 31tgccgccagg sagcaacggc a 21 32 21 DNA Homo sapiens 32ggcagttcgc kctataccag c 21 33 21 DNA Homo sapiens 33tggggccctc rcaggtggtc a 21 34 21 DNA Homo sapiens 34tggccggtta ytggcccttt g 21 35 21 DNA Homo sapiens 35cttcgacatc wtgtgctcca c 21 36 21 DNA Homo sapiens 36atcagcgtgg rccgctactg g 21 37 21 DNA Homo sapiens 37tggccctttg ragcgttctg c 21 38 21 DNA Homo sapiens 38agcctgcgcg yttccatcaa g 21 39 21 DNA Homo sapiens 39ggttctcaag mccctgtcgg t 21 40 21 DNA Homo sapiens 40ctacatcccc rttgccatca t 21 41 21 DNA Homo sapiens 41gatttcctcc ytggagaggg c 21 42 21 DNA Homo sapiens 42ccctcaacgc ytcgttcctc c 21 43 21 DNA Homo sapiens 43gctgctcaag ytggcgtcgc c 21 44 21 DNA Homo sapiens 44tggagtccca rgagcggatc a 21 45 21 DNA Homo sapiens 45ccccagtggt rtacctgaag g 21 46 21 DNA Homo sapiens 46atgtgatgag wgagaaacat c 21 47 21 DNA Homo sapiens 47ccccaagatc mggacaagcc t 21 48 21 DNA Homo sapiens 48ccaactcagc yttcctgcat a 21 49 21 DNA Homo sapiens 49gccgctcaga ytccgaggat g 21 50 21 DNA Homo sapiens 50ggtacaagtt rcttaaccaa g 21 51 21 DNA Homo sapiens 51ctggcctgcc rtgtccggga g 21 52 21 DNA Homo sapiens 52agtgcaggga ygaaggcctc a 21 53 21 DNA Homo sapiens 53gctgccacgg yctcgtcccg c 21 54 21 DNA Homo sapiens 54agaagaatga ycaaatttac g 21 55 21 DNA Homo sapiens 55ggattttctg wcatcaagtc c 21 56 21 DNA Homo sapiens 56caagtgggtg racagcgaag g 21 57 21 DNA Homo sapiens 57tcccaagagc ytccagtaga c 21 58 21 DNA Homo sapiens 58tcatcaacaa ratgaaactg g 21 59 21 DNA Homo sapiens 59tcccatgtca mccggatgac c 21 60 21 DNA Homo sapiens 60gactatggga ycaaatttgc c 21 61 21 DNA Homo sapiens 61tgcacacatg maaggccccc a 21 62 21 DNA Homo sapiens 62cctgatgaat yttcacaaca a 21 63 21 DNA Homo sapiens 63gacatgctgg ytggccatgg c 21 64 21 DNA Homo sapiens 64actatgggat yaaatttgcc c 21 65 21 DNA Homo sapiens 65tgcaaaggaa rggaaaggaa a 21 66 21 DNA Homo sapiens 66atacttgcaa rgcccccaag a 21 67 21 DNA Homo sapiens 67ggcaagggga raatgttgcc g 21 68 21 DNA Homo sapiens 68ctggccaagc ygtggagtgc t 21 69 21 DNA Homo sapiens 69caaattgcga ktgggtatta a 21 70 21 DNA Homo sapiens 70gggacctaac yggcgtgcag a 21 71 21 DNA Homo sapiens 71gccctcatca rtgcagatga g 21 72 21 DNA Homo sapiens 72ctgaaggtct yatggcagag g 21 73 21 DNA Homo sapiens 73tccgtgaagc raatgaacta c 21 74 21 DNA Homo sapiens 74tgagacagac wtcaccgtcc a 21 75 21 DNA Homo sapiens 75catgaatgtt rcctgtgctg g 21 76 21 DNA Homo sapiens 76gccgccctgg rcgctattac g 21 77 21 DNA Homo sapiens 77aacattaaga sgtgccacca a 21 78 21 DNA Homo sapiens 78ctcatagatg yaaaaactgg a 21 79 21 DNA Homo sapiens 79gatagatttt yagaagttaa a 21 80 21 DNA Homo sapiens 80tcgagatgga rcagcggctg g 21 81 21 DNA Homo sapiens 81gggagcgccg mgccatcgag a 21 82 21 DNA Homo sapiens 82gggatcgcca ygggaactca a 21 83 21 DNA Homo sapiens 83ccctccttct ycaagaactt t 21 84 21 DNA Homo sapiens 84tctccaactt stacaaattc t 21 85 21 DNA Homo sapiens 85actgaatctg maggccagga t 21 86 21 DNA Homo sapiens 86aatttgagct wcttgataag g 21 87 21 DNA Homo sapiens 87tcagaatcat ytgatggatc t 21 88 21 DNA Homo sapiens 88ttcaagtgaa satgctgaaa g 21 89 21 DNA Homo sapiens 89ctcttgacga kgacgaagat g 21 90 21 DNA Homo sapiens 90ccggactctt ycagccatta a 21 91 21 DNA Homo sapiens 91ctgagaaaga ygcggaagat t 21 92 21 DNA Homo sapiens 92tggaacagaa ygaagacaga t 21 93 21 DNA Homo sapiens 93gtttcctgta ytaaagcaac t 21 94 21 DNA Homo sapiens 94agaacagctg ygaaagagcc a 21 95 21 DNA Homo sapiens 95gatgtgcaga ygggagggcc a 21 96 21 DNA Homo sapiens 96aagaatttga kctacttgat a 21 97 21 DNA Homo sapiens 97acacttctga ytgcactccc g 21 98 21 DNA Homo sapiens 98gccaccccat kaacctggag g 21 99 21 DNA Homo sapiens 99gagtcaccac yttcacctta t 21 100 21 DNA Homo sapiens 100acgtacatca mtgcctcgac g 21 101 21 DNA Homo sapiens 101tctgtaccca yactcttgta c 21 102 21 DNA Homo sapiens 102aggcaacatg sgtgactgga g 21 103 21 DNA Homo sapiens 103tatgtgatgc raaaggaaga g 21 104 21 DNA Homo sapiens 104ttcattttcc raatcctgct g 21 105 21 DNA Homo sapiens 105caagcctact yaactgctgg a 21 106 21 DNA Homo sapiens 106agaaagagga rgaactcaag g 21 107 21 DNA Homo sapiens 107gcacttgaag magattgaga t 21 108 21 DNA Homo sapiens 108atgcacttga rgcagattga g 21 109 21 DNA Homo sapiens 109cgctgagccc ygccaaagac t 21 110 21 DNA Homo sapiens 110cctcaccaac ygctcccctc t 21 111 21 DNA Homo sapiens 111aagctggtta mtggcgacag a 21 112 21 DNA Homo sapiens 112ctaactccca ygcacagcct t 21 113 21 DNA Homo sapiens 113tggacatgaa ytacagccac t 21 114 21 DNA Homo sapiens 114ccgcaattac racaagcaag c 21 115 21 DNA Homo sapiens 115gtggaccagc raccttcaag c 21 116 21 DNA Homo sapiens 116tatttgtgtc ygtacccaca c 21 117 21 DNA Homo sapiens 117cgttaaggat ygggttaagg g 21 118 21 DNA Homo sapiens 118aactcttcta ygttttcttc a 21 119 21 DNA Homo sapiens 119agttcaagta yggtattgaa g 21 120 21 DNA Homo sapiens 120ccagcgacct kcaagcagag c 21 121 21 DNA Homo sapiens 121caacaagcaa rcaagtgagc a 21 122 21 DNA Homo sapiens 122caaaactggg staattacag t 21 123 21 DNA Homo sapiens 123agacctgtgc rtacaccaac c 21 124 21 DNA Homo sapiens 124gacaccccag ygcccggcta c 21 125 21 DNA Homo sapiens 125tccactcgga satcgtgaaa c 21 126 21 DNA Homo sapiens 126ggggctggcc rataccatcg t 21 127 21 DNA Homo sapiens 127ccatgttcga ygtgcatgtg a 21 128 21 DNA Homo sapiens 128aggtggacca rctgtaccgg a 21 129 21 DNA Homo sapiens 129cccccgacgg ygtgaagtgg c 21 130 21 DNA Homo sapiens 130gcagaggagc rgcagaggat c 21 131 21 DNA Homo sapiens 131atgacggacc ygtgtgtgaa g 21 132 21 DNA Homo sapiens 132ccatcaccat ygccaaccag a 21 133 21 DNA Homo sapiens 133acgtggggtc yctgttgctc a 21 134 21 DNA Homo sapiens 134tagaagaaag rtattgcatc g 21 135 21 DNA Homo sapiens 135atccaagagt ygcatgtcag c 21 136 21 DNA Homo sapiens 136cacagaagag wcgtggcccg g 21 137 21 DNA Homo sapiens 137caagtggctg sccctggaga g 21 138 21 DNA Homo sapiens 138ttggcgggaa ycgcctgaaa c 21 139 21 DNA Homo sapiens 139agagcctggc ygacaacctg t 21 140 21 DNA Homo sapiens 140ctctgagtga rgatgacttt g 21 141 21 DNA Homo sapiens 141ttgagacctt yggcaacagc a 21 142 21 DNA Homo sapiens 142catgatctgc ytgttccaaa t 21 143 21 DNA Homo sapiens 143aggtttggga raagtttgat c 21 144 21 DNA Homo sapiens 144gcaacagcat satctgcctg t 21 145 21 DNA Homo sapiens 145gctcagttaa rggagactgt g 21 146 21 DNA Homo sapiens 146tgtacatcgc sgtcatcctg g 21 147 21 DNA Homo sapiens 147atcaccctgg magctcagtt a 21 148 21 DNA Homo sapiens 148atggctacac ragctttgac a 21 149 21 DNA Homo sapiens 149tctgtgtgaa kgctggtaga a 21 150 21 DNA Homo sapiens 150tcccagctgt raccctctgt a 21 151 21 DNA Homo sapiens 151tctgtaacct saatggcttc c 21 152 21 DNA Homo sapiens 152tcaccaccaa ygacctgtac c 21 153 21 DNA Homo sapiens 153ccccatctgg mtgacccctc c 21 154 21 DNA Homo sapiens 154ccctgcggca raaggccaac t 21 155 21 DNA Homo sapiens 155cagtcaaagc rgctaaggga g 21 156 21 DNA Homo sapiens 156caaaggaagc sttggcagtc a 21 157 21 DNA Homo sapiens 157ctcccatgga kactgctcag a 21 158 21 DNA Homo sapiens 158ggaacctgtt magatagagc t 21 159 21 DNA Homo sapiens 159atgacacctc ygactgtgcc a 21 160 21 DNA Homo sapiens 160aagccaagga rtggtgggcc t 21 161 21 DNA Homo sapiens 161agtccctgta yggctttcca g 21 162 21 DNA Homo sapiens 162agtcattttg yacataaacg a 21 163 21 DNA Homo sapiens 163gaggaataca rcccattcct c 21 164 21 DNA Homo sapiens 164ctgcctactc rctccagatc t 21 165 21 DNA Homo sapiens 165cgtcctctga ragctctgtc a 21 166 21 DNA Homo sapiens 166actttgccga ygccctgtct g 21 167 21 DNA Homo sapiens 167gagcccatca ycaccacact c 21 168 21 DNA Homo sapiens 168gcgttcactt wccttcggga c 21 169 21 DNA Homo sapiens 169ccacagtgaa katctcgccg a 21 170 21 DNA Homo sapiens 170ggcctggctg kccaggacac a 21 171 21 DNA Homo sapiens 171aatgggcctc rgccccgcgg a 21 172 21 DNA Homo sapiens 172ttggcaagag ytacaaggag t 21 173 21 DNA Homo sapiens 173tggtcatgtt yatctactcc a 21 174 21 DNA Homo sapiens 174tcaacatgta satcgccatc a 21 175 21 DNA Homo sapiens 175gtcaagggtg rctgcggcaa c 21 176 21 DNA Homo sapiens 176gtacatcgcc rtcatcctgg a 21 177 21 DNA Homo sapiens 177gttcatctac kccatcttcg g 21 178 21 DNA Homo sapiens 178tggtgaagat kactttgaga t 21 179 21 DNA Homo sapiens 179ttctggctga ycttcagcat c 21 180 21 DNA Homo sapiens 180ggagacagac raccagagcc a 21 181 21 DNA Homo sapiens 181tctgcttctt mtgcagctat a 21 182 21 DNA Homo sapiens 182cagggcagac kgtgcgccca g 21 183 21 DNA Homo sapiens 183caggggacgc yggacccact a 21 184 21 DNA Homo sapiens 184cgctgctgct rccactattg c 21 185 21 DNA Homo sapiens 185tctgcgcgcg yagcccgcca t 21 186 21 DNA Homo sapiens 186cagcatgtgg ycgccgtgga t 21 187 21 DNA Homo sapiens 187atgagcgaaa rgtgaatgcg t 21 188 21 DNA Homo sapiens 188ggttcctgag rgccaagatg g 21 189 21 DNA Homo sapiens 189gtgaggctgt rtcgggtctg c 21 190 21 DNA Homo sapiens 190ccaagaaatt saagaggaaa t 21 191 21 DNA Homo sapiens 191atcagcctgg kgatgctgag g 21 192 21 DNA Homo sapiens 192gccacgggat ygtggaggtt g 21 193 21 DNA Homo sapiens 193ctttggcacc rtcatctgca a 21 194 21 DNA Homo sapiens 194gggtgtctgt ragtgtgtcc a 21 195 21 DNA Homo sapiens 195ctgctgcttc wgctcttgtt c 21 196 21 DNA Homo sapiens 196aaacgctgtg yatcatctgg t 21 197 21 DNA Homo sapiens 197gtgcgcttct ycgcctgccc c 21 198 21 DNA Homo sapiens 198atttcatcac sctgggcacc g 21 199 21 DNA Homo sapiens 199tgtgcatcat ytggttctcc t 21 200 21 DNA Homo sapiens 200tgaacatcat wgacattgtg g 21 201 21 DNA Homo sapiens 201cacagtgacc yggctctttt t 21 202 21 DNA Homo sapiens 202ccctggagga ygggttctac g 21 203 21 DNA Homo sapiens 203ataaatgccc rgagggaatt a 21 204 21 DNA Homo sapiens 204ttccgggcaa ytcagaagaa a 21 205 21 DNA Homo sapiens 205cactgtgcca ygtgccttta t 21 206 21 DNA Homo sapiens 206acctcttcga yacagcagaa g 21 207 21 DNA Homo sapiens 207acctggccga wgagatcctg t 21 208 21 DNA Homo sapiens 208cgttactctg kggactactc c 21 209 21 DNA Homo sapiens 209gcttggctgc rtcttcatga a 21 210 21 DNA Homo sapiens 210cggtgatcgc yctgcgccac g 21 211 21 DNA Homo sapiens 211ggaccctgcc ragcccaggt a 21 212 21 DNA Homo sapiens 212gtggctcatc rccttcgccc a 21 213 21 DNA Homo sapiens 213tggactactc rcgttttcac a 21 214 21 DNA Homo sapiens 214ggccaccgct wtgagcctgt g 21 215 21 DNA Homo sapiens 215ggccaccgct wtgagcctgt g 21 216 21 DNA Homo sapiens 216cgcgggtcac ygaggagggc g 21 217 21 DNA Homo sapiens 217ctggtgtcgc ycatcaccat c 21 218 21 DNA Homo sapiens 218tctccatcga sacgcagacc a 21 219 21 DNA Homo sapiens 219cactccccag maagactggg g 21 220 21 DNA Homo sapiens 220cccagcaaga stgggggcag c 21 221 21 DNA Homo sapiens 221gagtgtgcca mgcttttgga c 21 222 21 DNA Homo sapiens 222acaaccccca rctggcccac g 21 223 21 DNA Homo sapiens 223tcctgggcaa raccttgcag g 21 224 21 DNA Homo sapiens 224cgagctgctc rtgcgcttct t 21 225 21 DNA Homo sapiens 225ctctgggtcc rcgcgggcca t 21 226 21 DNA Homo sapiens 226gttatcctca yctccatcat c 21 227 21 DNA Homo sapiens 227caaccagcca rtggaggagg c 21 228 21 DNA Homo sapiens 228catcatctgg ytctccttcg a 21 229 21 DNA Homo sapiens 229gtgtattctg wggattactc c 21 230 21 DNA Homo sapiens 230ttctctactt yggcttgcgg t 21 231 21 DNA Homo sapiens 231gtggtctgca yctttggcga c 21 232 21 DNA Homo sapiens 232gatgatactt sgctgcagga c 21 233 21 DNA Homo sapiens 233tcgtggtctg yatctttggc g 21 234 21 DNA Homo sapiens 234cactcatgag ygcgacgtac t 21 235 21 DNA Homo sapiens 235ggatgtttca ytggtgtgca c 21 236 21 DNA Homo sapiens 236catcctgact ygaagtgaag c 21 237 21 DNA Homo sapiens 237ctggcaatga ycagattgac a 21 238 21 DNA Homo sapiens 238agtttttgga ycaagacgat g 21 239 21 DNA Homo sapiens 239tgcacgggat rttacgtcaa c 21 240 21 DNA Homo sapiens 240tgctggtaat wgatgcatct a 21 241 21 DNA Homo sapiens 241tctacctgca yacagtcatt c 21 242 21 DNA Homo sapiens 242caaaggtata yagatgacaa c 21 243 21 DNA Homo sapiens 243cctgaaaatg ragccacctt c 21 244 21 DNA Homo sapiens 244tgaacatcag rtggagctac t 21 245 21 DNA Homo sapiens 245actatgagaa ratagagaga a 21 246 21 DNA Homo sapiens 246ctgaagaggg ygggtactca t 21 247 21 DNA Homo sapiens 247agacaagcca rtaaaaacag a 21 248 21 DNA Homo sapiens 248caccacagca rctgtcatgg c 21 249 21 DNA Homo sapiens 249gcccaatgag rttaaagtct c 21 250 21 DNA Homo sapiens 250gattttcacc ratcaagaga t 21 251 21 DNA Homo sapiens 251atcaagagat yggggagtta c 21 252 21 DNA Homo sapiens 252tacttccaca yactgttacg a 21 253 21 DNA Homo sapiens 253tcactctcca stacctaaac a 21 254 21 DNA Homo sapiens 254aggtaatggt raaaaaagac a 21 255 21 DNA Homo sapiens 255gtcctgccga ktcccctgat g 21 256 21 DNA Homo sapiens 256cccctgatga rggaatcact a 21 257 21 DNA Homo sapiens 257agatgccact ratggcaagg a 21 258 21 DNA Homo sapiens 258caccgctcaa yggattttct g 21 259 21 DNA Homo sapiens 259ttccagagcc wacaacagat g 21 260 21 DNA Homo sapiens 260gcggcctcgt sctcaccagc a 21 261 21 DNA Homo sapiens 261tgtgggcgcc ktggtcgcct t 21 262 21 DNA Homo sapiens 262gccgtgtcac ycgaggatga t 21 263 21 DNA Homo sapiens 263aattccgatc kgatcctcag g 21 264 21 DNA Homo sapiens 264caagcttatc ragaccctct c 21 265 21 DNA Homo sapiens 265gcagatcact sttggcctcg t 21 266 21 DNA Homo sapiens 266tcttggcctc rtcttcctct g 21 267 21 DNA Homo sapiens 267tagagatagc ygcttacaga a 21 268 21 DNA Homo sapiens 268cagctgcaac yctaactatt c 21 269 21 DNA Homo sapiens 269gagcgaagca ygtgatcatg c 21 270 21 DNA Homo sapiens 270atggagagaa yactgcccag t 21 271 21 DNA Homo sapiens 271taatgtcggc ygagagcccc a 21 272 21 DNA Homo sapiens 272gaccctgacc rctatgtctg t 21 273 21 DNA Homo sapiens 273acttctcacc rggagatttg g 21 274 21 DNA Homo sapiens 274aacgtgcaga ygaagcctta a 21 275 21 DNA Homo sapiens 275cccacgttag yggaggtggt g 21 276 21 DNA Homo sapiens 276cattgttcga ratttaggac t 21 277 21 DNA Homo sapiens 277gacagcaggg ytataatgta t 21 278 21 DNA Homo sapiens 278aagagtcaga wccacccaga c 21 279 21 DNA Homo sapiens 279cagtaatttt yctcatcttg t 21 280 21 DNA Homo sapiens 280taatgaatga mattgcagat a 21 281 21 DNA Homo sapiens 281caatggaaga kgttcttgaa c 21 282 21 DNA Homo sapiens 282cacttatacc ycttgtgtat g 21 283 21 DNA Homo sapiens 283attcttggat ycagctattt g 21 284 21 DNA Homo sapiens 284gactttggca stgaccacca g 21 285 21 DNA Homo sapiens 285actactgctc rgaccaatac t 21 286 21 DNA Homo sapiens 286ttgaaggtgt yttcagaaga t 21 287 21 DNA Homo sapiens 287ccaaacacct ygtagaactc t 21 288 21 DNA Homo sapiens 288ttcaggagcc yatcatggct c 21 289 21 DNA Homo sapiens 289tatatattaa ktggcagaaa c 21 290 21 DNA Homo sapiens 290cattcagatt scaaacaagg a 21 291 21 DNA Homo sapiens 291ttccacatct rgtgattaga a 21 292 21 DNA Homo sapiens 292gagaaatatg magtcttcat g 21 293 21 DNA Homo sapiens 293aggagaaaag ytttaaaaaa t 21 294 21 DNA Homo sapiens 294ttcaaaatga rtggttacat a 21 295 21 DNA Homo sapiens 295cctgtgcact ycggtggtca c 21 296 21 DNA Homo sapiens 296ttgccaagaa rtccaagaac c 21 297 21 DNA Homo sapiens 297atgatccatg sgtagaacat g 21 298 21 DNA Homo sapiens 298ccaccagacc wgacgagggg c 21 299 21 DNA Homo sapiens 299tttgcaattc sttcaaggga g 21 300 21 DNA Homo sapiens 300ggcaggagtg yggagagcct g 21 301 21 DNA Homo sapiens 301tgcagcccac rgcagagaat g 21 302 21 DNA Homo sapiens 302ggtgtcaact sttagccacg c 21 303 21 DNA Homo sapiens 303acgcagatgc ygattgcttt g 21 304 21 DNA Homo sapiens 304actttattaa yggttcttac t 21 305 21 DNA Homo sapiens 305ttgcgtatgc ygataatagc c 21 306 21 DNA Homo sapiens 306attctgatga yggctgttta a 21 307 21 DNA Homo sapiens 307atttatgtgg watgctctca c 21 308 21 DNA Homo sapiens 308tcattcatta ycatggtgta g 21 309 21 DNA Homo sapiens 309cagcttttta ygactcactg a 21 310 21 DNA Homo sapiens 310atcctgttat ygagatgtta g 21 311 21 DNA Homo sapiens 311atttaatgga rgatccagac a 21 312 21 DNA Homo sapiens 312aaaatataac rgaatgcagg a 21 313 21 DNA Homo sapiens 313gaaataaagc mcaaactgta c 21 314 21 DNA Homo sapiens 314tatgtattac ygaaaaagcc t 21 315 21 DNA Homo sapiens 315ggatgaggat rtgaagctga t 21 316 21 DNA Homo sapiens 316atgaggagga ygagcagctg a 21 317 21 DNA Homo sapiens 317cactgagaat rgcaccagtc t 21 318 21 DNA Homo sapiens 318tggagatgag raaatgggtc c 21 319 21 DNA Homo sapiens 319tgaccatcaa yaaggaagat g 21 320 21 DNA Homo sapiens 320ataacaagga ygtgtcggtg a 21 321 21 DNA Homo sapiens 321cagatcaaga rtgacatcca g 21 322 21 DNA Homo sapiens 322atccctgccc yggacagcaa g 21 323 21 DNA Homo sapiens 323attgataatg raagctggcc a 21 324 21 DNA Homo sapiens 324agtttagaaa rccaagctac a 21 325 21 DNA Homo sapiens 325aaatgtagca matcagaagc c 21 326 21 DNA Homo sapiens 326cttataatca rctggcttca a 21 327 21 DNA Homo sapiens 327accatggttt yatatggaga c 21 328 21 DNA Homo sapiens 328gaaaaaaata wtgattacat g 21 329 21 DNA Homo sapiens 329agcatgtgag mccattgaga t 21 330 21 DNA Homo sapiens 330atgattctgt ygtttcaatg t 21 331 21 DNA Homo sapiens 331agtcagtgtg sagcatttga a 21 332 21 DNA Homo sapiens 332catctcaaga sgagctcatt a 21 333 21 DNA Homo sapiens 333tctcctgaac rtctaaaaga t 21 334 21 DNA Homo sapiens 334agcgtccaga raggagagct t 21 335 21 DNA Homo sapiens 335tatgggaagt rgtcatgcat c 21 336 21 DNA Homo sapiens 336atctgcccag rgtccagctg c 21 337 21 DNA Homo sapiens 337agtacaacca ratgccagtc a 21 338 21 DNA Homo sapiens 338tctccacaaa rtgtgaccac a 21 339 21 DNA Homo sapiens 339tccaggtccg yggcctggag a 21 340 21 DNA Homo sapiens 340tacaacacca rtaacggggc t 21 341 21 DNA Homo sapiens 341gcaatttgga yatctccaac a 21 342 21 DNA Homo sapiens 342tgaaatttct yagtgagaac a 21 343 21 DNA Homo sapiens 343ttcaccacac ytaaggagaa c 21 344 21 DNA Homo sapiens 344tttcttccct satcctgatc t 21 345 21 DNA Homo sapiens 345cagcaatgac mttcccatcg c 21 346 21 DNA Homo sapiens 346cagctgagaa ygctgccaag g 21 347 21 DNA Homo sapiens 347tgtccctagc ygaactcagg a 21 348 21 DNA Homo sapiens 348agcgaacgac rcttcgctat g 21 349 21 DNA Homo sapiens 349aaagcaatgc ygagaggatg a 21 350 21 DNA Homo sapiens 350ttcgtgaatg rtctaaagcg g 21 351 21 DNA Homo sapiens 351agtgtgaccc rgactgcctc c 21 352 21 DNA Homo sapiens 352catgccaatt rcatcgttca c 21 353 21 DNA Homo sapiens 353ctgaagccga ycagttgggc a 21 354 21 DNA Homo sapiens 354tatgcaacac ytgtggacat g 21 355 21 DNA Homo sapiens 355ttctggtgac ragtggtgga a 21 356 21 DNA Homo sapiens 356tgattgggct rcctccagag g 21 357 21 DNA Homo sapiens 357ctcttatcta yataaggatg a 21 358 21 DNA Homo sapiens 358cagacctcag ygcctctctg g 21 359 21 DNA Homo sapiens 359gtgagtgatg maggtttgaa g 21 360 21 DNA Homo sapiens 360aaggtttgaa rggcaagatt a 21 361 21 DNA Homo sapiens 361gtcacagcca yggacaagag c 21 362 21 DNA Homo sapiens 362tgacgtttga yattgatgcc a 21 363 21 DNA Homo sapiens 363tgaccgtgga ygagggtgtc c 21 364 21 DNA Homo sapiens 364cccactgccg mttctatgag g 21 365 21 DNA Homo sapiens 365tcatctcccg mtttgagggc t 21 366 21 DNA Homo sapiens 366acctgtgttc wcaaagatgg c 21 367 21 DNA Homo sapiens 367actcaagcta ygaggaaaag a 21 368 21 DNA Homo sapiens 368ggggtactgg racatccgcg g 21 369 21 DNA Homo sapiens 369gattgatggg rctcacaaga t 21 370 21 DNA Homo sapiens 370cccagagcaa ygccatcctg c 21 371 21 DNA Homo sapiens 371gtatatttga scccaagtgc c 21 372 21 DNA Homo sapiens 372caacaagcct rtatgctgag c 21 373 21 DNA Homo sapiens 373ggctttcatg kgccgttttg a 21 374 21 DNA Homo sapiens 374cagagcaatg mcatcttgcg c 21 375 21 DNA Homo sapiens 375tggacgcctt yccaaatctg a 21 376 21 DNA Homo sapiens 376tggggctgga racggccgga g 21 377 21 DNA Homo sapiens 377ggccggggac rcccacctgg g 21 378 21 DNA Homo sapiens 378tcagcgaggc sgacaagaag a 21 379 21 DNA Homo sapiens 379acaaggggga saccaaggca t 21 380 21 DNA Homo sapiens 380agctgctgca rgacttcttc a 21 381 21 DNA Homo sapiens 381attcctccga rgtcttttgt t 21 382 21 DNA Homo sapiens 382gacgccttcc yaaacttgaa g 21 383 21 DNA Homo sapiens 383ttggaaagtc rgctacatgg a 21 384 21 DNA Homo sapiens 384ctctcggcta ygaactgttt g 21 385 21 DNA Homo sapiens 385ggactgccat rgaccaggcc c 21 386 21 DNA Homo sapiens 386caggtgttgg rgccactcat t 21 387 21 DNA Homo sapiens 387tgttggggcc mctcattggg g 21 388 21 DNA Homo sapiens 388ccaggtgccc raggagaagg t 21 389 21 DNA Homo sapiens 389ccgcgttgac yctctggaga c 21 390 21 DNA Homo sapiens 390tggaccacta yaagaagggg a 21 391 21 DNA Homo sapiens 391tcatcgtggt ygccctgtat g 21 392 21 DNA Homo sapiens 392ccattcacca ygaagacctc a 21 393 21 DNA Homo sapiens 393ccctggccac scggaaggag g 21 394 21 DNA Homo sapiens 394ccagcgccag yccacactgt c 21 395 21 DNA Homo sapiens 395ccacgaagac ytcagcttcc a 21 396 21 DNA Homo sapiens 396gtgaattaag rgaaataatg a 21 397 21 DNA Homo sapiens 397gactgtgtga wttccctgat a 21 398 21 DNA Homo sapiens 398agatatggat yaggtggaaa a 21 399 21 DNA Homo sapiens 399gacagtttga wctgactact t 21 400 21 DNA Homo sapiens 400tcagctagat rctgttgtca g 21 401 21 DNA Homo sapiens 401gagtttctgg kctgagctca a 21 402 21 DNA Homo sapiens 402gcacgcgcac rcccgcaggg t 21 403 21 DNA Homo sapiens 403catcccgaat ycaggcatca c 21 404 21 DNA Homo sapiens 404gcgtggtccg yttcgccatg c 21 405 21 DNA Homo sapiens 405attttgccat kgttctgctc a 21 406 21 DNA Homo sapiens 406ctgccatggg yagctccgtg c 21 407 21 DNA Homo sapiens 407ccctcgaacc ygagacagca g 21 408 21 DNA Homo sapiens 408ctgctggttg yactgtcagt g 21 409 21 DNA Homo sapiens 409caccgttcac sttgctttgg c 21 410 21 DNA Homo sapiens 410tctactgaag rgcattctgg c 21 411 21 DNA Homo sapiens 411ccatcagcaa ygtcacagcc t 21 412 21 DNA Homo sapiens 412aaatactttt ytttctacaa c 21 413 21 DNA Homo sapiens 413ggacactctc rtcttttgct g 21 414 21 DNA Homo sapiens 414aagcactatg ytcctttcct c 21 415 21 DNA Homo sapiens 415tcttcatggc ygcgttaatc c 21 416 21 DNA Homo sapiens 416ggacatggaa raagacatct t 21 417 21 DNA Homo sapiens 417tgacattggc ratgcagctg a 21 418 21 DNA Homo sapiens 418cggaaaatga rtgccaggca g 21 419 21 DNA Homo sapiens 419tcataatgca ytaaaaacct c 21 420 21 DNA Homo sapiens 420ccactgtgac wttggcaatg c 21 421 21 DNA Homo sapiens 421gtcgctgact yggagagctc a 21 422 21 DNA Homo sapiens 422gaagtgtata rgaatcccaa t 21 423 21 DNA Homo sapiens 423ttctggctga mcctgtggag a 21 424 21 DNA Homo sapiens 424atctttacct saagatgaaa c 21 425 21 DNA Homo sapiens 425ctctgccgta rttttgcccc t 21 426 21 DNA Homo sapiens 426atcctgggct ycattgggtc t 21 427 21 DNA Homo sapiens 427ctgccgtagt yttgcccctg g 21 428 21 DNA Homo sapiens 428agctggatgt rcctgtggta a 21 429 21 DNA Homo sapiens 429cggcttcggc ytctccaact a 21 430 21 DNA Homo sapiens 430gccggggcca ygtgagattc c 21 431 21 DNA Homo sapiens 431tgtacggctt yggcctctcc a 21 432 21 DNA Homo sapiens 432tgatgggcaa rcagctggag a 21 433 21 DNA Homo sapiens 433gcaaagtccc ktttaacaaa a 21 434 21 DNA Homo sapiens 434tggcatacat ygagcggaag a 21 435 21 DNA Homo sapiens 435aaaggcttgg ygctgggcag t 21 436 21 DNA Homo sapiens 436agccacagaa rccatgggat a 21 437 21 DNA Homo sapiens 437cctgctattt waaagacttc t 21 438 21 DNA Homo sapiens 438acaaagttga yttagaagag a 21 439 21 DNA Homo sapiens 439tcatgagctt yggtatcctt a 21 440 21 DNA Homo sapiens 440tcatgtaaca raaaatcaaa t 21 441 21 DNA Homo sapiens 441aaaaaatcaa rtgtaataga t 21 442 21 DNA Homo sapiens 442ttaccatgta ragtaagtaa t 21 443 21 DNA Homo sapiens 443gaacgataca rtagtcaaat g 21 444 21 DNA Homo sapiens 444tttagaggat kcaacactac a 21 445 21 DNA Homo sapiens 445tttagacgtt wtatataaaa t 21 446 21 DNA Homo sapiens 446agacgtttta yataaaatga c 21 447 21 DNA Homo sapiens 447ataccaggag yttcaattac t 21 448 21 DNA Homo sapiens 448ttttctttct kaaaatcgat g 21 449 21 DNA Homo sapiens 449ctcagaaatc ytgatgacgt c 21 450 21 DNA Homo sapiens 450ctgccaggct rcaagggcca a 21 451 21 DNA Homo sapiens 451cacatgccag ygccaatccc c 21 452 21 DNA Homo sapiens 452ggggctcagc ygacggccct c 21 453 21 DNA Homo sapiens 453gacccctcag ycgtgcctgt g 21 454 21 DNA Homo sapiens 454ccggagccca rggactgcgt c 21 455 21 DNA Homo sapiens 455acggatgcac wgggccaggt c 21 456 21 DNA Homo sapiens 456gcgccgctgc stggccgccc g 21 457 21 DNA Homo sapiens 457ttggaattcc rggtcatgcc t 21 458 21 DNA Homo sapiens 458aatcaactac ycaggaaaaa c 21 459 21 DNA Homo sapiens 459cctgaggttg yggaaaagga a 21 460 21 DNA Homo sapiens 460agaagatgag wttatgcctg a 21 461 21 DNA Homo sapiens 461gagaggccgc racccaacac c 21 462 21 DNA Homo sapiens 462tgttccagga rtccagtatc t 21 463 21 DNA Homo sapiens 463agcttcagat ytgcccggcg a 21 464 21 DNA Homo sapiens 464gcagtggtcc rgcggccact c 21 465 21 DNA Homo sapiens 465tcatggacaa sgtggtgcgg t 21 466 21 DNA Homo sapiens 466ttgtgtcaga wcccaaagct g 21 467 21 DNA Homo sapiens 467aatattcagt yccaggcgcc a 21 468 21 DNA Homo sapiens 468ctaaagaata rcccacctta t 21 469 21 DNA Homo sapiens 469aactcatcct rgctacatgg c 21 470 21 DNA Homo sapiens 470tcgagaacct yatgagtcag g 21 471 21 DNA Homo sapiens 471tctttccaag yggactcttt c 21 472 21 DNA Homo sapiens 472ctctggatgg ygatcctaca a 21 473 21 DNA Homo sapiens 473ccggcactca yttccatttt c 21 474 21 DNA Homo sapiens 474agcggcccag yttcagcacc a 21 475 21 DNA Homo sapiens 475cccagcgggt yaagagtgac a 21 476 21 DNA Homo sapiens 476gaagcccctg yatgagcagc t 21 477 21 DNA Homo sapiens 477gagaggaagc ygatggggtc t 21 478 21 DNA Homo sapiens 478ctgctggcat kgagtacctg g 21 479 21 DNA Homo sapiens 479gatggtctgc yccggcactt c 21 480 21 DNA Homo sapiens 480gtgacaaggc yaaggacaag t 21 481 21 DNA Homo sapiens 481tgggcaccgg ytgcttcggg g 21 482 21 DNA Homo sapiens 482cagaagctac rgggcagcag a 21 483 21 DNA Homo sapiens 483tggatcaaca raatcccgat g 21 484 21 DNA Homo sapiens 484actacaacgt ygatagaacc a 21 485 21 DNA Homo sapiens 485ggccaatcca rtttgtggta c 21 486 21 DNA Homo sapiens 486gtccaggctt ytaatgtaga t 21 487 21 DNA Homo sapiens 487gcatcacaat ytgcagaaat c 21 488 21 DNA Homo sapiens 488aaattctcag sagctattat c 21 489 21 DNA Homo sapiens 489aaccaatgca kcgacacctt t 21 490 21 DNA Homo sapiens 490gacactgaag ragctgtcag t 21 491 21 DNA Homo sapiens 491ttctcttcag yagaatgatg a 21 492 21 DNA Homo sapiens 492actgtgaagg wtctgctctg t 21 493 21 DNA Homo sapiens 493aaaatcagag yaacttaaaa a 21 494 21 DNA Homo sapiens 494agtactgggg ytcctcagtc t 21 495 21 DNA Homo sapiens 495gccagtctct stgcctcaat a 21 496 21 DNA Homo sapiens 496attctgggac kcccaaagac c 21 497 21 DNA Homo sapiens 497ggagtgaccc rgtggagcaa g 21 498 21 DNA Homo sapiens 498tccagaacca ytttgtggac g 21 499 21 DNA Homo sapiens 499gcatacctca stggctacta a 21 500 21 DNA Homo sapiens 500ccatcttggt ygtgaagatc c 21 501 21 DNA Homo sapiens 501agagccaggt rtcggagcag c 21 502 21 DNA Homo sapiens 502gtcgccgggg mccagcaaat a 21 503 21 DNA Homo sapiens 503cctcccaaag ygctgggatt a 21 504 21 DNA Homo sapiens 504gacgcagggt ytcccatgac c 21 505 21 DNA Homo sapiens 505tatgatccat yttaactgag g 21 506 21 DNA Homo sapiens 506tgcaactcct rctattaaga c 21 507 21 DNA Homo sapiens 507taccgtgtaa ygtgaaccag c 21 508 21 DNA Homo sapiens 508ttctgctgct ratggagcga g 21 509 21 DNA Homo sapiens 509tgattcatga stgtcctcat c 21 510 21 DNA Homo sapiens 510tagaggacat raacgagttc a 21 511 21 DNA Homo sapiens 511gaattcagga ygttgtaccg t 21 512 21 DNA Homo sapiens 512actcatgaag yagcttaatg c 21 513 21 DNA Homo sapiens 513tttatgacat saagcggggc t 21 514 21 DNA Homo sapiens 514tggaagactt ygagacgatt g 21 515 21 DNA Homo sapiens 515aagacgcagt ytatcatgat g 21 516 21 DNA Homo sapiens 516ttcaggcaaa ygagatcatg t 21 517 21 DNA Homo sapiens 517tatgttgtat ytcgagagta a 21 518 21 DNA Homo sapiens 518tctcgacccc ygtggtgctc t 21 519 21 DNA Homo sapiens 519ggctgtgggg rctacgcaag a 21 520 21 DNA Homo sapiens 520aggcccaggc rgtttggcac g 21 521 21 DNA Homo sapiens 521gctgggacct sttccacaaa t 21 522 21 DNA Homo sapiens 522tacatcccca rtcgtggccc t 21 523 21 DNA Homo sapiens 523aaaacctcaa rgttataaag g 21 524 21 DNA Homo sapiens 524tgcattccag rgacacgtgg c 21 525 21 DNA Homo sapiens 525gggagccatc rtaaggaccc a 21 526 21 DNA Homo sapiens 526agcttgccag yggcatcctc a 21 527 21 DNA Homo sapiens 527cccatttgag magctgtgag c 21 528 21 DNA Homo sapiens 528atgacctcag rgactttcca a 21 529 21 DNA Homo sapiens 529gggacgcgaa stgcgcagcc a 21 530 21 DNA Homo sapiens 530aagcggtcta ytccagggat t 21 531 21 DNA Homo sapiens 531cctattgatc rgaagtcagt c 21 532 21 DNA Homo sapiens 532gagtggatct yattgaagtt t 21 533 21 DNA Homo sapiens 533tgccccctag ygactccgtg t 21 534 21 DNA Homo sapiens 534gaaagcgcct raaactgacg a 21 535 21 DNA Homo sapiens 535actcggggca yggcagcact t 21 536 21 DNA Homo sapiens 536tcgcaggaac rtgtggactc t 21 537 21 DNA Homo sapiens 537cgtcctgaga yctcagaaag a 21 538 21 DNA Homo sapiens 538ggactgctct yaacacaagc g 21 539 21 DNA Homo sapiens 539tgagctgttc sgatgctctg c 21 540 21 DNA Homo sapiens 540catcccagac rcgggcagtc a 21 541 21 DNA Homo sapiens 541ccttcggacc ycaggacgtc g 21 542 21 DNA Homo sapiens 542actagtaaaa rctggacctt c 21 543 21 DNA Homo sapiens 543atatttgcga yaagtaggat a 21 544 21 DNA Homo sapiens 544cacacaaggt sgtgttatat t 21 545 21 DNA Homo sapiens 545ttgaacacct ycctcgccgt g 21 546 21 DNA Homo sapiens 546tttgtggcac yagcttggag c 21 547 21 DNA Homo sapiens 547ttctatgaca yctaccatgc t 21 548 21 DNA Homo sapiens 548agaaagcaac ycaaagtggg a 21 549 21 DNA Homo sapiens 549tctgcaacga rcgcttcact c 21 550 21 DNA Homo sapiens 550agacacggga stgcatctac t 21 551 21 DNA Homo sapiens 551cctcacggat yacctcaagg g 21 552 21 DNA Homo sapiens 552ggctcctgag rtgctcgagg g 21 553 21 DNA Homo sapiens 553tgctgaagag ygacctcaca g 21 554 21 DNA Homo sapiens 554ccagagacag ygcgacccgg a 21 555 21 DNA Homo sapiens 555acctggccat ygtccacgcc a 21 556 21 DNA Homo sapiens 556agtgcttgac wgacatttac c 21 557 21 DNA Homo sapiens 557catgctggtc rtcctcatct t 21 558 21 DNA Homo sapiens 558acatccacgc mgctcgaggg a 21 559 21 DNA Homo sapiens 559ggtgctagtc ygcgccatca a 21 560 21 DNA Homo sapiens 560cacctacctg stctggacct g 21 561 21 DNA Homo sapiens 561cggtacacag ygacaattga g 21 562 21 DNA Homo sapiens 562gagcacgggt ycctgtttga t 21 563 21 DNA Homo sapiens 563cagagttatg wggcactgcg g 21 564 21 DNA Homo sapiens 564tatattggga sattgctcga a 21 565 21 DNA Homo sapiens 565gagatgtgtc yctccaaaga c 21 566 21 DNA Homo sapiens 566agctgtactt ycaacagtta t 21 567 21 DNA Homo sapiens 567ggggaaacca rtgaaaagcg t 21 568 21 DNA Homo sapiens 568tcacctgctg ytataacttc a 21 569 21 DNA Homo sapiens 569tgaaagaagt rgcaacgctg t 21 570 21 DNA Homo sapiens 570gcatctctgc ygaagccaag g 21 571 21 DNA Homo sapiens 571tgaccagcct ycgccgctcg g 21 572 21 DNA Homo sapiens 572cagagtgcaa rcgcagccac a 21 573 21 DNA Homo sapiens 573ataacaaccc yatctggtca g 21 574 21 DNA Homo sapiens 574tgaagctctt ytttggtggc c 21 575 21 DNA Homo sapiens 575cggcgggagg yactgaggag g 21 576 21 DNA Homo sapiens 576gcagctcttc rccaatgggg a 21 577 21 DNA Homo sapiens 577tcactgtcca rgtgcccagc a 21 578 21 DNA Homo sapiens 578gactggccag mccagcctca g 21 579 21 DNA Homo sapiens 579ggcttctgca kacagtcaag c 21 580 21 DNA Homo sapiens 580ttttacaaat ragcagagaa t 21 581 21 DNA Homo sapiens 581gctgtgtttc sggatgcaag c 21 582 21 DNA Homo sapiens 582cagtaacatg ygcatctact g 21 583 21 DNA Homo sapiens 583agcgccaggc mccgagcagt g 21 584 21 DNA Homo sapiens 584ggtggctggc rtcctggttc t 21 585 21 DNA Homo sapiens 585tgaagccgga rgacagtggc a 21 586 21 DNA Homo sapiens 586ctgcatgatc ktcgggagcc c 21 587 21 DNA Homo sapiens 587tctgggattc ygcaaaaggg a 21 588 21 DNA Homo sapiens 588gagtggccat scacctgtgc t 21 589 21 DNA Homo sapiens 589ttgtagcccc rtcacccttg g 21 590 21 DNA Homo sapiens 590ctgtgtgtga ygtgcatggg a 21 591 21 DNA Homo sapiens 591ggtggtaacc rtcgggctag a 21 592 21 DNA Homo sapiens 592ctgatgggat sctatggaac c 21 593 21 DNA Homo sapiens 593atgatgccat ygatgccctc g 21 594 21 DNA Homo sapiens 594ctgtctctgg ytggccaaag g 21 595 21 DNA Homo sapiens 595agaaagggat macctgccgc a 21 596 21 DNA Homo sapiens 596agaggccgca ygtcggatct c 21 597 21 DNA Homo sapiens 597ccgtttgcct rcctcgtcca g 21 598 21 DNA Homo sapiens 598gtttgactgt rgaccagctg c 21 599 21 DNA Homo sapiens 599gtgtctgaga ractccggac c 21 600 21 DNA Homo sapiens 600gggactaaga sctgggaaga a 21 601 21 DNA Homo sapiens 601tctccgatga yacactcttt c 21 602 21 DNA Homo sapiens 602gctgctctcc yggagatggc a 21 603 21 DNA Homo sapiens 603gtggccttct ycaccaatgg g 21 604 21 DNA Homo sapiens 604acagccctcc rtgtgctacc t 21 605 21 DNA Homo sapiens 605tgcctggaac yttggctggg c 21 606 21 DNA Homo sapiens 606agattcactc rggctctgtc a 21 607 21 DNA Homo sapiens 607ccattgctgc yttcttgccg g 21 608 21 DNA Homo sapiens 608tggccaataa matcttggcc a 21 609 21 DNA Homo sapiens 609atgacggaca ratttgccca g 21 610 21 DNA Homo sapiens 610agcagcttcg katggcaatg a 21 611 21 DNA Homo sapiens 611tcacgagggc rgagcaggtg g 21 612 21 DNA Homo sapiens 612ggcgcagcat ycggcttttc a 21 613 21 DNA Homo sapiens 613gcccctcacc rtatcagcct t 21 614 21 DNA Homo sapiens 614tcagggcgct ytgtgacaga g 21 615 21 DNA Homo sapiens 615caaggtggca ycattagtct t 21 616 21 DNA Homo sapiens 616tttcgaagtt ycttaccaac c 21 617 21 DNA Homo sapiens 617ctccagcatg sgaagtcggt g 21 618 21 DNA Homo sapiens 618acagtgcaac rgctgatgct g 21 619 21 DNA Homo sapiens 619gtctgagaga ytccggaccc t 21 620 21 DNA Homo sapiens 620ggagggccct ytggagcgcc c 21 621 21 DNA Homo sapiens 621tggttgtcgg ktgctgcaga c 21 622 21 DNA Homo sapiens 622agctgctgac rcggccacac a 21 623 21 DNA Homo sapiens 623tagtgagcca rcaccacatc t 21 624 21 DNA Homo sapiens 624catcgatggg rctgataggt t 21 625 21 DNA Homo sapiens 625tgagtgggat sgtggaaggg a 21 626 21 DNA Homo sapiens 626gtggaaggga racacacttg g 21 627 21 DNA Homo sapiens 627gaggggaaga raatgaggtg t 21 628 21 DNA Homo sapiens 628aagaaatata yacttgagtg g 21 629 21 DNA Homo sapiens 629tgatcgctat stagcaaccc t 21 630 21 DNA Homo sapiens 630tcttaaaatt sacatggacc a 21 631 21 DNA Homo sapiens 631cactgggagt ygccatatct g 21 632 21 DNA Homo sapiens 632agattatgag yctccatttg g 21 633 21 DNA Homo sapiens 633tgggaactgc ragatacatg g 21 634 21 DNA Homo sapiens 634tactccagtt sctgacggct g 21 635 21 DNA Homo sapiens 635tcgtgaagaa ygacctaacc t 21 636 21 DNA Homo sapiens 636tgtcatcatc mtcttctact g 21 637 21 DNA Homo sapiens 637cctccacagt ratcacactc c 21 638 21 DNA Homo sapiens 638cctgtctgac ratcctggac t 21 639 21 DNA Homo sapiens 639gaagccacag racttgcact t 21 640 21 DNA Homo sapiens 640agataaataa yggcggctgt t 21 641 21 DNA Homo sapiens 641gggtggatgt yttcacccaa c 21 642 21 DNA Homo sapiens 642ctgagacgta yggaccccag t 21 643 21 DNA Homo sapiens 643tggttatggg mcaaatggat g 21 644 21 DNA Homo sapiens 644tctgggttat saaaactgaa a 21 645 21 DNA Homo sapiens 645gcctttcact yacaccaggc a 21 646 21 DNA Homo sapiens 646gcaaggtgcc rggaaacttc a 21 647 21 DNA Homo sapiens 647agaggagtgc rtctccctca c 21 648 21 DNA Homo sapiens 648caggtatctt rgaagttttg c 21 649 21 DNA Homo sapiens 649tagaagccat ygtcagcagt g 21 650 21 DNA Homo sapiens 650acatgggagg ycctgaaact c 21 651 21 DNA Homo sapiens 651tactatattg ratttcggta c 21 652 21 DNA Homo sapiens 652agaagacgct rtccattttc a 21 653 21 DNA Homo sapiens 653atcgtggaga rcggcggggc a 21 654 21 DNA Homo sapiens 654gggcctcacg ytctttgcag t 21 655 21 DNA Homo sapiens 655tgaaaatggc yttggaggca g 21 656 21 DNA Homo sapiens 656aggagacgac yttctacacg c 21 657 21 DNA Homo sapiens 657ggtgtgcctg rcatgggcct g 21 658 21 DNA Homo sapiens 658catgttgcca ragccaacgt c 21 659 21 DNA Homo sapiens 659ctatgtctgc sgagtcagca t 21 660 21 DNA Homo sapiens 660agggcacggg ytccgaggcg t 21 661 21 DNA Homo sapiens 661cctcactgcc kccagccctc t 21 662 21 DNA Homo sapiens 662acagccaaga mctgggaact c 21 663 21 DNA Homo sapiens 663acctgcacct kcgctgcagc g 21 664 21 DNA Homo sapiens 664cctggctcta ytctcctgga c 21 665 21 DNA Homo sapiens 665tcctgaatcc ytggattact g 21 666 21 DNA Homo sapiens 666gccactgaag racaggcaaa t 21 667 21 DNA Homo sapiens 667cgctgaagac rccccacggg g 21 668 21 DNA Homo sapiens 668agagctgccc ragaagctcc c 21 669 21 DNA Homo sapiens 669tccgagaggc racaaggttt g 21 670 21 DNA Homo sapiens 670ccagtgtgga mgaactaaag g 21 671 21 DNA Homo sapiens 671tcttcagggg rcccaatggt g 21 672 21 DNA Homo sapiens 672gttccttttg matttctccc g 21 673 21 DNA Homo sapiens 673ccagggcctg ygggtagagt c 21 674 21 DNA Homo sapiens 674tcaagaacca yacagagatc g 21 675 21 DNA Homo sapiens 675tgcaattcaa rgatggtaca g 21 676 21 DNA Homo sapiens 676cggcgcagac racactggtg g 21 677 21 DNA Homo sapiens 677atgggcacaa ygtgtgggcc c 21 678 21 DNA Homo sapiens 678gcatctttgg ygatgaggat g 21 679 21 DNA Homo sapiens 679gctcgctgct yatcgtgcag a 21 680 21 DNA Homo sapiens 680agcctgagtg yttcggaccc g 21 681 21 DNA Homo sapiens 681accacaaggc rtccatggtg c 21 682 21 DNA Homo sapiens 682cagacgcccc rgctgtggtc a 21 683 21 DNA Homo sapiens 683tccaaagaag raggaagctg g 21 684 21 DNA Homo sapiens 684acatcccagc rcgccgaaac c 21 685 21 DNA Homo sapiens 685tgaagatcgc rcagggtgtc t 21 686 21 DNA Homo sapiens 686cccctacagg yatgtggtgg t 21 687 21 DNA Homo sapiens 687tgaacatgat yctcccggac t 21 688 21 DNA Homo sapiens 688gcaggccatc ycggaggcag g 21 689 21 DNA Homo sapiens 689ggcctgcctg yggctgacct g 21 690 21 DNA Homo sapiens 690gcagctgcct yaatgactgc c 21 691 21 DNA Homo sapiens 691gttcgaatgt kagaacctct a 21 692 21 DNA Homo sapiens 692tgaccagttt yccgcacatg g 21 693 21 DNA Homo sapiens 693ctgacatcta ygtgctaggc t 21 694 21 DNA Homo sapiens 694tgcgggcacg scagatgcac c 21 695 21 DNA Homo sapiens 695tgctggcaat ygctgtggac c 21 696 21 DNA Homo sapiens 696tggcaattgc kgtggaccgc t 21 697 21 DNA Homo sapiens 697cctagatctc rggagttaat g 21 698 21 DNA Homo sapiens 698tctcctctgt ycccataggt t 21 699 21 DNA Homo sapiens 699ttgatgtgga yggcaaccga a 21 700 21 DNA Homo sapiens 700atcaccatgg yctgcggctc c 21 701 21 DNA Homo sapiens 701tggacgaggt mcagaccgga g 21 702 21 DNA Homo sapiens 702attatgatgg rcctctgatg a 21 703 21 DNA Homo sapiens 703tgttctcgaa rgaatgccaa g 21 704 21 DNA Homo sapiens 704gcctaaacct stgtgaaccc a 21 705 21 DNA Homo sapiens 705taccaggaaa yctgtggagg a 21 706 21 DNA Homo sapiens 706tggccaggta yggtgtgaag c 21 707 21 DNA Homo sapiens 707tgaggtggca ytggcgtatg c 21 708 21 DNA Homo sapiens 708tgagtgaaaa yggagcattc c 21 709 21 DNA Homo sapiens 709ctctggtccc rtatctggta g 21 710 21 DNA Homo sapiens 710caggccccta yggcgccaac a 21 711 21 DNA Homo sapiens 711gacaaggact kgaatatttt c 21 712 21 DNA Homo sapiens 712aagagcatga yaaggcctgc g 21 713 21 DNA Homo sapiens 713cagtgacccg kcctctgtct c 21 714 21 DNA Homo sapiens 714ttgatttgga yaattctggt t 21 715 21 DNA Homo sapiens 715atgtgtgact yttatcagag a 21 716 21 DNA Homo sapiens 716caccacaaca ygcagacctt c 21 717 21 DNA Homo sapiens 717gtgctccggc rcgcctggac t 21 718 21 DNA Homo sapiens 718tgtgctccgg ygcgcctgga c 21 719 21 DNA Homo sapiens 719gcaaagctcc rccacaacat g 21 720 21 DNA Homo sapiens 720agttatcatc rtccaagttt a 21 721 21 DNA Homo sapiens 721gctggccttc rcgaccacac t 21 722 21 DNA Homo sapiens 722ctgctgccca ygggtcacac c 21 723 21 DNA Homo sapiens 723gctccaggcg ktgcttgttc c 21 724 21 DNA Homo sapiens 724cagaggtttg ytgggactcc c 21 725 21 DNA Homo sapiens 725ggatctggag ygagtggagt g 21 726 21 DNA Homo sapiens 726cgatgggacc rggacaggcc g 21 727 21 DNA Homo sapiens 727gggacaggcc rtggaagtgg a 21 728 21 DNA Homo sapiens 728ccagaacctg sagtgcttct t 21 729 21 DNA Homo sapiens 729ccccacagcc mgagggcctc c 21 730 21 DNA Homo sapiens 730gccgtggaga mggtgaacat c 21 731 21 DNA Homo sapiens 731ctgctgaacc kcctggcaga c 21 732 21 DNA Homo sapiens 732tatggcccaa sagcaggtgc g 21 733 21 DNA Homo sapiens 733gcccgggaag ycttccgcct g 21 734 21 DNA Homo sapiens 734accctaccac yggggaggtc a 21 735 21 DNA Homo sapiens 735gggaggtcat ygggcacgtg g 21 736 21 DNA Homo sapiens 736cggggtatgg yccaacagca g 21 737 21 DNA Homo sapiens 737cgcccagcac rtggatgttg a 21 738 21 DNA Homo sapiens 738ccctcatcaa sgaggcaggc t 21 739 21 DNA Homo sapiens 739tgccacagac rattttgcgg a 21 740 21 DNA Homo sapiens 740accagcctga rgtgtctcag g 21 741 21 DNA Homo sapiens 741cagaccatgg ygtgtgacat c 21 742 21 DNA Homo sapiens 742tatattggca ygggctatta t 21 743 21 DNA Homo sapiens 743gtgccacaga sgattttgcg g 21 744 21 DNA Homo sapiens 744ctgcatgcca yttcaagcaa a 21 745 21 DNA Homo sapiens 745ggaaatttct ygttgatccc c 21 746 21 DNA Homo sapiens 746cattgtggct rctcagtgaa g 21 747 21 DNA Homo sapiens 747aaactgaaca rttcgtctga a 21 748 21 DNA Homo sapiens 748gacaggtcta yctagacggg g 21 749 21 DNA Homo sapiens 749ggtgggaatc wgtcgccctg g 21 750 21 DNA Homo sapiens 750ttagtcctct stccctaagt t 21 751 21 DNA Homo sapiens 751tggtgtatgt stctgactcc g 21 752 21 DNA Homo sapiens 752tgcctagtgg ycattggcag a 21 753 21 DNA Homo sapiens 753acctcacttc rtggtggtcc a 21 754 21 DNA Homo sapiens 754ttgctggtac wcttctatcc a 21 755 21 DNA Homo sapiens 755ttacccacga satgaggcag g 21 756 21 DNA Homo sapiens 756cccccagtcc scggtgatgc a 21 757 21 DNA Homo sapiens 757ggcaagaaga rcttcgagac t 21 758 21 DNA Homo sapiens 758tacgataaga wgcaaacgtg g 21 759 21 DNA Homo sapiens 759ccactcaaac ytttcaacaa a 21 760 21 DNA Homo sapiens 760tggcgggcaa ygtgctggtg t 21 761 21 DNA Homo sapiens 761gcagcctgcc rgagatcgac a 21 762 21 DNA Homo sapiens 762tcctggctgc rgtcaccacc a 21 763 21 DNA Homo sapiens 763aaggagcctg ycggggagaa c 21 764 21 DNA Homo sapiens 764agaccaaggc yggccgcatc a 21 765 21 DNA Homo sapiens 765gccgccgctc rgatgaggac t 21 766 21 DNA Homo sapiens 766actatggact yacagcagcc g 21 767 21 DNA Homo sapiens 767ataaaaagag ygaatagcac c 21 768 21 DNA Homo sapiens 768atagccagtg sagtgctgga g 21 769 21 DNA Homo sapiens 769accctaccgc yttcgttgtc a 21 770 21 DNA Homo sapiens 770cctgccggga sttgccttgt t 21 771 21 DNA Homo sapiens 771tggtggtcct stcctctctt g 21 772 21 DNA Homo sapiens 772tagtatttca kgtatgctgc t 21 773 21 DNA Homo sapiens 773agagtcccag rcccggccgg g 21 774 21 DNA Homo sapiens 774aacatcatgt ytcgggtaac a 21 775 21 DNA Homo sapiens 775ggtcaccctg rtcaccctgc c 21 776 21 DNA Homo sapiens 776ccaaaccgcc yagatgtctt a 21 777 21 DNA Homo sapiens 777cttgcggtga ragcgaattc c 21 778 21 DNA Homo sapiens 778tgcttaagga rcattccata c 21 779 21 DNA Homo sapiens 779agccaaatat sagcgatggc t 21 780 21 DNA Homo sapiens 780ctgaagttta raatgggtat c 21 781 21 DNA Homo sapiens 781tttaagaaaa rtggattgat t 21 782 21 DNA Homo sapiens 782tctgcgctgt wcctcaggtg t 21 783 21 DNA Homo sapiens 783cccgcaggga rttgcgtggt g 21 784 21 DNA Homo sapiens 784aaggagatcc rctacccacc c 21 785 21 DNA Homo sapiens 785tgccgggcgc rcctctcgct g 21 786 21 DNA Homo sapiens 786gtgccgccga rgaaaaagtg c 21 787 21 DNA Homo sapiens 787gttatcttgc wgagatctct g 21 788 21 DNA Homo sapiens 788tgcaaaatat ycaggagacc g 21 789 21 DNA Homo sapiens 789tggagttgat ytttcagtgc t 21 790 21 DNA Homo sapiens 790tctactggct stctaactaa t 21 791 21 DNA Homo sapiens 791ttgtcaaggc wgaatattac t 21 792 21 DNA Homo sapiens 792ggtcccgatg yacaccttgc a 21 793 21 DNA Homo sapiens 793aagaagtaat kgcaccgtct c 21 794 21 DNA Homo sapiens 794tcgctgtcat rttcctggct a 21 795 21 DNA Homo sapiens 795ggcatctaca rctgcattca t 21 796 21 DNA Homo sapiens 796ctatgtattc yagggacaac a 21 797 21 DNA Homo sapiens 797ggacattgac racatggcgg g 21 798 21 DNA Homo sapiens 798aggtgtccaa rctggagtgg c 21 799 21 DNA Homo sapiens 799ggtcacccgc raggtgaccg t 21 800 21 DNA Homo sapiens 800gaccagccca wgttgttggg c 21 801 21 DNA Homo sapiens 801ttggcatggt kgtaatccat a 21 802 21 DNA Homo sapiens 802aaatggtata waattcaaaa t 21 803 21 DNA Homo sapiens 803ttatctacca stgcttctca a 21 804 21 DNA Homo sapiens 804attgatcaaa rccaatcttt g 21 805 21 DNA Homo sapiens 805atttaaggac ragaccagca g 21 806 21 DNA Homo sapiens 806caagtcaaca ytggatattg t 21 807 21 DNA Homo sapiens 807tgcatgtgat yaagcgagat g 21 808 21 DNA Homo sapiens 808caacacagct mgatatgtgg a 21 809 21 DNA Homo sapiens 809gaagattgca magtatggta t 21 810 21 DNA Homo sapiens 810gagtatgaaa satgacagca t 21 811 21 DNA Homo sapiens 811tcagcactgg saatccctga a 21 812 21 DNA Homo sapiens 812tcgctgcgcc kccactatgc t 21 813 21 DNA Homo sapiens 813ttgacctctc saaggacatt c 21 814 21 DNA Homo sapiens 814ccttgatggc rtatatttca g 21 815 21 DNA Homo sapiens 815ctgtagaccg yggcttcttc a 21 816 21 DNA Homo sapiens 816tcagaactag ygagacgggc a 21 817 21 DNA Homo sapiens 817ggggtgatca raagaaagct c 21 818 21 DNA Homo sapiens 818caattgtggc yattgcatca t 21 819 21 DNA Homo sapiens 819tggtggacaa ygagctgcct g 21 820 21 DNA Homo sapiens 820tgaatcttag ygtgacaact c 21 821 21 DNA Homo sapiens 821ctgaatacaa yaacttcaag t 21 822 21 DNA Homo sapiens 822agctgcgcta yggcgaagac g 21 823 21 DNA Homo sapiens 823tgggccagtc ygctcgagat g 21 824 21 DNA Homo sapiens 824tgcctgactt ygatgtggcc c 21 825 21 DNA Homo sapiens 825cccagagcac rgtggtggca g 21 826 21 DNA Homo sapiens 826ctgtgtcttc stgatctgca g 21 827 21 DNA Homo sapiens 827tggataagac ycgagctttg a 21 828 21 DNA Homo sapiens 828gatgctatta rgaaagccca c 21 829 21 DNA Homo sapiens 829cccagatata ytacaactca a 21 830 21 DNA Homo sapiens 830aactatctat raaaagccaa a 21 831 21 DNA Homo sapiens 831aactattggg waatgtgttc a 21 832 21 DNA Homo sapiens 832aatctgttca rtacagggat t 21 833 21 DNA Homo sapiens 833ctgtcagatt rtagcaatga a 21 834 21 DNA Homo sapiens 834tatagagata yacggaattc c 21 835 21 DNA Homo sapiens 835ttgaagggcc raggagatct g 21 836 21 DNA Homo sapiens 836gggccaagga ratctgttga a 21 837 21 DNA Homo sapiens 837acatttttga ycctgagcaa a 21 838 21 DNA Homo sapiens 838aagttgcctt ytgatccaga t 21 839 21 DNA Homo sapiens 839aattaaaaag watgatcatt g 21 840 21 DNA Homo sapiens 840aggtctttgg yaataaactc t 21 841 21 DNA Homo sapiens 841ttcatatcaa ratcatcagt g 21 842 21 DNA Homo sapiens 842tgaatgtttg yagcctggat a 21 843 21 DNA Homo sapiens 843ctcatcacca rtgacaatac t 21 844 21 DNA Homo sapiens 844ttgatgacat ytttaaaata g 21 845 21 DNA Homo sapiens 845tagaaatggc rgacacagtc c 21 846 21 DNA Homo sapiens 846tgacatcttt waaatagcgg t 21 847 21 DNA Homo sapiens 847tctgtcatct yggctcatca c 21 848 21 DNA Homo sapiens 848gagggctgcc yggaacgtct c 21 849 21 DNA Homo sapiens 849atgggagcca ygtggactac a 21 850 21 DNA Homo sapiens 850ggcttgaata ytgcctcaag g 21 851 21 DNA Homo sapiens 851tcagtgcgga yaactataca c 21 852 21 DNA Homo sapiens 852catgccttct yccaccttcg g 21 853 21 DNA Homo sapiens 853agtggctatc rggagtttgt a 21 854 21 DNA Homo sapiens 854tgttataatg sacaagccat a 21 855 21 DNA Homo sapiens 855cctgagtgtc rtctatcggg a 21 856 21 DNA Homo sapiens 856ttttaatgca ygatgtagct t 21 857 21 DNA Homo sapiens 857tcctcgtggg yctcagcggg g 21 858 21 DNA Homo sapiens 858agtcaagcat yctgggcctg c 21 859 21 DNA Homo sapiens 859gcctccgtgt stcccaccga g 21 860 21 DNA Homo sapiens 860acgatcgccc kgccagagat a 21 861 21 DNA Homo sapiens 861aggaggtggc ragaggcgtg c 21 862 21 DNA Homo sapiens 862cattgccatt rttctgaggt t 21 863 21 DNA Homo sapiens 863ccagtgcaag mttcttcttc a 21 864 21 DNA Homo sapiens 864ctactaataa wgacgatgat a 21 865 21 DNA Homo sapiens 865ttccccagat rgctggctgg g 21 866 21 DNA Homo sapiens 866atacagacta yttcttcccc a 21 867 21 DNA Homo sapiens 867tcagagggtc rtcacacaca a 21 868 21 DNA Homo sapiens 868ggaagcccca mcaaattcca g 21 869 21 DNA Homo sapiens 869ctggagacaa ragcccacag a 21 870 21 DNA Homo sapiens 870cctcttgatg rtctttgtgg c 21 871 21 DNA Homo sapiens 871atcatggtgc ytggctgcca g 21 872 21 DNA Homo sapiens 872aaagtccaat scagccagtg g 21 873 21 DNA Homo sapiens 873acgatgaccc rccagagatc c 21 874 21 DNA Homo sapiens 874aaatgaccca ygggaagaca a 21 875 21 DNA Homo sapiens 875agccccagct matatgcaca g 21 876 21 DNA Homo sapiens 876ctggtagtag sccctcagtg c 21 877 21 DNA Homo sapiens 877cctgccagtg ycctcaccgg t 21 878 21 DNA Homo sapiens 878tgatgctgag yttgaaactg g 21 879 21 DNA Homo sapiens 879cacgtgattg rcaagttcct a 21 880 21 DNA Homo sapiens 880cttcgagccc rcgtgattga c 21 881 21 DNA Homo sapiens 881gctggcgggc raatacgcag a 21 882 21 DNA Homo sapiens 882actgatgtcc rtcctttgta t 21 883 21 DNA Homo sapiens 883ccttactgaa rgtttctagt t 21 884 21 DNA Homo sapiens 884ctgttctccc raaaccagac t 21 885 21 DNA Homo sapiens 885ccagaagaca rtgaaagtca c 21 886 21 DNA Homo sapiens 886ttaagaacat rgcttcccat c 21 887 21 DNA Homo sapiens 887tacattctaa rcattggagc a 21 888 21 DNA Homo sapiens 888gtttgcacac rgaacaccta t 21 889 21 DNA Homo sapiens 889accctccaat yattgctcga t 21 890 21 DNA Homo sapiens 890gagaattatc rcttccatgc a 21 891 21 DNA Homo sapiens 891tgacagtaca rgaatttgct c 21 892 21 DNA Homo sapiens 892tttttcacca kctttgatga g 21 893 21 DNA Homo sapiens 893accacaattc yagaaaatga c 21 894 21 DNA Homo sapiens 894tgcaagtgga yttccagaag a 21 895 21 DNA Homo sapiens 895cagagaatat mcaacgcttt c 21 896 21 DNA Homo sapiens 896gagaatatac macgctttct c 21 897 21 DNA Homo sapiens 897cgcctttctt matcatccag a 21 898 21 DNA Homo sapiens 898tcggcatgtt ygcgtcggcc t 21 899 21 DNA Homo sapiens 899gcctggccga yctggccgtg g 21 900 21 DNA Homo sapiens 900tctctccgcc rgtcccgacg c 21 901 21 DNA Homo sapiens 901agactctgca rcagcccgcg c 21 902 21 DNA Homo sapiens 902ccttgaatag mtgctgtaat c 21 903 21 DNA Homo sapiens 903tgtaatccct rgatatacat g 21 904 21 DNA Homo sapiens 904aatatcctgt rgaaaaacta a 21 905 21 DNA Homo sapiens 905ttgtggaagc rgatacccca g 21 906 21 DNA Homo sapiens 906ctcttccaga yatttgttat c 21 907 21 DNA Homo sapiens 907ctctgaagac wtggagatac t 21 908 21 DNA Homo sapiens 908ctcatacgca rcctcaatgt c 21 909 21 DNA Homo sapiens 909agcgactgca wcttcctccc g 21 910 21 DNA Homo sapiens 910agtgcaacat maattagcag a 21 911 21 DNA Homo sapiens 911aaggacttat ytggagacaa a 21 912 21 DNA Homo sapiens 912tgaggggtct rgagggaaac t 21 913 21 DNA Homo sapiens 913ggttctctgg mccctgcatt c 21 914 21 DNA Homo sapiens 914aaaggagcga wcccacaatg t 21 915 21 DNA Homo sapiens 915cgcactggct rgcctgcatc t 21 916 21 DNA Homo sapiens 916acttcacctt yagcagcctc a 21 917 21 DNA Homo sapiens 917ccggccgcat ygccgtccac t 21 918 21 DNA Homo sapiens 918ccctcatgta ygctagcatc t 21 919 21 DNA Homo sapiens 919ccctgctctg rtcaccaccc g 21 920 21 DNA Homo sapiens 920accagcttac rcacaccgag g 21 921 21 DNA Homo sapiens 921gtggagagac yctgcatagc t 21 922 21 DNA Homo sapiens 922gagccatctt mcagcctgtt t 21 923 21 DNA Homo sapiens 923tattccatat rttaaagaaa g 21 924 21 DNA Homo sapiens 924cagaagaaac yagtacgtgt a 21 925 21 DNA Homo sapiens 925tgggaacgtt kcaatgaatt a 21 926 21 DNA Homo sapiens 926acatggcttc rgacatcctg c 21 927 21 DNA Homo sapiens 927gcacaagagg mggcttccgg a 21 928 21 DNA Homo sapiens 928atgacatgga ygaggaggac t 21 929 21 DNA Homo sapiens 929agttttccgg ragtccctac a 21 930 21 DNA Homo sapiens 930gctcccccta ytattatagc g 21 931 21 DNA Homo sapiens 931gtcctgcccc mctcatcagc a 21 932 21 DNA Homo sapiens 932tggcctctcc rgcagagtca g 21 933 21 DNA Homo sapiens 933catagagggt yccaggtccc c 21 934 21 DNA Homo sapiens 934ccggacagga rgtgcattcc c 21 935 21 DNA Homo sapiens 935atgcagccat ygaactgcct a 21 936 21 DNA Homo sapiens 936aactctttca ytgttgtttc a 21 937 21 DNA Homo sapiens 937ccatggtgcc rgtggcaggc c 21 938 21 DNA Homo sapiens 938actctgaagt rattcgttat g 21 939 21 DNA Homo sapiens 939gttccaatgc rcatctgggc g 21 940 21 DNA Homo sapiens 940acttgctctg raaatgaatt c 21 941 21 DNA Homo sapiens 941actccttatg scatcactgt t 21 942 21 DNA Homo sapiens 942ttgcttggaa racaatggtg g 21 943 21 DNA Homo sapiens 943tacacaaaat rtcataattc a 21 944 21 DNA Homo sapiens 944catctttgaa saccagttat a 21 945 21 DNA Homo sapiens 945tcatggccac rgacccccag t 21 946 21 DNA Homo sapiens 946agtggctggc rgtgggcatg g 21 947 21 DNA Homo sapiens 947ccatggcaga rttgaatgcc a 21 948 21 DNA Homo sapiens 948atcgccaaga rattgaatac g 21 949 21 DNA Homo sapiens 949gccacacaga yggagccagc t 21 950 21 DNA Homo sapiens 950ccgcctgcta ygccctggcc a 21 951 21 DNA Homo sapiens 951acaaatacat ygtgacaggc t 21 952 21 DNA Homo sapiens 952cggacagcgt ygccctgagg a 21 953 21 DNA Homo sapiens 953ctgagttgtg wcatctccag a 21 954 21 DNA Homo sapiens 954tgtcaccctc sgaaagcctc c 21 955 21 DNA Homo sapiens 955tggacaacac rgtgcgctcc t 21 956 21 DNA Homo sapiens 956acctggcctc rcccacgccc c 21 957 21 DNA Homo sapiens 957ggcttcgcca rcgccaacct g 21 958 21 DNA Homo sapiens 958cagcgccaac ytgcagggca g 21 959 21 DNA Homo sapiens 959gccgtggata ycggcgtccc t 21 960 21 DNA Homo sapiens 960agtggtttta ygaatatggg a 21 961 21 DNA Homo sapiens 961gagagaagcc stacgaatgt g 21 962 21 DNA Homo sapiens 962agccagcagt ygcagctggt t 21 963 21 DNA Homo sapiens 963gaggcagcgg ycccgggcct g 21 964 21 DNA Homo sapiens 964taaaagagag rgcggattcc c 21 965 21 DNA Homo sapiens 965cccttcgacc mgtcgggttt g 21 966 21 DNA Homo sapiens 966cactgcttac rttgccatga t 21 967 21 DNA Homo sapiens 967ctctaaaaga sagggcggat t 21 968 21 DNA Homo sapiens 968tgtggagact ygcagacatc g 21 969 21 DNA Homo sapiens 969tggtgccact kggacccgaa t 21 970 21 DNA Homo sapiens 970aaaagactca rtacttggcc t 21 971 21 DNA Homo sapiens 971gtgccttcaa rgaaccttcc a 21 972 21 DNA Homo sapiens 972gctgcagcaa rcaatatgac a 21 973 21 DNA Homo sapiens 973ggccaaactc rgcgcccacc a 21 974 21 DNA Homo sapiens 974agtcgcacga yaaactgcgg c 21 975 21 DNA Homo sapiens 975acttcgaacc ygagaggcct t 21 976 21 DNA Homo sapiens 976caggttctct rctcgcagta g 21 977 21 DNA Homo sapiens 977tgactccttc kagcaccctt t 21 978 21 DNA Homo sapiens 978ttatgcgaat rctttatttt c 21 979 21 DNA Homo sapiens 979gggactcgga yttggcggcc g 21 980 21 DNA Homo sapiens 980agaccctgga rctggagaag g 21 981 21 DNA Homo sapiens 981tcagactcag rgaaaactgc g 21 982 21 DNA Homo sapiens 982ggcgtgaaca rtcctcgagc a 21 983 21 DNA Homo sapiens 983atggagctgg rgcccgacaa c 21 984 21 DNA Homo sapiens 984gcgagctctg ygaccagtgc t 21 985 21 DNA Homo sapiens 985gcctgccccg yattgaggca g 21 986 21 DNA Homo sapiens 986ctggatcgca rgcaacatct a 21 987 21 DNA Homo sapiens 987aaggcaccaa ygtgtgcgcg g 21 988 21 DNA Homo sapiens 988ggctgaagga ygacggccgg a 21 989 21 DNA Homo sapiens 989actgcatgga yggctcagat g 21 990 21 DNA Homo sapiens 990acccgacctg yggccccagt g 21 991 21 DNA Homo sapiens 991ccctgcgctg yaacatgttc g 21 992 21 DNA Homo sapiens 992gaccagtatg rgaagccggg t 21 993 21 DNA Homo sapiens 993agaagcgcat yctttggatt g 21 994 21 DNA Homo sapiens 994ttggccgtgt sgagggcatt g 21 995 21 DNA Homo sapiens 995ctgtcggcat ygacttccac g 21 996 21 DNA Homo sapiens 996acgcctcaga ygagatgaac t 21 997 21 DNA Homo sapiens 997acggcagcga ygaggaggcc t 21 998 21 DNA Homo sapiens 998acgtctttga rgattacatc t 21 999 21 DNA Homo sapiens 999acggatctga ygaggcccct g 21 1000 21 DNA Homo sapiens 1000gccgccttgt ytactgggca g 21 1001 21 DNA Homo sapiens 1001gatgcctatc kggactatat t 21 1002 21 DNA Homo sapiens 1002caccagctac ytcattggcc g 21 1003 21 DNA Homo sapiens 1003gatggctcca rgaggatcac c 21 1004 21 DNA Homo sapiens 1004ctctgacgag rtcccttgca a 21 1005 21 DNA Homo sapiens 1005gtgcgcaccg rgaaagcggc c 21 1006 21 DNA Homo sapiens 1006tggggatcca rcctccaaaa g 21 1007 21 DNA Homo sapiens 1007ataagggagc rtgaggagtc t 21 1008 21 DNA Homo sapiens 1008atcttcaatt rtgggttcct t 21 1009 21 DNA Homo sapiens 1009agagaaggct rtgcagcttg c 21 1010 21 DNA Homo sapiens 1010tgtaccagac rcccttgcac t 21 1011 21 DNA Homo sapiens 1011agctgcagct stataagtta c 21 1012 21 DNA Homo sapiens 1012aacagccccg kaagtggcac c 21 1013 21 DNA Homo sapiens 1013cgccaaatga ktcagctggc a 21 1014 21 DNA Homo sapiens 1014ctcaccctaa raacacacag c 21 1015 21 DNA Homo sapiens 1015gtgccgaggg rcggccacac t 21 1016 21 DNA Homo sapiens 1016tccgtttcct ygagagcctg c 21 1017 21 DNA Homo sapiens 1017ggattaagaa rgcagccgaa g 21 1018 21 DNA Homo sapiens 1018tccaagaaga ygaaattcca g 21 1019 21 DNA Homo sapiens 1019agtggagcgt ygccgccgag a 21 1020 21 DNA Homo sapiens 1020cccttgtcat ygagttcacc g 21 1021 21 DNA Homo sapiens 1021tggcggccca maagtacctg c 21 1022 21 DNA Homo sapiens 1022ggacggtcat ygattacaac g 21 1023 21 DNA Homo sapiens 1023aacattgcaa yggcattttg a 21 1024 21 DNA Homo sapiens 1024taggcccttc yggctttgga c 21 1025 21 DNA Homo sapiens 1025cctcgtcgtc rtcttcagac a 21 1026 21 DNA Homo sapiens 1026tctcttctgt stcacacaca g 21 1027 21 DNA Homo sapiens 1027gttaaaacat kgcaatggca t 21 1028 21 DNA Homo sapiens 1028ctggggccga ygaagatgac a 21 1029 21 DNA Homo sapiens 1029cttggccgac rgctggcccc g 21 1030 21 DNA Homo sapiens 1030cagagtacag ygagccccac g 21 1031 21 DNA Homo sapiens 1031agactgctct ygaggctcat a 21 1032 21 DNA Homo sapiens 1032ctctgtctgc ratgctctta g 21 1033 21 DNA Homo sapiens 1033ggggactcca katgaaagga g 21 1034 21 DNA Homo sapiens 1034gcttttccca yctaccccca a 21 1035 21 DNA Homo sapiens 1035tctggagatc yatatgaggt c 21 1036 21 DNA Homo sapiens 1036agaccttgcc rgctcagcta c 21 1037 21 DNA Homo sapiens 1037caaggtttac rgactaccag c 21 1038 21 DNA Homo sapiens 1038gaagaccaac mctccccagc a 21 1039 21 DNA Homo sapiens 1039tccaacctcc mcaatgaaca c 21 1040 21 DNA Homo sapiens 1040ccctgcaggc ygcgttgact t 21 1041 21 DNA Homo sapiens 1041ccaacagacg mctattcgga g 21 1042 21 DNA Homo sapiens 1042tggtgtggtt ycagaatgcc c 21 1043 21 DNA Homo sapiens 1043accaggcttt wctccttatt a 21 1044 21 DNA Homo sapiens 1044gcagcctgtc rgaggacgag t 21 1045 21 DNA Homo sapiens 1045gccttccaga rgaggacgag g 21 1046 21 DNA Homo sapiens 1046ctctactgcc rtccactttg a 21 1047 21 DNA Homo sapiens 1047cgttgcgcta rccctgctcg t 21 1048 21 DNA Homo sapiens 1048agaaatatga rcaggcatgt a 21 1049 21 DNA Homo sapiens 1049gtaacttcag yaaacaggcc a 21 1050 21 DNA Homo sapiens 1050cctgcgaggc ygtgatgatc c 21 1051 21 DNA Homo sapiens 1051gaggccagat stacagccca c 21 1052 21 DNA Homo sapiens 1052acgcatggtg rgcatcatcc a 21 1053 21 DNA Homo sapiens 1053gtaacttcag yaaacaggcc a 21 1054 21 DNA Homo sapiens 1054agaagtatga rcaggcatgt a 21 1055 21 DNA Homo sapiens 1055atggacggag scttgaagat g 21 1056 21 DNA Homo sapiens 1056gggatgatga ygcccacggt g 21 1057 21 DNA Homo sapiens 1057ggcattgagc ytcccaaggg c 21 1058 21 DNA Homo sapiens 1058tgctggagct ygagagagac g 21 1059 21 DNA Homo sapiens 1059tggagttcat sgccagcaag a 21 1060 21 DNA Homo sapiens 1060gggacctgct rcgtccacca g 21 1061 21 DNA Homo sapiens 1061acgacagttc yggggaaggg a 21 1062 21 DNA Homo sapiens 1062tttgatgagt yccacgattt c 21 1063 21 DNA Homo sapiens 1063atacgggtcc rcggcagctc t 21 1064 21 DNA Homo sapiens 1064tcaggagcgc rcaggggcag c 21 1065 21 DNA Homo sapiens 1065ggggcagccc rccagcaagg a 21 1066 21 DNA Homo sapiens 1066tgtggcacta ygtccccctc c 21 1067 21 DNA Homo sapiens 1067tcttgtcacc rcgtcaacac c 21 1068 21 DNA Homo sapiens 1068ttcttggtac yggacagtcc c 21 1069 21 DNA Homo sapiens 1069ttatccggca kcacaacatc c 21 1070 21 DNA Homo sapiens 1070caaatccatg saccgcctag c 21 1071 21 DNA Homo sapiens 1071ttgacagcat rtctaattcg c 21 1072 21 DNA Homo sapiens 1072ccagctgata rttcatcaac a 21 1073 21 DNA Homo sapiens 1073caaagtcaac rgccagtcac t 21 1074 21 DNA Homo sapiens 1074cataggaata yggtcacaga a 21 1075 21 DNA Homo sapiens 1075ttctgcagca rccatctgaa c 21 1076 21 DNA Homo sapiens 1076cagaactgag yaccttgtca c 21 1077 21 DNA Homo sapiens 1077tgaaacttta ytaaaatcaa g 21 1078 21 DNA Homo sapiens 1078tcttctgtct rtaccttcac t 21 1079 21 DNA Homo sapiens 1079gcggtctgca rcctcagatt c 21 1080 21 DNA Homo sapiens 1080cctaaacata rtgttaccat a 21 1081 21 DNA Homo sapiens 1081tgggtcttct raaagtgagg a 21 1082 21 DNA Homo sapiens 1082ccgctctgta yacctggtac g 21 1083 21 DNA Homo sapiens 1083gggccgagcc ygacaccaag c 21 1084 21 DNA Homo sapiens 1084ccagttctcc yagcagctgc a 21 1085 21 DNA Homo sapiens 1085gaatgagtgt ragttgcaga a 21 1086 21 DNA Homo sapiens 1086cgccttcttc kcccgaggac a 21 1087 21 DNA Homo sapiens 1087ccttggacca kctcatccag a 21 1088 21 DNA Homo sapiens 1088ctgaggacaa rgccaacaag a 21 1089 21 DNA Homo sapiens 1089gtccctgtta yggctaccag t 21 1090 21 DNA Homo sapiens 1090tcatattcat yagaggaaat g 21 1091 21 DNA Homo sapiens 1091tactccagag rtcaagtcca a 21 1092 21 DNA Homo sapiens 1092tgacatccta ygtgctcctc g 21 1093 21 DNA Homo sapiens 1093atatcaccat ygcccttctg g 21 1094 21 DNA Homo sapiens 1094ccaagctcga kcctacatct t 21 1095 21 DNA Homo sapiens 1095tcacactttc racagggaat t 21 1096 21 DNA Homo sapiens 1096tttctggggg rttcccaggt t 21 1097 21 DNA Homo sapiens 1097agtgccggga rgaacccttg g 21 1098 21 DNA Homo sapiens 1098tggggaaaca saattcctca a 21 1099 21 DNA Homo sapiens 1099ctcaccacaa ygacattgcc t 21 1100 21 DNA Homo sapiens 1100ggcctaaagc ygcttgtcca a 21 1101 21 DNA Homo sapiens 1101tgattaccca magaaggagg a 21 1102 21 DNA Homo sapiens 1102acatcacaaa rcaacctgtg g 21 1103 21 DNA Homo sapiens 1103catgcgtgtg ractcagaca a 21 1104 21 DNA Homo sapiens 1104atgagaaagg kttcattgaa a 21 1105 21 DNA Homo sapiens 1105ggagatccac ycccgagaca g 21 1106 21 DNA Homo sapiens 1106ctcgcaacgt yctcctggca c 21 1107 21 DNA Homo sapiens 1107tcagggagga rctggctgcc c 21 1108 21 DNA Homo sapiens 1108ccagaggata rctggctact c 21 1109 21 DNA Homo sapiens 1109gcctgcctca ygcaatggga a 21 1110 21 DNA Homo sapiens 1110ctctgcgggg yttcccttca g 21 1111 21 DNA Homo sapiens 1111atgcctctga ygaggcagcc c 21 1112 21 DNA Homo sapiens 1112cttcaaaaga raataacgtt t 21 1113 21 DNA Homo sapiens 1113acagaatgtt yaacttcaag c 21 1114 21 DNA Homo sapiens 1114tgttttgtgg yaaaagattc a 21 1115 21 DNA Homo sapiens 1115agcagctcac rgaggaactg a 21 1116 21 DNA Homo sapiens 1116ccagcacgcc stcgcccccc g 21 1117 21 DNA Homo sapiens 1117tgcacagcga rgggaagccc t 21 1118 21 DNA Homo sapiens 1118tgttcggacc rgaagcaccc a 21 1119 21 DNA Homo sapiens 1119atcctagacg scttcgagga g 21 1120 21 DNA Homo sapiens 1120tgagcgacac rgtggcgctg t 21 1121 21 DNA Homo sapiens 1121tgcacagcac rtgcggaccg g 21 1122 21 DNA Homo sapiens 1122ttctgctcat yctagacgcc t 21 1123 21 DNA Homo sapiens 1123tactctagag ragcctgttg g 21 1124 21 DNA Homo sapiens 1124gaaactccag ktcaaagact t 21 1125 21 DNA Homo sapiens 1125ctgcttgaat ycatgtatga r 21 1126 21 DNA Homo sapiens 1126ccaacttcga ygctataaga g 21 1127 21 DNA Homo sapiens 1127ttgaccttgt rcaaataaaa c 21 1128 21 DNA Homo sapiens 1128gtcagaagtc rgccctaatt g 21 1129 21 DNA Homo sapiens 1129cccgacagct yattaagaaa g 21 1130 21 DNA Homo sapiens 1130acttctgtga ygtccagcgc t 21 1131 21 DNA Homo sapiens 1131tgtgaatgcc ygcctggcca t 21 1132 21 DNA Homo sapiens 1132agatagctcc ktcctgtggc t 21 1133 21 DNA Homo sapiens 1133gatctgcaat matggacgct g 21 1134 21 DNA Homo sapiens 1134gaactgcaca sacattgacg a 21 1135 21 DNA Homo sapiens 1135tctgcatgaa ygggcgttgc g 21 1136 21 DNA Homo sapiens 1136gcaaacacaa yggaatgtgg c 21 1137 21 DNA Homo sapiens 1137aagccagaca wtcagccctt t 21 1138 21 DNA Homo sapiens 1138ccactattgc ycatgtcctg c 21 1139 21 DNA Homo sapiens 1139gcccaaagac rttctcataa t 21 1140 21 DNA Homo sapiens 1140gtgcctgggc ygcagaagtg a 21 1141 21 DNA Homo sapiens 1141cctgggggtg yctgggctgc a 21 1142 21 DNA Homo sapiens 1142ttctttggcc rtggtgcgga g 21 1143 21 DNA Homo sapiens 1143tatccagaga ytctttggcc a 21 1144 21 DNA Homo sapiens 1144cttggtcctg rgtgtcagca g 21 1145 21 DNA Homo sapiens 1145ctgaccttca ycaagagcgc c 21 1146 21 DNA Homo sapiens 1146tatgcccgga maccatgaac a 21 1147 21 DNA Homo sapiens 1147gttcatgctc rgcttcctcc g 21 1148 21 DNA Homo sapiens 1148ccataaaaag yataagccag c 21 1149 21 DNA Homo sapiens 1149cagcctggac ragagcccca t 21 1150 21 DNA Homo sapiens 1150gggcatcagc wtctatgagg a 21 1151 21 DNA Homo sapiens 1151actttgccaa ygtgcaggag c 21 1152 21 DNA Homo sapiens 1152gggcggtgct rcagaacacg t 21 1153 21 DNA Homo sapiens 1153gttcttgctg raatggtcct t 21 1154 21 DNA Homo sapiens 1154aaggccaaca yagctgcagg c 21 1155 21 DNA Homo sapiens 1155cagcaacatt rtcaagactg a 21 1156 21 DNA Homo sapiens 1156gggtgcagtt rgtctatgtg t 21 1157 21 DNA Homo sapiens 1157tttttgtgga yttccgtgag a 21 1158 21 DNA Homo sapiens 1158caggccagga ratcactgaa a 21 1159 21 DNA Homo sapiens 1159tcaacaacct ygtgaacgcc a 21 1160 21 DNA Homo sapiens 1160agaagcacgt ktgccacatc c 21 1161 21 DNA Homo sapiens 1161tgtggtgaag ytgacaggtg g 21 1162 21 DNA Homo sapiens 1162cccactcccg yggcagcatg a 21 1163 21 DNA Homo sapiens 1163tcggatgcaa rtccaggccc a 21 1164 21 DNA Homo sapiens 1164aaagagtttc rgtcagagtt c 21 1165 21 DNA Homo sapiens 1165aaactcttac rgccattgca g 21 1166 21 DNA Homo sapiens 1166tagatgtagt saacaaccca g 21 1167 21 DNA Homo sapiens 1167atttgcggga sggcaacatc a 21 1168 21 DNA Homo sapiens 1168acagccggcc ractttggag g 21 1169 21 DNA Homo sapiens 1169tcttggatca sctgaactat g 21 1170 21 DNA Homo sapiens 1170caaaaagcct scatcagagc t 21 1171 21 DNA Homo sapiens 1171ccacaatggt rtcagaggag g 21 1172 21 DNA Homo sapiens 1172agaggattta saggaagatg a 21 1173 21 DNA Homo sapiens 1173acctgagccc ygaggagaag g 21 1174 21 DNA Homo sapiens 1174tacattggcc mcaagacaaa g 21 1175 21 DNA Homo sapiens 1175tcacagccct ycggccaggg t 21 1176 21 DNA Homo sapiens 1176cccagatgaa ygggaaaccc t 21 1177 21 DNA Homo sapiens 1177ggctggccca rtgagaacct g 21 1178 21 DNA Homo sapiens 1178gtgagaccga yttccgccga t 21 1179 21 DNA Homo sapiens 1179tgtcactgtc rgaactcagt t 21 1180 21 DNA Homo sapiens 1180agtggaaatg rcatccagtg c 21 1181 21 DNA Homo sapiens 1181gcagtgccca yggcgagctg g 21 1182 21 DNA Homo sapiens 1182gagcagtatg mcagcaaggt t 21 1183 21 DNA Homo sapiens 1183caccaggtga yggtacagaa a 21 1184 21 DNA Homo sapiens 1184gaagagccac kttcgtaccc a 21 1185 21 DNA Homo sapiens 1185agctgtggaa rggcctttgc c 21 1186 21 DNA Homo sapiens 1186agctgtcgca ytcggacgag a 21 1187 21 DNA Homo sapiens 1187ttcgattttc yaaagaacaa c 21 1188 21 DNA Homo sapiens 1188ggcgtgctga stgccctggg a 21 1189 21 DNA Homo sapiens 1189ttataacgtt katgtagctg a 21 1190 21 DNA Homo sapiens 1190ctcggaactg rgactgaggc c 21 1191 21 DNA Homo sapiens 1191tctcacggat rgcaccatca c 21 1192 21 DNA Homo sapiens 1192atctaatgac maaaagtgac a 21 1193 21 DNA Homo sapiens 1193gatgatgaac rgtttgtccc a 21 1194 21 DNA Homo sapiens 1194tcagcaagtc ycttttatgg t 21 1195 21 DNA Homo sapiens 1195gactggaagg saaagtcaaa c 21 1196 21 DNA Homo sapiens 1196ttacctcctg racatggacc g 21 1197 21 DNA Homo sapiens 1197tcccagattt ycagtctgat a 21 1198 21 DNA Homo sapiens 1198ctggaaggca ragtcaaaca g 21 1199 21 DNA Homo sapiens 1199agagcatgtc maatgttcca t 21 1200 21 DNA Homo sapiens 1200atctcaatcg rcacaagctc t 21 1201 21 DNA Homo sapiens 1201aaaggagaca kgacggcagg a 21 1202 21 DNA Homo sapiens 1202tgaagctcac wctttataat c 21 1203 21 DNA Homo sapiens 1203ctcaacagac rgcttccttg a 21 1204 21 DNA Homo sapiens 1204agagccagag ytctacctcg a 21 1205 21 DNA Homo sapiens 1205gctcagacag rgaaccctga g 21 1206 21 DNA Homo sapiens 1206aaaagcctta ygtgtgccgg g 21 1207 21 DNA Homo sapiens 1207ctggggatcc rggcccaggg g 21 1208 21 DNA Homo sapiens 1208gggaaaagcc ktatgtgtgc c 21 1209 21 DNA Homo sapiens 1209cagctctaat yacacacaag c 21 1210 21 DNA Homo sapiens 1210agcattgtat rtggagaagt c 21 1211 21 DNA Homo sapiens 1211cacagctcct ygctcagcca g 21 1212 21 DNA Homo sapiens 1212tcagccagca ygaaaggacg c 21 1213 21 DNA Homo sapiens 1213agtcacagct ygtccctcac c 21 1214 21 DNA Homo sapiens 1214gcgaatccac rctggggaga a 21 1215 21 DNA Homo sapiens 1215caggagagaa rccctatgaa t 21 1216 21 DNA Homo sapiens 1216aaagccgtat sggtgcaatg a 21 1217 21 DNA Homo sapiens 1217caccaaacat yagcgaatcc a 21 1218 21 DNA Homo sapiens 1218cctatgggcc rttcaccacg g 21 1219 21 DNA Homo sapiens 1219tccccaagtg ractcgcccc g 21 1220 21 DNA Homo sapiens 1220gagctggcct rtactttagc a 21 1221 21 DNA Homo sapiens 1221tgctgtgggc rtaagcaccc t 21 1222 21 DNA Homo sapiens 1222tgagtcctct ktttcatcag c 21 1223 21 DNA Homo sapiens 1223aaacatcatt ygattgaaca c 21 1224 21 DNA Homo sapiens 1224agatattcca waagagtagt t 21 1225 21 DNA Homo sapiens 1225agagaaggga mtgctaagaa c 21 1226 21 DNA Homo sapiens 1226tgccaacaga ycagacagtg t 21 1227 21 DNA Homo sapiens 1227ataactttag ytgctccctg t 21 1228 21 DNA Homo sapiens 1228cagttttacc rgtgggatca a 21 1229 21 DNA Homo sapiens 1229cttgccaaca rtccaaaata g 21 1230 21 DNA Homo sapiens 1230acaagtatct statgccatg c 21 1231 21 DNA Homo sapiens 1231tgacgatgtc rgaaaccatg c 21 1232 21 DNA Homo sapiens 1232gccattccca ygccaaaatg t 21 1233 21 DNA Homo sapiens 1233agagtaccag stgttggtgg a 21 1234 10 DNA Homo sapiens 1234attgttcccs 10 1235 21 DNA Homo sapiens 1235tgctggcaga rtcagatgaa t 21 1236 21 DNA Homo sapiens 1236tggccaaggc maaagctgtg a 21 1237 21 DNA Homo sapiens 1237aactgcctga rtgtcttaaa t 21 1238 21 DNA Homo sapiens 1238tcgaaatgga scgtgcgttc c 21 1239 21 DNA Homo sapiens 1239actgccccac sgtcattaac a 21 1240 21 DNA Homo sapiens 1240ctgccccacc rtcattaaca g 21 1241 21 DNA Homo sapiens 1241aagagactat yacagccctc t 21 1242 21 DNA Homo sapiens 1242ccgccaccag yagtaccggg t 21 1243 21 DNA Homo sapiens 1243ggagcgcaga stcggcaggc a 21 1244 21 DNA Homo sapiens 1244gccctcaagg rctgaaaata a 21 1245 21 DNA Homo sapiens 1245atgagtacga ygagcttcca g 21 1246 21 DNA Homo sapiens 1246tcatgggtct rgatggggcc a 21 1247 21 DNA Homo sapiens 1247ctcagatcca ytggacactt t 21 1248 21 DNA Homo sapiens 1248cgcaggctga rgtgggagta c 21 1249 21 DNA Homo sapiens 1249aggccttgtc ycctttctat t 21 1250 21 DNA Homo sapiens 1250cttctaacga raccactttt g 21 1251 21 DNA Homo sapiens 1251gcttacattc kgaattactt a 21 1252 21 DNA Homo sapiens 1252tggctcacta ygacaccacc g 21 1253 21 DNA Homo sapiens 1253tcatccccac rgtgctggac a 21 1254 21 DNA Homo sapiens 1254ggcacccaat rgaagccatg c 21 1255 21 DNA Homo sapiens 1255tcatgggcct rgcagtggtg c 21 1256 21 DNA Homo sapiens 1256cgtcacgcag saaagggacg a 21 1257 21 DNA Homo sapiens 1257aggcctatgg saatggctac t 21 1258 21 DNA Homo sapiens 1258cactctctgg rtatgaagag c 21 1259 21 DNA Homo sapiens 1259gcagaaacta ycagaggccg t 21 1260 21 DNA Homo sapiens 1260gcctccttca yggcctacag c 21 1261 21 DNA Homo sapiens 1261agatccagac rgagaggagg g 21 1262 21 DNA Homo sapiens 1262gcatcatcga ygtaatcaca c 21 1263 21 DNA Homo sapiens 1263atcatccata ygacgcagca c 21 1264 21 DNA Homo sapiens 1264aaaattctcc rttgaaggat t 21 1265 21 DNA Homo sapiens 1265tcaccaagtg yttctctagc a 21 1266 21 DNA Homo sapiens 1266caatatcaag ygaaatattc a 21 1267 21 DNA Homo sapiens 1267cagagaataa ycttcaattc c 21 1268 21 DNA Homo sapiens 1268ttctgacaag ygttgggtct a 21 1269 21 DNA Homo sapiens 1269ctatgaaaaa sgagaaaaat g 21 1270 21 DNA Homo sapiens 1270tcatctactc sagcccaggc g 21 1271 21 DNA Homo sapiens 1271ggagaactgg ytgtctgagt g 21 1272 21 DNA Homo sapiens 1272tggagctcca magaaggatg t 21 1273 21 DNA Homo sapiens 1273cacctcccac rtcccggagg t 21 1274 21 DNA Homo sapiens 1274ctggacaggg ygacccgaga g 21 1275 21 DNA Homo sapiens 1275caagagctac rtcatcgctg g 21 1276 21 DNA Homo sapiens 1276tggcacacat yctgggcatc c 21 1277 21 DNA Homo sapiens 1277ggggcatcaa ygtcctgctg a 21 1278 21 DNA Homo sapiens 1278acatggccca rgggaagcac a 21 1279 21 DNA Homo sapiens 1279ggacccggct yccgtccgtg a 21 1280 21 DNA Homo sapiens 1280cacctttgtg rtgataccaa c 21 1281 21 DNA Homo sapiens 1281tctacctgga yggcaggtgt g 21 1282 21 DNA Homo sapiens 1282ggcaggatgc rtgtggttcc a 21 1283 21 DNA Homo sapiens 1283gcgtgcccac ragtccggag g 21 1284 21 DNA Homo sapiens 1284agcagcgggc raggctcccc c 21 1285 21 DNA Homo sapiens 1285atgacagtgc rggaaagcag c 21 1286 21 DNA Homo sapiens 1286atcacagaca stctggttgc a 21 1287 21 DNA Homo sapiens 1287cactctccag sagctccgtg c 21 1288 21 DNA Homo sapiens 1288gctgctgccg scaacctaca a 21 1289 21 DNA Homo sapiens 1289ctccagaaat rctgaggaac a 21 1290 21 DNA Homo sapiens 1290ttgctcgtgc sgtggacaca c 21 1291 21 DNA Homo sapiens 1291aggacctgga sgtgattctc c 21 1292 21 DNA Homo sapiens 1292gcccctgaga rcaaggcctt c 21 1293 21 DNA Homo sapiens 1293tggcctcaac ygccaccaat g 21 1294 21 DNA Homo sapiens 1294actgtaccat ragtggagtc c 21 1295 21 DNA Homo sapiens 1295gctcgagtgt rccaaaacgt g 21 1296 21 DNA Homo sapiens 1296gccagaacta ygacctggag t 21 1297 21 DNA Homo sapiens 1297tctcggaacc rccgttgcac g 21 1298 21 DNA Homo sapiens 1298aactttgtcc rctacgtcca g 21 1299 21 DNA Homo sapiens 1299gccctaatgc yaacgtgcag g 21 1300 21 DNA Homo sapiens 1300ttaccagtga ygtcttccag g 21 1301 21 DNA Homo sapiens 1301acatggtgac ygtggagtac c 21 1302 21 DNA Homo sapiens 1302caggagcaag ragttcatgg a 21 1303 21 DNA Homo sapiens 1303cctgcagcgg ktgcgagaga t 21 1304 21 DNA Homo sapiens 1304tcagcgaggc mcagtccaaa g 21 1305 21 DNA Homo sapiens 1305aaacaaggag yaggacctgg a 21 1306 21 DNA Homo sapiens 1306tcaccttggt yacatcttca c 21 1307 21 DNA Homo sapiens 1307caggtgtgca rccagctgga g 21 1308 21 DNA Homo sapiens 1308accaaccaca ytgtgatgac c 21 1309 21 DNA Homo sapiens 1309tcactgccga ycagctcagg a 21 1310 21 DNA Homo sapiens 1310catctacaac wtgataggat a 21 1311 21 DNA Homo sapiens 1311tgaagaagct rgtatacctc t 21 1312 21 DNA Homo sapiens 1312ttcttggcgg yggccttgac a 21 1313 21 DNA Homo sapiens 1313aggtccacgc rccactcagc c 21 1314 21 DNA Homo sapiens 1314gaggcaccac yatgtaccct g 21 1315 21 DNA Homo sapiens 1315cgaggctgac ygagagcgag g 21 1316 21 DNA Homo sapiens 1316ggtgcccagc ygtgaccaga c 21 1317 21 DNA Homo sapiens 1317acaccgtcta yagcatggag c 21 1318 21 DNA Homo sapiens 1318gatcttggca rgagacaaga a 21 1319 21 DNA Homo sapiens 1319ggctgctctc rgagatccgg c 21 1320 21 DNA Homo sapiens 1320tgctgctgcc kgatgactac c 21 1321 21 DNA Homo sapiens 1321tgtactaccg yggtgccaac c 21 1322 21 DNA Homo sapiens 1322agctggtctc ygaagccaag g 21 1323 21 DNA Homo sapiens 1323agagtgtcat yggcagcgtg c 21 1324 21 DNA Homo sapiens 1324acgccagtga ygacggcagc g 21 1325 21 DNA Homo sapiens 1325cttgccaacc wggccgacct g 21 1326 21 DNA Homo sapiens 1326tcatgggtga yggcctggcc a 21 1327 21 DNA Homo sapiens 1327gacctctgcg sccggaaggt c 21 1328 21 DNA Homo sapiens 1328gtgacgacgg yagcggctcg g 21 1329 21 DNA Homo sapiens 1329tgacctctgc rgccggaagg t 21 1330 21 DNA Homo sapiens 1330tctggcactt ygccgacaac c 21 1331 21 DNA Homo sapiens 1331gctccgtggc ycaggttgtg c 21 1332 21 DNA Homo sapiens 1332ccctcatcct sgtgatgttt g 21 1333 21 DNA Homo sapiens 1333tgtgtgccca ygaggagctc c 21 1334 21 DNA Homo sapiens 1334ccatacacag kccttgcaaa c 21 1335 21 DNA Homo sapiens 1335ggagatctgt kttcgtacag t 21 1336 21 DNA Homo sapiens 1336tggctgctgt ycatgccgaa a 21 1337 21 DNA Homo sapiens 1337cccggggcag yggtgtcaat g 21 1338 21 DNA Homo sapiens 1338acgagctgat rgtgcgccgc g 21 1339 21 DNA Homo sapiens 1339gctggaggtg wcagtcactt a 21 1340 21 DNA Homo sapiens 1340ggtggcagtc mcagaatgat g 21 1341 21 DNA Homo sapiens 1341cttcatctac ytgtggactg a 21 1342 21 DNA Homo sapiens 1342gaggctactg yaatcgctac c 21 1343 21 DNA Homo sapiens 1343gaccaggcag wtgattaggg c 21 1344 21 DNA Homo sapiens 1344tttctccgag yttcatctac c 21 1345 21 DNA Homo sapiens 1345cacggccatg ytgatcgctg c 21 1346 21 DNA Homo sapiens 1346agtgtgatcc rgatggggca g 21 1347 21 DNA Homo sapiens 1347ctatggagac rtggccacag g 21 1348 21 DNA Homo sapiens 1348ggctgtgaac ygtgtgcctg c 21 1349 21 DNA Homo sapiens 1349cctgacagga ytggagaagc g 21 1350 21 DNA Homo sapiens 1350tgctgcgctc rgcggacctg a 21 1351 21 DNA Homo sapiens 1351tggagcagga kaagcaccgg c 21 1352 21 DNA Homo sapiens 1352cgtttggcag rgcagccagg c 21 1353 21 DNA Homo sapiens 1353ggtcccaatg rgcaaggagc c 21 1354 21 DNA Homo sapiens 1354ccacagagat ycctgacttc a 21 1355 21 DNA Homo sapiens 1355tttgggatga ytccagctgc c 21 1356 21 DNA Homo sapiens 1356ttcaggctta yggtatgaag c 21 1357 21 DNA Homo sapiens 1357agattgacaa rttcgagttt g 21 1358 21 DNA Homo sapiens 1358gcaaagtcgg ygggcgctgg a 21 1359 21 DNA Homo sapiens 1359ggagctctgg sagaccctgc a 21 1360 21 DNA Homo sapiens 1360gattctcctc rggcatcaca g 21 1361 21 DNA Homo sapiens 1361ttgagttcca ytgtgctgtg c 21 1362 21 DNA Homo sapiens 1362aatgctatga yagctcccca t 21 1363 21 DNA Homo sapiens 1363tggctgtgcc ygaggaaacc g 21 1364 21 DNA Homo sapiens 1364gtgccgctgg yggccagcat c 21 1365 21 DNA Homo sapiens 1365ggacagccac rcggtgctgc a 21 1366 21 DNA Homo sapiens 1366caaagaaatc rattcagtcg g 21 1367 21 DNA Homo sapiens 1367atctaaacag yctgcctcac a 21 1368 21 DNA Homo sapiens 1368ctaaggttgt rtctcagtat c 21 1369 21 DNA Homo sapiens 1369tacagcgtgg ygaagacgga t 21 1370 21 DNA Homo sapiens 1370attattgctg mccggaagca g 21 1371 21 DNA Homo sapiens 1371agatgtcctt rctggctaca a 21 1372 21 DNA Homo sapiens 1372agagagttaa kgccctggag g 21 1373 21 DNA Homo sapiens 1373aacttcacca raacatggca a 21 1374 21 DNA Homo sapiens 1374tcgatgtggc rggcaacctg g 21 1375 21 DNA Homo sapiens 1375ttcaccatgt ytctgaacct g 21 1376 21 DNA Homo sapiens 1376gaggtggacc rgatgttcca g 21 1377 21 DNA Homo sapiens 1377tcgagaacct rcggcggcga t 21 1378 21 DNA Homo sapiens 1378tcgctggcat rctggcagta g 21 1379 21 DNA Homo sapiens 1379aacccaacac rccatttgcc g 21 1380 21 DNA Homo sapiens 1380actcgtactc sttccgggtc t 21 1381 21 DNA Homo sapiens 1381agagagggag sctcggagtg g 21 1382 21 DNA Homo sapiens 1382ctgtcgacga yccctacgcc a 21 1383 21 DNA Homo sapiens 1383gaaagatgag ytttgccgtc a 21 1384 21 DNA Homo sapiens 1384atgacttggc ytccctcagt g 21 1385 21 DNA Homo sapiens 1385aagatcctaa yctggtgaat g 21 1386 21 DNA Homo sapiens 1386gctgctactt ygacatcgag t 21 1387 21 DNA Homo sapiens 1387gaaatatacc rtaagtatgg a 21 1388 21 DNA Homo sapiens 1388gtataataaa ytcctggagt t 21 1389 21 DNA Homo sapiens 1389agcagcctta rgcatcttgg a 21 1390 21 DNA Homo sapiens 1390tcaaccagct ktctgtgcct t 21 1391 21 DNA Homo sapiens 1391aaaaaggcaa wactgttcct g 21 1392 21 DNA Homo sapiens 1392tttttaatta yatttactcc a 21 1393 21 DNA Homo sapiens 1393ttagtaaaac yggagctgaa g 21 1394 21 DNA Homo sapiens 1394gctcattggc rtcaacctga t 21 1395 21 DNA Homo sapiens 1395ctgtccatgt kccagttcag c 21 1396 21 DNA Homo sapiens 1396actacaacac rtccagcaaa g 21 1397 21 DNA Homo sapiens 1397ctggtcccca rgggcattgg t 21 1398 21 DNA Homo sapiens 1398cagcctcctc rgagacctcc a 21 1399 21 DNA Homo sapiens 1399aatccaccga yggaagccgc a 21 1400 21 DNA Homo sapiens 1400ccggcaaacc ygacagccag t 21 1401 21 DNA Homo sapiens 1401tctcggacac ygtggctttt g 21 1402 21 DNA Homo sapiens 1402gctgcgttct yttccgcact c 21 1403 21 DNA Homo sapiens 1403ctggattacg ytgcgttctc t 21 1404 21 DNA Homo sapiens 1404gagtgcactt ycctatcccg c 21 1405 21 DNA Homo sapiens 1405agaagacgtt yaccaagccc c 21 1406 21 DNA Homo sapiens 1406aatttctcca ycaattttcc a 21 1407 21 DNA Homo sapiens 1407tgtgtgaact ktcacctgtc a 21 1408 21 DNA Homo sapiens 1408ctgatgagct yctgtttagc c 21 1409 21 DNA Homo sapiens 1409agctacggat yctgctggac c 21 1410 21 DNA Homo sapiens 1410tcttgaagtg maaaaagtct g 21 1411 21 DNA Homo sapiens 1411cctcctgagc yacggatcct g 21 1412 21 DNA Homo sapiens 1412atgttgaggt rtctgttact a 21 1413 21 DNA Homo sapiens 1413ctctgcgcgg ytttttgagc g 21 1414 21 DNA Homo sapiens 1414agacagcgat ygcctcggag g 21 1415 21 DNA Homo sapiens 1415accttctgga rtggattgaa c 21 1416 21 DNA Homo sapiens 1416agctcgaggc ygagaattac c 21 1417 21 DNA Homo sapiens 1417acatcaagaa ygagatcgac a 21 1418 21 DNA Homo sapiens 1418ccaagcacat ygcggaagag g 21 1419 21 DNA Homo sapiens 1419aaggccagac katgccccta t 21 1420 21 DNA Homo sapiens 1420ccaacaaagc kgttaagggc a 21 1421 21 DNA Homo sapiens 1421ctatggagtc ytcagatgag g 21 1422 21 DNA Homo sapiens 1422gggtccattg mccatgcatc t 21 1423 21 DNA Homo sapiens 1423atgaccacac rtcagaaaag t 21 1424 21 DNA Homo sapiens 1424tccatccagc rtctcctccc c 21 1425 21 DNA Homo sapiens 1425agggtgaaca yataagggaa a 21 1426 21 DNA Homo sapiens 1426ccatcctgaa rgaggagggt g 21 1427 21 DNA Homo sapiens 1427tgatcctaaa saaagagatg a 21 1428 21 DNA Homo sapiens 1428ccatctcccc ratggtgatg g 21 1429 21 DNA Homo sapiens 1429gggatgaaga ygcctgggcc a 21 1430 21 DNA Homo sapiens 1430aagcacagcg rtggattgat a 21 1431 21 DNA Homo sapiens 1431gccagggtgg ytacaaagat a 21 1432 21 DNA Homo sapiens 1432gaattcttca rtccttaaaa c 21 1433 21 DNA Homo sapiens 1433ttagacctgc mgaaatcctg a 21 1434 21 DNA Homo sapiens 1434agtgttctag mtattctgaa a 21 1435 21 DNA Homo sapiens 1435cttttggcaa ygtggagcct g 21 1436 21 DNA Homo sapiens 1436ctctggaaca rctcctaatt c 21 1437 21 DNA Homo sapiens 1437aaccttatta ytttatgtga g 21 1438 21 DNA Homo sapiens 1438attagatgac yttgttgaaa c 21 1439 21 DNA Homo sapiens 1439gtggtcccag rtgcacttcc t 21 1440 21 DNA Homo sapiens 1440cagacaagtg yaatatgatt a 21 1441 21 DNA Homo sapiens 1441agatgacttt rttgaaacgg g 21 1442 21 DNA Homo sapiens 1442atgcctccaa raaagatggg g 21 1443 21 DNA Homo sapiens 1443ggaactttgc rtactgggct g 21 1444 21 DNA Homo sapiens 1444ccgaggaggc yactggcgtc g 21 1445 21 DNA Homo sapiens 1445gctgctgctg ytcttcgtag g 21 1446 21 DNA Homo sapiens 1446ccataacctg mtgacatttc a 21 1447 21 DNA Homo sapiens 1447agctggaggt raagatccgt g 21 1448 21 DNA Homo sapiens 1448acaggacaat ygaggagctg c 21 1449 21 DNA Homo sapiens 1449ggaggaggcc racactgagc t 21 1450 21 DNA Homo sapiens 1450ctggctgctg mtgacttccg c 21 1451 21 DNA Homo sapiens 1451atcgattgca stcagagcct g 21 1452 21 DNA Homo sapiens 1452gtcctatcag yactgagagg c 21 1453 21 DNA Homo sapiens 1453acacccggga rctgtttctc a 21 1454 21 DNA Homo sapiens 1454acctgaagag ygtgatgctg c 21 1455 21 DNA Homo sapiens 1455tcgaggagaa stctggcatg g 21 1456 21 DNA Homo sapiens 1456agttccacag raaataccgg a 21 1457 21 DNA Homo sapiens 1457cctccttcct rcgggcaccc a 21 1458 21 DNA Homo sapiens 1458ccagccgcct ytttgaccag t 21 1459 21 DNA Homo sapiens 1459ggatcccagc ygatgtagac c 21 1460 21 DNA Homo sapiens 1460tagagttggc rttggaaaca t 21 1461 21 DNA Homo sapiens 1461tatttagtag ygaaaccaaa t 21 1462 21 DNA Homo sapiens 1462tcattatcac rcaaggtaac t 21 1463 21 DNA Homo sapiens 1463cggtcagtgg yttccagcca g 21 1464 21 DNA Homo sapiens 1464catgctgatg rtcacacacc t 21 1465 21 DNA Homo sapiens 1465agcctcctga wgctgatggt g 21 1466 21 DNA Homo sapiens 1466tacatcaact ytttggagat g 21 1467 21 DNA Homo sapiens 1467gctttgccta yattgcccgc c 21 1468 21 DNA Homo sapiens 1468gtcactggga ytgctgtagc g 21 1469 21 DNA Homo sapiens 1469gggagtacac rtgccagact g 21 1470 21 DNA Homo sapiens 1470tacacgctgt wctcatccaa g 21 1471 21 DNA Homo sapiens 1471ttacgtccat rctttatcat c 21 1472 21 DNA Homo sapiens 1472gagtgtcctg rctcctttta c 21 1473 21 DNA Homo sapiens 1473gccagcaagg wcttctctcc g 21 1474 21 DNA Homo sapiens 1474ccagggaaag rcgcttactt g 21 1475 21 DNA Homo sapiens 1475accgtgtgtg rctgcaggaa g 21 1476 21 DNA Homo sapiens 1476ttattggagt raaaaccttt t 21 1477 21 DNA Homo sapiens 1477tgctaaagct ragagggctg c 21 1478 21 DNA Homo sapiens 1478caggctgcag rcagttcagc g 21 1479 21 DNA Homo sapiens 1479tgcccagctc yaggagggac a 21 1480 21 DNA Homo sapiens 1480gaacaacatt rcttatgggc t 21 1481 21 DNA Homo sapiens 1481aaggggctga ygtttaccct a 21 1482 21 DNA Homo sapiens 1482tgcacttggg kgtgcagatg c 21 1483 21 DNA Homo sapiens 1483gtacctgctc rtaaggaggg t 21 1484 21 DNA Homo sapiens 1484tgctcagcaa ygtgggagct g 21 1485 21 DNA Homo sapiens 1485cccgcctggt kcagcagcgg c 21 1486 21 DNA Homo sapiens 1486tgataaggtg rtggcggctg c 21 1487 21 DNA Homo sapiens 1487gccaatcaaa kgagggctca c 21 1488 21 DNA Homo sapiens 1488ccgcccaccc rggcccggag t 21 1489 21 DNA Homo sapiens 1489accgccacgt ygcagatggg g 21 1490 21 DNA Homo sapiens 1490acaaaaaact yatcatgtat t 21 1491 21 DNA Homo sapiens 1491atcacatgaa ragagcaact c 21 1492 21 DNA Homo sapiens 1492agaattgtca kaattgtccc t 21 1493 21 DNA Homo sapiens 1493gtgcccggct sctgaaagcc g 21 1494 21 DNA Homo sapiens 1494ggctgtctgt rgagaccctg g 21 1495 21 DNA Homo sapiens 1495acacagtctt ygctcccaca a 21 1496 21 DNA Homo sapiens 1496gtaatagcct ytgcattgag a 21 1497 21 DNA Homo sapiens 1497gctgaccaat raggccaccc t 21 1498 21 DNA Homo sapiens 1498tgcccgagac ygaggacgag a 21 1499 21 DNA Homo sapiens 1499gcaaaacaag rgcatcagtg c 21 1500 21 DNA Homo sapiens 1500tgacctggcg ygctgccatg c 21 1501 21 DNA Homo sapiens 1501tcattatatt ygagcagatt c 21 1502 21 DNA Homo sapiens 1502tttcagttcc ytattttctg t 21 1503 21 DNA Homo sapiens 1503ttttctgttt saacattggc g 21 1504 21 DNA Homo sapiens 1504ggggttatgt ygctatgaag t 21 1505 21 DNA Homo sapiens 1505tccagccaac ratgaccagt c 21 1506 21 DNA Homo sapiens 1506ttcagtcctc rgcctctcca g 21 1507 21 DNA Homo sapiens 1507gctaaataaa racatgacct a 21 1508 21 DNA Homo sapiens 1508ccagcctctc raatgggcac a 21 1509 21 DNA Homo sapiens 1509caactcgacg rtccaggcct c 21 1510 21 DNA Homo sapiens 1510gatttctgga ytccactgtt g 21 1511 21 DNA Homo sapiens 1511acctgaagaa rtttatagaa a 21 1512 21 DNA Homo sapiens 1512gatgtctgca rtgggaagag t 21 1513 21 DNA Homo sapiens 1513aatttacaaa yttcaatctt t 21 1514 21 DNA Homo sapiens 1514ctccaggtca rcccctgcca c 21 1515 21 DNA Homo sapiens 1515cacatcgacc rggctctgga t 21 1516 21 DNA Homo sapiens 1516tcatcgtgcc rctgctgatc a 21 1517 21 DNA Homo sapiens 1517gccatggact yctcaagatt c 21 1518 21 DNA Homo sapiens 1518atggagagtg rcagctttga a 21 1519 21 DNA Homo sapiens 1519gctatgccag yccggagatg t 21 1520 21 DNA Homo sapiens 1520atggcggcag ytgtggctgt g 21 1521 21 DNA Homo sapiens 1521agcttgacaa ratggtgaca g 21 1522 21 DNA Homo sapiens 1522tggtcaacct rcccttggtg a 21 1523 21 DNA Homo sapiens 1523tctggagaca ytacttccag a 21 1524 21 DNA Homo sapiens 1524cgagatcttt ktcataatcc t 21 1525 21 DNA Homo sapiens 1525tcctcataaa rtacaggagg c 21 1526 21 DNA Homo sapiens 1526gcaagaagat mctgctgccc g 21 1527 21 DNA Homo sapiens 1527tagaagggca ygtggtgatt c 21 1528 21 DNA Homo sapiens 1528ccctgctcaa rcccaacatg g 21 1529 21 DNA Homo sapiens 1529tgaagccttc scatgtaatt t 21 1530 21 DNA Homo sapiens 1530ttttctcaac rcattacttc c 21 1531 21 DNA Homo sapiens 1531tgcaaggtaa rgccaattgg a 21 1532 21 DNA Homo sapiens 1532ctcctcgcca sgtctctgca a 21 1533 21 DNA Homo sapiens 1533gtggagcaga ratcttcgtt g 21 1534 21 DNA Homo sapiens 1534agttcccacg saaatgagag g 21 1535 21 DNA Homo sapiens 1535ggtgacttgg sagcctccca g 21 1536 21 DNA Homo sapiens 1536tctaaactgg stacggagtc g 21 1537 21 DNA Homo sapiens 1537ccagtgtccc ygagctggtc g 21 1538 21 DNA Homo sapiens 1538acaacaacac yaagctcgca a 21 1539 21 DNA Homo sapiens 1539gctgaaagtg magaaagtca t 21 1540 21 DNA Homo sapiens 1540gaagaaatat rtccgcaggg a 21 1541 21 DNA Homo sapiens 1541ttcaagccac rgagcttgcc a 21 1542 21 DNA Homo sapiens 1542acaaactggc ygagtcctgt g 21 1543 21 DNA Homo sapiens 1543gcctcaatga kcctggtcca t 21 1544 21 DNA Homo sapiens 1544tggatgtgca ygcggacagg a 21 1545 21 DNA Homo sapiens 1545cactttccat ygctttgaca a 21 1546 21 DNA Homo sapiens 1546tgcgggaggt ytttgagagc a 21 1547 21 DNA Homo sapiens 1547gtaccaaggg ycagctggcc a 21 1548 21 DNA Homo sapiens 1548cctggggagt ygctccaaca a 21 1549 21 DNA Homo sapiens 1549aggccatcat ygactgcctg g 21 1550 21 DNA Homo sapiens 1550tccaaattta ytctgctgac a 21 1551 21 DNA Homo sapiens 1551aaggctatga ygtcattgcc t 21 1552 21 DNA Homo sapiens 1552ggccctgcat ygcccgcaaa c 21 1553 21 DNA Homo sapiens 1553aatcccagac rctatgtcca g 21 1554 21 DNA Homo sapiens 1554tggacacctc stgcatcctc g 21 1555 21 DNA Homo sapiens 1555agtttgtgga rgagttcatc t 21 1556 21 DNA Homo sapiens 1556aggcactgaa rcttggggcc a 21 1557 21 DNA Homo sapiens 1557ccagtccagc rcactgtatg a 21 1558 21 DNA Homo sapiens 1558tgtcccacgg ygccacagga a 21 1559 21 DNA Homo sapiens 1559gaattctaca rccggttcaa g 21 1560 21 DNA Homo sapiens 1560ttctcgagat ygagttcaaa a 21 1561 21 DNA Homo sapiens 1561atgctcattt rgacatcgag g 21 1562 21 DNA Homo sapiens 1562cagttttcca ygagcaacat c 21 1563 21 DNA Homo sapiens 1563ttcagtggaa ygcaggctca g 21 1564 21 DNA Homo sapiens 1564ggtttcttct stgtctccgc g 21 1565 21 DNA Homo sapiens 1565ccacgagtgc rttcctgggg a 21 1566 21 DNA Homo sapiens 1566cgagtgattg ragagcccac g 21 1567 21 DNA Homo sapiens 1567gggtgctccc rgccggccga g 21 1568 21 DNA Homo sapiens 1568agccgtgctg yggacatttc c 21 1569 21 DNA Homo sapiens 1569gcaagaatct ygcagcagca t 21 1570 21 DNA Homo sapiens 1570acaacaccac ytctaacatg g 21 1571 21 DNA Homo sapiens 1571aagttgatta yccccgggat g 21 1572 21 DNA Homo sapiens 1572catcatttca rtgaaggaaa a 21 1573 21 DNA Homo sapiens 1573accctgctac rtttatctga t 21 1574 21 DNA Homo sapiens 1574acccaggtca rcacgcaggc c 21 1575 21 DNA Homo sapiens 1575acacgcaggc ygagcagctg c 21 1576 21 DNA Homo sapiens 1576ctcaattgct rttgacacaa t 21 1577 21 DNA Homo sapiens 1577atctttcatt kctgcaagga a 21 1578 21 DNA Homo sapiens 1578tccatcgcag ygaacgccga c 21 1579 21 DNA Homo sapiens 1579ctgccgccca ygctgctggg g 21 1580 21 DNA Homo sapiens 1580ttttgccttt raagtggatg g 21 1581 21 DNA Homo sapiens 1581agccggagcc rgagctggaa c 21 1582 21 DNA Homo sapiens 1582cagggcctgg kcgtcacacc c 21 1583 21 DNA Homo sapiens 1583agctgacact sgttcgcgtg a 21 1584 21 DNA Homo sapiens 1584accccaaacc ygaggttgct g 21 1585 21 DNA Homo sapiens 1585tttggcagaa raagccacgt t 21 1586 21 DNA Homo sapiens 1586gttacatgat ygacaacgtg a 21 1587 21 DNA Homo sapiens 1587taaaggtttc yaacaccctg g 21 1588 21 DNA Homo sapiens 1588tcactaccaa yctgatcaat t 21 1589 21 DNA Homo sapiens 1589aggtatacgg yattgaaggt c 21 1590 21 DNA Homo sapiens 1590atcacagcaa ragagaggtt c 21 1591 21 DNA Homo sapiens 1591tgccctggac rcccaccagc a 21 1592 21 DNA Homo sapiens 1592cgcaatgtct ytgacggcat c 21 1593 21 DNA Homo sapiens 1593gcactatctg ygtggcctac c 21 1594 21 DNA Homo sapiens 1594caggaccatg wtgaagaaca t 21 1595 21 DNA Homo sapiens 1595tgcactgacc yagattaatg t 21 1596 21 DNA Homo sapiens 1596atgtcacgct yatcatcctg g 21 1597 21 DNA Homo sapiens 1597agctgcgttc ragggatgca c 21 1598 21 DNA Homo sapiens 1598tgatccaagg raatgatctg a 21 1599 21 DNA Homo sapiens 1599tactagcact rttgaaggaa a 21 1600 21 DNA Homo sapiens 1600cctggcggct kcgccggtcc a 21 1601 21 DNA Homo sapiens 1601cagaccgtga raatagatgc c 21 1602 21 DNA Homo sapiens 1602tgaaaggcaa kccctccaga g 21 1603 21 DNA Homo sapiens 1603cgaggctgct rttacggctc a 21 1604 21 DNA Homo sapiens 1604cagtgacggg racaaaggtc t 21 1605 21 DNA Homo sapiens 1605accgccgagg mtgctgttac g 21 1606 21 DNA Homo sapiens 1606tttccccagg ygaatgggct g 21 1607 21 DNA Homo sapiens 1607tgcctcatgc rtacgtccca c 21 1608 21 DNA Homo sapiens 1608acaaatctct yactgaagaa g 21 1609 21 DNA Homo sapiens 1609ccagtgtcag yttgtgattc a 21 1610 21 DNA Homo sapiens 1610tgagcctttg saggccccag a 21 1611 21 DNA Homo sapiens 1611ctgtactcac yctttgggaa a 21 1612 21 DNA Homo sapiens 1612cggacaacct kacgctgcgg t 21 1613 21 DNA Homo sapiens 1613cggcctccgg stacctcttg c 21 1614 21 DNA Homo sapiens 1614tgccacaaga ragcaggagt t 21 1615 21 DNA Homo sapiens 1615aactacaact kgtcacttac a 21 1616 21 DNA Homo sapiens 1616agggctgagc mttcaggcag c 21 1617 21 DNA Homo sapiens 1617agtatgatct rtctgacatg c 21 1618 21 DNA Homo sapiens 1618atttctttaa yaactacaag a 21 1619 21 DNA Homo sapiens 1619gtgcagaaga mtatctatcc g 21 1620 21 DNA Homo sapiens 1620aagactatct mtccgtggtc c 21 1621 21 DNA Homo sapiens 1621ttgttgagct ygtgaaacac a 21 1622 21 DNA Homo sapiens 1622cagggcggac yttgccaagt a 21 1623 21 DNA Homo sapiens 1623tatctatccg wggtcctgaa c 21 1624 21 DNA Homo sapiens 1624ccagaatgcg ytattagttc g 21 1625 21 DNA Homo sapiens 1625cctaggaaaa rtgggcagca a 21 1626 21 DNA Homo sapiens 1626accagccctt yctcatcgag g 21 1627 21 DNA Homo sapiens 1627gctagccact sctcagtaat g 21 1628 21 DNA Homo sapiens 1628tgttcttcac yaccttcatg c 21 1629 21 DNA Homo sapiens 1629agaatgggca ygtggatata g 21 1630 21 DNA Homo sapiens 1630aaagtatgaa rttcctgaag g 21 1631 21 DNA Homo sapiens 1631aagaaaagta ygtgaacagg a 21 1632 21 DNA Homo sapiens 1632tcgtacccga ygtctcctac g 21 1633 21 DNA Homo sapiens 1633aggatggcca rgcctctgga g 21 1634 21 DNA Homo sapiens 1634tgctgcagaa rgagctggcc a 21 1635 21 DNA Homo sapiens 1635tctactgcca ygagtacttc a 21 1636 21 DNA Homo sapiens 1636acggggtcca ygccactaag c 21 1637 21 DNA Homo sapiens 1637ggaggccata ytggacataa t 21 1638 21 DNA Homo sapiens 1638cagacacacc yagtggagac a 21 1639 21 DNA Homo sapiens 1639aaggaggact rtcacaagtc c 21 1640 21 DNA Homo sapiens 1640tggtggagaa rtcagtgaca g 21 1641 21 DNA Homo sapiens 1641attggctacc yagtgatgat c 21 1642 21 DNA Homo sapiens 1642tggagaagtc mgtgacaggt t 21 1643 21 DNA Homo sapiens 1643gacaccattg rctacccagt g 21 1644 21 DNA Homo sapiens 1644agcctgtttt kaatatcaca a 21 1645 21 DNA Homo sapiens 1645cacaaaggcc yttgctatga c 21 1646 21 DNA Homo sapiens 1646aaagctacca mcattacatc a 21 1647 21 DNA Homo sapiens 1647gtgccaacgt ycctcaaccg t 21 1648 21 DNA Homo sapiens 1648agcagtgccc rccaggcctg c 21 1649 21 DNA Homo sapiens 1649ttttgttccg matgtctgag g 21 1650 21 DNA Homo sapiens 1650ggccatcgcc yggactccga g 21 1651 21 DNA Homo sapiens 1651tcgcctggac wccgagactc c 21 1652 21 DNA Homo sapiens 1652ttcgtgactt ygctggccgc a 21 1653 21 DNA Homo sapiens 1653tgcgccgccg yccgcccggc c 21 1654 21 DNA Homo sapiens 1654tctgttgatc mgaacctgtg g 21 1655 21 DNA Homo sapiens 1655tggtggccac rcagcaggag a 21 1656 21 DNA Homo sapiens 1656tctggggcca sccccaaaga g 21 1657 21 DNA Homo sapiens 1657acgacctcgc ygggctcggc a 21 1658 21 DNA Homo sapiens 1658gatggtggcc ytattgacgg g 21 1659 21 DNA Homo sapiens 1659ataagcggag rcggagcgtg a 21 1660 21 DNA Homo sapiens 1660agagccccat ygcgccctgt a 21 1661 21 DNA Homo sapiens 1661aaatccaaac mgatcggcag a 21 1662 21 DNA Homo sapiens 1662tatagcctga wttttgtgtt g 21 1663 21 DNA Homo sapiens 1663aaggatgcag yggtgtcctt t 21 1664 21 DNA Homo sapiens 1664tgtgttgggc ytcagcggga a 21 1665 21 DNA Homo sapiens 1665aaaatagctg yagccttggt g 21 1666 21 DNA Homo sapiens 1666tctgagaact mccctaacaa g 21 1667 21 DNA Homo sapiens 1667aggctgagga mccgggccaa g 21 1668 21 DNA Homo sapiens 1668gatggttgag rtctatctgc t 21 1669 21 DNA Homo sapiens 1669atgagcctgg rcaagtacct g 21 1670 21 DNA Homo sapiens 1670cagggccggg ytttaaaaat a 21 1671 21 DNA Homo sapiens 1671ttccagatgt kaccagtcaa c 21 1672 21 DNA Homo sapiens 1672tccaccccag yggggccata g 21 1673 21 DNA Homo sapiens 1673ttcctaacac rgtgactgtg g 21 1674 21 DNA Homo sapiens 1674cctgccctat yaccgacgcc c 21 1675 21 DNA Homo sapiens 1675atattgtcca yaagcatgga g 21 1676 21 DNA Homo sapiens 1676gggacagaag yacatgaccg c 21 1677 21 DNA Homo sapiens 1677tggtgaagct sttcgggccc t 21 1678 21 DNA Homo sapiens 1678tgaagtacta yaccctagag g 21 1679 21 DNA Homo sapiens 1679agaatttcgt mgttgggaag t 21 1680 21 DNA Homo sapiens 1680ctgttgatcc ygatgaacct g 21 1681 21 DNA Homo sapiens 1681tggatttcaa kaatatacca t 21 1682 21 DNA Homo sapiens 1682acacttactc rgagtggcac a 21 1683 21 DNA Homo sapiens 1683gggaaagtgc rtgtgagcgg c 21 1684 21 DNA Homo sapiens 1684ctggcaaaag ktggcctatt g 21 1685 21 DNA Homo sapiens 1685gttattttct ycttaccctg g 21 1686 21 DNA Homo sapiens 1686aatgaaacca matccgtggt t 21 1687 21 DNA Homo sapiens 1687ccctgcacca ygccttggaa c 21 1688 21 DNA Homo sapiens 1688ctgacgtctt yctggaggca t 21 1689 21 DNA Homo sapiens 1689ccttcccgac rtgaacaaga t 21 1690 21 DNA Homo sapiens 1690cgagctggcc rtgatggtga t 21 1691 21 DNA Homo sapiens 1691ttaccagcat kccagacacc t 21 1692 21 DNA Homo sapiens 1692gtttttcatt mtgcctgcca a 21 1693 21 DNA Homo sapiens 1693gcttgaatgt kaagaaattt t 21 1694 21 DNA Homo sapiens 1694catcacagtg rtggtgtttt t 21 1695 21 DNA Homo sapiens 1695gaaaagtttg raaaaaaact c 21 1696 21 DNA Homo sapiens 1696tgagagatac ratgaggaag a 21 1697 21 DNA Homo sapiens 1697tacttaggca satattacca g 21 1698 21 DNA Homo sapiens 1698cttacggtat ytacatcgtt g 21 1699 21 DNA Homo sapiens 1699gcgctcacgt sttcaccacg g 21 1700 21 DNA Homo sapiens 1700tgcaatcagc ygactaagtt t 21 1701 21 DNA Homo sapiens 1701catcaaagtg rttggcaatg g 21 1702 21 DNA Homo sapiens 1702aacccgggaa yaaatccgag a 21 1703 21 DNA Homo sapiens 1703aagaagtggc rgcacaagtc g 21 1704 21 DNA Homo sapiens 1704atggcgagcc ytccggagag c 21 1705 21 DNA Homo sapiens 1705agaaaccatt rtcatcaccc t 21 1706 21 DNA Homo sapiens 1706cgcgctggtg ktggccacca t 21 1707 21 DNA Homo sapiens 1707gaccctgccg ygggcgcggc a 21 1708 21 DNA Homo sapiens 1708aggtgctgac rtgctcctgg t 21 1709 21 DNA Homo sapiens 1709cgggagcaac ktgctggaga c 21 1710 21 DNA Homo sapiens 1710cttataggta ytttcagcca t 21 1711 21 DNA Homo sapiens 1711tgaaagccat yctcgttaca c 21 1712 21 DNA Homo sapiens 1712cgattccacg ygaagacatt g 21 1713 21 DNA Homo sapiens 1713attggtgaga ragacataaa g 21 1714 21 DNA Homo sapiens 1714attgcaaagc rccctaatgt t 21 1715 21 DNA Homo sapiens 1715tccctgccac rgtctgagag c 21 1716 21 DNA Homo sapiens 1716cccctgaacc rtccgcagct c 21 1717 21 DNA Homo sapiens 1717catgatcagc ygggccaaga a 21 1718 21 DNA Homo sapiens 1718ggaagtgtta ygaagtggga a 21 1719 21 DNA Homo sapiens 1719aggcctgccg rcttcggaag t 21 1720 21 DNA Homo sapiens 1720gctttgaagg rctatagcat g 21 1721 21 DNA Homo sapiens 1721gcaacatcaa rcaagtgcag g 21 1722 21 DNA Homo sapiens 1722gaggacatac rtcatgatgg t 21 1723 21 DNA Homo sapiens 1723cctgtatgaa mttcgattaa a 21 1724 21 DNA Homo sapiens 1724cactgttggc rtgtacaatg g 21 1725 21 DNA Homo sapiens 1725ccaatgtcaa rgagatcaag g 21 1726 21 DNA Homo sapiens 1726ccaacatgat ygtggaggag t 21 1727 21 DNA Homo sapiens 1727cttattttcc rgagatggaa g 21 1728 21 DNA Homo sapiens 1728cagcttgcat kgctgacttt g 21 1729 21 DNA Homo sapiens 1729ctgactttgg sttggcctta a 21 1730 21 DNA Homo sapiens 1730tctcttggaa ygaactgtgt c 21 1731 21 DNA Homo sapiens 1731tgagcgggaa ygcgtgtgtg c 21 1732 21 DNA Homo sapiens 1732tctggcagaa yttgcggctc a 21 1733 21 DNA Homo sapiens 1733tggacagcct rccccaggca g 21 1734 21 DNA Homo sapiens 1734aagccactgt sgcttctggc a 21 1735 21 DNA Homo sapiens 1735ccagcgaccc rgcaggacct a 21 1736 21 DNA Homo sapiens 1736tatgcagctg ytaccctcca g 21 1737 21 DNA Homo sapiens 1737gggatcccag ytttgaggag g 21 1738 21 DNA Homo sapiens 1738aaccccaacc rcgttcgcat g 21 1739 21 DNA Homo sapiens 1739gcttcctcaa yggggaggtg c 21 1740 21 DNA Homo sapiens 1740agcagagcca rggcacctgc a 21 1741 21 DNA Homo sapiens 1741atgctcttcg sgtgcctcca c 21 1742 21 DNA Homo sapiens 1742atgaggagga rgaagagcca c 21 1743 21 DNA Homo sapiens 1743gcctggccaa ygctgctgcc t 21 1744 21 DNA Homo sapiens 1744gcagcagagt ygccacatca t 21 1745 21 DNA Homo sapiens 1745gacgcttgtg yttgccctgg c 21 1746 21 DNA Homo sapiens 1746acagggaggt rgccgagatc c 21 1747 21 DNA Homo sapiens 1747tcatgctggc ygtgggagga g 21 1748 21 DNA Homo sapiens 1748ccatcgcgct rgcactgctg g 21 1749 21 DNA Homo sapiens 1749agtgaagatc magaagacaa g 21 1750 21 DNA Homo sapiens 1750atgatcgttt ycttagtcag t 21 1751 21 DNA Homo sapiens 1751tagtagcagt yttagaatac a 21 1752 21 DNA Homo sapiens 1752ctcagccccg magtgcttca g 21 1753 21 DNA Homo sapiens 1753gttgtaatga rtttataatg g 21 1754 21 DNA Homo sapiens 1754atttataatg raaggaactc t 21 1755 21 DNA Homo sapiens 1755aagcaggaac yggccaagta c 21 1756 21 DNA Homo sapiens 1756agtattgtcc rtatcagacc t 21 1757 21 DNA Homo sapiens 1757ccattgacat sgccacggaa a 21 1758 21 DNA Homo sapiens 1758gctacattgc ygagcagaac a 21 1759 21 DNA Homo sapiens 1759gctgcagcaa rtgctcgccg g 21 1760 21 DNA Homo sapiens 1760tctgcacctg yaggcccggc t 21 1761 21 DNA Homo sapiens 1761gatctgtaac rtggtggcca t 21 1762 21 DNA Homo sapiens 1762aatgcaagca kggatgcagt c 21 1763 21 DNA Homo sapiens 1763ccaagcacct ycttcctgct c 21 1764 21 DNA Homo sapiens 1764gccgctgccc rctcatgctg a 21 1765 21 DNA Homo sapiens 1765cgcgctacag ycagcgccca g 21 1766 21 DNA Homo sapiens 1766tcggcctcta ygactccgtc a 21 1767 21 DNA Homo sapiens 1767tgcaccacag ragccatggc g 21 1768 21 DNA Homo sapiens 1768tacgggaatc rccgttttga a 21 1769 21 DNA Homo sapiens 1769atcctgacca yggtgcggac t 21 1770 21 DNA Homo sapiens 1770actgtggcat mgagatatac t 21 1771 21 DNA Homo sapiens 1771atattaactt satggctgca a 21 1772 21 DNA Homo sapiens 1772cctgtagtga mtcggccgct g 21 1773 21 DNA Homo sapiens 1773cgctgcagcg mctggtggag g 21 1774 21 DNA Homo sapiens 1774ggaccgctac stggccgtgg t 21 1775 21 DNA Homo sapiens 1775tggccgtggt rcatcccatc a 21 1776 21 DNA Homo sapiens 1776tgcagctggt yaacgtgttt g 21 1777 21 DNA Homo sapiens 1777gccacggagc ygcgtccaga c 21 1778 21 DNA Homo sapiens 1778acgtgtcggc rggcccaagc c 21 1779 21 DNA Homo sapiens 1779ccacccgctc rgcccgctgg c 21 1780 21 DNA Homo sapiens 1780agctgaatga yactcaccct c 21 1781 21 DNA Homo sapiens 1781agctgatcac ytcagtggca g 21 1782 21 DNA Homo sapiens 1782tgtacaaccg yattaagaaa g 21 1783 21 DNA Homo sapiens 1783aagcaagttg raagtcatct t 21 1784 21 DNA Homo sapiens 1784gatgtggacc stctgagaag g 21 1785 21 DNA Homo sapiens 1785ccggggaagc kgccgtctaa a 21 1786 21 DNA Homo sapiens 1786ggacgactcc ragctgccta c 21 1787 21 DNA Homo sapiens 1787tgggaggcac rgtgattgga a 21 1788 21 DNA Homo sapiens 1788tgattggaag ygcccggtgc a 21 1789 21 DNA Homo sapiens 1789cgtgggatca scaatctctg t 21 1790 21 DNA Homo sapiens 1790cactgtggat rcctggccct t 21 1791 21 DNA Homo sapiens 1791atggcagcct yacaggtgcc a 21 1792 21 DNA Homo sapiens 1792cagcgttctt ygtgacgtta g 21 1793 21 DNA Homo sapiens 1793aatatctcgc ygtggagtcc c 21 1794 21 DNA Homo sapiens 1794acttcaaacg katgacagca c 21 1795 21 DNA Homo sapiens 1795cctcacatac saggcctcca t 21 1796 21 DNA Homo sapiens 1796tccgggatct yagtaagcca g 21 1797 21 DNA Homo sapiens 1797aagtatatca ktttcaaata t 21 1798 21 DNA Homo sapiens 1798gtagccatgc ytacgcaaat c 21 1799 21 DNA Homo sapiens 1799cacgagcact rtaaaatcca c 21 1800 21 DNA Homo sapiens 1800ccatgcttac rcaaatcttg g 21 1801 21 DNA Homo sapiens 1801tgccattcag sgattgtatg t 21 1802 21 DNA Homo sapiens 1802attctgcatc rtgggactct a 21 1803 21 DNA Homo sapiens 1803ttgtgaaatc wattcgaagt a 21 1804 21 DNA Homo sapiens 1804cgaagtaatg ytcagcgcca g 21 1805 21 DNA Homo sapiens 1805attgcttcaa sgacacctga a 21 1806 21 DNA Homo sapiens 1806gagtagtcgc yatggcacag g 21 1807 21 DNA Homo sapiens 1807gtaatgctca scgccaggaa a 21 1808 21 DNA Homo sapiens 1808tgcaagatta yaggctgttg c 21 1809 21 DNA Homo sapiens 1809ccctcagtca ygattcttta a 21 1810 21 DNA Homo sapiens 1810gttggcagtt wccagctccc a 21 1811 21 DNA Homo sapiens 1811gcagtactca rtctgaaaag c 21 1812 21 DNA Homo sapiens 1812tcctgaacca kggctttctg g 21 1813 21 DNA Homo sapiens 1813actatattac rtgcttcaaa a 21 1814 21 DNA Homo sapiens 1814acaatagcca yatgggaaat a 21 1815 21 DNA Homo sapiens 1815atcaaatgga rttccccacc a 21 1816 21 DNA Homo sapiens 1816atttgtcccc rcacagaagt a 21 1817 21 DNA Homo sapiens 1817tgcggtccat yttggtcaag g 21 1818 21 DNA Homo sapiens 1818accaacctgc mcttccaggc c 21 1819 21 DNA Homo sapiens 1819ccatctcata macgggcgac g 21 1820 21 DNA Homo sapiens 1820gggacctatg ytgataaact g 21 1821 21 DNA Homo sapiens 1821cctgttaata ytaggagtaa g 21 1822 21 DNA Homo sapiens 1822ggtaatgaag kcacgtgtgt t 21 1823 21 DNA Homo sapiens 1823gtacctttgt yatccaggcc a 21 1824 21 DNA Homo sapiens 1824ccaggcagat sgaggcctta c 21 1825 21 DNA Homo sapiens 1825gagtaatcat wgaagatgtg g 21 1826 21 DNA Homo sapiens 1826tccaataatc wgtcaacttt a 21 1827 21 DNA Homo sapiens 1827ttcaaaagca wttcaatcaa a 21 1828 21 DNA Homo sapiens 1828tattcagctc rtccgtatcc t 21 1829 21 DNA Homo sapiens 1829atctttacct yggtgctatg a 21 1830 21 DNA Homo sapiens 1830gtggaaatcc rtactacctg t 21 1831 21 DNA Homo sapiens 1831ttgtggcatt sctagcagac a 21 1832 21 DNA Homo sapiens 1832atccatctat ygtaaatggc a 21 1833 21 DNA Homo sapiens 1833ctatggacct yagataactg t 21 1834 21 DNA Homo sapiens 1834accatcacag rgatgtgcca g 21 1835 21 DNA Homo sapiens 1835ccctttacga rgcagcatta t 21 1836 21 DNA Homo sapiens 1836tatgtgggag rcacccattg c 21 1837 21 DNA Homo sapiens 1837aagagctcct ytgggagaat a 21 1838 21 DNA Homo sapiens 1838gtctttgcaa ygatgtcatt c 21 1839 21 DNA Homo sapiens 1839gctcattgcg rtatcttctt g 21 1840 21 DNA Homo sapiens 1840tatcttcttg watggataga a 21 1841 21 DNA Homo sapiens 1841agaagtcagc rttcacacgg t 21 1842 21 DNA Homo sapiens 1842cctgtgtgtt wgacatggaa g 21 1843 21 DNA Homo sapiens 1843ggggttctct yttcggcaga t 21 1844 21 DNA Homo sapiens 1844cagctcagca wctcgtgcgc a 21 1845 21 DNA Homo sapiens 1845ctttgttgta rcacaggccc t 21 1846 21 DNA Homo sapiens 1846agaactgtct scctgaccct g 21 1847 21 DNA Homo sapiens 1847ttaaaccaca ytttggcagt g 21 1848 21 DNA Homo sapiens 1848acgtggacaa ygccgagggc t 21 1849 21 DNA Homo sapiens 1849attccccatt ygccggggca c 21 1850 21 DNA Homo sapiens 1850ggcaaggtga rgcagcagca g 21 1851 21 DNA Homo sapiens 1851atgctcccat ygtctccgaa a 21 1852 21 DNA Homo sapiens 1852tccagaggaa yaggacactg c 21 1853 21 DNA Homo sapiens 1853cactcctcaa ytggataaat g 21 1854 21 DNA Homo sapiens 1854tggagaacca rgtgctggta a 21 1855 21 DNA Homo sapiens 1855gtaaatggac rgttaataga g 21 1856 21 DNA Homo sapiens 1856agcatatcat stcccgagtg g 21 1857 21 DNA Homo sapiens 1857agtcatcagc yttgtgccac c 21 1858 21 DNA Homo sapiens 1858ctcagtacca ygatcctgat g 21 1859 21 DNA Homo sapiens 1859ccgagccata ygatgagagc g 21 1860 21 DNA Homo sapiens 1860aaatctcctc rgaacacgcc c 21 1861 21 DNA Homo sapiens 1861gccccagaag racctgagca g 21 1862 21 DNA Homo sapiens 1862tcctggttta ycagctgctg c 21 1863 21 DNA Homo sapiens 1863tttgcatgca ragaacatca t 21 1864 21 DNA Homo sapiens 1864gacagtctaa rgaaagcact g 21 1865 21 DNA Homo sapiens 1865ccaaacagag rattttagtc t 21 1866 21 DNA Homo sapiens 1866aggaagaggc rtccttagca g 21 1867 21 DNA Homo sapiens 1867aagaagacaa kaggtttctt c 21 1868 21 DNA Homo sapiens 1868gcatatacct sgagtatgtg a 21 1869 21 DNA Homo sapiens 1869ataacaatta yggctgtgtc c 21 1870 21 DNA Homo sapiens 1870tgaaattcag rgaattgacc c 21 1871 21 DNA Homo sapiens 1871gaagctcaac ytggactcga t 21 1872 21 DNA Homo sapiens 1872aagacggcta ygagttcttt g 21 1873 21 DNA Homo sapiens 1873cattgaacca mcacagttca a 21 1874 21 DNA Homo sapiens 1874atcagaaatt ygtacaacag c 21 1875 21 DNA Homo sapiens 1875aggagtacct stcctttcgt t 21 1876 21 DNA Homo sapiens 1876aaaactgtct yttgaaagga a 21 1877 21 DNA Homo sapiens 1877agcacggaca ygcaggcccg g 21 1878 21 DNA Homo sapiens 1878tgaccctcac rtgagtagta a 21 1879 21 DNA Homo sapiens 1879ttctggggaa raagctgaag c 21 1880 21 DNA Homo sapiens 1880taagcattgc rgagacgcca a 21 1881 21 DNA Homo sapiens 1881ccctgaaagc mctgaggctc t 21 1882 21 DNA Homo sapiens 1882tggtgttccc rcctggactg g 21 1883 21 DNA Homo sapiens 1883tgaggctctc ycgtcagcgg t 21 1884 21 DNA Homo sapiens 1884gacgccaagt ktgaaggaac t 21 1885 21 DNA Homo sapiens 1885tctggagatg rtactgacta t 21 1886 21 DNA Homo sapiens 1886tgatcttgga ygaaggacac a 21 1887 21 DNA Homo sapiens 1887ctaacatatc ygtaaatgat g 21 1888 21 DNA Homo sapiens 1888gggcacctgc rggaagcttc t 21 1889 21 DNA Homo sapiens 1889tatcatggaa wtagatgaca c 21 1890 21 DNA Homo sapiens 1890cctcatgtta sacggcgcac c 21 1891 21 DNA Homo sapiens 1891ttttatgatg ratgtctgcg a 21 1892 21 DNA Homo sapiens 1892ttcatggaca rtatacagat t 21 1893 21 DNA Homo sapiens 1893cattctggag rattactagc a 21 1894 21 DNA Homo sapiens 1894aggggtatga wcacaaagca a 21 1895 21 DNA Homo sapiens 1895ccaattattg yggagagttt g 21 1896 21 DNA Homo sapiens 1896gatcttatat ktagagccca t 21 1897 21 DNA Homo sapiens 1897aaagatgcag rtctgaactc t 21 1898 21 DNA Homo sapiens 1898cgatgggaac kccccatcct t 21 1899 21 DNA Homo sapiens 1899cgccccatcc yttggtttac t 21 1900 21 DNA Homo sapiens 1900acttaaagga yattgcagga g 21 1901 21 DNA Homo sapiens 1901taaagatgtg yttggacatc t 21 1902 21 DNA Homo sapiens 1902atgttcaggg ytgcaggggg a 21 1903 21 DNA Homo sapiens 1903attatggcag yaacttacag a 21 1904 21 DNA Homo sapiens 1904caaagatgca ratctgaact c 21 1905 21 DNA Homo sapiens 1905acctttgtct yatagaaact c 21 1906 21 DNA Homo sapiens 1906tgcaagtggc yaacaccacc a 21 1907 21 DNA Homo sapiens 1907gtcatgcaag yggccaacac c 21 1908 21 DNA Homo sapiens 1908acaaggacgt rgagcccggc a 21 1909 21 DNA Homo sapiens 1909tccacgacgg mgagtgcatg c 21 1910 21 DNA Homo sapiens 1910cttctgctca satgctccaa g 21 1911 21 DNA Homo sapiens 1911agaaggagca ratgacattc c 21 1912 21 DNA Homo sapiens 1912aagtggccgg macctgagaa t 21 1913 21 DNA Homo sapiens 1913ctccaccacc wcgtcgaaga a 21 1914 21 DNA Homo sapiens 1914caccacgtcg ragaatcgca t 21 1915 21 DNA Homo sapiens 1915cccctgacta yagggatctc a 21 1916 21 DNA Homo sapiens 1916tctgcagact yttcaggaga g 21 1917 21 DNA Homo sapiens 1917aagcattaga rgccttacag a 21 1918 21 DNA Homo sapiens 1918caaatatcca ygtggactaa a 21 1919 21 DNA Homo sapiens 1919ttctgctgtg kcgctccatc c 21 1920 21 DNA Homo sapiens 1920cttgcccaga kcatgcaact t 21 1921 21 DNA Homo sapiens 1921gcaccaagca rtggacagtt g 21 1922 21 DNA Homo sapiens 1922tgaagacgtg ratgaatgtg c 21 1923 21 DNA Homo sapiens 1923ttactattgc rcttgcaaac a 21 1924 21 DNA Homo sapiens 1924tcaccagcag sgtctgccct g 21 1925 21 DNA Homo sapiens 1925ctcagcaaat rtcactccgg c 21 1926 21 DNA Homo sapiens 1926acactggcat ytttttggaa a 21 1927 21 DNA Homo sapiens 1927gacaacaaga ygggctgcgc c 21 1928 21 DNA Homo sapiens 1928tgcctcccta ygccttcttc t 21 1929 21 DNA Homo sapiens 1929aacgtgagcc rggagcagcg t 21 1930 21 DNA Homo sapiens 1930attgttttta rggtgagaaa t 21 1931 21 DNA Homo sapiens 1931ctcgccgaac raccctgtca c 21 1932 21 DNA Homo sapiens 1932tcctgccgct ygatttctcc a 21 1933 21 DNA Homo sapiens 1933ggccatgggc rtgaagcggg a 21 1934 21 DNA Homo sapiens 1934gacaaacagc ytttcaccct g 21 1935 21 DNA Homo sapiens 1935aggagaaagc yctcaaagca t 21 1936 21 DNA Homo sapiens 1936ccttcagcaa ygggaggaaa a 21 1937 21 DNA Homo sapiens 1937cctatcctta mcctcggtac a 21 1938 21 DNA Homo sapiens 1938tttctgctgc ygccaacaac a 21 1939 21 DNA Homo sapiens 1939tctatgacct yggagatgtg c 21 1940 21 DNA Homo sapiens 1940ccttcatgac kcagagctcc c 21 1941 21 DNA Homo sapiens 1941ttcatgactc rgagctcccc t 21 1942 21 DNA Homo sapiens 1942tcacccagga ygcccagctg a 21 1943 21 DNA Homo sapiens 1943cgccacgcgc rcctgcggcc t 21 1944 21 DNA Homo sapiens 1944ggccgcgcca scgaggtccc c 21 1945 21 DNA Homo sapiens 1945tcgatgccta maaacaggtg a 21 1946 21 DNA Homo sapiens 1946tgcctacaaa maggtgaaat t 21 1947 21 DNA Homo sapiens 1947tgtctccagt rcagaaggag g 21 1948 21 DNA Homo sapiens 1948cgagcctggg ragccccggg g 21 1949 21 DNA Homo sapiens 1949ggctcgccga wttgcccaga t 21 1950 21 DNA Homo sapiens 1950actgccaggc rttcagtggc a 21 1951 21 DNA Homo sapiens 1951ttggaaaaac wctaggagaa g 21 1952 21 DNA Homo sapiens 1952cgagtgagct kcgagacctg c 21 1953 21 DNA Homo sapiens 1953tcggctggaa wgaatggata a 21 1954 21 DNA Homo sapiens 1954ctgtggagca rtggaaagcc c 21 1955 21 DNA Homo sapiens 1955tgtgactgct scatgcactg t 21 1956 21 DNA Homo sapiens 1956agcacctact ycatgctggg c 21 1957 21 DNA Homo sapiens 1957aggaaatgat ygaggaactc c 21 1958 21 DNA Homo sapiens 1958aagtgcacac yataccagcc a 21 1959 21 DNA Homo sapiens 1959gtttatcagg kgctccagga g 21 1960 21 DNA Homo sapiens 1960aggtgctcca rgagcacttg g 21 1961 21 DNA Homo sapiens 1961ggctggctgg kgtttgacat c 21 1962 21 DNA Homo sapiens 1962ggcctgcagc kctcggtgga g 21 1963 21 DNA Homo sapiens 1963atctacaagg rctacatccg g 21 1964 21 DNA Homo sapiens 1964gccactagct yctccgagaa t 21 1965 21 DNA Homo sapiens 1965gttcccttta kgattatctg a 21 1966 21 DNA Homo sapiens 1966gctaaatcaa ygctgaagtt a 21 1967 21 DNA Homo sapiens 1967tatcagacag kgttgatgag g 21 1968 21 DNA Homo sapiens 1968tccttatcat racctagtgc c 21 1969 21 DNA Homo sapiens 1969gttacgcccc kcattcccaa a 21 1970 21 DNA Homo sapiens 1970tgttggacga ragcttgaac a 21 1971 21 DNA Homo sapiens 1971aaatttggca rcaagcacaa a 21 1972 21 DNA Homo sapiens 1972tggagttgcc wagatgaata c 21 1973 21 DNA Homo sapiens 1973atgatcagga yggcaatgga t 21 1974 21 DNA Homo sapiens 1974gggcacaatt scagctgatg a 21 1975 21 DNA Homo sapiens 1975tacctgtgga yacctttctg a 21 1976 21 DNA Homo sapiens 1976ttacggatat yctacaatgt g 21 1977 21 DNA Homo sapiens 1977cctacaatgt ktacttagca g 21 1978 21 DNA Homo sapiens 1978ggagagggct yttcaccaat g 21 1979 21 DNA Homo sapiens 1979tacggatatc ytacaatgtg t 21 1980 21 DNA Homo sapiens 1980tcgtgctctg yatctcatgc a 21 1981 21 DNA Homo sapiens 1981tgtcctcctg rtgtttgagg c 21 1982 21 DNA Homo sapiens 1982tctcccgcaa scggtccagc a 21 1983 21 DNA Homo sapiens 1983tcctattcat wttggagtag c 21 1984 21 DNA Homo sapiens 1984cattccagcc katgccagca c 21 1985 21 DNA Homo sapiens 1985agggatatct rcatcgactt c 21 1986 21 DNA Homo sapiens 1986gatatttgcc rtagaggaga t 21 1987 21 DNA Homo sapiens 1987ttctggtcca rtgagaacca c 21 1988 21 DNA Homo sapiens 1988agctggagga ygagatcatc t 21 1989 21 DNA Homo sapiens 1989tcagcaactc sacggcgcgc a 21 1990 21 DNA Homo sapiens 1990cggcgccctg ytagtcaacg c 21 1991 21 DNA Homo sapiens 1991gcggctccct rctattcatt g 21 1992 21 DNA Homo sapiens 1992aacgatgttg magcaggaac t 21 1993 21 DNA Homo sapiens 1993tggacaaatt wtacccagtg t 21 1994 21 DNA Homo sapiens 1994aggcattcca rgattccctg g 21 1995 21 DNA Homo sapiens 1995tgccaaccag sgggtaacag g 21 1996 21 DNA Homo sapiens 1996cataccacgt scatgtgaaa g 21 1997 21 DNA Homo sapiens 1997agtcatgcct sagggtttta t 21 1998 21 DNA Homo sapiens 1998agaagaaaac wgtgacaatg a 21 1999 21 DNA Homo sapiens 1999tgacaatgat wgttgattgt a 21 2000 21 DNA Homo sapiens 2000tagtccagac wgtgactctt c 21 2001 21 DNA Homo sapiens 2001agactgtgac wcttcagcac c 21 2002 21 DNA Homo sapiens 2002tgacgggaag wggcatcggg t 21 2003 21 DNA Homo sapiens 2003tggcatcggg wagcaatcag c 21 2004 21 DNA Homo sapiens 2004cgtcctggct yaccaggggc t 21 2005 21 DNA Homo sapiens 2005tgggtttcca rgtgccaatg g 21 2006 21 DNA Homo sapiens 2006gtccagaagg wcttcggggc a 21 2007 21 DNA Homo sapiens 2007gaaaaaggtg wccgagggct c 21 2008 21 DNA Homo sapiens 2008gctaaggggg magcaggtgc a 21 2009 21 DNA Homo sapiens 2009agacatactg raggcatgca a 21 2010 21 DNA Homo sapiens 2010aacaagacat ygagcatatg a 21 2011 21 DNA Homo sapiens 2011aagcactaga ktttcacaat t 21 2012 21 DNA Homo sapiens 2012gggagcctgg scctccaggt c 21 2013 21 DNA Homo sapiens 2013aattgatcaa rtacctattg t 21 2014 21 DNA Homo sapiens 2014ggagttcaag rtcctgttgg t 21 2015 21 DNA Homo sapiens 2015gagatgtcct wtgacaataa t 21 2016 21 DNA Homo sapiens 2016tcccctgaga ytccgtgggg c 21 2017 21 DNA Homo sapiens 2017caatggcgct ratggcccac a 21 2018 21 DNA Homo sapiens 2018gcctggctca racggacccc c 21 2019 21 DNA Homo sapiens 2019gcctctcctc ytgcagagac c 21 2020 21 DNA Homo sapiens 2020tgttggacaa raaatgacaa c 21 2021 21 DNA Homo sapiens 2021gcttgttgca wgctgtggca a 21 2022 21 DNA Homo sapiens 2022attccaccag mccgggatgt a 21 2023 21 DNA Homo sapiens 2023aagaagtaaa racattattt t 21 2024 21 DNA Homo sapiens 2024tggctcctat wgcattggga t 21 2025 21 DNA Homo sapiens 2025attacttgga ytcaagctcc a 21 2026 21 DNA Homo sapiens 2026cagataagat rgagaccatc t 21 2027 21 DNA Homo sapiens 2027gagcccatgg wagcctttgt t 21 2028 21 DNA Homo sapiens 2028ccaggatgag rtcaagaagg c 21 2029 21 DNA Homo sapiens 2029acctcggggg stgcctgggc c 21 2030 21 DNA Homo sapiens 2030tcgggggctg yctgggcccc c 21 2031 21 DNA Homo sapiens 2031ccccctggcc rtcctggaaa c 21 2032 21 DNA Homo sapiens 2032cagtatttgc macttacagc a 21 2033 21 DNA Homo sapiens 2033tgtgactgta sttcccgttt a 21 2034 21 DNA Homo sapiens 2034aggaaacaag kgctccatgg g 21 2035 21 DNA Homo sapiens 2035tccagggact ycagggaatg a 21 2036 21 DNA Homo sapiens 2036tgtgggtcca rgcagtgaag a 21 2037 21 DNA Homo sapiens 2037atattccaat rtactccttt g 21 2038 21 DNA Homo sapiens 2038ccatttgcaa katctgtcca c 21 2039 21 DNA Homo sapiens 2039ccagcagcac ycgtggtggc g 21 2040 21 DNA Homo sapiens 2040aaggcgacca rggagcccag g 21 2041 21 DNA Homo sapiens 2041ggcgaccagg ratttcaagg c 21 2042 21 DNA Homo sapiens 2042ccatgaaaac yatgaagggg c 21 2043 21 DNA Homo sapiens 2043ccaaaggtga maaaggggac a 21 2044 21 DNA Homo sapiens 2044gcccacgcga mgagtattcc c 21 2045 21 DNA Homo sapiens 2045ggggtctccc rgaggagttt g 21 2046 21 DNA Homo sapiens 2046ctcatgaaga mgtctgccat c 21 2047 21 DNA Homo sapiens 2047cctggtcctc ygggattgcc a 21 2048 21 DNA Homo sapiens 2048tcctggctgt kttgggagcc c 21 2049 21 DNA Homo sapiens 2049acctcatcca ycgactcagc c 21 2050 21 DNA Homo sapiens 2050acaggcgaga rgggccagaa a 21 2051 21 DNA Homo sapiens 2051gtcaggagct ytgggaccct c 21 2052 21 DNA Homo sapiens 2052tcctggtgaa saaggtccct c 21 2053 21 DNA Homo sapiens 2053atgaggagac yggcaacctg a 21 2054 21 DNA Homo sapiens 2054ggtgcaatcg rcagtccagg a 21 2055 21 DNA Homo sapiens 2055ggtgtcaagg rtgaaagtgg g 21 2056 21 DNA Homo sapiens 2056tcttggtcag ycctatgcgg a 21 2057 21 DNA Homo sapiens 2057ctggacctca rggaccccca g 21 2058 21 DNA Homo sapiens 2058tagaggtgga rctggtcccc c 21 2059 21 DNA Homo sapiens 2059gggattggag rtgaaaaagc t 21 2060 21 DNA Homo sapiens 2060gagattggcg ygactggtga t 21 2061 21 DNA Homo sapiens 2061ctcgtggaaa raaaggtccc c 21 2062 21 DNA Homo sapiens 2062gaaaggacca rtgggattcc c 21 2063 21 DNA Homo sapiens 2063atgatgtggg rccacctggt c 21 2064 21 DNA Homo sapiens 2064accaggaaag matggtgcct c 21 2065 21 DNA Homo sapiens 2065ctgtttgcca ytgtgttcct g 21 2066 21 DNA Homo sapiens 2066tccaggggat satgaagatg c 21 2067 21 DNA Homo sapiens 2067gccttcccgt rtttagcacg c 21 2068 21 DNA Homo sapiens 2068ctggaccacc rgggtgccca g 21 2069 21 DNA Homo sapiens 2069ggagcatccg sagagcaggg c 21 2070 21 DNA Homo sapiens 2070ctggtcttcc rggtcccaga g 21 2071 21 DNA Homo sapiens 2071gccacttttt mgcaaataag t 21 2072 21 DNA Homo sapiens 2072gacttgcctg ygatgtggtc t 21 2073 21 DNA Homo sapiens 2073ttcaaggttt wctgcaactt c 21 2074 21 DNA Homo sapiens 2074aacagggtat yactggtcct t 21 2075 21 DNA Homo sapiens 2075tcggtcctcc sggtgaacag g 21 2076 21 DNA Homo sapiens 2076acggcctggc wgggttgcca g 21 2077 21 DNA Homo sapiens 2077gtgaccctgg yccttccggc c 21 2078 21 DNA Homo sapiens 2078cgggcagaaa rgtgatgaag g 21 2079 21 DNA Homo sapiens 2079atggactgga rccagatact g 21 2080 21 DNA Homo sapiens 2080tatcctggcg rccactcaga g 21 2081 21 DNA Homo sapiens 2081gactcggtga ytttggcctg g 21 2082 21 DNA Homo sapiens 2082cggactatga kgtgaccgtg a 21 2083 21 DNA Homo sapiens 2083ccaagtgact ktgattgccc t 21 2084 21 DNA Homo sapiens 2084cgccgggagc yggaaactcc a 21 2085 21 DNA Homo sapiens 2085gcttagctac wctgtgcggg t 21 2086 21 DNA Homo sapiens 2086tgtccgccgg ragccggaaa c 21 2087 21 DNA Homo sapiens 2087gggccctgct rcagtcatcg t 21 2088 21 DNA Homo sapiens 2088gagccagata ytgagtatac g 21 2089 21 DNA Homo sapiens 2089tcatctgtca ycattacctg g 21 2090 21 DNA Homo sapiens 2090accaggagag ygtggtatgg c 21 2091 21 DNA Homo sapiens 2091gggtgaccga kgctttgacg g 21 2092 21 DNA Homo sapiens 2092cgccatccgt ragcttagct a 21 2093 21 DNA Homo sapiens 2093aggatccgtg wcatgcccta c 21 2094 21 DNA Homo sapiens 2094acggagaacc yggggaccct g 21 2095 21 DNA Homo sapiens 2095tgccagggcc scgaggcgag a 21 2096 21 DNA Homo sapiens 2096gcttggatgg ygacaaagga c 21 2097 21 DNA Homo sapiens 2097accgtggttc ycactggacc a 21 2098 21 DNA Homo sapiens 2098tcctagggcc rgctggagaa g 21 2099 21 DNA Homo sapiens 2099ccagggagat yctggagagg a 21 2100 21 DNA Homo sapiens 2100atcttgcaaa rgatccgtga c 21 2101 21 DNA Homo sapiens 2101atgggcaagg ragccgttcc c 21 2102 21 DNA Homo sapiens 2102caggcgggac rgcccggaag t 21 2103 21 DNA Homo sapiens 2103aagggagaga ygggccctca t 21 2104 21 DNA Homo sapiens 2104aagtgggtga yccaggggtg g 21 2105 21 DNA Homo sapiens 2105ccaccagggc stagcgggtg t 21 2106 10 DNA Homo sapiens 2106tgctccctgk 10 2107 21 DNA Homo sapiens 2107atggagagct raagtccaag a 21 2108 21 DNA Homo sapiens 2108gcgccgaggg rccaaatgag a 21 2109 21 DNA Homo sapiens 2109tgctgaagtt rtggaaacat c 21 2110 21 DNA Homo sapiens 2110gtatcagaag ytatttttag a 21 2111 21 DNA Homo sapiens 2111ccctggagac mctcgagacc a 21 2112 21 DNA Homo sapiens 2112ctcagcaaga rgccctgcct g 21 2113 21 DNA Homo sapiens 2113ccttcaggga yggaggcaat g 21 2114 21 DNA Homo sapiens 2114ccgcgctgat ygaggccatc c 21 2115 21 DNA Homo sapiens 2115ttgaccggaa ygtgccccgg a 21 2116 21 DNA Homo sapiens 2116atcacctcac wcatggaaag c 21 2117 21 DNA Homo sapiens 2117aagatgatga rgaccatgtg g 21 2118 21 DNA Homo sapiens 2118ccattgactc raacgactct g 21 2119 21 DNA Homo sapiens 2119taaacaggct rattctggaa g 21 2120 21 DNA Homo sapiens 2120ccaggacctg macgcgcctt c 21 2121 21 DNA Homo sapiens 2121catacaaggc matccccgtt g 21 2122 21 DNA Homo sapiens 2122gacagcagtc sggatgccgc c 21 2123 21 DNA Homo sapiens 2123cggccattga rgcagagctg g 21 2124 21 DNA Homo sapiens 2124ggacaaccgg racagttcca t 21 2125 21 DNA Homo sapiens 2125gtacaatgcc rtgtccaacg c 21 2126 21 DNA Homo sapiens 2126cagttcctcc rcctgtcctc t 21 2127 21 DNA Homo sapiens 2127cctgcaggcc mccaacatct t 21 2128 21 DNA Homo sapiens 2128gaactgaatt yggcctgaag t 21 2129 21 DNA Homo sapiens 2129tcatcgactt ygtgtggatc a 21 2130 21 DNA Homo sapiens 2130aagcagctca scatcagaaa a 21 2131 21 DNA Homo sapiens 2131gatgcttcac sagcagaggt c 21 2132 21 DNA Homo sapiens 2132acctgcattg kcatgtgcaa g 21 2133 21 DNA Homo sapiens 2133cgggaaccca ygtcggccga g 21 2134 21 DNA Homo sapiens 2134cctctttgag ygtcactggc a 21 2135 21 DNA Homo sapiens 2135atggcgtctg racagctcag c 21 2136 21 DNA Homo sapiens 2136cgtggaggtg sagctgctac a 21 2137 21 DNA Homo sapiens 2137taggagctgg yttgctaatg g 21 2138 21 DNA Homo sapiens 2138agaagaaagt raccttggaa a 21 2139 21 DNA Homo sapiens 2139caaatcatca kgtggcctag a 21 2140 21 DNA Homo sapiens 2140gaagattcca ycagatccca t 21 2141 21 DNA Homo sapiens 2141ctgggccctt ycctgatgaa c 21 2142 21 DNA Homo sapiens 2142tgccatcact yctgctgttg g 21 2143 21 DNA Homo sapiens 2143tgtttgaact yaaacatatg a 21 2144 21 DNA Homo sapiens 2144ccccgttact ktctctttgg g 21 2145 21 DNA Homo sapiens 2145gagcgccaag ygctcatgct c 21 2146 21 DNA Homo sapiens 2146gtccccgtgg ragcctgcag g 21 2147 21 DNA Homo sapiens 2147gctggcacaa rgctgcgggc a 21 2148 21 DNA Homo sapiens 2148tgatggccac rtcccggaaa t 21 2149 21 DNA Homo sapiens 2149cccactgcac magtgtgaca t 21 2150 21 DNA Homo sapiens 2150tccccttcag ytacctcgtc g 21 2151 21 DNA Homo sapiens 2151tcaggtactt ygtcagcttc a 21 2152 21 DNA Homo sapiens 2152agcccctcta yctgaacctc c 21 2153 21 DNA Homo sapiens 2153tcagcagcag ygtgtcctca g 21 2154 21 DNA Homo sapiens 2154cctttgtgct rctcatgttg c 21 2155 21 DNA Homo sapiens 2155ctagcaagat ygactttgtg c 21 2156 21 DNA Homo sapiens 2156tcgtcatcct sgcctgggcc a 21 2157 21 DNA Homo sapiens 2157tgtttgggag yggcctgcct g 21 2158 21 DNA Homo sapiens 2158ccttgttctc yggtatcggc t 21 2159 21 DNA Homo sapiens 2159tagaagacct yatcaaacct c 21 2160 21 DNA Homo sapiens 2160gattgttgtg stgggacctc g 21 2161 21 DNA Homo sapiens 2161ggcttttcct rgcctgtgct t 21 2162 21 DNA Homo sapiens 2162atacaatatc rgccagcctg g 21 2163 21 DNA Homo sapiens 2163ctgagctggg yaagccgcgg c 21 2164 21 DNA Homo sapiens 2164agagccccct racctatgag g 21 2165 21 DNA Homo sapiens 2165ctcgtgagat ygccaagtcc c 21 2166 21 DNA Homo sapiens 2166atctcgtctc ygaagacatc t 21 2167 21 DNA Homo sapiens 2167atgtgaacga yggtgcgatg c 21 2168 21 DNA Homo sapiens 2168gtatctcaat ktgttcatcc c 21 2169 21 DNA Homo sapiens 2169atgggcctcc ygagcaggtc t 21 2170 21 DNA Homo sapiens 2170aggatgtcca rtgcttttcc g 21 2171 21 DNA Homo sapiens 2171ctagtggtat sccagcaact a 21 2172 21 DNA Homo sapiens 2172gcctggcagt ragctggaca a 21 2173 21 DNA Homo sapiens 2173ctctgaggcc yggagtacca a 21 2174 21 DNA Homo sapiens 2174ccaacgactc yggcccccgc c 21 2175 21 DNA Homo sapiens 2175gaaaattata yttagaacga g 21 2176 21 DNA Homo sapiens 2176cagctggaac rtgaagaggg c 21 2177 21 DNA Homo sapiens 2177ggaagctttt saaagaatgt t 21 2178 21 DNA Homo sapiens 2178gcgtgtgcac rgaagctggc a 21 2179 21 DNA Homo sapiens 2179ctcacggagg rttccccaac a 21 2180 21 DNA Homo sapiens 2180ggttgtgatc ytagggaaac a 21 2181 21 DNA Homo sapiens 2181gctactggaa ygagtatgaa a 21 2182 21 DNA Homo sapiens 2182tcttttccta rtcagcaggt t 21 2183 21 DNA Homo sapiens 2183gctacaacgt rtatggaaca g 21 2184 21 DNA Homo sapiens 2184ctcagcatta rgaacgcctg t 21 2185 21 DNA Homo sapiens 2185tgcagacgac raccatgtgc a 21 2186 21 DNA Homo sapiens 2186cacagactgc rcctcaacag g 21 2187 21 DNA Homo sapiens 2187gtggtcttgg sctgtttgtt t 21 2188 21 DNA Homo sapiens 2188atcctgtttc raccccagaa g 21 2189 21 DNA Homo sapiens 2189acacccttgg ycaaagcatc g 21 2190 21 DNA Homo sapiens 2190ccctgctgac yaagacaaac t 21 2191 21 DNA Homo sapiens 2191gcgccaatgc ytccttcacc t 21 2192 21 DNA Homo sapiens 2192caacaaatgc ytggaactgg c 21 2193 21 DNA Homo sapiens 2193agggtatact ycaaggatgc a 21 2194 21 DNA Homo sapiens 2194gcgtggccca yggatgcacc a 21 2195 21 DNA Homo sapiens 2195agctgatggc rtcttcgacc c 21 2196 21 DNA Homo sapiens 2196cctcatggaa yaaataacac t 21 2197 21 DNA Homo sapiens 2197tttacctgct rgcggtgctg g 21 2198 21 DNA Homo sapiens 2198ctgggcctgg rgggtggagg t 21 2199 21 DNA Homo sapiens 2199tcactgatgg kcacataaaa g 21 2200 21 DNA Homo sapiens 2200gcaagccact sgaggttaat t 21 2201 21 DNA Homo sapiens 2201acactacccg ragaattggt c 21 2202 21 DNA Homo sapiens 2202accaaaatca rtgatggcca g 21 2203 21 DNA Homo sapiens 2203ctctgtgact rcttcctccc t 21 2204 21 DNA Homo sapiens 2204gtcagtcctc rggtggaaga t 21 2205 21 DNA Homo sapiens 2205tgtgagagcc ytggatggac c 21 2206 21 DNA Homo sapiens 2206aagtaacagc rgtgttgcca a 21 2207 21 DNA Homo sapiens 2207ggcgaggaac yctacatcat c 21 2208 21 DNA Homo sapiens 2208gccgtcaggg matctcccct a 21 2209 21 DNA Homo sapiens 2209ttggagttcc rgccatgtct a 21 2210 21 DNA Homo sapiens 2210tgaccttcgc ygaggcccag g 21 2211 21 DNA Homo sapiens 2211gaggtgacag rtgttgtgtt c 21 2212 21 DNA Homo sapiens 2212acaggatatc rccgatgcca g 21 2213 21 DNA Homo sapiens 2213agcgcagccc sagatgcccc t 21 2214 21 DNA Homo sapiens 2214gctttgcccg rgagctgggg g 21 2215 21 DNA Homo sapiens 2215acattgatga ytgcctctgc a 21 2216 21 DNA Homo sapiens 2216gccaagcgca rcccgagatg c 21 2217 21 DNA Homo sapiens 2217atgaaaacac rtggatcggc c 21 2218 21 DNA Homo sapiens 2218ccagggcaga sttcagagaa a 21 2219 21 DNA Homo sapiens 2219atatcaccga kgccagcgaa a 21 2220 21 DNA Homo sapiens 2220acaggacttg yccatcctgg t 21 2221 21 DNA Homo sapiens 2221gcatgagcaa rccagccgga t 21 2222 21 DNA Homo sapiens 2222ataaggatac macaagaagg a 21 2223 21 DNA Homo sapiens 2223ggcagcaaat katgacatgg t 21 2224 21 DNA Homo sapiens 2224cagacgaagg kcaatgctgg c 21 2225 21 DNA Homo sapiens 2225atctcccaga mactgaatgt t 21 2226 21 DNA Homo sapiens 2226gaagcctgaa racagtgaat g 21 2227 21 DNA Homo sapiens 2227taccggaaaa wtccagggga c 21 2228 21 DNA Homo sapiens 2228aactttttga rtccggaaaa a 21 2229 21 DNA Homo sapiens 2229tcgagactat rttgtgacca a 21 2230 21 DNA Homo sapiens 2230gaggaagcct saaaacagtg a 21 2231 21 DNA Homo sapiens 2231aagtaaaaga yttgaaaaag a 21 2232 21 DNA Homo sapiens 2232tccatgaata wcagcatttg g 21 2233 21 DNA Homo sapiens 2233cctggagcta rgtccatgaa t 21 2234 21 DNA Homo sapiens 2234tgaccaagac rtatgccact g 21 2235 21 DNA Homo sapiens 2235accttctacc ycaatcacaa a 21 2236 21 DNA Homo sapiens 2236cgtcagtgtc wgggaactgg a 21 2237 21 DNA Homo sapiens 2237catgtctgac rgatacaagc t 21 2238 21 DNA Homo sapiens 2238tgtccaacgc rgtcaagcag a 21 2239 21 DNA Homo sapiens 2239ttaaagtaga rcaggccgaa t 21 2240 21 DNA Homo sapiens 2240ccaaccccga ygagaagacg a 21 2241 21 DNA Homo sapiens 2241tacacgacat kttcatggac a 21 2242 21 DNA Homo sapiens 2242tatgacagag racagaggat g 21 2243 21 DNA Homo sapiens 2243gcatccacat sgtgacaggt c 21 2244 21 DNA Homo sapiens 2244ctaactggtc kggattacag a 21 2245 21 DNA Homo sapiens 2245gaaatgaaac rgattgttga g 21 2246 21 DNA Homo sapiens 2246gagtttttca ytgcactcaa t 21 2247 21 DNA Homo sapiens 2247tgtgagacac rgttcagatc c 21 2248 21 DNA Homo sapiens 2248tataatccat mtacacggag t 21 2249 21 DNA Homo sapiens 2249gattacctgc maacaggaat g 21 2250 21 DNA Homo sapiens 2250ccttctatac yccagagcca g 21 2251 21 DNA Homo sapiens 2251tcctgaaaga yaccaagagc a 21 2252 21 DNA Homo sapiens 2252cagacggaaa ktgctcacac c 21 2253 21 DNA Homo sapiens 2253tggtgggaca yggataaagc t 21 2254 21 DNA Homo sapiens 2254gaaaagcttt ytatcgaaac a 21 2255 21 DNA Homo sapiens 2255aatgactacg ycaacggctt c 21 2256 21 DNA Homo sapiens 2256actgggcaga yggaaagtgc t 21 2257 21 DNA Homo sapiens 2257actacgccaa mggcttcatg g 21 2258 21 DNA Homo sapiens 2258gctcagatac yagcagcctg g 21 2259 21 DNA Homo sapiens 2259tctttgacaa rtcctgcagc g 21 2260 21 DNA Homo sapiens 2260cttgattggg sagaacgaga a 21 2261 21 DNA Homo sapiens 2261gatggctatg rcctggagat c 21 2262 21 DNA Homo sapiens 2262cctgagacca raagaaacgc a 21 2263 21 DNA Homo sapiens 2263ccgcagggat ytactgagac t 21 2264 21 DNA Homo sapiens 2264agattaccaa rcccaacgtg t 21 2265 21 DNA Homo sapiens 2265tgtcctgcag kgacaagatt g 21 2266 21 DNA Homo sapiens 2266gggttggagg yccgtgactg c 21 2267 21 DNA Homo sapiens 2267atgatgaccc rtctcttgaa g 21 2268 21 DNA Homo sapiens 2268aagctggtct rccagatctt c 21 2269 21 DNA Homo sapiens 2269aaatccacag rtttctgatg a 21 2270 21 DNA Homo sapiens 2270aattccgact ygacctatga g 21 2271 21 DNA Homo sapiens 2271gggccacgtc rgaccctctg g 21 2272 21 DNA Homo sapiens 2272gttcttcctc ytggagaatg t 21 2273 21 DNA Homo sapiens 2273aggacctgat maacaagatc g 21 2274 21 DNA Homo sapiens 2274agacattcac wggacacaga g 21 2275 21 DNA Homo sapiens 2275cctctggctc mgtgttccga g 21 2276 21 DNA Homo sapiens 2276actcactttg wtgagctcca g 21 2277 21 DNA Homo sapiens 2277gaaccttcac rccatctatg a 21 2278 21 DNA Homo sapiens 2278tgaccaggag wtggaggagc t 21 2279 21 DNA Homo sapiens 2279aacgacgtgg rcggccagcg c 21 2280 21 DNA Homo sapiens 2280gtcctgccca ytggggggcg c 21 2281 21 DNA Homo sapiens 2281cgcagctggg rcccaagctc t 21 2282 21 DNA Homo sapiens 2282caggcagctg rtctgcaacg t 21 2283 21 DNA Homo sapiens 2283ctcaggcaaa yggagtaagc c 21 2284 21 DNA Homo sapiens 2284accgtctgaa sttgtaggga g 21 2285 21 DNA Homo sapiens 2285caagggtacc rcgtcgatgc t 21 2286 21 DNA Homo sapiens 2286ttttggcttc stggcctttg g 21 2287 21 DNA Homo sapiens 2287cccagttcat kgatggtgcc c 21 2288 21 DNA Homo sapiens 2288ctgtgagtgg satttgtttt g 21 2289 21 DNA Homo sapiens 2289ggtctgcagt kgccacctga a 21 2290 21 DNA Homo sapiens 2290gtgtaacaga mgacgggggt t 21 2291 21 DNA Homo sapiens 2291aggccatcaa satggggcag t 21 2292 21 DNA Homo sapiens 2292gtcaacagta rcctggtgtg c 21 2293 21 DNA Homo sapiens 2293ccttcactta ygaggatccc a 21 2294 21 DNA Homo sapiens 2294acctgtgtgg ytcatgcaga g 21 2295 21 DNA Homo sapiens 2295ctttgggata ytcatgtggg a 21 2296 21 DNA Homo sapiens 2296gagaccttca ycctttacta c 21 2297 21 DNA Homo sapiens 2297tttgaggtgc maggctcagc a 21 2298 21 DNA Homo sapiens 2298ctatgaccag rcagaagacg a 21 2299 21 DNA Homo sapiens 2299ggggctttgg scttcctcct g 21 2300 21 DNA Homo sapiens 2300ggccatccag rccctgtggg c 21 2301 21 DNA Homo sapiens 2301ggaggtcatt sggacaggct c 21 2302 21 DNA Homo sapiens 2302ttcctcaggc rgcgggaggg c 21 2303 21 DNA Homo sapiens 2303agccattgga ytggagtgct a 21 2304 21 DNA Homo sapiens 2304agctgaacct sctgacagag t 21 2305 21 DNA Homo sapiens 2305tttggtgttc ratagcatat t 21 2306 21 DNA Homo sapiens 2306tgaagcaaat scagatactt c 21 2307 21 DNA Homo sapiens 2307gcatcagcca ygatggtaga a 21 2308 21 DNA Homo sapiens 2308tacagaacag rctactcggg t 21 2309 21 DNA Homo sapiens 2309cagcaatggg yatcccctcg g 21 2310 21 DNA Homo sapiens 2310aaatcccgta rtgaatccaa g 21 2311 21 DNA Homo sapiens 2311taacaggaaa ygtgcagttt a 21 2312 21 DNA Homo sapiens 2312agatcagcag kgtagcccgt g 21 2313 21 DNA Homo sapiens 2313cagaagagtc sttcacagct g 21 2314 21 DNA Homo sapiens 2314ctagagaaat wctactttgc t 21 2315 21 DNA Homo sapiens 2315aagtcagtac rgtggatgcc a 21 2316 21 DNA Homo sapiens 2316gaacatgaca raagagtcct t 21 2317 21 DNA Homo sapiens 2317ggaagatcat rgaagttgaa g 21 2318 21 DNA Homo sapiens 2318ttctcttaac saagccatca t 21 2319 21 DNA Homo sapiens 2319tgttggctta ytcattcacg c 21 2320 21 DNA Homo sapiens 2320ggctgccatt ktcattgctc a 21 2321 21 DNA Homo sapiens 2321aaacccttgg rtttttattg g 21 2322 21 DNA Homo sapiens 2322ctgttggagc maccattaac a 21 2323 21 DNA Homo sapiens 2323gactttgtgc ycaacgtcaa g 21 2324 21 DNA Homo sapiens 2324cttctatgtc rcctccagtg a 21 2325 21 DNA Homo sapiens 2325atgcaagtat kttgggctcg c 21 2326 21 DNA Homo sapiens 2326cccagtttgt ycccactgtt t 21 2327 21 DNA Homo sapiens 2327acaggtggcc rtctgcctgg c 21 2328 21 DNA Homo sapiens 2328gtgcttggct kcctctttgc g 21 2329 21 DNA Homo sapiens 2329cctcttccag ycgcagaaga a 21 2330 21 DNA Homo sapiens 2330agcccgacct kggcacctgc t 21 2331 21 DNA Homo sapiens 2331ggacctgtcg ytcatctgcc t 21 2332 21 DNA Homo sapiens 2332accagcggac rctcgacccc c 21 2333 21 DNA Homo sapiens 2333atcgcaaatg macaggacag g 21 2334 21 DNA Homo sapiens 2334tcctgtcttc ytggcaatgt t 21 2335 21 DNA Homo sapiens 2335tgtgcacact rccatgtaag c 21 2336 21 DNA Homo sapiens 2336tgtgctgact wccggggtgt c 21 2337 21 DNA Homo sapiens 2337aagccagagg rgttctcaag t 21 2338 21 DNA Homo sapiens 2338tcatagacta ygatgaacac a 21 2339 21 DNA Homo sapiens 2339cgaactcttg mcaataatcg a 21 2340 21 DNA Homo sapiens 2340aaacaaaccg yatccaccga a 21 2341 21 DNA Homo sapiens 2341gagggcttca rgacgcgaac t 21 2342 21 DNA Homo sapiens 2342attagtccag satctcagct g 21 2343 21 DNA Homo sapiens 2343ttttctctgt kattcaatca c 21 2344 21 DNA Homo sapiens 2344ttaccatgta yaccacctgc a 21 2345 21 DNA Homo sapiens 2345aactcaggcc mcagcagagc c 21 2346 21 DNA Homo sapiens 2346gaagtcgctc wacaactgcc g 21 2347 21 DNA Homo sapiens 2347gtctgagaat raaattccca c 21 2348 21 DNA Homo sapiens 2348gcgtgtccaa ygatgtctgc a 21 2349 21 DNA Homo sapiens 2349tgggcaatcc rtttacatgc t 21 2350 21 DNA Homo sapiens 2350ggatcaagac wctccaagag g 21 2351 21 DNA Homo sapiens 2351gcaaatctgg ycgcacctaa c 21 2352 21 DNA Homo sapiens 2352ctccaagttt rgcatgaaag g 21 2353 21 DNA Homo sapiens 2353gtcggtggcc rcacaatgct g 21 2354 21 DNA Homo sapiens 2354tccttaagga yaactaacat t 21 2355 21 DNA Homo sapiens 2355aggatgccag ygacaatgca c 21 2356 21 DNA Homo sapiens 2356ggacctcaac magttcctca g 21 2357 21 DNA Homo sapiens 2357agcatgggga yctcaacaag t 21 2358 21 DNA Homo sapiens 2358gtaatgaaat yccttccaca g 21 2359 21 DNA Homo sapiens 2359tactaaaata yatgttacca a 21 2360 21 DNA Homo sapiens 2360catttgttca scacatcaag c 21 2361 21 DNA Homo sapiens 2361cacgcaagga yttccaccgt g 21 2362 21 DNA Homo sapiens 2362ctgtcattat yggaatgacc a 21 2363 21 DNA Homo sapiens 2363attggaatga scaagatccc t 21 2364 21 DNA Homo sapiens 2364ccagtacttt kgcatcacca a 21 2365 21 DNA Homo sapiens 2365gacataacat kgttctgaaa a 21 2366 21 DNA Homo sapiens 2366aaatctggcc kcacctaacc t 21 2367 21 DNA Homo sapiens 2367tgctgcccat ycgctggatg c 21 2368 21 DNA Homo sapiens 2368gatgctgcat wtagcccagc a 21 2369 21 DNA Homo sapiens 2369cgtcccagca mttcgtgcac c 21 2370 21 DNA Homo sapiens 2370cccattcgct rgatgcctcc a 21 2371 21 DNA Homo sapiens 2371tttggccacc mggaactgcc t 21 2372 21 DNA Homo sapiens 2372ggagaacttg ytggtgaaaa t 21 2373 21 DNA Homo sapiens 2373gggatgtcgt yctggataag g 21 2374 21 DNA Homo sapiens 2374tgtattggga ygttggtaac c 21 2375 21 DNA Homo sapiens 2375ggtataagag ycgccctgtc g 21 2376 21 DNA Homo sapiens 2376ccggagctgc rggaggccta c 21 2377 21 DNA Homo sapiens 2377tgcaattcaa ygcagtccga a 21 2378 21 DNA Homo sapiens 2378tgcacacagt rgaccacgtg g 21 2379 21 DNA Homo sapiens 2379acgtccggaa maaactgaag a 21 2380 21 DNA Homo sapiens 2380agcaagccct yagtgagatt g 21 2381 21 DNA Homo sapiens 2381gctgaattaa ragtggccta a 21 2382 21 DNA Homo sapiens 2382attgaggaaa ytcggcttaa c 21 2383 21 DNA Homo sapiens 2383cagctgacac rggatgatga t 21 2384 21 DNA Homo sapiens 2384ccggaagaaa ytgataatta t 21 2385 21 DNA Homo sapiens 2385tacagtatca ytctctctgc a 21 2386 21 DNA Homo sapiens 2386acttccagtc wgtcacctcc a 21 2387 21 DNA Homo sapiens 2387atttcgtgag rgccaagggc a 21 2388 21 DNA Homo sapiens 2388tccagatcaa ygttatcccc a 21 2389 21 DNA Homo sapiens 2389attctggcct wgatgaagtg g 21 2390 21 DNA Homo sapiens 2390agtccctgtc sccttcagga t 21 2391 21 DNA Homo sapiens 2391aagggaagaa rgtctggata g 21 2392 21 DNA Homo sapiens 2392gggagagcct rcgacaggga a 21 2393 21 DNA Homo sapiens 2393gcccaaatac kggaaataaa a 21 2394 21 DNA Homo sapiens 2394tcgtgcgcaa ygtgccctgg g 21 2395 21 DNA Homo sapiens 2395ctggggccac rtgccccaca g 21 2396 21 DNA Homo sapiens 2396gcagtgctgc maagctaaag a 21 2397 21 DNA Homo sapiens 2397ttaccttggt rttcccattg t 21 2398 21 DNA Homo sapiens 2398acagcttgtt raaaaaaagc t 21 2399 21 DNA Homo sapiens 2399gagcagtttt yggaggccag c 21 2400 21 DNA Homo sapiens 2400cggaggagtt sgtgccccag g 21 2401 21 DNA Homo sapiens 2401gagctcagaa ygtctctaag g 21 2402 21 DNA Homo sapiens 2402agagccagcg rgttgtgctg c 21 2403 21 DNA Homo sapiens 2403gaccacttaa ytgagcgact a 21 2404 21 DNA Homo sapiens 2404ctgcaaggca rcctggaaac t 21 2405 21 DNA Homo sapiens 2405tggtggtgat ycctgcagag g 21 2406 21 DNA Homo sapiens 2406gctggagcca statctggcc t 21 2407 21 DNA Homo sapiens 2407aaggatgaga rggaccactt a 21 2408 21 DNA Homo sapiens 2408actgcgcacc ygaaattctt a 21 2409 21 DNA Homo sapiens 2409agagccacaa rgctagccga g 21 2410 21 DNA Homo sapiens 2410catgttcagg wgaattctga a 21 2411 21 DNA Homo sapiens 2411tggcctcttc scgcctggga a 21 2412 21 DNA Homo sapiens 2412atgacattcc ygatcgtcca g 21 2413 21 DNA Homo sapiens 2413atagccttcc ytaatccata c 21 2414 21 DNA Homo sapiens 2414cattggagcg rtcgcaggaa g 21 2415 21 DNA Homo sapiens 2415atattttccg raagctggga c 21 2416 21 DNA Homo sapiens 2416gccattgaag yttcgaagca t 21 2417 21 DNA Homo sapiens 2417tcccttagct ktcctgacac a 21 2418 21 DNA Homo sapiens 2418catcatcaga rgttacttgg g 21 2419 21 DNA Homo sapiens 2419agtagtaaca ytaacaggat t 21 2420 21 DNA Homo sapiens 2420caatggagat ygtggtggat a 21 2421 21 DNA Homo sapiens 2421gagaggttga ycaggaaata c 21 2422 21 DNA Homo sapiens 2422ccctcccagg ytaagctgcg g 21 2423 21 DNA Homo sapiens 2423ctcacgcaag scgaagacca g 21 2424 21 DNA Homo sapiens 2424tcaacacctc ytccttgctg g 21 2425 21 DNA Homo sapiens 2425gagctaagcc rgggcaagct c 21 2426 21 DNA Homo sapiens 2426ctaagccggg kcaagctcta t 21 2427 21 DNA Homo sapiens 2427tcttcacggg rtactacggg a 21 2428 21 DNA Homo sapiens 2428gggtcatgag ygtctgtctg c 21 2429 21 DNA Homo sapiens 2429tgctgcccat ycgctggatg g 21 2430 21 DNA Homo sapiens 2430aagatctggt yagtcttgat t 21 2431 21 DNA Homo sapiens 2431taccaggagc yccggcctcg t 21 2432 21 DNA Homo sapiens 2432cgccccactc ygctccctgt g 21 2433 21 DNA Homo sapiens 2433tggagaacgg ygacctcaac c 21 2434 21 DNA Homo sapiens 2434tgaaagcttt kacctggagc c 21 2435 21 DNA Homo sapiens 2435ccacgcgatt satcaggatc t 21 2436 21 DNA Homo sapiens 2436gaccttctgg yatcacatgt c 21 2437 21 DNA Homo sapiens 2437ttcccaagct kacgaaaatc a 21 2438 21 DNA Homo sapiens 2438ttttttacac ygacagcgcg a 21 2439 21 DNA Homo sapiens 2439acttgggcct yctgcgcttt g 21 2440 21 DNA Homo sapiens 2440gaaatctggg mtggattccc t 21 2441 21 DNA Homo sapiens 2441cagaatggag stgctgggct g 21 2442 21 DNA Homo sapiens 2442ttgtctttgc rccaaagatg t 21 2443 21 DNA Homo sapiens 2443tgggtcccac rtcggcacac t 21 2444 21 DNA Homo sapiens 2444ggattgctaa ygaacagatc a 21 2445 21 DNA Homo sapiens 2445atgacacccc kgacatccga a 21 2446 21 DNA Homo sapiens 2446tggcactcag rtatcgccct c 21 2447 21 DNA Homo sapiens 2447atggctacta ygtcaaatcc t 21 2448 21 DNA Homo sapiens 2448gttcatcgac rgggatcctc t 21 2449 21 DNA Homo sapiens 2449gcaacctcag kgtctggcgc c 21 2450 21 DNA Homo sapiens 2450gctatatcac ytctcccggt t 21 2451 21 DNA Homo sapiens 2451cttttgcagt kgacatccca g 21 2452 21 DNA Homo sapiens 2452ttgcagtgga satcccagaa a 21 2453 21 DNA Homo sapiens 2453aaggatatga rgatgaaatt g 21 2454 21 DNA Homo sapiens 2454agatgaaatt katgatgaat a 21 2455 21 DNA Homo sapiens 2455tcgttcatcg wcggggatcc t 21 2456 21 DNA Homo sapiens 2456atggcggtgg ycaaggatgg c 21 2457 21 DNA Homo sapiens 2457acaatgggaa raaatcagta g 21 2458 21 DNA Homo sapiens 2458actggttcat rgccgtctgt t 21 2459 21 DNA Homo sapiens 2459tgtcagcaag rttgacaaaa t 21 2460 21 DNA Homo sapiens 2460caaaagaaag rcatcaaagc c 21 2461 21 DNA Homo sapiens 2461agaacaaatg mtttggttca c 21 2462 21 DNA Homo sapiens 2462aattacgatg yttcagctgc a 21 2463 21 DNA Homo sapiens 2463aaggctatga yattcgtctg a 21 2464 21 DNA Homo sapiens 2464ctctgggtgc ytgataccta t 21 2465 21 DNA Homo sapiens 2465ctggatggaa sctacagtga g 21 2466 21 DNA Homo sapiens 2466accaccatca ycacgggcgt g 21 2467 21 DNA Homo sapiens 2467cgtctcctac rtcaaggccg t 21 2468 21 DNA Homo sapiens 2468gtcctgctcc mgttcaccac t 21 2469 21 DNA Homo sapiens 2469gataacagca mgccacattt g 21 2470 21 DNA Homo sapiens 2470ctgggtagtg yaacgtgcaa g 21 2471 21 DNA Homo sapiens 2471ctggcctctt yaccgtggag a 21 2472 21 DNA Homo sapiens 2472ctaccccaac mcagaaacta c 21 2473 21 DNA Homo sapiens 2473gtgtgcccca ragtccgagc c 21 2474 21 DNA Homo sapiens 2474atcagcttct rcatgctctg t 21 2475 21 DNA Homo sapiens 2475accacctgga ygagtttaaa a 21 2476 21 DNA Homo sapiens 2476ccggctccaa ygccaacatc a 21 2477 21 DNA Homo sapiens 2477cttcacatag yccttttggt a 21 2478 21 DNA Homo sapiens 2478aagaggaccc wgctccatgt g 21 2479 21 DNA Homo sapiens 2479gctggacaga ygtgctctac t 21 2480 21 DNA Homo sapiens 2480ggcaagttta wttttgatga a 21 2481 21 DNA Homo sapiens 2481tgctgagcag ygctgccctg g 21 2482 21 DNA Homo sapiens 2482ttgaagatga yaacttttgg a 21 2483 21 DNA Homo sapiens 2483actgggttac yttgactatg c 21 2484 21 DNA Homo sapiens 2484tgcctctcaa yagtgacggg a 21 2485 21 DNA Homo sapiens 2485tgctttggtt ygaacggctc t 21 2486 21 DNA Homo sapiens 2486cagatatcgt rgctgaagag g 21 2487 21 DNA Homo sapiens 2487accaagcgga kcacctttga c 21 2488 21 DNA Homo sapiens 2488tcaccttttt ycgtcttttc c 21 2489 21 DNA Homo sapiens 2489gctacagcga ygaagagcca g 21 2490 21 DNA Homo sapiens 2490cccgagccaa yggggatgtg g 21 2491 21 DNA Homo sapiens 2491tacatcgagc rtgcttcatg a 21 2492 21 DNA Homo sapiens 2492gccactacat ygtgaacctg c 21 2493 21 DNA Homo sapiens 2493atgtagatca ygagaaaaac a 21 2494 21 DNA Homo sapiens 2494agaacgagaa ygaacgctgc g 21 2495 21 DNA Homo sapiens 2495tatggacccc rccgatgacg g 21 2496 21 DNA Homo sapiens 2496atgacggaca kttccaagaa c 21 2497 21 DNA Homo sapiens 2497gctggcagga rgccttgatg a 21 2498 21 DNA Homo sapiens 2498ccctcctttc ytacagctcc c 21 2499 21 DNA Homo sapiens 2499aacgctttgg saaccaacaa a 21 2500 21 DNA Homo sapiens 2500tgacttcatc rccgtgattg g 21 2501 21 DNA Homo sapiens 2501ttgatgccct ytgatgaggc c 21 2502 21 DNA Homo sapiens 2502tggacaggat yttcacagcg t 21 2503 21 DNA Homo sapiens 2503aggctctctt ygacttcctc a 21 2504 21 DNA Homo sapiens 2504catgcggcct rtggtgctgg t 21 2505 21 DNA Homo sapiens 2505actctgccta ygtagagcca a 21 2506 21 DNA Homo sapiens 2506catttgactc rgaaacccag g 21 2507 21 DNA Homo sapiens 2507ccaattgaaa racgaagtct a 21 2508 21 DNA Homo sapiens 2508ggagcaggtt kaaaagatcc g 21 2509 21 DNA Homo sapiens 2509acacttacaa rccccatagg a 21 2510 21 DNA Homo sapiens 2510tcctgcacgg ygggcaaccc c 21 2511 21 DNA Homo sapiens 2511acacacacca ycgctcaccc a 21 2512 21 DNA Homo sapiens 2512aagattttta yagaagacat t 21 2513 21 DNA Homo sapiens 2513acacttcaga ygtggtgatt g 21 2514 21 DNA Homo sapiens 2514ctggaacccc rctgattttg g 21 2515 21 DNA Homo sapiens 2515aagttatacg ygttccttca g 21 2516 21 DNA Homo sapiens 2516ccattagata matttcgaga c 21 2517 21 DNA Homo sapiens 2517gatactactc rgcgctgcga c 21 2518 21 DNA Homo sapiens 2518gaaaacgatc yagcccagag a 21 2519 21 DNA Homo sapiens 2519gcgactgggg ytgtccggac t 21 2520 21 DNA Homo sapiens 2520tggtcttcat ygtcacttcc t 21 2521 21 DNA Homo sapiens 2521tgatgtgtgt ractgtgagg c 21 2522 21 DNA Homo sapiens 2522gccgctgacc kccgtctaca c 21 2523 21 DNA Homo sapiens 2523tggaggagtc rgagcatctg c 21 2524 21 DNA Homo sapiens 2524cctccacctg ygtcaaccca t 21 2525 21 DNA Homo sapiens 2525agttcctggc rgataaggtg g 21 2526 21 DNA Homo sapiens 2526gggcttcatc ytggtctgtt a 21 2527 21 DNA Homo sapiens 2527catctaccgg ygcctgcaga g 21 2528 21 DNA Homo sapiens 2528gtgatggtgg wggcctttgc c 21 2529 21 DNA Homo sapiens 2529tggcctttgc ygtgctctgg c 21 2530 21 DNA Homo sapiens 2530caacagcctg raagactggc a 21 2531 21 DNA Homo sapiens 2531ccatctgcca ygggaacctc a 21 2532 21 DNA Homo sapiens 2532tgactcatgc ytactggggc a 21 2533 21 DNA Homo sapiens 2533accacccagc rtctaataca a 21 2534 21 DNA Homo sapiens 2534gagcccttcc rcaacctctc t 21 2535 21 DNA Homo sapiens 2535aaggtacttg ygttcagaaa a 21 2536 21 DNA Homo sapiens 2536tccacactct kcctgtgtca g 21 2537 21 DNA Homo sapiens 2537taaggaccag raagacaagg c 21 2538 21 DNA Homo sapiens 2538gggcctattc kcattgccgg a 21 2539 21 DNA Homo sapiens 2539cttagatggc racctgtccg a 21 2540 21 DNA Homo sapiens 2540atgtatgaga kttgggtgcc a 21 2541 21 DNA Homo sapiens 2541gacaggatgt rgcccggttt a 21 2542 21 DNA Homo sapiens 2542tggaggagga rtttaactac c 21 2543 21 DNA Homo sapiens 2543caaataagac mtactccttc c 21 2544 21 DNA Homo sapiens 2544caatctgggc katgagatca a 21 2545 21 DNA Homo sapiens 2545cagaattact rgcctcgatc c 21 2546 21 DNA Homo sapiens 2546ctggtcgaag mattggaatc c 21 2547 21 DNA Homo sapiens 2547gacttggaga wgtggaccag c 21 2548 21 DNA Homo sapiens 2548aataagaagt saggctgaaa c 21 2549 21 DNA Homo sapiens 2549taagaagtca rgctgaaact g 21 2550 21 DNA Homo sapiens 2550aggctgaaac ygggcgaatc t 21 2551 21 DNA Homo sapiens 2551gaaactgggc raatctacag a 21

Claims

1. A method for predicting the likelihood that a human will have myocardial infraction, comprising:determining the nucleotide present at nucleotide position 1186 of the thrombospondin-4 gene having the nucleotide sequence of SEQ ID NO: 3 in a nucleic acid sample obtained from a human, wherein presence of a C at nucleotide position 1186 is indicative of increased likelihood of a myocardial infraction in the human as compared with a human having a G at nucleotide position 1186, thereby predicting the likelihood that a human will have myocardial infraction.

2. A method for predicting the likelihood that a human will have coronary revascularization, comprising:determining the nucleotide present at nucleotide position 1186 of the thrombospondin-4 gene having the nucleotide sequence of SEQ ID NO: 3 from a nucleic acid sample obtained from a human, wherein presence of a C at nucleotide position 1186 is indicative of increased likelihood of a coronary revascularization in the human as compared with a human having a G at nucleotide position 1186, thereby predicting the likelihood that a human will have coronary revascularization.

3. A method for predicting the likelihood that a human will have myocardial infraction, comprising:determining the nucleotide present at nucleotide position 1186 of the thrombospondin-4 gene having the nucleotide sequence of SEQ ID NO: 3 in a nucleic acid sample obtained form a human, wherein presence of a G at nucleotide position 1186 is indicative of decreased likelihood of a myocardial infraction in the human as compared with a human having a C at nucleotide position 1186, thereby predicting the likelihood that a human will have myocardial infraction.

4. A method for predicting the likelihood that a human will have coronary revascularization, comprising:determining the nucleotide present at nucleotide position 1186 of the thrombospondin-4 gene having the nucleotide sequence of SEQ ID NO: 3 from a nucleic acid sample obtained from a human, wherein presence of a G at nucleotide position 1186 is indicative of decreased likelihood of a coronary revascularization in the human as compared with a human having a C at nucleotide position 1186, thereby predicting the likelihood that a human will have coronary revascularization.